Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,response to copper ion (GO:0046688),0.9128558511307795,2.4032955766725115,0.0,0.0,0.0,8/20,0.13%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H
prerank,response to cadmium ion (GO:0046686),0.8333328754258109,2.34915074593425,0.0,0.0,0.0,9/26,0.81%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;MAPK3
prerank,zinc ion homeostasis (GO:0055069),0.8251234210994787,2.3474473746523055,0.0,0.0,0.0,8/28,0.13%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H
prerank,cellular zinc ion homeostasis (GO:0006882),0.8283635465653008,2.3276804574450223,0.0,0.0,0.0,8/26,0.13%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H
prerank,cellular response to copper ion (GO:0071280),0.9308633190276521,2.3082996750148133,0.0,0.0,0.0,8/16,0.13%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H
prerank,cellular response to cadmium ion (GO:0071276),0.835880482387235,2.3034383960687657,0.0,0.0,0.0,9/24,0.81%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;MAPK3
prerank,response to zinc ion (GO:0010043),0.8403619309321468,2.289695579329407,0.0,0.0,0.0,8/25,0.13%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H
prerank,cellular response to zinc ion (GO:0071294),0.9132975046816668,2.2240661907365373,0.0,0.0,0.0,8/15,0.13%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H
prerank,cellular potassium ion homeostasis (GO:0030007),-0.8348636419012023,-2.0577212314060467,0.0,0.07470543898085988,0.062,8/13,9.45%,ATP1A2;KCNMA1;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7509660799586869,-2.042817598495921,0.0,0.04980362598723992,0.079,9/17,10.60%,ATP1A2;CACNA1C;ATP1B1;ATP1A1;GJC1;GJD3;ATP1B2;PRKACA;GJA1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.7788925511538322,-2.027788332196425,0.0,0.04074842126228721,0.094,6/14,10.09%,ANK2;ATP1B1;ATP1B3;AKAP9;ATP1B2;ACTN2
prerank,regulation of NMDA receptor activity (GO:2000310),-0.6250751414170403,-2.0137986862877453,0.0,0.039899495819322894,0.121,19/32,22.22%,DLG2;LRRC7;GRIA4;GRIA2;GRIN2B;DLG4;RELN;SLC6A9;NLGN1;DLG3;ACTN2;EPHB2;DLG1;NEFL;OPRM1;DAPK1;GRIN1;CAMK2B;CAPN1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.536681614722545,-1.975545965680353,0.0,0.05795331023969735,0.201,32/57,24.99%,DLG2;DLGAP1;LRRC7;GRIA4;GRIA2;GRIN2B;DLGAP2;SHISA9;DLG4;DLGAP4;NLGN2;RELN;SHISA6;AKAP9;NLGN1;DLG3;ACTN2;CACNG7;DLG1;NEFL;CACNG4;OPRM1;CACNG2;DAPK1;SHANK1;PRRT1;GRIN1;CAMK2B;CAPN1;CACNG3;CACNG8;CAMK2A
prerank,digestive tract development (GO:0048565),-0.6038440857229574,-1.9626120439515313,0.0,0.05885883071219263,0.235,12/32,9.91%,FGFR2;CLMP;PKD1;GLI2;GLI3;RARB;PCSK5;KIT;SMO;COBL;NIPBL;SALL1
prerank,chondrocyte differentiation (GO:0002062),-0.6152505751868078,-1.9531451609053998,0.0023752969121140144,0.05902053079656678,0.265,20/32,29.17%,SULF1;NFIB;WNT5B;SOX5;SULF2;BMP4;OSR1;SLC39A14;CREB3L2;GPLD1;TGFB1;BMPR1B;CCN3;SOX6;BMPR2;EIF2AK3;RUNX2;SNX19;BMP2;HMGA2
prerank,mesonephric tubule development (GO:0072164),-0.7311210368231502,-1.9345879423298709,0.002188183807439825,0.06876296088010966,0.335,8/15,9.91%,ROBO2;FGFR2;PKD1;BMP7;BMP4;OSR1;FOXC1;SALL1
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6617486128161331,-1.9150269339953039,0.0,0.0836348769735216,0.424,15/20,27.99%,IGF1;LRP1;PDGFRB;IGFBP5;NRP1;SORL1;VTN;S100A11;ACE;BMPR1A;PDGFA;NDRG4;SERPINE1;CCN4;TRIB1
prerank,eye morphogenesis (GO:0048592),-0.6779118845992776,-1.912541912816913,0.0,0.07866709104802669,0.437,10/19,7.76%,TENM3;FBN1;COL5A1;COL5A2;EFEMP1;FBN2;NKD1;SKI;MFAP5;NIPBL
prerank,ureteric bud development (GO:0001657),-0.6879025137208493,-1.9116108903330704,0.0,0.07213293763854377,0.44,8/17,9.91%,ROBO2;FGFR2;BMP7;BMP4;OSR1;GPC3;FOXC1;SALL1
prerank,cardiac muscle cell action potential (GO:0086001),-0.59369438418215,-1.900796902389211,0.0,0.07649761491600678,0.494,9/30,8.73%,ANK2;ATP1A2;FGF12;CACNA1C;CACNA1D;ATP1B1;ATP1A1;KCNJ2;SCN1A
prerank,cardiac muscle cell contraction (GO:0086003),-0.6748898932458887,-1.8943742414738016,0.0,0.07775286364791127,0.532,9/19,13.06%,FGF12;CACNA1C;CACNA1D;GSN;ATP1A1;KCNJ2;SCN1A;CAMK2D;CACNA1G
prerank,cellular transition metal ion homeostasis (GO:0046916),0.5478528603858601,1.8922570580689528,0.0,0.12623731296275154,0.651,22/91,12.10%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;CAND1;HMOX2;SOD1;ABCG2;FBXL5;ATP6V0D1;ISCU;ARF1;GLRX3;ATP6AP1;SLC39A10;APP;PRNP;ACO1
prerank,extracellular structure organization (GO:0043062),-0.4240118091058492,-1.890671439597549,0.0,0.07632243982460142,0.55,83/204,21.06%,LAMA2;COL1A2;FBN1;COL4A5;ADAMTS12;ADAMTSL3;ADAMTS2;ITGA9;ADAM12;COL1A1;THSD4;SMOC1;TNR;COL4A6;COL8A1;ITGB8;COL3A1;COL11A1;COL22A1;MMP16;TGFBR1;COL5A1;COL4A3;ADAMTS6;COL5A2;ADAMTSL5;LAMC3;COL4A4;LOXL1;FBN2;NID2;JAM3;ADAMTS17;VCAN;MMP14;ADAMTS9;ATP7A;ITGB5;ADAM19;ADAMTS5;COL6A1;DDR1;HSPG2;ITGA5;COL8A2;MFAP5;SH3PXD2A;COL15A1;COL13A1;SPARC;ADAMTS1;COL6A2;ADAMTSL4;SMOC2;THBS1;VTN;CDH1;ITGA11;FN1;ADAMTS3;SLC39A8;ITGA8;COL23A1;COL6A3;ADAMTS10;SPP1;ITGB4;COL5A3;LAMA1;LAMB1;VIT;ITGA4;TGFBI;ADAMTS15;COL14A1;ADAMTS16;MMP2;LUM;PDGFA;ITGA1;ADAMTS20;COL16A1;COL18A1
prerank,regulation of potassium ion transport (GO:0043266),-0.587999162563095,-1.8847782342209671,0.002551020408163265,0.0785539009889648,0.595,11/31,12.92%,ANK2;DPP6;ANK3;KCNIP4;CACNA1D;FHL1;KCNIP1;KCNIP3;ACTN2;DPP10;DLG1
prerank,regulation of cytoplasmic translation (GO:2000765),-0.7331639616827517,-1.8734097879844962,0.006521739130434782,0.08411436264038107,0.628,6/14,13.90%,CPEB4;CPEB1;CPEB2;YBX3;PKM;UNK
prerank,regulation of cellular localization (GO:0060341),-0.5445812218117936,-1.8713809719300991,0.0,0.08182975446299179,0.642,20/46,21.05%,MAP2;ADCY5;GSN;EFNA5;DYNC1H1;PARD6G;FER;LRP5;CDK16;CSNK1E;DVL3;BRSK1;CAMK2D;STXBP4;KDM1A;TTL;DVL1;PARP1;PINK1;PPM1F
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6522161585200981,-1.868998532100053,0.0,0.07954745817406376,0.653,13/21,27.12%,BMP6;DAB2;TGFBR1;SMAD4;BMP4;NUP93;TGFB1;CCN3;WWTR1;BMPR1A;TGFB3;SLC2A10;SH2B1
prerank,synaptic membrane adhesion (GO:0099560),-0.7284505618383044,-1.8669263212880491,0.0021645021645021645,0.07744582988446398,0.66,7/14,11.23%,LRRC4C;LRFN5;GPC6;NTNG1;PTPRS;PTPRF;LRRC4
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7714045869185935,-1.8646153564194758,0.0,0.07549776939429323,0.672,6/11,16.23%,DDX5;EGFR;BMP4;MAP2K2;TP53;TGFB1
prerank,membrane repolarization (GO:0086009),-0.7129700561873418,-1.864365313909383,0.002183406113537118,0.07222603768712282,0.673,6/15,9.45%,ATP1A2;ATP1B1;ATP1B3;ATP1A1;KCNJ2;ATP1B2
prerank,external encapsulating structure organization (GO:0045229),-0.4174860625472044,-1.8519152481477477,0.0,0.08278309319573247,0.734,82/205,21.06%,LAMA2;COL1A2;FBN1;COL4A5;ADAMTS12;ADAMTSL3;ADAMTS2;ITGA9;ADAM12;COL1A1;THSD4;SMOC1;TNR;COL4A6;COL8A1;ITGB8;COL3A1;COL11A1;COL22A1;MMP16;COL5A1;COL4A3;ADAMTS6;COL5A2;ADAMTSL5;LAMC3;COL4A4;LOXL1;FBN2;NID2;JAM3;ADAMTS17;VCAN;MMP14;ADAMTS9;ATP7A;ITGB5;ADAM19;ADAMTS5;COL6A1;DDR1;HSPG2;ITGA5;COL8A2;MFAP5;SH3PXD2A;COL15A1;COL13A1;SPARC;ADAMTS1;COL6A2;ADAMTSL4;SMOC2;THBS1;VTN;CDH1;ITGA11;FN1;ADAMTS3;SLC39A8;ITGA8;COL23A1;COL6A3;ADAMTS10;SPP1;ITGB4;COL5A3;LAMA1;LAMB1;VIT;ITGA4;TGFBI;ADAMTS15;COL14A1;ADAMTS16;MMP2;LUM;PDGFA;ITGA1;ADAMTS20;COL16A1;COL18A1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.6329923735442717,-1.8485685097482716,0.004514672686230248,0.08380985677496995,0.752,5/21,8.13%,ANK2;CACNA1D;SNTA1;FLNA;AKAP9
prerank,collagen fibril organization (GO:0030199),-0.464140719849336,-1.8441682913021877,0.0,0.08607160741165991,0.774,42/88,22.17%,COL1A2;COL4A5;ADAMTS2;COL1A1;COL4A6;COL8A1;COL3A1;COL11A1;PLOD2;COL25A1;COL22A1;TGFBR1;COL5A1;PLEC;COL4A3;COL5A2;COL4A4;LOXL1;COL12A1;ATP7A;COL6A1;COL8A2;P4HB;COL15A1;COL13A1;PLOD1;COL6A2;ADAMTS3;LOXL3;COL23A1;COL6A3;ITGB4;COL5A3;P4HA2;COL20A1;COL14A1;LUM;COL16A1;COL18A1;P3H1;LOX;CRTAP
prerank,positive regulation of chemotaxis (GO:0050921),-0.5381002813732785,-1.8418738081152444,0.0,0.08525475248542978,0.787,19/43,22.30%,NTRK3;PDGFRB;NRP1;DSCAM;IL6R;P2RX4;F3;STX3;SMOC2;THBS1;LGMN;TGFB1;SEMA5A;MET;HSPB1;PPM1F;PRKD1;P2RY12;VEGFA
prerank,embryonic digestive tract development (GO:0048566),-0.6615276590537215,-1.8382486034253447,0.0,0.08497961357263314,0.798,8/18,9.91%,FGFR2;GLI2;GLI3;RARB;PCSK5;PDGFRA;NIPBL;SALL1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.6171089774583877,-1.8365640241019792,0.004830917874396135,0.08397025492629762,0.805,11/24,9.78%,ROBO2;FGFR2;ROBO1;PARVA;NRP1;TGFBR2;SMAD4;BMP4;SMAD6;ACVR1;NRP2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5080688323266996,1.8342812285265797,0.0,0.2678553801368847,0.897,54/110,19.90%,NCBP1;RPL30;RPL17;RPL23;RPL31;SMG8;RPL3;RPS21;PPP2CA;SMG1;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;PYM1;RPL4;RPLP0;UPF2;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;RPS11;RPS3;RPS15A;RPL23A;RPL21;RPL35;DCP1A;UPF3B;RPL19;RPL38;RPL36;SMG6;RPSA;RPL26;RPS8;SMG5;RPL15;RPL10;RPL32;RPS2;EIF4G1;RPL27A;EIF3E;RPL7;RPL39;RPL14;SMG7
prerank,negative regulation of growth (GO:0045926),0.5032030803722989,1.8274976769979416,0.0,0.2687064491486409,0.916,18/121,5.65%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;CCDC85B;PTPRJ;FRZB;ST7L;RERG;PPT1;ING4;PPP2CA;SMARCA2;CDKN1A
prerank,receptor clustering (GO:0043113),-0.5901876687308534,-1.816774084397639,0.0023752969121140144,0.10336677893617896,0.871,10/27,12.92%,MAGI2;DLG2;LRRC7;NRXN1;DLG4;FLNA;NLGN1;DLG3;NRXN2;DLG1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7595359911095005,-1.801692536725666,0.004415011037527594,0.12080111475745106,0.927,5/11,9.35%,DAB2;WNT5B;NKD1;CSNK1E;RSPO3
prerank,cytoplasmic translation (GO:0002181),0.5123423351654239,1.7983549095703937,0.0,0.36515405147605506,0.968,45/91,19.87%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;RPL4;EIF2B3;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;DRG2;RPS11;RPS3;RPS15A;RPL23A;RPL21;RPL35;EIF3M;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;RPL27A;FTSJ1;RPL7;RPL39;RPL14
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.52446579476718,-1.7978636016944218,0.0,0.12262256398373465,0.941,20/43,26.36%,FOXP1;IGF1;PDGFRB;IGFBP5;IL6R;BMP4;ADAMTS1;THBS1;GJA1;IL18;RBPMS2;JUN;BMPR1A;DNMT1;STAT1;MMP2;CX3CL1;AKT1;MEF2D;CCN4
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6687717764075536,-1.7954924154215814,0.00847457627118644,0.1224278283982518,0.943,6/16,13.52%,IGF1;IGFBP5;IGFBP2;BMP5;IGFBP6;IGFBP4
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7824835868721327,1.7891400865233549,0.005940594059405941,0.38223104675115466,0.98,6/11,14.46%,TNFAIP3;TIRAP;LYN;PJA2;MFHAS1;CYBA
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5761551671298178,-1.7857286107928263,0.002506265664160401,0.1335642696930525,0.958,11/29,13.20%,DPP6;FGF12;KCNIP4;CACNA1D;SNTA1;KCNIP1;WNK1;KCNIP3;DPP10;DLG1;WNK3
prerank,endodermal cell differentiation (GO:0035987),-0.5502653372436099,-1.7855758141528746,0.007075471698113208,0.12965406765273202,0.958,14/31,19.90%,COL8A1;COL11A1;MMP14;COL12A1;ITGB5;COL6A1;ITGA5;CDC73;VTN;FN1;PAF1;LAMB1;ITGA4;MMP2
prerank,melanocyte differentiation (GO:0030318),-0.7368817951866828,-1.7848122193452816,0.0,0.12703919570007186,0.958,4/11,5.42%,LRMDA;KIT;USP13;ENPP1
prerank,respiratory tube development (GO:0030323),-0.563146140425328,-1.7830993219335831,0.0,0.12644946598058968,0.961,12/28,23.36%,FGFR2;GLI2;PCSK5;FGF1;PDPN;BMP4;RBP4;LOXL3;CCDC39;BAG6;VEGFA;STRA6
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.7032829488941656,-1.7801749368819941,0.0,0.12784188337381158,0.968,10/13,27.12%,BMP6;DAB2;TGFBR1;SMAD4;BMP4;NUP93;TGFB1;BMPR1A;TGFB3;SH2B1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.5708840774715591,-1.7787985089088363,0.004750593824228029,0.12671168233362884,0.969,11/30,13.06%,ANK2;FGF12;CACNA1C;CACNA1D;SNTA1;ATP1A1;GJC1;KCNJ2;SCN1A;GJA1;CACNA1G
prerank,cartilage development (GO:0051216),-0.5003845045400077,-1.7784910483887957,0.0,0.12406226210338173,0.969,17/49,17.75%,SULF1;NFIB;PKD1;ITGB8;WNT5B;SOX5;SULF2;BMP4;OSR1;ATP7A;SLC39A14;CREB3L2;DDRGK1;GPLD1;TGFB1;CCN3;SOX6
prerank,aorta development (GO:0035904),-0.6944521535117394,-1.778377723630762,0.0021413276231263384,0.12102629392004105,0.969,6/14,5.49%,ROBO2;LRP1;ROBO1;PDGFRB;HECTD1;ADAMTS9
prerank,peptide biosynthetic process (GO:0043043),0.46918686747212546,1.770064205760351,0.0,0.4541297164325727,0.992,62/153,19.87%,PCSK1;RPL30;MRPS33;RSL24D1;EEF1A1;MRPL23;RPL17;RPL23;MRPL24;RPL31;RPL3;RPS21;MRPL18;RPL35A;RPS14;RPL8;YARS2;RPL5;ABCF1;MRPS12;RPS12;HBS1L;RPS26;RPL37A;HARS1;RPL4;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;DMD;RPS11;MRPL52;RPS3;MRPS15;DHPS;RPS15A;RPL23A;RPL21;RPL35;HARS2;WARS1;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;EIF4G1;MRPL13;RPL27A;FURIN;RPL7;RPL39;RPL14
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5113282998751225,1.7695388936427028,0.0,0.42676290969439634,0.992,43/87,19.87%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;RPL4;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;RPS11;RPS3;RPS15A;RPL23A;SEC61A2;RPL21;SRP9;RPL35;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;RPL27A;RPL7;RPL39;RPL14
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.7359460087807879,1.7602083832208426,0.0071174377224199285,0.445990114831753,0.996,8/13,14.52%,SAE1;UBA1;UBA2;DESI2;DESI1;NAE1;ATG7;UBA6
prerank,bone morphogenesis (GO:0060349),-0.6921009674157996,-1.7601914407842998,0.004228329809725159,0.14533603583549104,0.983,8/14,19.93%,FGFR2;SKI;LRP5;CYP26B1;LRP6;BMPR1B;SFRP4;BMPR2
prerank,lung development (GO:0030324),-0.5355019169727769,-1.750405611033961,0.0,0.15879737066441466,0.985,14/33,23.36%,FGFR2;PKD1;GLI2;ERRFI1;FGF1;PDPN;BMP4;RBP4;LOXL3;RCN3;CCDC39;BAG6;VEGFA;STRA6
prerank,protein targeting to ER (GO:0045047),0.49101796288925537,1.739499666244008,0.0,0.5394640183598808,0.998,46/99,19.87%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;SGTB;RPL8;RPL5;SPCS3;RPS12;RPS26;RPL37A;RPL4;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;RPS11;SEC62;RPS3;RPS15A;SPCS2;RPL23A;RPL21;SRP9;RPL35;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;RPL27A;RPL7;RPL39;RPL14
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.45505330310277625,1.737376908858446,0.0,0.5207541634339425,0.998,87/168,21.53%,NCBP1;RPL30;RPL17;RPL23;PATL2;RPL31;SMG8;RPL3;RPS21;CNOT11;PPP2CA;ZFP36L1;SMG1;RPL35A;RPS14;RPL8;RPL5;CNOT2;RPS12;RPS26;RPL37A;PYM1;RPL4;CNOT7;RPLP0;EXOSC9;UPF2;XRN2;DXO;PATL1;RPS28;RPS24;RPS9;RPS23;RPL24;PAN3;RPL34;RPS11;RPS3;TUT7;PAN2;CNOT6;RPS15A;RPL23A;RPL21;RPL35;CNOT1;DCP1A;CNOT6L;TUT4;NBDY;UPF3B;PARN;CNOT10;LSM1;RPL19;RPL38;RPL36;SMG6;RPSA;RPL26;RPS8;SMG5;RPL15;RPL10;RPL32;RC3H1;RPS2;EIF4G1;DIS3L2;RPL27A;EIF3E;DCP1B;EXOSC7;RPL7;RPL39;RPL14;SMG7;AGO1;RPS27;CNOT8;CNOT4;RPS13;GSPT1;TENT2;MTPAP;RPL22
prerank,neurotransmitter uptake (GO:0001504),-0.7007097514060774,-1.7360763462345128,0.0066815144766146995,0.18142749466780259,0.994,4/12,6.01%,ATP1A2;SNAP25;SLC1A3;GLUL
prerank,positive regulation of kinase activity (GO:0033674),-0.4218130836816965,-1.73575697921468,0.0,0.17794530215314053,0.994,28/107,10.79%,ERBB4;NTRK3;FGFR2;PRKAG2;EGFR;LMO4;EPHA6;IQGAP1;PDGFRB;EPHB1;NTRK2;RASSF2;AXL;RYK;MAPT;EPHA7;PRKAG1;ROR1;KIT;RELN;DDR1;PDGFRA;RAD50;VAC14;EPHB4;MRE11;EPHB2;EPHA3
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.7665721086954821,1.7355389757115796,0.003861003861003861,0.5032962074581043,0.998,1/11,0.19%,RTP3
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.49769640332968906,-1.7342088086838339,0.002403846153846154,0.17639641704261577,0.994,16/44,14.22%,ANK2;KCNMA1;AKAP6;ATP1B1;WNK1;FLNA;ATP1B3;GABBR2;AKAP9;KCNJ2;ATP1B2;ACTN2;WNK4;KCNJ6;WNK3;ANO6
prerank,regulation of B cell activation (GO:0050864),0.6141374958252512,1.7320437315669075,0.005226480836236934,0.49717303337250063,0.998,4/25,5.32%,TNFAIP3;FCGR2B;ZFP36L1;SAMSN1
prerank,response to cholesterol (GO:0070723),-0.6331198668259429,-1.7292838847529453,0.004319654427645789,0.18175808150696748,0.997,13/17,31.27%,GRAMD1B;TGFBR1;TGFBR2;SMO;GRAMD1C;GRAMD1A;LRP6;GPLD1;TGFB1;OSBPL7;PTCH1;PMVK;ABCA2
prerank,regulation of cation channel activity (GO:2001257),-0.43048559714171625,-1.72671394964367,0.0,0.18238363429714538,0.997,39/89,24.99%,DLG2;ANK2;ANK3;LRRC7;FGF12;GRIA4;GRIA2;AHNAK;CACNB4;GRIN2B;FGF14;SHISA9;DLG4;NLGN2;RELN;SHISA6;NLGN1;DLG3;PRKACA;ACTN2;CAMK2D;CACNG7;DLG1;VAMP2;NEFL;CACNG4;OPRM1;CACNG2;DAPK1;SELENON;SHANK1;PRRT1;GRIN1;CAMK2B;CAPN1;CACNG3;CACNG8;CACNB1;CAMK2A
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.5117618552419932,-1.7259359096496214,0.0024449877750611247,0.18011669185617377,0.997,9/38,13.06%,ANK2;CTNNA3;CACNA1C;CACNA1D;AKAP9;KCNJ2;BIN1;CAMK2D;CACNA1G
prerank,cellular response to lectin (GO:1990858),0.4862959595846597,1.7251720832077584,0.0,0.4877534346016073,0.999,31/104,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TAB2;SRC;RPS6KA5;NRAS;PSMD11;PSMB4;FYN;PSMC1;EP300;PAK3;SYK;TAB3;RELA;LYN;PSMC2;PAK1;PSMD2;CREBBP;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.4862959595846597,1.7251720832077584,0.0,0.4877534346016073,0.999,31/104,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TAB2;SRC;RPS6KA5;NRAS;PSMD11;PSMB4;FYN;PSMC1;EP300;PAK3;SYK;TAB3;RELA;LYN;PSMC2;PAK1;PSMD2;CREBBP;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,translation (GO:0006412),0.44453010718288555,1.7244294456140334,0.0,0.469589631632257,0.999,80/208,19.87%,RPL30;MRPS2;MRPS33;RSL24D1;EEF1A1;MRPL23;RPL17;RPL23;MRPL24;FASTKD2;RPL31;RPL3;EEF1D;RPS21;MRPL18;FARS2;GARS1;RPL35A;RPS14;RPL8;YARS2;RPL5;IARS1;ABCF1;LARS2;MRPS12;RPS12;HBS1L;RPS26;RPL37A;HARS1;RPL4;RARS2;RPLP0;TSFM;RPS28;RPS24;RPS9;RPS23;RPL24;WARS2;RPL34;GTPBP2;DRG2;RPS11;MRPL52;RPS3;MRPS15;MRPS24;LARS1;DHPS;EEF1B2;RPS15A;RPL23A;RPL21;RPL35;MRPS28;GATB;HARS2;WARS1;MRPS34;RPL19;RPL38;RPL36;RPSA;IARS2;RPL26;RPS8;GFM2;RPL15;RPL10;RPL32;RPS2;EIF4G1;MRPL13;RPL27A;FTSJ1;RPL7;RPL39;RPL14
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.4857288534315186,1.7225230675216836,0.0,0.4596426802286746,0.999,31/105,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TAB2;SRC;RPS6KA5;NRAS;PSMD11;PSMB4;FYN;PSMC1;EP300;PAK3;SYK;TAB3;RELA;LYN;PSMC2;PAK1;PSMD2;CREBBP;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.4877423352625279,-1.7224370500160056,0.0026595744680851063,0.18350938325411983,0.997,29/50,30.73%,FGFR2;ZIC1;GLI3;TULP3;IFT81;GLIS2;MGRN1;SMO;DCDC2;VCP;GPC3;BTRC;GAS1;WDR11;RORA;RACK1;INTU;EVC;HERC4;KCTD6;GLI1;PTCH1;SFRP1;SUFU;DLG5;TTC23;FUZ;PDCL;FBXL17
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.7457566315972297,-1.712161691763704,0.0,0.20064670469627363,0.998,4/10,8.13%,DLGAP1;DLGAP2;DLGAP4;AKAP9
prerank,positive regulation of cell projection organization (GO:0031346),-0.4078170359004177,-1.7105390426798508,0.0,0.19959935014977018,0.999,44/115,18.67%,MAGI2;NTRK3;ROBO2;TENM3;LRRC7;PLXNA2;ROBO1;CUX1;DPYSL3;NTRK2;TIAM2;DLG4;TOX;PTK7;RHOA;ROR1;RELN;CBFA2T2;PLPPR5;STMN2;ARSB;ATP1B2;DVL3;EPHA3;CUX2;RIT2;GRIP1;IL1RAPL1;OBSL1;PLXND1;CAMK1;ROR2;SETX;ARHGDIA;PLXNB2;NGF;PLXNC1;RAPGEF2;ABL2;FZD4;DVL1;TWF2;SCARF1;SNX3
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.639342203503152,-1.7100686340298699,0.010869565217391304,0.19672876147544324,0.999,5/16,1.32%,ERBB4;FGFR2;TGFBR3;IGF1;AKAP6
prerank,regulation of muscle contraction (GO:0006937),-0.5554654143492193,-1.7096396683702937,0.0,0.19388151078161975,0.999,7/26,12.21%,ATP1A2;KCNB2;CHRM2;TPM1;PLCE1;KCNA1;SRI
prerank,positive regulation of telomerase activity (GO:0051973),0.5839936553105611,1.708517816256426,0.005067567567567568,0.5122245606716754,1.0,16/33,20.74%,MAP2K7;MAPK3;PNKP;GREM1;CCT2;MAP3K4;ACD;NEK7;TNKS;TCP1;DKC1;PARN;PARM1;NVL;PTGES3;HSP90AB1
prerank,actin filament polymerization (GO:0030041),-0.5461177825011648,-1.7072193352103235,0.010050251256281407,0.19511403388483015,0.999,10/29,7.49%,GSN;GAS7;SPIRE1;WASL;PSTPIP2;ARHGAP6;WASHC5;WASHC3;WASF1;COBL
prerank,positive regulation of bone mineralization (GO:0030501),-0.5270231394934657,-1.7068530153967023,0.01038961038961039,0.19225541142885716,0.999,18/35,21.82%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;OSR1;WNT4;ACVR1;KL;ANO6;TGFB1;BMPR1B;BMPR1A;BMPR2;CCN1;PKDCC
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5978537719695494,-1.7050103653559519,0.00683371298405467,0.19211440024416723,0.999,8/20,9.45%,ATP1A2;KCNMA1;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2
prerank,extracellular matrix organization (GO:0030198),-0.3689090420441154,-1.7038995435998578,0.0,0.19068482449822294,0.999,107/276,22.40%,LAMA2;COL1A2;FBN1;COL4A5;ADAMTS12;ADAMTSL3;ADAMTS2;ITGA9;ADAM12;COL1A1;GSN;THSD4;SMOC1;TNR;GPM6B;COL4A6;COL8A1;TIMP2;ITGB8;COL3A1;CAPN2;COL11A1;PLOD2;COL25A1;COL22A1;MMP16;FLRT2;TGFBR1;COL5A1;PLEC;COL4A3;ADAMTS6;COL5A2;ADAMTSL5;LAMC3;COL4A4;LOXL1;FBN2;NID2;JAM3;ADAMTS17;VCAN;MMP14;ADAMTS9;COL12A1;ATP7A;ITGB5;ADAM19;ADAMTS5;COL6A1;DDR1;HSPG2;ITGA5;COL8A2;MFAP5;SH3PXD2A;P4HB;COL15A1;COL13A1;SPARC;ADAMTS1;PLOD1;COL6A2;ADAMTSL4;SMOC2;THBS1;VTN;CDH1;ITGA11;FN1;ADAMTS3;LOXL3;SCUBE1;SLC39A8;ITGA8;COL23A1;COL6A3;ADAMTS10;SPP1;QSOX1;ITGB4;COL5A3;TGFB1;LAMA1;LAMB1;VIT;P4HA2;ITGA4;TGFBI;ADAMTS15;COL20A1;COL14A1;ADAMTS16;MMP2;LUM;FLOT1;PDGFA;ITGA1;ADAMTS20;COL16A1;COL18A1;P3H1;SH3PXD2B;LOX;CRTAP;CAPN1;KLK2
prerank,establishment of endothelial barrier (GO:0061028),0.6043590140200991,1.6978358726583582,0.004975124378109453,0.5500994834165146,1.0,12/29,12.24%,PDE4D;PECAM1;MARVELD2;PPP1R16B;ICAM1;RAPGEF3;F11R;RAPGEF6;TJP1;RAB1A;ROBO4;RAP2C
prerank,heart development (GO:0007507),-0.39028857792301763,-1.696289586995191,0.0,0.2024712003851269,1.0,41/150,14.43%,ERBB4;NTRK3;TGFBR3;FGF12;CACNA1C;FBN1;AKAP13;PDLIM5;PKD1;MICAL2;GLI2;ADAP2;COL3A1;PCSK5;FLRT2;CXADR;TGFBR1;NCOA6;TGFBR2;BMP5;BMP7;PLCE1;PDLIM7;BMP4;OSR1;GPC3;NIPBL;CDKN1B;EPHB4;RBP4;FOXC1;ACVR1;SALL1;FN1;FOXC2;SCUBE1;MTHFD1;WDR11;PDLIM1;TCF25;PTK2
prerank,cotranslational protein targeting to membrane (GO:0006613),0.48529707893206003,1.6942706901239746,0.002840909090909091,0.5495531024311784,1.0,43/91,19.87%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;RPL4;RPLP0;RPS28;RPS24;RPS9;RPS23;RPL24;RPL34;RPS11;SEC62;RPS3;RPS15A;RPL23A;RPL21;SRP9;RPL35;RPL19;RPL38;RPL36;RPSA;RPL26;RPS8;RPL15;RPL10;RPL32;RPS2;RPL27A;RPL7;RPL39;RPL14
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.5407142467559795,-1.694161266569436,0.007125890736342043,0.20262972124824144,1.0,9/27,11.96%,DDX5;EGFR;PUM1;BMP4;PUM2;EIF4E2;MAP2K2;TP53;LIMD1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.47662658124320556,1.693219463029725,0.0,0.5358341121624359,1.0,16/107,8.25%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;CXCL12;ATP2A2;SLC10A7;NPTN;HTR2A;ATP13A4;TRPV4;TMEM165
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.6474583143116598,-1.6920361583523242,0.00425531914893617,0.20353107399793077,1.0,6/14,8.52%,KMT2A;AUTS2;CTNNB1;SMAD4;PAXIP1;SNW1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.7520523066768412,1.6908955128200127,0.01639344262295082,0.5297056948262392,1.0,2/10,6.32%,SAG;GNB1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.49489360105998287,1.6893314048173889,0.004405286343612335,0.5201987192569065,1.0,27/74,14.75%,PSMB10;PSMC4;PSMB6;ELOC;PSMD8;PSMD5;PSMD12;STOX1;PSMD11;PSMB4;PSMC1;EP300;NOTCH1;PSMC2;PSMD2;CITED2;RBPJ;CREBBP;HIGD1A;ELOB;EGLN2;PSMD14;EPAS1;PSMC6;PSMD1;PSMB1;BACH1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.647482322567629,1.6873285572876884,0.005454545454545455,0.5135627087664516,1.0,8/18,12.07%,HRH4;GNAQ;RGS8;GNB1;RGS10;GNA11;PLCB1;AGRN
prerank,odontogenesis (GO:0042476),-0.5232354297555024,-1.6864296556500695,0.007281553398058253,0.21158995040639506,1.0,8/35,8.19%,FGFR2;COL1A2;EDA;GLI2;HDAC1;BMP4;OSR1;FOXC1
prerank,regulation of hippo signaling (GO:0035330),-0.6206221175898591,-1.6859593274381404,0.010615711252653927,0.2092160517906595,1.0,9/17,16.86%,WWC2;MAPK14;MOB3B;SCHIP1;CIT;VGLL4;LIMD1;NF2;SHANK2
prerank,positive regulation of immune effector process (GO:0002699),0.601025809119047,1.6854470460988686,0.005226480836236934,0.507653886281233,1.0,3/27,2.03%,PCK1;PTPRJ;PTPRC
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.65764220772854,1.6848102467726382,0.010869565217391304,0.4955755575575538,1.0,6/18,6.71%,LRP8;RPS6KA4;CAMK1D;PRKD2;RPS6KA5;EPHA5
prerank,neuron projection morphogenesis (GO:0048812),-0.39387345958773373,-1.68444452990521,0.0,0.2092007881920023,1.0,38/137,11.06%,MAP2;FGFR2;CNTN4;DCLK1;ALCAM;ANK3;DCC;MAP1B;EPB41L3;CTNNA2;IQGAP1;NRCAM;GAS7;EPHB1;NBL1;NTNG1;SDC2;WASL;DLG4;RYK;CTNNB1;BMP7;GPM6A;ATP7A;DCDC2;MYO16;CTNND2;TAOK3;SHTN1;ROCK1;CTTN;DOCK10;NLGN1;BRSK1;SGK1;BTBD3;EPHB2;PLPPR4
prerank,respiratory system development (GO:0060541),-0.5218776404159381,-1.6829696987962321,0.005141388174807198,0.20875480892703485,1.0,13/32,24.63%,FGFR2;GLI2;FGF1;PDPN;BMP4;RBP4;LOXL3;SMCHD1;CCDC39;BAG6;VEGFA;STRA6;BASP1
prerank,positive regulation of telomere capping (GO:1904355),0.6680303326651544,1.6801346348535446,0.005454545454545455,0.5027334157222952,1.0,6/17,11.70%,MAP2K7;MAPK3;PNKP;MAP3K4;NEK7;TNKS
prerank,regulation of kinase activity (GO:0043549),-0.42887931571006127,-1.6798490246076938,0.0,0.21221367479435077,1.0,27/89,10.79%,ERBB4;NTRK3;FGFR2;EGFR;LMO4;EPHA6;PDGFRB;EPHB1;NTRK2;AXL;RYK;MAPT;RBL2;EPHA7;PLCE1;ROR1;KIT;DDR1;PDGFRA;LDB1;RAD50;VAC14;CDKN1B;EPHB4;MRE11;EPHB2;EPHA3
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6185493072322826,-1.6787622617020745,0.0045045045045045045,0.2112823056304832,1.0,4/17,1.33%,ANK2;ATP1A2;CACNA1C;CACNA1D
prerank,modified amino acid transport (GO:0072337),-0.6369620825723397,-1.6770993209881966,0.009009009009009009,0.2115453603831282,1.0,7/15,17.61%,SLC16A12;SLC6A13;PDPN;SLC25A32;CTNS;SLC19A1;SLC5A6
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6491014707126295,1.6732239787708918,0.015901060070671377,0.5239209165991225,1.0,3/19,6.50%,SLC5A7;APOE;RIC3
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5545528209462112,-1.6719497923411801,0.004866180048661801,0.21920015169078627,1.0,12/26,14.04%,ANK2;CACNA1D;ATP1B1;FHL1;ATP1B3;WWP2;CAB39;AKAP9;ATP1B2;ACTN2;DLG1;VAMP2
prerank,glutamate metabolic process (GO:0006536),0.6363311315912485,1.6618696662021444,0.012259194395796848,0.568673847434603,1.0,7/19,6.17%,GCLC;ALDH5A1;GLS2;GLS;GOT2;GCLM;MTHFS
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.47205353610709033,1.6594443472812743,0.002881844380403458,0.56659400240806,1.0,28/86,14.95%,ATF3;PSMB10;PSMC4;PSMB6;ELOC;PSMD8;PSMD5;PSMD12;KLF2;STOX1;PSMD11;PSMB4;PSMC1;EP300;PSMC2;PSMD2;CREBBP;HIGD1A;ELOB;EGLN2;PSMD14;EPAS1;DDIT3;PSMC6;PSMD1;PSMB1;BACH1;INO80
prerank,cAMP biosynthetic process (GO:0006171),-0.7033286146703291,-1.6593345717854802,0.00998003992015968,0.24337527258002498,1.0,8/10,22.64%,ADCY5;ADCY2;ADCY1;ADCY9;ADCY7;ADCY8;ADCY3;ADCY4
prerank,connective tissue development (GO:0061448),-0.4970638386511554,-1.6545543895270385,0.012531328320802004,0.25119990933550884,1.0,11/35,13.84%,SULF1;PKD1;ITGB8;SOX5;SULF2;ATP7A;CREB3L2;SLC39A13;LRP5;DDRGK1;PGRMC2
prerank,ribosome assembly (GO:0042255),0.5238786933212461,1.6540488105800002,0.009584664536741214,0.5806730362351677,1.0,19/47,18.32%,MRPS2;MTERF3;RSL24D1;EIF2A;RPL3;RPS14;RPL5;MRPL20;RPLP0;RPS28;RRP7A;RPL24;DDX3X;EFL1;RPL23A;NPM1;EIF6;RPSA;RPL10
prerank,positive regulation of histone methylation (GO:0031062),-0.5505003032629364,-1.646474374930549,0.004694835680751174,0.26662726912454515,1.0,14/24,22.05%,OGT;KMT2A;AUTS2;CTNNB1;SMAD4;JARID2;TET1;PAXIP1;SNW1;MTF2;PAF1;RIF1;DNMT1;PHF1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.620391790393748,1.645174171472678,0.019748653500897665,0.616193456258797,1.0,4/22,2.51%,PHPT1;PTPRJ;SH2D1A;FCGR2B
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.6023723265040654,-1.6447544063756807,0.019313304721030045,0.26690534772034913,1.0,7/17,9.68%,IGF1;DOCK5;PDGFRB;IGFBP5;NRP1;ADAMTS1;VTN
prerank,potassium ion transport (GO:0006813),-0.3951865693116297,-1.643965886805909,0.003367003367003367,0.26513199251098524,1.0,23/120,12.75%,ATP1A2;KCNK2;SLC24A3;KCNQ3;KCNB2;HCN1;NALCN;KCNH7;KCNQ5;KCNMA1;SLC1A3;KCNC2;KCND2;ATP1B3;KCNH5;KCNK5;KCNJ2;KCNA1;SLC24A2;KCNK10;KCNJ6;SLC9A2;ABCC9
prerank,negative regulation of protein catabolic process (GO:0042177),-0.4850418159153337,-1.6437178052659662,0.010309278350515464,0.2620582449596332,1.0,13/40,9.26%,SNRNP70;EGFR;TIMP3;TIMP2;NELL1;FLNA;SIRT2;FMN2;ROCK1;PTPN3;IRAK3;BANP;AZIN1
prerank,regulation of synapse assembly (GO:0051963),-0.480243809410944,-1.6430900279165306,0.0027624309392265192,0.26019947225704493,1.0,15/46,12.29%,ROBO2;LRFN5;GPC6;PDLIM5;NRXN1;GRID2;EPHB1;NLGN2;IL1RAPL2;SYNDIG1;CLSTN2;NLGN1;EPHB2;CUX2;IL1RAPL1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6255843662939606,-1.6430180318098653,0.015283842794759825,0.25688106603903355,1.0,7/15,15.55%,COL11A1;ADGRV1;KIT;PIEZO2;SCN1A;KCNA1;WHRN
prerank,peptidyl-methionine modification (GO:0018206),0.6995443205834535,1.6385167208875144,0.025145067698259187,0.6383719926675975,1.0,4/12,16.28%,NAA25;METAP2;METAP1;NAA15
prerank,regulation of telomerase activity (GO:0051972),0.5261555933844251,1.63742767143786,0.014563106796116505,0.6284770810233375,1.0,17/45,18.05%,MAP2K7;CERS1;MAPK3;PNKP;GREM1;SRC;CCT2;ERCC4;MAP3K4;ACD;NEK7;TNKS;TCP1;DKC1;PARN;SMG6;PARM1
prerank,chordate embryonic development (GO:0043009),-0.44539592408245304,-1.6370826997395318,0.005714285714285714,0.2673966211049359,1.0,12/55,4.70%,FGFR2;SULF1;ARNT2;ALDH1A2;COL1A1;PKD1;PCSK5;TGFBR1;BMP5;BMP7;SULF2;FUT8
prerank,cellular sodium ion homeostasis (GO:0006883),-0.6228963322091311,-1.635400024640066,0.008948545861297539,0.2679958398386573,1.0,6/15,9.45%,ATP1A2;ATP1B1;ATP1B3;SLC12A2;ATP1A1;ATP1B2
prerank,regulation of cell communication (GO:0010646),-0.499450651135853,-1.6340970101913428,0.0025575447570332483,0.2677235127734817,1.0,16/35,25.33%,ANK2;CXADR;IGFBP7;SCG5;GRK5;GRK3;SOCS2;CAMK2D;ANXA1;SRI;GRK4;MTCH1;TBX18;GRK2;TSPYL2;GLRX2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.45267725246770174,-1.6336760472580407,0.007751937984496124,0.2652659181610356,1.0,17/54,12.92%,DPP6;KCNIP4;KCNMA1;AKAP6;CACNA1D;FHL1;KCNIP1;FLNA;KCNIP3;WWP2;CAB39;GABBR2;KCNJ2;BIN1;DPP10;KCNJ6;DLG1
prerank,central nervous system neuron differentiation (GO:0021953),-0.5043848484247924,-1.6284065709428652,0.00936768149882904,0.2747830171301666,1.0,9/33,5.67%,MAP2;GRID2;SPOCK1;NTRK2;TOX;RYK;MAPT;CTNNB1;ATP7A
prerank,mesenchyme development (GO:0060485),-0.6185622903948627,-1.6277493223162667,0.010638297872340425,0.2732352129429019,1.0,4/15,4.74%,FGFR2;TGFBR1;BMP7;BMP4
prerank,regulation of protein metabolic process (GO:0051246),0.5234971013357151,1.6266736012456249,0.008375209380234505,0.6767690551344221,1.0,18/44,16.46%,KLF2;MAP2K5;SPOP;LTBP4;NEDD4L;APOE;WFS1;TMEM9;MAPK8;TRAF3;MDM2;SPOPL;APP;CHEK2;FAF1;VPS35;ODC1;FKBP1A
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.4855006824088452,-1.6253847353376991,0.01804123711340206,0.2759076707962726,1.0,19/40,21.82%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;OSR1;WNT4;ACVR1;KL;ANO6;TGFB1;BMPR1B;BMPR1A;BMPR2;CEBPB;CCN1;PKDCC
prerank,negative regulation of transferase activity (GO:0051348),0.5855981992537647,1.6243633747661232,0.015126050420168067,0.6750866179095669,1.0,9/28,9.76%,PHPT1;CERS1;GSK3A;SRC;ERCC4;FBXO5;SMAD7;IRS2;PARK7
prerank,renal system development (GO:0072001),-0.4458766770324555,-1.6241604999514916,0.0,0.27566552456354537,1.0,25/52,24.84%,SULF1;GREB1L;PKD1;GLI2;PCSK5;TGFBR1;SULF2;BMP4;WNT4;RBP4;FOXC1;PYGO1;SALL1;ITGA8;ACE;TBX18;PYGO2;SIX1;STAT1;AGTR1;BAG6;VEGFA;STRA6;IFT88;PAX2
prerank,"phototransduction, visible light (GO:0007603)",0.6660488452335325,1.6216410519247062,0.019642857142857142,0.6758148977818984,1.0,4/14,8.84%,SAG;GNAQ;GNB1;GNA11
prerank,membrane assembly (GO:0071709),-0.4899270369923655,-1.6194329475034324,0.007556675062972292,0.28437654838601495,1.0,12/34,12.29%,ANK3;NRXN1;ANXA2;NLGN2;UBXN2A;FLOT2;NLGN1;UBXN2B;TLCD2;NSFL1C;NRXN2;IL1RAPL1
prerank,myotube cell development (GO:0014904),-0.7022121523978685,-1.6191563654787895,0.018292682926829267,0.2817233987663229,1.0,5/10,18.72%,IGF1;SKI;CAV2;SELENON;SIX1
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.581188193653472,-1.6174401503862585,0.026490066225165563,0.2829751476547723,1.0,6/17,7.60%,ATP1A2;TFPI;BMP7;MED1;BMP4;ATP1A1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.5110915159174722,-1.6170728478625538,0.00963855421686747,0.28080241893484825,1.0,6/30,12.54%,LPAR1;ROBO1;AKAP13;COL3A1;PRAG1;GPR4
prerank,regulation of intracellular pH (GO:0051453),0.5487639122866198,1.616874899612353,0.012280701754385965,0.6894375105072896,1.0,9/34,8.25%,SLC4A4;SLC4A5;SLC9A7;CA2;GPR89A;GPR89B;SLC9A6;SLC9A8;TMEM165
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3718321634123663,-1.612611715529908,0.0,0.28903338831592673,1.0,36/159,12.31%,LRRC4C;TENM2;ROBO2;LRFN5;CNTN4;TENM3;ALCAM;SDK1;GPC6;ROBO1;CDH10;UNC5D;CNTN6;GRID2;KIRREL3;PKD1;NTNG1;CXADR;PTPRS;TGFBR2;DSCAM;CLDN11;IGSF11;PALLD;CDH11;SDK2;CDH7;NLGN1;ACVR1;MPZL2;CDH1;PTPRF;LRRC4;CDH4;IL1RAPL1;OBSL1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.55855069459126,-1.608543632796451,0.028761061946902654,0.29610010731228803,1.0,6/19,12.92%,DLG2;LRRC7;PARD3B;CLIC4;DLG3;DLG1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.5204393845245827,-1.6084570035825512,0.011111111111111112,0.29301133289159487,1.0,13/25,26.46%,ELL;LDB1;CDC73;RNF168;RNF8;BRD4;NELFB;WDR43;EAF1;NELFA;CDK12;LARP7;SUPT4H1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.5115378877134209,-1.6083967959555057,0.016908212560386472,0.2899655666869473,1.0,8/29,10.52%,PKD1;IFNAR2;FER;STAT2;GHR;IL31RA;STAT6;SOCS2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6261235209810585,1.6051242970358177,0.028119507908611598,0.7477156795517912,1.0,3/17,2.15%,PHPT1;PTPRJ;SH2D1A
prerank,nuclear migration (GO:0007097),-0.640582949168043,-1.6031528111850442,0.018,0.2995968617626678,1.0,6/13,5.77%,SYNE2;CLMN;DYNC1H1;SYNE3;FBXW11;CEP120
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.648309541115171,-1.6020427713454028,0.017391304347826087,0.29893129469027363,1.0,9/12,22.51%,KHDRBS1;PTPN14;BMP4;RBM4;SIRT7;TGFB1;AAAS;NEDD4;NUP214
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.7052750572187436,1.6011144358345044,0.012684989429175475,0.7573529700092281,1.0,2/10,2.51%,PTPRC;FCGR2B
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.5528117091750107,-1.5985287235847416,0.018475750577367205,0.3046980057981429,1.0,7/22,7.58%,MAGI2;NTRK3;NTRK2;SH3GL2;MAPT;WASF1;STMN2
prerank,sulfation (GO:0051923),-0.6646050677266069,-1.598406610800861,0.020618556701030927,0.30189575963269977,1.0,2/11,1.14%,UST;HS3ST5
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4494228646189072,1.5977664201273303,0.005502063273727648,0.7625932957423337,1.0,33/109,14.01%,PSMB10;PSMC4;MAP2K7;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;MAP3K7;VAV3;TAB2;PPP3CB;PSMD11;PSMB4;PSMC1;MAPK8;SYK;LCP2;TAB3;PLCG1;RELA;LYN;PSMC2;PAK1;PSMD2;PPP3CA;PPP3R1;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.630987134148079,1.5954883510161746,0.024344569288389514,0.7625743601453895,1.0,5/16,5.63%,SLC25A1;DIP2A;MLYCD;PPT1;ACAT1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.7222049846543181,1.5944351391764326,0.02594810379241517,0.7538124807272707,1.0,4/10,4.52%,INSIG1;DERL2;SVIP;YOD1
prerank,camera-type eye development (GO:0043010),-0.5323098763359001,-1.5922643156210774,0.024498886414253896,0.3146801548232591,1.0,6/25,6.85%,TENM3;CACNA1C;FBN1;EFEMP1;FBN2;SKI
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5259815946155388,-1.5901713961720545,0.02122641509433962,0.3173055758774667,1.0,10/24,17.35%,CTNNA2;BOC;CDON;CTNNA1;MAPK14;CTNNB1;RBM4;CAMK1;OLFM2;CDC42
prerank,regulation of biosynthetic process (GO:0009889),0.7012408799708088,1.59011853153348,0.011516314779270634,0.767760485990871,1.0,2/11,7.38%,PCK1;PIKFYVE
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.45132196568962707,1.5899125111795542,0.001443001443001443,0.7544466193030954,1.0,31/94,14.29%,PSMB10;PSMC4;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;IL1R1;MAP3K7;TAB2;RPS6KA4;RPS6KA5;PSMD11;PSMB4;PSMC1;TAB3;RELA;PSMC2;PLCB1;PSMD2;UBE2V1;NOD1;TNIP2;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;NFKBIA;PSMB1;MAP3K3
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.5437731828120379,-1.5885694036635722,0.03177966101694915,0.31834126610860547,1.0,12/22,26.46%,KAT7;ERCC6;ELL;DDX39B;CDC73;BRD4;CCNT1;THOC5;CCNK;CDK12;THOC1;SUPT4H1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5907875704051688,1.5882766373919093,0.03185840707964602,0.7507585476520758,1.0,7/20,10.33%,MAPK3;DIP2A;RUVBL2;RPS6KA4;RPS6KA5;DIP2B;PRKAA2
prerank,glutathione biosynthetic process (GO:0006750),0.6846570337138056,1.5875255993741644,0.02529182879377432,0.741770450969128,1.0,5/11,13.17%,GCLC;GCLM;CNDP2;HAGH;GSS
prerank,metanephros development (GO:0001656),-0.5150241466225374,-1.5871266634946357,0.02288329519450801,0.3188986997328043,1.0,7/26,7.76%,ROBO2;PKD1;FOXD1;BMP7;BMP4;OSR1;NIPBL
prerank,regulation of lipid catabolic process (GO:0050994),0.6021151663926589,1.5866567910580716,0.02877697841726619,0.7335058088506502,1.0,1/19,0.14%,CIDEA
prerank,positive regulation of tissue remodeling (GO:0034105),-0.6688058262598131,-1.5862924898272586,0.035269709543568464,0.3175999867218102,1.0,4/10,17.90%,ROCK2;ROCK1;IL18;TMBIM1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6369687064608547,-1.585395953308571,0.023157894736842106,0.3170218208656712,1.0,7/12,13.20%,ANK3;ATP1B1;WNK1;ATP1B3;ATP1B2;WNK4;WNK3
prerank,retina homeostasis (GO:0001895),0.5851166917682354,1.5847074172170768,0.018739352640545145,0.7326777576554395,1.0,5/23,5.45%,SOD1;POC1B;POTEF;ACTB;B2M
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.5336669149654327,-1.5842371216747555,0.01951219512195122,0.31696545656718667,1.0,14/23,26.14%,GLI3;TULP3;GLIS2;MGRN1;ENPP1;VCP;GPC3;BTRC;RACK1;HERC4;KCTD6;PTCH1;GPR161;SUFU
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6653259939735123,1.584083144093956,0.0275049115913556,0.7233158846277944,1.0,6/13,16.30%,PTPRC;PTPRT;MGAT5;DOT1L;HES1;PIGU
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6719656589960734,1.5826712289148448,0.02495201535508637,0.7193228449178757,1.0,6/12,15.46%,GCLC;GCLM;CNDP2;HAGH;GSS;BDH2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.45295040902090977,-1.5816466930789375,0.013440860215053764,0.3210641519954108,1.0,19/46,27.99%,FOXP1;IGF1;PDGFRB;IGFBP5;CTNNB1;IL6R;BMP4;OGN;THBS1;IL18;TCF7L2;RBPMS2;APOD;STAT1;CX3CL1;AKT1;NDRG4;CCN4;TRIB1
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.5392232373156607,-1.5793844223692386,0.026128266033254157,0.3237888708742106,1.0,4/23,5.49%,FGFR2;TGFBR3;TPM1;ADAMTS9
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.5271599414923981,-1.5789180056648173,0.031746031746031744,0.32214968809581773,1.0,5/25,6.53%,CTNNA3;PARVA;CXADR;JAM3;ITGA5
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.6400448367854668,-1.5767049393546997,0.025210084033613446,0.3256670208745375,1.0,9/12,28.53%,UST;DSE;VCAN;CSPG4;DSEL;BGN;DCN;CSPG5;CHST12
prerank,Fc receptor signaling pathway (GO:0038093),0.44363496729222024,1.575648802727965,0.004149377593360996,0.7490331617338868,1.0,33/110,14.01%,PSMB10;PSMC4;MAP2K7;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;MAP3K7;VAV3;TAB2;PPP3CB;PSMD11;PSMB4;PSMC1;MAPK8;SYK;LCP2;TAB3;PLCG1;RELA;LYN;PSMC2;PAK1;PSMD2;PPP3CA;PPP3R1;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,regulation of phospholipase C activity (GO:1900274),-0.5946554587623799,-1.5722160202898163,0.02857142857142857,0.3350637318436358,1.0,5/15,6.19%,NTRK3;BICD1;PDGFRB;KIT;PDGFRA
prerank,neural tube development (GO:0021915),-0.5909377162535562,-1.5720793332916407,0.02736842105263158,0.33225474559079965,1.0,6/15,17.27%,ALDH1A2;PKD1;ARL13B;DACT1;TGFB1;DVL1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.6411711790283618,1.5705387437349503,0.030710172744721688,0.7535746744632188,1.0,2/14,2.40%,HMOX2;ABCG2
prerank,heme catabolic process (GO:0042167),0.6411711790283618,1.5705387437349503,0.030710172744721688,0.7535746744632188,1.0,2/14,2.40%,HMOX2;ABCG2
prerank,muscle contraction (GO:0006936),-0.374074898527696,-1.5696643932356877,0.0038910505836575876,0.33599794045936926,1.0,20/126,10.09%,SORBS1;CALD1;GNAO1;PABPN1;TMOD2;SNTA1;TPM1;VIM;TLN1;PXN;ROCK2;VCL;ITGB5;EDNRA;ROCK1;GLRA1;GJC1;SMTN;MYOF;ACTN2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6020833244183602,1.5687319405907452,0.03374777975133215,0.7519899722791706,1.0,7/19,15.12%,KLF2;MAP2K5;PAX8;WFS1;MAPK8;APP;SLCO1C1
prerank,protein import into mitochondrial matrix (GO:0030150),0.609158293676979,1.5682949430878694,0.02909090909090909,0.7428813393232001,1.0,6/18,9.73%,TOMM20;ROMO1;TIMM17B;GRPEL2;TOMM40L;TIMM21
prerank,potassium ion transmembrane transport (GO:0071805),-0.3706989289745971,-1.5680983849163193,0.0036101083032490976,0.3371314459132111,1.0,36/135,19.95%,ATP1A2;KCNK2;SLC24A3;KCNQ3;KCNB2;HCN1;NALCN;KCNH7;KCNQ5;SLC1A3;KCNC2;KCND2;ATP1B1;ATP1B3;SLC12A2;KCNH5;ATP1A1;KCNK5;KCNJ2;KCNA1;ATP1B2;SLC24A2;KCNK10;KCNJ6;SLC9A2;ABCC9;SLC12A6;KCNJ13;KCNS3;SLC12A4;KCNQ4;ATP1A3;SLC12A9;KCNJ10;KCNA6;KCNA2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.7090677392550038,1.5676050768046612,0.043151969981238276,0.7355059243133514,1.0,6/10,10.33%,DIP2A;DIP2B;SIRT1;SETD5;PARK7;PRKAA2
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5664853060153838,-1.566996925554435,0.03248259860788863,0.3371942056756885,1.0,6/19,7.87%,ERBB4;FGFR2;TGFBR3;TGFBR1;VGLL4;RBP4
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.5413468986121667,-1.5650614018032885,0.031630170316301706,0.3394084771013525,1.0,6/22,5.85%,FGFR2;NOTCH2;MED1;KLF9;SRSF6;EPB41L4B
prerank,endoderm formation (GO:0001706),-0.46884383591093254,-1.564472594059639,0.028708133971291867,0.33803760381966724,1.0,13/35,22.53%,COL8A1;COL11A1;MMP14;COL12A1;ITGB5;COL6A1;ITGA5;VTN;FN1;LAMB1;ITGA4;MMP2;DUSP1
prerank,central nervous system neuron development (GO:0021954),-0.5884511698400585,-1.5637227656802999,0.02850877192982456,0.33722694438409423,1.0,9/15,29.32%,MAP2;NTRK2;MAPT;ATP7A;B4GALT6;RAPGEF2;LHX6;HSP90AA1;GBA2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5808148225030841,-1.5634385758885287,0.031180400890868598,0.3350228895955874,1.0,5/16,10.68%,ANK2;ATP1A2;CACNA1C;PRKACA;CAMK2D
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5173179333820962,-1.5598914966136568,0.03588516746411483,0.3417168852024181,1.0,12/25,14.18%,ANK2;ANK3;ATP1B1;WNK1;ATP1B3;SLC6A9;AKAP9;ATP1B2;ACTN2;WNK4;WNK3;NDUFA4
prerank,regulation of smooth muscle contraction (GO:0006940),-0.5425238010332232,-1.5593022630443734,0.03036876355748373,0.3405085904958981,1.0,6/20,9.97%,KCNB2;CHRM2;PLCE1;CTTN;CHRM3;ZDHHC21
prerank,T cell activation involved in immune response (GO:0002286),0.6625550882144681,1.5545021016065066,0.0364963503649635,0.8051672179615234,1.0,2/12,6.67%,LCP1;ICAM1
prerank,positive regulation of ossification (GO:0045778),-0.4614093256578035,-1.5532839587169076,0.01808785529715762,0.3543520315089811,1.0,18/39,21.82%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;OSR1;WNT4;ACVR1;KL;ANO6;TGFB1;BMPR1B;BMPR1A;BMPR2;CCN1;PKDCC
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.5443706248541649,-1.5512799915349913,0.026905829596412557,0.35741425708489827,1.0,8/20,17.89%,B4GALT1;FUT8;ST6GALNAC5;B3GALT5;ST3GAL4;B3GALT1;ST6GALNAC6;MPDU1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.5874072886500502,1.551130392014375,0.030965391621129327,0.8136798148804553,1.0,7/20,8.20%,BBS12;CCT2;NDUFAF1;PFDN6;LONP1;PSMG1;TMEM35A
prerank,T cell receptor signaling pathway (GO:0050852),0.4181698684207275,1.5504314121622058,0.009395973154362415,0.8063376335132764,1.0,37/138,15.09%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PTPRJ;PDE4D;PTPRC;MAP3K7;TAB2;PRKD2;PSMD11;PSMB4;FYN;PSMC1;PAK3;SPPL3;LCP2;PRAM1;PLCG1;EIF2B3;RELA;RBCK1;INPP5D;PSMC2;PAK1;PSMD2;PIK3CD;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;PAG1;DENND1B
prerank,actin polymerization or depolymerization (GO:0008154),-0.43671708344532506,-1.549605406027474,0.024725274725274724,0.359095462373906,1.0,14/50,7.49%,SVIL;GSN;GAS7;MICAL2;SPIRE1;WASL;ABI1;MICAL3;PSTPIP2;ARHGAP6;WASHC5;WASHC3;WASF1;COBL
prerank,neuromuscular synaptic transmission (GO:0007274),0.5925047029644661,1.5474350501467256,0.04081632653061224,0.8141148273107933,1.0,5/18,12.73%,SLC5A7;KIF1B;DTNA;TBC1D24;ERC1
prerank,regulation of bone mineralization (GO:0030500),-0.42817930167185086,-1.545891230189826,0.011019283746556474,0.36695094601830586,1.0,24/55,22.34%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;ENPP1;OSR1;WNT4;ANKH;ACVR1;KL;ECM1;ANO6;TGFB1;BMPR1B;BCOR;BMPR1A;BMPR2;TXLNG;CCN1;PKDCC;NOTUM
prerank,cellular response to metal ion (GO:0071248),0.4255375042210291,1.5442468510953224,0.00411522633744856,0.8224306053735018,1.0,11/123,1.88%,MT1B;MT1G;MT1F;MT1E;MT1A;MT1X;MT1M;MT1H;CPNE5;MAPK3;SLC25A24
prerank,regulation of chemotaxis (GO:0050920),-0.47996732679632736,-1.54419387039332,0.015706806282722512,0.36865631121515985,1.0,14/30,21.63%,PDGFRB;ADGRA2;EFNB2;P2RX4;PDGFRA;ZSWIM8;YTHDF1;STX3;THBS1;TGFB1;PTPN2;ZSWIM4;PPM1F;P2RY12
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.5224076367106267,-1.5441668942392832,0.03225806451612903,0.3657143200958798,1.0,11/21,22.64%,ADCY5;ADCY2;ADCY1;ADCY9;ADCY7;GUCY1A1;NPR1;ADCY8;ADCY3;GUCY1B1;ADCY4
prerank,regulation of nervous system process (GO:0031644),-0.5546620444838575,-1.5433307584870934,0.026066350710900472,0.3654121979280061,1.0,6/18,8.13%,DLGAP1;HTR2C;DLGAP2;DLGAP4;ROCK2;AKAP9
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5214109756070386,1.540820768025401,0.01644736842105263,0.8316254489799405,1.0,8/33,11.93%,PHPT1;PTPRJ;SH2D1A;PRKD2;RELA;CD81;RPS3;PRNP
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.5364397377214773,1.5406802437428087,0.034653465346534656,0.8206164986553391,1.0,9/30,8.88%,CERS1;DACH1;CTC1;SRC;ERCC4;CDKN1A;HNRNPC;ACD;ACVRL1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6847081240305608,1.5389454997322554,0.05009633911368015,0.8200123375434413,1.0,5/10,11.65%,MAPK3;GREM1;LYN;RNF13;NBR1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.6013913133559627,1.5387770223793744,0.034420289855072464,0.8097131020839407,1.0,2/16,5.41%,PTPRC;CYRIB
prerank,ceramide metabolic process (GO:0006672),0.48569113803533015,1.5387130475607558,0.03414634146341464,0.7991395096179408,1.0,8/49,6.76%,CERS1;ACER2;SMPD4;ST6GALNAC3;CERS4;PPP2CA;SGMS1;PLPP1
prerank,T cell proliferation (GO:0042098),0.6609072006254225,1.5385277747331951,0.045112781954887216,0.7895750065403665,1.0,3/13,2.55%,CADM1;PIK3CG;PPP3CB
prerank,axonal fasciculation (GO:0007413),-0.6352666894611827,-1.5369315913131365,0.03285420944558522,0.38109734605435985,1.0,4/12,10.79%,CNTN4;NRCAM;EPHB2;EPHA3
prerank,circulatory system development (GO:0072359),-0.3659465517282561,-1.5353587721450157,0.0,0.3827351163756054,1.0,34/118,14.21%,ERBB4;NTRK3;FGF12;CACNA1C;FBN1;AKAP13;PDLIM5;PKD1;MICAL2;GLI2;ADAP2;COL3A1;NXN;PCSK5;CXADR;TGFBR1;NCOA6;TGFBR2;PLCE1;PDLIM7;OSR1;HSPG2;CDKN1B;RBP4;FOXC1;ACVR1;SALL1;FN1;STK11;FOXC2;MTHFD1;WDR11;PDLIM1;TCF25
prerank,kidney development (GO:0001822),-0.4009204824965092,-1.5337905301079657,0.0,0.384373832847476,1.0,17/65,9.91%,ROBO2;SULF1;GREB1L;KANK2;PKD1;GLI2;PCSK5;TGFBR1;BMP7;SULF2;BMP4;OSR1;WNT4;NIPBL;FOXC1;PYGO1;SALL1
prerank,ganglion development (GO:0061548),-0.6453312375685425,-1.53209121306118,0.029723991507430998,0.38643793601604837,1.0,5/11,9.78%,NRP1;CTNNB1;UNC5C;SEMA3A;NRP2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5674259746842085,1.5312621666660313,0.047706422018348627,0.824069206137918,1.0,7/22,10.58%,TNFAIP3;TIRAP;IFI35;RAB7B;WDFY1;LYN;MFHAS1
prerank,cellular response to drug (GO:0035690),0.5544207132994466,1.53103183430354,0.03163444639718805,0.8146536455804537,1.0,4/25,2.08%,CERS1;RBM22;RAP2A;ACER2
prerank,pre-replicative complex assembly (GO:0036388),0.4608192485316181,1.5301102952293584,0.013412816691505217,0.8103852858456512,1.0,18/64,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ORC3;PSMD11;PSMB4;PSMC1;ORC4;PSMC2;PSMD2;ORC2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,positive regulation of protein binding (GO:0032092),0.46659638097596395,1.5276770256249683,0.022116903633491312,0.8148193499527281,1.0,16/56,11.27%,TRIB3;RALB;PIN1;TIAM1;HIPK2;PPP2CA;APOE;B2M;PPP2CB;BDNF;SPPL3;EPB41;AKTIP;CLDN5;TERT;APP
prerank,regulation of cell cycle phase transition (GO:1901987),0.4341598869640133,1.5257582236516514,0.008708272859216255,0.8164726432879659,1.0,25/91,14.01%,PSMB10;ERCC3;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ANAPC2;NEK11;PSMD11;PSMB4;PSMC1;CDKN1A;FBXO5;ANAPC7;PSMC2;TFAP4;PSMD2;ANAPC11;ANAPC10;ANAPC4;PSMD14;PSMC6;PSMD1;PSMB1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5543721314405319,-1.525626995538318,0.02643171806167401,0.40210549121163564,1.0,3/17,8.13%,ANK2;SNTA1;AKAP9
prerank,regulation of ERAD pathway (GO:1904292),-0.624195463021511,-1.5251737233014988,0.044444444444444446,0.4005360843819949,1.0,9/11,26.05%,USP13;HERPUD1;TMEM259;USP19;RNFT1;BAG6;UBXN1;AQP11;RNF185
prerank,histone H2B ubiquitination (GO:0033523),-0.656020870624076,-1.5248911110021837,0.028397565922920892,0.39826483910996696,1.0,7/10,21.13%,WAC;UBE2E1;CDC73;RNF8;PAF1;RNF40;DTX3L
prerank,embryonic organ morphogenesis (GO:0048562),-0.4486515778521314,-1.5242126116654817,0.017811704834605598,0.39710845720886373,1.0,11/42,9.13%,FGFR2;FBN1;EFEMP1;FBN2;HOXA3;DYNC2I1;PDGFRA;MFAP5;NIPBL;RBP4;ACVR1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3787417105386567,1.5240644096583598,0.0011534025374855825,0.8163795082037355,1.0,74/306,14.75%,POLR2J;RPL30;MRPS33;NR4A2;RSL24D1;EEF1A1;POLR2B;MRPL23;RPL17;RPL23;MRPL24;RPL31;RPL3;EEF1D;RPS21;ING4;MRPL18;PAX8;ORC3;EXT2;APOE;RAD1;RPL35A;RPS14;RPL8;YARS2;RPL5;ABCF1;PWP1;MRPS12;RPS12;POLE;CDC45;HBS1L;RPS26;RPL37A;HARS1;ORC4;RPL4;POLD3;RPLP0;POLA1;TSFM;RPS28;RPS24;EIF4G2;TERT;RPS9;RPS23;RPL24;THRB;RPL34;GTPBP2;HUS1;RPS11;ORC2;MRPL52;RPS3;TOP3A;MRPS15;NBN;DHPS;HELB;RRAGC;ING5;PPP5C;EEF1B2;RPS15A;RPL23A;RPL21;RPL35;RMI1;BAZ2A;BRIP1
prerank,dermatan sulfate metabolic process (GO:0030205),-0.605821686816189,-1.5239706580345111,0.038461538461538464,0.3947439480803399,1.0,9/13,28.53%,UST;DSE;VCAN;CSPG4;DSEL;BGN;DCN;CSPG5;CHST12
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.6418423368165727,1.5238830474150098,0.042884990253411304,0.8075431699815743,1.0,4/12,10.52%,BOD1;CHAMP1;CENPC;MIS12
prerank,dicarboxylic acid metabolic process (GO:0043648),0.47318347171955283,1.52160433977925,0.02923076923076923,0.8113050048119745,1.0,9/52,6.17%,PCK1;ALDH1L1;GCLC;ALDH5A1;SDHAF3;ME3;GOT2;GCLM;MTHFS
prerank,regulation of cardiac conduction (GO:1903779),-0.42181969209360987,-1.51740757165245,0.008746355685131196,0.4117246163280272,1.0,13/54,10.32%,ANK2;ATP1A2;ITPR1;RYR3;ATP1B1;STIM1;TMEM65;ATP1B3;ATP1A1;TRPC1;ATP1B2;PRKACA;DMPK
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3848013180509197,-1.5157274111567811,0.01567398119122257,0.41389831596971366,1.0,22/82,11.96%,DDX5;BMP6;FGFR2;RANBP3L;IGF1;SMOC1;NELL1;BMP7;IL6R;BMP4;FBN2;CRIM1;WNT4;SKI;TMEM64;LRP5;SMAD6;ACVR1;PRKACA;CDK6;SEMA4D;LIMD1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.4046690684989232,-1.5157252139621806,0.00909090909090909,0.41087991439472926,1.0,23/66,17.45%,FGFR2;TGFBR3;SULF1;ROBO1;NR2F2;NFIB;MCC;MTSS1;MED1;KLF9;NUPR1;XDH;SPARC;CDC73;THBS1;CDK6;AIMP1;CAV2;MAGED1;PEX2;TGFB1;ATP5IF1;SCG2
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.43086555988113484,-1.5147390171260207,0.030303030303030304,0.41097905897200987,1.0,17/46,20.03%,TMEFF2;PARVA;NTNG1;NRP1;FER;LAMC3;RHOA;PXN;SRCIN1;RADIL;FN1;ILK;NTN4;ITGA8;LAMB1;ITGA4;PIK3R1
prerank,skin development (GO:0043588),-0.4064994139173931,-1.5140502564482152,0.005813953488372093,0.41015812271375485,1.0,12/65,6.02%,COL1A2;COL1A1;PKD1;COL3A1;ERRFI1;COL5A1;CLIC4;COL5A2;MED1;ATP7A;BCR;PIP5K1A
prerank,neurogenesis (GO:0022008),-0.42951840247891004,-1.512160033525469,0.01881720430107527,0.41327400629143446,1.0,11/43,11.85%,LPAR1;SPOCK1;EPHB1;RYK;MAPT;CIT;ERCC6;TRAK1;CDK6;BTBD3;ANXA1
prerank,embryonic digit morphogenesis (GO:0042733),-0.5437672073350392,-1.510980347550044,0.05239179954441914,0.41401689603158803,1.0,7/18,14.49%,GLI3;HDAC1;OSR1;MAP3K20;SALL1;TBX3;INTU
prerank,amide biosynthetic process (GO:0043604),0.48261411045140734,1.5084025112567085,0.029459901800327332,0.8832860855807428,1.0,8/47,11.71%,PCSK1;CERS1;SMPD4;CERS4;SGMS1;DMD;SLC25A2;PAM
prerank,hexose metabolic process (GO:0019318),0.4907431154396016,1.5078978056316306,0.03782894736842105,0.8760489322531211,1.0,7/39,8.49%,PCK1;HECTD4;FUCA1;PPARD;OMA1;IRS2;GALM
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.5001835718894398,-1.506573495433856,0.038461538461538464,0.4251209899107453,1.0,4/25,8.60%,ANK2;AKAP6;CEMIP;TRPC1
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.39518012809798775,-1.5063488575546864,0.01791044776119403,0.4227170438107107,1.0,24/70,21.91%,TMEFF2;PARVA;NTNG1;NRP1;FER;LAMC3;RHOA;RILPL1;PXN;RELN;SRCIN1;RADIL;FN1;ILK;ARL13B;NTN4;UNK;ITGA8;LAMB1;ITGA4;PIK3R1;SIPA1L3;ATF4;RILPL2
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.628594328904889,-1.5046076423628616,0.04040404040404041,0.4255787912952863,1.0,4/12,10.13%,DPYD;DPYSL3;CTPS1;ALDH6A1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5142445185224263,1.5021625419247864,0.042105263157894736,0.9017959146842259,1.0,4/32,6.03%,ROMO1;RPL30;RNASE6;FAM3A
prerank,Rap protein signal transduction (GO:0032486),0.686562757296254,1.5018256021674183,0.05628517823639775,0.8936034673877753,1.0,4/10,12.24%,RAP2A;PLK2;RAPGEF3;RAP2C
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.5679417227508484,-1.5016453181906722,0.052752293577981654,0.4317650523758052,1.0,8/16,21.78%,PID1;PPARGC1A;VCP;PPARA;ATPSCKMT;PARP1;PINK1;FLCN
prerank,dopamine metabolic process (GO:0042417),-0.5479689058563315,-1.5010319590569823,0.04047619047619048,0.4309028455322325,1.0,5/18,13.43%,MOXD1;SNCAIP;ATP7A;COMT;MAOB
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.6368731353303745,-1.5006055026944605,0.037444933920704845,0.42933144457057476,1.0,7/11,30.50%,CAT;PRDX1;PRDX2;GPX1;PRDX3;PRDX4;PRDX5
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.428204036674284,1.5003873360698092,0.01694915254237288,0.8922590993639601,1.0,22/84,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ANAPC2;PSMD11;PSMB4;PSMC1;FBXO5;ANAPC7;PSMC2;PSMD2;ANAPC11;ANAPC10;ANAPC4;CUL3;PSMD14;PSMC6;PSMD1;PSMB1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5272208905699198,1.5000493421106438,0.030927835051546393,0.8843272698647361,1.0,3/29,6.81%,CADM1;CYRIB;AP1G1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.4945445211363744,-1.4986161261941922,0.037122969837587005,0.43247842566470585,1.0,7/25,10.52%,PKD1;IFNAR2;STAT2;GHR;IL31RA;STAT6;SOCS2
prerank,positive regulation of receptor internalization (GO:0002092),-0.5195699221816126,-1.498328476844078,0.04888888888888889,0.43061934293789067,1.0,2/22,1.74%,MAGI2;AHI1
prerank,regulation of cytokine production (GO:0001817),0.40237584739413995,1.4981582229123447,0.0013908205841446453,0.8862869268488858,1.0,19/126,9.60%,CIDEA;CADM1;PIK3CG;PTPRC;SOD1;FCGR2B;RPS6KA4;HDAC9;BCL6B;RPS6KA5;TNFRSF1B;NPTN;RGCC;PPP1R11;TRAF3;CD47;POLA1;LYN;LURAP1
prerank,negative regulation of hippo signaling (GO:0035331),-0.6088196737261389,-1.4980729296027395,0.04276985743380855,0.4285421215973427,1.0,6/12,16.86%,WWC2;MAPK14;CIT;VGLL4;LIMD1;SHANK2
prerank,neuron development (GO:0048666),-0.347711056579892,-1.4980639698966374,0.0036363636363636364,0.42570026612790196,1.0,42/141,17.07%,TENM2;MAP2;CNTN4;TENM3;PLP1;PBX1;PPP1R9A;MYT1L;GPM6B;GLI2;NTRK2;HDGFL3;SH3GL2;RASGRF1;RYK;MAPT;WNK1;ATP8A2;GPM6A;ATP7A;ERCC6;ROCK1;STMN2;ETV1;TDP2;NLGN1;CDK16;STX3;B4GALT6;GSK3B;DCX;UGDH;RAB11A;UNK;BICDL1;STMN1;SRRM4;RAPGEF2;EHD1;GPRIN3;PBX4;LAMB1
prerank,inorganic anion transport (GO:0015698),-0.4133237783054566,-1.4980038726445213,0.020588235294117647,0.4230909479186929,1.0,20/53,27.13%,SLC4A10;CLIC4;SLC26A7;ENPP1;SLC13A4;GLRA1;CLCN6;ANO1;CLCN2;ANO6;SLC26A11;ENPP3;CLIC5;SLC5A5;ANO10;TTYH3;SLC25A30;SLC25A11;TTYH1;FXYD1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.4769679994312396,-1.497792024474312,0.04556962025316456,0.4209553189941216,1.0,13/31,17.35%,FGFR2;CTNNA2;BOC;CDON;CTNNA1;MAPK14;CTNNB1;RBM4;CAMK1;IGF2;MEGF10;CDK9;CDC42
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.443521063997028,1.496433173630213,0.017673048600883652,0.8874843779318468,1.0,20/70,14.46%,PSMB10;PSMC4;PSMB6;MFSD6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;B2M;PSMC2;PSMD2;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;CYBA
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.40932601426715126,1.4953462383728622,0.010958904109589041,0.8850893189493871,1.0,27/114,14.01%,PSMB10;PSMC4;PSMB6;EIF5A;PSMD8;PSMD5;PSMD12;BIRC2;PSMD11;PSMB4;TNFRSF1B;PSMC1;EDAR;TRAF5;ACTN4;TRAF3;RELA;PSMC2;PSMD2;CDIP1;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;NFKBIA;PSMB1
prerank,regulation of blood circulation (GO:1903522),-0.4558575170803343,-1.4948071492847244,0.026004728132387706,0.4269928522141305,1.0,20/34,40.01%,CELF2;TPM1;PER2;DMPK;CAMK2D;SRI;ACE;BDKRB2;AGTR1;TBX2;FXYD1;KCNQ1;KCNJ12;DES;S100A1;KCNMB4;CACNA1H;ACE2;AGT;KCNIP2
prerank,negative regulation of catalytic activity (GO:0043086),0.551212771418861,1.494548404766947,0.03806228373702422,0.8809181760937217,1.0,7/24,10.41%,PHPT1;CAND1;IFIT1;SIRT1;NOTCH1;PPP1R12A;CCAR2
prerank,membrane depolarization during action potential (GO:0086010),-0.49459095971026423,-1.4935561341168428,0.04195804195804196,0.42822592344577515,1.0,7/26,8.73%,ATP1A2;CACNA1C;CACNA1D;SCN8A;SCN3A;KCNJ2;SCN1A
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.5075855850538085,1.4926069210788726,0.05016722408026756,0.8839523423291579,1.0,12/32,16.46%,MAP2K7;MAPK3;PNKP;CCT2;CCT5;MAP3K4;ACD;NEK7;TNKS;ATR;TCP1;PARN
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.397785267936471,1.492420439527531,0.013422818791946308,0.8756712989983929,1.0,38/163,14.51%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PTPRJ;PDE4D;PTPRC;MAP3K7;VAV3;TAB2;PRKD2;PSMD11;PSMB4;FYN;PSMC1;PAK3;SYK;SPPL3;LCP2;PRAM1;PLCG1;EIF2B3;RELA;RBCK1;INPP5D;PSMC2;PAK1;PSMD2;PIK3CD;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;PAG1
prerank,regulation of protein localization to centrosome (GO:1904779),-0.6363502884730319,-1.4918155173166228,0.052,0.43095471906319305,1.0,5/10,16.53%,BICD1;UBXN2B;GSK3B;NSFL1C;CEP250
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5882534631589763,-1.4902348572318977,0.04742268041237113,0.43322043951342276,1.0,4/13,10.60%,ANK2;CACNA1C;GJC1;GJA1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5961935382206571,-1.48918659286676,0.0625,0.43367653648095583,1.0,5/12,18.15%,RIMS1;UNC13C;UNC13B;SYT7;SYT2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.4574478314802827,-1.4885570566611686,0.03940886699507389,0.43288750056170305,1.0,5/31,4.07%,FGFR2;TGFBR3;TGFBR1;SMAD4;TPM1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.495502105139167,1.4878829654586894,0.04180064308681672,0.8944418572662797,1.0,13/38,18.84%,MIS18A;ASF1B;HJURP;RUVBL1;RSF1;CENPC;CABIN1;CENPP;RBBP4;CENPO;NPM1;ATRX;HAT1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5352614714390008,-1.4876381482357703,0.053452115812917596,0.43324740908482484,1.0,13/18,26.68%,RIMS1;NRXN1;DLG4;NLGN2;PRKCZ;RELN;NLGN1;CUX2;SHANK1;GRIN1;NLGN3;CHRNA7;STX1B
prerank,regulation of mRNA processing (GO:0050684),0.5080472071986434,1.4864742848762604,0.044189852700491,0.8935040571866821,1.0,13/32,10.59%,NCBP1;KHDRBS3;AHCYL1;ZFP36L1;SF1;QKI;HNRNPK;CPSF4;SRSF10;CDK11B;YTHDC1;PAPOLA;SRPK2
prerank,cellular response to alcohol (GO:0097306),-0.43303492024916185,-1.486090583307844,0.035623409669211195,0.43548460348331175,1.0,20/42,21.67%,ADCY5;GRAMD1B;ADCY2;CTNNA1;SPIDR;ADCY1;CTNNB1;KLF9;SMO;GLRA1;GRAMD1C;CDH1;ADCY7;GRAMD1A;LRP6;GPLD1;OSBPL7;BLM;ADCY8;ADCY3
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.5531656849314183,-1.4852162656057433,0.04925053533190578,0.4356129968655241,1.0,7/16,18.55%,IGF1;AKAP6;ROCK2;ROCK1;CAMK2D;IL6ST;PARP1
prerank,regulation of immune effector process (GO:0002697),0.4774376307427721,1.4848750378440283,0.030448717948717948,0.8938560130832648,1.0,6/41,12.58%,C1QB;C1QC;FCGR2B;PHB2;CD81;CD55
prerank,regulation of glucose import (GO:0046324),-0.45880584191656826,-1.4846830659616752,0.041666666666666664,0.4344541896586109,1.0,10/30,9.89%,SORBS1;PRKAG2;IGF1;PID1;OCLN;ENPP1;APPL2;AKT2;CREBL2;ARPP19
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.5144106847414879,-1.4845418796940875,0.0518018018018018,0.43217770035441494,1.0,6/20,10.68%,ANK2;ATP1A2;CACNA1C;ATP1B1;PRKACA;CAMK2D
prerank,axonal transport of mitochondrion (GO:0019896),-0.6057675801908562,-1.4826037722688359,0.06578947368421052,0.43525718809025754,1.0,4/11,16.19%,MAPT;TRAK1;NEFL;ACTR10
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.5347687811012398,-1.4820540864600646,0.049773755656108594,0.4343068266187547,1.0,6/18,16.23%,DDX5;EGFR;BMP4;MAP2K2;TP53;TGFB1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.5413164898969073,1.4818607471886827,0.044169611307420496,0.903262402606568,1.0,8/24,15.25%,TNFAIP3;RAMP2;TEK;KRIT1;ICAM1;TNIP2;CDH5;GAS6
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5639993896475959,1.481691996599731,0.07321428571428572,0.8952477562722339,1.0,4/19,5.71%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5850835113769477,1.4797573036369378,0.066543438077634,0.8983977096972411,1.0,2/17,6.81%,CADM1;AP1G1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5919997890228409,1.4797314322345427,0.07208872458410351,0.8897591955277908,1.0,2/16,6.81%,CADM1;AP1G1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.5518984173367609,1.4792738878121419,0.05719557195571956,0.88367981993496,1.0,8/20,12.22%,GNAQ;RGS8;GNB1;RGS10;GNA11;PLCB1;AGRN;LYPD1
prerank,regulation of T cell cytokine production (GO:0002724),0.6031119477946184,1.4792061339563398,0.06095238095238095,0.8756023948909694,1.0,6/15,12.58%,MAP3K7;TNFRSF1B;B2M;SMAD7;TRPM4;CD55
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.48836762709183107,-1.47772517356256,0.02564102564102564,0.44474147061770763,1.0,8/23,20.02%,FBXW11;HTT;UBXN2B;GJA1;NSFL1C;DCTN1;NDE1;ZW10
prerank,heterocycle biosynthetic process (GO:0018130),0.610259614643867,1.476449719014255,0.04961832061068702,0.8845239326038518,1.0,2/14,0.85%,GPHN;MOCS3
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.5822890259471566,-1.4753140530895281,0.058695652173913045,0.44997454078210003,1.0,6/14,17.46%,MALT1;PRKCZ;ANXA1;RARA;IL18;SOCS5
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5114592188416396,-1.4746478629086586,0.04408352668213457,0.44937127197929394,1.0,7/21,12.21%,ANK2;ATP1A2;CACNA1C;AKAP6;PRKACA;CAMK2D;SRI
prerank,mitochondrial fusion (GO:0008053),0.5719678605075358,1.4739403478776487,0.05860805860805861,0.8912192330315891,1.0,2/18,0.19%,THG1L;MIGA1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.5903670715411701,1.4737003420072892,0.058935361216730035,0.8845040312661822,1.0,7/16,18.78%,NAA25;EP300;NAA35;CREBBP;NAA80;NAA15;NAA50
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.39867481222747725,1.473536797424977,0.014124293785310734,0.877248335240753,1.0,35/124,14.38%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;FRZB;LEF1;MAP3K7;TIAM1;PPP3CB;AP2S1;PSMD11;PFN1;PSMB4;PSMC1;GNB1;CCDC88C;DAAM1;WNT5A;PSMC2;PLCB1;FZD9;FZD3;PSMD2;CELSR1;NLK;AGO4;PPP3CA;PPP3R1;PSMD14;PSMC6;PSMD1;PSMB1;AP2M1
prerank,actin cytoskeleton reorganization (GO:0031532),-0.3895988245773285,-1.472763106231918,0.008620689655172414,0.45251912132892386,1.0,19/63,13.71%,MCU;GSN;PARVA;AUTS2;NRP1;CXADR;CDC42BPB;PTK7;FER;RHOA;FLNA;NEDD9;KIT;PIP5K1A;CTTN;EZR;ANXA1;GRB2;MKLN1
prerank,cellular response to light stimulus (GO:0071482),0.4393788661142489,1.4726195300294058,0.03587443946188341,0.8745785897926637,1.0,20/66,17.96%,GPR52;SAG;EIF2S1;RUVBL2;ERCC4;YY1;POLK;EP300;GNB1;USP47;CREBBP;BMF;INO80;TAF1;ATR;N4BP1;TMEM161A;USP28;NPM1;RPL26
prerank,stem cell differentiation (GO:0048863),-0.42951332109321494,-1.4722827806616394,0.020151133501259445,0.4515817279856381,1.0,14/39,17.68%,FGFR2;PUM1;UFL1;JARID2;KIT;GPM6A;OSR1;TP53;NELFB;LMBR1L;MTF2;LRP6;METTL5;ACE
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6021758114816524,1.47141390535767,0.05321100917431193,0.8733868505984159,1.0,5/15,9.76%,RPL23;RPL5;FBXO5;SMAD7;PARK7
prerank,protein localization to cell surface (GO:0034394),-0.4819991630065861,-1.4714024415878206,0.02733485193621868,0.4516614321655142,1.0,13/26,23.94%,ANK2;CTNNB1;FLNA;JAM3;VCL;USP4;GGA2;MESD;PTPRU;GGA3;PRRT1;UNC50;EMP2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6686868500204097,1.4710272193806877,0.06857142857142857,0.8676966060145226,1.0,3/10,13.01%,PRKAR1A;PRNP;CD274
prerank,iron ion transmembrane transport (GO:0034755),-0.6301143225004866,-1.4697655112796015,0.053061224489795916,0.45430672833365593,1.0,5/10,22.62%,SLC39A14;SCARA5;SLC39A8;SLC11A2;SLC25A28
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.5050585423042345,-1.469182377348959,0.041666666666666664,0.4534995701594273,1.0,4/22,8.00%,ZBTB20;SORBS1;PPARA;CREBL2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.4228063873697518,-1.4678885326579194,0.02127659574468085,0.45510209953857167,1.0,16/43,18.74%,SORBS1;OGT;TNS2;PID1;GKAP1;PRKCZ;ENPP1;SORL1;PRKCD;PIP4K2B;NUCKS1;GRB10;IGF2;PTPN2;TSC2;RPS6KB1
prerank,snRNA metabolic process (GO:0016073),-0.5361776986469455,-1.4677465980634743,0.06047516198704104,0.4529801483623844,1.0,13/17,33.07%,INTS10;INTS8;MTREX;INTS11;RBM7;ZCCHC8;INTS7;TUT1;INTS12;INTS9;INTS3;MEPCE;INTS1
prerank,nerve growth factor signaling pathway (GO:0038180),-0.6433231134804986,-1.4658187297446297,0.06153846153846154,0.45638103188694557,1.0,1/10,0.01%,MAGI2
prerank,positive regulation of lipid localization (GO:1905954),-0.6094657351731145,-1.46580013042911,0.052313883299798795,0.4538729520824815,1.0,4/11,14.24%,LRP1;NFKB1;IKBKE;VSTM2A
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.6410025968095863,-1.4657123136699461,0.05360824742268041,0.44908630192836363,1.0,3/10,6.59%,HDAC4;NUPR1;PPARA
prerank,negative regulation of glycolytic process (GO:0045820),-0.6410025968095863,-1.4657123136699461,0.05360824742268041,0.44908630192836363,1.0,3/10,6.59%,HDAC4;NUPR1;PPARA
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.6215577555832452,-1.4653500894450995,0.06167400881057269,0.4475912235504751,1.0,5/11,30.08%,BIN1;CAMK2D;CACNA2D1;CACNB1;NOS1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.5042325868601253,1.4637741070311256,0.04948805460750853,0.9034065098768203,1.0,9/31,10.17%,TOMM20;ROMO1;TIMM17B;PEX1;PEX7;GRPEL2;TOMM40L;TIMM21;AIFM1
prerank,regulation of heart contraction (GO:0008016),-0.3652820652756561,-1.462053422093787,0.020338983050847456,0.45506155899541373,1.0,20/90,12.75%,CELF2;ANK2;ATP1A2;ITPR1;RYR3;ATP1B1;STIM1;ASB3;TMEM65;TPM1;P2RX4;ATP1B3;ATP1A1;TRPC1;ATP1B2;PRKACA;DMPK;CAMK2D;SRI;ABCC9
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.5421503244320184,-1.461598250018353,0.05790645879732739,0.45389835607226914,1.0,5/17,7.71%,HDAC4;PID1;NUPR1;PPARA;FIS1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.5046971899815895,1.4615385834496137,0.04965753424657534,0.9012706314906542,1.0,6/31,8.79%,POLR2J;ERCC3;NCBP1;POLR2B;CCNH;GTF2H1
prerank,7-methylguanosine RNA capping (GO:0009452),0.5046971899815895,1.4615385834496137,0.04965753424657534,0.9012706314906542,1.0,6/31,8.79%,POLR2J;ERCC3;NCBP1;POLR2B;CCNH;GTF2H1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5690176617247016,1.4614756722576137,0.07540394973070018,0.8937180234909089,1.0,4/17,5.71%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.45681678982244195,1.4610223951499304,0.03206106870229008,0.8887716254088561,1.0,16/50,15.27%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;PSMB1;ODC1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.48775740963935754,1.460695691897289,0.0467741935483871,0.8829464933366408,1.0,11/39,12.65%,TNFAIP3;RAMP2;TEK;KRIT1;ICAM1;RGCC;PLCG1;TNIP2;PRKCI;CDH5;ECSCR
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4606582748117242,1.460521440018605,0.0327613104524181,0.8764113176673456,1.0,5/53,6.74%,HRH4;MTNR1A;HTR1F;TSHR;HTR2A
prerank,neuron cell-cell adhesion (GO:0007158),-0.5749492455947395,-1.4600238596980026,0.06941431670281996,0.4562858282512033,1.0,7/14,11.97%,NRXN3;CNTN4;NRXN1;NCAM2;NLGN2;NLGN1;NRXN2
prerank,positive regulation of biosynthetic process (GO:0009891),-0.4332472816869449,-1.4597182831756639,0.03980099502487562,0.454685697578417,1.0,7/40,8.00%,ZBTB20;SORBS1;VIM;BMP4;PPARA;WNT4;CREBL2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.43130145527517916,1.4595475801295708,0.021994134897360705,0.8750117070840248,1.0,22/72,14.88%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TIRAP;BIRC2;PSMD11;TNFRSF10B;PSMB4;PSMC1;RELA;PSMC2;PSMD2;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;COPS8
prerank,cardiac myofibril assembly (GO:0055003),-0.5499862130194261,-1.4593426670441547,0.075,0.453378192786298,1.0,3/15,12.31%,PDGFRB;PDGFRA;OBSL1
prerank,import into cell (GO:0098657),-0.4319978899723395,-1.4590565116658496,0.03208556149732621,0.45180481478136036,1.0,16/41,17.61%,ATP1A2;SNAP25;SLC1A3;SLC6A13;SLC47A1;LRRC8D;GLUL;SLC39A14;SLC22A4;SLC27A1;SLC12A6;SLC19A1;SLC16A2;LRSAM1;SLC12A4;SLC5A6
prerank,embryonic eye morphogenesis (GO:0048048),-0.6017180469574759,-1.4590546457596283,0.06765327695560254,0.44939479919745273,1.0,5/11,15.42%,FBN1;EFEMP1;FBN2;MFAP5;LRP6
prerank,cardiac muscle tissue development (GO:0048738),-0.4099226488366867,-1.4586922251116068,0.035398230088495575,0.4481844679025797,1.0,17/50,19.93%,NOTCH2;AKAP13;GJB6;BMP5;BMP7;SMAD4;MAML1;BMP4;ADAMTS9;RBP4;SIK1;GJA1;CACNA1G;SMAD5;TBX18;BMPR1A;BMPR2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.5263561471054308,1.4561456443145473,0.05595667870036101,0.8880719224541792,1.0,3/23,4.01%,SLC12A1;SLC9A7;CLCN3
prerank,microtubule-based transport (GO:0099111),0.6135253960530744,1.4556039241507746,0.082,0.8839925376036984,1.0,2/12,2.17%,DYNC1I1;CABYR
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.44774218973498364,1.4549624368332637,0.03125,0.880263130610001,1.0,15/53,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,striated muscle tissue development (GO:0014706),-0.46697239647652916,-1.4548021615994458,0.055299539170506916,0.45747948315455544,1.0,6/29,7.87%,SVIL;CFLAR;BMP5;BMP7;IGSF8;RBP4
prerank,metanephric mesenchyme development (GO:0072075),-0.6222653152339322,-1.4542090657298747,0.05776892430278884,0.4569363536898671,1.0,6/10,24.84%,OSR1;WNT4;SIX1;STAT1;BASP1;PAX2
prerank,positive regulation of immune response (GO:0050778),0.4343134920059725,1.4534234379035107,0.03930817610062893,0.8817965732580353,1.0,9/64,14.46%,PCK1;PTPRC;FCGR2B;IFI35;SIRT1;CD81;POLR3F;POLR3B;CYBA
prerank,bone development (GO:0060348),-0.4371668362585993,-1.4532907900426404,0.042821158690176324,0.4570093080982842,1.0,17/39,22.34%,FGFR2;RANBP3L;SULF1;AKAP13;SULF2;SKI;LRP5;GJA1;TP53;DYM;CYP26B1;LRP6;MBTPS2;SFRP4;P3H1;SH3PXD2B;NOTUM
prerank,embryonic limb morphogenesis (GO:0030326),-0.444405572588283,-1.4532843464812708,0.041237113402061855,0.45465263254757693,1.0,14/34,15.42%,AFF3;CACNA1C;GLI3;CTNNB1;HDAC1;OSR1;MAP3K20;SKI;NIPBL;SALL1;TBX3;CYP26B1;INTU;LRP6
prerank,sphingolipid catabolic process (GO:0030149),0.5850287907214144,1.4525091044512335,0.10112359550561797,0.8797795969742253,1.0,3/15,3.22%,ACER2;SMPD4;PPT1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.6110340463481883,-1.452435538480031,0.07032967032967033,0.45480704094258934,1.0,3/10,9.11%,ATP1A2;VDAC1;BIN1
prerank,positive regulation of cilium assembly (GO:0045724),-0.5205727831428901,-1.4522330613206196,0.059496567505720827,0.4531278122126305,1.0,9/18,33.31%,TAPT1;CEP120;HTT;ENTR1;CCP110;FUZ;KCTD17;WRAP73;CROCC
prerank,regulation of humoral immune response (GO:0002920),0.463862354699141,1.4521287534987708,0.04567699836867863,0.8745955338512285,1.0,6/44,12.58%,C1QB;C1QC;FCGR2B;PHB2;CD81;CD55
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.5092815133100892,-1.4517251531543134,0.04377880184331797,0.4524003499060029,1.0,7/23,9.05%,IGF1;AKAP6;MAPK14;EFNB2;MAML1;MMP14;NIBAN2
prerank,metal ion export (GO:0070839),-0.45781954766082683,-1.4500303866161255,0.03349282296650718,0.4550702374529807,1.0,7/31,9.45%,ATP1A2;ATP1B1;ATP1B3;ATP7A;ATP1A1;KCNK5;ATP1B2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.39756950955782316,1.4499193982597576,0.017711171662125342,0.880198681583711,1.0,18/116,10.62%,GPR176;PRKAR1A;PTGER2;FCGR2B;PLK2;SRC;TSHR;INSL3;RAMP2;FYN;GNB1;RXFP1;SYK;PLCG1;LYN;RHBDF2;CD163;YES1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.4455622074082848,1.4492830957458886,0.029275808936825885,0.8767962665011036,1.0,17/55,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;USP47;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;AVEN;PSMB1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.4595698343766158,-1.4481517325805375,0.03341288782816229,0.4583737736945131,1.0,7/31,6.19%,FGFR2;TGFBR1;TGFBR2;HOXA3;OSR1;DYNC2I1;PDGFRA
prerank,plasma membrane organization (GO:0007009),-0.39514853407420525,-1.4462796600918637,0.025157232704402517,0.46195264104417855,1.0,29/61,33.15%,ANK2;ANK3;EPB41L3;A4GALT;COL5A1;BIN1;BIN3;MYOF;PLSCR1;AHNAK2;TLCD2;SYT11;ABCD2;ANO6;SYT7;PACSIN1;ARV1;DEGS1;ANXA6;CLN3;SERP1;SPTBN1;SYTL4;ABCA7;PACSIN3;PLSCR4;CAVIN2;MICALL1;SMPD1
prerank,regulation of telomere capping (GO:1904353),0.5356045938382876,1.4461266682670029,0.06457242582897033,0.8881457712822625,1.0,7/23,12.55%,MAP2K7;MAPK3;PNKP;MAP3K4;NEK7;TNKS;NBN
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.49572160848352964,-1.4460345996240485,0.059850374064837904,0.4602796964526529,1.0,6/21,6.46%,ERRFI1;MAFG;BMP4;CBFB;ROCK2;ROCK1
prerank,cellular response to hypoxia (GO:0071456),0.39454749652235865,1.4457063980477505,0.014627659574468085,0.8839101424634291,1.0,36/126,14.01%,PSMB10;PSMC4;PSMB6;ELOC;PSMD8;PSMD5;PSMD12;HIPK2;STOX1;ZFP36L1;PSMD11;SCN2A;PSMB4;PSMC1;EP300;CARD16;RGCC;SIRT1;MDM2;PSMC2;PSMD2;BAD;TERT;HYOU1;HP1BP3;CREBBP;HIGD1A;UBQLN1;ELOB;EGLN2;BNIP3L;PSMD14;EPAS1;PSMC6;PSMD1;PSMB1
prerank,positive regulation of neutrophil migration (GO:1902624),0.5587657572486641,1.4453720315163496,0.0867992766726944,0.8790614914773995,1.0,4/18,5.71%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,protein localization to membrane (GO:0072657),-0.3253001909509799,-1.4450743291092807,0.004166666666666667,0.4610061320502957,1.0,56/187,18.37%,MAGI2;DLG2;ANK2;DPP6;ANK3;KCNB2;LRRC7;KCNIP4;EPB41L3;NRXN1;MAP7;RAB3C;ATP1B1;PACS2;DLG4;NLGN2;FLNA;KCNIP3;SYNE3;ROCK2;ATP1B3;FLOT2;RAB8B;PIP5K1A;ROCK1;TTC7B;NUP155;NLGN1;EZR;DLG3;TM9SF4;ACTN2;TTC7A;CDH1;DPP10;LRRC4;NRXN2;RAMP1;ARL5A;DLG1;MYADM;RAB11A;WNK3;WDR19;STXBP1;AP4M1;FYB1;LRP6;RAPGEF2;EHD1;RAB8A;EHD3;DVL1;ITGA4;FRMPD1;ZFYVE27
prerank,negative regulation of lipid metabolic process (GO:0045833),0.5342249848047563,1.4445135019811555,0.06304728546409807,0.877214800443111,1.0,2/22,6.15%,CIDEA;ASXL3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5192076801827284,1.4444597088397408,0.06445993031358885,0.8708584319809656,1.0,9/25,15.70%,RPL23;PDCL3;PSME3IP1;HIPK2;RPL5;EFNA1;OPHN1;CSNK2A2;TAF1
prerank,plasma membrane invagination (GO:0099024),-0.45995835230754634,-1.4432031476330258,0.034653465346534656,0.46450159312047545,1.0,6/29,5.56%,GULP1;GSN;DOCK1;SPIRE1;RHOA;ARHGAP12
prerank,response to X-ray (GO:0010165),-0.5579672319969898,-1.4431568784019124,0.06278026905829596,0.4624206155457906,1.0,7/14,20.02%,NIPBL;IKBIP;ANXA1;NUCKS1;MSH2;ATM;BLM
prerank,regulation of cell killing (GO:0031341),0.5735537858282865,1.4430616771242726,0.06751824817518248,0.8724224631052054,1.0,5/16,14.46%,MAPK8;ICAM1;WNT5A;CD55;CYBA
prerank,regulation of cellular component movement (GO:0051270),-0.4053257085158139,-1.4418349646711828,0.028089887640449437,0.46425766983313593,1.0,26/49,29.61%,ERBB4;TGFBR3;EGFR;TGFBR1;PDPN;RHOA;ROCK2;ROCK1;ZSWIM8;YTHDF1;CDK6;PRAG1;RAF1;ABL2;DIAPH1;ZSWIM4;CADM4;VEGFA;ERBB2;ZSWIM5;INPP5F;DAPK3;HDAC6;HBEGF;NRG4;ARAP1
prerank,relaxation of muscle (GO:0090075),-0.5646010520928761,-1.4409681697399566,0.08158995815899582,0.46467293511067087,1.0,7/13,10.68%,ATP1A2;GSN;ATP1B1;P2RX4;ATP1A1;KCNJ2;CAMK2D
prerank,positive regulation of catalytic activity (GO:0043085),0.4849087580318863,1.4406049190873642,0.05679862306368331,0.8791385034849951,1.0,9/37,9.71%,MAPK3;SOD1;PSEN2;CIB1;MAPK8;CHTOP;YWHAB;SSBP1;MSH3
prerank,immunoglobulin mediated immune response (GO:0016064),0.6381530284786314,1.439211335993221,0.08269230769230769,0.8808536728989691,1.0,2/10,10.70%,FCGR2B;CD81
prerank,neuron projection fasciculation (GO:0106030),-0.6294519799807261,-1.4372745422207591,0.05421686746987952,0.4742829118682854,1.0,4/10,19.12%,CNTN4;NRCAM;EPHB2;SEMA5A
prerank,retinoic acid metabolic process (GO:0042573),-0.5485914719099507,-1.4372562557669424,0.08590308370044053,0.47203001960346647,1.0,3/14,13.51%,ALDH1A2;SCPEP1;CYP26B1
prerank,neuron fate commitment (GO:0048663),-0.5532140104660056,-1.4371862802044744,0.07505518763796909,0.470012151046685,1.0,2/14,3.29%,MYT1L;TGFBR1
prerank,synaptic vesicle cycle (GO:0099504),-0.4594836701401256,-1.4368776481389784,0.04976303317535545,0.46863405366511585,1.0,9/30,16.64%,RIMS1;SNAP25;PCLO;SYNDIG1;NLGN1;BRSK1;VAMP2;SYT7;STX1A
prerank,cell-matrix adhesion (GO:0007160),-0.35946535675354774,-1.436868614477407,0.013333333333333334,0.4664134486349597,1.0,25/95,14.06%,SORBS1;ITGBL1;ADAMTS12;PKD1;ITGB8;COL3A1;SGCE;NID2;PPFIA1;ADAMTS9;VCL;ITGB5;BCR;PIP5K1A;DDR1;CTTN;COL13A1;VTN;ACTN2;ITGA11;FN1;ILK;CD34;MKLN1;ITGA8
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.5389313549986909,-1.4368180768885024,0.08247422680412371,0.46434335229163765,1.0,6/15,18.55%,IGF1;ROCK2;ROCK1;CAMK2D;IL6ST;PARP1
prerank,estrogen metabolic process (GO:0008210),0.5891406511105974,1.436788862409184,0.09550561797752809,0.8882777635315514,1.0,4/15,11.74%,SULT1A1;HSD17B11;CYP1B1;HSD17B4
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.49608432746049247,-1.4363254624617325,0.06993006993006994,0.4636286277006891,1.0,8/21,19.90%,IGF1;IGFBP5;ADAMTS1;GJA1;JUN;BMPR1A;DNMT1;MMP2
prerank,nervous system development (GO:0007399),-0.29496865642322656,-1.4362218939295393,0.0,0.46172467535918965,1.0,112/429,17.97%,NAV3;ERBB4;ROBO2;NOTCH2;CNTN4;DCLK1;SDK1;LPAR1;FGF12;TEAD1;ROBO1;ZIC1;ADAM22;ARNT2;ALDH1A2;ZIC4;NRXN1;CNTN6;SPOCK1;GSN;KIRREL3;MYT1L;GPM6B;NRCAM;EFNA5;AHI1;ADAM23;PKD1;GLRB;ADGRA2;CHRM2;EPHB1;NBL1;HDAC4;TMOD2;MBP;SH3GL2;NELL1;TGFBR1;MOBP;DLG4;AXL;RYK;ZEB2;TRPC5;DNER;DSCAM;JARID2;ADGRV1;NLGN2;GLIS2;IL1RAPL2;GPM6A;CRIM1;SCN8A;GMFB;VCAN;RELN;SMO;ZIC5;ERCC6;IGSF8;LDB1;FEZ1;TRAK1;MOG;SDK2;CHRM3;NLGN1;FUT10;RBFOX3;BTBD3;CDH1;EPHB2;NUMBL;NR2C2;ZIC2;FN1;DCX;TBX3;NRXN2;ALDH3A2;ACVR1B;OBSL1;APBA1;ATXN1;DPF2;COX7B;FKTN;PLXND1;VLDLR;INTU;DACT1;ATN1;ARHGAP26;SRRM4;NINJ2;DCTN1;NGF;NPAS2;TGFB1;NHEJ1;NES;WWTR1;SZT2;SHANK2;DVL1;S100B;CYP51A1;SOX6;MYLIP;GFRA2
prerank,positive regulation of phosphatase activity (GO:0010922),-0.4935814794963739,-1.4352344033490625,0.07058823529411765,0.4627241498974516,1.0,2/21,1.84%,MAGI2;PDGFRB
prerank,carbohydrate biosynthetic process (GO:0016051),-0.49795238073093495,-1.4351799487897792,0.05694760820045558,0.4607523006982218,1.0,8/21,17.89%,B4GALT1;FUT8;ST6GALNAC5;B3GALT5;ST3GAL4;B3GALT1;ST6GALNAC6;MPDU1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5681417955739377,-1.4342060978904876,0.08185840707964602,0.4616311780857434,1.0,7/13,15.77%,PLXNA2;NRP1;SEMA3A;NRP2;PLXND1;PLXNB2;PLXNC1
prerank,skeletal system development (GO:0001501),-0.3331295541401744,-1.433405589926429,0.00392156862745098,0.46209317583973103,1.0,27/148,8.02%,BMP6;FGFR2;IGF1;COL1A2;SULF1;FBN1;AKAP13;COL1A1;PKD1;GLI2;ITGB8;PCSK5;MMP16;TGFBR1;SOX5;BMP5;BMP7;SULF2;VCAN;MMP14;NPR3;ATP7A;CREB3L2;CDH11;ANKH;RBP4;COL13A1
prerank,regulation of microtubule polymerization (GO:0031113),-0.4159468938562712,-1.433069874808201,0.03611111111111111,0.46092348244265346,1.0,12/40,15.74%,NAV3;MAP2;EML2;MAPT;OCLN;STMN2;AKAP9;SLAIN2;CLIP3;STMN1;TUBB4A;DCTN1
prerank,neutral amino acid transport (GO:0015804),0.4968953427429987,1.4316444438618376,0.05679862306368331,0.9117481635772564,1.0,5/28,5.53%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC6A6
prerank,positive regulation of potassium ion transport (GO:0043268),-0.42697511214975403,-1.4315990740678934,0.03278688524590164,0.4631082999040753,1.0,10/38,12.92%,ANK2;KCNMA1;AKAP6;FHL1;FLNA;GABBR2;KCNJ2;ACTN2;KCNJ6;DLG1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4305610648440601,1.4311655704668977,0.0532724505327245,0.9078153284299771,1.0,24/60,20.78%,MAP2K7;MAPK3;PNKP;GREM1;CCT2;PRKD2;CCT5;MAP3K4;RGCC;ACD;NEK7;TNKS;ATR;TCP1;DKC1;PARN;PARM1;TNKS2;NVL;CCT8;RFC5;PTGES3;HSP90AB1;PDGFB
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5210924966498828,-1.4304742203319807,0.06100217864923747,0.4642756449960344,1.0,2/17,1.32%,ANK3;AKAP6
prerank,inositol lipid-mediated signaling (GO:0048017),-0.40220135034778676,-1.4296772036458503,0.030136986301369864,0.4645783074142359,1.0,19/50,16.54%,IGF1;OGT;PDGFRB;ADAP2;PLCL2;RHOA;PLCE1;PIK3C2B;PIK3C3;PDGFRA;PLCD3;EZR;PLCB3;GAB2;PLCH1;PLCL1;NGF;EXOC1;PLCD1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4795358439848809,1.429603205238365,0.05737704918032787,0.9103864472573722,1.0,7/33,6.17%,GCLC;ALDH5A1;GLS2;GLS;GOT2;GCLM;MTHFS
prerank,skeletal muscle tissue development (GO:0007519),-0.45157737499742456,-1.429439831503627,0.07159904534606205,0.4632239145582004,1.0,7/32,18.72%,SVIL;CFLAR;IGSF8;SKI;CAV2;SELENON;SIX1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.4250323880609035,1.4291843573342935,0.04769001490312966,0.9063572168978152,1.0,19/67,14.46%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;B2M;PSMC2;PSMD2;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;CYBA
prerank,myeloid dendritic cell activation (GO:0001773),-0.580148778417263,-1.4287576614582425,0.058333333333333334,0.4632175700825895,1.0,3/12,9.65%,TGFBR2;CAMK4;DOCK2
prerank,ribosomal large subunit assembly (GO:0000027),0.5171700172197619,1.4287097112533031,0.06896551724137931,0.9025527389191502,1.0,8/24,13.61%,RSL24D1;FASTKD2;RPL3;RPL5;MRPL20;RPLP0;RPL24;RPL23A
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.4759622548776784,-1.4284380972227384,0.07888631090487239,0.46209460927969176,1.0,10/26,24.40%,SULF1;SULF2;CCBE1;IL6ST;RORA;TGFB1;SARS1;PTGS2;ATF4;EIF2AK3
prerank,histone H2A acetylation (GO:0043968),0.5746560035413164,1.4283383085818668,0.07649253731343283,0.8984049976971805,1.0,7/16,13.11%,ACTL6A;RUVBL2;DMAP1;RUVBL1;YEATS4;ING3;TRRAP
prerank,protein import into peroxisome membrane (GO:0045046),-0.4821142317086769,-1.4275021144417503,0.06575963718820861,0.4628109071170167,1.0,13/22,30.45%,ACBD5;RAB8B;PEX14;FIS1;ALDH3A2;PXMP4;ABCD2;PEX2;PEX5;GDAP1;ABCD3;PEX26;PEX19
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.40626006790903524,-1.4269775834155327,0.034482758620689655,0.46220783317733627,1.0,19/45,20.15%,DDX5;EGFR;BMP4;RIOK1;LIN28B;RIOK2;MAP2K2;NFKB1;TP53;POLR2A;ZC3H18;WDR43;SETX;SIRT7;TGFB1;HABP4;GRSF1;PIK3R1;SUPV3L1
prerank,lung epithelium development (GO:0060428),-0.6192074820195197,-1.4268055723510384,0.07976653696498054,0.4607085824304343,1.0,4/10,14.41%,PKD1;ERRFI1;BMP4;RCN3
prerank,organelle fusion (GO:0048284),0.5287663493972937,1.425122960204667,0.078125,0.9104404504328807,1.0,3/22,4.40%,THG1L;MIGA1;VPS11
prerank,neuron projection extension (GO:1990138),-0.4439807762747661,-1.4251202245330217,0.036855036855036855,0.4638797883052593,1.0,10/32,9.78%,ALCAM;MAP1B;ULK2;IQGAP1;AUTS2;SH3GL2;NRP1;CTNNB1;SEMA3A;NRP2
prerank,regulation of defense response (GO:0031347),0.4133608174414532,1.424096694231493,0.03468208092485549,0.9099501111637537,1.0,17/76,11.90%,LRP8;PIK3AP1;IL1R1;SEMA7A;FCGR2B;TIRAP;BCL6B;BIRC2;SBNO2;APOE;SPATA2;WNT5A;TRAF3;RELA;PARK7;NLRP6;USP18
prerank,eye development (GO:0001654),-0.40403978711526534,-1.423960364818623,0.03551912568306011,0.46533525465131176,1.0,21/54,21.64%,CACNA1C;FBN1;PBX1;SMOC1;COL5A1;COL5A2;EFEMP1;MEIS2;FBN2;SKI;NIPBL;RBP4;FOXC1;HIPK1;BMPR1B;PBX4;LAMA1;PBX2;SIPA1L3;SMG9;SH3PXD2B
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.537781014873602,-1.4232012551762732,0.06550218340611354,0.465744964857052,1.0,5/15,13.04%,DAB2;SNAP91;WASL;SCYL2;HIP1R
prerank,positive regulation of neuron projection development (GO:0010976),-0.3555714761901851,-1.4229031318822571,0.024844720496894408,0.46458121545923153,1.0,38/85,22.79%,MAGI2;NTRK3;TENM3;LRRC7;DPYSL3;NTRK2;BMP5;TOX;BMP7;PTK7;ROR1;RELN;CBFA2T2;PLPPR5;COBL;STMN2;ARSB;ATP1B2;EPHA3;CUX2;RIT2;CAMK1;VLDLR;ROR2;SETX;PLXNB2;RAPGEF2;ABL2;TWF2;SCARF1;SNX3;PACSIN1;CX3CL1;P3H1;PRKD1;DBNL;CAMK2B;SCN1B
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.42432869885826974,-1.422077471481793,0.0532994923857868,0.46498084262427636,1.0,9/40,6.20%,NTRK3;LPAR1;EGFR;PDGFRB;NTRK2;KIT;ARHGAP6;PDGFRA;EDNRA
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.6120095243533071,-1.4213233551212163,0.07983193277310924,0.4650794129343305,1.0,3/10,13.39%,PRKCZ;RARA;IL18
prerank,regulation of immunoglobulin production (GO:0002637),0.5148263236885651,1.4212323449936435,0.06770833333333333,0.9202606089951483,1.0,4/23,10.85%,PTPRC;FCGR2B;PHB2;GPI
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.4407055656760858,-1.4210742067269544,0.06928406466512702,0.46383634503137605,1.0,13/31,26.45%,SYT9;SYT12;SYT11;CACNA1G;SYT4;STXBP1;SYT7;SCAMP5;STX1A;SYT2;ADRA2A;SYT10;SYT6
prerank,SNARE complex assembly (GO:0035493),-0.617815958411366,-1.4210378109693567,0.08870967741935484,0.46203795134510317,1.0,6/10,29.10%,UVRAG;STXBP1;VAMP2;VAMP1;VAMP8;SNCA
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3722916667798849,1.4209272828465391,0.011568123393316195,0.9157316936335347,1.0,36/175,14.01%,PSMB10;PSMC4;PSMB6;EIF5A;PSMD8;PSMD5;PSMD12;SMPD4;BIRC2;ZFP36L1;PSMD11;GBP3;PSMB4;TNFRSF1B;PSMC1;CIB1;EDAR;TRAF5;ACTN4;SIRT1;CCL25;ERBIN;TRAF3;RELA;PSMC2;PSMD2;NPNT;CDIP1;RPS3;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;NFKBIA;PSMB1
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5422093583272818,-1.419679784149182,0.09523809523809523,0.46407924215382657,1.0,12/15,43.75%,ENTPD7;ENTPD5;ENTPD6;AK5;ENTPD1;ENTPD2;AK4;CMPK2;AK1;NME2;ENTPD3;AK7
prerank,cellular response to interleukin-1 (GO:0071347),0.3796319841931631,1.41951657034991,0.017356475300400534,0.9176638550537012,1.0,34/143,14.29%,PSMB10;PSMC4;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;IL1R1;MAP3K7;TAB2;RPS6KA4;RPS6KA5;PSMD11;GBP3;PSMB4;PSMC1;TAB3;CCL25;RELA;CD47;PSMC2;PLCB1;PSMD2;UBE2V1;NOD1;TNIP2;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;NFKBIA;PSMB1;MAP3K3
prerank,type I interferon signaling pathway (GO:0060337),0.45662879934780426,1.4185444728243946,0.06369426751592357,0.9110802740068857,1.0,13/41,12.68%,IFITM2;IFIT1;XAF1;IFI35;IRF9;IFITM3;ADAR;IFITM1;IFNAR1;IFI27;IP6K2;TYK2;IRF2
prerank,cellular response to type I interferon (GO:0071357),0.45662879934780426,1.4185444728243946,0.06369426751592357,0.9110802740068857,1.0,13/41,12.68%,IFITM2;IFIT1;XAF1;IFI35;IRF9;IFITM3;ADAR;IFITM1;IFNAR1;IFI27;IP6K2;TYK2;IRF2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5667482583181394,-1.4176743120472375,0.08744394618834081,0.4680456904099366,1.0,3/13,0.39%,ERBB4;FGFR2;TGFBR3
prerank,inorganic cation transmembrane transport (GO:0098662),-0.3079406086693127,-1.4161295472738034,0.0,0.47056498477855535,1.0,53/268,14.22%,TRPM3;ATP1A2;KCNK2;SLC24A3;KCNQ3;KCNB2;CACNA1C;HCN1;NALCN;KCNH7;KCNQ5;SLC1A3;CACNA1D;RYR3;SLC6A13;KCNC2;PKD1;KCND2;ATP1B1;SLC41A1;TRPM6;TRPC5;SLC6A1;P2RX4;SCN8A;SCN3A;ATP1B3;SLC12A2;SLC39A14;SLC30A10;KCNH5;SLC6A9;ATP1A1;SLC6A12;SLC39A13;KCNK5;KCNJ2;TRPC1;SCN1A;KCNA1;SCARA5;SLC24A2;KCNK10;SLC30A4;ATP6V0A4;SLC9A2;ABCC9;ATP6V0C;CACNA1G;TMCO1;SLC39A8;SLC6A15;ANO6
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.5520265808612179,-1.4160193075869287,0.07127429805615551,0.4689397564547203,1.0,6/15,12.56%,FGFR2;TGFBR1;TGFBR2;PDGFRA;NIPBL;MTHFD1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.42254711340065343,-1.4159590471117738,0.0398936170212766,0.4671860487958605,1.0,14/37,15.12%,BICD1;PHLDB2;EFNA5;PHLDB1;CYLD;MAPT;ROCK1;STMN2;SKA2;GSK3B;EPHA3;TAOK1;TRIM36;STMN1
prerank,organophosphate biosynthetic process (GO:0090407),0.4738252384725703,1.4155303324800619,0.059130434782608696,0.9220878288051223,1.0,9/37,12.03%,GPHN;MOCS3;PPIP5K2;GPAM;FITM2;TPI1;MBOAT1;AGPAT3;IP6K2
prerank,embryonic skeletal system development (GO:0048706),-0.4316564381909503,-1.414631015736938,0.046228710462287104,0.4688426571393486,1.0,9/35,7.87%,SULF1;COL1A1;PCSK5;SULF2;HOXA3;OSR1;DYNC2I1;PDGFRA;RBP4
prerank,histone ubiquitination (GO:0016574),-0.48907350635247393,-1.4146188384346392,0.07538802660753881,0.46693482538659176,1.0,12/21,25.70%,UBE2N;WAC;UBE2E1;CDC73;HUWE1;RNF8;PHC1;PAF1;RNF40;DTX3L;UBR2;UBE2B
prerank,protein localization to plasma membrane (GO:0072659),-0.337698322245083,-1.4144993212283161,0.017543859649122806,0.46544500650283804,1.0,39/129,16.80%,ANK2;DPP6;ANK3;KCNB2;KCNIP4;EPB41L3;MAP7;RAB3C;ATP1B1;PACS2;ASB3;FLNA;KCNIP3;ROCK2;ATP1B3;FLOT2;RAB8B;PIP5K1A;ROCK1;TTC7B;EZR;AFDN;ACTN2;TTC7A;CDH1;DPP10;RAMP1;DLG1;MYADM;RAB11A;WNK3;STXBP1;NECTIN3;FYB1;LRP6;RAPGEF2;EHD1;RAB8A;EHD3
prerank,relaxation of cardiac muscle (GO:0055119),-0.5564871649994062,-1.413891827880535,0.08658008658008658,0.4652670390699083,1.0,7/13,10.68%,ATP1A2;GSN;ATP1B1;P2RX4;ATP1A1;KCNJ2;CAMK2D
prerank,negative regulation of developmental growth (GO:0048640),-0.4522068034959039,-1.41382327971407,0.06157635467980296,0.46354112547959775,1.0,7/30,7.77%,MAP2;DCC;ULK2;WWC2;PTPRS;NKD1;CDKN1B
prerank,regulation of programmed cell death (GO:0043067),0.37245894828347126,1.4134420888427606,0.01637107776261937,0.9278873883248917,1.0,28/161,12.04%,LRP8;CIDEA;MECOM;ACER2;GLS2;CHM;DNAJA3;PAX8;BIRC2;NME1;TNFRSF10B;SLK;TOX3;CASP6;WFS1;AKT1S1;CRADD;ACTN4;SIRT1;OMA1;PHLPP1;FBXO11;TARDBP;NAE1;CREBBP;RPS3;ACER3;BNIP3L
prerank,phagolysosome assembly (GO:0001845),0.5912297829732319,1.4132831951721372,0.0914179104477612,0.9227336323219633,1.0,4/12,8.22%,RAB7A;RAB7B;PIKFYVE;RAB14
prerank,regulation of metal ion transport (GO:0010959),-0.5356732591973481,-1.4126377730175599,0.07743362831858407,0.4650124826407859,1.0,9/16,22.10%,ANK2;STIM1;SLC30A10;IL16;SRI;DLG1;BCL2;CACNA2D1;CAMK2B
prerank,mesenchymal cell differentiation (GO:0048762),-0.39752027006387686,-1.4125731239991146,0.04899135446685879,0.46326942709712343,1.0,14/51,11.62%,DDX5;FGFR2;TGFBR3;RANBP3L;DDX17;TGFBR1;CTNNB1;BMP7;ROCK2;ROCK1;WNT4;FOXC1;GSK3B;LOXL3
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4925678270654881,1.4121996159264636,0.06756756756756757,0.9230472323836392,1.0,9/29,9.76%,TRIB3;PIN1;DCUN1D4;FBXO5;SMAD7;BMI1;AXIN1;MAGEC2;PARK7
prerank,positive regulation of filopodium assembly (GO:0051491),-0.47703375448746177,-1.411943284752568,0.08755760368663594,0.46301608046547177,1.0,8/24,8.48%,TENM2;DPYSL3;NRP1;WASL;GPM6A;PLPPR5;NLGN1;DOCK11
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.38853736472011546,1.411521238833391,0.024896265560165973,0.9211553121348207,1.0,18/117,10.70%,GPR176;PRKAR1A;PTGER2;PLK2;SRC;TSHR;INSL3;RAMP2;FYN;GNB1;RXFP1;SYK;PLCG1;LYN;RHBDF2;CD163;YES1;CD81
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.37463242895798937,-1.4110972485261408,0.02830188679245283,0.4635908818183578,1.0,14/67,6.19%,ERBB4;FGFR2;EGFR;PDGFRB;ABI1;FER;PIBF1;EFEMP1;KIT;TEC;GHR;RELN;DDR1;PDGFRA
prerank,cellular response to BMP stimulus (GO:0071773),-0.3758524627385745,-1.4100866440803081,0.025787965616045846,0.46467474005491527,1.0,15/66,10.15%,DDX5;BMP6;TGFBR3;ADAMTS12;SMAD3;RGMA;BMP5;BMP7;SMAD4;BMP4;SMAD6;ZFYVE16;ACVR1;HIVEP1;RGMB
prerank,tRNA modification (GO:0006400),0.42832643230074047,1.4097902182535946,0.03442879499217527,0.925145866629074,1.0,15/62,16.85%,THG1L;MOCS3;THUMPD1;TRMO;BCDIN3D;THUMPD2;PUS10;TRMT61B;ANKRD16;METTL2B;METTL2A;WDR4;SSB;NSUN6;CDKAL1
prerank,cellular response to fluid shear stress (GO:0071498),0.5985596059372313,1.4093401248134103,0.0900562851782364,0.9218489489667465,1.0,3/12,3.90%,KLF2;MAP2K5;HDAC3
prerank,protein polymerization (GO:0051258),-0.3952436463607701,-1.4092048724281327,0.051515151515151514,0.4653650812247698,1.0,14/55,9.09%,GSN;GAS7;HDGFL3;SPIRE1;WASL;MAPT;PSTPIP2;ARHGAP6;WASHC5;WASHC3;WASF1;COBL;CKAP5;RNF135
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4841421275004438,1.4085422888610326,0.06655844155844155,0.9203944798809213,1.0,6/32,8.79%,ERCC3;MAPK3;POLR1C;CCNH;POLR1G;GTF2H1
prerank,tRNA metabolic process (GO:0006399),0.5572199333804357,1.4084829015344282,0.08286252354048965,0.9148568276833623,1.0,4/17,8.67%,THG1L;FARS2;YARS2;POP5
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.6004686657184473,1.4079308978320817,0.11320754716981132,0.9122870496470256,1.0,2/11,0.84%,TIMM29;ROMO1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.509143144027409,1.4072376023890223,0.10273972602739725,0.9103345037817254,1.0,2/23,6.81%,CADM1;AP1G1
prerank,acute inflammatory response (GO:0002526),-0.4826979740167149,-1.4060600332889763,0.06756756756756757,0.4727736817502951,1.0,8/23,31.91%,IL6R;F3;LBP;PLSCR1;ANO6;CEBPB;IL22;CTNNBIP1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.578899703202207,-1.4060532375136934,0.09829059829059829,0.4709155623876449,1.0,4/12,5.91%,SORBS1;GKAP1;PRKCZ;SORL1
prerank,chloride transport (GO:0006821),-0.3620101330498197,-1.404208477464414,0.03559870550161812,0.4743558257769571,1.0,35/74,27.26%,GABRB1;SLC4A10;SLC1A3;GLRB;GABRA2;ANO3;CLIC4;SLC6A1;SLC26A7;SLC12A2;GLRA3;GABRG2;GLRA1;CLCN6;ANO1;CLCN2;ANO6;SLC12A6;GABRA5;SLC12A4;GABRG3;CLIC5;ANO10;GABRA4;SLC12A9;GABRG1;SLC4A8;TTYH3;GABRA1;SLC12A7;TTYH1;FXYD1;LRRC8A;SLC12A8;SLC12A5
prerank,presynapse assembly (GO:0099054),-0.5319100134171407,-1.4039360397218572,0.08582834331337326,0.47330824263875615,1.0,7/16,17.27%,LRRTM3;PCLO;NLGN2;NLGN1;IL1RAPL1;BSN;DVL1
prerank,regulation of aerobic respiration (GO:1903715),-0.5306391391895702,-1.403593708094027,0.08144796380090498,0.47235321352995974,1.0,7/15,24.89%,ATP7A;VCP;COX7A2L;SLC25A33;PINK1;NOP53;UQCC2
prerank,positive regulation of cell killing (GO:0031343),0.5864221310659333,1.4030203412943405,0.11886792452830189,0.9281481607265613,1.0,4/13,14.46%,MAPK8;SYK;WNT5A;CYBA
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5561329608977164,-1.4019450615934843,0.09271523178807947,0.4751285373724089,1.0,4/13,6.59%,PID1;PPARGC1A;VCP;PPARA
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5056114657325284,-1.4015118518999368,0.07981220657276995,0.4746583286077839,1.0,11/18,24.78%,NRXN1;TSHZ3;NLGN2;RELN;NLGN1;CACNG7;CACNG4;CACNG2;NLGN3;CACNG3;CACNG8
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.4097151193940302,-1.40138982353388,0.056910569105691054,0.4731827062062862,1.0,17/43,28.28%,DDX5;TEAD1;SMAD3;NFIB;BMP4;PPARA;TP53;TGFB1;JUN;NR3C1;NFATC4;GNL3;KLF5;ATOH8;GATA2;EGR1;FOXO3
prerank,regulation of histone methylation (GO:0031060),0.5959857125636681,1.4003803315045347,0.11797752808988764,0.9377580872542318,1.0,4/13,6.16%,CTCFL;AASS;TTLL12;CHTOP
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.416698371007135,1.4003284745907787,0.03851851851851852,0.9322949287433056,1.0,18/65,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;USP47;PSMC2;PSMD2;CHFR;PSMD14;PSMC6;PSMD1;AVEN;PSMB1
prerank,regulation of striated muscle contraction (GO:0006942),-0.46310096584897986,-1.4002777142807021,0.0812807881773399,0.4747208558146662,1.0,6/27,12.21%,ANK2;ATP1A2;ASB3;P2RX4;PRKACA;SRI
prerank,response to organonitrogen compound (GO:0010243),-0.4139785704303713,-1.400082366386003,0.06426735218508997,0.47345224973691463,1.0,11/38,17.58%,GLRB;KAT7;VCP;RHBDD1;GLRA3;HLCS;GLRA1;IRAK3;RCN3;RNF139;ERLEC1
prerank,acetyl-CoA metabolic process (GO:0006084),0.5618111013389415,1.3999441087108404,0.1057347670250896,0.9288270539420216,1.0,5/15,9.95%,DIP2A;MLYCD;ACAT1;ACACB;HMGCS2
prerank,mitochondrial gene expression (GO:0140053),0.4557561931155436,1.3990065410132249,0.07177033492822966,0.9284198924233339,1.0,15/42,18.15%,MRPS2;MRPL23;FASTKD2;LARS2;MRPS12;HARS1;RARS2;MRPS15;MRPS24;TFAM;MRPS28;GATB;MRPS34;IARS2;GFM2
prerank,base conversion or substitution editing (GO:0016553),0.6047225206847558,1.3976157095353605,0.10857142857142857,0.9303391862784417,1.0,3/11,15.67%,ADAR;ADARB2;ADARB1
prerank,positive regulation of cellular senescence (GO:2000774),0.6331255744338894,1.3973686484928176,0.10325047801147227,0.9262595562469118,1.0,3/10,7.73%,B2M;SIRT1;YPEL3
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4110395195082746,1.3967219485036848,0.049204052098408106,0.9241491037867855,1.0,18/70,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TAL1;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;LMO2;N4BP2L2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.47394540254305584,-1.3965352051763515,0.07727272727272727,0.48199015954561525,1.0,9/24,24.40%,SULF1;SULF2;CCBE1;IL6ST;RORA;TGFB1;PTGS2;ATF4;EIF2AK3
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6285551132083613,1.3962990893764096,0.10196078431372549,0.9210202644992859,1.0,2/10,3.42%,PTPRC;MAP2K5
prerank,cGMP-mediated signaling (GO:0019934),-0.5727373934750399,-1.3962627963331562,0.08137044967880086,0.48095838569408905,1.0,3/13,1.83%,HTR2C;IRAG1;KCNC2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5642407606498827,-1.3959935523480662,0.1007905138339921,0.4799129390089125,1.0,4/12,16.23%,TMEFF2;AP2A1;SELENOS;TGFB1
prerank,histone exchange (GO:0043486),0.4677167576113571,1.3955842444067579,0.058919803600654665,0.9194680332749307,1.0,12/37,17.31%,MIS18A;DMAP1;VPS72;HJURP;RUVBL1;RSF1;CENPC;ZNHIT1;CENPP;RBBP4;CENPO;NPM1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.432178164395596,-1.3945889699374412,0.06553398058252427,0.48237401419993126,1.0,13/35,22.97%,ADCY5;LGR4;ADCY2;ADCY1;ADCY9;EDNRA;ADCY7;RAF1;LGR5;ADCY8;ADCY3;ADCY4;CAP1
prerank,cardiac muscle cell differentiation (GO:0055007),-0.4775804071798972,-1.394314007899754,0.0896551724137931,0.4813353870070383,1.0,10/21,34.54%,AKAP13;CXADR;SIK1;ACVR1;KDM6B;VEGFA;MYH11;BMP2;CBY1;MYOCD
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.4956168505275284,-1.3939806309402791,0.09832635983263599,0.48047903492166855,1.0,6/18,11.71%,SMAD3;ITGB8;SMAD4;LTBP1;FN1;CD34
prerank,smooth muscle cell differentiation (GO:0051145),0.5966224821961339,1.3936536532217074,0.11371841155234658,0.9244557750335393,1.0,5/12,8.25%,MRTFA;MRTFB;HEY1;HEY2;EDNRB
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5573534362528907,-1.3934543508028465,0.1148936170212766,0.48032010793158586,1.0,10/13,39.55%,ENPP1;ENTPD7;ENTPD5;ENPP3;ENTPD6;ITPA;ENTPD1;ENTPD2;SMPDL3A;ENTPD3
prerank,ventricular septum morphogenesis (GO:0060412),-0.45036154987470417,-1.39344011693515,0.08488063660477453,0.47855743329055134,1.0,7/27,4.74%,ROBO2;TGFBR3;ROBO1;TGFBR1;TGFBR2;SMAD4;BMP4
prerank,activin receptor signaling pathway (GO:0032924),-0.5193285208687702,-1.3933818717469477,0.09327548806941431,0.476984592010439,1.0,4/15,12.18%,SMAD3;TGFBR1;ACVR1;ACVR1B
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5992184601343609,1.3920876776717468,0.10699588477366255,0.9275042902566636,1.0,4/12,8.25%,PPT1;TMEM9;ATP6AP2;TMEM165
prerank,intracellular pH reduction (GO:0051452),0.4698505367811888,1.3914945765520959,0.07214765100671142,0.9253898466584115,1.0,11/33,14.80%,ATP6V1D;CLCN3;RAB7A;ATP6V0D1;TMEM9;GPR89A;GPR89B;ATP6V0E1;DMXL2;DMXL1;ATP6V1B2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3995678880483962,1.3912407618126967,0.03735632183908046,0.9214871133158513,1.0,24/87,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ZFP36L1;PSMD11;PSMB4;PSMC1;CDKN1A;RGCC;FBXO5;USP47;CDK4;WEE1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;AVEN;APC;PSMB1
prerank,atrial septum development (GO:0003283),-0.5553235580603482,-1.390617441526395,0.08453608247422681,0.4834557033754615,1.0,2/13,0.30%,ANK2;NOTCH2
prerank,positive regulation of cartilage development (GO:0061036),-0.5099610229856362,-1.389492423716283,0.10262008733624454,0.4848669515247166,1.0,9/17,28.26%,SOX5;TAPT1;BMP4;BMPR1B;SOX6;BMPR2;PKDCC;BMP2;MDK
prerank,calcium ion transport (GO:0006816),-0.3400657962275237,-1.3891129272705112,0.018050541516245487,0.48420793023038733,1.0,16/113,6.12%,TRPM3;ANK2;SLC24A3;CACNA1C;NALCN;ITPR1;CALCRL;STIM2;CACNA1D;RYR3;PKD1;STIM1;TRPM6;TRPC5;P2RX4;CACNA1B
prerank,regulation of microtubule-based process (GO:0032886),-0.41885430177881705,-1.387616603910163,0.05822784810126582,0.4868167617104386,1.0,12/36,14.42%,BICD1;PHLDB2;EFNA5;PHLDB1;CYLD;MAPT;MACF1;ROCK1;GSK3B;EPHA3;TAOK1;TRIM36
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.5163122102649891,1.3862652681569496,0.1172291296625222,0.9443612845754848,1.0,6/20,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,regulation of cellular pH (GO:0030641),0.4825273169629351,1.3855292820914482,0.08480565371024736,0.9431166699208446,1.0,6/29,6.96%,SLC4A4;SLC4A5;SLC9A7;CA2;SLC9A6;SLC9A8
prerank,positive regulation of wound healing (GO:0090303),-0.41765138391158424,-1.385512168161056,0.05198019801980198,0.491108532534924,1.0,18/36,33.10%,OCLN;PLPP3;RREB1;SMOC2;THBS1;VTN;FOXC2;ANXA1;PTK2;ST3GAL4;ENPP4;ADRA2A;DMTN;SERPINE1;HBEGF;MYLK;CLDN1;MTOR
prerank,regulation of establishment of planar polarity (GO:0090175),0.3904116856213355,1.3845080164034724,0.04610951008645533,0.9434061015413201,1.0,24/88,14.38%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TIAM1;AP2S1;PSMD11;PFN1;PSMB4;PSMC1;DAAM1;WNT5A;PSMC2;FZD3;PSMD2;CELSR1;PSMD14;PSMC6;PSMD1;PSMB1;SPEF1;AP2M1
prerank,positive regulation of dendritic spine development (GO:0060999),0.5059585037901373,1.3844520409426029,0.11090909090909092,0.9384328658799264,1.0,3/20,4.59%,LRP8;SHANK3;APOE
prerank,sphingolipid metabolic process (GO:0006665),0.38695892183776315,1.3840260978013514,0.04499274310595065,0.9355665886948948,1.0,19/108,8.19%,SERINC1;CERS1;GLB1;ACER2;SMPD4;ST6GALNAC3;CERS4;PPT1;PRKD2;PPP2CA;ESYT2;SGMS1;KDSR;ELOVL6;CERKL;UGCG;PLPP1;TEX2;SGPP2
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5423036554372701,-1.383991308984553,0.11158798283261803,0.4938502856881824,1.0,3/14,9.33%,PIBF1;IRAK3;THBS1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.47920239577115437,1.3836709861683485,0.08747855917667238,0.9322221602897718,1.0,7/30,12.37%,NUDT14;ASGR1;ALG8;OST4;STT3B;MCFD2;MGAT5
prerank,regulation of stress fiber assembly (GO:0051492),-0.35863689166341706,-1.3830007504577857,0.043343653250773995,0.4951080822575368,1.0,18/74,6.57%,TMEFF2;PHLDB2;LPAR1;CGNL1;WASF2;NRP1;ARHGEF10L;CCN2;TGFBR1;TPM1;ARHGAP28;RHOA;PXN;PPFIA1;ROCK2;ARHGAP6;ROCK1;PPM1E
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.46544064882911296,1.382616705473976,0.09917355371900827,0.9327110125406108,1.0,12/35,16.46%,MAP2K7;MAPK3;PNKP;CCT2;CCT5;MAP3K4;ACD;NEK7;TNKS;ATR;TCP1;PARN
prerank,transcription by RNA polymerase I (GO:0006360),0.4699405389380075,1.382274291269377,0.06623586429725363,0.9294439960928021,1.0,6/34,8.79%,ERCC3;MAPK3;POLR1C;CCNH;POLR1G;GTF2H1
prerank,protein targeting to mitochondrion (GO:0006626),0.4250469448001918,1.3822113872589425,0.05591054313099041,0.9247028037011834,1.0,11/52,10.17%,TOMM20;TIMM29;ROMO1;IMMP2L;TIMM17B;TSPO;GRPEL2;TOMM40L;TIMM21;FBXO7;AIFM1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5745067892125599,-1.3820713636492328,0.09795918367346938,0.4960298945655618,1.0,2/12,1.68%,MAGI2;IQGAP1
prerank,positive regulation of phospholipase activity (GO:0010518),-0.4742578707328015,-1.3819077265407143,0.09156626506024096,0.49474641930685886,1.0,9/22,19.78%,NTRK3;FGFR2;PDGFRB;KIT;PDGFRA;ARL1;ARF4;ABL2;AGTR1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.4371766451249316,-1.3818012673852262,0.07213930348258707,0.4932976939589831,1.0,3/29,4.07%,FGFR2;TGFBR3;TPM1
prerank,peptidyl-tyrosine modification (GO:0018212),-0.37776041480669703,-1.381512723297534,0.04857142857142857,0.4923484594045383,1.0,11/56,6.19%,ERBB4;FGFR2;EGFR;PDGFRB;ABI1;FER;EFEMP1;KIT;TEC;RELN;PDGFRA
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.47226615528566734,1.381374151708434,0.09298245614035087,0.9243897387641039,1.0,9/33,10.93%,PIK3CG;ACER2;CIB1;NEXMIF;RET;SYK;EFNA1;LYN;CYP1B1
prerank,embryonic appendage morphogenesis (GO:0035113),0.5912300141196569,1.3807325571240106,0.10401459854014598,0.9226552825859862,1.0,1/12,0.04%,TBX4
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5694554283996903,1.3803468102040652,0.11306042884990253,0.9198204437774558,1.0,5/13,16.80%,KPNA3;NUP54;KPNA1;NUP35;KPNB1
prerank,peripheral nervous system development (GO:0007422),0.5046949656514242,1.380124220839211,0.09943714821763602,0.9160632711804978,1.0,7/23,14.16%,GFRA3;BDNF;NFASC;PMP22;NF1;ARTN;ADGRG6
prerank,regulation of acute inflammatory response (GO:0002673),-0.5030937790433461,-1.3801103732452127,0.09382151029748284,0.4947976546237951,1.0,3/18,16.65%,OSMR;IL6ST;PTGES
prerank,regulation of mRNA metabolic process (GO:1903311),0.602789172455555,1.3799848867801083,0.10606060606060606,0.9119157872806004,1.0,7/11,21.70%,NCBP1;CDK11B;SRPK2;PTCD2;SAFB;DHX9;SLTM
prerank,positive regulation of synapse assembly (GO:0051965),-0.46313179752539446,-1.3798292170104878,0.08823529411764706,0.493861874715506,1.0,11/27,12.29%,NRXN1;GRID2;EPHB1;NLGN2;SYNDIG1;CLSTN2;NLGN1;EPHB2;CUX2;SEMA4D;IL1RAPL1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.5261668642331332,1.3787845271474815,0.09523809523809523,0.9135060960439022,1.0,6/20,11.74%,SLC25A1;PPT1;FITM2;FAR2;ACSL4;HSD17B4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.45510860016866117,1.3785689609770035,0.08237232289950576,0.909908452850476,1.0,15/40,16.34%,RPL23;PDCL3;HIPK2;UBE3A;RPL5;FOXF2;AXIN1;DESI1;GNA12;RAD23A;XPO1;CSNK2A2;UBQLN4;TAF1;PTK2B
prerank,signal release from synapse (GO:0099643),-0.4004729521001824,-1.3784309097645548,0.062034739454094295,0.4961764232129014,1.0,14/43,17.27%,RIMS1;SNAP25;NRXN1;SYN2;PCLO;PTPRN2;SYN1;BRSK1;NRXN2;STXBP1;SNPH;VAMP2;STX1A;DVL1
prerank,neutrophil migration (GO:1990266),0.42256596149130476,1.378345943644815,0.06581059390048154,0.9064436549945026,1.0,8/58,11.50%,PIK3CG;BSG;PECAM1;PPIB;SYK;PIKFYVE;CCL25;PIK3CD
prerank,regulation of stem cell differentiation (GO:2000736),0.39511669956982703,1.378344422507569,0.05293276108726753,0.9017225942914063,1.0,20/89,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TAL1;OCIAD1;PSMD11;PSMB4;PSMC1;NOTCH1;PSMC2;PSMD2;LMO2;PSMD14;PSMC6;PSMD1;HES1;PSMB1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.4371541231806661,1.3777953085991634,0.06885758998435054,0.89986195113984,1.0,18/51,18.25%,MAP2K7;MAPK3;CTC1;PNKP;SRC;CCT2;CCT5;MAP3K4;HNRNPC;ACD;NEK7;TNKS;ATR;TCP1;PARN;SMG6;TNKS2;SMG5
prerank,myoblast differentiation (GO:0045445),-0.5487799232230924,-1.3771139964872825,0.08333333333333333,0.49856235451310943,1.0,3/14,2.05%,DDX5;IGF1;DDX17
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.48998082239970936,-1.3766737047512851,0.09200968523002422,0.4980640609395372,1.0,7/20,14.25%,ZC3H7A;PUM1;ZC3H7B;PUM2;TSN;AGO3;DICER1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4449629995168302,1.3765426899905808,0.06220095693779904,0.9015952182397957,1.0,20/42,19.09%,ACTL6A;DMAP1;ACTB;SMARCA2;VPS72;ACTR8;HNRNPC;ACTR5;CHD3;CECR2;ZNHIT1;INO80;PBRM1;SMARCA4;RBBP4;SMARCAD1;CHD8;HDAC2;ACTR6;SMARCB1
prerank,inner mitochondrial membrane organization (GO:0007007),0.436464155085371,1.3764770586555781,0.06528662420382166,0.8973258943393517,1.0,16/47,14.72%,TIMM29;ROMO1;ATP5F1E;UQCC3;ATP5MG;ATP5PF;ATP5MC2;IMMT;MAIP1;CHCHD6;CHCHD3;LETM1;DNAJC11;NDUFA13;MICOS10;ATP5F1C
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.5971324661821817,1.376209747573908,0.12284069097888675,0.8941574368713595,1.0,2/10,6.24%,CTCFL;PCGF3
prerank,endocytic recycling (GO:0032456),0.4300657032238481,1.375484709310903,0.06935483870967742,0.8933418624874377,1.0,20/50,18.25%,VPS50;EHD4;VPS29;RAB7A;VPS26A;RAB11B;DENND1A;SNX17;RAB14;VPS53;EIPR1;ACAP2;CCDC93;ANKRD27;VPS35;DENND1B;ARF6;ANKRD50;SNX27;VPS26C
prerank,CENP-A containing chromatin organization (GO:0061641),0.48499283981297403,1.3748827112025503,0.08843537414965986,0.8873871579825674,1.0,9/29,17.31%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;CENPP;RBBP4;CENPO;NPM1
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.48499283981297403,1.3748827112025503,0.08843537414965986,0.8873871579825674,1.0,9/29,17.31%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;CENPP;RBBP4;CENPO;NPM1
prerank,regulation of axonogenesis (GO:0050770),-0.38616636262624016,-1.3745255297654755,0.05649717514124294,0.502615312261722,1.0,15/51,15.77%,LRRC4C;ROBO2;PLXNA2;ROBO1;NTRK2;TIAM2;RHOA;BRSK1;GSK3B;GDI1;PLXND1;ARHGDIA;PLXNB2;NGF;PLXNC1
prerank,regulation of catabolic process (GO:0009894),0.5310650718625661,1.3743868221274342,0.10476190476190476,0.88563604726325,1.0,10/18,19.50%,NEDD4L;TMEM9;MDM2;CHEK2;FAF1;ZDHHC7;ODC1;HPGD;CENATAC;FURIN
prerank,regulation of mitotic cell cycle (GO:0007346),0.36095487201214455,1.3739685993397512,0.02621231979030144,0.8832828556281722,1.0,38/171,14.16%,DYNLT3;PSMB10;ERCC3;PSMC4;PSMB6;CKS2;PSMD8;PSMD5;PSMD12;TAL1;BRINP3;PIN1;ANAPC2;NEK11;TTLL12;PSMD11;PSMB4;PSMC1;CDK11B;FBXO5;SIRT1;ANAPC7;MDM2;PSMC2;TFAP4;PSMD2;NEK7;USP22;APP;ANAPC11;ANAPC10;ANAPC4;PSMD14;PSMC6;NEK6;PSMD1;PSMB1;RNF20
prerank,histone H4 acetylation (GO:0043967),0.44288670295814236,1.3733824047952545,0.07232704402515723,0.8819743602682257,1.0,16/47,14.04%,JADE3;ACTL6A;LEF1;RUVBL2;DMAP1;ING4;KANSL2;BEND3;EP300;RUVBL1;KANSL3;YEATS4;ING3;TRRAP;ING5;HCFC1
prerank,Rho protein signal transduction (GO:0007266),-0.3875059869974859,-1.3730417284060332,0.053824362606232294,0.5051234562533835,1.0,25/53,26.98%,COL1A2;ARHGAP29;PDPN;RHOA;ROCK2;CTNNAL1;ARHGAP6;SHTN1;ROCK1;PLEKHG5;RHOJ;RHOB;ARHGDIA;CDC42EP5;CDC42EP1;CDC42;AGTR1;ARHGEF1;ARHGDIB;RHOU;EPS8L2;RIPOR1;ADRA2A;ADGRG1;CDC42EP2
prerank,vacuolar acidification (GO:0007035),0.5056009643596607,1.3728750339147728,0.11072056239015818,0.8801817670274913,1.0,7/21,13.76%,PPT1;ATP6V0D1;TMEM9;ATP6AP2;ATP6V0E1;DMXL2;DMXL1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.49971492858842526,1.3727226980651746,0.10801393728222997,0.8765933863582049,1.0,6/25,11.52%,PDE4D;PTPRC;MAP3K7;PRKD2;PNP;RPS3
prerank,retrograde axonal transport (GO:0008090),-0.5053831879923256,-1.3726534415159324,0.10986547085201794,0.504505386164618,1.0,9/16,16.19%,DLG2;DYNC1H1;KIF1C;FBXW11;KIF1A;MAP1A;NEFL;KIF5A;ACTR10
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.414722096046315,1.3724337334636403,0.05925925925925926,0.8737316715974959,1.0,17/61,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PANK2;PSMD11;PSMB4;PSMC1;SIRT1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.34899723134145055,-1.372279025117039,0.03785488958990536,0.5038876767664647,1.0,14/85,5.85%,BMP6;FGFR2;TGFBR3;IGF1;EGFR;MCC;FGF1;BMP5;MTSS1;BMP4;NUPR1;OSR1;SRSF6;EPB41L4B
prerank,JNK cascade (GO:0007254),0.44827308730449694,1.3718733287238418,0.07980456026058631,0.8721816842525197,1.0,11/40,12.14%,MAP2K7;MAP3K11;MAP3K7;TAB2;MAPK8;ARHGEF6;TAB3;MINK1;UBE2V1;NOD1;CRKL
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.541782905930705,-1.3701738972699375,0.10940919037199125,0.508184334133122,1.0,7/13,17.23%,RNF152;DEPDC5;CASTOR2;STK11;ATM;SZT2;ITFG2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.35440197429270975,-1.3699813177775393,0.03514376996805112,0.5070331192060828,1.0,19/75,13.92%,MAP2;FGFR2;CNTN4;ANK3;DCC;MAP1B;CTNNA2;NRCAM;NTNG1;SDC2;RYK;DCDC2;SHTN1;BRSK1;BTBD3;PLPPR4;AFG3L2;UNK;MAP1A
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.568925098057322,-1.3698802402687424,0.08620689655172414,0.5056106905370215,1.0,2/11,1.47%,ST18;GSN
prerank,stabilization of membrane potential (GO:0030322),-0.5056478192856058,-1.369659145568048,0.09829059829059829,0.5046113274670534,1.0,3/16,10.34%,KCNK2;KCNK5;KCNK10
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5974504818157247,1.3686292964734244,0.11984282907662082,0.8841354039496947,1.0,2/11,7.28%,PTPRC;SMAD7
prerank,positive regulation of viral life cycle (GO:1903902),-0.47201177645002146,-1.3685121035151098,0.1013215859030837,0.5064100142417751,1.0,8/22,21.09%,AXL;DDB1;P4HB;TSG101;CHMP2B;LGALS1;TRIM11;VPS4A
prerank,stress-activated MAPK cascade (GO:0051403),0.4131434105537757,1.368415941818657,0.05623100303951368,0.8810208887858321,1.0,16/61,12.87%,MAP2K7;MAP3K11;MAPK3;MAP3K7;TAB2;ZFP36L1;MAPK8;ARHGEF6;TAB3;MINK1;UBE2V1;NOD1;CRKL;TNIP2;IKBKB;CHUK
prerank,protein localization to cell periphery (GO:1990778),-0.32182558381829496,-1.3682223974001169,0.028268551236749116,0.5055528471843409,1.0,38/133,16.80%,ANK2;DPP6;ANK3;KCNB2;KCNIP4;EPB41L3;MAP7;RAB3C;ATP1B1;PACS2;FLNA;KCNIP3;ROCK2;ATP1B3;FLOT2;RAB8B;PIP5K1A;ROCK1;TTC7B;EZR;ACTN2;TTC7A;CDH1;DPP10;RAMP1;DLG1;MYADM;RAB11A;WNK3;WDR19;STXBP1;AP4M1;FYB1;LRP6;RAPGEF2;EHD1;RAB8A;EHD3
prerank,synaptic vesicle exocytosis (GO:0016079),-0.4010080710712576,-1.3681866277928556,0.06553398058252427,0.5039366740998494,1.0,17/40,29.69%,RIMS1;SNAP25;PCLO;STX3;UNC13C;SNPH;UNC13B;VAMP2;SYT7;STX1A;SYT2;SNAP29;CPLX1;SYT10;STX1B;SNCA;CDK5
prerank,neuromuscular process controlling balance (GO:0050885),-0.5523621148056201,-1.3675545261172877,0.10325047801147227,0.5040959297009661,1.0,2/12,1.35%,PCDH15;NRXN1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.3713135596675515,-1.3673080938641213,0.0679886685552408,0.5031526024749627,1.0,8/61,3.24%,NOTCH2;LPAR1;IGF1;ROBO1;AKAP13;COL3A1;AUTS2;RASGRF1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.5498239779042634,-1.3673023877147732,0.1127659574468085,0.5014811747134139,1.0,4/13,9.97%,NFAT5;RHOA;IRAK1;ZDHHC21
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.3458711127817151,-1.3671672360814129,0.03821656050955414,0.5001717789867005,1.0,21/85,16.71%,NOTCH2;IGF1;AKAP13;DENND4A;OGT;KANK2;RALGPS1;RASGRF1;PLCE1;ARFGAP1;BCR;STARD13;LZTR1;EPHB2;GRB2;ARHGDIA;MADD;RAF1;NGF;RASGEF1A;RABL3
prerank,epithelium development (GO:0060429),-0.32718356851985925,-1.366355672838062,0.007220216606498195,0.5008528497141723,1.0,43/107,31.89%,FGFR2;ALDH1A2;AHI1;KANK2;PKD1;ERRFI1;ANXA4;OSR1;SMO;VDAC1;VCL;MEOX2;CPT1A;WNT4;SALL1;PTER;LOXL3;CD34;MTHFD1;TOLLIP;RCN3;DACT1;ANXA7;TGFB1;DVL1;SIX1;TAGLN2;STAT1;PGK1;VEGFA;PAX2;NDRG4;PTCH1;TBX2;TAGLN;CTSB;BMP2;PCNA;ALDOC;PIH1D1;GATA6;MFSD2A;FGF10
prerank,protein acylation (GO:0043543),0.4547780882165401,1.3663349125078201,0.10299003322259136,0.8871296364136977,1.0,13/38,14.05%,ZDHHC17;ING4;ZDHHC13;EP300;ZDHHC14;CLOCK;SELENOK;ZDHHC15;CREBBP;NAA80;ZDHHC9;ING5;ZDHHC7
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5276902971991686,1.3656761375499862,0.11496350364963503,0.8861469837705157,1.0,2/18,4.13%,PCK1;ZFP36L1
prerank,cell-cell junction assembly (GO:0007043),-0.3688993660064289,-1.365505190454257,0.05063291139240506,0.5017505429363182,1.0,28/63,23.00%,EPB41L3;CDH10;GJB6;CTNNA1;CTNNB1;RHOA;TLN1;CLDN11;JAM3;VCL;CTNND2;CDH11;TLN2;CDH7;GJC1;GJD3;ARVCF;GJA1;GJB2;WDR1;CTNND1;CDH9;CDH8;CDH19;CLDN12;FLCN;RHOC;DCHS1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.5644398737656158,-1.3648829080401548,0.12666666666666668,0.501869032169347,1.0,5/11,22.42%,KIT;VCL;ITGB5;CCN3;PLEKHA7
prerank,positive regulation of ion transport (GO:0043270),-0.38278097912422826,-1.3646893326031897,0.05263157894736842,0.5008734580633589,1.0,18/48,25.10%,ANK2;ANK3;STIM2;CACNA1D;FHL1;SNX4;P2RX4;ACTN2;DLG1;WNK3;ANO6;GPD1L;TRPC6;SCN1B;VAMP8;CRACR2A;CAMK2A;ADRA2A
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5486713569094642,-1.3646713537174073,0.11255411255411256,0.4992832060968189,1.0,4/13,5.91%,SORBS1;GKAP1;PRKCZ;SORL1
prerank,positive regulation of axonogenesis (GO:0050772),-0.39744875851259404,-1.364577738394636,0.0583756345177665,0.4979215902047221,1.0,19/43,21.60%,ROBO2;PLXNA2;ROBO1;NTRK2;TIAM2;MAPT;MACF1;RHOA;SHTN1;SEMA4D;PLXND1;ARHGDIA;PLXNB2;NGF;PLXNC1;TWF2;ZFYVE27;SLITRK1;DBNL
prerank,peptidyl-asparagine modification (GO:0018196),0.4696567414360271,1.3645276997617113,0.09475465313028765,0.8880899067841681,1.0,7/31,12.37%,NUDT14;ASGR1;ALG8;OST4;STT3B;MCFD2;MGAT5
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4523235448707291,1.3645239920262129,0.07504078303425775,0.8839222399751233,1.0,6/40,7.66%,ROMO1;DMBT1;TIRAP;RNASE6;GBP4;PPP1R11
prerank,neurotransmitter secretion (GO:0007269),-0.39438299505167607,-1.3622152755456802,0.0775,0.5030910993178024,1.0,14/44,17.27%,RIMS1;SNAP25;NRXN1;SYN2;PCLO;PTPRN2;SYN1;BRSK1;NRXN2;STXBP1;SNPH;VAMP2;STX1A;DVL1
prerank,protein neddylation (GO:0045116),0.5710371726470751,1.3614963731526382,0.12884615384615383,0.8952494204711766,1.0,7/13,16.97%,RNF7;DCUN1D4;UBE2M;NAE1;UBE2F;DCUN1D2;DCUN1D1
prerank,protein-DNA complex assembly (GO:0065004),0.3725499307287094,1.3612262897839065,0.0431266846361186,0.8925652865186297,1.0,24/116,14.01%,PSMB10;ERCC3;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;NAP1L4;ORC3;PSMD11;CCNH;PSMB4;PSMC1;ORC4;GTF2H1;RSF1;PSMC2;PSMD2;ORC2;PSMD14;PSMC6;PSMD1;BRD2;PSMB1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.5021875270234203,-1.3609593213134528,0.11353711790393013,0.5049011634544657,1.0,7/17,30.46%,AKAP13;ADCY9;ADRA1B;RAPGEF2;ADRA1A;ADRA2A;DRD2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.45765387155534754,-1.360937351271041,0.09026128266033254,0.5033404412808666,1.0,11/23,27.74%,MTMR7;PIP4P2;SACM1L;MTMR12;MTMR9;MTMR4;MTMR11;PIP4P1;INPP5F;OCRL;INPP5K
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.39515453837424347,1.3608447368018746,0.056296296296296296,0.8903542343575165,1.0,24/80,15.69%,SURF4;VPS50;HEATR5B;PREPL;SNX8;VPS29;RAB7A;RAB7B;VPS26A;TBC1D10B;GOSR2;RAB6B;PIKFYVE;RAB6A;SNX1;VPS53;GCC2;RBSN;TBC1D14;ERC1;TRIM27;TBC1D23;VPS35;TRAPPC10
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.41874639821452747,-1.359576000772688,0.08641975308641975,0.5058244661943041,1.0,7/35,3.73%,HTR2C;KSR1;AKAP6;IRAG1;ADCY2;ADCY1;NUDT4
prerank,mammary gland development (GO:0030879),-0.46636051532986555,-1.3586161368433314,0.08647450110864745,0.5071096623560435,1.0,8/21,26.13%,ERBB4;GLI2;WNT4;TBX3;PRLR;VEGFA;TGFB3;NOTCH4
prerank,negative regulation of DNA metabolic process (GO:0051053),0.4955788979759964,1.3581466279859713,0.10175438596491228,0.9000762493348504,1.0,7/24,11.52%,ZRANB3;DACH1;ERCC4;CDKN1A;ACVRL1;MSH3;RPS3
prerank,'de novo' posttranslational protein folding (GO:0051084),0.46675454888937506,1.3578361944352377,0.1075085324232082,0.8975116927524753,1.0,12/30,17.99%,HSPA8;CCT2;DNAJB5;BAG1;HSPE1;SDF2;HSPA13;DNAJB14;HSPA14;GAK;ST13;UGGT1
prerank,cardiac muscle contraction (GO:0060048),-0.41313578023468067,-1.357368234477087,0.07106598984771574,0.5089707098087003,1.0,4/34,4.07%,ATP1A2;GSN;ATP1B1;TPM1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.3891507871375017,-1.357136438316615,0.061046511627906974,0.5080931785385707,1.0,14/47,14.45%,DOCK5;EFNA5;DOCK1;FBLN1;NRP1;PDPN;FLNA;NEDD9;RREB1;P4HB;ILK;MYADM;PTK2;TRIOBP
prerank,BMP signaling pathway (GO:0030509),-0.3644749130213026,-1.3563342105337568,0.05722070844686648,0.5088001298201336,1.0,14/62,10.15%,DDX5;BMP6;TGFBR3;SMAD3;RGMA;BMP5;BMP7;SMAD4;BMP4;SMAD6;ZFYVE16;ACVR1;HIVEP1;RGMB
prerank,defense response to Gram-negative bacterium (GO:0050829),0.43476744894533664,1.3561072918954074,0.0821256038647343,0.9020709919030764,1.0,5/42,6.63%,ROMO1;RPL30;DMBT1;RNASE6;SELP
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.5520527770349918,-1.3556347809122054,0.11316872427983539,0.5092474657223407,1.0,4/12,12.92%,CTNNA3;CACNA1C;BIN1;DLG1
prerank,vascular transport (GO:0010232),-0.3365304706602438,-1.3546033960696755,0.0462046204620462,0.5105301499359416,1.0,17/81,6.96%,ATP1A2;SLC24A3;LRP1;SLCO3A1;SLC2A13;SLC1A3;LEPR;SLC16A12;SLC6A13;SLC13A3;SLC7A2;SLC22A8;SLC6A1;SLC16A7;SLC1A5;SLC12A2;SLC6A9
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.49373820519713985,1.353584828437441,0.12435233160621761,0.9113573113476363,1.0,7/21,11.52%,PTPRC;PRKCH;PRKD2;RELA;CD81;SLC39A10;RPS3
prerank,transport across blood-brain barrier (GO:0150104),-0.33350531026818364,-1.3534955720280892,0.052805280528052806,0.5120546880073221,1.0,17/83,6.96%,ATP1A2;SLC24A3;LRP1;SLCO3A1;SLC2A13;SLC1A3;LEPR;SLC16A12;SLC6A13;SLC13A3;SLC7A2;SLC22A8;SLC6A1;SLC16A7;SLC1A5;SLC12A2;SLC6A9
prerank,histone deacetylation (GO:0016575),-0.39758336388775306,-1.3530005307153588,0.06806282722513089,0.5120248426432578,1.0,15/43,12.62%,PRDM5;MIER1;HDAC4;TBL1XR1;HDAC1;SIRT2;MORF4L2;PER2;MTA3;MIDEAS;MORF4L1;MTA1;TBL1X;PER1;RCOR3
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5285791870509208,1.3525836504245623,0.12007168458781362,0.9125484193481078,1.0,1/17,0.14%,CIDEA
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.38048163521750766,-1.3522130662445144,0.06666666666666667,0.5128964469367024,1.0,17/52,17.39%,CELF2;DDX5;DDX17;KHDRBS1;CELF4;KHDRBS2;RBMX;SRSF6;RBM15;RBFOX3;HNRNPA1;SMU1;RBM4;SRRM4;RBM7;NOVA1;RNPS1
prerank,regulation of neuron projection development (GO:0010975),-0.30969834564334536,-1.3521767351536529,0.025974025974025976,0.5113573149482475,1.0,55/163,22.10%,MAGI2;LRRC4C;NTRK3;TENM3;DCC;LPAR1;LRRC7;CTNNA2;PDLIM5;SPOCK1;DPYSL3;NTRK2;NTNG1;PTPRS;EFNB2;TOX;PTK7;ROR1;RELN;CBFA2T2;SEMA3A;SRCIN1;PLPPR5;STMN2;ARSB;ULK4;ATP1B2;BRSK1;GSK3B;PRAG1;EPHA3;DISC1;RIT2;IL1RAPL1;KIF1A;CAMK1;ROR2;SETX;PLXNB2;PTPRO;RAPGEF2;ABL2;TWF2;MYLIP;SCARF1;SNX3;NCS1;KNDC1;MAG;PAQR3;CX3CL1;P3H1;PRKD1;RTN4IP1;CAMK2B
prerank,organic anion transport (GO:0015711),0.3968995679249166,1.3518721775849534,0.06092124814264487,0.9119890722519265,1.0,13/76,10.47%,SLC4A4;SLC4A5;ABCC4;SLC25A24;ABCG2;CA2;SLC52A2;CA4;SLC52A3;LRRC8C;SLC35A1;CYB5R4;SLC35B1
prerank,catecholamine metabolic process (GO:0006584),-0.5342038798275783,-1.350419543298867,0.10526315789473684,0.5148031985278315,1.0,3/14,6.37%,SNCAIP;ATP7A;COMT
prerank,regulation of leukocyte migration (GO:0002685),0.5538547040992625,1.3501200137088631,0.125,0.9170028533662118,1.0,4/16,11.05%,RAC2;HOXA7;CD81;RHOG
prerank,negative regulation of epithelial cell migration (GO:0010633),0.4606750341866766,1.3500850429003293,0.10782608695652174,0.9130537658898309,1.0,8/33,11.09%,PTPRR;PTPRG;PTPRM;EVL;APOE;KRIT1;ACVRL1;ADIPOR1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.5319116450169534,-1.3491579286242756,0.12896405919661733,0.5170184436902349,1.0,10/14,37.64%,ENPP1;ENPP3;AK5;AK3;ITPA;AK4;SMPDL3A;CMPK2;AK1;NME2
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.5747745357317287,1.3490074428794856,0.13553113553113552,0.9145446985080515,1.0,4/11,10.32%,RGS2;GSK3A;NOTCH1;GLRX3
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5461444329444809,1.3475007560611891,0.12790697674418605,0.9180138982411884,1.0,3/15,8.70%,REEP1;ATL1;REEP3
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.4995300145712487,-1.3474904810807706,0.11842105263157894,0.5204254638150164,1.0,11/16,40.90%,NUPR1;ATP7A;VCP;COX7A2L;SLC25A33;PINK1;UQCC2;AK4;PDE12;MLXIPL;PPIF
prerank,positive regulation of actin nucleation (GO:0051127),-0.5560101806895634,-1.3473143019176803,0.13247863247863248,0.5193537209957254,1.0,4/11,13.84%,GSN;WASF2;WASF1;FCHSD2
prerank,microvillus organization (GO:0032528),0.5623175503189782,1.3470259180824191,0.13941480206540446,0.916441334339291,1.0,6/13,15.52%,RAP2A;MINK1;RAPGEF6;RAP2C;MAP4K4;FXYD5
prerank,regulation of calcium ion transport (GO:0051924),-0.37228396551576226,-1.3469864707973886,0.05962059620596206,0.5187274026689161,1.0,21/54,30.08%,ANK2;STIM2;CACNA1D;STIM1;CTNNB1;P2RX4;IL16;SRI;WNK3;EFHB;BCL2;CACNA2D1;CAMK2B;TRPC6;CRACR2A;CAMK2A;ADRA2A;INPP5K;PACSIN3;MYLK;NOS1
prerank,dendrite morphogenesis (GO:0048813),-0.41037818115289704,-1.346236881577911,0.08888888888888889,0.519459040989331,1.0,11/35,10.62%,MAP2;CTNNA2;EPHB1;SDC2;WASL;DLG4;DCDC2;CTNND2;DOCK10;BTBD3;EPHB2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.5646721692868281,1.3457537267885222,0.13740458015267176,0.9189066485184609,1.0,1/12,1.52%,IL1R1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.4033513375986481,-1.3455619850175495,0.08740359897172237,0.5198192886698485,1.0,20/41,27.26%,ATP1A2;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2;KCNJ6;ABCC9;SLC12A6;KCNJ13;SLC12A4;ATP1A3;SLC12A9;KCNJ10;SLC12A7;KCNK9;HCN2;SLC12A8;SLC12A5
prerank,sprouting angiogenesis (GO:0002040),-0.3720608453944461,-1.3453912321805355,0.0684931506849315,0.518779718562068,1.0,14/51,10.86%,ROBO1;PARVA;ADGRA2;BMPER;NRP1;EFNB2;BMP4;PIK3R3;EPHB4;CCBE1;THBS1;RSPO3;OTULIN;RNF213
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.54702656593532,-1.344910484409791,0.11591355599214145,0.5185102428960289,1.0,3/12,13.42%,NUPR1;IL18;IL33
prerank,T cell mediated immunity (GO:0002456),0.5659739690591679,1.3445004002353462,0.12920353982300886,0.9211310828542467,1.0,4/13,20.23%,CADM1;CD55;CD46;BTN3A3
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.5838722188738196,1.3425421446325374,0.13980582524271845,0.9271304857660745,1.0,4/11,10.58%,NCBP1;AHCYL1;ZFP36L1;PAPOLA
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.4590016120248941,-1.3421395647394485,0.10344827586206896,0.5253013440991602,1.0,5/22,7.83%,CACNA1C;CACNA1D;STIM1;ADGRV1;GABBR2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.39452383458119916,1.3420841770490304,0.07060518731988473,0.9253757070641312,1.0,17/73,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TAL1;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;LMO2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3942008193277908,1.3419511873623038,0.06537890044576523,0.9220268414279507,1.0,19/79,10.49%,DYNC1I1;MFSD6;KIF18A;CAPZA2;FCGR2B;AP2S1;KIFAP3;RAB7A;DCTN2;CLTA;AP1G1;AP1S2;PIKFYVE;KIF15;DCTN3;ARF1;OSBPL1A;KIF2A;DYNLL1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.3933743201073111,-1.3411400761153012,0.078125,0.5267201938727403,1.0,22/43,28.14%,BMP6;IGF1;NELL1;BMP7;IL6R;BMP4;FBN2;WNT4;LRP5;ACVR1;IL6ST;BMPR1B;WWTR1;BMPR1A;BMPR2;CCN1;PRKD1;YAP1;RUNX2;CCN4;LRP3;BMP2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.440977512078322,-1.3410529320134943,0.1108433734939759,0.5254030250558313,1.0,12/27,14.52%,PER2;PER3;CRY2;PML;BHLHE40;SIK1;MTA1;TP53;CRY1;PER1;RBM4;FBXL12
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.4887858141562835,-1.3403952312042797,0.11353711790393013,0.525772922993876,1.0,4/17,19.44%,PLA2G4A;LPGAT1;CRLS1;LPCAT1
prerank,cellular response to UV-A (GO:0071492),0.5885629706873495,1.3403819149189464,0.14779270633397312,0.9257587228058632,1.0,2/11,4.44%,CERS1;MME
prerank,acute-phase response (GO:0006953),-0.5442785455263135,-1.340027254076509,0.13535353535353536,0.5252865971453575,1.0,5/12,29.14%,IL6R;LBP;PLSCR1;CEBPB;IL22
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5119560733196535,-1.3399765461888848,0.14512471655328799,0.523907790685445,1.0,8/14,37.92%,SULF1;SULF2;THBS1;CREB3L1;FUZ;GPC1;SPRY4;SPRY1
prerank,amino sugar metabolic process (GO:0006040),0.6003868505369991,1.3387250993825226,0.1425661914460285,0.9302933625059097,1.0,4/10,13.43%,CSGALNACT1;EXTL2;SLC35A3;ST3GAL1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.49332262790587555,1.338685170883851,0.12056737588652482,0.9265818771465962,1.0,7/20,13.17%,GCLC;GCLM;CNDP2;GATM;MTHFS;HAGH;GSS
prerank,positive regulation of glucose import (GO:0046326),-0.4622122459995321,-1.3385401494686093,0.09903381642512077,0.5265931685232267,1.0,11/21,25.65%,SORBS1;IGF1;OCLN;AKT2;CREBL2;ARPP19;PIK3R1;OSBPL8;APPL1;AKT1;CAPN10
prerank,negative regulation of ion transport (GO:0043271),-0.44934106694853704,-1.3381125534519518,0.1258741258741259,0.5263404921488001,1.0,12/24,30.08%,GPM6B;WNK1;ACTN2;WNK4;SYT11;WNK3;NEDD4;ADRA2A;INPP5K;SNCA;PACSIN3;NOS1
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.39295233039122046,-1.338020394200327,0.07211538461538461,0.5250109914032772,1.0,9/41,11.70%,ANK2;ANK3;KCNMA1;AKAP6;FLNA;GABBR2;KCNJ2;ACTN2;KCNJ6
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.42138690258872213,-1.3377979778025066,0.08486238532110092,0.5241868363494749,1.0,18/29,33.66%,ZBTB20;SORBS1;LPGAT1;PPARA;CREBL2;LDLR;SLC27A1;GPLD1;SREBF1;CTDNEP1;NR1H2;AKT1;SLC45A3;MFSD2A;SIRT4;MTOR;CHP1;MID1IP1
prerank,non-motile cilium assembly (GO:1905515),-0.42044544111652155,-1.3371612375243864,0.11363636363636363,0.5245793287224169,1.0,17/30,31.81%,PIBF1;TTC8;IFT57;CEP89;ARL13B;DISC1;DCTN1;CEP250;GORAB;TMEM80;IFT88;TOGARAM1;C2CD3;FUZ;TMEM216;BBS1;VANGL2
prerank,response to metal ion (GO:0010038),0.40231331875824405,1.3371254153563854,0.08069620253164557,0.930536811584711,1.0,14/67,14.95%,MT1A;MT1X;GPHN;AHCYL1;PPP2CA;NEDD4L;CALM3;PPP2CB;PAM;PPP3CA;SLC25A12;PPP5C;MT2A;HOMER1
prerank,positive regulation of signal transduction (GO:0009967),-0.2908330237755879,-1.3370677161531879,0.016483516483516484,0.5233197988716531,1.0,55/238,14.71%,SORBS1;BMP6;NTRK3;FGFR2;RIMS1;IGF1;SULF1;ROBO1;SASH1;WLS;NRXN1;NRP1;FGF1;TGFBR1;DLG4;AXL;MACF1;SULF2;NLGN2;MAML1;FLNA;GKAP1;PRKCZ;RELN;SMO;F3;DCDC2;SORL1;SLC39A14;ITGA5;SKI;HTT;PTGIS;ZDHHC5;CDC73;NLGN1;SNW1;CCBE1;SMOC2;RSPO3;VTN;SALL1;CUX2;ILK;DISC1;ADAMTS3;LOXL3;ATP6V0C;LY86;GRB10;TRIM39;IL6ST;IGF2;CAV2;DACT1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.5276058665672496,-1.3365061186863296,0.11203319502074689,0.5234312108426339,1.0,3/13,3.91%,NRP1;TGFBR2;CTNNB1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5261992327426146,-1.3358135205945674,0.1366742596810934,0.5239412733894833,1.0,3/13,5.12%,GLI3;TGFBR2;CBFB
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5193347562857797,1.3354463160441836,0.12454212454212454,0.9352747068941398,1.0,5/19,4.52%,NDST3;CSGALNACT1;XYLT1;EXT2;HS6ST1
prerank,negative regulation of response to wounding (GO:1903035),-0.47575498208246836,-1.3349358414282986,0.11546840958605664,0.5250570960647363,1.0,8/19,28.26%,PTPRS;AJAP1;CERS2;CD109;GIT1;SERPINE1;INPP5F;MDK
prerank,regulation of protein dephosphorylation (GO:0035304),0.4470965887155669,1.3348701929631883,0.08907563025210084,0.934158672629434,1.0,15/37,15.44%,PIN1;TIPRL;PPP1R16B;CNEP1R1;YWHAB;CALM3;SPPL3;TSC1;MFHAS1;ANKLE2;PTBP1;CDH5;PTPA;PPP6R1;PPP1R8
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5681705681985576,-1.33469245485827,0.13267326732673268,0.5242274552779418,1.0,2/10,4.74%,GLI3;BMP4
prerank,insulin secretion (GO:0030073),0.5128303215425838,1.3343839631870842,0.13282732447817835,0.932777052841575,1.0,6/19,9.76%,SELENOT;RAB11B;RAB11FIP5;RAB11FIP2;CYB5R4;PARK7
prerank,macrophage activation involved in immune response (GO:0002281),0.5630809663618555,1.3340245475544525,0.13711151736745886,0.9307452788022346,1.0,3/13,6.70%,IFI35;SBNO2;SYK
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.4299964115036158,-1.3337470508967577,0.10714285714285714,0.5253360009958568,1.0,12/28,28.01%,NAV3;MAPT;OCLN;AKAP9;SLAIN2;CKAP5;DCTN1;MET;GIT1;ARL2;TOGARAM1;MAPRE1
prerank,actomyosin structure organization (GO:0031032),-0.3424064345439643,-1.333512988549442,0.051829268292682924,0.5245266480465134,1.0,19/75,14.39%,SORBS1;EPB41L3;TMOD2;EPB41L1;CDC42BPB;TPM1;RHOA;ROCK2;ITGB5;EPB41L4B;CIT;FRMD3;ROCK1;TNFAIP1;EPB41L2;ACTN2;CSRP2;PDLIM1;WDR1
prerank,regulation of insulin secretion (GO:0050796),-0.3202135304498764,-1.3331001983191109,0.022508038585209004,0.52431066496154,1.0,25/101,16.68%,CACNA1C;ITPR1;SNAP25;ADCY5;MCU;CACNA1D;EFNA5;KCNC2;NLGN2;PER2;GLUD1;DPP4;ENSA;RBP4;LRP5;CDK16;STXBP4;TM7SF3;NNAT;PSMD9;SYT7;CCN3;TCF7L2;STX1A;KCNS3
prerank,mitotic metaphase plate congression (GO:0007080),0.41667992318965763,1.3327352408955933,0.0928,0.9336044588667141,1.0,11/51,12.84%,KIF18A;NUDC;BOD1;CHAMP1;DCTN2;CHMP1A;CDCA8;CENPC;CHMP2A;MIS12;CUL3
prerank,regulation of complement activation (GO:0030449),0.4316606068239709,1.3318392383172697,0.09461663947797716,0.9344108952979094,1.0,5/40,12.58%,C1QB;C1QC;PHB2;CD81;CD55
prerank,sodium ion transport (GO:0006814),-0.3373366457550494,-1.3317111262548678,0.03761755485893417,0.5268786436900942,1.0,23/85,18.17%,ATP1A2;SLC24A3;HCN1;NALCN;SLC6A13;ATP1B1;SLC6A1;SCN8A;SCN3A;ATP1B3;SLC12A2;SLC6A9;SLC6A12;SCN1A;SLC24A2;SGK1;SLC9B2;SLC6A15;ANO6;NDUFA9;SLC5A6;SLC38A7;SLC5A5
prerank,epithelial cell migration (GO:0010631),-0.39819068804360724,-1.3307447005894892,0.08121827411167512,0.528225665625054,1.0,13/37,9.85%,FSTL1;KANK2;ADGRA2;NRP1;ZEB2;RHOA;KIT;PXN;ROCK1;DPP4;STARD13;FAP;PLEKHG5
prerank,protein localization to cell junction (GO:1902414),-0.45660443017939506,-1.3294630820360387,0.10792951541850221,0.5304228058313379,1.0,9/22,13.67%,CGNL1;PCLO;JAK1;DLG4;NLGN2;JAM3;NLGN1;KIF3A;BSN
prerank,innate immune response (GO:0045087),0.34063180564651635,1.3294507913329767,0.03945745992601726,0.9429964836526354,1.0,40/217,14.46%,DMBT1;PIK3CG;CAPZA2;TRIM28;IFNLR1;IFITM2;SRC;IFIT1;TRIM8;RNASE6;FYN;PHB2;TRIM14;B2M;SYK;IFITM3;RNF187;ADAR;TRIM25;IFITM1;RELA;LYN;PJA2;MFHAS1;SRPK2;YES1;SERINC5;DDX3X;APP;SERINC3;PIK3CD;ANKHD1;IFI27;IKBKB;CHUK;NLRC5;ANKRD17;TRIM27;GCH1;CYBA
prerank,alanine transport (GO:0032328),0.5991181515992202,1.3293274565677418,0.14476190476190476,0.9397142980595509,1.0,2/10,5.53%,SLC36A4;SLC6A6
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.3433943401084192,-1.3292325517134949,0.03571428571428571,0.5295879888359063,1.0,18/85,11.29%,PCDH15;EYA1;CACNA1D;COL1A1;EML2;COL11A1;COL4A3;ADGRV1;ROR1;CEMIP;P2RX4;PIEZO2;DCDC2;GSDME;NIPBL;TIMM9;ATP6V0A4;TBL1X
prerank,positive regulation of integrin activation (GO:0033625),0.5851454591082041,1.3285932311294426,0.14677103718199608,0.9396960714456939,1.0,3/11,13.32%,SRC;RASIP1;PLEK
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.39845975811728723,-1.3284904005455112,0.0951219512195122,0.5303483342397323,1.0,14/37,23.40%,MAPK14;APPL2;PPARA;IL17RA;ADCY7;PER1;SIRPA;ABCD2;PLD3;GBP5;APOD;CHID1;APPL1;IL17D
prerank,organelle organization (GO:0006996),0.3249768193277619,1.3283217474225872,0.009060022650056626,0.9372295050033825,1.0,67/388,11.15%,CIDEA;ROPN1;SURF4;FAM161B;CHCHD2;SEMA6A;SYNE1;SH3D19;SMPD4;TNFAIP3;LYSMD3;CYCS;KIFAP3;GORASP2;DNAJA3;SORT1;FITM2;CLASP2;GABPA;ZMYM4;MTFR1;LMAN2;ATL1;SIRT3;CFAP126;VPS11;APOE;PRPF40A;PLAAT3;RAB7A;PHB2;TMED4;SEC23IP;RAB43;CFL1;DST;PEX1;TRAPPC8;SSBP1;USP6NL;ARHGEF7;PEX7;CHMP1A;TRIP11;TTC17;LONP1;VMP1;TMED5;AGTPBP1;PIKFYVE;ODF2;TMED10;RAB14;FGD5;CDCA8;TMEM135;AUP1;RAB1A;GOLPH3L;PARK7;TRAPPC11;DOP1B;CHMP2A;TERT;TMED7;HPS3;NOS3
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.32985138805753067,1.328070534078865,0.020190023752969122,0.9346980126824453,1.0,102/341,18.10%,PSMB10;PSMC4;PSMB6;ELOC;GSK3A;RNF7;CBL;PSMD8;PSMD5;PSMD12;ARIH1;RNF149;ANAPC2;KLHL3;TNFAIP3;FEM1C;SPOP;UBXN11;UBA1;RFFL;BIRC2;PSMD11;NEDD4L;UBAP1;NHLRC1;RBBP6;PSMB4;PSMC1;UBE2I;RNF130;COP1;SIRT1;UBL7;CLOCK;RNF187;PPP1R11;TTC3;TRIM25;FBXO11;CRBN;ANAPC7;RBCK1;MDM2;RAD23A;PSMC2;UBE3D;PSMD2;RNF6;ZNRF1;FBXO7;RNF13;VPS37B;CHFR;SPOPL;UBQLN1;ANAPC11;IFI27;ANAPC10;PLAA;ANAPC4;FBXO8;RNF11;CUL3;PSMD14;USP33;UBE2R2;RNF146;RNF216;DDIT3;PSMC6;PSMD1;FAF1;APPBP2;PSMB1;RNF20;USP9X;TRIM3;UBA6;NHLRC3;UBE2G1;FBXO22;UBQLN4;RMND5A;RNF114;TAF1;PELI1;KLHL42;RNF128;RNF125;UBE2H;UFD1;UBQLN2;PSMA4;VPS37C;UBR3;ATXN3;CDC26;RNF215;RAD23B;KCTD10;AGAP3;VPS4B
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.36996949223964354,1.3274502206992862,0.07317073170731707,0.9338429247284765,1.0,19/104,10.80%,TRIB3;RALB;EZH2;MTCP1;ACTB;RPTOR;SRC;CDC37;PPP2CA;CCNH;CIB1;CDKN1A;CALM3;SIRT1;GTF2H1;CCNG2;CSF1R;BCCIP;DDX3X
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5655719652380984,1.327388126008527,0.17025440313111545,0.9303779553125276,1.0,2/11,1.58%,ATF3;ATF6
prerank,myeloid cell differentiation (GO:0030099),0.42431601103929434,1.327183947230864,0.09313725490196079,0.9275175541940021,1.0,8/47,10.58%,PRKX;SNRK;TAL1;TIRAP;HIPK2;RPS14;LYN;MFHAS1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5026264771355609,-1.3271518509441993,0.14285714285714285,0.532706311013876,1.0,9/15,17.78%,WNT5B;GPC3;CSNK1E;RSPO3;ZNRF3;RNF213;DAAM2;DACT1;SFRP4
prerank,membrane lipid biosynthetic process (GO:0046467),0.41100607781056,1.327098420786621,0.09902597402597403,0.9242328532269853,1.0,17/58,16.13%,CERS1;ACER2;CERS4;PRKD2;SGMS1;KDSR;ELOVL6;PLPP1;SGPP2;HACD2;ACER3;SGPP1;SPNS2;ST8SIA6;CERT1;GBGT1;PPM1L
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.4410613099401944,-1.3270287659889706,0.09951456310679611,0.5315405173547243,1.0,5/25,11.75%,ITPR1;MAPT;P2RX4;HTT;RIT2
prerank,cardiocyte differentiation (GO:0035051),-0.5720468595100903,-1.3270157132768927,0.1419753086419753,0.5300951184544562,1.0,8/10,34.54%,AKAP13;SIK1;KDM6B;EEF1AKMT4-ECE2;BMP2;GATA6;CBY1;MYOCD
prerank,myofibril assembly (GO:0030239),-0.3872156562434519,-1.3268325064262008,0.09283819628647215,0.5290795054823474,1.0,9/42,14.39%,CFLAR;PDGFRB;TMOD2;TPM1;PDGFRA;ACTN2;CSRP2;OBSL1;WDR1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5054491367035209,-1.326366821915124,0.13793103448275862,0.5290971297110638,1.0,11/15,40.90%,IGF1;GHITM;AKT1;BCL2L1;GPX1;FXN;PRELID1;CLU;HGF;OPA1;PPIF
prerank,establishment of protein localization to membrane (GO:0090150),0.3967431634250971,1.3263423287148344,0.07894736842105263,0.9243275100883324,1.0,19/66,17.24%,RTP3;REEP1;GORASP2;CHM;RAB11B;ZDHHC14;PIKFYVE;ZDHHC15;ICMT;VPS37B;PRKCI;ZDHHC9;NPC1;ZDHHC7;PARD3;RAB3GAP1;BRAF;VPS37C;RTP4
prerank,positive regulation of coagulation (GO:0050820),-0.5682800046531093,-1.3255626634614532,0.1414141414141414,0.5284686649185163,1.0,5/10,25.87%,THBS1;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,positive regulation of hemostasis (GO:1900048),-0.5682800046531093,-1.3255626634614532,0.1414141414141414,0.5284686649185163,1.0,5/10,25.87%,THBS1;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.49263968023166865,-1.3255591484828688,0.14439655172413793,0.5270204400931273,1.0,5/16,7.45%,DDX5;DDX17;CELF4;SRSF6;SRSF1
prerank,cellular metal ion homeostasis (GO:0006875),-0.326061211579024,-1.3252325387820332,0.02768166089965398,0.5265620308343273,1.0,17/102,10.32%,ANK2;ATP1A2;SLC24A3;HTR2C;KCNMA1;STIM2;ATP1B1;STIM1;SLC41A1;ATP13A5;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2;SLC24A2;DMPK
prerank,cardiac conduction system development (GO:0003161),-0.4424144514302648,-1.325110412650902,0.12100456621004566,0.5254887469242187,1.0,10/24,19.14%,NOTCH2;GJB6;SMAD4;MAML1;BMP4;GJA1;CACNA1G;SMAD5;TBX18;BMPR1A
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.4705987183162793,1.3249679581050604,0.12695652173913044,0.9272347043936321,1.0,10/25,17.74%,HSPA8;DNAJB5;BAG1;HSPE1;SDF2;HSPA13;DNAJB14;HSPA14;GAK;ST13
prerank,ceramide biosynthetic process (GO:0046513),0.4347534499713249,1.3248882857263764,0.11149228130360206,0.924033180725198,1.0,5/40,5.24%,CERS1;SMPD4;ST6GALNAC3;CERS4;SGMS1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.3007221547605221,-1.3245402379436797,0.0182648401826484,0.5256527685133007,1.0,43/182,16.23%,FOXP1;NOTCH2;SLC24A3;IGF1;ROBO1;ITGB8;SH3GL2;DLG4;MAPT;OCLN;PARP14;RBL2;HDAC1;TET1;BMP4;KDM4A;ROCK2;FLOT2;SMO;WWP2;WNT4;XDH;LDLR;MAP2K2;OPTN;SFMBT2;AGO3;LGMN;NDFIP1;NFKB1;REL;CD34;DDRGK1;MYADM;SETDB2;HINFP;RACK1;DICER1;PTPN22;ANXA7;RIN3;RBMS3;TGFB1
prerank,sodium ion export across plasma membrane (GO:0036376),-0.526183690018718,-1.3239625186771604,0.13404255319148936,0.5259182275717313,1.0,5/13,9.45%,ATP1A2;ATP1B1;ATP1B3;ATP1A1;ATP1B2
prerank,regulation of osteoblast proliferation (GO:0033688),-0.4833571687675206,-1.323904799508953,0.13991769547325103,0.524660664748464,1.0,11/17,30.40%,FGFR2;NELL1;RHOA;NPR3;EIF2AK2;MN1;CCN1;PLXNB1;SFRP1;BMP2;TMEM119
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3890700560729083,-1.3238364096932198,0.09307875894988067,0.5234007025352094,1.0,6/40,3.36%,MAGI2;BICD1;DAB2;AHI1;ANXA2;WASL
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.37416467764095684,1.3232576612327258,0.07660738714090287,0.9282820054937734,1.0,11/88,5.30%,FBXL6;PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;FBXL5;PSMC1
prerank,microvillus assembly (GO:0030033),0.546539808304937,1.3218291453561208,0.14359861591695502,0.9318951313919556,1.0,6/14,15.52%,RAP2A;MINK1;RAPGEF6;RAP2C;MAP4K4;FXYD5
prerank,sodium ion transmembrane transport (GO:0035725),-0.33550575797188886,-1.3214152612933234,0.015527950310559006,0.5288559444321906,1.0,17/84,9.99%,ATP1A2;SLC24A3;HCN1;NALCN;SLC6A13;ATP1B1;SLC6A1;SCN8A;SCN3A;ATP1B3;SLC12A2;SLC6A9;ATP1A1;SLC6A12;SCN1A;ATP1B2;SLC24A2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.495089074875283,1.321063532468701,0.13240418118466898,0.9319225044681266,1.0,7/21,12.02%,NUDT11;PDE4D;MLYCD;FITM2;ACAT1;PNP;NT5C2
prerank,regulation of postsynapse organization (GO:0099175),0.45905379658830164,1.3209152077393438,0.1254295532646048,0.9290496446964985,1.0,12/28,16.31%,FCGR2B;SHANK3;CFL1;TANC2;WNT5A;ZDHHC15;PPFIA2;ABHD17B;HOMER1;VPS35;CDKL5;ABI2
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.46953365772634104,-1.3205106192396687,0.12389380530973451,0.5301098440878821,1.0,4/18,14.13%,IGF1;IGFBP2;IL18;IGF2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.4199983965681784,-1.3204969664676927,0.10696517412935323,0.5287199434505329,1.0,9/29,9.75%,SMAD3;ZC3H7A;PUM1;ZC3H7B;PUM2;LIN28B;SRRT;HNRNPA2B1;AGO3
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5308683300519877,1.320294840706002,0.15037593984962405,0.9285171245118299,1.0,6/16,19.12%,ZC3H12D;ZFP36L1;TARDBP;MOV10;RC3H1;DHX36
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.48027191027715654,-1.3199936875095455,0.13596491228070176,0.5287409702335596,1.0,2/17,1.84%,MAGI2;PDGFRB
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.4719515670565752,-1.319712428763546,0.13733905579399142,0.5280955231377916,1.0,7/18,15.37%,PABPN1;ENY2;POLDIP3;NXF1;NUP93;DDX19B;DDX19A
prerank,activation of protein kinase A activity (GO:0034199),-0.4850612268640424,-1.3196433004259418,0.12910284463894967,0.5268830347099999,1.0,11/16,22.64%,ADCY5;ADCY2;ADCY1;PRRC1;ADCY9;PRKACA;ADCY7;PRKAR1B;ADCY8;ADCY3;ADCY4
prerank,muscle cell migration (GO:0014812),-0.5573948869541338,-1.3189120480048808,0.14038876889848811,0.5274929134780024,1.0,8/10,28.89%,DDR1;ROCK1;MEGF10;CCN3;SIX1;AAMP;ITGB1BP1;ITGB3
prerank,mitochondrial translation (GO:0032543),0.36686121384083215,1.3186342994128601,0.06601123595505617,0.9333123242787973,1.0,19/104,12.45%,MRPS22;MRPS2;MRPS33;MRPL23;MRPL24;FASTKD2;MRPL18;MRPL38;LARS2;MRPS12;HARS1;RARS2;MRPL20;EARS2;TSFM;MRPL52;MRPS15;MRPS24;MRPL48
prerank,calcium ion transmembrane transport (GO:0070588),-0.33501270645549924,-1.3184419221665333,0.07430340557275542,0.5273207919528963,1.0,13/86,4.75%,TRPM3;SLC24A3;CACNA1C;NALCN;MCU;CACNA1D;GRIN2B;RYR3;PKD1;TRPM6;TRPC5;MICU2;P2RX4
prerank,positive regulation of blood coagulation (GO:0030194),-0.4909251767406669,-1.3181075785906409,0.13140311804008908,0.526872631567985,1.0,7/17,25.87%,F3;THBS1;ANO6;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.2911188797694802,-1.3172428698095036,0.011428571428571429,0.5280661529954022,1.0,56/224,17.50%,DLG2;DLGAP1;KCNQ3;PLP1;HTR2C;GABRB1;GRIA4;SNAP25;GRIA2;SLC1A3;NRXN1;CACNB4;AMPH;GRIN2B;GRM5;GLRB;CHRM2;KCND2;SYN2;MBP;GABRA2;DLG4;NLGN2;SLC6A1;CACNA1B;GLRA3;CAMK4;CHRM3;GABRG2;GLRA1;GABBR2;AKAP9;NLGN1;SYN1;KCNA1;PRKACA;HTR4;RIT2;NRXN2;PRKAR1B;APBA1;DLG1;UNC13C;CAMK1;BSN;HTR7;UNC13B;GRIK4;SLC12A6;LRP6;KIF5A;GABRA5;SLC12A4;NOVA1;GABRG3;HCRTR2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.503188065106438,-1.3172085843068329,0.1425438596491228,0.5267500026328394,1.0,8/15,22.30%,P2RX4;SMOC2;LGMN;SEMA5A;MET;HSPB1;PRKD1;VEGFA
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.37405323768549537,-1.317156174882114,0.09560723514211886,0.5255065016468434,1.0,8/49,7.05%,ERBB4;IGF1;PARP14;IL6R;PIBF1;KIT;GHR;IL31RA
prerank,regulation of tissue remodeling (GO:0034103),-0.4839410219836608,-1.3165223212742325,0.1313364055299539,0.5258571849155105,1.0,7/18,30.88%,LEPR;IL18;SYT7;TGFB1;MDK;CEACAM1;FLT4
prerank,negative regulation of interleukin-17 production (GO:0032700),0.5746160490527269,1.3163705340977576,0.15415821501014199,0.9409092295341164,1.0,3/10,13.40%,VSIR;PRNP;DDIT3
prerank,regulation of B cell proliferation (GO:0030888),0.4258363643850221,1.3162703758739531,0.11128526645768025,0.9378265746240232,1.0,7/44,10.70%,PTPRC;VAV3;FCGR2B;TIRAP;IRS2;LYN;CD81
prerank,proteolysis (GO:0006508),0.3336159312239204,1.316170630241717,0.029556650246305417,0.9347396984948212,1.0,31/252,9.39%,LRP8;CAPN8;PCSK1;LVRN;FBXL6;CELA1;PSMC4;PRCP;PSEN2;RSPRY1;DPP8;MMP12;MME;ATG4C;UBE3A;CASP6;METAP2;FBXW2;CNDP2;RET;SPCS3;PGPEP1;LONP1;NAPSA;SPPL3;ATG4B;DESI2;DESI1;TPP1;SPRTN;MDM2
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5228295050016991,-1.3156592489262116,0.14760914760914762,0.5269784529270217,1.0,9/13,28.06%,VCAN;HEXA;HEXB;ARSB;CSPG4;BGN;DCN;HYAL1;CSPG5
prerank,centromere complex assembly (GO:0034508),0.4493447244220267,1.315542943728511,0.11655405405405406,0.9341749315238598,1.0,11/36,17.31%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;MIS12;POGZ;CENPP;RBBP4;CENPO;NPM1
prerank,response to light stimulus (GO:0009416),0.41114419609905695,1.315102729208465,0.0985691573926868,0.9328466907053566,1.0,9/55,10.41%,ERCC3;ZRANB3;MAP2K7;GPR52;ERCC4;MAPK8;CLOCK;SPRTN;CCAR2
prerank,regulation of osteoclast differentiation (GO:0045670),-0.4016322246817907,-1.314521707175084,0.11455847255369929,0.5288109183388124,1.0,12/33,35.43%,FBN1;CAMK4;UBASH3B;TCTA;CEBPB;PRXL2A;TLR3;GPR137B;TMEM178A;MAFB;MTOR;GPR137
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4442902555959627,1.3145172924097852,0.12561174551386622,0.9321492761053065,1.0,7/34,6.45%,PTPRQ;PTPN18;DUSP7;PTPRJ;PTPRB;PTPN12;PTPRT
prerank,neurotrophin signaling pathway (GO:0038179),-0.45456601447675604,-1.314319020165583,0.1261682242990654,0.5280124157226588,1.0,9/21,26.28%,MAGI2;NTRK2;GRB2;NGF;RAPGEF2;ZFYVE27;CASP3;KIDINS220;DDIT4
prerank,leukotriene biosynthetic process (GO:0019370),-0.4989078895729276,-1.3140464720800173,0.14225053078556263,0.5274037744149461,1.0,3/14,13.80%,PLA2G4A;GGTA1;GGT5
prerank,potassium ion homeostasis (GO:0055075),-0.458282157670089,-1.3139977625237564,0.09903381642512077,0.5261985345673089,1.0,12/23,19.52%,ATP1A2;KCNMA1;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2;SLC12A6;SLC12A4;ATP1A3;SLC12A9
prerank,positive regulation of calcium ion transport (GO:0051928),-0.4018335159202947,-1.3139339451700045,0.1008174386920981,0.524996607100772,1.0,5/36,4.75%,ANK2;STIM2;CACNA1D;PDGFRB;P2RX4
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4727540232484344,1.3125000089147212,0.13961605584642234,0.938854801594217,1.0,3/25,4.48%,NDST3;CSGALNACT1;EXT2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5526848979241419,-1.3117987964828763,0.1504950495049505,0.5296124841006258,1.0,7/11,24.53%,IGF1;GHR;TSC2;PIK3R1;GIGYF1;EIF2AK3;AKT1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.2986809857635308,-1.3108218136023124,0.016597510373443983,0.5310014059393984,1.0,62/151,26.26%,MAGI2;BMP6;NTRK3;ADAMTS12;EGFR;SMAD3;IQGAP1;NTRK2;NRP1;TGFBR1;MAPK14;SOX5;TGFBR2;MAPT;CTNNB1;BMP7;SMAD4;SIRT2;MED1;BMP4;APPL2;WNT4;STMN2;CLEC3B;GAS1;FOXC1;ACVR1;LGMN;ANXA1;ACVR1B;MTSS2;PDCD5;DUSP22;RACK1;VSTM2A;SETX;RAPGEF2;TGFB1;BMPR1B;EHD1;NR3C1;TWF2;SOX6;RPS6KB1;BMPR1A;CPNE3;BMPR2;HSPB1;PRKD1;VEGFA;APPL1;ITGB1BP1;EMD;AKT1;KIDINS220;ERBB2;HYAL1;RUNX2;DSTYK;SFRP1;NR4A1;PDE2A
prerank,glutamate receptor signaling pathway (GO:0007215),-0.38934022842351235,-1.310703667137201,0.0859375,0.5300000850342261,1.0,6/37,1.54%,GRIA4;GRIA2;CPEB4;GRID2;GRIN2B;GRM5
prerank,regulation of receptor internalization (GO:0002090),-0.3995694111898554,-1.3106551248901164,0.13075060532687652,0.5287630074438974,1.0,3/35,3.56%,MAGI2;AHI1;DLG4
prerank,granulocyte differentiation (GO:0030851),0.5102754344250092,1.3105905165108218,0.14545454545454545,0.9449143717823374,1.0,5/18,8.52%,TAL1;LEF1;CDKN1A;EP300;CDK4
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3800579639794765,-1.3100287374974486,0.09852216748768473,0.5291678684440557,1.0,7/45,4.74%,BMP6;DAB2;TGFBR1;BMP5;BMP7;SMAD4;BMP4
prerank,cristae formation (GO:0042407),0.4681548100077947,1.309858112691549,0.14035087719298245,0.9449835090985664,1.0,11/27,14.72%,ATP5F1E;UQCC3;ATP5MG;ATP5PF;ATP5MC2;IMMT;CHCHD6;CHCHD3;LETM1;DNAJC11;ATP5F1C
prerank,cell chemotaxis (GO:0060326),-0.35704111679524353,-1.3095404038812404,0.0708215297450425,0.5291895136279843,1.0,12/60,10.71%,LPAR1;PARVA;PDGFRB;EPHB1;NRP1;KIT;PIP5K1A;PRKCD;PDGFRA;CCR9;PLEKHG5;ACKR3
prerank,regulation of cellular senescence (GO:2000772),0.466212047730885,1.3094005831823952,0.1488294314381271,0.9435147590099686,1.0,11/28,16.20%,B2M;FBXO5;SIRT1;YPEL3;ZKSCAN3;ING2;TERT;NEK6;YBX1;MAP3K3;RSL1D1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3436384036689582,1.3093935180798728,0.041237113402061855,0.9400471905292896,1.0,40/184,14.95%,PSMB10;ERCC3;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ANAPC2;ALMS1;NEK11;HAUS4;HAUS5;CEP41;TUBB;ZFP36L1;PSMD11;PSMB4;DCTN2;PSMC1;RGCC;FBXO5;ODF2;CEP164;ANAPC7;DCTN3;PSMC2;TFAP4;PSMD2;DYNLL1;ANAPC11;ANAPC10;ANAPC4;CUL3;PSMD14;PSMC6;NEK6;PSMD1;PSMB1;DYNC1I2;INO80
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.5213935020876543,-1.3093222538953542,0.14412416851441243,0.5284132459519401,1.0,6/12,15.56%,MAP2;EML2;STMN2;CLIP3;STMN1;TUBB4A
prerank,chromatin remodeling (GO:0006338),0.3698500053796041,1.30915410555367,0.08695652173913043,0.9377488950661292,1.0,38/100,19.09%,ACTL6A;RUVBL2;ACTB;NUDT5;SMARCA2;ACTR8;HNRNPC;SIRT1;ACTR5;KDM6A;RUVBL1;KDM4D;RSF1;PAK1;ESR1;SMARCD1;CHD3;CECR2;HDAC5;KDM5C;DR1;HCFC1;BAZ2A;INO80;EZH1;PBRM1;TAF6L;TOP1;SMARCA4;RBBP4;SMARCAD1;NPM1;TADA2A;CHD8;KDM4C;HDAC2;ATRX;SMARCB1
prerank,synapse organization (GO:0050808),-0.3099641923256328,-1.3088206327605896,0.02768166089965398,0.5284682978328764,1.0,23/125,6.09%,LRRC4C;LRFN5;PDZRN3;ANK3;SDK1;GPC6;NRXN1;CACNB4;GRM5;KIRREL3;NRCAM;NTNG1;PPFIBP1;PTPRS;RYK;MAPT;DNER;DSCAM;NLGN2;SLC6A1;GPM6A;PPFIA1;CTNND2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.4176524411167823,1.30853861658143,0.09688013136288999,0.9374089544504398,1.0,10/46,10.17%,TOMM20;ROMO1;TIMM17B;RALA;TSPO;GRPEL2;TOMM40L;TIMM21;FBXO7;AIFM1
prerank,T cell activation (GO:0042110),0.3927177002344411,1.3077429008833283,0.08784773060029283,0.9380303529314203,1.0,11/69,11.89%,LCP1;JAG2;PIK3CG;PTPRC;PPP3CB;GPR89A;GPR89B;NLRC3;LFNG;PIK3CD;PPP3CA
prerank,negative regulation of peptidase activity (GO:0010466),-0.3707457288502949,-1.307512629227587,0.0893854748603352,0.5308613770003527,1.0,5/47,1.97%,SPOCK3;LRP1;TIMP3;SPOCK1;TIMP2
prerank,transition metal ion transport (GO:0000041),-0.4063182208538884,-1.307464936801365,0.1111111111111111,0.5296380096953403,1.0,15/35,30.35%,CP;TRPC5;ATP7A;SLC30A10;TRPC1;SLC31A1;SLC39A8;SLC31A2;COX17;SLC11A2;TRPC6;SLC30A5;TTYH1;TRPC3;ATOX1
prerank,triglyceride metabolic process (GO:0006641),0.41209954514073843,1.3073423554910408,0.11594202898550725,0.9367199312498179,1.0,7/48,7.29%,GPAM;FABP7;APOE;PLAAT3;LMF1;GPAT4;SIRT1
prerank,positive regulation of protein acetylation (GO:1901985),0.5521781659790077,1.306538265249284,0.12835249042145594,0.9373690621094118,1.0,6/12,15.22%,DIP2A;DIP2B;RAPGEF3;PRKAA2;DDX3X;TERF2IP
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.3762915285909881,1.306397213688235,0.08235294117647059,0.9347137555329271,1.0,20/87,13.09%,TTC19;IMMP2L;SDHAF3;NDUFAF1;NDUFAF5;UQCC3;NDUFB6;NDUFB4;NDUFA10;OMA1;NDUFA1;NDUFS2;TIMM21;AIFM1;NDUFB7;TIMMDC1;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.31885705626201394,-1.3063839741424228,0.06312292358803986,0.5313916881083003,1.0,44/95,29.10%,UST;GPC6;HS3ST5;HS6ST2;DSE;SDC2;GLCE;B4GALT1;CEMIP;CHSY1;VCAN;OGN;HS3ST3A1;GPC3;HSPG2;HEXA;CSGALNACT2;CHST15;GPC5;B4GALT6;CHST11;SLC35D2;UGDH;CSPG4;ST3GAL4;PRELP;HS3ST3B1;DSEL;LUM;NDST2;B4GALT4;GPC4;SDC3;BGN;DCN;HYAL1;CHPF2;CHST2;XYLT2;CHST3;CSPG5;OMD;CHST12;B4GALT7
prerank,secretion (GO:0046903),-0.49756822841076637,-1.3062455724216233,0.14967462039045554,0.5304774408703689,1.0,4/14,16.75%,RIMS1;SLC22A4;SLC22A6;NPR1
prerank,negative regulation of immune response (GO:0050777),0.3460472666056803,1.305966314323961,0.057068741893644616,0.9334360619370647,1.0,22/154,10.62%,GPR176;PRKAR1A;PTGER2;TNFAIP3;FCGR2B;PLK2;SRC;TSHR;INSL3;RAMP2;FYN;SAMSN1;GNB1;RXFP1;SYK;NLRC3;PLCG1;LYN;RHBDF2;CD163;TRAF3IP1;YES1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.3511143671399604,1.305279904373793,0.06657789613848203,0.9334655342497076,1.0,31/145,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ALMS1;HAUS4;HAUS5;CEP41;STOX1;TUBB;PSMD11;PSMB4;DCTN2;PSMC1;FBXO5;ODF2;USP47;CDK4;CEP164;DCTN3;PSMC2;PSMD2;DYNLL1;RAD51B;PSMD14;PSMC6;PSMD1;AVEN;PSMB1
prerank,diol metabolic process (GO:0034311),0.5028145058758682,1.3052172100691102,0.13799283154121864,0.930419491460664,1.0,7/19,14.26%,SPR;PTS;PLPP1;SGPP2;NOS3;SGPP1;GCH1
prerank,diterpenoid metabolic process (GO:0016101),-0.3645618174405408,-1.3050927794796245,0.1023391812865497,0.532265614575181,1.0,13/55,11.98%,GPC6;LRP1;ALDH1A1;SDC2;DHRS3;GPC3;HSPG2;ABCA4;NAPEPLD;RBP4;GPC5;RBP1;ALDH3A2
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.4908967144385773,-1.3050521544054838,0.13539192399049882,0.5310198430830395,1.0,5/15,14.71%,MAGI2;SKI;ACVR1;ACVR1B;DACT1
prerank,AMP metabolic process (GO:0046033),-0.5226831704313238,-1.3048322243684967,0.15296803652968036,0.5303278876945497,1.0,11/13,42.67%,AMPD3;XDH;AK3;AMPD2;ADSS2;ADSL;AK4;NUDT2;NT5C1A;ADSS1;NT5E
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.3054073296162786,-1.3035770934563111,0.033707865168539325,0.5326324353871672,1.0,33/138,15.76%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;AHI1;PDGFRB;EPHB1;NTRK2;AXL;RYK;ABI1;FER;EPHA7;MTSS1;NEDD9;ROR1;KIT;DDR1;PDGFRA;FRK;IL31RA;EPHB4;EPHB2;EPHA3;PTPRF;ACVR1B;SHC3;IL6ST;ROR2;PTK2;PTPRU;NGF
prerank,muscle organ development (GO:0007517),-0.3649117183429119,-1.3034096427873003,0.08033240997229917,0.5317320697623675,1.0,16/54,17.75%,LAMA2;IGF1;VAMP5;SGCE;FHL1;CHD2;MKX;SMTN;SPEG;ITGA11;LARGE1;SRI;FKTN;COL6A3;EVC;SOX6
prerank,spindle assembly (GO:0051225),0.39206125901137234,1.302898392984106,0.10993975903614457,0.9383702781090951,1.0,23/67,17.20%,ABRAXAS1;HAUS4;HAUS5;CLASP2;HDAC3;TUBGCP5;MZT1;STARD9;KIF2A;BCCIP;NEK7;RPS3;TNKS;KIF3B;CHEK2;NEK6;ARHGEF10;RCC1;INO80;STAG2;TUBGCP2;KPNB1;CLASP1
prerank,regulation of presynapse assembly (GO:1905606),-0.4755096875366086,-1.3027412478588638,0.1341991341991342,0.5309060940607229,1.0,9/18,29.17%,LRFN5;GPC6;IL1RAPL2;IL1RAPL1;SLITRK1;GPC4;LRRC4B;SNCA;MDGA1
prerank,regulation of presynapse organization (GO:0099174),-0.4755096875366086,-1.3027412478588638,0.1341991341991342,0.5309060940607229,1.0,9/18,29.17%,LRFN5;GPC6;IL1RAPL2;IL1RAPL1;SLITRK1;GPC4;LRRC4B;SNCA;MDGA1
prerank,extracellular matrix assembly (GO:0085029),-0.4316631843520775,-1.3027359112819026,0.14055299539170507,0.5296040194477193,1.0,11/23,24.78%,GPM6B;TNXB;NTNG1;ATP7A;NTN4;QSOX1;TGFB1;LAMB1;EFEMP2;EMILIN1;MYH11
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5429403281419016,1.3024414648310798,0.1491395793499044,0.9373112401108381,1.0,8/14,18.79%,ACD;TPP1;TERT;TNKS;TERF2IP;ATR;TNKS2;ATRX
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.42792848002095496,-1.3006966724014375,0.12826603325415678,0.5340763084076149,1.0,2/27,0.64%,LPAR1;HTR2C
prerank,spinal cord development (GO:0021510),-0.5241877018359469,-1.3005427523126354,0.154,0.5331445980446653,1.0,5/12,17.21%,PKD1;GLI2;RELN;LOXL3;VIT
prerank,positive regulation of nuclear division (GO:0051785),-0.42915982711340256,-1.300153973613628,0.1310344827586207,0.5328539648371394,1.0,4/25,7.88%,IGF1;PDGFRB;SIRT2;LRP5
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.5035445309722935,-1.2999347178961875,0.1629327902240326,0.5321313142483645,1.0,8/14,25.87%,GHR;PXN;STAT6;SOCS2;PTK2;PIK3R1;PRLR;STAT5A
prerank,regulation of fat cell differentiation (GO:0045598),0.373011572682465,1.2999219334458756,0.07446808510638298,0.9463479544562873,1.0,15/74,12.48%,CCDC85B;PTPRQ;TRIB3;FRZB;CCDC71L;BBS12;ZFP36L1;PPARD;TRIO;SIRT1;WNT5A;AAMDC;TRPM4;CARM1;WDFY2
prerank,L-amino acid transport (GO:0015807),0.4531517815055705,1.2995401713515573,0.14576271186440679,0.9449920056999483,1.0,8/28,13.69%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC1A2;SFXN1;SLC25A12;SLC38A5
prerank,positive regulation of neurogenesis (GO:0050769),-0.34198464902503534,-1.2989233790632464,0.06424581005586592,0.533681489420776,1.0,23/68,16.89%,ROBO2;PLXNA2;ROBO1;CUX1;NTRK2;TIAM2;CTNNB1;RHOA;SPEN;SNW1;SMARCD3;NUMBL;CUX2;DISC1;IL1RAPL1;OBSL1;PLXND1;ARHGDIA;KDM1A;PLXNB2;NGF;PLXNC1;OPRM1
prerank,dephosphorylation (GO:0016311),0.3489753279379748,1.2987204946182767,0.05483028720626632,0.9457514576175708,1.0,22/147,6.91%,PHPT1;PTPRR;PTPN18;PTPRG;DUSP7;PTPRJ;PTPRC;CTDSP1;PPP3CB;PNKP;PTPRM;PTPRB;DUSP12;PTPRE;PPP2CA;PLPP6;PTPN12;PXYLP1;SSH2;PTPRT;PLPP1;PPP2CB
prerank,positive regulation of dephosphorylation (GO:0035306),0.46969504851338717,1.2982252353216461,0.1371527777777778,0.9449078143100899,1.0,10/27,14.15%,PIN1;SRC;PPP1R16B;CNEP1R1;CALM3;SPPL3;ANKLE2;PTBP1;CDH5;PTPA
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.3545078742265135,-1.297900288374047,0.10416666666666667,0.5353120540799715,1.0,12/56,10.91%,BMP6;LDLRAD4;DAB2;BMPER;TGFBR1;BMP5;BMP7;SMAD4;BMP4;SMAD6;ACVR1;SNX25
prerank,axon extension (GO:0048675),-0.44266114485339886,-1.2977204735504744,0.15308641975308643,0.5344818144826962,1.0,7/23,9.78%,ALCAM;MAP1B;ULK2;AUTS2;NRP1;SEMA3A;NRP2
prerank,DNA biosynthetic process (GO:0071897),0.5129368864300261,1.2976931339825692,0.152014652014652,0.9441431646586983,1.0,5/16,10.59%,POLE;SIRT1;POLD3;POLA1;TERT
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5662145077957312,-1.2976884356471363,0.13934426229508196,0.5332810195672559,1.0,5/10,25.77%,UFL1;TP53;LMBR1L;ACE;SFRP1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.33196281157432345,-1.2975738439427824,0.08227848101265822,0.5323260290899008,1.0,25/80,17.63%,TENM2;DPYSL3;WASF2;AUTS2;NRP1;WASL;OCLN;TAPT1;PLCE1;GPM6A;CEP120;HTT;PLPPR5;ACTR3;NLGN1;DOCK11;FAM98A;ENTR1;CCP110;CDC42EP5;CDC42EP1;PLEKHM1;ACTR2;CDC42;TWF2
prerank,RNA splicing (GO:0008380),0.37027829938631046,1.2973990307456398,0.08415147265077139,0.942284919176633,1.0,33/95,17.93%,SNRPD2;NCBP1;PRPF3;SNRPD1;PPP2CA;PPIG;SRSF10;USB1;SFPQ;HNRNPC;IVNS1ABP;SMNDC1;SF3B3;SRSF4;YJU2;RSRC1;TARDBP;U2AF1;CCAR2;SRPK2;PTBP1;RRAGC;SRSF7;USP39;FUS;TCERG1;TRA2B;LSM1;NONO;SNRPA1;DHX8;DDX23;PRPF18
prerank,lymphocyte proliferation (GO:0046651),0.47943102627456413,1.2969711949855338,0.1589648798521257,0.9409918664212942,1.0,3/22,2.55%,PIK3CG;PTPRC;PPP3CB
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.43475228734935445,-1.2960244508892753,0.15056179775280898,0.5355821643194012,1.0,7/25,12.92%,ANK2;CTNNA3;CACNA1C;CXADR;AKAP9;CAMK2D;DLG1
prerank,response to cAMP (GO:0051591),-0.39073226701330666,-1.2956237209532553,0.0903954802259887,0.5353998369224514,1.0,14/37,27.74%,HCN1;AKAP6;IGFBP5;AKAP9;EZR;RAPGEF2;SLC5A5;STAT1;DGKQ;DMTN;PDE2A;HCN2;KCNQ1;INPP5K
prerank,positive regulation of phagocytosis (GO:0050766),0.4103084766299613,1.2948986241085565,0.10883280757097792,0.9479068100837641,1.0,12/47,18.30%,PTPRJ;PTPRC;FCGR2B;CAMK1D;LMAN2;MERTK;CD47;CYBA;GAS6;CALR;RAB27A;MYO18A
prerank,neuron projection development (GO:0031175),-0.2959624351689679,-1.2941550244061069,0.02880658436213992,0.5383270466853691,1.0,48/168,17.35%,MAP2;CNTN4;DCLK1;PLP1;EPB41L3;PPP1R9A;GPM6B;GAS7;EPHB1;NBL1;HDGFL3;SH3GL2;RASGRF1;WASL;DLG4;RYK;MAPT;BMP7;ADGRV1;GPM6A;ATP7A;MYO16;CTNND2;TAOK3;SHTN1;ERCC6;ROCK1;CTTN;STMN2;DOCK10;NLGN1;CDK16;STX3;SGK1;GSK3B;EPHB2;RAB11A;TAOK1;DICER1;BICDL1;STMN1;WHRN;NGF;RAPGEF2;EHD1;GPRIN3;LAMB1;CDC42
prerank,synapse assembly (GO:0007416),-0.3441986002473216,-1.293880453793063,0.056657223796033995,0.5378391794480119,1.0,24/67,17.27%,SDK1;NRXN1;GRID2;KIRREL3;LRRTM3;NRCAM;GABRA2;RYK;DNER;DSCAM;NLGN2;GPM6A;SDK2;GABRG2;NLGN1;CDH1;LRRC4;NRXN2;OBSL1;PLXND1;PLXNB2;LGI2;SHANK2;DVL1
prerank,N-terminal protein amino acid modification (GO:0031365),0.512761280068434,1.2937977600943062,0.17518248175182483,0.9498941652615355,1.0,6/14,18.78%,METAP2;NAA35;METAP1;NTMT1;NAA15;NAA50
prerank,DNA-dependent DNA replication (GO:0006261),0.35019361714147645,1.2936788567477249,0.06666666666666667,0.9471983824768099,1.0,27/128,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PNKP;ORC3;PSMD11;PSMB4;PSMC1;SSBP1;POLE;CDC45;ORC4;POLD3;CDK2AP1;POLA1;PSMC2;PSMD2;SRPK2;ORC2;HELB;PSMD14;PSMC6;PSMD1;PSMB1
prerank,chromatin organization (GO:0006325),0.3537620649168809,1.2930122489200409,0.06666666666666667,0.9473598471489613,1.0,43/132,19.09%,MECOM;EZH2;ACTL6A;RUVBL2;NUDT5;HDAC3;SMARCA2;SOX2;FAM50A;SIRT1;KDM6A;SETD5;RUVBL1;KDM4D;RSF1;PAK1;CHD1;ESR1;HP1BP3;PWWP3A;SMARCD1;HDAC5;KDM5C;DR1;HCFC1;BAZ2A;INO80;EZH1;PBRM1;TAF6L;TOP1;SMARCA4;TCF7L1;RBBP4;SETD2;SMARCAD1;NPM1;TADA2A;KDM4C;SAFB;HDAC2;ATRX;SMARCB1
prerank,in utero embryonic development (GO:0001701),-0.4271905923565299,-1.2924484270842245,0.12558139534883722,0.5406011120824895,1.0,11/25,24.52%,FGFR2;ARNT2;PKD1;TGFBR1;FUT8;HINFP;IGF2;FLCN;VEGFA;TGFB3;ZNF568
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4692443277129643,1.2921763756238176,0.1567291311754685,0.9484043017079906,1.0,6/26,14.26%,ACER2;SPR;CYP1B1;NOS3;ACER3;GCH1
prerank,Golgi organization (GO:0007030),0.35743787222719814,1.2920748478032527,0.0707482993197279,0.9456421656409558,1.0,22/112,10.98%,SURF4;SYNE1;LYSMD3;GORASP2;CLASP2;LMAN2;TMED4;SEC23IP;RAB43;TRAPPC8;USP6NL;ARHGEF7;GOSR2;TRIP11;VMP1;TMED5;TMED10;RAB1A;GOLPH3L;TRAPPC11;GCC2;TMED7
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4159884826486541,-1.2919333753712945,0.12224938875305623,0.5408468373175959,1.0,6/26,8.44%,NAV3;MAPT;OCLN;STMN2;AKAP9;SLAIN2
prerank,regulation of intracellular protein transport (GO:0033157),0.4418841821567637,1.2911740933718978,0.14833333333333334,0.9465898493665502,1.0,7/32,11.88%,LCP1;PRR5L;ZFAND1;ICE1;RUFY3;GCC2;IFI27
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5309259457416757,-1.2908194664129997,0.13616071428571427,0.5427785199485059,1.0,5/12,16.68%,NFIB;GLI2;EPHB1;EPHB2;SZT2
prerank,regulation of TORC1 signaling (GO:1903432),-0.3966187184960187,-1.2908145965158728,0.11386138613861387,0.5415033832625091,1.0,23/33,36.55%,RNF152;GPR137C;DEPDC5;KLHL22;CASTOR2;STK11;SEH1L;ATM;SZT2;ITFG2;FLCN;DGKQ;TELO2;LAMTOR5;SESN2;PIP4P1;GPR137B;SPAAR;PIH1D1;SMCR8;RRAGD;GPR137;RRAGA
prerank,regulation of innate immune response (GO:0045088),0.39953550432656076,1.2903531458094881,0.10329341317365269,0.9473069732977377,1.0,7/57,4.02%,LRP8;TNFAIP3;FCGR2B;TIRAP;CDC37;BIRC2;IFI35
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4166439610760479,-1.2900321298384965,0.13316582914572864,0.5423405575184237,1.0,12/26,25.65%,SORBS1;IGF1;OCLN;AKT2;CREBL2;ARPP19;CLIP3;PIK3R1;OSBPL8;APPL1;AKT1;CAPN10
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.5222224857103389,-1.2899457009119264,0.17276422764227642,0.5412988320936144,1.0,6/13,10.98%,FBN1;FSTL1;NBL1;FBN2;LTBP1;GREM2
prerank,negative regulation of dephosphorylation (GO:0035305),0.5011994881538933,1.2898206059246282,0.15467625899280577,0.9466941588627465,1.0,6/18,15.44%,PPP1R36;PPP1R16B;YWHAB;MFHAS1;PTPA;PPP1R8
prerank,neutrophil chemotaxis (GO:0030593),0.40032589763241555,1.2897053833017003,0.12924071082390953,0.9440236376466068,1.0,7/53,11.50%,PIK3CG;BSG;PPIB;SYK;PIKFYVE;CCL25;PIK3CD
prerank,receptor catabolic process (GO:0032801),-0.4323710708944826,-1.2892419005327982,0.1400862068965517,0.542002360982667,1.0,13/24,20.31%,AP2B1;RNF43;AP2A2;AP2A1;ZNRF3;LGMN;GPRASP1;UVRAG;SNX25;VLDLR;TGFB1;MYLIP;NEDD4
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5312563775387449,-1.2892302080722093,0.16079295154185022,0.5407701461051166,1.0,4/11,9.13%,TGFBR3;TGFBR1;TGFBR2;ACVR1
prerank,cell-cell junction organization (GO:0045216),-0.33366176142021814,-1.288407658209837,0.06116207951070336,0.5418947631313407,1.0,33/79,24.41%,SDK1;CDH10;SMAD3;CTNNA1;CXADR;OCLN;TLN1;NLGN2;CTNND2;CDH11;SDK2;TLN2;CDH7;GJC1;ARVCF;AFDN;CDH1;CSK;CDH4;MYADM;CTNND1;NECTIN3;CADM2;TGFB1;CDH9;CDH8;CADM3;CDH19;FLCN;NECTIN2;DCHS1;TGFB3;PVR
prerank,positive regulation of nervous system development (GO:0051962),-0.3871825486422801,-1.2881204709564353,0.10025706940874037,0.5414521671419495,1.0,13/42,12.29%,NRXN1;GRID2;EPHB1;NLGN2;SYNDIG1;CLSTN2;SPEN;NLGN1;SNW1;EPHB2;NUMBL;CUX2;IL1RAPL1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.4762731162780021,1.2877608088948502,0.1648148148148148,0.9503506321641609,1.0,9/21,16.46%,TIPRL;BOD1;PPP1R16B;YWHAB;PPP1R11;MFHAS1;PTPA;PPP1R8;FKBP1A
prerank,regulation of filopodium assembly (GO:0051489),-0.3861943840978571,-1.2876269984278428,0.11166253101736973,0.541548624437361,1.0,10/38,8.48%,TENM2;DPYSL3;NRP1;WASL;GPM6A;PRKCD;GAP43;PLPPR5;NLGN1;DOCK11
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.47835087150645816,-1.2875629001414002,0.16122448979591836,0.5404680878135422,1.0,4/15,8.19%,EDA;GLI2;HDAC1;FOXC1
prerank,anterior/posterior axis specification (GO:0009948),-0.48786966083411,-1.286971428185265,0.16233766233766234,0.5409200954433775,1.0,3/15,11.62%,WLS;SKI;TBX3
prerank,endothelial cell development (GO:0001885),0.4772588854083664,1.2866425373584156,0.1509433962264151,0.9525908032109379,1.0,7/25,10.83%,PDE4D;PECAM1;MARVELD2;PPP1R16B;ICAM1;RAPGEF3;ROBO4
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5373775045752467,1.2863077374530703,0.17647058823529413,0.9510022966123607,1.0,5/13,14.70%,PTTG1IP;SIRT1;YJU2;MDM2;CD44
prerank,negative regulation of receptor binding (GO:1900121),0.5628667850503905,1.2861201575343635,0.18860510805500982,0.948789277720221,1.0,2/10,5.45%,ATP2A2;B2M
prerank,regulation of cytoskeleton organization (GO:0051493),-0.3196872832949324,-1.285578421988766,0.04411764705882353,0.5435658501421744,1.0,33/108,17.63%,BICD1;PHLDB2;LRP1;GPM6B;IQGAP1;EFNA5;PDGFRB;CAPN2;PHLDB1;CYLD;MAPT;CLIC4;RHOA;ROCK2;PRKCD;ROCK1;EZR;RND3;RHOBTB2;GSK3B;EPHA3;RHOB;RHOBTB1;HIP1R;TAOK1;PFDN2;TRIM36;PTK2;ARHGEF5;IQGAP2;NEXN;DIAPH1;TWF2
prerank,regulation of T cell migration (GO:2000404),0.5034508219959776,1.2852294743212156,0.1761467889908257,0.9497435493641737,1.0,5/18,15.24%,CXCL12;LRCH1;RIPOR2;APP;DOCK8
prerank,photoreceptor cell development (GO:0042461),-0.5018294963025642,-1.2847167069473966,0.17286652078774617,0.5448301778375781,1.0,6/14,31.52%,AHI1;DCX;TOPORS;VEGFA;RP1;MFSD2A
prerank,magnesium ion transport (GO:0015693),-0.5177952537624492,-1.2846865956487925,0.1524008350730689,0.5436531547095101,1.0,6/12,22.63%,SLC41A1;NIPA2;MRS2;NIPAL2;MAGT1;NIPAL3
prerank,positive regulation of cell division (GO:0051781),-0.38423586794571196,-1.2846028092937383,0.1015625,0.5426606618268751,1.0,6/38,6.06%,FGFR2;SVIL;FGF1;RHOA;SIRT2;CIT
prerank,protein localization to organelle (GO:0033365),-0.3023932364252126,-1.2840654889593317,0.045774647887323945,0.5430247755668225,1.0,54/133,25.35%,ANK2;BICD1;TIA1;COL1A1;TULP3;BMP7;BMP4;WDR35;LMNA;TTC21B;SORL1;UBE2J2;CYB5A;DDX1;BANP;TOR1AIP1;OPTN;RPA1;TRAM1;DDRGK1;ALDH3A2;OBSL1;BBS9;TOLLIP;RAB11A;ARL1;TOPORS;VAMP2;TOR1B;BBS2;PAF1;TRAM2;CEP250;EHD1;STX1A;ZNF423;DVL1;IFT20;SCG3;SGTA;GBP5;SIX1;PAQR3;CNTLN;MTCH2;GBP2;CTDNEP1;EMD;RAB33B;SERP1;ARFRP1;RIPOR1;DNAJA1;SEC61B
prerank,protein acetylation (GO:0006473),0.4444027464192319,1.2839935876799982,0.15448504983388706,0.9525063703807729,1.0,12/30,18.84%,ING4;EP300;SIRT1;CLOCK;NAA35;ESCO1;CREBBP;NAA80;ING5;NAA15;NAA50;HAT1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5227154292144028,1.283758556474116,0.1839080459770115,0.9506171304204405,1.0,6/15,16.16%,RUVBL2;CCT2;CCT5;RUVBL1;TCP1;DKC1
prerank,positive regulation of transporter activity (GO:0032411),-0.5084092472140392,-1.2837328423801717,0.1883495145631068,0.5427566701935483,1.0,4/13,13.20%,KMT2A;SGK1;RXRA;WNK3
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5703445774006666,1.2833737311167082,0.1791044776119403,0.9494382565171462,1.0,5/11,18.84%,ASF1B;CABIN1;RBBP4;ATRX;HAT1
prerank,spliceosomal snRNP assembly (GO:0000387),0.4240251513461399,1.283255736751816,0.1371610845295056,0.946905179901389,1.0,7/38,8.83%,SNRPD2;PRPF31;PRPF3;SNRPD1;SRSF10;GEMIN5;COIL
prerank,tight junction assembly (GO:0120192),0.40253197127333873,1.2828657775972974,0.1426256077795786,0.9456899437705372,1.0,12/49,14.50%,PECAM1;MARVELD2;RAMP2;F11R;ESAM;CLDN5;PRKCI;CDH5;LSR;APC;PATJ;PARD3
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3624486230080849,-1.2827189790792632,0.0968586387434555,0.5445292700091723,1.0,13/51,7.23%,DCLK1;EPB41L3;GAS7;NBL1;SNX2;BMP7;GPM6A;ATP7A;MYO16;TAOK3;SHTN1;CTTN;WASF1
prerank,membrane lipid catabolic process (GO:0046466),0.5670562443245355,1.2819902416917106,0.1786407766990291,0.9469681001455984,1.0,3/10,10.93%,PPT1;FUCA1;CYP1B1
prerank,regulation of hormone secretion (GO:0046883),-0.49027084073011873,-1.2816735713847551,0.1522198731501057,0.5462295000193492,1.0,7/15,35.12%,SCG5;ANXA1;VAMP2;SNX6;EDN1;SOX11;EDN3
prerank,androgen receptor signaling pathway (GO:0030521),-0.5332287041472739,-1.2813400417792298,0.16837782340862423,0.5459302848632205,1.0,3/11,4.49%,DDX5;DDX17;RNF14
prerank,purine ribonucleotide transport (GO:0015868),0.5130010277566323,1.2810458811474716,0.16991150442477876,0.948311309435444,1.0,3/16,6.45%,ABCC4;SLC25A24;LRRC8C
prerank,response to glucagon (GO:0033762),-0.44767837534010907,-1.280748693943485,0.1492204899777283,0.5462854431933365,1.0,8/19,12.02%,ADCY5;ADCY2;ADCY1;ADCY9;PRKACA;CRY1;ADCY7;PRKAR1B
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4226448534328018,-1.2807435648972214,0.15690866510538642,0.5450676236907414,1.0,14/25,26.46%,KAT7;ERCC6;ELL;LDB1;DDX39B;HTATSF1;CCNT1;WDR43;THOC5;CCNK;EAF1;THOC1;ZNF326;SUPT4H1
prerank,myotube differentiation (GO:0014902),-0.4667385891680521,-1.2805710716749124,0.13537117903930132,0.5443090698280909,1.0,5/17,6.85%,IGF1;ADGRB3;ADAM12;ADAMTS5;SKI
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3072110257638204,1.2803441008872978,0.014223194748358862,0.9486171480997188,1.0,90/532,14.01%,LRP8;CISH;LCP1;PSMB10;PSMC4;PSMB6;MAPK3;EIF5A;CBL;PSMD8;PSMD5;PSMD12;PTPRJ;IL1R1;HSPA8;MAP3K7;SOD1;TAB2;CXCL12;RPS6KA4;IFNLR1;IFITM2;CRLF1;SRC;IFIT1;TRIM8;RPS6KA5;BIRC2;XAF1;IFI35;PSMD11;IRF9;SOX2;PSMB4;FYN;TNFRSF1B;PSMC1;CFL1;B2M;RALA;EDAR;CDKN1A;UGCG;TRAF5;ICAM1;SYK;TALDO1;PIM1;ACTN4;ADIPOR2;SIRT1;IFITM3;IRS2;TAB3;ADAR;TRIM25;CCL25;RPLP0;IFITM1;TRAF3;RELA;CSF1R;SOD2;ARF1;INPP5D;IL10RB;PSMC2;PLCB1;PSMD2;PITPNA;IFNAR1;UBE2V1;ADIPOR1;CDIP1;NOD1;PIK3CD;IFI27;IP6K2;CRKL;TYK2;TNIP2;IKBKB;IRF2;CHUK;PSMD14;MID1;PSMC6;PSMD1;NFKBIA;PSMB1
prerank,cellular response to sterol (GO:0036315),-0.50662643418778,-1.2802861043215108,0.1593625498007968,0.5438489824288946,1.0,9/13,19.50%,GRAMD1B;SMO;GRAMD1C;INSIG2;RORA;GRAMD1A;LRP6;GPLD1;OSBPL7
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.3139951964801725,-1.2802794545258824,0.05714285714285714,0.5426651206034232,1.0,29/108,16.69%,ST18;UACA;ROBO1;GSN;SMAD3;CFLAR;COL4A3;MAPT;MALT1;CASP8AP2;F3;VCP;XDH;FAM162A;FIS1;IFT57;ANP32B;GRAMD4;MAP3K5;CASP12;CTSD;HIP1R;PDCD5;RACK1;HSPD1;NGF;EGLN3;TRAF2;MTCH1
prerank,translational elongation (GO:0006414),0.35828005080811703,1.2802071814976896,0.07779349363507779,0.9461098184056803,1.0,20/101,15.14%,MRPS22;MRPS2;MRPS33;EEF1A1;MRPL23;MRPL24;EEF1D;MRPL18;MRPL38;MRPS12;MRPL20;TSFM;GTPBP2;MRPL52;MRPS15;MRPS24;MRPL48;EEF1B2;MRPS28;MRPS35
prerank,mesonephros development (GO:0001823),-0.5344823471336823,-1.2785629519717416,0.1721311475409836,0.546259783021728,1.0,4/11,5.59%,FGF1;BMP7;BMP4;OSR1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.4969236469512089,-1.2784774103528502,0.17735042735042736,0.545270370456381,1.0,5/14,20.25%,UFL1;BCL2L11;TMEM33;DDRGK1;COPS5
prerank,bicellular tight junction assembly (GO:0070830),0.4081638189750421,1.2781323123500639,0.13861386138613863,0.9527860007817908,1.0,11/46,14.50%,PECAM1;MARVELD2;RAMP2;F11R;ESAM;CLDN5;PRKCI;CDH5;APC;PATJ;PARD3
prerank,ventricular septum development (GO:0003281),-0.3813644562879732,-1.2780219432510298,0.12737127371273713,0.5453643259932963,1.0,9/37,9.91%,ROBO2;TGFBR3;ROBO1;TGFBR1;TGFBR2;SMAD4;HECTD1;ACVR1;SALL1
prerank,positive regulation of phosphorylation (GO:0042327),-0.2769767700972361,-1.2773430582629741,0.005263157894736842,0.5461546116469396,1.0,52/240,14.43%,ZBTB20;ERBB4;NTRK3;FGFR2;IGF1;SLCO3A1;DAB2;EGFR;LMO4;EPHA6;LEPR;EFNA5;PDGFRB;EPHB1;NTRK2;NRP1;FGF1;AXL;RYK;DSCAM;EPHA7;ROR1;BMP4;KIT;ROCK2;IL34;DDR1;PDGFRA;AKT2;PIK3R3;RAD50;VAC14;EPHB4;NIBAN1;PELI2;THBS1;MRE11;CCND3;DVL3;EPHB2;EPHA3;SEMA4D;ILK;PFKFB4;CLIP3;FNIP1;FAM20A;RALBP1;ROR2;IGF2;RACK1;PTK2
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.40181357641806414,1.2770691683342905,0.13838550247116968,0.9550574770899928,1.0,26/52,21.02%,PATL2;CNOT11;CNOT2;HBS1L;CNOT7;EXOSC9;PATL1;PAN3;NT5C3B;TUT7;PAN2;CNOT6;EXOSC1;CNOT1;DCP1A;CNOT6L;TUT4;PARN;CNOT10;LSM1;RC3H1;DCP1B;EXOSC7;CNOT8;DDX6;CNOT4
prerank,phagosome-lysosome fusion (GO:0090385),0.5625477249828589,1.2767579183789566,0.17681728880157171,0.9534018959806254,1.0,3/10,7.38%,RAB7A;RAB7B;PIKFYVE
prerank,Rac protein signal transduction (GO:0016601),0.4967488900011707,1.275842390084197,0.170018281535649,0.9549207157601306,1.0,10/18,20.98%,RAC2;TIAM1;RHOG;ELMO1;ABI2;CDH13;CYFIP1;HACE1;EPS8;RAC1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5567108801689017,1.2757521868239043,0.19924098671726756,0.9523212272122431,1.0,2/10,1.01%,RSC1A1;GSK3A
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.4084749949033736,1.2749360121664997,0.11258278145695365,0.9531765062337075,1.0,11/42,12.59%,FARS2;GARS1;YARS2;IARS1;LARS2;HARS1;NARS2;RARS2;EARS2;WARS2;LARS1
prerank,bicarbonate transport (GO:0015701),0.46243616193095277,1.2747917616962687,0.1400709219858156,0.9509121999381357,1.0,5/25,9.58%,SLC4A4;SLC4A5;CA2;CA4;CYB5R4
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4702159061752073,-1.2746451555287266,0.16114790286975716,0.5526887371702291,1.0,5/17,8.66%,ROBO2;NOTCH2;ROBO1;BMP4;SMAD6
prerank,negative regulation of neuron projection development (GO:0010977),-0.34877154485090145,-1.274290508199992,0.08882521489971347,0.552445118572357,1.0,16/56,15.44%,DCC;LPAR1;SPOCK1;DPYSL3;PTPRS;EFNB2;RHOA;CBFA2T2;SEMA3A;STMN2;NLGN1;BCL11A;PRAG1;GDI1;ARHGDIA;PTPRO
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5333597008789144,1.2742359118783184,0.18518518518518517,0.9505650730498246,1.0,2/12,1.42%,CBL;PTPRJ
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3991499742851027,-1.2742331842563261,0.1380952380952381,0.5513755135323235,1.0,11/30,20.30%,TGFBR3;SMAD3;FSTL1;SMURF2;SMAD4;DKK3;XIAP;PCSK6;TGFB1;SFRP4;TWSG1
prerank,regulation of mRNA catabolic process (GO:0061013),0.3503982784839113,1.2740414851379684,0.08979591836734693,0.9485891700539043,1.0,28/121,14.70%,PSMB10;PSMC4;PSMB6;PRR5L;PSMD8;PSMD5;PSMD12;HSPA8;ZFP36L1;PSMD11;PSMB4;PSMC1;FXR1;YWHAB;CNOT7;EXOSC9;PCID2;PSMC2;PSMD2;ZC3H14;XPO1;PSMD14;EXOSC1;PSMC6;PSMD1;PSMB1;CNOT1;DCP1A
prerank,negative regulation of lymphocyte activation (GO:0051250),0.4787433054913272,1.2738935198033394,0.17761989342806395,0.9463206883978353,1.0,3/21,5.32%,TNFAIP3;FCGR2B;SAMSN1
prerank,ncRNA processing (GO:0034470),0.32847452159522456,1.2737757795274554,0.05597964376590331,0.944018415770266,1.0,67/200,20.28%,THG1L;RPL30;UTP20;UTP18;RPL17;RPL23;RPL31;RPL3;DDX54;DDX10;FARS2;SMAD1;RPL35A;RPS14;RPL8;RPL5;RPL37A;PUS10;ADAR;RPL4;EMG1;SNU13;POP5;RPLP0;EXOSC9;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;AGO4;DDX27;WDR12;TUT7;EXOSC1;UTP11;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;SSB;TUT4;DKC1;INTS6;RPL19;RPL38;RPL36;DCAF13;RPL26;RPL15;RPL10;RPL32;RPS2;RPL27A;NOP58;NVL;EXOSC7;RPL7;RPL39;POP1;RPL14;AGO1;MDN1;INTS2
prerank,negative regulation of cell projection organization (GO:0031345),-0.36184272099086706,-1.2734500544046479,0.10649350649350649,0.5523300906255091,1.0,10/48,7.58%,DCC;LPAR1;SPOCK1;GRIN2B;DPYSL3;PTPRS;EFNB2;CBFA2T2;SEMA3A;STMN2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.5020891356670385,-1.2731607630918327,0.16075156576200417,0.551892338743416,1.0,5/13,25.42%,CACNA1G;SYT4;SCAMP5;STX1A;SYT10
prerank,positive regulation of B cell proliferation (GO:0030890),0.44831557081593526,1.2731544050678036,0.1456953642384106,0.944025068524427,1.0,5/29,10.70%,PTPRC;VAV3;TIRAP;IRS2;CD81
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.34273393739184815,-1.2729930727559404,0.09826589595375723,0.5511263691534543,1.0,27/67,29.30%,DOCK5;RSU1;DOCK1;PLEKHA2;NRP1;FLNA;NEDD9;RREB1;P4HB;CDK6;GSK3B;FN1;ILK;MYADM;TRIOBP;VIT;CDC42;CX3CL1;PPM1F;EMP2;DMTN;SFRP1;ARL2;CSPG5;MDK;MYOC;NDNF
prerank,cellular response to osmotic stress (GO:0071470),0.4849923310977878,1.2729010558285652,0.17647058823529413,0.9422697958721038,1.0,6/21,10.80%,OXSR1;ZFP36L1;SCN2A;ZFAND1;TRPV4;DDX3X
prerank,ribosomal large subunit biogenesis (GO:0042273),0.39354117494938423,1.2727698847730036,0.1296,0.940031804550041,1.0,24/54,21.16%,RSL24D1;RPL3;RRP15;RPL35A;RPL5;MRPL20;SNU13;RPLP0;RPL24;WDR12;PAK1IP1;LTO1;RPL23A;RSL1D1;NPM1;EIF6;RPL26;RPL10;NVL;RPL7;RPL14;MDN1;GTF3A;SDAD1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4304967875661622,-1.2720216399878317,0.13348946135831383,0.5525631559390933,1.0,7/24,5.82%,TMEFF2;PHLDB2;CGNL1;WASF2;ARHGAP28;PPFIA1;ARHGAP6
prerank,regulation of actin filament depolymerization (GO:0030834),-0.5071541343217625,-1.2718941658515155,0.17248908296943233,0.5517150389733744,1.0,4/12,19.12%,PLEKHH2;LIMA1;WDR1;SEMA5A
prerank,lipid droplet organization (GO:0034389),0.46892246396114007,1.2715683507285078,0.17028985507246377,0.9426828094377279,1.0,3/22,9.48%,CIDEA;FITM2;AUP1
prerank,regulation of lipid kinase activity (GO:0043550),-0.5285202846312791,-1.2707933007225156,0.17391304347826086,0.5535388450424729,1.0,6/11,30.75%,RBL2;PIK3R3;PIK3R1;RBL1;PIK3R2;WDR81
prerank,digestive tract morphogenesis (GO:0048546),-0.48773351377943963,-1.2707757975283571,0.21052631578947367,0.5523797914894047,1.0,6/14,23.36%,FGFR2;PDGFRA;NIPBL;RBPMS2;GLI1;STRA6
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.47277107541658914,-1.27061126440489,0.16335540838852097,0.5516210722144187,1.0,9/17,25.90%,ROBO1;NRP1;EFNB2;PIK3R3;EPHB4;GPLD1;VEGFA;AKT1;NR4A1
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4670794527585094,1.2702842903698166,0.1607773851590106,0.9458552358771556,1.0,4/23,5.71%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,protein heterooligomerization (GO:0051291),-0.46781591406283085,-1.2700301380632644,0.15184381778741865,0.5518995379779418,1.0,3/17,1.93%,GRIN2B;KCNC2;PKD1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.4513202864930859,1.2696450524624254,0.15502555366269166,0.9458617297663591,1.0,8/27,12.87%,MAP2K7;MAPK3;MAP3K7;MAPK8;CCDC88C;TNIP2;IKBKB;CHUK
prerank,response to hydroxyurea (GO:0072710),-0.5397817883719138,-1.2688886278916176,0.1729957805907173,0.5538978764936652,1.0,5/11,20.02%,SPIDR;KAT7;DDI2;RTF2;BLM
prerank,protein heterotetramerization (GO:0051290),-0.4992864770644862,-1.2686961391600924,0.1722689075630252,0.5532652024836411,1.0,2/13,1.93%,GRIN2B;PKD1
prerank,nucleoside salvage (GO:0043174),0.5678749295008245,1.2686086749140442,0.19881889763779528,0.9477686296647155,1.0,3/10,9.50%,UPP1;UCK2;UPP2
prerank,cellular response to organic cyclic compound (GO:0071407),-0.2979799082335688,-1.2684321643185048,0.048672566371681415,0.5528324194324558,1.0,42/141,22.88%,ATP1A2;GABRB1;HCN1;EGFR;ADCY5;AKAP6;RYR3;TFPI;ADCY2;IGFBP5;CTNNA1;SPIDR;ADCY1;CTNNB1;MED1;P2RX4;ROCK2;ATP1A1;GABRG2;AKAP9;EZR;CDH1;NCOA4;IL18;RORA;SPP1;CASP7;RAPGEF2;TGFB1;NR3C1;DIAPH1;ATP1A3;SLC5A5;MSN;RIOK3;SSH1;BLM;P2RY12;ADCY8;ADCY3;IMPACT;CASP3
prerank,rRNA processing (GO:0006364),0.3343128259252619,1.2676340542063003,0.07731305449936629,0.949447077649447,1.0,60/172,19.87%,RPL30;THUMPD1;UTP20;UTP18;RPL17;RPL23;RPL31;RPL3;DDX54;DDX10;RRP15;RPL35A;RPS14;RPL8;RPL5;RPL37A;RPL4;EMG1;SNU13;POP5;RPLP0;EXOSC9;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;DDX27;WDR12;SRFBP1;EXOSC1;UTP11;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;DKC1;RSL1D1;PRKDC;RPL19;RPL38;EIF6;RPL36;DCAF13;RPL26;RPL15;RPL10;RPL32;RPS2;TFB1M;RPL27A;NOP58;NVL;EXOSC7;RPL7;RPL39;RPL14
prerank,ear morphogenesis (GO:0042471),-0.4434570044960068,-1.2676133408361678,0.1655773420479303,0.5539560354029414,1.0,5/20,10.62%,FGFR2;ZIC1;OSR1;NIPBL;EPHB2
prerank,RNA destabilization (GO:0050779),-0.45991973663953295,-1.2669618034221677,0.16273584905660377,0.5544373878032476,1.0,6/18,13.32%,PUM1;ROCK2;ROCK1;LIN28B;YTHDF1;ZC3H18
prerank,carbohydrate homeostasis (GO:0033500),0.3793022344490477,1.2666131606315456,0.13210445468509985,0.9513289532817399,1.0,11/67,11.09%,PCK1;HECTD4;PYGL;SELENOT;WFS1;ADIPOR2;CYB5R4;PARK7;PRKAA2;BAD;ADIPOR1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4273654804276777,1.2662917778198342,0.15551839464882944,0.9499733100566671,1.0,7/34,11.11%,MT1G;SEMA6A;PRKD2;RAMP2;NOTCH1;RELA;FLT1
prerank,water transport (GO:0006833),-0.5256693728766085,-1.2659421059950122,0.19290465631929046,0.55599537473051,1.0,3/12,24.93%,PDPN;AQP4;AQP11
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.39425873024442176,-1.2657638344468936,0.14047619047619048,0.5552684360044697,1.0,7/32,6.59%,ZBTB20;IGF1;PID1;NUPR1;PPARGC1A;VCP;PPARA
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5411519798269251,-1.2655608648128105,0.18580375782881003,0.5545686736260002,1.0,6/10,20.31%,ATP1A2;OSR1;HECW1;CAMK2D;HECW2;NEDD4
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5753164102145094,1.2655592556463982,0.2127659574468085,0.9506368128832781,1.0,3/10,7.78%,TIRAP;IFI35;WDFY1
prerank,nuclear export (GO:0051168),-0.3277899625931257,-1.265438292710334,0.08385093167701864,0.5537517233393058,1.0,26/80,16.23%,RANBP3L;SRSF5;PKD1;SRSF11;CASC3;SRSF2;MALT1;SRSF6;XPO6;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;PHAX;LSG1;RANBP3;STRADA;HNRNPA1;ATXN1;THOC5;SLU7;CDC40;NUTF2;TGFB1
prerank,sensory perception of sound (GO:0007605),-0.324856858291893,-1.265378247527042,0.06884057971014493,0.5527391928652213,1.0,17/88,11.29%,PCDH15;EYA1;CACNA1D;COL1A1;EML2;COL11A1;COL4A3;ADGRV1;ROR1;CEMIP;KIT;DCDC2;GSDME;NIPBL;TIMM9;ATP6V0A4;TBL1X
prerank,inner dynein arm assembly (GO:0036159),0.5569583493484613,1.2651909979763625,0.2019607843137255,0.9495517925166186,1.0,1/10,1.21%,CFAP73
prerank,cellular protein-containing complex assembly (GO:0034622),0.33370517512434356,1.2649422525106215,0.08689839572192513,0.9479295084636902,1.0,33/159,14.60%,HIGD2A;IMMP2L;TIAM1;AP2S1;SRC;BBS12;CCT2;NDUFAF1;SMAD1;PSMD11;SGIP1;CLTA;PFDN6;LONP1;OMA1;PSMG1;AXIN1;PDE4DIP;TMEM35A;EIF4H;TBCEL;CENPC;AIFM1;CHMP2A;MIS12;DMD;HIGD1A;EIF4B;PICALM;POGZ;AP2M1;CYBA;PIK3C2A
prerank,TOR signaling (GO:0031929),0.4498775141210716,1.264350836038873,0.16981132075471697,0.9478811460340207,1.0,4/26,4.89%,PRR5L;TIPRL;RPTOR;SMG1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5344176639875358,1.2640727720278204,0.2034548944337812,0.9463944125846082,1.0,3/12,9.50%,UPP1;UCK2;UPP2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.38361474974667775,-1.263680950839818,0.14950980392156862,0.5562992274829763,1.0,11/34,17.35%,DOCK5;DOCK1;NRP1;FLNA;NEDD9;RREB1;P4HB;ILK;MYADM;TRIOBP;CDC42
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5035168375581401,1.2633178739592885,0.18629173989455183,0.947010425817057,1.0,6/17,14.70%,RFFL;PTTG1IP;SIRT1;YJU2;MDM2;CD44
prerank,isotype switching (GO:0045190),-0.5417578154868015,-1.2632702830460052,0.18448637316561844,0.5562073535168739,1.0,8/10,43.86%,RNF168;RNF8;MSH2;HSPD1;MSH6;EXOSC3;BATF;LIG4
prerank,renal filtration (GO:0097205),-0.5431992375216985,-1.2629303779293366,0.16699410609037327,0.555956208831531,1.0,4/10,11.71%,SULF1;SULF2;TBC1D8B;CD34
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4735014995009218,1.2629031498585452,0.18928571428571428,0.9462835118089641,1.0,6/20,15.09%,IL1R1;MAP3K7;B2M;CD81;CD55;DENND1B
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.4397553674864579,-1.2627610657820116,0.1728110599078341,0.5551877279289941,1.0,9/21,10.79%,GPM6B;EFNA5;MACF1;RHOA;ROCK2;VCL;ROCK1;LDB1;EPHA3
prerank,axon development (GO:0061564),-0.3240316311730535,-1.2626388653823928,0.0778816199376947,0.5543536534094281,1.0,16/78,11.06%,FGFR2;CNTN4;ANK3;DCC;PLP1;MAP1B;CTNNA2;NRCAM;NTNG1;RYK;MAPT;SHTN1;GAP43;BRSK1;EPHB2;PLPPR4
prerank,modification-dependent protein catabolic process (GO:0019941),0.33014333891616054,1.2625629825970812,0.08701298701298701,0.9449851302316528,1.0,61/193,19.04%,ELOC;RNF7;CBL;ARIH1;RNF149;ANAPC2;KLHL3;FEM1C;UBA1;RFFL;PSMD11;NEDD4L;RBBP6;UBE2I;RNF130;LONP1;UBL7;PPP1R11;TTC3;TRIM25;FBXO11;ANAPC7;MDM2;PSMC2;RNF6;FBXO7;RNF13;CHFR;UBQLN1;ANAPC11;ANAPC10;ANAPC4;FBXO8;RNF11;CUL3;PSMD14;USP33;UBE2R2;RNF146;RNF20;UBA6;UBE2G1;FBXO22;UBQLN4;RNF114;TAF1;RNF128;RNF125;UBE2H;UFD1;UBQLN2;UBR3;ATXN3;CDC26;RNF215;KCTD10;NDFIP2;RC3H1;FBXW4;TRPC4AP;HACE1
prerank,copper ion transport (GO:0006825),-0.5291667536893645,-1.2622142777357703,0.2,0.5542500425517016,1.0,7/11,23.25%,ATP7A;STEAP3;SLC31A1;SLC31A2;COX17;SLC11A2;STEAP2
prerank,positive regulation of cellular component movement (GO:0051272),0.45717595022868507,1.261906383119246,0.17892976588628762,0.9451188299448107,1.0,5/24,9.31%,PHPT1;SPOCK2;ACTN4;CSF1R;LYN
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5143059611877718,-1.2618847644418334,0.18333333333333332,0.5539601834164313,1.0,3/12,4.40%,FOXP1;DAB2;HDAC1
prerank,acylglycerol biosynthetic process (GO:0046463),-0.4324720575690415,-1.261205387655894,0.15856236786469344,0.5546477962869669,1.0,6/23,7.97%,AGMO;PLA2G4A;LPGAT1;PLCE1;GK;LPIN1
prerank,ATP transport (GO:0015867),0.5704960523426824,1.2610657538321304,0.21973929236499068,0.9464123972694353,1.0,3/10,15.36%,SLC25A24;CD47;SLC25A42
prerank,positive regulation of cellular respiration (GO:1901857),0.5551422939642465,1.260191778510312,0.21292775665399238,0.9477063703827536,1.0,5/11,9.96%,IFNLR1;ISCU;IL10RB;PARK7;IFNAR1
prerank,protein insertion into ER membrane (GO:0045048),-0.3772592378374372,-1.259802530571587,0.13178294573643412,0.5575939980178847,1.0,18/37,27.58%,UBE2J2;EMC7;CYB5A;CAMLG;TRAM1;ALDH3A2;VAMP2;TRAM2;STX1A;SGTA;BAG6;EMC1;EMC8;EMD;EMC9;SERP1;SEC61B;GET4
prerank,membrane repolarization during action potential (GO:0086011),-0.505127766057896,-1.2595425217155982,0.21604938271604937,0.5570993962928571,1.0,3/13,8.46%,ATP1B1;ATP1A1;KCNJ2
prerank,regulation of Golgi organization (GO:1903358),0.501098224111355,1.2595295461849014,0.19478260869565217,0.9480707609601512,1.0,6/17,11.03%,MAPK3;MYO5A;USP6NL;CAMSAP2;PDE4DIP;RBSN
prerank,regulation of primary metabolic process (GO:0080090),0.3469395148632325,1.2586135476382676,0.09959072305593451,0.9493839843449223,1.0,31/126,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;GPAM;HMGCR;HDAC3;PSMD11;APOE;PSMB4;PSMC1;ELOVL6;PLPP1;PPARD;SC5D;IRS2;ACACB;PSMC2;PSMD2;IDI1;CREBBP;ADIPOR1;CARM1;LSS;SP1;PSMD14;PSMC6;PSMD1;PSMB1
prerank,chromatin remodeling at centromere (GO:0031055),0.4392555013297218,1.2585920324894297,0.17537942664418213,0.9467318261102299,1.0,9/31,17.31%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;CENPP;RBBP4;CENPO;NPM1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.47955415704491106,1.25825074981365,0.18518518518518517,0.9455052856607917,1.0,12/21,16.90%,CNOT11;CNOT2;CNOT7;PAN3;TUT7;PAN2;CNOT6;CNOT1;CNOT6L;TUT4;PARN;CNOT10
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4880349726612057,-1.2580789708826732,0.18181818181818182,0.5599252095569945,1.0,5/14,13.20%,ANK3;ATP1B1;WNK1;WNK4;WNK3
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.42649327642525126,1.2580093563536034,0.1632996632996633,0.9439602337478363,1.0,2/31,0.85%,GPHN;MOCS3
prerank,V(D)J recombination (GO:0033151),0.5366540454965224,1.257964470864917,0.21005385996409337,0.9415202958133564,1.0,4/11,16.75%,DCAF1;TCF3;XRCC4;PRKDC
prerank,regulation of protein modification process (GO:0031399),0.39885876174801516,1.2578308604424913,0.14217252396166133,0.9394205355603259,1.0,13/50,12.63%,ROPN1;PIN1;PPIB;PPP2CA;PPP1R16B;SPRED1;HPF1;CCDC88C;KDM4D;LYN;CCAR2;ATG7;CDH5
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.37120335747937466,1.257824773899205,0.14329268292682926,0.9367904591235068,1.0,19/72,14.98%,ACER2;PLK2;HIPK2;ING4;CNOT11;CDKN1A;EP300;CRADD;CNOT2;RGCC;CNOT7;MDM2;TFAP4;CARM1;NBN;CNOT6;CHEK2;CNOT1;CNOT6L
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.27470511689836286,-1.2576975337088516,0.011363636363636364,0.559867498953759,1.0,79/248,17.36%,RNF220;BICC1;FGFR2;LRRK1;WLS;DAB2;EGFR;COL1A1;LGR4;ADGRA2;GLI3;IGFBP2;MCC;TBL1XR1;SMURF2;FZD6;CYLD;ZEB2;CTNNB1;WNK1;PTK7;HDAC1;PPM1B;NKD1;HECW1;VCP;SHISA6;GPC3;CTNND2;CSNK1A1;BTRC;DKK3;IGFBP6;TMEM64;PSMD4;PSMA2;CSNK1E;UBR5;GPC5;PSMA6;TLE1;DVL3;ZNRF3;CSNK1G2;OTULIN;XIAP;INVS;GSK3B;NFKB1;PSMD13;PSMA1;TBL1X;ILK;PSMF1;PSME4;STK11;DAAM2;LIMD1;PPM1A;SCYL2;USP34;SIAH2;IGFBP4;PSMA5;PSMD9;LMBR1L;CTNND1;DACT1;LRP6;PTPRU;PTPRO;RBMS3;TGFB1;TCF7L2;WWTR1;GPRC5B;FZD4;DVL1;PSMB3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3923762133719991,1.25752748501101,0.15875613747954173,0.9354240678134286,1.0,21/52,20.97%,RAC2;GSK3A;SAE1;VPS11;MAPK8;YWHAB;BAD;PPP3R1;YWHAH;CSNK2A2;ATG13;YWHAQ;LEPROT;UBE2D3;USP36;SH3GLB1;YWHAE;FBXW7;YWHAZ;UBE2L3;TFDP2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.3425490957608164,-1.2574196330399314,0.10204081632653061,0.5595463051638564,1.0,16/59,12.31%,ROBO2;CNTN4;TENM3;SDK1;ROBO1;CNTN6;KIRREL3;PKD1;DSCAM;IGSF11;PALLD;SDK2;MPZL2;CDH1;CDH4;OBSL1
prerank,axonogenesis (GO:0007409),-0.2760523429452496,-1.2569690409299095,0.017543859649122806,0.5595571530847515,1.0,60/237,13.92%,NRXN3;NCAM1;ROBO2;FGFR2;NOTCH2;CNTN4;ANK3;LAMA2;DCC;MAP1B;ROBO1;CTNNA2;UNC5D;NRXN1;CNTN6;EPHA6;TNR;ULK2;NRCAM;EFNA5;SEMA3D;GLI2;EPHB1;NTNG1;AUTS2;NRP1;EFNB2;RYK;DSCAM;EPHA7;PDLIM7;KIF5C;UNC5C;RELN;DAB1;SHTN1;PALLD;SEMA3A;FEZ1;NOTCH3;EPHB4;EZR;NIBAN2;NRP2;B4GALT6;SPTAN1;BRSK1;EPHB2;EPHA3;PLPPR4;SEMA4D;GAB2;GRB2;NTN4;SHC3;RANBP9;AFG3L2;GRB10;VLDLR;MAP1A
prerank,artery development (GO:0060840),-0.42235119224882833,-1.2567468586246273,0.16083916083916083,0.5589799259640279,1.0,5/23,4.10%,ROBO2;ROBO1;NRP1;TGFBR1;HECTD1
prerank,positive regulation of binding (GO:0051099),0.3604404222611083,1.25671939138595,0.14368650217706821,0.9364763149443073,1.0,18/84,11.27%,NCBP1;TRIB3;RALB;PIN1;TIAM1;HIPK2;NME1;APOE;B2M;CEBPG;SPPL3;TXN;EPB41;KDM4D;AKTIP;CLDN5;TERT;APP
prerank,negative regulation of phosphatase activity (GO:0010923),0.44856430821800075,1.2552813012628414,0.1634446397188049,0.9403517721249602,1.0,4/25,7.66%,PPP1R36;TIPRL;BOD1;PPP1R11
prerank,regulation of receptor binding (GO:1900120),0.5635695715276341,1.2551368367633378,0.19556451612903225,0.9384303127657316,1.0,3/10,7.11%,ATP2A2;B2M;BDNF
prerank,ERBB signaling pathway (GO:0038127),0.37596938384725975,1.2550184786331495,0.14096916299559473,0.9363133949129415,1.0,10/64,8.78%,FAM83B;PTPRR;PTPN18;CBL;SRC;CDC37;RPS6KA5;PTPN12;PLCG1;ERBIN
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3222235604912591,-1.2549895895639178,0.10465116279069768,0.5626960811115146,1.0,33/71,31.42%,OTUD7A;ADAMTS12;CAPN2;NGLY1;DDB1;MALT1;VCP;RHBDD1;PSMA6;FAP;LGMN;CLPP;UBC;NEDD8;CTSO;DDI2;RNF123;HM13;CTSZ;STUB1;VPS4A;BAG6;OTUD7B;CTSK;CTSF;CLPX;CTSB;CTSC;HDAC6;CTSS;ZRANB1;FBXL17;PRPF19
prerank,supramolecular fiber organization (GO:0097435),-0.2644508536657371,-1.2549486787284059,0.014598540145985401,0.5616379623845479,1.0,125/333,28.02%,COL1A2;COL4A5;ADAMTS2;PPP1R9A;COL1A1;GSN;TNXB;COL4A6;COL8A1;CGNL1;COL3A1;COL11A1;TMOD2;PLOD2;COL25A1;HDGFL3;COL22A1;TGFBR1;DYNC1H1;COL5A1;PLEC;COL4A3;CLIP4;SNCAIP;MAPT;SHROOM3;COL5A2;TPM1;VIM;RHOA;COL4A4;LOXL1;ARHGAP12;COL12A1;ATP7A;SORL1;COL6A1;TUBGCP4;HSPG2;COL8A2;STMN2;P4HB;COL15A1;COL13A1;PLOD1;COL6A2;SLAIN2;GGA2;RND3;CEP126;CKAP5;BACE1;RHOBTB2;BIN3;UBC;ADAMTS3;LOXL3;RHOB;CLIP3;TUBGCP6;RHOBTB1;INPPL1;DLG1;HIP1R;SIAH2;FIGNL2;COL23A1;TRIOBP;NEFL;STMN1;COL6A3;KATNAL1;ERMN;DCTN1;MYO1B;TPM4;ITGB4;COL5A3;GGA3;CDC42;P4HA2;TGFBI;COL20A1;COL14A1;LUM;MYO1F;ALDOA;COL16A1;TMOD1;COL18A1;WDR73;EFEMP2;P3H1;MYO19;LOX;GFAP;CRTAP;HOOK2;EMILIN1;RHOC;COL26A1;TPPP;STMN4;EMP2;ARHGAP17;KATNAL2;MYH11;ELMO2;COL9A2;TSPAN15;MFGE8;COL27A1;APH1B;STMN3;DPT;TPPP3;HIP1;DBN1;CDC42EP2;MYO5B;MPRIP;RHOH;BFSP2;CD151;MAP7D3
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.4770049207123255,-1.2545428096387248,0.19222462203023757,0.561709133096531,1.0,5/15,9.67%,LRP1;PDPN;DDR1;DPP4;FAP
prerank,histone monoubiquitination (GO:0010390),-0.41418792289103507,-1.2543184229078623,0.16166281755196305,0.5611691103300253,1.0,10/24,21.13%,WAC;UBE2E1;DDB1;DDB2;CDC73;RNF168;PAF1;BCOR;RNF40;DTX3L
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3683059780607981,1.2543120022113272,0.12965722801788376,0.9344087312046745,1.0,18/78,10.49%,DYNC1I1;KIF18A;CAPZA2;FCGR2B;AP2S1;KIFAP3;RAB7A;DCTN2;CLTA;AP1G1;AP1S2;PIKFYVE;KIF15;DCTN3;ARF1;OSBPL1A;KIF2A;DYNLL1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3683059780607981,1.2543120022113272,0.12965722801788376,0.9344087312046745,1.0,18/78,10.49%,DYNC1I1;KIF18A;CAPZA2;FCGR2B;AP2S1;KIFAP3;RAB7A;DCTN2;CLTA;AP1G1;AP1S2;PIKFYVE;KIF15;DCTN3;ARF1;OSBPL1A;KIF2A;DYNLL1
prerank,diol biosynthetic process (GO:0034312),0.5089870926490233,1.2537383313695514,0.20113851992409867,0.9343555708788425,1.0,4/15,14.26%,ACER2;SPR;ACER3;GCH1
prerank,tRNA aminoacylation (GO:0043039),0.41089778232960544,1.2537007022644224,0.15966386554621848,0.931961195242908,1.0,13/37,17.80%,FARS2;GARS1;YARS2;IARS1;LARS2;HARS1;RARS2;WARS2;LARS1;GATB;HARS2;WARS1;IARS2
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.5458335564050534,1.2532232515958757,0.20747663551401868,0.9315284269723256,1.0,5/11,12.24%,F11R;RAPGEF6;TJP1;RAB1A;RAP2C
prerank,wound healing (GO:0042060),-0.3399742319025898,-1.2529380754886263,0.11538461538461539,0.5639763711088308,1.0,17/62,15.32%,IGF1;SMAD3;CFLAR;COL3A1;FGF1;TGFBR1;PLEC;TPM1;MACF1;EPB41L4B;PDGFRA;FUT10;MYOF;AHNAK2;SYT11;SYT7;RAF1
prerank,mammary gland epithelium development (GO:0061180),-0.48883586862937867,-1.2527797679140662,0.1885593220338983,0.5632387849697451,1.0,3/14,7.03%,ERBB4;WNT4;AKT2
prerank,somite development (GO:0061053),-0.5323792854008303,-1.2523421288285954,0.19189765458422176,0.5632740607147204,1.0,4/11,12.56%,SMO;MEOX2;LOXL3;MTHFD1
prerank,DNA conformation change (GO:0071103),0.48040089291872357,1.252122822813912,0.1982142857142857,0.9340651415963418,1.0,5/17,19.18%,ERCC3;TOP3A;TOP1;HAT1;TOP3B
prerank,positive regulation of cell cycle process (GO:0090068),-0.31406334623047477,-1.2515944352109458,0.08561643835616438,0.5642718811004245,1.0,17/91,15.16%,SVIL;IGF1;PDGFRB;DYNC1H1;RHOA;SIRT2;CEP120;CIT;MAP3K20;LRP5;UBXN2B;PLSCR1;NSFL1C;USP19;CENPV;IGF2;CEP295
prerank,mitochondrion organization (GO:0007005),0.33015990788836674,1.2514572809401976,0.08152866242038216,0.9343955506520247,1.0,26/165,11.20%,THG1L;MIGA1;TOMM20;HIGD2A;CHCHD2;DNM3;IMMP2L;CYCS;DNAJA3;GABPA;MTFR1;SIRT3;PHB2;TIMM17B;TSPO;SSBP1;LONP1;AGTPBP1;OMA1;PARK7;FBXO7;AIFM1;TERT;NOS3;CHCHD3;HIGD1A
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.45484546887995686,-1.2510483292151895,0.16993464052287582,0.5646152915887539,1.0,9/16,19.28%,KMT2A;AUTS2;CTNNB1;SMAD4;PAXIP1;SNW1;KDM1A;BCOR;DNMT1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5552907289404025,1.2503534902463829,0.18813905930470348,0.9368009432659743,1.0,4/10,9.20%,CSGALNACT1;XYLT1;PXYLP1;B3GAT2
prerank,cellular response to UV (GO:0034644),0.3668363037649362,1.2500100982384623,0.13185185185185186,0.9357388421039335,1.0,23/76,17.96%,CERS1;EIF2S1;RUVBL2;MME;ERCC4;YY1;POLK;CDKN1A;EP300;CARD16;SIRT1;ACTR5;USP47;CREBBP;BMF;INO80;TAF1;ATR;N4BP1;TMEM161A;USP28;NPM1;RPL26
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4820008967761318,1.249920221920359,0.17863720073664824,0.9336027355726053,1.0,2/19,0.97%,LRP8;SS18L1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.549545108261492,1.2489372559660143,0.212406015037594,0.9354621232556433,1.0,3/10,9.68%,HIPK2;ING4;TFAP4
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.4584963450973024,-1.2485761183007529,0.17763157894736842,0.5702752032000589,1.0,10/17,35.39%,NLGN1;CACNA1G;SYT4;SCAMP5;STX1A;SLC4A8;SYT10;RAB3D;CACNA1H;RAB3A
prerank,clathrin coat assembly (GO:0048268),0.5025390029199224,1.248357517580376,0.22160148975791433,0.9354074048021189,1.0,5/15,14.60%,AP2S1;SGIP1;CLTA;PICALM;PIK3C2A
prerank,muscle cell differentiation (GO:0042692),0.43106321635154293,1.2481322041917506,0.1724137931034483,0.9339060978083097,1.0,7/32,10.98%,SYNE1;MRTFA;MRTFB;TBX1;HEY2;SEMA4C;DMD
prerank,early endosome to Golgi transport (GO:0034498),0.5475830051307367,1.2467110490416933,0.2119460500963391,0.9375405008560398,1.0,5/11,11.03%,SURF4;SNX8;RAB6A;SNX1;RBSN
prerank,positive regulation of JNK cascade (GO:0046330),0.37186680133773875,1.2466736827954963,0.13823529411764707,0.9352108083133082,1.0,14/70,11.27%,MAP3K11;FCGR2B;TIRAP;HIPK2;EDAR;TRAF5;AXIN1;MTURN;MINK1;TRAF3;PJA2;PLCB1;MFHAS1;APP
prerank,protein prenylation (GO:0018342),0.5652737157175718,1.2457597959277176,0.218,0.9365609198144098,1.0,2/10,2.99%,CHML;CHM
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.4857189526125093,-1.2453970385786082,0.19624217118997914,0.5778329786182927,1.0,4/13,6.99%,GLI2;TOX;BMP4;CAMK4
prerank,regulation of BMP signaling pathway (GO:0030510),-0.32323447256383087,-1.245118603140098,0.10140845070422536,0.5775210867178571,1.0,26/73,21.41%,SULF1;FSTL1;FOXD1;NBL1;BMPER;SMURF2;SMAD4;VWC2L;BMP4;CRIM1;SORL1;SKI;HTRA3;SMAD6;XIAP;SPART;PCSK6;SMAD5;BMPR1B;RBPMS2;ZNF423;SFRP4;BMPR1A;BMPR2;TWSG1;CCN1
prerank,regulation of microtubule-based movement (GO:0060632),-0.5169252429218877,-1.244399254378309,0.20824742268041238,0.5784238398181669,1.0,2/11,5.89%,MAP2;TTC21B
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4753899843676189,-1.2442402460351913,0.18202247191011237,0.5777957140652649,1.0,9/15,21.58%,FGF1;P2RX4;SMOC2;THBS1;LGMN;SEMA5A;MET;HSPB1;PRKD1
prerank,regulation of pH (GO:0006885),0.5527309394728052,1.2441222933693687,0.21264367816091953,0.9414859808663376,1.0,3/11,10.69%,SLC9A7;CLCN3;ATP6AP1
prerank,adenine nucleotide transport (GO:0051503),0.49167575469507807,1.2440707452395467,0.1978798586572438,0.9391740996095559,1.0,3/17,6.45%,ABCC4;SLC25A24;LRRC8C
prerank,neurotransmitter biosynthetic process (GO:0042136),0.5098585186340548,1.2437676072969859,0.21505376344086022,0.9380638322356275,1.0,1/14,0.32%,SLC5A7
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.32930016370636417,-1.2424992840935112,0.10493827160493827,0.5814722149625761,1.0,34/67,31.20%,SULF1;CYFIP2;DOCK1;WASF2;NRP1;MAPK14;AXL;ABI1;VAV2;RHOA;PXN;ROCK2;ROCK1;NRP2;PTK2;CDC42;SHB;PIK3R1;AAMP;HSPB1;PRKD1;VEGFA;ELMO2;VEGFB;HSP90AA1;NCKAP1L;MAPKAPK2;PGF;ITGB3;NCF2;PIK3R2;CLEC14A;FLT4;NCK1
prerank,positive regulation of heart contraction (GO:0045823),0.47801602425938267,1.2423769066397503,0.1863799283154122,0.9416920482071585,1.0,3/19,3.95%,RGS2;GSK3A;ATP2A2
prerank,positive regulation of cation channel activity (GO:2001259),-0.3695655169271242,-1.2423700423548931,0.13402061855670103,0.5807077586759063,1.0,7/40,10.62%,ANK2;ANK3;AKAP6;RELN;HTT;ACTN2;EPHB2
prerank,regulation of extracellular matrix organization (GO:1903053),-0.47411368460144965,-1.2419098471252894,0.19703389830508475,0.5807570822023057,1.0,4/15,9.67%,LRP1;AEBP1;DDR1;FAP
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5258216573574811,1.2418997370755023,0.21956087824351297,0.9413336088613864,1.0,4/13,6.27%,FCGR2B;MANF;WFS1;LPCAT3
prerank,motor neuron axon guidance (GO:0008045),0.5179479978255114,1.2418792413780109,0.20404411764705882,0.9389458060573544,1.0,3/15,11.05%,RAC2;TMEFF1;RHOG
prerank,photoperiodism (GO:0009648),-0.403649588668523,-1.2418540400359217,0.18632075471698112,0.5797706894516382,1.0,12/28,14.52%,PER2;PER3;CRY2;PML;BHLHE40;SIK1;MTA1;TP53;CRY1;PER1;RBM4;FBXL12
prerank,regulation of sodium ion transport (GO:0002028),-0.3805628914658106,-1.2415979667059664,0.13447432762836187,0.579354145781856,1.0,12/34,13.92%,ANK3;FGF12;SNTA1;WNK1;P2RX4;ATP1A1;SIK1;WNK4;PER1;DLG1;WNK3;NKAIN4
prerank,regulation of interleukin-2 production (GO:0032663),0.40230912875388375,1.2413923282313457,0.15384615384615385,0.9386132232416208,1.0,10/43,14.10%,PDE4D;PTPRC;MAP3K7;TNFAIP3;HDAC7;PRKD2;PNP;RPS3;PRNP;TRIM27
prerank,epithelial cell morphogenesis (GO:0003382),-0.4664815346310077,-1.2411724672802582,0.16289592760180996,0.5793098478426109,1.0,7/17,21.91%,COL22A1;RILPL1;COL15A1;MET;SIPA1L3;COL18A1;RILPL2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.28280761540123656,-1.2411258130212466,0.04119850187265917,0.5783053913232903,1.0,44/152,13.00%,RNF220;FGFR2;LRRK1;SULF1;WLS;EGFR;COL1A1;LGR4;ADGRA2;WNT5B;TBL1XR1;SMURF2;ZEB2;WNK1;PTK7;MACF1;SULF2;PPM1B;VCP;GPC3;SKI;CDC73;PSMD4;PSMA2;CSNK1E;UBR5;GPC5;RSPO3;PSMA6;SALL1;CSNK1G2;XIAP;NFKB1;PSMD13;PSMA1;TBL1X;ILK;PSMF1;DISC1;PSME4;DAAM2;PPM1A;ATP6V0C;USP34
prerank,homeostasis of number of cells (GO:0048872),0.5344706296281696,1.241021941442055,0.22686025408348456,0.9378410526693653,1.0,4/12,11.15%,OCIAD1;LPCAT3;NOTCH1;NOS3
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4071774967753981,-1.2408808422176805,0.17966903073286053,0.5778341396244138,1.0,8/26,11.22%,RIMS1;NRXN1;DLG4;NLGN2;PRKCZ;RELN;NLGN1;CUX2
prerank,negative regulation of inflammatory response (GO:0050728),0.32493562511909796,1.2392746885888986,0.08300907911802853,0.9429498996753142,1.0,25/182,10.62%,GPR176;PRKAR1A;PTGER2;TNFAIP3;PLK2;SRC;TSHR;INSL3;RAMP2;APOE;TEK;FYN;TNFRSF1B;LPCAT3;GNB1;RXFP1;SYK;PPARD;NLRC3;PLCG1;LYN;RHBDF2;CD163;MFHAS1;YES1
prerank,negative regulation of MAPK cascade (GO:0043409),0.3532594204030705,1.238867690430738,0.13509544787077826,0.9422582442071946,1.0,13/87,9.31%,RGS2;SEMA6A;PTPRR;DUSP7;PTPRJ;PIN1;PTPRC;PRDM15;APOE;SPRED1;CNKSR3;DAG1;LYN
prerank,response to UV (GO:0009411),0.35204857591804145,1.2386227098811022,0.1318051575931232,0.9408837757220698,1.0,28/95,17.96%,ERCC3;ZRANB3;MAP2K7;EIF2S1;RUVBL2;SDF4;ERCC4;YY1;MAP3K4;POLK;EP300;MAPK8;USP47;RELA;SPRTN;CCAR2;CREBBP;BMF;INO80;TAF1;ATR;N4BP1;TMEM161A;USP28;NPM1;UVSSA;POLH;RPL26
prerank,regulation of macrophage cytokine production (GO:0010935),0.5293259094851582,1.238611198028423,0.21951219512195122,0.9384942201981856,1.0,4/13,8.56%,SEMA7A;SIRT1;CUEDC2;WNT5A
prerank,spermatid development (GO:0007286),0.42620705236116024,1.2382686544849362,0.1840277777777778,0.9375251477979807,1.0,4/32,10.36%,SOX30;CIB1;CDYL;ING2
prerank,ribosome biogenesis (GO:0042254),0.32306622088162934,1.2381967701779668,0.07860824742268041,0.9353938287416891,1.0,62/187,19.87%,RPL30;UTP20;UTP18;RPL17;RPL23;EIF2A;RPL31;RPL3;DDX54;DDX10;RPL35A;RPS14;RPL8;RPL5;RPL37A;RPL4;EMG1;SNU13;POP5;RPLP0;EXOSC9;TSC1;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;LTV1;RBIS;DDX27;WDR12;PAK1IP1;XPO1;EXOSC1;UTP11;LTO1;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;DKC1;RPL19;NPM1;RPL38;EIF6;RPL36;DCAF13;RPL26;RPL15;RPL10;RPL32;RPS2;RPL27A;NOP58;NVL;EXOSC7;RPL7;RPL39;RPL14
prerank,gene expression (GO:0010467),0.3061253076261897,1.2378762228273166,0.05022321428571429,0.9344166593269916,1.0,100/348,18.37%,POLR2J;NCBP1;RPL30;MRPS33;NR4A2;RSL24D1;EEF1A1;POLR2B;MRPL23;RPL17;RPL23;MRPL24;FASTKD2;RPL31;RPL3;RPS21;DDX54;MRPL18;PAX8;SMG1;HNRNPK;LMF1;RPL35A;CPSF4;RPS14;RPL8;CHTOP;YARS2;RPL5;ABCF1;NUP54;PWP1;MRPS12;RPS12;HBS1L;RPS26;RPL37A;NXT1;HARS1;NUP50;ADAR;YTHDC1;FYTTD1;RPL4;SRSF4;RPLP0;SARNP;UPF2;XRN2;RPS28;U2AF1;RPS24;DUSP11;RPS9;RPS23;RPL24;THRB;ADARB2;RPL34;RPS11;MRPL52;RPS3;MRPS15;DHPS;NUP35;RRAGC;PPP5C;TSPAN17;RPS15A;RPL23A;RPL21;RPL35;SRSF7;BAZ2A;HNRNPL;NDC1;ADARB1;SLBP;UPF3B;DKC1;U2AF2;HARS2;WDR33;WARS1;NUP160;RPL19;RPL38;HNRNPF;POM121;RPL36;SMG6;RPSA;DHX8;RPL26;RPS8;SMG5;CLP1;RPL15;RPL10;NUP42
prerank,termination of RNA polymerase I transcription (GO:0006363),0.43063815218203655,1.2374841776591667,0.1912479740680713,0.9338020024130376,1.0,5/30,8.79%,ERCC3;POLR1C;CCNH;POLR1G;GTF2H1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.30289040967211067,-1.237291591942618,0.08361204013377926,0.5866263460981865,1.0,33/104,19.95%,MAGI2;LDLRAD4;SMAD3;NBL1;BMPER;SMURF2;TGFBR1;TGFBR2;SMAD4;VWC2L;CRIM1;SORL1;PPARA;SKI;HTRA3;SMAD6;ACVR1;SPART;SNX25;UBC;PPM1A;SMAD5;MTMR4;TGFB1;BMPR1B;CCN3;RBPMS2;PRDM16;CD109;BMPR1A;STUB1;BMPR2;SPRED3
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.35941591759456937,-1.2372852803329815,0.13687150837988826,0.5854916397526788,1.0,20/44,24.21%,LPAR1;NRP1;ARHGEF10L;CCN2;TGFBR1;TPM1;RHOA;PXN;ROCK2;PPM1E;FHOD1;NF2;ARHGEF5;CDC42;PPM1F;PFN2;ARHGEF15;RHOC;ITGB1BP1;TGFB3
prerank,rRNA metabolic process (GO:0016072),0.3270915222822964,1.237127697249514,0.10533159947984395,0.9329924021100955,1.0,53/160,19.87%,RPL30;UTP20;UTP18;RPL17;RPL23;RPL31;RPL3;DDX54;DDX10;RPL35A;RPS14;RPL8;RPL5;RPL37A;RPL4;EMG1;SNU13;POP5;RPLP0;EXOSC9;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;DDX27;WDR12;EXOSC1;UTP11;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;DKC1;RPL19;RPL38;RPL36;DCAF13;RPL26;RPL15;RPL10;RPL32;RPS2;RPL27A;NOP58;NVL;EXOSC7;RPL7;RPL39;RPL14
prerank,neuron maturation (GO:0042551),-0.44834610816544085,-1.2369866172404307,0.17715617715617715,0.5852235557568437,1.0,12/18,34.83%,ADGRB3;B4GALT6;SRRM4;MTCH1;SCARF1;CX3CL1;EPHA8;PICK1;LGI4;CLN5;B4GALT5;C1QA
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.5162624964209961,-1.2366197068050813,0.2145748987854251,0.5851771603127702,1.0,3/11,8.46%,ATP1B1;ATP1A1;KCNJ2
prerank,camera-type eye morphogenesis (GO:0048593),-0.5346094104984231,-1.236368024255018,0.20964360587002095,0.5847433685397844,1.0,6/10,30.06%,TENM3;SKI;LRP6;VEGFA;TBX2;KDM2B
prerank,histone H2A ubiquitination (GO:0033522),-0.4541733546483596,-1.2359891175644417,0.20787746170678337,0.5846870963484333,1.0,11/17,32.70%,DDB1;DDB2;RNF168;RNF8;BCOR;DTX3L;UBR2;UBE2B;KDM2B;RING1;TRIM37
prerank,axon guidance (GO:0007411),-0.2766598476474736,-1.2358947644729483,0.03940886699507389,0.5838369569682811,1.0,52/201,13.66%,NRXN3;NCAM1;ROBO2;NOTCH2;CNTN4;ALCAM;LAMA2;DCC;PLXNA2;ROBO1;UNC5D;NRXN1;CNTN6;EPHA6;TNR;EFNA5;NFIB;SEMA3D;GLI2;EPHB1;NRP1;EFNB2;RYK;DSCAM;EPHA7;PDLIM7;KIF5C;UNC5C;RELN;SMO;DAB1;PALLD;SEMA3A;FEZ1;GAP43;NOTCH3;EPHB4;EZR;NIBAN2;NRP2;SPTAN1;EPHB2;EPHA3;SEMA4D;GAB2;GRB2;NTN4;SHC3;PLXND1;RANBP9;GRB10;VLDLR
prerank,central nervous system development (GO:0007417),-0.2707876729697928,-1.235733872357545,0.026595744680851064,0.5831433617275942,1.0,34/250,6.38%,ROBO2;CNTN4;DCLK1;ZIC1;ADAM22;ARNT2;PBX1;ZIC4;CNTN6;SPOCK1;GSN;GRIN2B;NRCAM;AHI1;NFIB;ADAM23;PKD1;ADGRA2;AFF2;MBP;SH3GL2;NCOA6;TGFBR2;DNER;EPHA7;JARID2;MEIS2;GLIS2;IL1RAPL2;VCAN;RELN;SMO;ZIC5;HSPG2
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.3046572698518046,-1.2356177280127674,0.08278145695364239,0.5823104106029136,1.0,30/108,14.71%,FGFR2;TRABD2B;SULF1;LRP1;WLS;NXN;CTNNB1;PTK7;MACF1;SULF2;RNF43;CBFB;NKD1;DCDC2;GPC3;CTNND2;VGLL4;BTRC;SKI;CDC73;RSPO3;TLE1;SALL1;OTULIN;DISC1;DAAM2;ATP6V0C;GRB10;RACK1;DACT1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4833007272027938,1.2347328088093055,0.20415879017013233,0.9411969939834194,1.0,4/17,9.46%,CIB1;RET;SYK;PODXL
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.30421679287075554,1.2342782392079596,0.041666666666666664,0.9407761036669957,1.0,101/366,18.81%,TBX4;ONECUT1;TRAPPC2;FOXN2;EZH2;ZFAT;HES6;EIF2A;GTF2IRD1;RPS6KA4;ATXN1L;RPS6KA5;ORC3;PPP2CA;SBNO2;MYBL2;SMARCA2;SOX2;RBBP6;SPIN1;EP300;RFX3;NFX1;MED23;TGFBRAP1;SRSF10;ACTR8;CDK11B;ZNF205;SFPQ;FBXO5;ACTR5;GEMIN5;DRAP1;CLOCK;PFDN5;NOTCH1;TSC1;SOX13;ACVRL1;RELA;NAB2;ESCO1;RNF6;UBE2V1;RYBP;ING2;CCAR2;ESR1;METAP1;NLK;HP1BP3;CREBBP;CARM1;NANOS3;APP;USP37;JMJD1C;SP1;MZF1;IRF2;CHD3;ERC1;NUP35;TRRAP;CHEK2;DDIT3;ANKRD17;ZKSCAN5;HCFC1;YBX1;RNF20;BAZ2A;NSD2;BACH1;FUS;TERF2IP;RBM4B;TFEB;TAF6L;APBB2;TCF7L1;TCF3;SOX17;WTIP;CYFIP1;MYT1;CALR;NONO;ZNF219;INSR;STAT3;FOXK2;RPL10;PATZ1;ZSCAN21;NCOA2;HINT1;YAF2;ATRX;MSL3
prerank,response to laminar fluid shear stress (GO:0034616),0.5439519364878641,1.2342026671487911,0.2159090909090909,0.9387407467652131,1.0,3/10,7.28%,KLF2;MAP2K5;SMAD7
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5082527405761796,-1.2339048105937434,0.1975806451612903,0.5859755577817304,1.0,6/11,20.62%,PARP4;PARP14;PARP6;PARP3;PARP12;PARP16
prerank,protein deubiquitination (GO:0016579),0.31486362728963924,1.2338416743778,0.07484662576687116,0.9379522064928453,1.0,59/242,14.95%,TOMM20;PSMB10;PSMC4;ABRAXAS1;PSMB6;PSMD8;PSMD5;PSMD12;ACTL6A;MAP3K7;TNFAIP3;ACTB;BIRC2;SMAD1;PSMD11;YOD1;OTUD1;PSMB4;YY1;SPATA2;PSMC1;EP300;ACTR8;SMAD7;ACTR5;DESI2;RUVBL1;USP47;ATXN7L3;TRAF3;MDM2;RAD23A;PSMC2;USP48;USP31;PSMD2;ESR1;OTUD3;USP22;USP15;USP37;NFRKB;USP18;TNIP2;OTUD5;PSMD14;TRRAP;USP33;BRCC3;PSMC6;PSMD1;APC;NFKBIA;PSMB1;HCFC1;MINDY2;USP9X;UCHL5;INO80
prerank,response to interleukin-4 (GO:0070670),0.546961877348898,1.2335283129316967,0.2320754716981132,0.9370065864098737,1.0,1/10,2.03%,LEF1
prerank,regulation of spindle organization (GO:0090224),-0.44651749353103154,-1.2334430880523124,0.17920353982300885,0.5861808416349558,1.0,6/18,20.58%,DYNC1H1;RNF4;PARP3;DCTN1;RAE1;MAP9
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.4433685126868089,-1.2334332912739139,0.1729490022172949,0.5850818051003155,1.0,7/19,9.11%,IGF1;NTRK2;RTN1;FLOT2;SORL1;ROCK1;BIN1
prerank,negative regulation of innate immune response (GO:0045824),0.42605774785052253,1.2333733566946947,0.1793103448275862,0.935283070845538,1.0,9/34,13.10%,TNFAIP3;TTLL12;FAM3A;NLRC3;CNOT7;USP15;A2M;USP18;NLRC5
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.5259341933115992,1.233269970409022,0.23865877712031558,0.9334148453349942,1.0,3/13,4.52%,DERL2;SVIP;YOD1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.33129614516769634,1.2331996637651443,0.11360634081902246,0.9314030006567314,1.0,37/153,15.85%,PCK1;PRKX;STK32A;PLK2;RPS6KA1;PRKCH;RPS6KA4;CAMK1D;HIPK2;PRKD2;RPS6KA5;PKN3;SMG1;MAPK8;CSNK1G3;SBK1;PIKFYVE;DCLK3;LATS2;PKN1;SRPK2;NLK;TNKS;PRKCI;MAST4;IKBKB;MAPK12;CHUK;TLK2;NEK6;CSNK2A2;MAP3K10;GAS6;DYRK2;TOP1;TAF1;ATR
prerank,positive regulation of cellular protein localization (GO:1903829),-0.3240419723272707,-1.2331282282995388,0.12684365781710916,0.5848174735451321,1.0,31/69,31.63%,BICD1;MAPT;KAT7;GNL3L;STX3;TM9SF4;GSK3B;DDRGK1;SYT11;ENTR1;MAP1A;TGFB1;CEP250;WWTR1;LIMK2;GPD1L;CARD10;GNL3;DTX3L;YAP1;LAMTOR5;EIF2AK3;AKT1;SESN2;SLC5A3;ABCA7;GPR137B;ORMDL3;PARP9;CDK5RAP3;PRKAA1
prerank,positive regulation of organelle organization (GO:0010638),-0.38364828010726937,-1.2329484924582206,0.1630170316301703,0.5842360086750142,1.0,11/32,13.50%,STX18;ANXA2;RAB3GAP2;PPARGC1A;AKT2;LMAN1;TMED9;GSK3B;UVRAG;ANXA1;PFDN2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.426966497152616,1.2328351851472268,0.1888111888111888,0.9305379457212484,1.0,4/30,4.40%,RAC2;GSK3A;SAE1;VPS11
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5338128575698767,-1.2322791508620132,0.22267206477732793,0.5850068354058071,1.0,8/10,30.46%,CTNNB1;SMARCD3;DISC1;KDM1A;CX3CL1;VEGFA;CX3CR1;DRD2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.42825370476359503,-1.2320204403800954,0.19815668202764977,0.5845695210249473,1.0,9/21,28.33%,SIRT2;AATF;SLC30A10;PPARA;ABCD2;SIRT5;PINK1;PAX2;HDAC6
prerank,positive regulation of response to external stimulus (GO:0032103),-0.29010428592382703,-1.2312986134996289,0.08455882352941177,0.5854874159601732,1.0,40/128,29.26%,BMP6;SASH1;PDGFRB;PUM1;PUM2;NAPEPLD;STX3;OPTN;THBS1;PLSCR1;IL16;IL17RA;POLR3C;GPR4;LY86;IL18;IL33;TNIP1;TGFB1;LRSAM1;GPRC5B;SCARF1;GBP5;RIOK3;AGTR1;SLC15A4;CX3CL1;SETD4;PPM1F;P2RY12;PLA2G7;TLR3;FEM1A;SERPINE1;PDE2A;CCN4;CD180;MDK;SNCA;POLR3G
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3576750903731105,1.2312528876378246,0.12660028449502134,0.9351215788939004,1.0,22/80,13.53%,SURF4;ARF5;KIF18A;KIFAP3;LMAN2;COPG2;TMEM115;RAB6B;NAPA;RAB6A;KDELR2;TMED10;KIF15;RAB1A;GOLPH3L;KIF2A;TMED7;SCFD1;ARCN1;COPG1;KIF3B;COG3
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.508753559699071,1.2312178831123688,0.23518850987432674,0.9329052017428431,1.0,3/13,10.12%,NCBP1;CPSF4;CPSF6
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.4082893136485503,-1.2311793044440555,0.15681818181818183,0.5847136417225396,1.0,4/26,2.15%,IGF1;AKAP6;FHL2;CAMTA1
prerank,establishment of spindle localization (GO:0051293),0.5066473191748604,1.230810664313055,0.22058823529411764,0.93236392290809,1.0,6/14,17.20%,CLASP2;CFL1;MAP4;ZBED3;KPNB1;CLASP1
prerank,calcium-mediated signaling (GO:0019722),-0.30708907696595544,-1.23044360744876,0.1064516129032258,0.5856513680894487,1.0,17/93,10.71%,ANK2;CACNA1C;EGFR;MCU;PPP1R9A;GRM5;ATP1B1;NUDT4;PLCE1;P2RX4;CHRM3;FIS1;CCR9;KSR2;PRKACA;DMPK;ACKR3
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.45583936344214226,-1.2301662396876882,0.20140515222482436,0.5851733480621379,1.0,6/17,19.00%,CTNNA2;WASF2;GMFB;WASF1;FCHSD2;ARFIP2
prerank,protein K48-linked ubiquitination (GO:0070936),0.38084423962430547,1.2299202256301836,0.16897081413210446,0.9338528957780885,1.0,17/54,16.45%,KLHL3;TNFAIP3;RFFL;NEDD4L;UBE3A;RNF187;TTC3;RNF6;ZNRF1;IFI27;CUL3;UBE2R2;RNF146;RNF216;UBE2G1;PELI1;UBE2H
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.504929340446306,1.229299531818796,0.20588235294117646,0.9343918422335175,1.0,4/13,10.81%,GSK3A;HEY2;NOTCH1;RBPJ
prerank,peptide cross-linking (GO:0018149),-0.414821304677421,-1.2291952417043068,0.17475728155339806,0.5868925918974894,1.0,4/25,11.85%,COL3A1;THBS1;FN1;ANXA1
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.3236257273454876,-1.2291869556564077,0.11918604651162791,0.5858129124534027,1.0,23/72,22.06%,LPAR1;ROBO1;AKAP13;KANK2;COL3A1;NRP1;BCR;TNFAIP1;STARD13;PRAG1;RIT2;ABCA1;GPR4;RALBP1;ARHGDIA;STMN1;RAF1;ABL2;KCTD13;MET;ARHGDIB;FLCN;CCDC125
prerank,positive regulation of autophagy (GO:0010508),0.35509775125933574,1.2290717160168954,0.13940256045519203,0.9331103099183053,1.0,28/81,19.34%,GSK3A;ATF6;MAP3K7;PLK2;SVIP;TRIM8;EPM2A;PHB2;TRIM14;SIRT1;PARK7;FBXO7;PRKAA2;BAD;TMEM59;BNIP3L;TRIM27;SCOC;CAMKK2;PIK3C2A;TFEB;SESN3;BNIP3;ULK1;MID2;SH3GLB1;SESN1;LARP1
prerank,cellular response to heat (GO:0034605),-0.3747774375922537,-1.2288466485670153,0.17379679144385027,0.5857245135223524,1.0,12/35,19.24%,FGF1;MAPT;RBBP7;BAG3;VCP;THBS1;PRKACA;ANO1;HSF1;SLU7;CLPB;STUB1
prerank,regulation of actin filament-based process (GO:0032970),-0.3191850318066863,-1.2284493859402883,0.11711711711711711,0.5857659883884689,1.0,20/70,15.35%,LRP1;GPM6B;IQGAP1;EFNA5;PDGFRB;RHOA;ROCK2;PRKCD;ROCK1;EZR;RND3;RHOBTB2;CNN2;EPHA3;RHOB;RHOBTB1;HIP1R;TAOK1;ARHGEF5;IQGAP2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.2919702541192442,-1.2282144403555961,0.09407665505226481,0.5853346228399033,1.0,29/121,14.13%,ERBB4;BMP6;IGF1;GRM5;EFNA5;NRP1;DLG4;PARP14;IL6R;NEDD9;PIBF1;KIT;TEC;GHR;RELN;IL34;ITGA5;IL31RA;SRCIN1;ACVR1;DLG3;VTN;TP53;SEMA4D;NOX4;CSPG4;IL18;IL6ST;IGF2
prerank,regulation of histone acetylation (GO:0035065),0.41347920340376904,1.2277114319748454,0.18632478632478633,0.9367042440701552,1.0,9/33,13.21%,MAPK3;RUVBL2;RPS6KA4;RPS6KA5;RAPGEF3;SETD5;PARK7;CTBP1;HDAC5
prerank,glucose metabolic process (GO:0006006),0.3740377122678046,1.2277018034209772,0.17436661698956782,0.9344295577305234,1.0,9/58,8.49%,PCK1;HECTD4;SLC25A1;GOT2;TPI1;PPARD;OMA1;IRS2;GALM
prerank,nuclear envelope organization (GO:0006998),-0.43097305773944916,-1.227473150042482,0.20045558086560364,0.5863096960264182,1.0,13/20,26.02%,NUP155;TOR1AIP1;DMPK;NUP93;TOR1B;NEMP1;SUN1;VPS4A;CTDNEP1;EMD;LEMD2;TMEM170A;TMEM43
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.4007315440678334,-1.227019808522767,0.171021377672209,0.5864913345725146,1.0,7/24,8.19%,ERRFI1;MED1;CBFB;ROCK2;SRSF6;ROCK1;FOXC1
prerank,fluid transport (GO:0042044),-0.5002699335378544,-1.2266341096686832,0.2172043010752688,0.5865078864833023,1.0,2/12,9.82%,PDPN;AQP4
prerank,intracellular protein transmembrane transport (GO:0065002),0.39555762991456583,1.2265022976832596,0.1870860927152318,0.9372474449470903,1.0,10/42,11.48%,TOMM20;ROMO1;TIMM17B;PEX1;PEX7;GRPEL2;TOMM40L;TIMM21;AIFM1;SEC62
prerank,positive regulation of synaptic transmission (GO:0050806),-0.3162290909058607,-1.2264436095105726,0.10793650793650794,0.585891101625321,1.0,32/72,26.68%,RIMS1;NRXN1;GRIN2B;TSHZ3;ADCY1;DLG4;NLGN2;PRKCZ;RELN;CLSTN2;NLGN1;SLC24A2;LGMN;EPHB2;CACNG7;VAMP2;CACNG4;SHANK2;CACNG2;NFATC4;KCTD13;CLSTN3;FLOT1;ADRA1A;ADCY8;GRIN2D;NLGN3;CACNG3;MPP2;CACNG8;CHRNA7;STX1B
prerank,negative regulation of nervous system development (GO:0051961),-0.4451778721794589,-1.2262512428120962,0.21019108280254778,0.5853186054158152,1.0,3/17,5.91%,ROBO2;APPL2;SORL1
prerank,chemical synaptic transmission (GO:0007268),-0.2616131434956833,-1.2262303298560393,0.0196078431372549,0.584284988765369,1.0,70/284,17.50%,DLG2;RIMS1;DLGAP1;KCNQ3;PLP1;HTR2C;GABRB1;GRIA4;SNAP25;GRIA2;SLC1A3;NRXN1;CACNB4;AMPH;GRID2;GRIN2B;GRM5;GLRB;CHRM2;KCND2;SYN2;DLGAP2;MBP;GABRA2;DLG4;PTPRN2;NLGN2;SLC6A1;SHISA6;CACNA1B;GLRA3;CAMK4;GRID1;CHRM3;GABRG2;GLRA1;GABBR2;AKAP9;NLGN1;SYN1;KCNA1;PRKACA;BRSK1;HTR4;RIT2;NRXN2;PRKAR1B;APBA1;DLG1;UNC13C;CAMK1;BSN;STXBP1;HTR7;SNPH;FCHSD2;UNC13B;VAMP2;GRIK4;SLC12A6;LRP6;KIF5A;ERC2;GABRA5;STX1A;SLC12A4;NOVA1;GABRG3;DVL1;HCRTR2
prerank,sympathetic nervous system development (GO:0048485),-0.46433959929836455,-1.2261688223711213,0.20652173913043478,0.5833786352723117,1.0,4/15,9.78%,NRP1;CTNNB1;SEMA3A;NRP2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.44829300140023226,-1.225782592756718,0.19727891156462585,0.5833381261536303,1.0,2/17,2.50%,ANK2;SNTA1
prerank,cellular response to cAMP (GO:0071320),-0.3894340598316892,-1.2255536553179942,0.18406593406593408,0.5828579300987,1.0,12/30,27.74%,HCN1;AKAP6;IGFBP5;AKAP9;EZR;RAPGEF2;SLC5A5;DMTN;PDE2A;HCN2;KCNQ1;INPP5K
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.4394041122142808,1.2251747075880806,0.20136518771331058,0.940702678034056,1.0,6/24,13.40%,ATF3;ATF6;KLF2;NOTCH1;RBPJ;DDIT3
prerank,phosphatidylserine metabolic process (GO:0006658),0.4262643844442891,1.2251596289721536,0.2222222222222222,0.9384703530688346,1.0,7/32,12.53%,SERINC1;OSBPL10;PLAAT3;LPCAT3;MBOAT1;SERINC5;ABHD12
prerank,regulation of signal transduction (GO:0009966),-0.27762411288467886,-1.2247200996798477,0.039647577092511016,0.5841730625386659,1.0,73/190,25.75%,NCAM1;FGFR2;SULF1;ZIC1;KCTD8;OGT;TULP3;IGFBP5;IGFBP2;PLCE1;IGFBP7;IFT81;PXN;CBFB;DHRS3;POFUT1;DCDC2;IRAK1;IGFBP6;UBASH3B;CASTOR2;GAS1;SNW1;RGS12;ACVR1;ELF1;RSPO3;GRK5;GRK3;PLSCR1;SOCS2;CSK;PRAG1;ILK;NUCKS1;IGFBP4;WDR11;FRRS1L;USP20;RORA;INTU;TMEM204;TGFB1;RGS20;PTPN2;GRK4;WWTR1;MTCH1;SOCS5;TSC2;FRMPD1;SNX3;TRIM5;SEMA5A;TMEM237;CX3CL1;DTX1;GLI1;PRKD1;GRK2;DOK5;DGKQ;IRAK2;ITGB1BP1;TSPYL2;RIC8B;LLGL1;TSPAN15;FOXL1;RGS4;GLRX2;PTCH1;GIT1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4364813348273677,1.2243373446094425,0.19964664310954064,0.9397695298701211,1.0,7/26,14.46%,TIRAP;IFI35;WDFY1;PJA2;MFHAS1;DDX3X;CYBA
prerank,stress granule assembly (GO:0034063),-0.42886636385470506,-1.2236870610681392,0.1981981981981982,0.5860545113043937,1.0,7/20,13.81%,BICD1;DYNC1H1;MAPT;OGFOD1;YTHDF1;G3BP1;ATXN2L
prerank,cellular response to nutrient levels (GO:0031669),0.3745790052050256,1.2235899731237139,0.17304747320061256,0.9407403109991039,1.0,21/62,21.13%,RALB;GAS2L1;MAP1LC3B;HSPA8;RPTOR;SIRT1;TSC1;PRKAA2;ATG7;RRAGC;USP33;ATG14;TFEB;ZFYVE1;ULK1;LAMP2;EIF4G1;XBP1;WDR45B;STK24;LRRK2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5611429546303778,1.2234570572254266,0.2222222222222222,0.9390698956899526,1.0,5/10,13.57%,PSMC4;PSMC2;ESR1;PSMC6;THRA
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.38476952822449284,-1.2231678971462374,0.16995073891625614,0.5864716944790287,1.0,10/31,18.58%,DLG2;LRRC7;PARD3B;RHOA;EZR;DLG3;DLG1;WDR1;CDC42;MSN
prerank,regulation of adaptive immune response (GO:0002819),0.4728058781416131,1.2222995795880918,0.22621184919210055,0.9417435272913052,1.0,4/18,14.10%,FCGR2B;SAMSN1;SIRT1;TRIM27
prerank,RNA transport (GO:0050658),-0.32502965545750534,-1.2220959330129249,0.11384615384615385,0.5883565468547429,1.0,30/71,24.61%,SRSF5;SRSF11;CASC3;TGFBR2;SIDT1;SRSF2;KIF5C;SRSF6;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;CKAP5;HNRNPA2B1;SIDT2;HNRNPA1;THOC5;SLU7;CDC40;RTRAF;RNPS1;RAE1;FLOT1;NUP214;EIF4A3;NCBP2;THOC1;RBM8A
prerank,negative regulation of viral entry into host cell (GO:0046597),0.5285677112541713,1.2220768629576089,0.22634508348794063,0.9404466885317583,1.0,4/12,8.83%,LY6E;IFITM2;IFITM3;IFITM1
prerank,positive regulation of rRNA processing (GO:2000234),-0.5269079963815906,-1.2216369793670143,0.1995841995841996,0.5885180797130193,1.0,6/10,25.27%,RIOK1;RIOK2;WDR43;SIRT7;UTP15;BUD23
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.49687773011816616,-1.2216223404214188,0.23162583518930957,0.5874811475278235,1.0,2/12,7.21%,ANK2;UBASH3B
prerank,nucleic acid-templated transcription (GO:0097659),0.40613887228951745,1.2215261602717824,0.18760195758564438,0.940589363604194,1.0,10/42,14.55%,POLR2J;NR4A2;POLR2B;PAX8;PWP1;TERT;THRB;RRAGC;PPP5C;BAZ2A
prerank,hyaluronan catabolic process (GO:0030214),-0.44300662802152885,-1.2211998568936606,0.22384937238493724,0.5874666965366765,1.0,9/18,33.38%,CEMIP;CEMIP2;HEXA;HEXB;TGFB1;GUSB;HYAL1;SLC9A1;CHP1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5237742176621276,1.220581513801902,0.23827392120075047,0.9425426327792047,1.0,3/11,9.68%,HIPK2;ING4;TFAP4
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5184417913469841,-1.2202712770073139,0.21991701244813278,0.5889395866155668,1.0,5/11,15.87%,PDK1;PRKCD;MAP3K5;STK25;PRODH
prerank,epithelial structure maintenance (GO:0010669),-0.5143470143021239,-1.2202005363124666,0.21108742004264391,0.588061317173033,1.0,2/11,7.87%,CXADR;RBP4
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.5157438315759524,-1.2199276636630874,0.2222222222222222,0.5877245421142567,1.0,5/10,20.50%,FGFR2;TGFBR2;LRP5;STAT1;PDGFA
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3205045212009751,1.2198846467059767,0.1181592039800995,0.9431275420339228,1.0,38/173,13.85%,BCAP29;DYNC1I1;TRAPPC2;MIA2;SPTB;CAPZA2;CNIH1;LMAN2;TMED4;COG5;DCTN2;GOPC;COPG2;TRAPPC8;TMEM115;GOSR2;F8;TRIP11;NAPA;TMED5;KDELR2;TMED10;DCTN3;RAB1A;NRBP1;TRAPPC11;DYNLL1;HYOU1;TMED7;SCFD1;TRAPPC6B;MCFD2;ARCN1;CD55;COPG1;CUL3;COG3;PROC
prerank,negative regulation of transmembrane transport (GO:0034763),0.5407099536796466,1.2197763899809129,0.2274436090225564,0.941351703019712,1.0,3/10,12.75%,RSC1A1;IRS2;CTTNBP2NL
prerank,protein K11-linked ubiquitination (GO:0070979),0.4351303717018897,1.2190720225926586,0.22569444444444445,0.9422677649773106,1.0,11/27,21.31%,ANAPC2;ANAPC13;ANAPC7;ANAPC11;ANAPC10;ANAPC4;UBE2H;CDC26;UBE2D3;UBE2L3;UBE2A
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.325675593829877,1.2190236646963217,0.12158469945355191,0.9402390152727877,1.0,31/151,16.60%,PCSK1;GPHN;CERS1;MOCS3;ACER2;CERS4;PRKD2;LPCAT2;APOE;SGMS1;KDSR;ELOVL6;LPCAT3;GPAT4;PLPP1;SLC44A1;SGPP2;DMD;SLC25A2;HACD2;ACER3;PAM;CEPT1;SGPP1;GCH1;CSNK2A2;SPNS2;CERT1;AKR1A1;PPM1L;SLC44A2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.40789270897418345,1.218914797904409,0.19663865546218487,0.9384934146165639,1.0,11/36,11.97%,LEF1;MAP3K7;PPP3CB;GNB1;WNT5A;PLCB1;FZD3;NLK;AGO4;PPP3CA;PPP3R1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.40538919229680465,1.2179388671801683,0.2026578073089701,0.9405979791458476,1.0,11/35,15.57%,CBL;PPT1;SGIP1;HNRNPK;B2M;ARF1;PICALM;SMAP1;LDLRAP1;BMP2K;ARF6
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.37807785033466956,-1.2175852904553432,0.17955112219451372,0.593130211477425,1.0,10/33,14.98%,KANK2;FHL1;RBL2;MYO16;CDC73;BRD7;CDK6;DLG1;DACT1;NACC2
prerank,positive regulation of cell adhesion (GO:0045785),0.3605646760739216,1.217575241649346,0.16323529411764706,0.939948741304086,1.0,13/74,11.89%,FRMD5;PTPRJ;CXCL12;PRKD2;CIB1;RET;SYK;MAGI1;SMAD7;CD47;CITED2;NPNT;PPP3CA
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.30246178729353573,-1.2171579561118153,0.09737827715355805,0.5932138035895372,1.0,21/107,8.70%,LRRC4C;ATP1A2;RIMS1;DLGAP1;DGKI;GRID2;GRM5;DLGAP2;DLG4;DLGAP4;SNCAIP;NLGN2;RELN;BCR;SLC12A2;CACNA1B;GRID1;CLSTN2;AKAP9;NLGN1;SYN1
prerank,cellular response to interleukin-12 (GO:0071349),0.391324897146248,1.21712784187144,0.19572368421052633,0.9397024785066928,1.0,16/48,17.46%,LCP1;SOD1;CFL1;RALA;TALDO1;RPLP0;CD47;SOD2;ARF1;PLCB1;PITPNA;TYK2;TCP1;SNRPA1;HNRNPF;CAPZA1
prerank,stress fiber assembly (GO:0043149),-0.4647663382072773,-1.2169402583792892,0.2193158953722334,0.5917299917055836,1.0,6/15,18.43%,SORBS1;RHOA;ITGB5;TNFAIP1;PDLIM1;KCTD13
prerank,contractile actin filament bundle assembly (GO:0030038),-0.4647663382072773,-1.2169402583792892,0.2193158953722334,0.5917299917055836,1.0,6/15,18.43%,SORBS1;RHOA;ITGB5;TNFAIP1;PDLIM1;KCTD13
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4496587038799944,1.2169298625095792,0.2103386809269162,0.9383756425598994,1.0,5/24,7.28%,PECAM1;SELP;ICAM1;SYK;F11R
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.516396216454031,-1.2158840914192024,0.23015873015873015,0.5934911811855936,1.0,6/10,37.93%,ERRFI1;ENPP1;IMPACT;CAV1;CHP1;TESK1
prerank,protein localization to synapse (GO:0035418),-0.496693300887763,-1.2155848864833916,0.22355289421157684,0.5932394263645955,1.0,7/12,13.67%,NRXN1;PCLO;DLG4;NLGN2;NLGN1;NRXN2;BSN
prerank,regulation of response to external stimulus (GO:0032101),0.33421524099407734,1.2149985098285154,0.13324175824175824,0.9444625203964508,1.0,21/121,12.58%,LRP8;SAG;PIK3AP1;IL1R1;SEMA7A;FCGR2B;TIRAP;BCL6B;BIRC2;SBNO2;SPATA2;METAP2;CYRIB;WNT5A;TRAF3;RELA;PARK7;METAP1;NLRP6;USP18;CD55
prerank,positive regulation of T cell differentiation (GO:0045582),0.3970584196741003,1.2147615848489068,0.20634920634920634,0.9432666745987628,1.0,7/36,16.08%,PCK1;LEF1;VSIR;PNP;NKAP;BCL6;IL7
prerank,negative regulation of cell motility (GO:2000146),-0.2978337896167986,-1.2147560617285675,0.10801393728222997,0.5944236589167787,1.0,12/108,4.07%,MAGI2;NAV3;SPOCK3;LDLRAD4;TMEFF2;SULF1;ROBO1;DPYSL3;IGFBP5;FBLN1;CLIC4;TPM1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.5078952321437642,1.2147253184835927,0.2350674373795761,0.9412501232458206,1.0,5/13,18.08%,HEY1;HEY2;DDIT3;TAF1;SIN3A
prerank,regulation of neuron migration (GO:2001222),-0.39866367527097235,-1.2145122105409445,0.21379310344827587,0.5939713922837297,1.0,14/26,25.81%,CTNNA2;COL3A1;NTNG1;SHTN1;SEMA3A;NIPBL;ULK4;PLXNB2;RAPGEF2;CX3CL1;NSMF;CAMK2B;CAMK2A;ADGRG1
prerank,pharyngeal system development (GO:0060037),-0.4555893344211227,-1.2142591825173366,0.2141280353200883,0.5936959581856452,1.0,4/15,4.74%,TGFBR1;BMP5;BMP7;BMP4
prerank,retinoid metabolic process (GO:0001523),-0.32463322074658113,-1.213665332406287,0.14240506329113925,0.5943141559355731,1.0,14/71,10.87%,GPC6;LRP1;ALDH1A1;ALDH1A2;SDC2;DHRS3;GPC3;HSPG2;ABCA4;NAPEPLD;RBP4;SCPEP1;GPC5;RBP1
prerank,regulation of cellular component size (GO:0032535),0.4161603792357066,1.2132284437310574,0.20033670033670034,0.9454023926336104,1.0,8/30,14.38%,PEX11G;VAV3;RPTOR;HP1BP3;RAB22A;PICALM;LARS1;AP2M1
prerank,error-free translesion synthesis (GO:0070987),-0.4132919182643946,-1.2130528158967826,0.2112970711297071,0.594968292897774,1.0,7/22,14.27%,RFC1;RCHY1;VCP;RPA1;UBC;NPLOC4;POLDIP2
prerank,protein localization to cell-cell junction (GO:0150105),0.478116896914461,1.2127084029475226,0.23161764705882354,0.9455518012675269,1.0,6/15,13.39%,ACTB;F11R;ARHGEF18;TJP1;CDH5;LSR
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.2743613579553107,-1.2120074439971693,0.08196721311475409,0.5968521831153843,1.0,46/166,19.13%,SORBS1;IGF1;PLD1;SAMD4A;EGFR;SMAD3;PDGFRB;GLI2;LPGAT1;ZEB2;KAT7;VIM;P2RX4;DDB1;PPARGC1A;ATP7A;LDB1;SLC6A9;AKT2;POLDIP3;LDLR;PRR16;EIF3C;YTHDF1;NIBAN1;SMOC2;THBS1;STN1;ARPP19;DDAH1;EEF2;RBM3;BRPF3;SLC27A1;ATAD5;IGF2;PLXNB2;GPLD1;PTPN2;METTL5;SREBF1;NAT10;PCIF1;UPF3A;RPS6KB1;CIRBP
prerank,protein deacetylation (GO:0006476),-0.35831065901215686,-1.2118734251100007,0.15324675324675324,0.596203638304042,1.0,14/41,12.62%,PRDM5;MIER1;HDAC4;TBL1XR1;HDAC1;FLNA;SIRT2;MORF4L2;MTA3;MIDEAS;MORF4L1;MTA1;TBL1X;RCOR3
prerank,response to reactive oxygen species (GO:0000302),0.371500257983469,1.2115950301417862,0.17771084337349397,0.9480464282606961,1.0,12/54,12.87%,MAPK3;ROMO1;TXNRD2;SOD1;APOE;FYN;MAPK8;SIRT1;SOD2;APTX;RPS3;CHUK
prerank,apical protein localization (GO:0045176),0.5281462310679506,1.2112237691661112,0.24765478424015008,0.9473703929507459,1.0,4/10,9.79%,ACTB;MAL;GOPC;CELSR1
prerank,cellular response to nitrogen compound (GO:1901699),-0.41821191790865336,-1.210774424811,0.22276029055690072,0.5981785195334504,1.0,13/20,39.91%,SPIDR;ROCK2;HSF1;DDI2;RTF2;RIOK3;BLM;DDX11;NSMCE3;ATP2B4;PDE12;TIMELESS;NR1H4
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.3903862891320822,1.210353400585253,0.19800332778702162,0.9489718389037869,1.0,15/46,17.46%,LCP1;SOD1;CFL1;RALA;TALDO1;RPLP0;SOD2;ARF1;PLCB1;PITPNA;TYK2;TCP1;SNRPA1;HNRNPF;CAPZA1
prerank,mitochondrial translational elongation (GO:0070125),0.3465675552754853,1.2101797559165974,0.15169366715758467,0.947623983073386,1.0,14/88,12.45%,MRPS22;MRPS2;MRPS33;MRPL23;MRPL24;MRPL18;MRPL38;MRPS12;MRPL20;TSFM;MRPL52;MRPS15;MRPS24;MRPL48
prerank,cellular protein localization (GO:0034613),0.30488956064346284,1.2100070156429983,0.08834355828220859,0.9462447863161522,1.0,62/285,13.53%,RTP3;REEP1;ARF5;RAP2A;TM9SF2;ARL5C;ARL4D;TM9SF3;EVI5L;RAB5C;TBC1D30;TBC1D8;ITSN1;SNX8;VPS29;TBC1D9;TMED4;VPS26A;SEC23IP;RAB43;CNTNAP2;TBC1D10B;TRAPPC8;LAMTOR1;USP6NL;RIC3;TBC1D4;RAB6B;NAPA;TMED5;IFT22;RABGAP1L;SNX17;HEY2;RAB6A;TMED10;RAB14;WNT5A;ACD;DNAJC27;TBC1D12;SNX1;ESAM;ARL5B;ARF1;RAB1A;ZDHHC15;CELSR1;TBC1D25;KIF13A;TMED7;DMD;SCFD1;RAB5B;RAB22A;ADPRH;ARCN1;TBC1D14;RRAGC;YWHAH;RABGAP1;COG3
prerank,negative regulation of axonogenesis (GO:0050771),-0.39264204971193156,-1.2099941048594902,0.20707070707070707,0.5993592977773773,1.0,5/27,4.24%,MAP2;DCC;ULK2;PTPRS;RHOA
prerank,cholesterol biosynthetic process (GO:0006695),0.41928263986937353,1.2095800925370293,0.2059800664451827,0.9459804790457383,1.0,8/31,12.00%,EBP;INSIG1;HMGCR;PLPP6;SC5D;IDI1;NSDHL;LSS
prerank,cellular response to glucagon stimulus (GO:0071377),-0.43647766808034794,-1.2091700845526743,0.22943722943722944,0.6006692074502739,1.0,10/17,22.64%,ADCY5;ADCY2;ADCY1;ADCY9;PRKACA;ADCY7;PRKAR1B;ADCY8;ADCY3;ADCY4
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.5207461656308896,-1.2086657694004757,0.2202020202020202,0.6009458814647729,1.0,5/10,32.28%,APPL2;RAB31;ANO6;NCKAP1L;CD300A
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.4400757755957999,-1.2081341976714755,0.20309050772626933,0.6013524190361055,1.0,5/18,14.70%,ATP1A2;CAB39;BIN1;CAMK2D;COMMD1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2604664345044121,-1.2077957724767476,0.058823529411764705,0.601286569517036,1.0,80/259,20.10%,GSN;PARVA;AHI1;PKD1;CC2D2A;EXOC3;NRP1;MTSS1;RILPL1;FLNA;PIBF1;IFT81;KIT;DZIP1;TTC8;WDR35;DYNC2I1;RAB8B;VCL;DCDC2;PIP5K1A;SHTN1;NUDCD3;CCDC66;CCDC57;CFAP20;EXOC6;TTC39C;IFT46;IFT52;ACTR3;CEP89;EZR;SPATA13;CEP126;IFT172;CEP20;ABLIM2;FGD1;ACTN2;IFT74;CFAP44;RP2;EMP1;ARL13B;DISC1;TTBK2;ABLIM3;KIF3A;DZIP1L;BBS9;RAB11A;WDR19;WDR11;ANO6;FGD4;INTU;RAB23;BBS2;PTPRO;CYS1;ARF4;EXOC7;EXOC1;RAPGEF2;PTPN23;CEP250;EHD1;RAB8A;EHD3;DYNLL2;ACTR2;IFT20;SNAP29;ARFIP2;BBS5;TMEM237;CCDC28B;TTLL3;ARHGEF4
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.364129883347491,-1.2072338061998291,0.17506631299734748,0.6018372726739022,1.0,5/37,3.16%,TENM2;TENM3;ALCAM;GRID2;CXADR
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.41208647244977487,1.2070707628129205,0.21993127147766323,0.9546757317547175,1.0,9/31,16.31%,LRP8;SHANK3;CFL1;TANC2;EFNA1;ZDHHC15;PPFIA2;CAPRIN1;ABI2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.5279481459908363,1.207057582511398,0.2413793103448276,0.9525549023543347,1.0,4/11,14.26%,SPR;PTS;NOS3;GCH1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.41702763196141646,1.2068540563465182,0.2131979695431472,0.9512555337711339,1.0,7/29,11.62%,ACSL5;SLC25A1;PPT1;HSD17B12;ELOVL6;ACSL4;HACD2
prerank,pteridine-containing compound metabolic process (GO:0042558),0.5113030386288487,1.206828808079502,0.24860853432282004,0.9492036036295213,1.0,4/13,14.26%,SPR;PTS;NOS3;GCH1
prerank,vasodilation (GO:0042311),0.5095311420110898,1.2066434732345968,0.26476190476190475,0.9478251607171153,1.0,4/13,11.15%,SOD1;KLF2;SOD2;NOS3
prerank,I-kappaB phosphorylation (GO:0007252),0.5422422105136524,1.205999934603862,0.2635814889336016,0.9484492573205484,1.0,3/10,12.87%,MAP3K7;ERC1;CHUK
prerank,cellular response to glucose starvation (GO:0042149),-0.3533774514152378,-1.2059669645400208,0.18253968253968253,0.6042298323567532,1.0,21/41,31.63%,PRKAG2;CPEB4;PRKAG1;PIK3C3;SIK1;BRSK1;HNRNPA1;TP53;SZT2;ITFG2;ATF4;IMPACT;EIF2AK3;SESN2;PICK1;ZC3H12A;FOXO3;MYBBP1A;PRKAG3;TBL2;PRKAA1
prerank,negative regulation of lyase activity (GO:0051350),0.4766188001348346,1.2056274584240945,0.21673003802281368,0.9479159830373012,1.0,4/16,14.83%,PHPT1;EDNRB;PALM;GRM3
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.40929134697087327,1.2054702493813076,0.21043771043771045,0.9464823243131413,1.0,9/33,15.25%,TNFAIP3;RAMP2;TEK;WFS1;KRIT1;ICAM1;TNIP2;CDH5;GAS6
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.4931044054918976,1.2052729399522275,0.25765765765765763,0.9452385066119594,1.0,3/14,10.12%,NCBP1;CPSF4;CPSF6
prerank,pyruvate metabolic process (GO:0006090),0.3791912384113495,1.2051168298953163,0.18552036199095023,0.9437542184149145,1.0,5/52,5.68%,PCK1;ENO4;BSG;ME3;TPI1
prerank,sphingolipid biosynthetic process (GO:0030148),0.35349606478875084,1.205037264391799,0.18433179723502305,0.941947888643214,1.0,17/71,16.13%,CERS1;ACER2;SMPD4;CERS4;PRKD2;SGMS1;KDSR;ELOVL6;ST8SIA1;PLPP1;SGPP2;HACD2;ACER3;SGPP1;SPNS2;CERT1;PPM1L
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3625986647387289,-1.2049430640446575,0.18622448979591838,0.606064852241085,1.0,13/34,23.83%,AMBRA1;PDGFRB;KIT;PDGFRA;PIK3R3;PIK3IP1;PTK2;TGFB1;PIK3R1;PRKD1;P2RY12;EPHA8;TNFAIP8L3
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.45725614750840865,1.2046378661888943,0.23722627737226276,0.94158685464748,1.0,3/19,9.21%,PIK3AP1;TIRAP;RAB11FIP2
prerank,negative regulation of axon extension (GO:0030517),0.4166378539249393,1.2044652370697564,0.22030981067125646,0.9402902394358473,1.0,8/30,9.78%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;DIP2B;SEMA6B;SEMA4C;RNF6
prerank,retinal metabolic process (GO:0042574),0.5142426679751744,1.2044424310314434,0.23461538461538461,0.9382919973796554,1.0,4/12,14.01%,RDH13;RDH11;CYP1B1;RDH10
prerank,tRNA processing (GO:0008033),0.36392551067866785,1.2043997812793592,0.1884272997032641,0.9364091726746557,1.0,20/61,19.86%,THG1L;THUMPD1;FARS2;CPSF4;TRMT10B;POP5;ANKRD16;PTCD1;WDR4;SSB;TSEN2;NSUN6;CDKAL1;TSEN15;CLP1;NSUN2;TRNT1;FTSJ1;URM1;POP1
prerank,negative regulation of viral process (GO:0048525),0.3721445147747463,1.204339207677994,0.16927899686520376,0.9345988661292955,1.0,10/57,10.59%,ILF3;BANF1;TRIM28;IFITM2;IFIT1;TRIM8;TRIM14;IFITM3;IFITM1;SRPK2
prerank,regulation of oxidoreductase activity (GO:0051341),-0.474838644813089,-1.2039293138975617,0.2281449893390192,0.6078384775832191,1.0,8/13,42.58%,ATP7A;SZT2;ABL2;ECSIT;HDAC6;SIRT4;MT3;NOD2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.42881128303847416,-1.2039088152070847,0.21212121212121213,0.6068497674305452,1.0,5/18,4.40%,ST18;JAK1;SMAD4;FER;IL6R
prerank,regulation of fatty acid oxidation (GO:0046320),-0.4487640655855571,-1.203824838278519,0.2234513274336283,0.6060485591391579,1.0,4/16,6.59%,PRKAG2;PPARGC1A;APPL2;PPARA
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3425829501270438,1.2033497281651935,0.17037037037037037,0.936798535379312,1.0,18/85,9.79%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TIAM1;AP2S1;PSMD11;PFN1;PSMB4;PSMC1;DAAM1;WNT5A;PSMC2;FZD3;PSMD2;CELSR1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5298234928305803,1.203136255642208,0.2387218045112782,0.9355866205081766,1.0,3/12,9.31%,MAPK3;CSF1R;LYN
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5336219496379501,1.2027754511330175,0.2565130260521042,0.9350377838943695,1.0,4/10,11.27%,SHANK3;NETO1;NPTN;APP
prerank,regulation of neuron projection arborization (GO:0150011),-0.4654918448603502,-1.2026885409461838,0.227765726681128,0.6081336302739292,1.0,7/15,17.27%,NTNG1;DLG4;MACF1;DVL3;GRIP1;FZD4;DVL1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3107403516842515,1.2022548411751548,0.1308641975308642,0.9351675613185504,1.0,30/198,12.19%,NUDT14;MAPK3;PIK3CG;PPIP5K2;NUDT11;PTPRC;PPP3CB;PNKP;PTPRB;DUSP12;NUDT5;PANK2;ACYP1;PLAAT3;CERKL;PXYLP1;PLPP1;PLCG1;INPP5D;PLCB1;PAK1;GPI;PGP;PFKFB3;PI4KA;PIK3CD;PPP3CA;INPP4B;IP6K2;PLAA
prerank,nitric oxide metabolic process (GO:0046209),0.49553508856898976,1.201780743491989,0.23049645390070922,0.9350943513246346,1.0,4/14,14.26%,SPR;CYP1B1;NOS3;GCH1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.3127730798870494,-1.201186529125103,0.1495601173020528,0.6113102357022332,1.0,12/74,4.04%,LDLRAD4;PHLDB2;DAB2;COL1A1;SMAD3;PHLDB1;TGFBR1;TGFBR2;BMP5;CTNNB1;PDPN;SMAD4
prerank,motile cilium assembly (GO:0044458),-0.4890082566340581,-1.2003016351763292,0.24842105263157896,0.612695257050189,1.0,5/12,27.80%,SPATA6;BBOF1;BBS5;CCDC39;E2F4
prerank,cellular response to organonitrogen compound (GO:0071417),-0.2899584509400126,-1.1997957149611302,0.09375,0.613081702376663,1.0,15/99,8.71%,GABRB1;HCN1;CPEB4;AKAP6;RYR3;CPEB1;CAPN2;IGFBP5;CTNNA1;CTNNB1;P2RX4;GABRG2;GLRA1;AKAP9;EZR
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.29700196794876804,-1.1997260374765066,0.11589403973509933,0.6122592024921286,1.0,32/101,19.78%,PLD1;SAMD4A;OGT;CYFIP2;VIM;FBXW11;VGLL4;BTRC;IST1;POLDIP3;PRR16;EIF3C;YTHDF1;EZR;NIBAN1;THBS1;EEF2;RBM3;ASPSCR1;TBC1D10A;DACT1;PLXNB2;TGFB1;METTL5;NAT10;PCIF1;UPF3A;MSN;RPS6KB1;CIRBP;STUB1;AGTR1
prerank,muscle cell development (GO:0055001),-0.372259571322178,-1.1992652852290397,0.19298245614035087,0.6125985545818394,1.0,11/30,24.91%,ANK2;IGF1;CXADR;BIN1;MYOF;KDM1A;MEGF10;EFEMP2;VEGFA;MYH11;SGCZ
prerank,positive regulation of phospholipid transport (GO:2001140),0.5415027955482923,1.1989819779968345,0.263254113345521,0.9448966835402038,1.0,2/10,5.62%,APOE;DBI
prerank,nucleosome assembly (GO:0006334),0.4130572268948794,1.1985592559850409,0.2387312186978297,0.94466037762178,1.0,9/31,18.84%,ASF1B;NAP1L4;RSF1;CABIN1;BRD2;RBBP4;NPM1;ATRX;HAT1
prerank,myoblast fusion (GO:0007520),-0.48972709249797575,-1.1985487222481064,0.22483940042826553,0.6134107903305628,1.0,3/12,6.00%,ADGRB3;ADAM12;ADAMTS5
prerank,positive regulation of histone modification (GO:0031058),0.4028015898480174,1.1984114757503057,0.20299500831946754,0.943240163918507,1.0,8/33,11.22%,MAPK3;RUVBL2;RPS6KA4;RPS6KA5;CHTOP;AKAP8L;ING2;CTBP1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.49376075410485915,1.1982088847245764,0.24334600760456274,0.9421074271953916,1.0,4/14,11.78%,CRAT;ACOX3;HSD17B4;ACOT8
prerank,mitochondrion morphogenesis (GO:0070584),-0.4951912804642763,-1.1979547703370999,0.24691358024691357,0.6139865338558007,1.0,3/11,7.71%,PID1;WASF1;FIS1
prerank,nitric oxide biosynthetic process (GO:0006809),0.5006276268977556,1.1973407924949762,0.23971377459749552,0.9437357557481385,1.0,4/13,14.26%,SPR;CYP1B1;NOS3;GCH1
prerank,positive regulation of histone acetylation (GO:0035066),0.43582103208475825,1.1972824211239372,0.22702702702702704,0.9419114399510661,1.0,4/23,3.78%,MAPK3;RUVBL2;RPS6KA4;RPS6KA5
prerank,inorganic anion transmembrane transport (GO:0098661),-0.3193643508545386,-1.197146974884991,0.16883116883116883,0.61519471998285,1.0,32/63,27.26%,GABRB1;SLC1A3;GLRB;GABRA2;ANO3;SLC6A1;SLC12A2;SLC26A2;GLRA3;GABRG2;GLRA1;SLC25A3;ANO1;SLC20A1;ANO6;SLC12A6;GABRA5;SLC12A4;GABRG3;SLC5A6;SLC5A5;GABRA4;SLC12A9;GABRG1;SLC4A8;GABRA1;SLC12A7;SLC25A30;SLC25A11;LRRC8A;SLC12A8;SLC12A5
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.34391713943006713,-1.1971117210670446,0.14130434782608695,0.6142447205092924,1.0,14/48,14.45%,CUX1;DOCK5;DOCK1;NRP1;FLNA;NEDD9;RREB1;P4HB;CUX2;ILK;IL1RAPL1;OBSL1;MYADM;TRIOBP
prerank,negative regulation of cell population proliferation (GO:0008285),-0.2537570847261816,-1.1969220338669342,0.02702702702702703,0.6137245715112264,1.0,83/351,16.89%,MAGI2;ERBB4;ST18;TGFBR3;ALDH1A2;KANK2;CLMN;TNS2;IGFBP5;MCC;FBLN1;NELL1;PTPN14;COL4A3;BMP5;ABI1;CTNNB1;PDPN;MTSS1;ATP8A2;SIRT2;IGFBP7;BMP4;NUPR1;ZBTB7C;LMNA;PDS5B;OGN;APPL2;MYO16;PER2;VGLL4;FRK;PML;PODN;SKI;GSDME;IGFBP6;CDKN1B;RBP4;CDC73;ADAMTS1;SMAD6;NIBAN2;DLG3;CGRRF1;EIF2AK2;BRD7;FAP;CDK6;SPEG;CAMK2N1;DDAH1;TP53;NOX4;STK11;TBX3;WNT9A;P3H3;FKTN;PDCD5;NF2;ROR2;MAGED1;MED25;TOB1;NACC2;PEX2;RAF1;PTPRU;MN1;NGF;GPLD1;SLC16A2;RAPGEF2;TGFB1;RNF139;BMPR1B;CCN3;S100A11;PTPN2;SMYD2;OPRM1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5172007436684727,-1.1966300893867363,0.23092369477911648,0.6134575060307319,1.0,5/10,22.56%,ZEB2;ATP7A;CTNS;RAPGEF2;APPL1
prerank,sulfate transport (GO:0008272),-0.46323962350277215,-1.196613425350827,0.2290249433106576,0.6124558962256405,1.0,6/14,26.06%,SLC26A7;SLC13A4;SLC26A2;SLC26A11;SLC25A30;SLC25A11
prerank,body fluid secretion (GO:0007589),-0.45853344776099436,-1.1959781987906117,0.20175438596491227,0.6131191932328096,1.0,5/15,22.30%,ERBB4;SLC22A4;NPR1;PRLR;VEGFA
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3815284511548208,-1.1957885718661088,0.1990521327014218,0.612543370211757,1.0,5/27,10.68%,ANK2;AHNAK;CACNB4;PRKACA;CAMK2D
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2954144484634113,1.1956253909098933,0.0955794504181601,0.9467153440258839,1.0,90/327,19.29%,TBX4;ONECUT1;TRAPPC2;FOXN2;EZH2;ZFAT;HES6;GTF2IRD1;RPS6KA4;ATXN1L;RPS6KA5;PPP2CA;SBNO2;MYBL2;SMARCA2;SOX2;SPIN1;EP300;RFX3;NFX1;MED23;TGFBRAP1;SRSF10;ACTR8;CDK11B;ZNF205;SFPQ;ACTN4;ACTR5;DRAP1;CLOCK;PFDN5;NOTCH1;SOX13;ACVRL1;RELA;NAB2;RNF6;UBE2V1;RYBP;ING2;CCAR2;ESR1;NLK;HP1BP3;CREBBP;CARM1;JMJD1C;SP1;MZF1;IRF2;CHD3;ERC1;NUP35;TRRAP;CHEK2;DDIT3;ZKSCAN5;HCFC1;YBX1;RNF20;BAZ2A;NSD2;BACH1;FUS;TERF2IP;TFEB;TAF6L;APBB2;TCF7L1;TCF3;SOX17;WTIP;MYT1;CALR;NONO;ZNF219;INSR;STAT3;FOXK2;PATZ1;ZSCAN21;NCOA2;HINT1;YAF2;ATRX;MSL3;TCF7;MYBL1;ACVR2B
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.4103886341474391,-1.1950556511010209,0.20673076923076922,0.6136006423954384,1.0,5/23,7.08%,TGFBR3;SMAD3;SMURF2;SMAD4;DKK3
prerank,response to ATP (GO:0033198),-0.42905010734237253,-1.194020322872422,0.22624434389140272,0.6155161270550578,1.0,8/18,29.77%,RYR3;P2RX4;ABCC9;SSH1;P2RY12;DGKQ;TRPC3;P2RY1
prerank,protein modification by small protein removal (GO:0070646),0.3028223579366992,1.1937381312169257,0.11808118081180811,0.9527215612283614,1.0,59/252,14.95%,TOMM20;PSMB10;PSMC4;ABRAXAS1;PSMB6;PSMD8;PSMD5;PSMD12;ACTL6A;MAP3K7;TNFAIP3;ACTB;BIRC2;SMAD1;PSMD11;YOD1;OTUD1;PSMB4;YY1;PSMC1;EP300;ACTR8;SMAD7;ACTR5;DESI2;DESI1;RUVBL1;USP47;TRAF3;MDM2;RAD23A;PSMC2;USP48;USP31;PSMD2;ESR1;OTUD3;USP22;USP15;COPS7B;USP37;NFRKB;USP18;TNIP2;OTUD5;PSMD14;TRRAP;USP33;BRCC3;PSMC6;PSMD1;APC;NFKBIA;PSMB1;HCFC1;USP9X;UCHL5;COPS8;INO80
prerank,negative regulation of secretion by cell (GO:1903531),0.39642772911467195,1.1934370833083565,0.2173202614379085,0.9519854739403613,1.0,7/38,10.01%,PNKD;HMGCR;APOE;TNFRSF1B;GRM7;NOTCH1;RHBDF2
prerank,regulation of cell adhesion (GO:0030155),0.3257199988414532,1.193361282693633,0.15803814713896458,0.9502717655084368,1.0,19/129,10.04%,PRKX;RAC2;FRMD5;PIK3CG;PTPRJ;CXCL12;SRC;PRKD2;CD164;PPP2CA;RIPOR2;RET;MINK1;EFNA1;ACVRL1;PLXNA4;LYN;PODXL;PPP1R12A
prerank,regulation of DNA repair (GO:0006282),-0.3416333322477394,-1.1925565752405822,0.19843342036553524,0.61869762249722,1.0,18/44,19.32%,EYA2;EYA1;EGFR;UBE2N;KAT7;DEK;ERCC6;PML;UBR5;RNF168;RNF8;WRNIP1;SIRT7;NPAS2;USP1;CDK9;BABAM1;SMCHD1
prerank,regulation of integrin activation (GO:0033623),0.4875160619171,1.1922783896327098,0.2314990512333966,0.9527087481590013,1.0,4/15,13.32%,SRC;SELP;RASIP1;PLEK
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.33534354292211,-1.1918593728802371,0.17679558011049723,0.6195572589597358,1.0,14/51,10.98%,FBN1;FSTL1;NBL1;BMPER;SMURF2;SMAD4;VWC2L;CRIM1;SORL1;SKI;HTRA3;SMAD6;SPART;GREM2
prerank,plasma membrane repair (GO:0001778),-0.4777134191899872,-1.1917839466733362,0.2326086956521739,0.6187218479290433,1.0,9/13,37.42%,MYOF;AHNAK2;SYT11;SYT7;ANXA6;SYTL4;SMPD1;RAB3A;ARL8B
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.4308026534643645,1.191641699257068,0.2616487455197133,0.953375558809921,1.0,6/24,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.3425686397504837,-1.1910718802673441,0.19321148825065274,0.6197467525955794,1.0,13/45,8.36%,SMAD3;BRINP1;TOM1L2;CTNNB1;BMP7;ZWINT;BMP4;TRIM35;PTPN3;CDKN1B;GAS1;FOXC1;BRINP2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.32407345629135453,1.1905492240956228,0.16462585034013605,0.9560310321125106,1.0,32/125,17.79%,DYNC1I1;EML1;KIF18A;NUDC;PLK2;CLASP2;NEK9;DCTN2;MAP4;CDCA8;CENPC;KIF2A;DYNLL1;BCCIP;MIS12;TNKS;XPO1;KIF3B;NEK6;PTPA;EFHC2;RCC1;DYNC1I2;CLIP1;CENPP;CENPO;SETD2;KPNB1;NUP160;CLASP1;RANGAP1;PAFAH1B1
prerank,natural killer cell mediated immunity (GO:0002228),0.47787319779446047,1.1903527746038876,0.2518248175182482,0.954883640828203,1.0,2/15,6.48%,TUBB;CEBPG
prerank,granulocyte chemotaxis (GO:0071621),0.369232923149993,1.1901382358845818,0.1993517017828201,0.9538467881453792,1.0,7/55,11.50%,PIK3CG;BSG;PPIB;SYK;PIKFYVE;CCL25;PIK3CD
prerank,positive regulation of hormone secretion (GO:0046887),-0.4430490148254598,-1.1900188102115403,0.22869955156950672,0.6216152798552069,1.0,8/17,35.29%,SNX4;SPP1;C1QTNF3;VAMP8;EDN1;SOX11;EDN3;HFE
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5075627569949068,-1.1899227994208745,0.24489795918367346,0.6208578324458323,1.0,7/10,39.46%,GALNT13;POGLUT3;POGLUT2;GALNT2;GALNT1;GALNT3;MGAT5B
prerank,organic cation transport (GO:0015695),0.44975159635150735,1.1893091406171727,0.2476894639556377,0.9553186029870638,1.0,3/19,7.94%,SLC5A7;SLC44A1;SLC25A26
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.42038538326581665,-1.1887812638703632,0.2386634844868735,0.6230172634588468,1.0,5/19,13.86%,ABHD5;PRKCD;PPARA;AKT2;ABCD2
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4142289110271868,1.1885611145627162,0.23174603174603176,0.9564283112198999,1.0,10/30,16.78%,CXCL12;PTTG1IP;FBXO5;SIRT1;YJU2;MDM2;CCAR2;RPS3;CD44;TMEM161A
prerank,positive regulation of protein secretion (GO:0050714),-0.3171356677256684,-1.1882492733328627,0.16463414634146342,0.6234970223520145,1.0,27/69,28.09%,BMP6;IGF1;WLS;MCU;NLGN2;GLUD1;RBP4;EZR;PPID;TM7SF3;NNAT;UNC13B;PSMD9;EXOC1;TGFB1;PTPN23;TCF7L2;C1QTNF3;TGFB3;IER3IP1;CAPN10;APBB1;SYTL4;PPIA;AACS;LRRC8A;MYOM1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.37429838477202965,-1.1877303681244322,0.21103117505995203,0.6238721222215557,1.0,9/31,14.71%,KANK2;FHL1;RBL2;MYO16;CDC73;BRD7;CDK6;DLG1;DACT1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4759085320348161,1.1876359412844324,0.25704225352112675,0.9582990550693753,1.0,6/15,15.42%,ARPC3;ARPC5L;ARPC4;ARPC5;TRIM27;WHAMM
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.38632387227146237,-1.1872784839349888,0.2128205128205128,0.624118760206963,1.0,20/30,29.30%,DSE;CHSY1;VCAN;HEXA;CSGALNACT2;CHST15;HEXB;ARSB;CHST11;UGDH;CSPG4;DSEL;BGN;DCN;HYAL1;CHPF2;CHST3;CSPG5;CHST12;NDNF
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.49858098190765754,-1.187174207293194,0.24364406779661016,0.6233578277397057,1.0,7/10,31.58%,MAPT;WWP2;NDFIP1;SNX3;PPM1F;DNAJA1;TERF1
prerank,positive regulation of dendrite development (GO:1900006),0.5085331314221108,1.1866855991283927,0.2737864077669903,0.9602038754443735,1.0,1/10,0.02%,LRP8
prerank,nucleic acid metabolic process (GO:0090304),0.3572013745402382,1.1865644042094903,0.1908284023668639,0.958733200284224,1.0,13/69,11.65%,POLR2J;NCBP1;POLR2B;HNRNPH2;DDX54;PCBP1;HNRNPK;HNRNPC;XRN2;DXO;EXD2;DUSP11;PTBP1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3438111996257753,1.1865220555455867,0.19760479041916168,0.9568834706223917,1.0,10/72,8.79%,POLR2J;ERCC3;POLR2B;CCNH;ERCC4;XRCC1;POLK;EP300;POLD3;GTF2H1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.34210997819154754,1.186403329639148,0.1744186046511628,0.9553747146737054,1.0,15/80,9.54%,GSK3A;TRIB3;PIN1;DCUN1D4;BIRC2;HDAC3;UBE3A;WFS1;PTTG1IP;SMAD7;BMI1;AXIN1;MAGEC2;SPRTN;MYCBP2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3865129541710908,-1.18638497680032,0.20714285714285716,0.6244883897753015,1.0,8/27,15.64%,ANK2;CTNNA3;CACNA1C;AKAP9;CAMK2D;SRI;DLG1;PDE4B
prerank,cellular response to chemical stress (GO:0062197),0.3377657742498257,1.1862644798798236,0.17446808510638298,0.9539194727130246,1.0,17/96,11.74%,CHCHD2;PRR5L;TXNRD2;SLC25A24;SOD1;EIF2S1;CYCS;STOX1;ZFAND1;LONP1;GPX7;TRPV4;SOD2;PARK7;PRKAA2;DDX3X;ATG7
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.37916987316236717,-1.1858896015898996,0.22962962962962963,0.6247942325929132,1.0,5/30,4.49%,DDX5;FOXP1;DAB2;HDAC1;RNF14
prerank,regulation of secretion (GO:0051046),-0.4735047616343152,-1.185851254361212,0.2543103448275862,0.6238798151920005,1.0,9/13,38.57%,SGK1;GPLD1;OAS2;KCNQ1;FGF10;POFUT2;EGF;ERBB3;OPRK1
prerank,cAMP metabolic process (GO:0046058),-0.46057652020821555,-1.1851137654772415,0.232409381663113,0.6250410728640772,1.0,8/13,22.64%,ADCY5;ADCY2;ADCY1;ADCY9;ADCY7;ADCY8;ADCY3;ADCY4
prerank,ether lipid biosynthetic process (GO:0008611),0.5239874025917746,1.1849847469323624,0.2693069306930693,0.9572090397352155,1.0,5/10,14.30%,LPCAT2;PEDS1;PEX7;AGPS;GNPAT
prerank,regulation of double-strand break repair (GO:2000779),-0.3503349941201498,-1.18493610550396,0.23615160349854228,0.6245330978908006,1.0,11/39,17.14%,SPIRE1;SPIDR;FMN2;DEK;PML;UBR5;MGMT;RNF169;KDM1A;SIRT7;ACTR2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4804411532885954,1.1848911528304056,0.25996204933586337,0.9556431179394622,1.0,3/15,5.04%,SH3D19;APOE;TNFRSF1B
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.44906752846967923,1.1842788593668896,0.22992700729927007,0.956278944200189,1.0,6/20,10.81%,SMAD1;EP300;CARF;NOTCH1;RELA;RBPJ
prerank,regulation of cartilage development (GO:0061035),-0.4287793725284268,-1.1839278485399118,0.23058823529411765,0.6262036571415522,1.0,11/18,37.28%,SOX5;TAPT1;BMP4;BMPR1B;SOX6;BMPR2;BMP2;MDK;PTHLH;WNT11;KAT2A
prerank,cellular protein metabolic process (GO:0044267),0.29000750867036174,1.1835175321202265,0.09028571428571429,0.9574518715735716,1.0,104/396,18.74%,RPL30;DMBT1;MRPS33;RSL24D1;EEF1A1;MRPL23;RPL17;RPL23;MRPL24;PSEN2;RPL31;RPL3;RPS21;MRPL18;DUSP12;CDH2;SEC11A;APOE;RPL35A;WFS1;PDIA6;VWA1;UBE2I;FBXW2;RPS14;RPL8;YARS2;RPL5;ABCF1;CSNK1G3;SPCS3;MRPS12;RPS12;HBS1L;NAPSA;RPS26;RPL37A;SPPL3;HARS1;OMA1;RPL4;MAGEC2;SLC35A1;RPLP0;PIGH;FBXO11;RPS28;UBE2M;ICMT;MBTPS1;RPS24;YES1;RPS9;RPS23;RPL24;RPL34;APP;RPS11;MRPL52;RPS3;PLAT;ST3GAL6;MRPS15;ADPRH;DHPS;CHEK2;ST3GAL1;RPS15A;SPCS2;RPL23A;RPL21;RPL35;PROC;MSRA;QPCT;UBE2G1;FBXO22;GAS6;APH1A;NTAQ1;CALU;HARS2;PRKDC;WARS1;YME1L1;LCMT1;MELTF;PRSS23;RPL19;RPL38;CKAP4;RPL36;RPSA;SEPHS1;MGAT4A;RPL26;RPS8;RPL15;RPL10;MIA3;UBE2D3;MSRB3;RPL32;RPS2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.48741618686606303,-1.1829293714292535,0.2601626016260163,0.6278595334861788,1.0,1/11,4.87%,MALT1
prerank,cellular response to lipid (GO:0071396),-0.2649868418458349,-1.1828762557956634,0.08133971291866028,0.6269733789425627,1.0,46/191,18.87%,ATP1A2;EGFR;ADCY5;TFPI;PABPN1;ADCY2;WNT5B;BRINP1;ADCY1;MAPK14;PID1;AXL;PTK7;VIM;RHOA;MED1;ROCK2;LBP;IRAK1;ATP1A1;CDC73;BRINP2;SNW1;TRIM41;NFKB1;EPHA3;NCOA4;SIRPA;WNT9A;ATM;RORA;SETX;PAF1;PDE4B;GPLD1;SPP1;SELENOS;UPF1;DEFA6;ABL2;NR3C1;FZD4;TWF2;ATP1A3;MSN;CHMP5
prerank,sphingosine metabolic process (GO:0006670),0.4647279902357476,1.1827271562815052,0.24584103512014788,0.9586199720853354,1.0,5/17,13.89%,ACER2;PLPP1;SGPP2;ACER3;SGPP1
prerank,bile acid biosynthetic process (GO:0006699),-0.3943669805128911,-1.182665930107863,0.20140515222482436,0.6265447069273531,1.0,5/24,10.21%,OSBPL9;OSBPL6;CYP27A1;CYP7B1;OSBP
prerank,positive regulation of GTPase activity (GO:0043547),0.3060325645871265,1.181794281798024,0.15243101182654403,0.9605839362752425,1.0,46/188,15.63%,EZH2;PIN1;TIAM1;EVI5L;ARHGEF26;TBC1D30;BCAR3;TBC1D8;RALGAPA2;RGS8;TBC1D9;ARHGAP25;TBC1D10B;USP6NL;ARHGEF7;TBC1D4;RALGAPB;RAPGEF3;F11R;RABGAP1L;RGS10;RAP1GDS1;CCL25;RAPGEF6;DOCK9;ITGA6;TBC1D12;TSC1;RAB11FIP2;TBC1D25;DOCK7;RHOG;PICALM;NF1;AGRN;ADPRH;MAP4K4;LARS1;TBC1D14;RABGAP1;RALGAPA1;SYDE1;ARHGEF10;DOCK8;RAB3GAP1;CDKL5
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.2822902421248806,-1.1817823709448758,0.09473684210526316,0.6278667276171758,1.0,25/128,10.15%,DDX5;BMP6;TGFBR3;COL1A2;SMAD3;COL3A1;SMURF2;TGFBR1;RGMA;TGFBR2;BMP5;BMP7;SMAD4;RHOA;BMP4;PRKCZ;PXN;APPL2;ITGB5;SKI;SMAD6;ZFYVE16;ACVR1;HIVEP1;RGMB
prerank,triglyceride biosynthetic process (GO:0019432),0.4572405199359208,1.1816919641678418,0.2380038387715931,0.9590811560028198,1.0,3/18,6.73%,PCK1;GPAM;GPAT4
prerank,regulation of urine volume (GO:0035809),-0.500091009383585,-1.1814251078986917,0.27125506072874495,0.6278911243884148,1.0,7/10,46.40%,NPR3;NPR1;INPP5K;ADCY6;ADM;HYAL2;HAS2
prerank,protein polyubiquitination (GO:0000209),0.29338225626230063,1.1801927487521626,0.1272294887039239,0.9633688241756189,1.0,73/297,16.68%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ARIH1;ANAPC2;KLHL3;TNFAIP3;SPOP;RFFL;BIRC2;PSMD11;NEDD4L;ANKRD39;NHLRC1;RBBP6;PSMB4;FBXL5;UBE3A;ANAPC13;TRIM14;PSMC1;FBXW2;TRAF5;RNF187;LMO7;UBE2V2;FBXO32;TTC3;AKTIP;FBXO11;TRAF3;ANAPC7;RBCK1;MDM2;PSMC2;UBE3D;PSMD2;RNF6;ZNRF1;FBXO7;UBE2V1;CHFR;ANAPC11;TNKS;IFI27;ANAPC10;ANAPC4;CUL3;PSMD14;UBE2R2;RNF146;RNF216;PSMC6;PSMD1;PSMB1;TRIM27;RNF20;TRIM3;NHLRC3;UBE2G1;FBXO22;RMND5A;RNF114;TAF1;PELI1;KLHL42;RNF125;UBE2H;PSMA4;FBXL20
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.4380989088323308,-1.1800094901418408,0.24836601307189543,0.6309448331068083,1.0,6/17,9.11%,IGF1;NTRK2;RTN1;SORL1;ROCK1;BIN1
prerank,aminoglycan biosynthetic process (GO:0006023),-0.33310723346547977,-1.179529597176052,0.1751412429378531,0.6313170972689316,1.0,18/49,21.73%,GPC6;HS3ST5;HS6ST2;SDC2;HS3ST3A1;GPC3;HSPG2;HEXA;GPC5;SLC35D2;UGDH;B3GALT5;B3GALNT1;HS3ST3B1;B3GALT1;NDST2;GPC4;SDC3
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.41338313634506435,1.1791273314800563,0.24315068493150685,0.96583044893343,1.0,9/29,11.13%,GPAM;SRARP;VPS11;CNOT2;AXIN1;PAK1;WBP2;ESR1;CARM1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3128364318835391,1.179124716601744,0.16334661354581673,0.9638726364982634,1.0,31/149,14.10%,MAP3K7;TAB2;PRKCH;RPS6KA4;TIRAP;TRIM8;PRKD2;RPS6KA5;RAB7B;TRIM14;CIB1;EP300;CARD16;TRAF5;CLOCK;TAB3;TRIM25;WNT5A;RELA;RBCK1;UBE2V1;RNF25;APP;NOD1;RPS3;PRKCI;IKBKB;ERC1;CHUK;NFKBIA;TRIM27
prerank,nuclear pore complex assembly (GO:0051292),-0.5090862822154327,-1.178879134521969,0.2815734989648033,0.6320715462628383,1.0,5/10,27.49%,NUP205;AHCTF1;NUP93;TMEM170A;NUP153
prerank,DNA recombination (GO:0006310),-0.35927074406292936,-1.1787554466286057,0.1919191919191919,0.6313909183449666,1.0,19/37,33.56%,TSN;RAD50;MRE11;RPA1;RAD51D;MSH2;BLM;SUPV3L1;RECQL;RTEL1;DMC1;RAD21;RPAIN;RHNO1;RAD54B;RAD51C;IGHMBP2;ERCC1;HMGB1
prerank,presynapse organization (GO:0099172),-0.5123002282822217,-1.1785693301382565,0.28489483747609945,0.6308325841486652,1.0,6/10,27.81%,LRRTM3;NLGN2;NLGN1;DVL1;NLGN3;FZD1
prerank,triglyceride homeostasis (GO:0070328),0.4265847491379489,1.178468885704332,0.26455026455026454,0.9646495086102271,1.0,5/26,11.85%,FITM2;APOE;SIRT1;PNPLA8;SCARB1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.47922627379772986,1.1782344977125363,0.286231884057971,0.9637215603748295,1.0,2/15,3.44%,CIDEA;FITM2
prerank,response to interferon-alpha (GO:0035455),0.46529404052529166,1.1781331821995826,0.2589928057553957,0.9621938831074033,1.0,6/16,9.96%,IFITM2;RO60;IFITM3;ADAR;IFITM1;IFNAR1
prerank,regulation of vacuole organization (GO:0044088),0.4403699851020314,1.1780629032470582,0.2710951526032316,0.9605365010201555,1.0,7/20,16.58%,ENO4;PIKFYVE;TBC1D12;ADPRH;TBC1D14;LAPTM4B;UBQLN2
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.4497468649196241,-1.1778013171596664,0.26401869158878505,0.6319239297342,1.0,5/14,16.95%,SEC31A;SEC24D;SEC23A;SEC24C;SEC24A
prerank,endochondral bone morphogenesis (GO:0060350),-0.4951698890010067,-1.1774754109452168,0.2574468085106383,0.6318417840182599,1.0,6/11,19.93%,BMP4;COL13A1;FOXC1;INPPL1;BMPR1B;BMPR2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4539545178428918,1.1771649970677591,0.2764811490125673,0.9622337376301087,1.0,8/18,18.22%,TEK;CYRIB;RIPOR2;KRIT1;RUFY3;CDH5;PTK2B;ARFGEF1
prerank,dicarboxylic acid transport (GO:0006835),-0.3830906620677954,-1.1770467628373464,0.21614583333333334,0.6320116358599646,1.0,9/28,15.92%,SLC1A3;SLC13A3;PDPN;SLC26A7;SLC25A13;SLC25A32;GJA1;SLC22A6;SLC19A1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.24660751658099367,-1.1770226606547578,0.051470588235294115,0.6310833992636673,1.0,63/348,13.65%,MAGI2;ANK2;BMP6;NTRK3;ANK3;RIMS1;SLC24A3;IGF1;ROBO1;GSN;SMAD3;AHI1;ITGB8;FOXD1;NTRK2;ANXA2;FGF1;TGFBR1;MAPK14;PID1;OCLN;MED26;BMP7;PRKAG1;MED1;BMP4;PPARGC1A;ROCK2;OSR1;SMO;F3;EPB41L4B;ADAM19;ROCK1;HOXA5;MPHOSPH8;FUBP3;PIK3R3;EZR;UBR5;TLE1;AGO3;AFDN;PLSCR1;GSK3B;GJA1;EPHB2;CAMK2N1;FN1;CUX2;TP53;FAM98A;CD34;DDRGK1;IFNGR1;RPS7;SNF8;SCYL2;PDCD5;SETDB2;IL33;HINFP;ATM
prerank,regulation of DNA recombination at telomere (GO:0072695),0.45459279031402283,1.1770023099899007,0.24179620034542315,0.9590044860961714,1.0,3/19,8.57%,POLR2J;POLR2B;ACD
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.45459279031402283,1.1770023099899007,0.24179620034542315,0.9590044860961714,1.0,3/19,8.57%,POLR2J;POLR2B;ACD
prerank,nucleotide-excision repair (GO:0006289),0.3268107514032319,1.1769848205738485,0.18155619596541786,0.9571773493504342,1.0,17/101,11.28%,POLR2J;ERCC3;POLR2B;PNKP;CCNH;ERCC4;XRCC1;POLK;EP300;POLE;SIRT1;POLD3;GTF2H1;POLA1;RAD23A;COPS7B;HUS1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.4764249137164215,1.1767354891073065,0.27340823970037453,0.956302786151145,1.0,3/17,5.08%,SORT1;HDAC9;LMF1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.3932696926906527,1.1767055572988567,0.23344947735191637,0.9545137346241365,1.0,6/34,8.56%,CCDC85B;TRIB3;BBS12;TRIO;SIRT1;WNT5A
prerank,positive regulation of T cell migration (GO:2000406),0.45055348269980044,1.1764718178635887,0.2585278276481149,0.953553811845468,1.0,5/20,15.24%,OXSR1;CXCL12;WNT5A;APP;DOCK8
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.4994958206865284,1.1759103845420418,0.26857142857142857,0.9539059560858245,1.0,3/13,6.39%,PRPF31;PRPF3;SRSF10
prerank,T cell differentiation (GO:0030217),0.3913714006755113,1.1755891314347193,0.22061191626409019,0.953259428155996,1.0,8/40,11.50%,JAG2;PTPRC;ZFP36L1;GPR89A;GPR89B;SOX13;LFNG;PIK3CD
prerank,regulation of cell migration (GO:0030334),-0.24639188032397255,-1.1747415238267593,0.05785123966942149,0.6365198742376001,1.0,76/382,14.16%,MAGI2;NAV3;ERBB4;NTRK3;LDLRAD4;TMEFF2;IGF1;SULF1;PLXNA2;ROBO1;CTNNA2;SASH1;DAB2;EGFR;LMO4;COL1A1;SYNE2;DPYSL3;PDGFRB;SEMA3D;NTNG1;IGFBP5;WNT5B;FGF1;TGFBR1;CLIC4;PDPN;TPM1;MACF1;FER;RHOA;FLNA;NEDD9;CEMIP;AMOTL2;KIT;MMP14;ROCK2;LMNA;NKD1;SMO;APPL2;VCL;F3;SORL1;PDGFRA;ROCK1;LDB1;PODN;SEMA3A;AKT2;PIK3R3;SRCIN1;DOCK10;ARSB;ULK4;SPATA13;ACVR1;THBS1;AFDN;SGK1;CDH1;EPHB2;SEMA4D;DDRGK1;ANXA1;TTBK2;RHOB;TBCCD1;MYADM;PLXND1;NF2;DUSP22;ATM;ROR2;RACK1
prerank,protein transport (GO:0015031),0.2890584756734774,1.1747202337755678,0.10177514792899409,0.9550524158152188,1.0,67/332,13.25%,ARF5;MIA2;ZDHHC17;ARL5C;ARL4D;EVI5L;PPT1;PREPL;RAB5C;TBC1D30;TBC1D8;ATP6V1D;SLC10A7;SNX8;VPS29;RAMP2;APOE;RAB7A;TBC1D9;TMED4;VPS26A;SEC23IP;RAB43;RAB11B;ATP6V0D1;COPG2;TBC1D10B;USP6NL;TBC1D4;RAB6B;CHMP1A;VMP1;NAPA;TMED5;IFT22;RABGAP1L;SNX17;RAB6A;TMED10;RAB14;ATP6V0E1;ACD;DNAJC27;TBC1D12;SNX1;ARL5B;ARF1;RAB1A;GOLPH3L;GCC2;CHMP2A;TBC1D25;PPY;KIF13A;ATP6AP1;TMED7;SCFD1;RAB5B;RAB22A;ADPRH;ARCN1;COPG1;TBC1D14;SCAMP1;YWHAH;KIF3B;RABGAP1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4593065245559553,1.1742259355901445,0.2690166975881262,0.9552414395058045,1.0,5/17,11.25%,SOD1;SFPQ;SIRT1;SOD2;UBQLN1
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.3343073609881889,-1.1740600317363257,0.18413597733711048,0.6373555591607492,1.0,7/47,9.68%,SPOCK3;TIMP3;SPOCK1;TIMP2;SORL1;BIN1;VTN
prerank,peroxisome organization (GO:0007031),0.42493560161347754,1.1740527802185161,0.24909090909090909,0.9540797999550884,1.0,8/25,17.12%,PEX11G;PLAAT3;PEX1;PEX7;TMEM135;ACOT8;DNM1L;LONP2
prerank,histone acetylation (GO:0016573),0.3553279715984171,1.1735625750110472,0.2006125574272588,0.9541912696845173,1.0,16/69,14.00%,JADE3;ACTL6A;LEF1;MAP3K7;RUVBL2;DMAP1;ING4;BEND3;EP300;RUVBL1;YEATS4;ING3;CREBBP;TRRAP;ING5;DR1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.30255249945025714,-1.1732799002835284,0.16507936507936508,0.6384945059766786,1.0,19/76,16.83%,UACA;NFAT5;SASH1;EGFR;CYLD;RASSF2;BMP7;RHOA;PPM1B;IRAK1;EZR;EIF2AK2;ILK;PPM1A;NR3C2;DLG1;PTPN22;CCN3;RTKN2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.28265714133151504,-1.1732194486040544,0.1213235294117647,0.6376409260506285,1.0,34/122,19.13%,SORBS1;IGF1;PLD1;SAMD4A;EGFR;PDGFRB;GLI2;KAT7;VIM;LDB1;SLC6A9;AKT2;POLDIP3;PRR16;EIF3C;YTHDF1;NIBAN1;SMOC2;THBS1;STN1;NFKB1;EEF2;RBM3;BRPF3;IL33;ATAD5;IGF2;PLXNB2;METTL5;NAT10;PCIF1;UPF3A;RPS6KB1;CIRBP
prerank,antibacterial humoral response (GO:0019731),0.47576872866730857,1.1728632972328459,0.2667946257197697,0.955152282792192,1.0,2/16,4.64%,DMBT1;RNASE6
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3639763413452467,-1.1723480627384006,0.2302158273381295,0.6390699971713755,1.0,11/28,18.74%,TNS2;PID1;PRKCZ;ENPP1;APPL2;PRKCD;PIP4K2B;GRB10;PTPN2;TSC2;RPS6KB1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.30290138509805375,-1.1721084282413299,0.14420062695924765,0.6386928180762929,1.0,20/69,16.54%,IGF1;OGT;PDGFRB;PLCL2;RHOA;PLCE1;PIK3C2B;SIRT2;PIK3C3;MYO16;PDGFRA;PLCD3;EZR;PLCB3;GAB2;PLCH1;PLCL1;NGF;EXOC1;PLCD1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5206996193881104,1.1718883185213516,0.25851703406813625,0.9572715045582136,1.0,3/11,9.71%,ZRANB3;FBXO5;MSH3
prerank,regulation of protein neddylation (GO:2000434),0.5236247460344681,1.1718006693164882,0.26705653021442494,0.9558126086906367,1.0,5/10,16.97%,DCUN1D4;RPL5;EPAS1;DCUN1D2;DCUN1D1
prerank,regulation of peptide hormone secretion (GO:0090276),-0.31311244639316327,-1.1717139903691056,0.1976401179941003,0.6387799622215902,1.0,9/67,7.24%,HTR2C;CACNA1C;ITPR1;SNAP25;CACNA1D;KCNC2;PER2;DPP4;ENSA
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3276632822011352,-1.170997004010806,0.18075801749271136,0.6398880414608048,1.0,22/51,24.21%,LPAR1;NRP1;ARHGEF10L;CCN2;TGFBR1;TPM1;RHOA;PXN;ROCK2;PPM1E;SYNPO2;FHOD1;NF2;ARHGEF5;CDC42;CX3CL1;PPM1F;PFN2;ARHGEF15;RHOC;ITGB1BP1;TGFB3
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2907753738762433,1.1706576083438371,0.1242672919109027,0.958504532153655,1.0,80/314,18.06%,FBXL6;PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;ANAPC2;DERL2;FEM1C;SPOP;UBXN11;RFFL;BIRC2;PSMD11;NEDD4L;YOD1;NHLRC1;PSMB4;FBXL5;WFS1;PSMC1;FAM8A1;SGTB;COP1;FBXO5;SIRT1;CLOCK;RNF187;TRIM25;CRBN;ANAPC7;RBCK1;MDM2;RAD23A;AUP1;PSMC2;UBE3D;PSMD2;ZNRF1;RHBDD2;ERLIN2;STT3B;SPOPL;UBQLN1;ANAPC11;IFI27;ANAPC10;PLAA;ANAPC4;CUL3;PSMD14;RNF216;DDIT3;PSMC6;PSMD1;FAF1;APPBP2;PSMB1;TRIM3;NHLRC3;UBE2G1;RMND5A;DNAJC10;TAF1;PELI1;KLHL42;UFD1;UBQLN2;PSMA4;FBXL20;DNAJB14;UBR3;ATXN3;CDC26;RAD23B;UBXN4;KCTD10;AGAP3
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.46747012821971634,1.1704411840177933,0.27171903881700554,0.9575219781468564,1.0,5/15,14.70%,PTTG1IP;SIRT1;MDM2;ING2;CD44
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.41698540249318083,-1.1695071875375709,0.24217118997912318,0.6430122265436303,1.0,11/21,31.78%,CTNNB1;CSNK1A1;DVL3;FZD2;GSK3B;LRP6;DVL1;AMER1;FZD1;PPP1CA;CAV1
prerank,response to exogenous dsRNA (GO:0043330),0.4500985715278088,1.1691206747517104,0.23345588235294118,0.9610064485544995,1.0,3/18,4.17%,RALB;IFIT1;SLC3A2
prerank,positive regulation of protein kinase activity (GO:0045860),0.31103772944196617,1.168832892982133,0.19333333333333333,0.9604164184725662,1.0,26/148,12.33%,LRP8;RALB;EZH2;PTPRC;MTCP1;TAB2;RPTOR;SRC;STOX1;PPP2CA;CIB1;CDKN1A;PAK3;CALM3;LCP2;AXIN1;MINK1;EFNA1;CSF1R;NAB2;PAK1;DDX3X;MMD;PRNP;STRADB;MAP4K4
prerank,dendritic cell chemotaxis (GO:0002407),0.48983665637268925,1.1683502218610708,0.27692307692307694,0.9605174026224481,1.0,2/14,10.54%,PIK3CG;TRPM4
prerank,negative regulation of reproductive process (GO:2000242),-0.44156735431635674,-1.168201855709132,0.2654462242562929,0.6456051297974983,1.0,2/17,0.63%,IGF1;SULF1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.35460002978119165,1.1679998838496735,0.23003194888178913,0.960132776024517,1.0,14/56,13.50%,RPTOR;STOX1;PHB2;RGCC;FBXO5;CDK4;ANAPC7;PLCB1;DDX3X;RAD51B;ANAPC11;ANAPC4;CUL3;ANKRD17
prerank,regulation of response to biotic stimulus (GO:0002831),0.4177005488992993,1.1677122432261733,0.2525597269624573,0.9595250392828975,1.0,4/28,3.83%,LRP8;FCGR2B;TIRAP;BIRC2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.2427308980266139,-1.1675359475982736,0.02564102564102564,0.6464698296318575,1.0,73/390,11.20%,ERBB4;SORBS1;NTRK3;FGFR2;IGF1;SULF1;HNRNPH1;TIA1;EGFR;EPHA6;COL1A1;GRIN2B;EFNA5;AHI1;PDGFRB;CYFIP2;COL4A6;AP2B1;EPHB1;NTRK2;DOCK1;WASF2;SDC2;NRP1;FLRT2;FGF1;WASL;MAPK14;AXL;EFNB2;RYK;ABI1;SULF2;VAV2;FER;EPHA7;RHOA;MTSS1;AP2A2;SIRT2;NEDD9;ROR1;KIT;ATP6V1E1;GHR;PXN;ROCK2;ARPC1A;ATP6V0B;SLC39A14;DDR1;PDGFRA;ROCK1;FRK;AKT2;IL31RA;PIK3R3;UBASH3B;EPHB4;CEP57;AP2A1;FOXC1;ACTR3;ARPC1B;NRP2;SOCS2;GSK3B;EPHB2;KL;EPHA3;HNRNPA1;TCIRG1;ATP6V0A4
prerank,negative regulation of bone remodeling (GO:0046851),0.4976007933647366,1.1669704718308669,0.287378640776699,0.960600862812341,1.0,3/11,10.95%,TNFAIP3;GREM1;P2RX7
prerank,protein kinase B signaling (GO:0043491),-0.3961820298861146,-1.166370226911522,0.24285714285714285,0.6488345144201129,1.0,9/23,24.84%,IGF1;SIRT2;PIK3R3;SETX;TGFB1;TSC2;THEM4;AKT1;PAX2
prerank,positive regulation of growth (GO:0045927),0.3481830279477964,1.1653716737945297,0.22330097087378642,0.9652889562584859,1.0,12/64,10.80%,NCBP1;DERL2;RPS6KA1;RPTOR;WFS1;CIB1;USP47;EXOSC9;LGI1;PLCB1;EIF4G2;DDX3X
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.43892984564636534,1.1646305018983536,0.25448028673835127,0.9664246022602112,1.0,4/20,6.18%,PIN1;PPIB;PPIG;PPIL3
prerank,smooth muscle contraction (GO:0006939),-0.4478103010685035,-1.1646195266076378,0.26126126126126126,0.6528444791480726,1.0,8/14,29.87%,ROCK2;EDNRA;ROCK1;SMTN;BDKRB2;ADRA1A;MYH11;MYLK
prerank,regulation of interleukin-8 production (GO:0032677),0.34549484532824565,1.1645687427240765,0.21375186846038863,0.9648535480282691,1.0,11/69,13.40%,PTPRC;TIRAP;MAP2K5;PRKD2;SYK;RELA;RAB1A;PARK7;NOD1;MAPKBP1;DDIT3
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.469249679230383,-1.1641900589087075,0.2769556025369979,0.6529952193228253,1.0,6/12,35.41%,WNK1;PPARA;AKT1;MDK;ASS1;SKAP1
prerank,regulation of actin filament-based movement (GO:1903115),-0.4900299435727712,-1.1639378261026698,0.2839248434237996,0.652626333516312,1.0,4/10,15.64%,ANK2;PDPN;SRI;PDE4B
prerank,cellular response to radiation (GO:0071478),0.37920090509145077,1.163785171244561,0.2476340694006309,0.9662550543693696,1.0,8/40,11.28%,GPR52;EEF1D;RAD1;CDKN1A;SIRT1;CLOCK;KDM4D;HUS1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.32779345456317904,-1.1633572180597618,0.19889502762430938,0.6531965581238524,1.0,20/48,22.64%,ADCY5;AMPD3;ADCY2;ADCY1;ADCY9;DCAKD;SLC26A2;SLC35B3;PANK3;ADCY7;GMPS;GUCY1A1;PAPSS2;NPR1;ACOT7;AK5;ADCY8;ADCY3;GUCY1B1;ADCY4
prerank,hematopoietic stem cell proliferation (GO:0071425),0.49905961420388534,1.1625455271144023,0.2767676767676768,0.9694811706657808,1.0,2/11,8.56%,MECOM;WNT5A
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.46104281099574307,1.1623494154772747,0.2756052141527002,0.9684482295160667,1.0,2/16,2.28%,GSK3A;PRCP
prerank,cation transmembrane transport (GO:0098655),-0.33799877056055727,-1.1623346687746265,0.1958762886597938,0.655046538844543,1.0,7/44,7.66%,TRPM3;ATP1A2;SLC7A2;ATP1B1;TRPM6;SLC6A9;SFXN2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.38920366519926036,-1.1622142470733012,0.24449877750611246,0.6543123609815695,1.0,5/24,5.65%,LEPR;PID1;COQ10B;PPARGC1A;SLC25A13
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.37907621745351244,-1.1622056900306612,0.24766355140186916,0.653329511136065,1.0,10/30,16.58%,ANK3;VAMP5;MACF1;RAB31;GGA2;OPTN;VAMP2;BBS2;GOLGA7;GGA3
prerank,phospholipid homeostasis (GO:0055091),-0.47984589083503293,-1.1621677624381532,0.2569593147751606,0.6524215430613134,1.0,3/11,14.41%,TLCD2;ABCA1;RCN3
prerank,negative regulation of cell communication (GO:0010648),-0.40615418531373026,-1.161590688043365,0.2541966426858513,0.653010420489712,1.0,5/21,17.46%,UBASH3B;GLRA1;ACVR1;OPRM1;SOCS5
prerank,response to insulin (GO:0032868),0.3374550601124924,1.1614827365376827,0.23273273273273273,0.970311826328286,1.0,17/80,13.21%,PCK1;GSK3A;TRIB3;INSIG1;SORT1;HDAC9;ZFP36L1;MYO5A;TBC1D4;SIRT1;IRS2;EPM2AIP1;TSC1;RHOQ;ZBED3;PRKCI;HDAC5
prerank,negative regulation of phosphorylation (GO:0042326),-0.29645670678418556,-1.161479492246965,0.1875,0.6523363195519319,1.0,17/85,8.75%,NTRK3;PTPN13;HDAC4;SH3GL2;FBLN1;PID1;MAPT;OCLN;BMP7;PLPP3;BMP4;NUPR1;ROCK1;PPARA;XDH;CDKN1B;NIBAN1
prerank,exit from mitosis (GO:0010458),0.4917904671686748,1.1614780136073521,0.2572992700729927,0.9684913236290672,1.0,3/12,10.23%,PPP2R2D;CLASP2;CHMP2A
prerank,positive regulation of cell aging (GO:0090343),0.5170248449942362,1.161254887541686,0.3005671077504726,0.967548754232849,1.0,3/11,7.73%,B2M;SIRT1;YPEL3
prerank,regulation of neuroblast proliferation (GO:1902692),-0.4462054697699275,-1.1608477559092758,0.25,0.653063039069548,1.0,10/15,33.70%,TAFA1;CTNNB1;SMARCD3;DISC1;KDM1A;CX3CL1;VEGFA;CX3CR1;DRD2;PTN
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.30877213433472755,1.1605334065093795,0.1651006711409396,0.9687505805282073,1.0,32/166,13.57%,POLR2J;MAZ;ERCC3;MAPK3;NR4A2;POLR2B;POLR1C;GTF3C1;HDAC7;HDAC9;HDAC3;NR5A1;CCNH;MED23;PPARD;POLR1G;NOTCH1;NRBF2;GTF2H1;RSF1;NRBP1;TAF15;ESR1;THRB;RBPJ;GTF2A2;CREBBP;E2F3;TAF4B;TBP;HDAC5;THRA
prerank,integrin-mediated signaling pathway (GO:0007229),-0.2982786302297932,-1.1604915000010196,0.1846590909090909,0.6530613647635897,1.0,16/73,11.33%,ITGBL1;DAB2;ITGB8;DOCK1;COL3A1;FBLN1;NRP1;PLPP3;NEDD9;TEC;ITGB5;ITGA5;ADAMTS1;ITGA11;FN1;ILK
prerank,regulation of neutrophil migration (GO:1902622),0.5163270867770147,1.1604478329008272,0.2945590994371482,0.9672623037977005,1.0,2/10,11.05%,RAC2;RHOG
prerank,regulation of phosphatase activity (GO:0010921),0.4270399614478265,1.1604189227551218,0.2512998266897747,0.9655536892352188,1.0,5/24,14.98%,PPP1R36;TIPRL;TSC1;PTPA;PPP6R1
prerank,sensory perception (GO:0007600),-0.3363787078688731,-1.1602044491052015,0.2198952879581152,0.6528788697006228,1.0,14/45,26.66%,PCDH15;ADGRV1;P2RX4;TTC8;GNAL;WHRN;PTGES;OPRM1;KCNA2;TMEM150C;ADORA2A;NIPSNAP1;CHRNA7;TRPV2
prerank,positive regulation of hydrolase activity (GO:0051345),0.3131385575622653,1.159400048421903,0.1952191235059761,0.9678834988287297,1.0,27/137,13.09%,EZH2;PIN1;EVI5L;TBC1D30;BCAR3;RGS8;MAPK8;USP6NL;ARHGEF7;CALM3;RAPGEF3;F11R;RGS10;RAP1GDS1;CCL25;RAPGEF6;DOCK9;ITGA6;RAB11FIP2;RPS3;PICALM;NF1;AGRN;MAP4K4;LARS1;MAPK12;NDUFA13
prerank,negative regulation of B cell activation (GO:0050869),0.4333702583659028,1.1593713968059278,0.2867513611615245,0.9662057091516024,1.0,4/21,9.31%,TNFAIP3;FCGR2B;SAMSN1;LYN
prerank,neurotransmitter transport (GO:0006836),-0.30341373517318443,-1.1591844215056246,0.2,0.654790603322338,1.0,19/73,14.04%,ATP1A2;RIMS1;SNAP25;SLC1A3;NRXN1;SYN2;GABRA2;PTPRN2;PPFIA1;GLUL;SYN1;BRSK1;NRXN2;APBA1;STXBP1;SNPH;UNC13B;SLC6A15;VAMP2
prerank,negative regulation of viral life cycle (GO:1903901),0.47670335034430167,1.1590812385752112,0.2922794117647059,0.9655690656178835,1.0,4/15,8.83%,LY6E;IFITM2;IFITM3;IFITM1
prerank,defense response to bacterium (GO:0042742),0.3220755861756337,1.1584115241145223,0.20402298850574713,0.9664858929020321,1.0,11/105,9.48%,ROMO1;RPL30;DMBT1;TIRAP;RNASE6;STAB1;GBP4;SELP;SYK;PPP1R11;RAB1A
prerank,regulation of AMPA receptor activity (GO:2000311),-0.3806068022369625,-1.1579097852381908,0.22355769230769232,0.657284099322271,1.0,13/25,24.78%,SHISA9;NLGN2;RELN;SHISA6;NLGN1;CACNG7;CACNG4;CACNG2;SHANK1;PRRT1;NLGN3;CACNG3;CACNG8
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3310818856830409,1.157787659938461,0.21470588235294116,0.9672483796549968,1.0,18/93,11.77%,MAP3K11;FCGR2B;TIRAP;HIPK2;MAP3K4;EDAR;TRAF5;AXIN1;KLHDC10;MTURN;MINK1;TRAF3;SEMA4C;PJA2;PLCB1;MFHAS1;APP;RELL1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4298727638851521,1.157719550210788,0.26383763837638374,0.9657636823338014,1.0,6/23,13.09%,TIMM29;ROMO1;BAD;MAIP1;BMF;NDUFA13
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.45235908582561246,1.1571682687983345,0.2933579335793358,0.9661631408065601,1.0,5/17,10.77%,SOD1;APOE;LPCAT3;MBTPS1;ERLIN2
prerank,engulfment of apoptotic cell (GO:0043652),0.4598940801880159,1.1570800041771396,0.28867924528301886,0.9646977700049643,1.0,2/15,0.45%,RAC2;XKR8
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4381135166186818,1.1569361648182772,0.2857142857142857,0.9635508950387812,1.0,5/19,11.21%,AEN;HIPK2;EP300;SIRT1;CDIP1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3401265850894942,1.156063351254508,0.24205748865355523,0.9654071544462203,1.0,11/75,9.68%,RGS2;PRKAR1A;DUSP7;PTPRJ;CDK5RAP1;APOE;SIRT1;RASIP1;LATS2;LYN;TFAP4
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.4920593040227652,1.15603045086329,0.2894248608534323,0.9637517319269466,1.0,4/13,10.70%,INSIG1;TMEM30B;GCC2;CD81
prerank,postsynaptic membrane organization (GO:0001941),0.45747628519448214,1.1555404150150814,0.2857142857142857,0.9639670922527009,1.0,4/17,4.59%,GPHN;SHANK3;DNAJA3;APOE
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3064246669398881,1.1554996117733423,0.19972451790633608,0.9623287569586088,1.0,19/144,7.75%,RAC2;GSK3A;PRR5L;RBM22;TRIM28;SAE1;DMAP1;TCAF1;HDAC3;VPS11;FYN;ZFAND1;CIB1;MAPK8;ICE1;YWHAB;RAPGEF3;TMEM30B;RUFY3
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.482020683596385,-1.1553658800922662,0.28105906313645623,0.6624037784628337,1.0,3/12,2.15%,IGF1;AKAP6;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.482020683596385,-1.1553658800922662,0.28105906313645623,0.6624037784628337,1.0,3/12,2.15%,IGF1;AKAP6;CAMTA1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.431815249831748,1.1546501210005375,0.3010948905109489,0.9640535588934067,1.0,5/21,4.52%,NDST3;XYLT1;SGSH;EXT2;HS6ST1
prerank,actin filament bundle assembly (GO:0051017),-0.3584399423493177,-1.1544513009611446,0.23577235772357724,0.6639804784733141,1.0,13/33,26.91%,CALD1;PAWR;DPYSL3;LIMA1;NEDD9;EZR;BAIAP2L1;MYO1B;ADD2;PLS1;DMTN;FAM107A;MICAL1
prerank,glucose transmembrane transport (GO:1904659),0.45758876792786063,1.1544456548942892,0.28545780969479356,0.9631385383127459,1.0,3/18,8.35%,SORT1;PPARD;SLC2A1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.37717796621657534,-1.154088177880122,0.24330900243309003,0.6641293195981443,1.0,7/27,5.82%,TMEFF2;PHLDB2;CGNL1;WASF2;ARHGAP28;PPFIA1;ARHGAP6
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.4480807232952007,-1.1534112318245053,0.2727272727272727,0.6650965300221916,1.0,8/14,27.57%,LPIN1;CHKA;SLC27A1;ETNK2;PCYT2;LPIN2;CHKB;LPIN3
prerank,regulation of cell differentiation (GO:0045595),0.3104268257069752,1.153397955815792,0.20767195767195767,0.9656232240000402,1.0,26/148,12.07%,SPOCK2;PTPRQ;TIAM1;OCIAD1;RPS6KA1;GREM1;LTBP4;CLASP2;BCL6B;BIRC2;PPP2CA;ZFP36L1;HEY1;CDK5RAP1;SINHCAF;SLC6A6;TBX1;BDNF;SMAD7;HEY2;DAG1;TRPS1;CREBBP;PA2G4;PTBP1;NF1
prerank,metal ion homeostasis (GO:0055065),0.3767862650249059,1.1532400310676936,0.26101694915254237,0.9645312091678249,1.0,4/40,5.19%,SLC12A1;SLC7A8;TMTC2;WFS1
prerank,negative regulation of signaling (GO:0023057),-0.39204888090332546,-1.1528231130010114,0.25870646766169153,0.6658357990225378,1.0,6/25,17.46%,UBASH3B;GLRA1;ACVR1;OPTN;OPRM1;SOCS5
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.3772247482377076,-1.151807241972836,0.23134328358208955,0.6676481333748799,1.0,15/26,38.12%,B4GALT1;OGN;B4GALT6;SLC35D2;ST3GAL4;PRELP;LUM;B4GALT4;CHST2;OMD;B4GALT3;B4GALT2;B4GALT5;FMOD;CHST1
prerank,cellular response to hydroxyurea (GO:0072711),-0.5032076086608852,-1.1517297833556701,0.30721649484536084,0.6668401396325474,1.0,7/10,38.96%,SPIDR;DDI2;RTF2;BLM;DDX11;NSMCE3;TIMELESS
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.47213150524425423,1.151517717443945,0.29444444444444445,0.9697939441058195,1.0,4/14,11.52%,PRKD2;RELA;CD81;RPS3
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3892236710551381,-1.1514096822617754,0.2753303964757709,0.6666826085961504,1.0,4/24,6.94%,HTR2C;ITPR1;RYR3;ERO1A
prerank,blood vessel endothelial cell migration (GO:0043534),-0.3900008688440839,-1.1511590736074278,0.25925925925925924,0.6664009241946818,1.0,10/22,25.90%,ROBO1;NRP1;EFNB2;PIK3R3;EPHB4;GPLD1;VEGFA;EMP2;AKT1;NR4A1
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.39231346278572954,-1.1510036843308176,0.2747747747747748,0.6658558644577568,1.0,10/24,30.95%,TRAF3IP2;AIM2;PTPN22;MAVS;STAT1;DTX3L;HSP90AA1;ZC3H12A;TOMM70;PARP9
prerank,regulation of type I interferon production (GO:0032479),0.3314740140998512,1.1509996354315046,0.22451994091580502,0.9700484595996601,1.0,19/84,13.48%,LRRFIP1;PIN1;TNFAIP3;POLR1C;TIRAP;EP300;TRIM25;TRAF3;RELA;POLA1;TRAF3IP1;CREBBP;POLR3F;OTUD5;DTX4;NLRP4;NLRC5;RNF216;POLR3B
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.37736952159470816,-1.1504273118007098,0.2660332541567696,0.6664579614380657,1.0,8/26,11.85%,FOXP1;DAB2;KANK2;HDAC1;CRY2;CNOT9;CRY1;PER1
prerank,negative regulation of immune system process (GO:0002683),0.4532082834529008,1.150241453201695,0.30654205607476637,0.9713478735603331,1.0,3/16,9.31%,FCGR2B;HOXA7;LYN
prerank,positive regulation of response to stimulus (GO:0048584),0.38112027455044584,1.1500678334397398,0.27107438016528923,0.9702863326100657,1.0,7/40,9.37%,FCGR2B;B2M;FXR1;SIRT1;YPEL3;WNT5A;BCLAF1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.46628565563646795,-1.1500605158263042,0.29411764705882354,0.6664906004735888,1.0,3/12,7.03%,SORBS1;IGF1;AKT2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.3985357800676221,-1.1499840821908338,0.2408256880733945,0.6657238535177284,1.0,4/22,5.44%,MBP;WNK1;BMP7;FLOT2
prerank,icosanoid biosynthetic process (GO:0046456),-0.48976223944523456,-1.1497228165783668,0.300796812749004,0.6654846854196581,1.0,1/10,1.27%,PLA2G4A
prerank,response to histamine (GO:0034776),-0.5079295367660326,-1.1496827189837004,0.30145530145530147,0.6646303701186144,1.0,3/10,17.49%,GABRB1;GABRG2;DIAPH1
prerank,chloride transmembrane transport (GO:1902476),-0.3227881240372113,-1.1494059793855647,0.20630372492836677,0.6644036844431396,1.0,25/48,27.26%,GABRB1;SLC1A3;GLRB;GABRA2;ANO3;SLC6A1;SLC12A2;GLRA3;GABRG2;GLRA1;ANO1;ANO6;SLC12A6;GABRA5;SLC12A4;GABRG3;GABRA4;SLC12A9;GABRG1;SLC4A8;GABRA1;SLC12A7;LRRC8A;SLC12A8;SLC12A5
prerank,artery morphogenesis (GO:0048844),-0.36472505672944633,-1.1491750016252726,0.24120603015075376,0.6641220071907057,1.0,6/30,5.49%,LRP1;PDGFRB;NRP1;TGFBR1;BMP4;ADAMTS9
prerank,regulation of protein localization to cell surface (GO:2000008),0.3855194212402136,1.1489406251959546,0.25967741935483873,0.9731272408598047,1.0,8/33,8.20%,NEDD4L;RAB11B;GOPC;LEPROTL1;RIC3;BDNF;RAB11FIP5;TMEM35A
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3741659333365219,1.1488620013867974,0.25254237288135595,0.9717004599905987,1.0,4/38,4.40%,RAC2;GSK3A;SAE1;VPS11
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.384413197732831,1.1487377696364585,0.275,0.9704360373060023,1.0,10/36,15.61%,MAZ;NR4A2;SGMS1;CRADD;BDNF;RPS3;PTPMT1;ING5;CSNK2A2;TPD52L1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3938226379852031,1.148721399557449,0.2707641196013289,0.9687462294946844,1.0,6/34,7.28%,RGS2;PIK3CG;PDE4D;ATP2A2;CALM3;SMAD7
prerank,regulation of ATP metabolic process (GO:1903578),-0.31440102650922647,-1.14834483588417,0.19946091644204852,0.6654514316036538,1.0,23/54,24.95%,PRKAG2;OGT;PRKAG1;ATP7A;NUP205;NUP155;FIS1;NUP188;NUP88;NUP93;SEH1L;COX7A2L;ATP5IF1;NUP85;AAAS;RAE1;SLC25A33;PINK1;NUP37;NUP214;PGAM1;UQCC2;SEC13
prerank,response to cytokine (GO:0034097),-0.26684107737604656,-1.1481845112303937,0.13127413127413126,0.6649302086208729,1.0,30/141,13.88%,AFF3;NFAT5;PTPN13;ALDH1A2;TIMP3;AKAP6;SMAD3;DPYSL3;TIMP2;COL3A1;HDAC4;PTPN14;OSMR;PID1;IFNAR2;RHOA;IL6R;PML;IRAK1;KLHL20;IRAK3;EIF2AK2;PLSCR1;REL;IKBKE;ANXA1;IL1RAPL1;RELB;GGT5;IL6ST
prerank,protein oxidation (GO:0018158),-0.492508656631014,-1.1476712837567964,0.29694323144104806,0.6653543425785869,1.0,5/11,25.72%,LOXL1;SUMF1;LOXL3;LOX;PRDX3
prerank,replicative senescence (GO:0090399),0.48840139321545994,1.147647599160663,0.32432432432432434,0.971195820668128,1.0,5/12,15.85%,ROMO1;MME;TERT;CHEK2;ATR
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.29295609705016445,-1.1475721006142448,0.20972644376899696,0.6646285503548348,1.0,16/79,10.48%,SULF1;ADAMTS12;NBL1;BMPER;SMURF2;SMAD4;SULF2;VWC2L;CRIM1;SORL1;SKI;HTRA3;SMAD6;NIBAN2;THBS1;SPART
prerank,regulation of vasoconstriction (GO:0019229),-0.3724121267994328,-1.1467221298894354,0.27045454545454545,0.6659694519368236,1.0,15/27,38.43%,PER2;ADRA1B;CHRM3;ZDHHC21;ACE;BDKRB2;AGTR1;BMPR2;ADRA1A;CAV1;TBXA2R;KCNMB4;ADM;ACE2;AGT
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3440804271005765,1.1464403511367711,0.23716012084592145,0.974229540098679,1.0,8/62,9.35%,POLR2J;ERCC3;NCBP1;ELOC;POLR2B;CCNH;GTF2H1;PCID2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.3202520264433198,-1.1460230225534733,0.21508379888268156,0.6670071156918039,1.0,20/52,24.74%,SORBS1;LRP1;EGFR;ZDHHC5;STX3;DPP10;EPHB2;EPHA3;CLIP3;DLG1;WNK3;RACK1;CNST;ZDHHC8;PIK3R1;NKD2;CLN3;PLS1;AKT1;SPTBN1
prerank,organelle fission (GO:0048285),0.4126837956263637,1.1460109077156309,0.28547008547008546,0.9743159313239019,1.0,7/24,17.28%,PEX11G;DNM3;MTFR1;ACOT8;MIEF1;DNM1L;CORO1C
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.37986242607808235,-1.1459202724698763,0.2540045766590389,0.666318825557361,1.0,4/26,6.94%,HTR2C;ITPR1;RYR3;ERO1A
prerank,mitochondrial translational termination (GO:0070126),0.3280361790079495,1.145479690577207,0.2328966521106259,0.9746584560933677,1.0,13/88,12.45%,MRPS22;MRPS2;MRPS33;MRPL23;MRPL24;MRPL18;MRPL38;MRPS12;MRPL20;MRPL52;MRPS15;MRPS24;MRPL48
prerank,T cell differentiation in thymus (GO:0033077),0.4737338931884929,1.1451039504837677,0.31273408239700373,0.97443594474715,1.0,2/14,4.13%,PTPRC;ZFP36L1
prerank,positive regulation of telomere maintenance (GO:0032206),0.39824650861394045,1.1442040510667064,0.25585284280936454,0.9762843374916034,1.0,7/31,12.55%,MAP2K7;MAPK3;PNKP;MAP3K4;NEK7;TNKS;NBN
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.505912795350278,1.14414201422407,0.3090551181102362,0.9747891938738441,1.0,2/10,8.56%,OXSR1;WNT5A
prerank,negative regulation of nuclear division (GO:0051784),-0.4826133578113575,-1.1437624591257107,0.2804123711340206,0.6713454100979117,1.0,3/11,4.74%,TOM1L2;BMP7;BMP4
prerank,positive regulation of histone deacetylation (GO:0031065),0.48951334979725497,1.1437274410444103,0.30185185185185187,0.9747287883105895,1.0,4/12,11.22%,PRKD2;AKAP8L;ING2;CTBP1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.2956541660393977,-1.1437203126911641,0.20180722891566266,0.6704713274950649,1.0,16/75,9.33%,SULF1;COL4A3;CTNNB1;GTF2I;ROCK2;HSPG2;ROCK1;HOXA5;PML;WNT4;SPARC;ADAMTS1;FOXC1;THBS2;NIBAN2;THBS1
prerank,negative regulation of cell differentiation (GO:0045596),-0.25924168659937685,-1.1437085405366187,0.11016949152542373,0.6695283409859173,1.0,38/181,14.13%,LDLRAD4;CNTN4;RANBP3L;ADAMTS12;EGFR;SMAD3;TGFBR1;COL5A1;BMP5;COL5A2;BMP7;ADGRV1;SIRT2;EFEMP1;MED1;BMP4;MEIS2;CRIM1;ENPP1;OSR1;PPARA;SKI;XDH;TMEM64;LRP5;ABCA5;CDC73;SMAD6;ANP32B;CDK6;SEMA4D;TBX3;LIMD1;ABCA1;NELFB;WNT9A;RORA;IGF2
prerank,response to estrogen (GO:0043627),0.39049120914660956,1.1435734949441938,0.26776859504132233,0.9736293842005639,1.0,6/31,10.46%,ARID5A;EP300;TRIM25;CITED2;WBP2;ESR1
prerank,cellular component maintenance (GO:0043954),0.49121698687698867,1.1434425962098382,0.31910569105691056,0.9724262732503383,1.0,5/12,17.56%,FYN;PRNP;ITGA3;MTMR2;INSR
prerank,inner ear morphogenesis (GO:0042472),-0.3875480807988198,-1.1433385153647393,0.2703296703296703,0.6695440945254717,1.0,6/22,18.72%,FGFR2;ZIC1;TTC39C;EPHB2;TBX18;SIX1
prerank,peptidyl-serine modification (GO:0018209),0.3040949141702122,1.1433353052696749,0.20838794233289645,0.9711680945782911,1.0,37/166,15.85%,PCK1;PRKX;STK32A;PLK2;RPS6KA1;PRKCH;RPS6KA4;CAMK1D;HIPK2;PRKD2;RPS6KA5;PKN3;SMG1;HPF1;MAPK8;CSNK1G3;SBK1;DCLK3;LATS2;PKN1;SRPK2;TNKS;PRKCI;MAST4;IKBKB;MAPK12;CHUK;TLK2;NEK6;CSNK2A2;NTMT1;MAP3K10;GAS6;DYRK2;TOP1;TAF1;ATR
prerank,regulation of protein binding (GO:0043393),0.3135488723013894,1.1431310900313583,0.2217573221757322,0.9702439855187974,1.0,24/114,13.21%,TRIB3;RALB;PIN1;TIAM1;BTBD1;ACTB;PSME3IP1;HIPK2;IFIT1;PPP2CA;B2M;CDKN1A;MAPK8;CARD16;SPPL3;EPB41;AKTIP;PARK7;CLDN5;TERT;APP;LDLRAP1;USP33;HDAC5
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.31789736405074187,-1.142420304009738,0.20923913043478262,0.6711905342642797,1.0,13/52,13.20%,SORBS1;LRP1;EGFR;ZDHHC5;EPB41L2;STX3;EFCAB7;DPP10;EPHB2;EPHA3;CLIP3;DLG1;WNK3
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.48117117905526724,-1.1418531511621712,0.30103092783505153,0.6718624321528237,1.0,3/11,19.51%,JAK1;IL6ST;STAT1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.34597233679876926,-1.1416353037213638,0.27455919395465994,0.6714764785476703,1.0,8/40,4.04%,DAB2;COL1A1;SMAD3;TGFBR1;TGFBR2;CTNNB1;PDPN;SMAD4
prerank,negative regulation of interleukin-10 production (GO:0032693),0.4509999908156661,1.1415468505357673,0.3014705882352941,0.9747653949127667,1.0,3/16,13.01%,FCGR2B;VSIR;CD274
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.2893707155998766,-1.1414707370826107,0.1762917933130699,0.6709596501028099,1.0,24/86,21.78%,BMP6;SULF1;DAB2;FOXD1;TGFBR1;BMP5;ZEB2;BMP7;SMAD4;BMP4;SNW1;ACVR1;THBS1;NUP93;STK11;ACVR1B;TGFB1;BMPR1B;ZNF423;BMPR1A;BMPR2;TWSG1;CCN1;FLCN
prerank,response to chemokine (GO:1990868),0.4856780020281666,1.141203995539715,0.3170289855072464,0.9743452926419469,1.0,4/13,5.71%,OXSR1;CXCL12;LRCH1;RIPOR2
prerank,embryonic organ development (GO:0048568),-0.30512411109389503,-1.1411651115986197,0.2099125364431487,0.6708282168464559,1.0,24/61,21.82%,FGFR2;TEAD1;PBX1;GLI2;GLI3;KMT2A;RARB;PCSK5;TGFBR2;KIT;COBL;RBP4;COL13A1;SALL1;TEAD3;TGFB1;NES;PBX4;BMPR1A;TEAD2;PBX2;PDGFA;ATF4;PKDCC
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.39236925853630356,-1.1410727374698328,0.27740492170022374,0.6701048920986628,1.0,4/22,6.92%,ANK2;AKAP6;ATP1B1;HTT
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3553756783134532,-1.1410664322760793,0.2766990291262136,0.6691454585901376,1.0,12/33,20.31%,AKAP6;WNK1;WWP2;CHRM3;AKAP9;KCNJ2;KCNJ6;WNK3;ANO6;KCNJ13;KCNJ10;NEDD4
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.4468467141509973,-1.1410501766718617,0.29978118161925604,0.668236378681823,1.0,3/14,4.07%,LRP1;IGFBP5;TPM1
prerank,peptide metabolic process (GO:0006518),0.3374921907328114,1.1408751638631314,0.26259541984732826,0.9738805000972129,1.0,10/75,9.07%,PCSK1;LVRN;SOD1;PSEN2;MME;SEC11A;SPCS3;SPPL3;TPP1;CARNMT1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.40342985544432725,-1.1408556808623616,0.2676659528907923,0.6677902252941746,1.0,11/21,30.46%,TOX;CTNNB1;SMARCD3;DISC1;KDM1A;NES;CX3CL1;VEGFA;CX3CR1;MDK;DRD2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.3164382233979181,1.140725653587763,0.22253129346314326,0.9727801432432192,1.0,22/113,13.81%,LCP1;ERCC3;PSMC4;TAL1;SLF1;TIRAP;SRC;ERCC4;ICE1;SYK;GTF2H1;RASIP1;PSMC2;PARK7;ESR1;DDX3X;RPS3;BMF;CDH5;PLEK;PSMC6;FAF1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2971418810227029,1.1403525221923256,0.18915343915343916,0.9726306052020474,1.0,33/161,14.01%,PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;FRZB;RUVBL2;GREM1;TPBG;PSMD11;APOE;SOX2;PSMB4;PSMC1;CCDC88C;PFDN5;AXIN1;WNT5A;SOX13;LATS2;PSMC2;PSMD2;TMEM131L;TLE4;CUL3;PSMD14;DDIT3;PSMC6;PSMD1;APC;PSMB1
prerank,B cell differentiation (GO:0030183),0.3631231402554808,1.1397576909943832,0.2660098522167488,0.9733794126008086,1.0,6/46,10.07%,DCAF1;PTPRJ;PTPRC;HDAC9;CEBPG;KLF6
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.4932836536286186,-1.1396767813081905,0.32323232323232326,0.6702830686804097,1.0,2/10,3.01%,ANXA2;NELL1
prerank,monocarboxylic acid transport (GO:0015718),-0.3206995617387261,-1.1395051699231784,0.23055555555555557,0.6698401495186611,1.0,14/51,19.20%,SLCO3A1;SLC16A12;SLC6A13;SLC16A7;SLC6A12;RXRA;SLC27A1;NCOA1;SLC16A11;STARD5;ATP8B1;SLC16A2;SLC5A6;SLC16A9
prerank,negative regulation of ATPase activity (GO:0032780),0.4483219589401269,1.1394809472593368,0.2895204262877442,0.9728246905448055,1.0,3/16,8.86%,IFIT1;SIRT1;TSC1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.3404253078145004,1.1391219564143067,0.25504322766570603,0.9725385709306859,1.0,17/68,18.65%,MAZ;ERCC3;NCBP1;POLR1C;CCNH;CPSF4;POLR1G;GTF2H1;PAPOLA;TBP;SCAF8;SLBP;WDR33;TAF1D;CLP1;POLR3K;SNRPD3
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.4013848859405437,1.138711545236137,0.2646048109965636,0.9725417104548472,1.0,9/27,17.21%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC1A2;SLC25A12;SLC38A5;SLC25A38;SLC7A5
prerank,negative regulation of metabolic process (GO:0009892),-0.31836124493279916,-1.1386607165399592,0.23770491803278687,0.6712496698506824,1.0,21/54,24.49%,NRDC;ALDH1A1;LGR4;PLCL2;IP6K1;NPR3;ADAMTS5;ARRDC3;FIS1;ACOT11;STK11;FOXC2;RHEB;PLCL1;ZNF423;NOVA1;TFE3;ATF4;FLCN;CCDC3;NR1H2
prerank,regulation of catecholamine secretion (GO:0050433),-0.3640079053386702,-1.138584977363243,0.273972602739726,0.6704988226681082,1.0,13/29,30.46%,SYT9;SYT12;SYT11;SYT4;SYT7;STX1A;SYT2;KCNA2;GRK2;SYT10;SYT6;SNCA;DRD2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4179353798338522,1.1385625127820334,0.2817391304347826,0.9714346496532287,1.0,3/22,5.45%,MAP3K7;CYRIB;B2M
prerank,defense response to symbiont (GO:0140546),0.3208931464298096,1.1382169987967155,0.23919308357348704,0.9710723539741939,1.0,19/92,13.10%,PTPRC;IFNLR1;IFITM2;IFIT1;RNASE6;MLKL;IFITM3;CNOT7;IFITM1;RELA;NCBP3;SERINC5;SERINC3;ATG7;IFI27;BNIP3L;AGBL5;IRF2;NLRC5
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.2892109073992594,-1.1377326868314632,0.19865319865319866,0.6718984674030242,1.0,31/84,25.87%,FOXP1;ANXA3;SASH1;NRP1;FGF1;MAPK14;PLPP3;BMP4;P2RX4;ROCK2;SPARC;SMOC2;THBS1;NRP2;LGMN;FOXC2;RHOB;GPLD1;TGFB1;SEMA5A;MET;BMPR2;AAMP;HSPB1;PRKD1;VEGFA;ITGB1BP1;AKT1;ATOH8;GATA2;STAT5A
prerank,rRNA transcription (GO:0009303),0.45032507051534554,1.137437692842119,0.3029259896729776,0.9724382340319344,1.0,4/17,6.79%,GTF3C1;SPIN1;GTF3C5;POLR1G
prerank,small GTPase mediated signal transduction (GO:0007264),0.3154771083013589,1.136967593498903,0.22852983988355166,0.9726448949050376,1.0,24/103,12.99%,RALB;TRIM28;TIAM1;PLK2;NUCB2;RERG;NRAS;RRAD;RASGRP3;RALA;CDKN1A;KRIT1;GNB1;GRAP;CCDC88C;ARHGEF18;RAPGEF5;RAPGEF6;PARK7;NF1;CRKL;G3BP2;RIT1;RRAGC
prerank,smooth muscle tissue development (GO:0048745),-0.4841283206711925,-1.1367427847875424,0.2979591836734694,0.6738040195927241,1.0,6/10,29.87%,BMP4;SMO;EFEMP2;STRA6;PTCH1;MYLK
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.33960820939364617,1.1365949812669611,0.26112759643916916,0.9724885315009599,1.0,8/64,9.35%,POLR2J;ERCC3;NCBP1;ELOC;POLR2B;CCNH;GTF2H1;PCID2
prerank,lymphocyte differentiation (GO:0030098),0.3342186021477011,1.13641273955888,0.2518740629685157,0.971576579812049,1.0,11/68,11.50%,DCAF1;JAG2;PTPRJ;PTPRC;HDAC9;GPR89A;GPR89B;CEBPG;LFNG;KLF6;PIK3CD
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.4608813798352137,1.135709368616193,0.29642857142857143,0.9728030640405168,1.0,3/14,4.58%,MAP3K7;TIRAP;TNFRSF10B
prerank,aerobic electron transport chain (GO:0019646),0.33692370753599554,1.1352872649806838,0.26564885496183205,0.9728026011260289,1.0,19/68,14.41%,CYCS;NDUFAF1;UQCC3;NDUFB6;NDUFB4;COX6B1;NDUFA10;NDUFA1;NDUFS2;COX5A;SDHA;NDUFB7;COX15;UQCRB;NDUFV3;NDUFA8;NDUFC2;NDUFA13;COX10
prerank,regulation of cell-cell adhesion (GO:0022407),0.37338761490616096,1.1352603126540395,0.279874213836478,0.9712774687910695,1.0,9/39,10.27%,PTPRR;PTPRG;SRC;MAGI1;SMAD7;MINK1;CD47;PODXL;CITED2
prerank,glutathione derivative metabolic process (GO:1901685),-0.40198249261969954,-1.1351040488084343,0.298876404494382,0.6764053327726613,1.0,12/20,40.23%,GSTT1;GSTZ1;ESD;GSTA4;GSTM1;HPGDS;MGST1;GSTA3;GSTM2;MGST3;GSTM5;GSTO1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.40198249261969954,-1.1351040488084343,0.298876404494382,0.6764053327726613,1.0,12/20,40.23%,GSTT1;GSTZ1;ESD;GSTA4;GSTM1;HPGDS;MGST1;GSTA3;GSTM2;MGST3;GSTM5;GSTO1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.39127857423949136,1.1350694573606288,0.295221843003413,0.9703010199347974,1.0,7/31,9.48%,TRIB3;PIN1;DCUN1D4;BMI1;AXIN1;MAGEC2;RAB1A
prerank,glycogen metabolic process (GO:0005977),-0.37038885953141354,-1.1346612803451366,0.26570048309178745,0.6766307690619666,1.0,12/27,19.39%,PRKAG2;PYGB;AGL;PER2;PGM1;PHKA2;GSK3B;GYS1;PYGM;PGM2;GAA;PHKG2
prerank,renal water homeostasis (GO:0003091),-0.37681285474422554,-1.1345027993712045,0.2665198237885463,0.6760837383685405,1.0,9/23,13.00%,ADCY5;ADCY2;ADCY1;ADCY9;PRKACA;AQP4;ADCY7;PRKAR1B;RAB11A
prerank,monosaccharide transmembrane transport (GO:0015749),-0.42537822449035556,-1.1342875120510432,0.30022075055187636,0.6757043427495029,1.0,7/16,36.94%,SLC2A12;SLC2A10;SLC50A1;SLC5A3;SLC45A3;SLC2A8;SLC2A9
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.34401926372663016,1.133980203318583,0.26825633383010433,0.973042360860275,1.0,12/62,10.96%,TXNDC12;CXCL12;BCL2L2;SRC;PTTG1IP;SIRT1;SOD2;MDM2;PARK7;CCAR2;DDX3X;HYOU1
prerank,actin nucleation (GO:0045010),0.42033201634490297,1.133957852283457,0.2916666666666667,0.9714690365486616,1.0,7/21,15.42%,ARPC3;ARPC5L;ARPC4;ARPC5;TRIM27;LMOD1;WHAMM
prerank,negative regulation of RNA splicing (GO:0033119),0.44028834526833655,1.1338804991532383,0.30996309963099633,0.9701352050572679,1.0,7/19,16.18%,SFSWAP;SRSF10;RPS26;SRSF4;PTBP1;SRSF7;U2AF2
prerank,prostanoid biosynthetic process (GO:0046457),-0.4297369922752745,-1.1337601395438845,0.3008658008658009,0.6762840362380848,1.0,5/15,19.91%,PLA2G4A;PTGDS;PTGIS;PTGES;PTGS2
prerank,transport along microtubule (GO:0010970),0.48837310356534447,1.1337573809330859,0.308529945553539,0.9689935131914058,1.0,6/13,14.76%,DYNC1I1;COPG2;APP;SPG11;COPG1;DYNC1I2
prerank,anterograde axonal transport (GO:0008089),-0.3422705289523937,-1.1335468284979169,0.263681592039801,0.6759617074003541,1.0,12/37,15.75%,DLG2;AP3B1;KIF5C;KIF1C;TRAK1;AP3S2;RAB27B;KIF3A;KIF1A;MAP1A;NEFL;KIF5A
prerank,proteoglycan biosynthetic process (GO:0030166),0.38898046682185256,1.133270355145309,0.30363036303630364,0.9691069631096606,1.0,6/31,9.20%,NDST3;CSGALNACT1;XYLT1;EXT2;PXYLP1;B3GAT2
prerank,B cell mediated immunity (GO:0019724),0.5110578687762579,1.133061678591713,0.3138401559454191,0.968251345289733,1.0,1/10,2.51%,FCGR2B
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.4419084538596619,1.1330052496608056,0.31539888682745826,0.9668492847578419,1.0,7/18,16.46%,RUVBL2;CCT2;CCT5;RUVBL1;TCP1;DKC1;PARN
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.3340760527752213,-1.1329551556293862,0.248,0.6767561382337665,1.0,10/38,20.12%,BMP6;SASH1;PUM1;PUM2;PLSCR1;POLR3C;LY86;GBP5;RIOK3;SLC15A4
prerank,iron ion homeostasis (GO:0055072),0.3546062144375046,1.1328234373449666,0.26443768996960487,0.9658842414863822,1.0,12/58,12.10%,CAND1;HMOX2;SOD1;ABCG2;FBXL5;ATP6V0D1;B2M;ISCU;GLRX3;ATP6AP1;PICALM;ACO1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3736881030830379,1.132746923185453,0.26588628762541805,0.9645488080580041,1.0,8/39,12.03%,CISH;PIK3CG;PIK3C2G;EFR3B;SMG1;PI4KA;PIK3CD;IP6K2
prerank,regulation of phagocytosis (GO:0050764),0.3531562753624828,1.1324640031750741,0.2624,0.9639516741903675,1.0,12/53,17.51%,PTPRC;FCGR2B;CAMK1D;LMAN2;SYK;MERTK;CD47;SCARB1;CYBA;GAS6;CALR;RAB27A
prerank,response to peptide hormone (GO:0043434),0.3710466390568533,1.1323862399151772,0.2750809061488673,0.9626254587265484,1.0,10/43,11.54%,PCK1;SORT1;SRC;ZFP36L1;SIRT1;EPM2AIP1;EIF2B3;TSC1;ZBED3;GNAI1
prerank,cell junction assembly (GO:0034329),-0.28026757821749076,-1.1320480677129032,0.21782178217821782,0.6783483446097455,1.0,41/100,23.54%,SDK1;CDH10;NRXN1;KIRREL3;NRCAM;RYK;DNER;DSCAM;RHOA;TLN1;NLGN2;FLNA;GPM6A;CTNND2;CDH11;SDK2;TLN2;CDH7;GJC1;NLGN1;ARVCF;CDH1;FN1;ILK;NRXN2;OBSL1;PLXND1;CTNND1;SHANK2;CDC42;CDH9;CDH8;CDH19;SLITRK1;DBNL;FLCN;FLNC;DCHS1;NLGN3;FARP1;RAB29
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.39739473675848364,-1.1319414023545369,0.2979214780600462,0.6776850536120861,1.0,13/21,38.62%,SMO;DCDC2;EVC;GLI1;SFRP1;DLG5;TTC23;PDCL;KIF7;GAS8;ULK3;STK36;RAB34
prerank,positive regulation of locomotion (GO:0040017),0.40011385316045894,1.1315413571544783,0.28499156829679595,0.9642397953080122,1.0,2/27,0.42%,PHPT1;SPOCK2
prerank,cilium assembly (GO:0060271),-0.2438566641738301,-1.131486186330268,0.10625,0.6779988614029477,1.0,83/296,19.87%,GSN;PARVA;AHI1;PKD1;CC2D2A;EXOC3;DYNC1H1;RILPL1;FLNA;PIBF1;IFT81;DZIP1;TTC8;WDR35;NINL;SPATA6;DYNC2I1;RAB8B;DCDC2;TTC21B;NUDCD3;CCDC66;CCDC57;CFAP20;EXOC6;TTC39C;IFT46;CEP57;IFT57;IFT52;AKAP9;CEP70;ACTR3;CEP89;CSNK1E;CEP152;CEP126;IFT172;CKAP5;CEP20;PRKACA;IFT74;CFAP44;RP2;DCX;ARL13B;DISC1;TTBK2;ABLIM3;KIF3A;DZIP1L;BBS9;RAB11A;WDR19;WDR11;INTU;RAB23;CCP110;BBS2;TUBB4A;CYS1;DCTN1;ARF4;EXOC7;EXOC1;PTPN23;CEP250;EHD1;BBOF1;RAB8A;EHD3;GORAB;DYNLL2;ACTR2;IFT20;NDE1;TUBA1A;SNAP29;BBS5;TMEM237;TMEM80;CCDC28B;TTLL3
prerank,fatty acid elongation (GO:0030497),-0.44436031037871876,-1.1313304849017902,0.2868525896414343,0.677464055894514,1.0,4/13,7.28%,HACD3;HACD1;HACD4;TECR
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4429080800354069,1.1311066408074497,0.2828828828828829,0.964391467226696,1.0,3/18,6.70%,IFI35;SBNO2;SYK
prerank,organic acid transport (GO:0015849),-0.2789457989132813,-1.1307877575793894,0.21830985915492956,0.6779606269953152,1.0,23/94,17.61%,SLC7A11;ACSL1;SLC6A13;SLC13A3;SLC7A2;PDPN;LRRC8D;SLC26A7;SLC7A14;SLC1A5;SLC6A12;SLC25A32;RXRA;SLC27A1;SLC6A15;NCOA1;SLC25A47;SLC22A6;STARD5;ATP8B1;SLC19A1;SLC16A10;SLC5A6
prerank,detection of mechanical stimulus (GO:0050982),-0.40123890272253365,-1.1306101193046005,0.2922374429223744,0.6775037948677172,1.0,3/19,5.60%,PKD1;CTNNB1;PIEZO2
prerank,actin filament bundle organization (GO:0061572),-0.34793105584647943,-1.1301098723405594,0.27411167512690354,0.6778574277188838,1.0,5/33,4.60%,CALD1;PAWR;DPYSL3;LIMA1;NEDD9
prerank,positive regulation of interferon-gamma production (GO:0032729),0.35995964937108116,1.129350712967243,0.2841269841269841,0.9696074182405058,1.0,4/48,6.48%,IL1R1;PDE4D;CYRIB;CEBPG
prerank,natural killer cell activation (GO:0030101),-0.38243648334586056,-1.12901869597553,0.2772511848341232,0.6800611150202039,1.0,8/23,22.17%,PBX1;AXL;TOX;KAT7;ELF4;RABL3;PRDX1;BAG6
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.48928097358241296,1.128154084327791,0.3531669865642994,0.9727285350200762,1.0,2/11,2.84%,SEMA6A;KLF2
prerank,pulmonary valve development (GO:0003177),-0.4084492537929136,-1.1277878911870858,0.29910714285714285,0.6828055562839344,1.0,5/18,8.66%,ROBO2;NOTCH2;ROBO1;BMP4;SMAD6
prerank,protein dephosphorylation (GO:0006470),0.3079395014397246,1.1277393961306996,0.24193548387096775,0.9727282095209798,1.0,19/135,6.91%,PHPT1;PTPRR;PTPN18;PTPRG;DUSP7;PTPRJ;PTPRC;CTDSP1;PPP3CB;PTPRM;PPP2R2D;PTPRB;DUSP12;PTPRE;PPP2CA;PTPN12;SSH2;PTPRT;PPP2CB
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.42505221765615453,1.1276139603356423,0.3027027027027027,0.9716067974395426,1.0,4/21,7.71%,OSBPL10;PLAAT3;LPCAT3;MBOAT1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3452675686646984,-1.1274319664519692,0.2631578947368421,0.682836840915643,1.0,10/32,15.56%,NAV3;MAP2;EML2;HDGFL3;STMN2;TTBK2;CLIP3;TAOK1;STMN1;TUBB4A
prerank,regulation of secretion by cell (GO:1903530),-0.309511519849097,-1.1273329175147648,0.23076923076923078,0.682170875924829,1.0,27/54,35.93%,RIMS1;RAB3C;SNCAIP;RAB8B;SCG5;SYN1;STXBP5;ANXA1;VAMP2;RAB8A;RHBDF1;P3H1;CPLX1;VAMP8;LLGL1;CAMK2A;RAB13;DNAJC1;KCNMB4;RAB3D;LGI3;RAB21;LLGL2;RAB3B;CPLANE2;RAB3A;CPLX2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3287511733024877,-1.126955344341046,0.2631578947368421,0.6822708409421615,1.0,18/46,21.78%,NRDC;ALDH1A1;LGR4;PLCL2;IP6K1;NPR3;ADAMTS5;ARRDC3;ACOT11;STK11;FOXC2;RHEB;PLCL1;ZNF423;NOVA1;TFE3;ATF4;FLCN
prerank,regulation of glycolytic process (GO:0006110),-0.3002407521590874,-1.126504196371418,0.23275862068965517,0.6825581266283645,1.0,14/68,11.55%,ZBTB20;PRKAG2;IGF1;OGT;HDAC4;PRKAG1;NUPR1;NUP205;PPARA;NUP155;NUP188;PFKFB4;NUP88;NUP93
prerank,ameboidal-type cell migration (GO:0001667),0.35039329779555956,1.126481180288189,0.28378378378378377,0.9744357090878003,1.0,10/51,9.74%,SEMA6A;SEMA6D;SEMA7A;PKN3;SEMA3C;TBX1;AMOTL1;SEMA6B;SEMA4C;PKN1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.37770685164937917,-1.1261981240050871,0.2795969773299748,0.6824809566708884,1.0,4/23,10.68%,ANK2;ATP1A2;UBASH3B;CAMK2D
prerank,regulation of protein localization to nucleus (GO:1900180),-0.320925326321621,-1.1255598362736934,0.28690807799442897,0.683380265333814,1.0,18/43,24.64%,CTNNA1;KAT7;BMP4;ILRUN;GLUL;GSK3B;TGFB1;WWTR1;LIMK2;CARD10;DTX3L;FLCN;YAP1;LAMTOR5;EIF2AK3;OTUD7B;AKT1;SESN2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.48214037975381285,1.1254065514091607,0.34328358208955223,0.9737311813347288,1.0,4/12,12.84%,ANAPC7;ANAPC11;ANAPC4;CUL3
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.48214037975381285,1.1254065514091607,0.34328358208955223,0.9737311813347288,1.0,4/12,12.84%,ANAPC7;ANAPC11;ANAPC4;CUL3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.48214037975381285,1.1254065514091607,0.34328358208955223,0.9737311813347288,1.0,4/12,12.84%,ANAPC7;ANAPC11;ANAPC4;CUL3
prerank,peptidyl-proline modification (GO:0018208),0.4035347731773862,1.1253615432458606,0.2807625649913345,0.9722994351735439,1.0,5/25,6.18%,PIN1;PPIB;PPIG;P3H2;PPIL3
prerank,positive regulation of MAPK cascade (GO:0043410),-0.2440879905647426,-1.1253529567880576,0.1256544502617801,0.6829913282255292,1.0,30/245,7.09%,ERBB4;NTRK3;FGFR2;NOTCH2;LPAR1;IGF1;HTR2C;ROBO1;EGFR;KSR1;IQGAP1;PDGFRB;NTRK2;BMPER;NRP1;CCN2;FGF1;RYK;ROR1;KIT;PRKCZ;ROCK2;IL34;TAOK3;PDGFRA;ROCK1;SLC30A10;ADRA1B;IRAK1;GSDME
prerank,regulation of JNK cascade (GO:0046328),0.3201122667387714,1.125081540901586,0.27023319615912206,0.971828972369345,1.0,19/101,12.33%,MAP3K11;MECOM;RAP2A;FCGR2B;TIRAP;HIPK2;HDAC3;EDAR;TRAF5;AXIN1;MTURN;MINK1;PHLPP1;TRAF3;PJA2;PLCB1;MFHAS1;APP;MAP4K4
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.4302527554231763,-1.1250409659595875,0.3130434782608696,0.6829405303155819,1.0,10/15,28.53%,UST;DSE;VCAN;CSGALNACT2;CSPG4;DSEL;BGN;DCN;CSPG5;CHST12
prerank,glucose homeostasis (GO:0042593),0.3270939671638625,1.12501819323638,0.2702702702702703,0.9704883302766942,1.0,12/83,11.09%,PCK1;HECTD4;PYGL;SELENOT;WFS1;ADIPOR2;SIRT1;CYB5R4;PARK7;PRKAA2;BAD;ADIPOR1
prerank,regulation of steroid metabolic process (GO:0019218),0.4152774314676633,1.1246872893913598,0.2978723404255319,0.9702080073616648,1.0,4/23,6.46%,PANK2;NR5A1;APOE;LAMTOR1
prerank,gastrulation (GO:0007369),-0.42537663381345336,-1.1246453192666264,0.3125,0.6830824369263343,1.0,3/15,12.24%,GPC3;LRP5;UGDH
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.3338839638724447,1.1246044063665812,0.27889060092449924,0.9689247961717974,1.0,19/69,14.41%,CYCS;NDUFAF1;UQCC3;NDUFB6;NDUFB4;COX6B1;NDUFA10;NDUFA1;NDUFS2;COX5A;SDHA;NDUFB7;COX15;UQCRB;NDUFV3;NDUFA8;NDUFC2;NDUFA13;COX10
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3450734380638252,1.1240170861251093,0.26993865030674846,0.968017273803365,1.0,14/56,13.09%,NDUFAF1;NDUFAF5;NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;TIMM21;NDUFB7;TIMMDC1;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3450734380638252,1.1240170861251093,0.26993865030674846,0.968017273803365,1.0,14/56,13.09%,NDUFAF1;NDUFAF5;NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;TIMM21;NDUFB7;TIMMDC1;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,intracellular protein transport (GO:0006886),0.2797731655114473,1.1238915038843693,0.1950354609929078,0.9669607670601985,1.0,62/304,13.25%,SURF4;ARF5;ARL5C;ARL4D;EVI5L;RAB5C;CDC37;TBC1D30;TBC1D8;SNX8;MMP12;VPS29;RAB7A;TBC1D9;PHB2;TMED4;VPS26A;SEC23IP;RAB43;TBC1D10B;PTTG1IP;USP6NL;TBC1D4;SYK;RAB6B;NAPA;TMED5;NXT1;IFT22;RABGAP1L;SNX17;RAB6A;NUP50;DESI1;TMED10;RAB14;ACD;XPO5;RANBP17;DNAJC27;TBC1D12;SNX1;ARL5B;ARF1;AP4S1;RAB1A;CCHCR1;TBC1D25;KIF13A;MAIP1;TMED7;SCFD1;RAB5B;RAB22A;STRADB;ADPRH;ARCN1;E2F3;TBC1D14;XPO1;YWHAH;RABGAP1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3379115370121798,1.123781085132638,0.2719298245614035,0.965801621079506,1.0,14/70,10.62%,MAPK3;ARPC3;VAV3;FCGR2B;ACTB;SRC;ARPC4;FYN;SYK;PLCG1;LYN;PAK1;WIPF3;YES1
prerank,protein polyglutamylation (GO:0018095),0.4776641454124573,1.1237276328559755,0.3488843813387424,0.9644285589358172,1.0,2/11,3.12%,TTLL1;CEP41
prerank,dopaminergic neuron differentiation (GO:0071542),0.430717944076197,1.1235786622081916,0.31886792452830187,0.9634549193317626,1.0,2/19,3.05%,NR4A2;MANF
prerank,regulation of T cell chemotaxis (GO:0010819),0.4859071892812332,1.1231738558023439,0.32625482625482627,0.9634197168245369,1.0,2/11,8.56%,OXSR1;WNT5A
prerank,negative regulation of cell migration (GO:0030336),-0.26864459740985186,-1.1229067539224569,0.18292682926829268,0.6870417709253055,1.0,14/137,4.07%,MAGI2;NAV3;LDLRAD4;TMEFF2;PHLDB2;SULF1;LRP1;ROBO1;DPYSL3;COL3A1;IGFBP5;MCC;CLIC4;TPM1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.3200347195321561,-1.1222775123361395,0.24633431085043989,0.6879582502829247,1.0,7/46,5.33%,ATP1A2;DGKI;NRXN1;GRM5;TSHZ3;NLGN2;RELN
prerank,negative regulation of cytokine production (GO:0001818),0.2987705742817515,1.1219181955714272,0.2222222222222222,0.9664801861479251,1.0,27/163,13.40%,CIDEA;PIN1;LEF1;PTPRC;TNFAIP3;FCGR2B;RPS6KA4;MAP2K5;HDAC7;HDAC9;RPS6KA5;NPTN;RGCC;PPP1R11;NLRC3;CUEDC2;TRIM25;CD84;VSIR;TRAF3IP1;PRNP;OTUD5;MAPKBP1;CD274;NLRC5;RNF216;DDIT3
prerank,cellular response to ketone (GO:1901655),0.37944913006481285,1.1217715206917405,0.29679595278246207,0.9655064828508588,1.0,4/35,6.32%,PCK1;PTGER2;SRC;GNB1
prerank,defense response to virus (GO:0051607),0.31191932958677554,1.121759466453,0.2672292545710267,0.9640019398097711,1.0,20/100,13.10%,PTPRC;IFNLR1;IFITM2;IFIT1;RNASE6;MLKL;PHB2;IFITM3;CNOT7;IFITM1;RELA;NCBP3;SERINC5;SERINC3;ATG7;IFI27;BNIP3L;AGBL5;IRF2;NLRC5
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.35054243028108234,1.1216481547117707,0.2830188679245283,0.962899866557853,1.0,7/46,9.31%,SEMA6A;PTPRR;PIN1;PTPRC;SPRED1;CNKSR3;LYN
prerank,blood vessel morphogenesis (GO:0048514),0.3475070289721366,1.1216318682515156,0.28837209302325584,0.9614290309559363,1.0,13/54,12.07%,SLC1A1;CDH2;EGFL7;RAMP2;TBX1;SYK;SMAD7;HEY2;RASIP1;RBPJ;CYP1B1;FLT1;NF1
prerank,retinol metabolic process (GO:0042572),0.46516710294314534,1.1214345743460965,0.34111310592459604,0.9606365903801376,1.0,4/14,14.01%,RETSAT;RDH11;CYP1B1;RDH10
prerank,aminoglycan metabolic process (GO:0006022),0.4998576624358553,1.1213980234287397,0.3185328185328185,0.9592653818795629,1.0,2/10,9.20%,XYLT1;B3GAT2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.40680938855076165,-1.1211435245769619,0.3235294117647059,0.6902520010785366,1.0,7/19,24.21%,VIM;BMP4;WNT4;TGFB1;EMILIN1;CREB3L1;TGFB3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.41247779411953256,1.1211321858012078,0.339041095890411,0.9587770554961437,1.0,3/22,4.90%,PSMB10;PSMB6;PSMB4
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.4744756038844076,-1.120945252133601,0.3333333333333333,0.689886403720082,1.0,8/12,33.60%,GLUD1;ACLY;IDH2;IDH3B;IDH3A;ASS1;SIRT4;IDH3G
prerank,cell cycle checkpoint signaling (GO:0000075),0.47301287216056104,1.1207695224258905,0.3352165725047081,0.9586255231673186,1.0,4/12,10.99%,PLK2;PRCC;WEE1;CHFR
prerank,heart looping (GO:0001947),-0.3175540020339166,-1.1199839180546036,0.2398989898989899,0.691701652272019,1.0,10/39,25.89%,AHI1;MICAL2;TGFBR2;SMO;TBX3;SETDB2;BBS5;CCDC39;NDRG4;TBX2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.4672997259601244,-1.1199739852071946,0.3497854077253219,0.690782316824762,1.0,2/11,3.17%,ANK3;JAK1
prerank,phagosome maturation (GO:0090382),0.36999018175149473,1.11994794262386,0.30655737704918035,0.9601624451068363,1.0,7/35,8.45%,ATP6V1D;RAB7A;RAB43;ATP6V0D1;PIKFYVE;RAB14;ATP6V0E1
prerank,regulation of gluconeogenesis (GO:0006111),-0.36488105416108924,-1.1197734390619987,0.2900763358778626,0.6903802822911764,1.0,14/27,23.90%,OGT;DDB1;PPARGC1A;SIK1;ARPP19;CRY1;SIRT7;SELENOS;USP7;PTPN2;ZNF692;DGKQ;CLK2;C1QTNF3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.3501930555318855,1.1197072403395107,0.2995391705069124,0.9595871527774102,1.0,10/54,12.41%,PRCP;PRKD2;APOE;RGCC;SIRT1;PLCG1;ACVRL1;NOS3;NF1;SP1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.38434591795845696,-1.1194099199657634,0.3113207547169811,0.6904221980147512,1.0,5/22,3.74%,MAP2;MAP1B;AEBP1;AKAP13;MAPT
prerank,neural crest cell development (GO:0014032),0.36090480288780075,1.11939230281501,0.29541864139020535,0.9592711092353343,1.0,8/44,9.12%,SEMA6A;SEMA6D;SEMA7A;CDH2;SEMA3C;TBX1;SEMA6B;SEMA4C
prerank,smoothened signaling pathway (GO:0007224),-0.3428522391471138,-1.1192479084557565,0.25060827250608275,0.6899336141016738,1.0,8/32,11.86%,GLI2;GLI3;CC2D2A;SMO;EVC2;HIPK1;ARL13B;TTBK2
prerank,hyaluronan metabolic process (GO:0030212),-0.3789239602353965,-1.1189902084761487,0.2793791574279379,0.6896779937034926,1.0,17/23,52.53%,CEMIP;CEMIP2;HEXA;HEXB;TGFB1;GUSB;HYAL1;SLC9A1;CHP1;HAS1;HYAL2;LYVE1;HAS2;HMMR;HAS3;HYAL3;STAB2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.3458310473357283,-1.1188099063408459,0.2718204488778055,0.689244186346571,1.0,12/33,28.28%,TEAD1;SMAD3;TP53;TGFB1;JUN;NR3C1;GNL3;KLF5;ATOH8;GATA2;EGR1;FOXO3
prerank,positive regulation of lipid storage (GO:0010884),0.4245101318299277,1.1187802091192147,0.32269503546099293,0.9601176868427522,1.0,2/21,3.44%,CIDEA;FITM2
prerank,dendritic cell migration (GO:0036336),0.4489091367457564,1.118499202372279,0.33079847908745247,0.9596871146898753,1.0,2/16,10.54%,PIK3CG;TRPM4
prerank,histone modification (GO:0016570),-0.2728625760772814,-1.118380302111506,0.1952054794520548,0.6895461398011312,1.0,31/109,16.66%,EYA2;EYA1;PRDM5;MIER1;HDAC4;NSD3;TBL1XR1;UBE2N;UFL1;HDAC1;SIRT2;KDM4A;PHF20;MORF4L2;PRKCD;ENY2;MTA3;HLCS;MIDEAS;MORF4L1;HUWE1;EHMT2;MTA1;TBL1X;RCOR3;PHC1;MAP3K12;SIRT7;SGF29;TAF6;USP16
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3940645603985183,1.1182755124692336,0.30272108843537415,0.9589945298631286,1.0,6/26,9.90%,FYN;SIRT1;TXN;SOD2;PARK7;FBXO7
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.2995544859510313,-1.1176192680397057,0.24925816023738873,0.6907515628757661,1.0,15/63,17.45%,IGF1;CFLAR;TGFBR1;CYLD;BMP4;PML;HTT;ACVR1;THBS1;DEPTOR;SIAH2;MADD;TRAF2;TCF7L2;SCG2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.29289112361051806,-1.1176012782741371,0.2411764705882353,0.6898557823507606,1.0,20/73,16.69%,ROBO1;SMAD3;CFLAR;COL4A3;MAPT;CASP8AP2;F3;VCP;XDH;FAM162A;IFT57;ANP32B;CASP12;HIP1R;RACK1;HSPD1;NGF;EGLN3;TRAF2;MTCH1
prerank,positive regulation of lyase activity (GO:0051349),-0.4334796602487566,-1.1175801625358646,0.30472103004291845,0.6889639631558915,1.0,3/14,3.09%,CACNA1C;CACNA1D;STIM1
prerank,protein localization to chromosome (GO:0034502),0.38450543038642154,1.1175438001732276,0.3075684380032206,0.9601662424340942,1.0,12/34,18.79%,SLF1;BOD1;ACD;TPP1;ESR1;TNKS;TERF2IP;ATR;SLF2;XRCC4;TNKS2;ATRX
prerank,DNA repair (GO:0006281),0.2815133185940032,1.1172481861847159,0.215311004784689,0.9597690127478431,1.0,69/284,17.81%,ERCC3;ZRANB3;ABRAXAS1;RAD18;TRIM28;ALKBH2;PNKP;ERCC4;RAD1;HPF1;XRCC1;CIB1;TENT4A;POLK;APLF;MAPK8;TDG;ACTR8;POLE;PMS2;SIRT1;ACTR5;DCLRE1B;UBE2V2;EYA3;POLD3;USP47;MLH1;PMS1;GTF2H1;SPRTN;POLA1;RAD23A;RFWD3;EXD2;MSH3;PARK7;UBE2V1;ASCC3;RAD51B;SMUG1;APTX;HUS1;KMT5B;PWWP3A;NBN;DOT1L;TRRAP;MPG;BRCC3;PPP5C;CHEK2;FANCL;NSD2;BRIP1;BACH1;INO80;FTO;ATR;ENDOV;WDR33;XRCC4;SETD2;PRKDC;ATXN3;NPM1;DCLRE1C;POLH;RAD23B
prerank,protein kinase A signaling (GO:0010737),0.4729342432675804,1.11675145140212,0.31688804554079697,0.9601451732645361,1.0,1/12,0.56%,LCP1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.3877924474333,-1.1166611334183048,0.2857142857142857,0.6906768567375469,1.0,5/20,9.97%,AKAP13;ADCY9;ADRA1B;LMBRD2;ZDHHC21
prerank,regulation of cell motility (GO:2000145),-0.27186580251500553,-1.116354779549403,0.17829457364341086,0.6906887995865536,1.0,35/121,17.49%,ERBB4;SPOCK3;PLXNA2;EGFR;LMO4;FBLN1;FGF1;MACF1;RHOA;FLNA;AMOTL2;ROCK2;LMNA;ROCK1;LDB1;CFAP20;AKT2;SRCIN1;DOCK10;CAVIN1;SPATA13;CDK6;SGK1;PRAG1;TTBK2;RHOB;TBCCD1;PLXND1;PLXNB2;RAF1;PLXNC1;TGFB1;ABL2;NEXN;DIAPH1
prerank,neuron migration (GO:0001764),-0.32274344856469595,-1.1163471715015487,0.2612137203166227,0.6897841915042926,1.0,11/48,6.81%,MAP1B;SPOCK1;NRCAM;NTRK2;AUTS2;NRP1;DNER;GPM6A;RELN;DCDC2;SEMA3A
prerank,positive regulation of cell communication (GO:0010647),-0.36265693707670993,-1.1160092107853374,0.29723502304147464,0.6898629005324528,1.0,9/28,18.91%,ANK3;RIMS1;WLS;DLG4;CLSTN2;ILK;PTPN23;KCTD13;CLSTN3
prerank,epithelial cell differentiation (GO:0030855),-0.27716552101019737,-1.1159220557949123,0.24242424242424243,0.6891720709114624,1.0,35/88,30.99%,ERBB4;FGFR2;DAB2;FSTL1;MAF;HDAC1;BMP4;ANXA4;VDAC1;CPT1A;AKT2;PTER;ANXA1;SCUBE1;TOLLIP;ANXA7;SIX1;TAGLN2;FZD7;PGK1;PCK2;GLI1;KDM6B;VEGFA;AKT1;BASP1;PAX2;TAGLN;E2F4;CTSB;PCNA;SCRIB;ALDOC;PIH1D1;GATA6
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.33502047492475473,1.1158037661124949,0.2846715328467153,0.9623123706860252,1.0,14/71,10.62%,MAPK3;ARPC3;VAV3;FCGR2B;ACTB;SRC;ARPC4;FYN;SYK;PLCG1;LYN;PAK1;WIPF3;YES1
prerank,regulation of interleukin-1 production (GO:0032652),-0.4298639702632279,-1.115674142060713,0.2989247311827957,0.6889106038243511,1.0,3/15,12.80%,FOXP1;ANXA1;SIRPA
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3912707701684762,1.1152469480385276,0.3232830820770519,0.9629432727723872,1.0,7/30,12.00%,EBP;INSIG1;HMGCR;PLPP6;IDI1;NSDHL;LSS
prerank,negative regulation of cell cycle (GO:0045786),-0.2899218271541681,-1.115141369513222,0.24786324786324787,0.6894717960039498,1.0,16/73,12.51%,NR2F2;SMAD3;BRINP1;BMP7;BMP4;TRIM35;NUPR1;PTPN3;CDKN1B;GAS1;FOXC1;BRINP2;CDK6;CAMK2N1;RHOB;SIPA1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.308448877536321,-1.1146311886576208,0.28160919540229884,0.6900102415446374,1.0,15/56,18.70%,ANK3;SON;SPIRE1;RHOA;ROCK2;CIT;ROCK1;IST1;BIN3;RHOB;MITD1;TRIM36;STMN1;JTB;SNX18
prerank,proteasomal protein catabolic process (GO:0010498),0.2897556619340392,1.1145877033898186,0.26436781609195403,0.9640075183102316,1.0,45/201,15.40%,PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;FEM1C;SPOP;UBXN11;RFFL;BIRC2;PSMD11;NEDD4L;NHLRC1;PSMB4;PSMC1;COP1;SIRT1;CLOCK;RNF187;CRBN;RBCK1;MDM2;RAD23A;PSMC2;UBE3D;PSMD2;ZNRF1;SPOPL;IFI27;PLAA;CUL3;PSMD14;RNF216;DDIT3;PSMC6;PSMD1;FAF1;APPBP2;PSMB1;TRIM3;NHLRC3;UBE2G1;RMND5A
prerank,liver development (GO:0001889),0.38486730086553633,1.1145502674121577,0.2988505747126437,0.9626461077780968,1.0,6/32,13.39%,PCK1;GFER;CEBPG;CITED2;NF1;LSR
prerank,ethanol metabolic process (GO:0006067),-0.4510049547812498,-1.1143374043327023,0.32461873638344224,0.6898653776383904,1.0,6/12,32.01%,ALDH1A1;ACSS2;ALDH2;ADH5;ACSS1;ADH1A
prerank,glutathione metabolic process (GO:0006749),0.36646996894667394,1.114220956513886,0.30097087378640774,0.9623236458545208,1.0,7/38,13.17%,GCLC;SOD1;GCLM;CNDP2;PARK7;HAGH;GSS
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.44098623901981937,-1.1139817304643023,0.32083333333333336,0.689972098258688,1.0,10/13,52.13%,B3GALT5;B3GALNT1;B3GALT1;B3GALT2;B3GNT9;B3GNT3;B3GNT8;GAL3ST3;B3GNT6;B4GAT1
prerank,nucleocytoplasmic transport (GO:0006913),0.3594785745986639,1.113608896939278,0.31100478468899523,0.963194775135778,1.0,7/40,9.26%,SNRPD2;NCBP1;SNRPD1;BACH2;NXT1;GEMIN5;RSRC1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.4771694653865137,1.1134342625320341,0.3268101761252446,0.962365164594047,1.0,1/11,1.14%,SAG
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.4368233873910332,1.11329879423831,0.3320825515947467,0.961350994253849,1.0,4/17,14.60%,BOD1;CHAMP1;MIS12;MTBP
prerank,oligodendrocyte development (GO:0014003),-0.432762508876506,-1.1129573171465297,0.3225806451612903,0.691920705899979,1.0,10/15,33.88%,PLP1;B4GALT6;TPPP;CNTNAP1;EIF2B5;EIF2B2;EIF2B4;MYRF;B4GALT5;NSUN5
prerank,negative regulation of cell junction assembly (GO:1901889),-0.3669074489585193,-1.112695492388155,0.2975609756097561,0.6917059601281129,1.0,9/25,18.52%,ROBO2;PHLDB2;ROCK2;ARHGAP6;ROCK1;THBS1;DUSP22;ACE;APOD
prerank,endomembrane system organization (GO:0010256),0.29063761692603124,1.1123341207405493,0.24289405684754523,0.9636075346838677,1.0,29/178,10.20%,SURF4;SYNE1;SMPD4;LYSMD3;GORASP2;EXOC8;CLASP2;LEMD3;LMAN2;ATL1;VPS11;TMED4;SEC23IP;RAB43;SYNGR2;TRAPPC8;LAMTOR1;USP6NL;ARHGEF7;TRIP11;VMP1;TMED5;TMED10;REEP3;AKTIP;RAB1A;GOLPH3L;TRAPPC11;DOP1B
prerank,basement membrane organization (GO:0071711),-0.4402584516110789,-1.1123225962605097,0.3303964757709251,0.6918188467393466,1.0,5/14,17.07%,NTNG1;FLRT2;NID2;NTN4;LAMB1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.4344116109654189,1.1120214276188727,0.33454545454545453,0.9633029088506498,1.0,3/18,8.35%,RSC1A1;TRIB3;SLC2A1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3472616281716614,1.1114049225291873,0.28731942215088285,0.9641350074696948,1.0,8/50,10.51%,ACTB;STOX1;CDC37;CCNH;CDKN1A;GTF2H1;CCNG2;BCCIP
prerank,intestinal absorption (GO:0050892),0.4817756414218448,1.1108423335651665,0.3156934306569343,0.9648428918578507,1.0,2/13,7.28%,UGCG;F11R
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.3458977294196536,-1.1107227531709416,0.30632911392405066,0.6953707853138014,1.0,24/29,64.47%,SIRT7;BAG6;RAD21;PRDM9;P3H4;TERB1;MEI4;FANCD2;ZCWPW1;TEX11;REC8;TRIP13;SYCE2;MAJIN;MEIOB;TEX12;STAG3;IHO1;SYCP2;RAD21L1;RNF212B;ANKRD31;HORMAD1;TERB2
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3713739630612889,-1.1105917280271134,0.3063457330415755,0.6948306310844442,1.0,9/25,21.41%,SULF1;FOXD1;SMAD4;BMP4;BMPR1B;ZNF423;BMPR1A;BMPR2;CCN1
prerank,response to alcohol (GO:0097305),-0.359626708280012,-1.110491794109265,0.29064039408866993,0.6941763176547966,1.0,5/27,7.73%,TGFBR3;GRIN2B;TGFBR1;TGFBR2;GLRA1
prerank,regulation of defense response to virus (GO:0050688),0.4636164129024675,1.1104101809385114,0.32437619961612285,0.9649803590560182,1.0,6/14,16.99%,TNFAIP3;IFNLR1;TRAF3;TRAF3IP1;RNF216;ZMPSTE24
prerank,regulation of cholesterol esterification (GO:0010872),0.4869313369681333,1.110300104504944,0.35384615384615387,0.9639464179670767,1.0,2/10,6.46%,APOE;LAMTOR1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.34554354860953873,1.1102942551264015,0.2969502407704655,0.9624911150755497,1.0,17/54,17.96%,PLK2;CNOT11;CDKN1A;EP300;CRADD;CNOT2;RGCC;CNOT7;MDM2;CARM1;CNOT6;CHEK2;CNOT1;CNOT6L;CNOT10;BAX;RPL26
prerank,cholesterol metabolic process (GO:0008203),0.33453342744338427,1.1100775054529992,0.28869047619047616,0.961846328429765,1.0,13/68,12.69%,EBP;INSIG1;HMGCR;PLPP6;APOE;SOAT1;PPARD;SNX17;OSBPL1A;IDI1;NSDHL;LSS;LDLRAP1
prerank,thyroid hormone generation (GO:0006590),-0.4720078028515232,-1.1099449003297852,0.3382978723404255,0.6947620817280772,1.0,3/10,24.76%,CPQ;SLC5A5;CTSK
prerank,regulation of trophoblast cell migration (GO:1901163),-0.43954075211696597,-1.1096668060766746,0.34841628959276016,0.6945707346451576,1.0,5/14,22.30%,SMURF2;GJA1;ACVR1B;ARHGDIB;VEGFA
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.28798247384548864,-1.1096243242141048,0.23492063492063492,0.6937758140557067,1.0,26/80,19.13%,PLD1;SLC2A13;SAMD4A;LRRTM3;VIM;ROCK2;PRKCD;POLDIP3;PRR16;EIF3C;YTHDF1;NIBAN1;THBS1;SMPD3;EEF2;RBM3;IFNGR1;GSAP;RACK1;PLXNB2;METTL5;NAT10;PCIF1;UPF3A;RPS6KB1;CIRBP
prerank,ERBB2 signaling pathway (GO:0038128),0.38925186272905354,1.1095635319621384,0.32830820770519265,0.9623691339093092,1.0,6/31,8.78%,PTPRR;PTPN18;SRC;CDC37;PTPN12;ERBIN
prerank,cytoskeleton organization (GO:0007010),-0.2703370369629595,-1.109482268298118,0.24125874125874125,0.6932786588463631,1.0,55/114,28.81%,EPB41L3;MICAL2;PCLO;PDZD8;ARHGAP10;CDC42BPB;TPM1;RHOA;PLCE1;NEDD9;SYNE3;MICAL3;ZMYM6;PALLD;KLHL20;RND3;BIN1;FGD1;RHOBTB2;RANBP10;CNN2;SPRYD3;PAK5;LIMD1;RHOB;OBSL1;SIPA1;RHOBTB1;RANBP9;FGD4;PPP2R3C;BRWD1;STRIP2;DIAPH1;FMNL2;ARAP3;DIAPH3;CAPZB;PACSIN1;SIPA1L3;ZMYM3;CCL13;NECTIN2;RHOC;RHOU;MAST3;CNTNAP1;DMTN;FGD3;MICAL1;RHOH;CSPG5;MDK;BRWD3;AJUBA
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4387092818585564,-1.1094536120472502,0.3375,0.6924249004336864,1.0,3/13,7.03%,SORBS1;IGF1;AKT2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4248154193871725,1.1091931004858782,0.32656826568265684,0.9622557720501566,1.0,2/18,5.93%,CABYR;RFX3
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4239085303150876,-1.1089075911681576,0.34292035398230086,0.6930597529503034,1.0,7/14,26.73%,FLNA;LOXL3;PRKD1;ITGB1BP1;EMP2;DMTN;SLC2A10
prerank,tRNA methylation (GO:0030488),0.37404776048612265,1.1087577750116455,0.31751227495908346,0.96238762108196,1.0,6/34,11.85%,TRMO;BCDIN3D;THUMPD2;TRMT61B;METTL2B;METTL2A
prerank,nuclear membrane disassembly (GO:0051081),0.45137458747002995,1.108149777246358,0.3375912408759124,0.9632028228270392,1.0,4/14,13.66%,NEK9;CNEP1R1;AKAP8L;NEK6
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3740777164483673,1.1080840887336978,0.3185689948892675,0.961990849600068,1.0,12/31,20.97%,GSK3A;MAPK8;YWHAB;ZNF205;BAD;PPP3R1;YWHAH;YWHAQ;BAX;YWHAE;YWHAZ;TFDP2
prerank,regulation of neuroinflammatory response (GO:0150077),-0.39515662078796326,-1.1076311268795622,0.3318777292576419,0.6957663527971304,1.0,5/19,19.91%,IGF1;NUPR1;IL18;IL33;PTGS2
prerank,skeletal muscle organ development (GO:0060538),-0.37008307934602475,-1.1069727843727075,0.2900232018561485,0.696762056086039,1.0,7/26,24.63%,SVIL;CFLAR;IGSF8;LARGE1;SIX1;STRA6;BASP1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.33928219298565193,-1.10695294575243,0.2915601023017903,0.6958874392567731,1.0,14/37,25.06%,IGF1;IGFBP5;TPM1;TAFA5;CDKN1B;ADAMTS1;GJA1;JUN;BMPR1A;DNMT1;MMP2;EFEMP2;TGFB3;MEF2D
prerank,energy reserve metabolic process (GO:0006112),-0.38937190929801896,-1.106799518563427,0.3047619047619048,0.6954462416755813,1.0,8/19,25.00%,PRKAG2;LEPR;PID1;GSK3B;PYGM;PHKG2;GFPT1;GFPT2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.47173161329125085,-1.106718303492498,0.3313253012048193,0.6947679805650727,1.0,1/10,0.36%,ANK3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.3272039857175175,-1.106483278792119,0.28641975308641976,0.6945643470149026,1.0,18/38,37.04%,SMAD3;P2RX4;ROCK2;PTGIS;DDAH1;CD34;SIRPA;PTGS2;AKT1;HSP90AA1;CX3CR1;DDAH2;ZC3H12A;ASS1;CAV1;EDN1;CLU;ATP2B4
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.38258407857128673,-1.1064672102571904,0.33489461358313816,0.693700108252872,1.0,4/23,5.00%,ERBB4;PIBF1;KIT;GHR
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.47571962126495937,-1.1064608808747167,0.3333333333333333,0.6928086435347366,1.0,7/10,24.45%,GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3493111607508123,-1.1064547207479187,0.32186732186732187,0.691920969232761,1.0,19/29,44.38%,CYLD;PML;THBS1;TRAF2;PPP2R1B;LTBR;TNFSF12;SFRP1;BCL10;INHBA;BID;CAV1;DEDD2;GPER1;HTRA2;AGT;HYAL2;G0S2;PYCARD
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.4563725463414915,-1.1059545836672708,0.3303964757709251,0.6924041712924354,1.0,4/12,8.17%,DOCK5;IGFBP5;TPM1;ADAMTS1
prerank,regulation of cell projection organization (GO:0031344),-0.4394193607911845,-1.1058621546715885,0.30462184873949577,0.6917674321664143,1.0,4/13,15.51%,NTNG1;MACF1;SEMA4D;ERMN
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.3030335975433798,-1.1058521552997085,0.24873096446700507,0.6908889546727887,1.0,23/55,25.36%,GPC6;SDC2;CEMIP;VCAN;OGN;GPC3;CEMIP2;HSPG2;HEXA;HEXB;ARSB;GPC5;CSPG4;PRELP;TGFB1;GNS;LUM;GUSB;GPC4;SDC3;BGN;DCN;HYAL1
prerank,regulation of dephosphorylation (GO:0035303),0.4425045396072906,1.105835211405102,0.34,0.9689902695856902,1.0,7/15,19.90%,SRC;PPP1R16B;MTMR2;SMG6;SMG5;IGBP1;SMG7
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.3981616001099757,-1.1054142748524216,0.31683168316831684,0.6912134725728174,1.0,6/20,17.31%,LBP;IRAK1;IL18;PTPN22;TGFB1;MTDH
prerank,epithelial to mesenchymal transition (GO:0001837),-0.3162968504872982,-1.1049835121793066,0.27297297297297296,0.691518140675071,1.0,12/47,11.62%,DDX5;TGFBR3;DDX17;TGFBR1;CTNNB1;BMP7;ROCK2;ROCK1;WNT4;GSK3B;LOXL3;TBX3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.33186395865762136,1.1045230653775169,0.28989751098096633,0.9724250050938428,1.0,14/73,10.62%,MAPK3;ARPC3;VAV3;FCGR2B;ACTB;SRC;ARPC4;FYN;SYK;PLCG1;LYN;PAK1;WIPF3;YES1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.46389104587419994,1.1044775132341569,0.31467181467181465,0.9711414366091086,1.0,2/12,3.70%,RALB;IFIT1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.4912818003335768,1.1040055010178635,0.3660531697341513,0.9713916678137978,1.0,1/10,0.88%,SEMA6A
prerank,response to ethanol (GO:0045471),0.4541396656743415,1.1038417720158866,0.34501845018450183,0.970565238380041,1.0,3/14,4.49%,SOD1;GOT2;SDF4
prerank,regulation of lipid biosynthetic process (GO:0046890),0.37995127362800235,1.1035751159251164,0.31951640759930916,0.9701485948674277,1.0,8/32,11.09%,PCK1;FITM2;NR5A1;APOE;ASXL3;ADIPOR2;PRKAA2;ADIPOR1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.31037781460058766,1.1034508786472872,0.27607361963190186,0.969149099077636,1.0,17/93,11.27%,PDE4D;MTCP1;RPTOR;STOX1;BCAR3;PRKD2;CNKSR3;RAPGEF3;BDNF;SMAD7;TXN;AXIN1;PAK1;PARK7;DOCK7;DMD;APP
prerank,aggrephagy (GO:0035973),-0.35998919559312104,-1.103445206681214,0.2985781990521327,0.6948321478496619,1.0,8/27,11.40%,WDFY3;ACBD5;UBE2N;DYNC1H1;DYNC1LI2;VIM;UBC;ARL13B
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.32776631033164955,1.103434574065161,0.3009118541033435,0.9677437957849658,1.0,13/72,11.82%,MAZ;PIK3CG;CBL;PIK3AP1;SRC;TEK;SELP;SIRT1;IRS2;LYN;FLT1;PIK3CD;PIK3R5
prerank,activation of protein kinase activity (GO:0032147),-0.27201089431349373,-1.102773648821443,0.2528301886792453,0.6957994222135419,1.0,40/106,25.13%,NTRK3;IGF1;ADCY5;ADCY2;FGF1;ADCY1;TGFBR2;PRRC1;PIBF1;MALT1;ADCY9;GHR;TAOK3;PRKCD;IRAK1;PRKACA;STRADA;STK11;ADCY7;PAK5;PRKAR1B;TAOK1;IL18;TOM1L1;TRAF2;CARD10;PINK1;CARD14;PRLR;OSBPL8;ADCY8;ADCY3;VEGFA;ADCY4;ITGB1BP1;EMP2;NRK;AKT1;ADRA2A;TLR3
prerank,alpha-amino acid metabolic process (GO:1901605),-0.3115965087138737,-1.1025963193106865,0.27624309392265195,0.6954035952899497,1.0,23/45,30.70%,ASPA;SRR;SLC25A13;ATP7A;GLUL;GLUD1;MTHFR;DDAH1;NOX4;MTHFD1;NAALAD2;KYAT1;GPT2;GOT1;ASPG;KYAT3;RIMKLB;OAT;MTRR;DDAH2;ALDH18A1;ASS1;RIMKLA
prerank,regulation of amyloid-beta formation (GO:1902003),-0.34149673427398425,-1.1025524192113552,0.31690140845070425,0.6946479744169662,1.0,11/34,12.54%,IGF1;SLC2A13;LRRTM3;NTRK2;RTN1;ROCK2;SORL1;ROCK1;BIN1;IFNGR1;GSAP
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.40860181608496726,1.1023452128295546,0.33575317604355714,0.9702436597313491,1.0,5/23,13.87%,PLAAT3;LPCAT3;MBOAT1;PNPLA8;ABHD4
prerank,response to amino acid (GO:0043200),-0.34962543362007337,-1.1023260906754586,0.29528535980148884,0.6944043026441794,1.0,6/31,7.73%,CPEB4;CPEB1;GLRB;CAPN2;GLRA3;GLRA1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.26540046107345405,-1.1018143351124947,0.24825174825174826,0.6949187583737628,1.0,14/113,5.83%,BMP6;FGFR2;NOTCH2;IGF1;EGFR;NRP1;FGF1;TGFBR1;BMP5;BMP4;RREB1;OSR1;SRSF6;F3
prerank,phospholipid dephosphorylation (GO:0046839),-0.3270251645624332,-1.101487649436613,0.2849740932642487,0.6949217442962309,1.0,17/37,27.74%,PLPPR1;PLPP3;MTMR7;PIP4P2;SACM1L;PLPPR5;MTMR12;PLPPR4;MTMR9;MTMR4;MTMR11;PLPP5;EPHX2;PIP4P1;INPP5F;OCRL;INPP5K
prerank,defense response to tumor cell (GO:0002357),-0.48073342613798375,-1.1014758824318482,0.36254980079681276,0.6940707310878677,1.0,8/10,48.44%,RBMS3;DAPK1;PRDX2;ABI3;PLK5;LAPTM5;SPI1;DLEC1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.4208490682660475,1.1013184582922773,0.35648994515539306,0.9725376934964478,1.0,5/18,11.62%,ACSL5;HSD17B12;ELOVL6;ACSL4;HACD2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.31115937549267225,1.1010379640213117,0.2710144927536232,0.9720981534395658,1.0,23/88,13.65%,SH3D19;HSPA8;SORT1;EXOC8;EXOC6B;GOPC;MYO5A;CLTA;DTNBP1;AP1G1;AP1S2;NAPA;RAB14;ARF1;AP4S1;RABEP1;DOP1B;CHMP2A;CLVS1;APP;SCFD1;SCAMP1;CCDC93
prerank,positive regulation of transferase activity (GO:0051347),0.2966513048831446,1.1008561016879208,0.2749003984063745,0.9713131565493917,1.0,28/142,11.70%,SERINC1;MAP2K7;MAPK3;GSK3A;TRIB3;PIN1;PNKP;GREM1;CCT2;DCUN1D4;TEK;MAP3K4;UBE2I;DBI;RET;EPHA5;BMI1;AXIN1;MAGEC2;EPM2AIP1;ACD;MERTK;CSF1R;TIE1;SERINC5;NEK7;FLT1;TNKS
prerank,positive regulation of interleukin-8 production (GO:0032757),0.34452849908679134,1.100810944705878,0.30974842767295596,0.9700327602683753,1.0,8/49,13.40%,TIRAP;PRKD2;SYK;RELA;RAB1A;PARK7;NOD1;DDIT3
prerank,positive regulation of axon extension (GO:0045773),-0.37376644013764665,-1.1006454634669844,0.29718004338394793,0.6954235322165792,1.0,10/22,22.30%,NRP1;MAPT;MACF1;DSCAM;SHTN1;TWF2;ZFYVE27;SEMA5A;DBNL;VEGFA
prerank,regulation of phospholipase activity (GO:0010517),-0.47057856065501863,-1.1006081031768573,0.3786610878661088,0.6946390187085657,1.0,2/10,0.70%,FGFR2;LRP1
prerank,post-translational protein modification (GO:0043687),0.27150200250339795,1.1004300230886206,0.23494687131050768,0.9699770507855374,1.0,57/332,14.01%,CISH;PSMB10;PSMC4;PSMB6;CAND1;ELOC;RNF7;PSMD8;PSMD5;PSMD12;KLHL5;KLHL3;FEM1C;CHML;BTBD1;CHM;CDH2;PSMD11;NEURL2;PTP4A2;APOE;PSMB4;FBXL5;WFS1;RAB11B;PSMC1;PDIA6;VWA1;FBXW2;DCAF6;COP1;LMO7;KLHL2;FBXO32;FBXO11;ESCO1;RAB1A;PSMC2;PSMD2;FBXO7;UBE2M;ICMT;MBTPS1;NAE1;STT3B;COPS7B;APP;ELOB;CUL3;DCAF10;PSMD14;EPAS1;UBE2F;PSMC6;PSMD1;PROC;PSMB1
prerank,positive regulation of cell differentiation (GO:0045597),-0.24102015268002908,-1.1004288907198307,0.18009478672985782,0.6942054465635403,1.0,36/237,8.36%,BMP6;RANBP3L;IGF1;CTNNA2;DAB2;COL1A1;SMAD3;NRCAM;BOC;NBL1;CDON;NELL1;CTNNA1;CCN2;BRINP1;TGFBR1;MEDAG;MAPK14;SOX5;TGFBR2;CTNNB1;PDPN;BMP7;SMAD4;RHOA;IL6R;BMP4;ZEB1;FBN2;HOXA5;WNT4;TMEM64;LRP5;CREBL2;FOXC1;BRINP2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.32819721034123905,1.1000159059123737,0.33478893740902477,0.9700698448202545,1.0,16/73,14.63%,CTCFL;EZH2;EED;POLR1C;ACTB;EP300;TDG;POLR1G;BMI1;WBP2;TBP;HDAC5;PPHLN1;TRIM27;TASOR;AEBP2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.43870927350862865,1.099875110646107,0.34317343173431736,0.969179396032747,1.0,4/16,6.85%,ATP5F1E;ATP5MG;ATP5PF;ATP5MC2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4038159880235995,-1.0996748066982158,0.33043478260869563,0.6953426616806841,1.0,2/17,2.80%,PLA2G4A;LPGAT1
prerank,pyroptosis (GO:0070269),-0.4201298238792701,-1.0995887610787611,0.3448979591836735,0.6946935601998585,1.0,9/15,51.23%,GSDME;AIM2;GSDMD;APIP;CASP8;ZBP1;CASP1;TREM2;NLRC4
prerank,aortic valve morphogenesis (GO:0003180),-0.3452072856167354,-1.0993958205961405,0.3261904761904762,0.6943262084882365,1.0,6/30,8.66%,ROBO2;ROBO1;BMP4;ROCK2;ROCK1;SMAD6
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.4138311869900468,-1.0991601992575002,0.3463203463203463,0.6940544716592558,1.0,7/16,19.18%,APPL2;PPARA;ADCY7;SIRPA;ABCD2;APOD;CHID1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.3012027841879259,-1.0990314164009827,0.2682926829268293,0.6935212230145468,1.0,11/57,13.88%,ERBB4;IGF1;PARP14;IL6R;PIBF1;KIT;GHR;IL31RA;NF2;IL18;IL6ST
prerank,cytosolic transport (GO:0016482),0.31237193569669747,1.0990043691514626,0.29784172661870506,0.9709699042496953,1.0,35/108,18.89%,VPS50;HEATR5B;SORT1;PREPL;VPS29;RAB7A;VPS26A;TBC1D10B;GOSR2;AP1G1;RAB6B;PIKFYVE;RAB6A;RAB14;AKTIP;SNX1;VPS53;GCC2;DOP1B;RBSN;MYO1D;ERC1;TRIM27;ANKRD27;TBC1D23;CORO7;VPS35;HOOK3;SNX16;BECN1;GAK;KIF16B;HEATR5A;GOSR1;EVI5
prerank,heart process (GO:0003015),0.4532744490261166,1.0988612905784858,0.3527272727272727,0.9700485352708519,1.0,2/14,4.94%,SOD1;FYN
prerank,sodium ion homeostasis (GO:0055078),-0.38695880687442336,-1.0986315664393735,0.31890660592255127,0.6937305672942755,1.0,6/21,9.45%,ATP1A2;ATP1B1;ATP1B3;SLC12A2;ATP1A1;ATP1B2
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.33918761502097716,-1.0981449077895171,0.30455635491606714,0.6942223580744878,1.0,9/31,11.96%,RANBP3L;CRIM1;SKI;TMEM64;LRP5;SMAD6;CDK6;SEMA4D;LIMD1
prerank,negative regulation of double-strand break repair (GO:2000780),-0.3461574748122359,-1.0977504515135412,0.31234866828087166,0.6944345723140557,1.0,21/30,44.30%,ERCC6;UBR5;SHLD1;RNF169;HSF1;RIF1;SMCHD1;SHLD2;HMGA2;OTUB1;POLQ;TWIST1;OGG1;CYREN;FANCB;CGAS;MAD2L2;NUDT16L1;RMI2;TFIP11;PARPBP
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.3313377846232479,-1.097746699138801,0.3071253071253071,0.6935642462806272,1.0,16/34,24.53%,GRID2;GRIN2B;GABRA2;GABRG2;GLRA1;GSK3B;GABRA5;GABRG3;GABRA4;GRIN2D;GRIN1;GABRG1;NLGN3;MPP2;GABRA1;AKT1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.40654569228990445,-1.0977264815042638,0.3613636363636364,0.6927473656224556,1.0,8/17,22.16%,SULF1;FSTL1;XIAP;PCSK6;TMEM204;SFRP4;TWSG1;DOK5
prerank,RNA modification (GO:0009451),0.3389754607202864,1.0975608384126152,0.3052147239263804,0.9735014935139448,1.0,15/54,19.85%,THG1L;THUMPD1;BCDIN3D;ADAR;ANKRD16;WDR4;SSB;ADARB1;NSUN6;PARN;CDKAL1;NSUN2;TFB1M;FTSJ1;URM1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.3065988834669301,-1.0974370608670245,0.30456852791878175,0.6926534841612187,1.0,7/43,13.21%,AHI1;MICAL2;TGFBR2;SMO;ACVR1;TBX3;SETDB2
prerank,regulation of cellular response to stress (GO:0080135),0.296622102948183,1.0966624643331995,0.2876712328767123,0.9753928449150674,1.0,34/115,19.39%,ATF3;MAPK3;CHCHD2;HSPA8;RPTOR;MANF;SMG1;AKT1S1;EP300;BAG1;NUP54;SIRT1;NUP50;ING2;CCAR2;CREBBP;FKBP4;NUP35;NEK6;CORO2B;NDC1;CAMK2G;ATR;RSL1D1;HIKESHI;NUP160;NPM1;POM121;NUP42;NUAK1;EIF4G1;YWHAE;NUP133;HSPB8
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3999735151725671,-1.096433186768426,0.3243801652892562,0.6945310779605866,1.0,6/16,24.99%,RIMS1;SNCAIP;SYN1;FLOT1;CPLX1;CAMK2A
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.33456240041434593,1.095947380664954,0.30326594090202175,0.976693189414776,1.0,13/60,11.53%,TRIM28;LEF1;CCNC;CDKN1A;MED23;MED12;HEY2;MED15;CDK4;RELA;CSF1R;AGO4;MED4
prerank,ribosomal small subunit assembly (GO:0000028),0.43648168058971,1.0956185195056802,0.33882783882783885,0.9765496086194116,1.0,7/16,21.79%,RPS14;RPS28;RRP7A;PRKDC;RPSA;RPS27;RPS5
prerank,establishment of spindle orientation (GO:0051294),-0.34543152338476096,-1.0953139569809451,0.3222748815165877,0.6967727556772001,1.0,9/28,24.02%,FBXW11;HTT;UBXN2B;GJA1;NSFL1C;DCTN1;NDE1;ZW10;LLGL1
prerank,regulation of mRNA stability (GO:0043488),0.2955199539689835,1.0952346645557205,0.2727272727272727,0.976591695660417,1.0,32/145,16.62%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;HSPA8;ZFP36L1;PSMD11;PSMB4;PSMC1;FXR1;YWHAB;EXOSC9;PCID2;PSMC2;PSMD2;TAF15;ZC3H14;XPO1;PSMD14;EXOSC1;PSMC6;PSMD1;PSMB1;YBX1;DCP1A;FUS;NOCT;FTO;PARN;PSMA4
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.38450579806742463,1.0949280566878425,0.33665008291873966,0.976295646578394,1.0,8/30,13.62%,TNFAIP3;RFFL;TNFRSF10B;ICAM1;PARK7;DDX3X;NOS3;FAIM
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2782779528137052,1.0947501567393865,0.26282853566958697,0.9755340494859099,1.0,43/234,14.10%,LRP8;MAP3K7;TAB2;PRKCH;RPS6KA4;CAMK1D;TIRAP;HIPK2;TRIM8;PRKD2;RPS6KA5;RAB7B;PHB2;TRIM14;CIB1;EP300;CARD16;CEBPG;TRAF5;EPHA5;RGCC;CLOCK;TAB3;TRIM25;WNT5A;RELA;RBCK1;PARK7;BUD31;UBE2V1;ESR1;RNF25;APP;NOD1;RPS3;PRKCI;IKBKB;ERC1;CHUK;HDAC5;DDIT3;NFKBIA;TRIM27
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.309141237870264,1.0943405977164717,0.29385964912280704,0.9756013185032223,1.0,15/102,9.89%,PCK1;PRKAR1A;GSK3A;TRIB3;NR4A2;INSIG1;SRC;HDAC9;ZFP36L1;TSHR;MYO5A;TBC1D4;IRS2;RELA;RHOQ
prerank,"wound healing, spreading of cells (GO:0044319)",-0.3659718190522643,-1.0942681914129437,0.3201754385964912,0.6988147416086473,1.0,7/24,6.53%,TMEFF2;COL5A1;PDPN;RHOA;FLNA;DDR1;ITGA5
prerank,bile acid metabolic process (GO:0008206),-0.3493721526391926,-1.0941992074095555,0.331002331002331,0.6981817520571432,1.0,5/27,10.21%,OSBPL9;OSBPL6;CYP27A1;CYP7B1;OSBP
prerank,brain development (GO:0007420),-0.25910683077332836,-1.0941854649244853,0.23308270676691728,0.6973412028198602,1.0,58/136,31.52%,ROBO2;CNTN4;ZIC1;CTNNA2;ARNT2;PBX1;GRIN2B;NFIB;AFF2;NCOA6;TGFBR2;EPHA7;MEIS2;FBXW11;RELN;HSPG2;NIPBL;SMARCA1;ZIC2;ATXN1;SCYL2;NNAT;CTNS;CIC;BBS2;PLXNB2;RAPGEF2;NES;PBX4;SOX6;APOD;BPTF;PBX2;SMG9;GRIN2D;GRIN1;BAG6;IER3IP1;PCDH18;PAX2;NDRG4;PTCH1;ADGRG1;DDIT4;CX3CR1;POU6F1;EEF1AKMT4-ECE2;UTP3;AATK;SLC6A17;QARS1;MDGA1;TMX2;CLN5;COL4A1;CDK5RAP3;VPS51;MFSD2A
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4037954720449921,1.0938765778564183,0.32717190388170053,0.9758260592285697,1.0,6/23,11.62%,ACSL5;HSD17B12;ELOVL6;FAR2;ACSL4;HACD2
prerank,autophagosome maturation (GO:0097352),0.37567136934313083,1.0938502432324004,0.333889816360601,0.9745141297530888,1.0,12/32,18.89%,MAP1LC3B;ATP2A2;VMP1;EPG5;TECPR1;UBQLN1;ATG14;GABARAPL1;VPS33A;GABARAP;CALM1;LAMP2
prerank,regulation of axon extension (GO:0030516),-0.3360341749389501,-1.0937102616809047,0.2992874109263658,0.6977969552534905,1.0,8/37,6.89%,MAP2;NRCAM;PTPRS;MAPT;MACF1;SHTN1;SEMA3A;CTTN
prerank,cell junction organization (GO:0034330),-0.2888327823795097,-1.0934412087717247,0.27605633802816903,0.6976863270623318,1.0,15/71,7.34%,SDK1;GRM5;SMAD3;PPFIBP1;CXADR;MAPT;OCLN;RHOA;NLGN2;SLC6A1;FLNA;PPFIA1;RAB8B;CTNND2;SDK2
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.32194488782454045,-1.0933881641680934,0.29533678756476683,0.6969494867984827,1.0,12/41,20.69%,ANK3;JAK1;BMP7;PLPP3;ADAM19;AFDN;DENND6A;PTPRU;MEGF10;PTPN23;FLOT1;CX3CL1
prerank,negative regulation of cellular senescence (GO:2000773),0.46331497574584424,1.0930382039432263,0.3516068052930057,0.9760767385954,1.0,6/13,14.29%,FBXO5;SIRT1;ZKSCAN3;TERT;YBX1;MAP3K3
prerank,negative regulation of cellular process (GO:0048523),-0.22515213624301159,-1.0926944659893343,0.11578947368421053,0.6980100511740723,1.0,178/521,27.86%,MAGI2;ERBB4;ST18;TGFBR3;PLXNA2;ADAM22;ALDH1A2;SMAD3;KANK2;CLMN;VPS13C;TNS2;FBLN1;FHL1;CCN2;PTPN14;BRINP1;PACRG;COL4A3;BMP5;ABI1;CTNNB1;PDPN;BMP7;SMAD4;DSCAM;RBBP7;ATP8A2;SIRT2;IGFBP7;BMP4;NUPR1;ZBTB7C;LMNA;PDS5B;ENPP1;PIP4P2;APPL2;SRSF6;MYO16;VGLL4;FRK;PML;PODN;SKI;GSDME;IGFBP6;CDKN1B;CDC73;ADAMTS1;NDUFS3;SMAD6;ANP32B;NIBAN2;DLG3;SERTAD2;CGRRF1;EIF2AK2;BRD7;CDK6;PLSCR1;SPEG;GJA1;EPHB2;CAMK2N1;DDAH1;TP53;SEMA4D;NOX4;STK11;CD34;RHOB;ACVR1B;SYT11;SIPA1;TNFRSF21;SIRPA;WNT9A;P3H3;FKTN;PDCD5;PLXND1;NF2;ROR2;RACK1;DUS2;ARHGDIA;TOB1;NACC2;PLXNB2;SIRT7;RAF1;PTPRU;NGF;PLXNC1;GPLD1;CBLL1;NPAS2;RAPGEF2;TAF6;TGFB1;RNF139;CCN3;S100A11;PTPN2;NPR1;SMYD2;OPRM1;SFRP4;TSC2;CRYAB;RNF167;SNX3;ORC6;SUZ12;MDM4;SEMA5A;ATF5;TGFBI;BMPR2;BLM;DNAJB2;ITGA1;PARP16;BCL2;CCN5;TMEM109;COL18A1;ADRA1A;P3H1;CCN1;PRKD1;ARHGDIB;FLCN;IFIT3;HGS;MNT;IMPACT;EMILIN1;DUSP1;TBRG1;KLF10;UBR2;OSGIN2;ANXA6;ITGB1BP1;TSPYL2;BST2;VAMP8;TGFB3;EIF2AK3;BTG2;PLXNB1;NR1H2;SESN2;AQP11;HYAL1;SFRP1;ADGRG1;APBB1;NR4A1;NOTCH4;CCN4;ZBTB17;DLG5;TEX15;VHL;PLXNA1;DCBLD2;CELF1;RBM5;SH3BP4;FGFBP1;INHBA;CHERP;KLF11;DACT3;NME6
prerank,regulation of viral entry into host cell (GO:0046596),0.3777089537477135,1.0922876410017355,0.3489583333333333,0.9773525090204433,1.0,6/30,8.83%,LY6E;IFITM2;TRIM14;IFITM3;TRIM25;IFITM1
prerank,gas transport (GO:0015669),0.46920893274631315,1.091701102303811,0.35968379446640314,0.9781595891621877,1.0,1/10,3.98%,CA2
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.3374989160210953,-1.0915538392980437,0.3222748815165877,0.7003108275768911,1.0,13/36,16.58%,ANK3;VAMP5;MACF1;RILPL1;RAB31;GGA2;OPTN;AFDN;VAMP2;BBS2;NECTIN3;GOLGA7;GGA3
prerank,positive regulation of developmental growth (GO:0048639),0.34448379873966584,1.0914674286745072,0.32,0.9776187276069106,1.0,9/49,12.19%,CPNE5;SEMA7A;PPIB;NEDD4L;BDNF;RUFY3;PLCB1;AGRN;PLAA
prerank,negative regulation of biomineral tissue development (GO:0070168),0.41245666169361367,1.0911229577070989,0.3362521891418564,0.977473464778671,1.0,8/21,16.34%,GREM1;HEY1;HEY2;NOTCH1;TRPM4;NOS3;GAS6;PTK2B
prerank,actin filament depolymerization (GO:0030042),-0.4532672661186053,-1.0910161298666434,0.3644251626898048,0.7009522330390091,1.0,5/11,17.63%,GSN;MICAL2;MICAL3;WDR1;TWF2
prerank,negative regulation of viral genome replication (GO:0045071),0.35738458567367504,1.0907119085017807,0.3092436974789916,0.9775883093660394,1.0,7/40,10.59%,ILF3;BANF1;IFITM2;IFIT1;IFITM3;IFITM1;SRPK2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.4093307511267087,-1.090433541892318,0.33995584988962474,0.7016929132927117,1.0,6/16,24.21%,VIM;BMP4;WNT4;TGFB1;CREB3L1;TGFB3
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.32158981231487105,1.0903310849727323,0.31008902077151335,0.977535185658305,1.0,7/72,4.99%,POLR2J;MAPK3;NCBP1;CBL;POLR2B;SHCBP1;SPRED1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3184609301883776,1.0902185754488958,0.30988023952095806,0.9765262260107578,1.0,17/76,13.90%,TNFAIP3;NWD1;MAP2K5;SIRT1;NLRC3;MTURN;ERBIN;TRAF3;RBCK1;NFKBIL1;CYP1B1;G3BP2;CHUK;NLRC5;DDIT3;FAF1;NFKBIA
prerank,regulation of blood coagulation (GO:0030193),-0.35754100825701324,-1.0899866616783072,0.31263858093126384,0.7021085621534101,1.0,10/27,25.87%,TFPI;THBS1;FAP;VTN;EPHB2;CD34;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.4566539932195498,-1.089532429776785,0.37627811860940696,0.7024812624765283,1.0,1/11,1.32%,AKAP6
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.35760247423686176,1.0891148294131014,0.326158940397351,0.9791897537700458,1.0,11/38,13.09%,NDUFAF1;NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;NDUFB7;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,protein trimerization (GO:0070206),0.45356714615886384,1.088987112210627,0.3575525812619503,0.9768372046351165,1.0,3/14,8.22%,SIGMAR1;MLKL;SLC1A2
prerank,protein homotrimerization (GO:0070207),0.45356714615886384,1.088987112210627,0.3575525812619503,0.9768372046351165,1.0,3/14,8.22%,SIGMAR1;MLKL;SLC1A2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4229788247884434,1.0885973377406277,0.35283018867924526,0.9768505503922409,1.0,7/19,17.78%,PTPRJ;PTPRC;SELP;PRNP;ADGRL1;BCAP31;RYR2
prerank,regulation of transmembrane transport (GO:0034762),0.3739048419285866,1.0885524816475145,0.3298791018998273,0.9756212500454327,1.0,5/31,8.35%,TRIB3;ACTB;NEDD4L;PIM1;SLC2A1
prerank,heme biosynthetic process (GO:0006783),0.4100823858562022,1.0882331320085128,0.3409490333919156,0.9754625494452516,1.0,9/22,18.60%,ABCB10;ABCG2;TSPO;COX15;COX10;SLC25A38;ALAS1;FECH;NFE2L1
prerank,translational termination (GO:0006415),0.30763835164537556,1.088175956431246,0.3015647226173542,0.9742775708381023,1.0,13/95,12.45%,MRPS22;MRPS2;MRPS33;MRPL23;MRPL24;MRPL18;MRPL38;MRPS12;MRPL20;MRPL52;MRPS15;MRPS24;MRPL48
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.46867481526003485,-1.0880906048340195,0.3548387096774194,0.705415521472557,1.0,5/10,38.77%,CBFB;NCKAP1L;HMGB1;ZBTB7B;SH3RF1
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.292440991932278,-1.0877141132426222,0.26216216216216215,0.7055811060991172,1.0,12/63,8.12%,TIMP3;LEPR;TIMP2;NELL1;SIRT2;NUPR1;KDM4A;KLHL22;SORL1;ROCK1;PTPN3;GOLGA2
prerank,regulation of transport (GO:0051049),0.36767816747915955,1.0876311275877228,0.3409090909090909,0.9749008517434216,1.0,6/36,11.59%,RSC1A1;ACTB;ICA1;EPB41;MBTPS1;SCFD1
prerank,positive regulation of protein metabolic process (GO:0051247),0.3036855958350037,1.087364862885056,0.30027932960893855,0.974466272080224,1.0,20/110,13.90%,GSK3A;ABCB10;TNFAIP3;PLK2;KLF2;MAP2K5;NEDD4L;APOE;RAB7A;WFS1;MAPK8;AXIN1;WNT5A;RAB1A;APP;ATG7;EGLN2;NDUFA13;APC;NFKBIA
prerank,activation of GTPase activity (GO:0090630),0.3050201594654072,1.0873639872577459,0.31314623338257014,0.9730866288819636,1.0,24/89,14.63%,TIAM1;EVI5L;ARHGEF26;TBC1D30;TBC1D8;RALGAPA2;TBC1D9;ARHGAP25;TBC1D10B;USP6NL;TBC1D4;RALGAPB;RABGAP1L;TBC1D12;TSC1;TBC1D25;DOCK7;RHOG;ADPRH;TBC1D14;RABGAP1;RALGAPA1;SYDE1;ARHGEF10
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.3978824433264216,-1.0871560996670844,0.3487858719646799,0.7063672276188666,1.0,6/17,25.96%,EGFR;PKD1;CCND3;CCNYL1;AKT1;SPDYA
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.39895335061094056,1.087040995364161,0.34956521739130436,0.9728579727892488,1.0,7/26,16.11%,RRM2B;ALG6;TPI1;ALG8;ST8SIA6;RRM1;GBGT1
prerank,regulation of viral genome replication (GO:0045069),0.3346731133090309,1.086762959852842,0.3201267828843106,0.9724435536943449,1.0,12/56,12.53%,ILF3;BANF1;IFITM2;IFIT1;IFITM3;ADAR;CNOT7;IFITM1;RAD23A;SRPK2;DDX3X;TMEM39A
prerank,cellular response to increased oxygen levels (GO:0036295),0.4743764390669679,1.0865774554574312,0.3716475095785441,0.9717042278766211,1.0,6/11,22.61%,ATP6V0D1;ATP6AP1;ATG7;ATP6V1A;FAS;FOXO1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.28742821639209254,1.086432844942835,0.30641025641025643,0.9708490474122526,1.0,38/158,16.60%,ZDHHC17;JMJD8;MAP3K7;TAB2;PLK2;EEF1D;TIRAP;TRIM8;BIRC2;ZDHHC13;TNFRSF10B;TMED4;TRIM14;EDAR;GPR89A;CARD16;TRAF5;TAB3;TRIM25;RELA;RBCK1;LURAP1;UBE2V1;NOD1;TNIP2;IKBKB;CHUK;PPP5C;ANKRD17;NEK6;ATP2C1;TRIM27;MAP3K3;S100A13;TERF2IP;PELI1;FKBP1A;SLC44A2
prerank,leukotriene metabolic process (GO:0006691),-0.39026181264747867,-1.0862140575429238,0.3447488584474886,0.7080705654130138,1.0,14/19,55.79%,PLA2G4A;GGT5;MAPKAPK2;ABCC10;MGST3;ALOX12;LTA4H;PTGR1;GGT1;PLA2G5;ALOX5AP;MGST2;ALOX5;DPEP1
prerank,response to calcium ion (GO:0051592),-0.273434808931322,-1.0860214757668005,0.2668918918918919,0.7077323021739997,1.0,26/102,15.96%,KCNMA1;CPNE8;RYR3;IQGAP1;SEC31A;STIM1;ADCY1;CLIC4;ADGRV1;SLC25A13;ANXA11;SYT9;NLGN1;TRPC1;THBS1;LGMN;CAMK2D;SYT12;SYT11;SYT4;RASGRP2;CPNE2;SYT7;GPLD1;PEF1;D2HGDH
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.33047865994984466,1.0858659394837276,0.33183183183183185,0.9689361977217292,1.0,15/61,15.69%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;GOSR2;F8;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3;PPP6R1;TRAPPC10
prerank,vesicle coating (GO:0006901),0.33047865994984466,1.0858659394837276,0.33183183183183185,0.9689361977217292,1.0,15/61,15.69%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;GOSR2;F8;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3;PPP6R1;TRAPPC10
prerank,COPII vesicle coating (GO:0048208),0.33047865994984466,1.0858659394837276,0.33183183183183185,0.9689361977217292,1.0,15/61,15.69%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;GOSR2;F8;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3;PPP6R1;TRAPPC10
prerank,oligosaccharide metabolic process (GO:0009311),-0.31532665683864275,-1.0858410490849497,0.3213367609254499,0.7073227370915613,1.0,13/46,18.89%,AMY1A;AMY1C;AMY1B;B4GALT1;FUT8;ST6GALNAC5;B3GALT5;ST3GAL4;ST6GAL2;B3GALT1;ST6GALNAC6;MPDU1;ST8SIA2
prerank,lipid biosynthetic process (GO:0008610),0.31583644489613605,1.0858307964875893,0.31470588235294117,0.9677200147924887,1.0,13/77,12.29%,ACSL5;MLYCD;GPAM;FITM2;HMGCR;GPAT4;MBOAT1;AGPS;PRKAA2;AGPAT3;PAM;LSS;PDSS2
prerank,epidermis development (GO:0008544),-0.2968021671325295,-1.0858133815923352,0.300561797752809,0.7065345653608185,1.0,8/56,11.98%,FGFR2;SVEP1;CCN2;HDAC1;FLOT2;PLOD1;EMP1;ALDH3A2
prerank,manganese ion transport (GO:0006828),-0.4221068285195653,-1.085809844939537,0.3605150214592275,0.7056777498811024,1.0,7/14,22.45%,TRPC5;SLC39A14;SLC30A10;TRPC1;SLC39A8;SLC11A2;TRPC6
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.4639039071990816,-1.085730696026775,0.36016096579476864,0.7050552114834174,1.0,6/10,20.31%,OSR1;HECW1;CAMK2D;COMMD1;HECW2;NEDD4
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.43265500647238686,-1.0855583515613982,0.35456475583864117,0.7046937003879663,1.0,7/13,21.65%,IDH2;PHYH;ADHFE1;D2HGDH;GPT2;L2HGDH;GOT1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.43915630968816244,-1.0854414080664645,0.3613963039014374,0.704160734296612,1.0,9/12,52.13%,B3GALT5;B3GALNT1;B3GALT1;B3GALT2;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,neural crest cell migration (GO:0001755),0.35806629288237635,1.0852019374399566,0.3545751633986928,0.9686522120407306,1.0,7/36,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;TBX1;SEMA6B;SEMA4C
prerank,hemopoiesis (GO:0030097),0.3061730984653441,1.0849432037729312,0.3154848046309696,0.9682495831866114,1.0,12/87,9.17%,PRKX;MECOM;SNRK;TAL1;PTPRC;TIRAP;CD164;TEK;MEIS1;BMI1;WNT5A;CSF1R
prerank,regulation of protein-containing complex assembly (GO:0043254),0.30273860936876534,1.0849038286640103,0.29555236728837875,0.9670280301253077,1.0,23/110,14.33%,RALB;TAL1;SLF1;HSPA8;TIRAP;SRC;SVIP;APOE;EP300;ICE1;SELP;SYK;NAPA;HJURP;PARK7;TRAF3IP1;DDX3X;RPS3;BMF;CDH5;FAF1;HCFC1;AIDA
prerank,cytoplasmic translational initiation (GO:0002183),0.4269518823003189,1.0844024764252043,0.36823104693140796,0.9674806537881518,1.0,9/17,18.94%,MCTS1;EIF2B3;EIF4H;EIF4B;EIF5;EIF3M;EIF2S2;EIF3A;EIF4G1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3130198254277634,1.0842050701587744,0.3104956268221574,0.9668370222525867,1.0,9/87,5.97%,POLR2J;MAPK3;NCBP1;CBL;POLR2B;SHCBP1;ZFP36L1;SPRED1;TBX1
prerank,regulation of endopeptidase activity (GO:0052548),-0.2885813031094775,-1.0841904750172504,0.2988165680473373,0.7067658892242517,1.0,8/59,9.68%,SPOCK3;NRDC;TIMP3;SPOCK1;TIMP2;HDAC1;BIRC3;VTN
prerank,negative regulation of multicellular organismal process (GO:0051241),0.27922394442142656,1.084029978343382,0.28983688833124216,0.9660902583732731,1.0,28/199,11.15%,CIDEA;RGS2;PTPRR;GSK3A;PTPRG;FCGR2B;RPS6KA4;HDAC9;HMGCR;RPS6KA5;EVL;PPP2CA;HEY1;SPRED1;NPTN;RGCC;SMAD7;HEY2;PPP1R11;RAB11FIP5;NOTCH1;EFNA1;NOVA2;HOXA7;DOCK7;RBPJ;ADIPOR1;NOS3
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3750705853549895,1.083775307265391,0.343042071197411,0.9656460136429196,1.0,9/32,14.77%,ACER2;SRC;CLASP2;MMP12;NEXMIF;ACVRL1;HOXA7;MAP4K4;SEMA3E
prerank,neuropeptide signaling pathway (GO:0007218),-0.2898356554176007,-1.083486993425561,0.3275862068965517,0.7078270889025992,1.0,10/58,17.50%,SORCS1;GLRB;SORCS3;SORL1;GLRA3;GLRA1;GPR37;RAPGEF2;OPRM1;HCRTR2
prerank,inositol phosphate biosynthetic process (GO:0032958),0.481990845029173,1.0830545044192361,0.36472945891783565,0.9669590480298367,1.0,3/11,16.52%,PPIP5K2;IP6K2;ITPKB
prerank,positive regulation of cyclase activity (GO:0031281),-0.4179974313748831,-1.0829557653089368,0.3665943600867679,0.7084722394582125,1.0,4/14,3.50%,CACNA1C;CACNA1D;STIM1;MAPK14
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.38119758784437996,1.0828123928749556,0.3378151260504202,0.9664531456482243,1.0,5/29,11.53%,LPCAT2;PLAAT3;DBI;LPCAT3;PNPLA8
prerank,triglyceride catabolic process (GO:0019433),0.41637343021108375,1.0825978443376714,0.35727109515260325,0.9658681860756713,1.0,1/19,3.33%,FABP7
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.3957922588347828,1.0825732109449022,0.3426086956521739,0.9646132041130805,1.0,2/24,1.75%,PRKAR1A;PDE4D
prerank,negative regulation of proteolysis (GO:0045861),-0.3351830204430779,-1.0819073398215335,0.3269689737470167,0.710511150740551,1.0,7/34,12.39%,TIMP3;TIMP2;ROCK1;PTPN3;GAS1;CAMK2N1;ECM1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3125632520336171,1.081851082091987,0.3074433656957929,0.9658589890489202,1.0,17/73,15.96%,MTCP1;RPTOR;STOX1;BCAR3;PRKD2;RAPGEF3;BDNF;TXN;AXIN1;PAK1;PARK7;DOCK7;APP;CD44;TERF2IP;GAS6;BRAF
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.3134084361762966,-1.0816306393297468,0.30971128608923887,0.7103964325450985,1.0,21/46,23.53%,ZIC1;SMAD3;KHDRBS1;FLNA;BAG3;PRKCD;UBR5;ANP32B;EFCAB7;CDH1;GSK3B;TP53;CAMK1;TGFB1;TCF7L2;MAVS;PIK3R1;NEDD4;NRDE2;EMD;NCBP2
prerank,protein methylation (GO:0006479),0.34894226073260914,1.0815150925453225,0.346218487394958,0.9657680256573907,1.0,9/40,14.58%,CTCFL;EZH2;PRMT3;RAB6A;ICMT;SETD3;CARM1;ETFBKMT;NTMT1
prerank,histone methylation (GO:0016571),0.38656196479631294,1.0807354301824987,0.37657657657657656,0.9672825927165642,1.0,5/26,11.13%,CTCFL;EZH2;SMYD3;CREBBP;CARM1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3225439565622877,1.0806093850809841,0.3244047619047619,0.9663833921451763,1.0,11/69,9.76%,FOXQ1;SOD1;CRLF1;PPT1;APOE;TOX3;WFS1;BDNF;SOD2;FZD9;PARK7
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.31629014381815296,1.0805776954140713,0.31432748538011696,0.9651624935645653,1.0,15/76,11.40%,GSK3A;SAE1;DCUN1D4;BIRC2;HDAC3;UBE3A;WFS1;PTTG1IP;SMAD7;UBA2;AXIN1;SPRTN;MYCBP2;UBQLN1;PIAS1
prerank,regulation of cytoplasmic transport (GO:1903649),0.47775149261496197,1.0802140074537305,0.3879472693032015,0.9651364818036802,1.0,2/11,3.25%,MAPK3;SRC
prerank,peroxisomal membrane transport (GO:0015919),-0.3526922305814961,-1.0799280701465914,0.3341121495327103,0.7142689644788652,1.0,10/27,18.06%,ACBD5;RAB8B;PEX14;FIS1;ALDH3A2;PXMP4;ABCD2;PEX2;PEX5;PEX6
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.42626809510598995,1.079887124708424,0.37857142857142856,0.963689024872375,1.0,6/17,18.42%,CISH;IRS2;SMARCA4;IL7;STAT3;IRS1
prerank,cellular response to interleukin-7 (GO:0098761),0.42626809510598995,1.079887124708424,0.37857142857142856,0.963689024872375,1.0,6/17,18.42%,CISH;IRS2;SMARCA4;IL7;STAT3;IRS1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3486425977933332,-1.0798153879117598,0.35384615384615387,0.7137098013950953,1.0,10/27,23.83%,AMBRA1;PDGFRB;KIT;PDGFRA;PTK2;TGFB1;PRKD1;P2RY12;EPHA8;TNFAIP8L3
prerank,negative regulation of cellular component organization (GO:0051129),-0.2794135499823792,-1.0797200490741676,0.2962962962962963,0.7131315066072342,1.0,24/74,22.32%,BMP6;TMEFF2;WASL;PRKCZ;SORL1;IRAK3;FAP;GSK3B;EPHA3;HSF1;SYT11;SACS;SCAMP5;RAF1;LRSAM1;PEX5;CDC42;CRYAB;RIOK3;DNAJB2;RTEL1;PRKD1;VEGFA;IMPACT
prerank,ketone body metabolic process (GO:1902224),-0.470182489818468,-1.0795673442687925,0.36885245901639346,0.7127332546711161,1.0,4/10,11.04%,OXCT1;HMGCLL1;ACSS3;HMGCL
prerank,regulation of mitotic nuclear division (GO:0007088),-0.3020135005141006,-1.0791154541060055,0.2786885245901639,0.7131055446574674,1.0,11/55,15.46%,IGF1;PDGFRB;TOM1L2;BMP7;CUL9;BMP4;LRP5;OBSL1;IGF2;CAV2;TOM1L1
prerank,regulation of coagulation (GO:0050818),-0.45647124926814964,-1.0786966644803222,0.35234215885947046,0.7133544985463086,1.0,2/11,10.62%,HS3ST5;EPHB2
prerank,negative regulation of protein transport (GO:0051224),0.38832048036135347,1.078681740824611,0.358974358974359,0.9667105317425373,1.0,3/25,4.59%,RSC1A1;HMGCR;APOE
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.48805599100821245,1.0785467742104842,0.40545808966861596,0.9658801374223968,1.0,4/10,16.16%,CCT2;CCT5;TCP1;DKC1
prerank,negative regulation of locomotion (GO:0040013),0.46345513328858473,1.0783753340583375,0.3677298311444653,0.9651657708366057,1.0,2/12,2.02%,FRMD5;PIN1
prerank,cholesterol efflux (GO:0033344),0.40580204351992666,1.0783092643097916,0.38086642599277976,0.9640952156960664,1.0,5/20,13.55%,APOE;SOAT1;SCARB1;NPC2;NPC1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.3234358429333721,-1.07789358166744,0.3282051282051282,0.714718449406483,1.0,8/39,9.91%,PKD1;GLI2;NRP1;TGFBR2;CTNNB1;BMP4;LRP5;SALL1
prerank,positive regulation of cellular process (GO:0048522),0.25626340672548925,1.0778763580896726,0.2559652928416486,0.9643200165649882,1.0,96/565,15.25%,FRMD5;MAZ;RAD18;ROMO1;NCBP1;PTPRJ;TAL1;EZH2;LEF1;ACER2;TIAM1;RPL23;DERL2;FCGR2B;CXCL12;RPS6KA1;RPTOR;CAMK1D;GREM1;CRLF1;STOX1;MCTS1;TBC1D8;PRKD2;ZFP36L1;TSHR;LMAN2;CSPP1;SLC35F6;MEIS1;TNFRSF1B;SINHCAF;CIB1;SLC6A6;MAPK8;TBX1;FXR1;CHTOP;FBXO5;ACTN4;SIRT1;RNF187;IRS2;NOTCH1;USP47;CNOT7;CDK4;WNT5A;TJP1;MERTK;EXOSC9;ACACB;RELA;CD47;CSF1R;LGI1;LYN;BCLAF1;MDM2;RAD23A;PAK1;CLDN5;CITED2;PRKAA2;EIF4G2;ESM1;TRPM4;SRPK2;RPS9;CD81;DDX3X;P2RX7;RHOG;FLT1;PA2G4;ACER3;PPP3CA;CRKL;DHPS;DOT1L;CUL3;TENM4;CNOT6;ANKRD17;RPS15A;FAF1;APC;HES1;HCFC1;CYBA;PARD3;INO80;CNOT6L;S100A13;VEGFC;GAS6
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.3970125714333532,1.0778360358020047,0.37084870848708484,0.9631672978185133,1.0,4/23,6.61%,DYNC1I1;TUBB;KIF1B;CCDC88C
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3659841121516963,-1.0778021463100305,0.3405639913232104,0.714131554644045,1.0,5/22,25.15%,ALDH1A2;LGMN;RBP1;PIAS4;CUBN
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.31786135033311774,-1.0777486376192174,0.3261390887290168,0.7134240643563007,1.0,4/41,1.57%,HTR2C;ITPR1;GRIN2B;RYR3
prerank,negative regulation of coagulation (GO:0050819),-0.42055846576911915,-1.0772616568411493,0.36764705882352944,0.7139286962080168,1.0,4/14,11.71%,HS3ST5;TFPI;VTN;CD34
prerank,regulation of inclusion body assembly (GO:0090083),-0.4478496661705468,-1.0772032822698865,0.391304347826087,0.713228548144136,1.0,9/11,49.66%,SNCAIP;SACS;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.2884018015580537,-1.0771423340998363,0.30153846153846153,0.7125435782449738,1.0,9/59,10.59%,ALDH1A2;OSBPL9;OSBPL6;CYP27A1;SRR;CYP7B1;PER2;OSBP;ACLY
prerank,negative regulation of cartilage development (GO:0061037),-0.431009152530062,-1.0769121919846587,0.3644859813084112,0.7123553633595845,1.0,4/13,12.87%,ADAMTS12;TGFBR1;EFEMP1;WNT9A
prerank,intraciliary retrograde transport (GO:0035721),-0.44084923669264675,-1.0768848620175289,0.36983471074380164,0.7115868238018309,1.0,6/12,27.65%,WDR35;DYNC2I1;TTC21B;WDR19;DYNLT2B;DYNC2I2
prerank,negative regulation of angiogenesis (GO:0016525),-0.27302279660724155,-1.0763533348793093,0.30246913580246915,0.712126979312575,1.0,17/84,9.33%,SULF1;COL4A3;CTNNB1;GTF2I;ROCK2;ADAMTS9;SLC12A2;HSPG2;ROCK1;HOXA5;PML;SPARC;ADAMTS1;FOXC1;THBS2;NIBAN2;THBS1
prerank,central nervous system myelination (GO:0022010),-0.45262072614954185,-1.0760867680745823,0.3724279835390947,0.7119883245992176,1.0,8/11,38.33%,PLP1;B4GALT6;CNTNAP1;ABCA2;MYRF;B4GALT5;CLU;SOX10
prerank,regulation of lipid metabolic process (GO:0019216),0.31249023313273533,1.0758945811718856,0.32894736842105265,0.9687072172357253,1.0,18/88,13.15%,PCK1;GPAM;HMGCR;HDAC3;PANK2;ELOVL6;PLPP1;PPARD;SC5D;IRS2;ACACB;IDI1;CREBBP;ADIPOR1;CARM1;LSS;SP1;NPC2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2911734193429229,1.0757536353747932,0.3263598326359833,0.9678857706386131,1.0,28/138,14.00%,POLR2J;MAZ;ERCC3;NR4A2;POLR2B;HDAC7;HDAC9;HDAC3;NR5A1;CCNH;MED23;PPARD;NOTCH1;NRBF2;GTF2H1;NRBP1;TAF15;ESR1;THRB;RBPJ;GTF2A2;CREBBP;E2F3;TAF4B;TBP;HDAC5;THRA;DR1
prerank,transcription by RNA polymerase III (GO:0006383),0.3861478616068385,1.075157266393678,0.3634782608695652,0.9686795167167042,1.0,9/27,18.57%,GTF3C1;ICE1;GTF3C5;RO60;IVNS1ABP;TBP;GTF3C2;POLR3K;POLR3GL
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.3374422187925709,-1.0744860441580009,0.34285714285714286,0.7155518374276912,1.0,10/27,18.74%,TNS2;PID1;PRKCZ;ENPP1;PRKCD;PIP4K2B;GRB10;PTPN2;TSC2;RPS6KB1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3703883462593271,1.0742420624765168,0.36777583187390545,0.9705711232779971,1.0,8/32,16.58%,CDK17;NPAT;CDC45;FBXO5;POLA1;BACH1;ID2;CDK14
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.3678818103339803,-1.0741352974175722,0.34151785714285715,0.7156307372744805,1.0,5/22,7.69%,NRDC;TIMP3;TIMP2;ROCK1;PTPN3
prerank,cellular response to gamma radiation (GO:0071480),-0.39788191355617714,-1.074070023326729,0.37028824833702884,0.7149727103466731,1.0,8/17,23.08%,MAP3K20;TP53;HSF1;ATM;KDM1A;CRYAB;TMEM109;YAP1
prerank,regulation of GTPase activity (GO:0043087),0.28097575590847007,1.0736867641715375,0.311284046692607,0.9712930605915181,1.0,32/177,12.59%,EZH2;PIN1;SOD1;VAV3;EVI5L;CHN2;TBC1D30;BCAR3;PRKG1;LRCH1;RGS8;TBC1D10B;USP6NL;ARHGEF7;EPHA5;RAPGEF3;F11R;RGS10;RAP1GDS1;FGD5;CCL25;RAPGEF6;DOCK9;ITGA6;RASIP1;PLXNA4;RAB11FIP2;PICALM;NF1;AGRN;MAP4K4;LARS1
prerank,glycogen catabolic process (GO:0005980),-0.41816510673724416,-1.073513234903269,0.3476190476190476,0.7155819340247538,1.0,7/15,19.39%,PYGB;AGL;PHKA2;PYGM;PGM2;GAA;PHKG2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.25950844844589954,-1.073336953527829,0.2923728813559322,0.7152262004735637,1.0,17/118,5.85%,LRRC4C;FGFR2;PHLDB2;ADGRB3;PDLIM5;EFNA5;ADGRA2;PDZD8;BMPER;SDC2;PHLDB1;PID1;MAPT;CTNNB1;STAT2;ZMYM6;HECW1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.32922028094681677,-1.0733175010690537,0.31630170316301703,0.7144294909454952,1.0,12/34,14.70%,GPM6B;CTNNA1;MAPT;ROCK2;ILRUN;UBXN2B;ACTN2;GSK3B;NSFL1C;TTBK2;MAP1A;COMMD1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3540734374279145,1.0727916198832645,0.3457792207792208,0.973158966241327,1.0,6/39,6.54%,PTPN18;CBL;PTPRJ;PTPN12;EPS15L1;ARHGEF7
prerank,negative regulation of cilium assembly (GO:1902018),0.45987660263024444,1.0725737964532318,0.38191881918819187,0.9726652403310957,1.0,3/12,7.53%,EVI5L;TBC1D30;MAP4
prerank,cellular protein modification process (GO:0006464),0.25151887075092316,1.0724151954964782,0.24846625766871167,0.971929162840642,1.0,203/982,17.11%,CISH;PHPT1;PSMB10;PSMC4;JMJD4;PSMB6;MAP3K11;MAPK3;SNRK;CAND1;ELOC;PTPRR;PTPN18;GSK3A;PTPRG;ILF3;RNF7;DUSP7;PSMD8;PSMD5;PSMD12;PTPRJ;CDK17;KLHL5;OXSR1;PTPRC;CDK19;KLHL3;CTDSP1;FEM1C;CHML;PPP3CB;PLK2;NEK11;PTPRM;BTBD1;PRKCH;RPS6KA4;ENGASE;CHM;HIPK2;PTPRB;MEX3B;PRKG1;DUSP12;PRKD2;RPS6KA5;PTPRE;PPP2CA;CDH2;PSMD11;MAP3K9;NEURL2;SIRT3;PTP4A2;APOE;PKN3;PSMB4;PTPN12;FYN;FBXL5;METAP2;WFS1;RAB11B;PSMC1;PDIA6;VWA1;UBE2I;FBXW2;DCAF6;MAPK8;UGCG;COP1;RET;SSH2;PTPRT;PAK3;ST8SIA1;CSNK1G3;SIK3;SYK;CDK11B;PPP2CB;PIM1;SIRT1;ATG4B;LMO7;KLHL2;FBXO32;PEAK1;MINK1;SLC35A1;SERP2;CDK4;MERTK;ACVRL1;PIGH;FBXO11;LATS2;CDKL4;LYN;RAB1A;NRBP1;PSMC2;ERG;PKN1;PAK1;PSMD2;PARK7;FBXO7;PIGT;UBE2M;PPP1R12A;NIM1K;ICMT;MBTPS1;DUSP11;PRKAA2;ACVR2A;SRPK2;YES1;NAE1;METAP1;SETD3;NLK;STT3B;NEK7;CTBP1;COPS7B;APP;PIK3CD;ELOB;TNKS;ATG7;PPP3CA;PLAT;ST3GAL6;STRADB;TYK2;ADPRH;PRKCI;MAP4K4;MAPK6;IKBKB;CTTNBP2NL;NAA80;CUL3;CHUK;DCAF10;PSMD14;EPAS1;UBE2F;PPP5C;CHEK2;ST3GAL1;PSMC6;TLK2;COG3;NPC1;NEK6;PSMD1;BRD2;PGGT1B;PROC;PSMB1;PTPRA;ST6GALNAC2;MSRA;B3GALNT2;CAMKK2;ST8SIA6;QPCT;COPS8;BMP2K;KLHL11;FBXO22;GAS6;DYRK2;CDKL5;PPP2R3A;TAF1;MAN2A1;NTAQ1;BRAF;PPM1L;MTMR2;CALU;KLHL42;PIGU;PTK2B;PIK3R4;CDK14;PSMA4;KLHL13;WNK2;FBXL20;PRKDC;DCUN1D1;LCMT1;MELTF;PRSS23;PPP2R5A;TIPARP
prerank,amyloid precursor protein metabolic process (GO:0042982),0.4309836577362726,1.0721803587341576,0.3735632183908046,0.9714627400472619,1.0,5/18,15.68%,PSEN2;TMCC2;APOE;LDLRAP1;APH1A
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.27898664350868413,-1.0720200287747665,0.28285714285714286,0.7172916703916606,1.0,23/72,17.54%,CFLAR;JAK1;CYLD;AXL;IFNAR2;CBFB;IRAK1;TAX1BP1;IRAK3;BIRC3;ELF1;OTULIN;VRK2;HIPK1;IFNGR1;CLIP3;IKBKG;RACK1;MADD;TRAF2;PTPN2;RNF31;IFNGR2
prerank,regulation of axon guidance (GO:1902667),-0.4800344834415603,-1.0720135532047104,0.37659574468085105,0.7164651092590563,1.0,6/10,25.48%,NRP1;ZSWIM8;YTHDF1;ZSWIM4;VEGFA;ZSWIM5
prerank,skeletal system morphogenesis (GO:0048705),-0.3178782745061193,-1.0718392281456488,0.3484042553191489,0.716102029474525,1.0,16/42,23.69%,FGFR2;TGFBR1;FBN2;HOXA3;DYNC2I1;PDGFRA;SKI;LRP5;CYP26B1;LRP6;SFRP4;HOXC4;SIX1;HOXB3;HOXC9;RAB33B
prerank,regulation of Notch signaling pathway (GO:0008593),0.3157609796796168,1.071581100052865,0.34379671150971597,0.9723256889165532,1.0,14/76,12.23%,JAG2;TM2D3;SRC;HEY1;EGFL7;EP300;TSPEAR;NOTCH1;LFNG;BEND6;RBPJ;CREBBP;NOS3;PRKCI
prerank,DNA dealkylation (GO:0035510),0.4884322311030892,1.0714195916051996,0.4130019120458891,0.9703011912906594,1.0,4/10,15.62%,ALKBH2;ASCC3;MPG;FTO
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.4884322311030892,1.0714195916051996,0.4130019120458891,0.9703011912906594,1.0,4/10,15.62%,ALKBH2;ASCC3;MPG;FTO
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3430437953860974,1.071260660763006,0.33438985736925514,0.9695985778723929,1.0,12/45,17.75%,FAM83B;CBL;SRC;RPS6KA5;PLCG1;ERBIN;PIK3C2A;BRAF;PTK2B;SHC1;PTPN11;KIF16B
prerank,cilium organization (GO:0044782),-0.23929811423856878,-1.0711309078042806,0.25,0.7173127718248082,1.0,58/209,17.47%,GSN;PARVA;AHI1;PKD1;CC2D2A;EXOC3;RILPL1;FLNA;PIBF1;IFT81;DZIP1;TTC8;WDR35;DYNC2I1;RAB8B;DCDC2;NUDCD3;CCDC66;CCDC57;CFAP20;EXOC6;TTC39C;IFT46;IFT52;ACTR3;CEP89;CEP126;IFT172;CEP20;IFT74;CFAP44;RP2;ARL13B;DISC1;TTBK2;ABLIM3;KIF3A;DZIP1L;BBS9;RAB11A;WDR19;WDR11;INTU;RAB23;CCP110;BBS2;CYS1;ARF4;EXOC7;EXOC1;PTPN23;CEP250;EHD1;RAB8A;EHD3;DYNLL2;ACTR2;IFT20
prerank,protein insertion into membrane (GO:0051205),0.3607710588425659,1.0706904231584038,0.34782608695652173,0.9703010817059281,1.0,2/32,0.33%,RTP3;REEP1
prerank,regulation of fibroblast migration (GO:0010762),0.40891947410474705,1.07030107074743,0.3724137931034483,0.9704030228572327,1.0,4/20,8.47%,PRR5L;RFFL;ARHGEF7;GNA12
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.45216811134963625,1.0702351524849438,0.3977055449330784,0.9693583114732306,1.0,4/12,17.56%,JMJD4;FYCO1;BNIP3;INSR
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.40906037458651184,1.0699766318546382,0.35583941605839414,0.968925516912214,1.0,4/18,16.34%,CAMK1D;LYN;MTUS1;PTK2B
prerank,phospholipid transport (GO:0015914),0.3329151538284782,1.069812558900196,0.3420647149460709,0.9682281678230696,1.0,12/52,13.91%,ATP8A1;ATP11A;APOE;PRELID3B;TMEM30B;PRELID2;PITPNA;SCARB1;ATP11C;NPC2;OSBPL2;ATP10A
prerank,programmed necrotic cell death (GO:0097300),0.4163004507917068,1.069730979138775,0.39184397163120566,0.9672637106227393,1.0,5/18,16.21%,MLKL;TRPM7;ALKBH7;ITPK1;DNM1L
prerank,positive regulation of cell cycle (GO:0045787),-0.28523024639288114,-1.0694308206699064,0.3137254901960784,0.7211493917663176,1.0,17/62,16.40%,FGFR2;EGFR;PKD1;MEIS2;NUPR1;CCDC57;CDKN1B;SMOC2;CCND3;LGMN;TBX3;RARA;HSF1;USP19;LRP6;TTL;CCPG1
prerank,dendritic cell differentiation (GO:0097028),-0.3661383450668213,-1.0691111912178193,0.3422222222222222,0.7211996066455935,1.0,3/22,6.99%,TGFBR2;AXL;CAMK4
prerank,histone H3 acetylation (GO:0043966),0.34933846431463533,1.068948686594916,0.3618421052631579,0.9688522581981839,1.0,5/40,3.39%,JADE3;LEF1;MAP3K7;PHF14;ING4
prerank,Ras protein signal transduction (GO:0007265),0.28700496981054513,1.0687545902654996,0.3333333333333333,0.9682439825333101,1.0,38/137,16.92%,RAC2;RALB;TRIM28;RAP2A;TIAM1;PLK2;RERG;NRAS;CFL1;RASGRP3;RALA;CDKN1A;GNB1;GRAP;RAPGEF3;GNA12;RAPGEF6;PARK7;CELSR1;RHOG;NF1;CDC42EP3;CRKL;G3BP2;RAP2C;MYO9B;RIT1;EPS8L1;RGL2;ELMO1;GNA13;MRAS;ABI2;CDH13;SHC1;KPNB1;CYFIP1;USP28
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.3557645435843096,1.0686519538010604,0.3637846655791191,0.9673371285517832,1.0,9/39,12.23%,JAG2;TM2D3;SRC;EP300;NOTCH1;RBPJ;CREBBP;NOS3;PRKCI
prerank,axonal transport (GO:0098930),0.3513426866502122,1.068428452581652,0.35034013605442177,0.9668662109028746,1.0,10/36,14.02%,SOD1;KIF1B;AP3S1;DST;DTNBP1;TMEM108;AP3M2;KIF3B;AP3M1;SNAPIN
prerank,negative regulation of cellular component movement (GO:0051271),-0.40676774923681763,-1.0678966460423807,0.3691588785046729,0.7236273572336335,1.0,3/15,2.87%,SPOCK3;TGFBR3;FBLN1
prerank,glycine transport (GO:0015816),0.48074564286558563,1.0678833881153131,0.38113207547169814,0.9675940939406366,1.0,3/10,16.37%,SLC7A8;SLC38A5;SLC25A38
prerank,protein ADP-ribosylation (GO:0006471),-0.34471531332226846,-1.0674659665284627,0.37028301886792453,0.7240170392364425,1.0,13/28,21.51%,PARP4;ZC3HAV1;PARP14;SIRT2;PARP6;PARP3;ART3;ARF4;PARP12;PARP1;SIRT5;PARP16;PARP2
prerank,transcription preinitiation complex assembly (GO:0070897),0.455656092069698,1.0669676703671978,0.37988826815642457,0.969471988645104,1.0,5/12,15.70%,BDP1;GTF2A2;TBP;DR1;TAF1
prerank,proteoglycan metabolic process (GO:0006029),-0.3487854847942096,-1.0667575868789667,0.35336538461538464,0.725150726570761,1.0,6/26,10.38%,IGF1;SULF1;ADAMTS12;SULF2;CSGALNACT2;CHST11
prerank,Golgi to plasma membrane transport (GO:0006893),-0.30778941788067626,-1.0666758356039479,0.321256038647343,0.7245021280409609,1.0,16/47,16.58%,ANK3;ARFGEF2;VAMP5;MACF1;RAB31;EXOC6;GGA2;OPTN;OSBPL5;VPS35L;VAMP2;COMMD1;BBS2;GOLGA7;EXOC1;GGA3
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.41214439357860305,-1.0666430701537954,0.38923395445134573,0.7237746601992071,1.0,6/13,26.46%,RNF168;RNF8;NELFB;NELFA;LARP7;SUPT4H1
prerank,positive regulation of cell growth (GO:0030307),0.2986642256474716,1.0665902250853248,0.33037037037037037,0.9695259604171719,1.0,15/96,10.80%,CPNE5;NCBP1;SEMA7A;DERL2;RPS6KA1;RPTOR;NEDD4L;CIB1;BDNF;RUFY3;USP47;EXOSC9;LGI1;EIF4G2;DDX3X
prerank,negative regulation of chemotaxis (GO:0050922),0.36810572960206617,1.0663616923006318,0.3797250859106529,0.9690974160365641,1.0,7/31,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;NOTCH1;SEMA4C
prerank,determination of bilateral symmetry (GO:0009855),0.39186272421081925,1.0663558276466827,0.36619718309859156,0.9678548205383616,1.0,5/24,17.83%,TBX1;NOTCH1;CITED2;KIF3B;BBS7
prerank,cellular response to glucose stimulus (GO:0071333),0.3714714212890899,1.066125178159096,0.37918871252204583,0.9674260173607264,1.0,6/30,10.33%,PCK1;SELENOT;RAB11B;RAB11FIP5;RAB11FIP2;PRKAA2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3203752110874072,-1.0656860478214452,0.3469387755102041,0.7255601240581333,1.0,10/39,13.20%,ANK3;FGF12;FGF14;WNK1;OSR1;HECW1;PTPN3;WNK4;CAMK2D;WNK3
prerank,sphingoid metabolic process (GO:0046519),0.4529121082681043,1.065308353134542,0.3816046966731898,0.969146337636415,1.0,4/12,13.89%,KDSR;PLPP1;SGPP2;SGPP1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.44408341208011015,1.0644487313125246,0.37057728119180633,0.970830271469722,1.0,2/13,2.91%,UTP20;RPS21
prerank,ribonucleoprotein complex assembly (GO:0022618),0.28992424169151704,1.0642233903243155,0.34889753566796367,0.9703473370944959,1.0,38/132,18.65%,SNRPD2;NCBP1;RSL24D1;RPL3;SNRPD1;MCTS1;SF1;RPS14;RPL5;SRSF10;GEMIN5;YTHDC1;MRPL20;EIF4H;RPLP0;COIL;RPS28;CPSF6;RRP7A;SRPK2;RPL24;EIF4B;STRAP;RPL23A;USP39;EIF5;PRKDC;RPL38;EIF2S2;EIF6;EIF3A;RPSA;DDX23;PRPF18;LUC7L2;CLP1;RPL10;SNRPD3
prerank,negative regulation of cell aging (GO:0090344),0.43207653637232935,1.0639783086586483,0.3935018050541516,0.9698974849532392,1.0,6/16,14.29%,FBXO5;SIRT1;ZKSCAN3;TERT;YBX1;MAP3K3
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3399472186880388,1.0638055296423963,0.35714285714285715,0.9692368765253023,1.0,17/47,20.44%,EIF2A;APOE;GEMIN5;EDNRB;TSC1;METAP1;NANOS3;APP;NFKBIA;VPS35;RBM4B;CYFIP1;RPL10;EIF4G1;NR1H3;EIF4E;MTPN
prerank,sterol biosynthetic process (GO:0016126),0.3637676545797909,1.0634724393016337,0.38825448613376834,0.9691165027417143,1.0,8/33,12.00%,EBP;INSIG1;HMGCR;PLPP6;SC5D;IDI1;NSDHL;LSS
prerank,ATP synthesis coupled proton transport (GO:0015986),0.4168921919265225,1.0634707837345085,0.3888888888888889,0.9678785058439087,1.0,4/17,6.85%,ATP5F1E;ATP5MG;ATP5PF;ATP5MC2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.4135203757389767,1.0633717422648803,0.38405797101449274,0.9669990577406256,1.0,4/18,9.65%,GSK3A;SLC35F6;ZNF205;FZD9
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.46617883071272775,1.0632642114908606,0.39801980198019804,0.966100793323485,1.0,4/11,11.90%,NEDD4L;GOPC;LEPROTL1;PICALM
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.45089874053731627,1.0630783703712738,0.3927893738140417,0.9655159989586231,1.0,3/12,13.66%,NEK9;CNEP1R1;NEK6
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.445443779429429,1.0629202611407982,0.38333333333333336,0.9648030307225657,1.0,2/13,6.81%,SYK;AP1G1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.392583893371851,1.0627702700782733,0.36476868327402134,0.9640790585600456,1.0,4/21,9.48%,RPL23;RPL5;FBXO5;RAB1A
prerank,heart trabecula morphogenesis (GO:0061384),-0.38431739455870395,-1.0625112013117444,0.3881278538812785,0.7334334583110327,1.0,5/18,7.87%,TGFBR3;TGFBR1;BMP5;BMP7;RBP4
prerank,positive regulation of protein maturation (GO:1903319),-0.4413340421570413,-1.0624645034026103,0.37701612903225806,0.7326981610879045,1.0,6/11,44.72%,RHBDD1;CCBE1;NKD2;SOX4;BAG2;ADAM8
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.2579991772500857,-1.0623179396726272,0.30036630036630035,0.7323055808381334,1.0,29/117,17.61%,IGF1;ALDH1A2;ME1;ABAT;MCCC2;VDAC1;PER2;CPT1A;PPARA;HLCS;PCCB;PDHX;DLD;SCPEP1;ACOT11;CKB;LDHB;CPT1C;ALDH4A1;ACADSB;MSMO1;CYP26B1;GGT5;PCCA;GLO1;ACSF2;ACOT7;AASDH;SLC5A6
prerank,male meiosis I (GO:0007141),0.42274125698499404,1.0621934668277853,0.3838951310861423,0.9648146923842473,1.0,16/16,57.77%,ING2;FOXJ3;ZSCAN21;MYBL1;BRDT;BTBD18;MEIOC;DNMT3L;CCNA1;MOV10L1;FOXJ2;SLC25A31;DDX4;TDRD9;SYCP3;HSF2BP
prerank,peptidyl-lysine acetylation (GO:0018394),0.4893636324367331,1.0621808437856621,0.3996212121212121,0.963627049058258,1.0,4/10,11.07%,EP300;SIRT1;ESCO1;CREBBP
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.27390064578179885,1.0621469551144274,0.31829896907216493,0.9625040444090955,1.0,35/186,14.01%,SOX30;PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;FRZB;RUVBL2;GREM1;TPBG;PSMD11;APOE;SOX2;PSMB4;PSMC1;CCDC88C;PFDN5;AXIN1;WNT5A;SOX13;LATS2;PSMC2;PSMD2;TMEM131L;NLK;TLE4;CUL3;PSMD14;DDIT3;PSMC6;PSMD1;APC;PSMB1
prerank,positive regulation of protein polymerization (GO:0032273),-0.27731285323829163,-1.0620530479445307,0.3136094674556213,0.7322139153982598,1.0,25/65,28.01%,NAV3;MAPT;OCLN;FER;CTTN;AKAP9;SLAIN2;BIN1;BAIAP2L1;FCHSD2;CDC42EP5;DCTN1;CDC42EP1;MET;PINK1;PFN2;TPPP;HSP90AA1;TPPP3;TTBK1;CDC42EP2;NCKAP1L;ARL2;TOGARAM1;MAPRE1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.41330534290766674,-1.062046963299529,0.36613272311212813,0.7313765852118274,1.0,3/14,4.71%,ADAMTS12;TGFBR1;EFEMP1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.4306817153180196,1.0615926207090862,0.36813186813186816,0.9631483286007537,1.0,2/14,8.56%,OXSR1;WNT5A
prerank,determination of left/right symmetry (GO:0007368),0.3547501874281571,1.0612163646664161,0.37970540098199673,0.9632785487705295,1.0,6/36,13.20%,RFX3;TBX1;NOTCH1;CITED2;DAND5;KIF3B
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.32760209098584114,1.0611350633524559,0.3610698365527489,0.9623443772297936,1.0,5/57,6.77%,HRH4;MTNR1A;HTR1F;INSL3;GRM7
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4068198721217392,-1.0605706007716673,0.3869653767820774,0.7346047903563507,1.0,3/14,7.78%,PUM1;PUM2;ZDHHC5
prerank,actin crosslink formation (GO:0051764),0.4607611679068924,1.060564916193712,0.40111940298507465,0.9630858534809823,1.0,2/12,1.76%,LCP1;GAS2L1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.36602242762451265,-1.0604835749521149,0.38197424892703863,0.7340290470258922,1.0,7/20,23.35%,IGF1;FOXC1;NIBAN2;DDRGK1;TGFB1;GTF2B;LAMTOR5
prerank,regulation of neuron apoptotic process (GO:0043523),0.2965820404307242,1.0603486088152863,0.35694050991501414,0.962593163930891,1.0,19/96,12.23%,FOXQ1;SOD1;CRLF1;PPT1;SIGMAR1;APOE;TOX3;WFS1;AKT1S1;BDNF;SOD2;FZD9;PARK7;SRPK2;NAE1;EGLN2;PRNP;NF1;PRKCI
prerank,negative regulation of endothelial cell migration (GO:0010596),0.35328567533828575,1.0600151742928559,0.36938435940099834,0.962563099812821,1.0,6/36,8.88%,PTPRM;APOE;KRIT1;RGCC;NOTCH1;ACVRL1
prerank,intestinal lipid absorption (GO:0098856),-0.4500218222479402,-1.0598721962254554,0.4031936127744511,0.7348577697347966,1.0,2/11,8.09%,LIMA1;LDLR
prerank,regulation of calcium ion import (GO:0090279),0.40695783951842734,1.0597732379246114,0.3888888888888889,0.9622082548176871,1.0,6/21,17.23%,PSEN2;CXCL12;FYN;PRNP;TRIM27;SLC30A1
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3067806205891482,-1.0597688829512084,0.35233160621761656,0.7342986907476866,1.0,5/41,4.74%,FGFR2;TGFBR3;TGFBR2;TPM1;BMP4
prerank,protein K63-linked deubiquitination (GO:0070536),0.3702910320143853,1.0595127354196356,0.36695652173913046,0.9619014793729037,1.0,9/31,13.29%,ABRAXAS1;TNFAIP3;YOD1;OTUD1;SPATA2;OTUD5;PSMD14;USP33;BRCC3
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3265634905081533,1.0593088303908629,0.366306027820711,0.9613943936077113,1.0,13/59,11.53%,TRIM28;LEF1;CCNC;CDKN1A;MED23;MED12;MED15;CDK4;RELA;CSF1R;BCLAF1;AGO4;MED4
prerank,regulation of peptidase activity (GO:0052547),-0.36828834881966865,-1.0592957629444073,0.3905191873589165,0.7347478982147299,1.0,5/19,19.93%,NRDC;HDAC1;ECM1;RCN3;PINK1
prerank,myeloid cell development (GO:0061515),-0.3870313124610977,-1.0591792420903345,0.3543123543123543,0.7342448098754962,1.0,4/18,4.76%,FOXP1;ANXA2;MED1;KIT
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.28509067195749943,-1.0590685544952985,0.33810888252148996,0.7337285968461038,1.0,25/65,23.37%,LDLRAD4;FBN1;SMAD3;SMURF2;TGFBR1;TGFBR2;FBN2;PPARA;SKI;HTRA3;SMAD6;LTBP1;SNX25;UBC;PPM1A;MTMR4;TGFB1;PRDM16;CD109;STUB1;SPRED3;SNX6;ASPN;EMILIN1;NRROS
prerank,negative regulation of protein polymerization (GO:0032272),-0.34377850855626685,-1.058081660840039,0.36855670103092786,0.7357120457459002,1.0,13/27,21.71%,MAP2;EML2;PRKCD;STMN2;CLIP3;MYADM;HIP1R;KANK4;STMN1;TUBB4A;TWF2;SSH1;PFN2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.42092565129162085,1.057827886794631,0.38917089678510997,0.9654388696884673,1.0,2/16,0.93%,NCBP1;RBMXL1
prerank,regulation of dendrite extension (GO:1903859),0.41245361116485985,1.0575988866061603,0.3884007029876977,0.9650088335915574,1.0,2/18,4.22%,CPNE5;NEDD4L
prerank,positive regulation of protein phosphorylation (GO:0001934),0.25853996978487476,1.0574899599220098,0.3157262905162065,0.9641803730011728,1.0,52/348,12.55%,LRP8;GDF1;MAPK3;RALB;PTPRJ;LIMCH1;RAP2A;PIN1;PTPRC;MTCP1;PECAM1;TAB2;RPTOR;RPS6KA4;SRC;STOX1;BCAR3;PRKD2;RPS6KA5;HDAC3;TEK;NPTN;CIB1;CDKN1A;TBX1;FXR1;CALM3;RAPGEF3;BDNF;SIRT1;TXN;LCP2;AXIN1;EFNA1;AKTIP;ACVRL1;CDK2AP1;CSF1R;LYN;PAK1;PARK7;DOCK7;ACVR2A;CD81;DDX3X;APP;MMD;PRNP;CRKL;RAP2C;WDFY2;NBN
prerank,inflammatory response (GO:0006954),0.2727309707806539,1.0573020998351657,0.33550065019505854,0.9636786884846584,1.0,21/195,13.21%,HRH4;PTGER2;PIK3CG;TACR1;FCGR2B;HDAC9;LY75;NFX1;ABCF1;F11R;CCL25;RELA;CSF1R;PJA2;IL10RB;MFHAS1;NOD1;PIK3CD;IKBKB;CHUK;HDAC5
prerank,protein homooligomerization (GO:0051260),0.2922968909983291,1.0569083778250918,0.36185133239831696,0.9637560380731933,1.0,18/114,12.25%,THG1L;RS1;GLS;EHD4;SIGMAR1;ATL1;MLKL;B2M;BEND3;SSBP1;SLC1A2;ACACB;SOD2;TRMT61B;CHMP2A;TRPM4;G3BP2;LETM1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3464926663379791,1.0563938216500592,0.3813559322033898,0.9642973413916263,1.0,13/37,18.52%,EIF5A;SOD1;SFPQ;BCLAF1;BAD;RPS3;BMF;DDIT3;DNM1L;BECN1;BCAP31;BAX;FBH1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.36731377909300034,-1.05603176204408,0.3752913752913753,0.7396524067462874,1.0,2/21,0.72%,EYA2;EYA1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.36731377909300034,-1.05603176204408,0.3752913752913753,0.7396524067462874,1.0,2/21,0.72%,EYA2;EYA1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.4196922982677581,-1.0559833888946772,0.3924843423799583,0.7389217615924384,1.0,4/12,20.02%,KAT7;WRNIP1;METTL4;BLM
prerank,ion homeostasis (GO:0050801),0.3702283721319948,1.0554205869454196,0.3826086956521739,0.966423891762007,1.0,4/30,4.22%,SLC4A4;SLC4A5;KLHL3;NEDD4L
prerank,protein phosphorylation (GO:0006468),0.2560970655278342,1.0554096018567405,0.3256578947368421,0.9652450640296891,1.0,103/478,16.75%,PCK1;PRKX;STK32A;MAP3K11;MAPK3;SNRK;GSK3A;ILF3;CDK17;OXSR1;MAP3K7;CDK19;PPP3CB;PLK2;NEK11;RPS6KA1;PRKCH;RPS6KA4;CAMK1D;HIPK2;SRC;MEX3B;PRKG1;PRKD2;RPS6KA5;MAP3K9;TEK;CCNH;PKN3;SMG1;FYN;SLK;MAPK8;RET;PAK3;CSNK1G3;SIK3;SYK;CDK11B;SBK1;PIM1;SMAD7;PEAK1;MINK1;CDK4;DCLK3;MERTK;GTF2H1;ACVRL1;LATS2;CDKL4;CSF1R;LYN;NRBP1;ERG;PKN1;PAK1;NIM1K;PRKAA2;ACVR2A;SRPK2;NLK;NEK7;FLT1;USP15;CTBP1;APP;PIK3CD;TNKS;STRADB;TYK2;PRKCI;MAST4;MAP4K4;MAPK6;IKBKB;MAPK12;ERC1;CHUK;CHEK2;TLK2;NEK6;BRD2;MAP2K6;MAP3K3;CSNK2A2;CAMKK2;MAP3K10;COPS8;BMP2K;GAS6;DYRK2;CDKL5;TOP1;TAF1;ATR;BRAF;ABI2;PTK2B;PIK3R4;CDK14;WNK2;PRKDC
prerank,RNA catabolic process (GO:0006401),0.33555405431303914,1.0553246056524543,0.38961038961038963,0.9643032273449349,1.0,7/46,11.26%,ZC3H12D;NCBP1;NUDT12;RNASE6;XRN2;DXO;AGO4
prerank,positive regulation of ERAD pathway (GO:1904294),-0.4274251923761146,-1.0551025796975513,0.3874458874458874,0.7404449680018025,1.0,8/13,26.05%,USP13;HERPUD1;TMEM259;RNFT1;SGTA;BAG6;NFE2L2;RNF185
prerank,sphingosine biosynthetic process (GO:0046512),0.4657278732128449,1.0549660257623141,0.4161735700197239,0.9631451139583702,1.0,2/11,11.64%,ACER2;ACER3
prerank,sphingoid biosynthetic process (GO:0046520),0.4657278732128449,1.0549660257623141,0.4161735700197239,0.9631451139583702,1.0,2/11,11.64%,ACER2;ACER3
prerank,positive regulation of gene expression (GO:0010628),-0.21574520860792729,-1.0547255183651987,0.18181818181818182,0.7406304027436159,1.0,83/442,15.15%,ANK2;DDX5;BMP6;NTRK3;ANK3;RIMS1;SLC24A3;IGF1;ROBO1;PLD1;SAMD4A;EGFR;GSN;SMAD3;ITGB8;FOXD1;NTRK2;FGF1;TGFBR1;MAPK14;PID1;OCLN;MED26;BMP7;VIM;ELAVL4;PRKAG1;MED1;BMP4;PPARGC1A;ROCK2;OSR1;SMO;F3;EPB41L4B;ADAM19;DEK;ERCC6;ROCK1;HOXA5;FUBP3;PLA2R1;PIK3R3;POLDIP3;PRR16;EIF3C;MAP2K2;YTHDF1;EZR;NIBAN1;UBR5;THBS1;EIF2AK2;TLE1;AGO3;AFDN;PLSCR1;GSK3B;GJA1;EPHB2;CAMK2N1;EEF2;FN1;CUX2;TP53;FAM98A;CD34;DDRGK1;RBM3;IFNGR1;RPS7;SNF8;PDCD5;POLR2A;IL33;HINFP;ATM;DDX21;VSTM2A;SETX;PTPN22;SCAMP5;PLXNB2
prerank,ncRNA transcription (GO:0098781),0.4312223702135012,1.0544507694552068,0.3978494623655914,0.9637702890956211,1.0,3/13,6.79%,GTF3C1;SPIN1;POLR1G
prerank,fatty acid transmembrane transport (GO:1902001),-0.3824712291377408,-1.0542449253644235,0.37850467289719625,0.741111589779353,1.0,6/19,14.84%,PRKAG2;CPT1A;PRKAB2;SLC27A1;ABCD2;CPT2
prerank,regulation of vasculature development (GO:1901342),-0.3418577757056042,-1.0539248833982655,0.36255924170616116,0.7411466404759699,1.0,12/26,37.62%,ADGRA2;BMPER;CTNNB1;PLXND1;EMP2;ERBB2;SFRP1;EGLN1;HTATIP2;ETS1;EPHA2;VASH1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.3548416185413693,-1.053863407821013,0.3598130841121495,0.7404801158900994,1.0,7/24,19.44%,PLA2G4A;LPGAT1;CDS2;SLC27A1;CRLS1;PGS1;LPCAT1
prerank,negative regulation of vascular permeability (GO:0043116),0.44579903990841446,1.0533053096992713,0.3965183752417795,0.9665949602499896,1.0,3/12,9.84%,PTPRJ;RAMP2;CLDN5
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.366385235265994,1.0530620263421213,0.3833605220228385,0.9650489863311544,1.0,5/29,11.78%,MLYCD;DBI;ACAT1;GPAT4;ACOT8
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.366385235265994,1.0530620263421213,0.3833605220228385,0.9650489863311544,1.0,5/29,11.78%,MLYCD;DBI;ACAT1;GPAT4;ACOT8
prerank,regulation of protein transport (GO:0051223),0.36955093435770814,1.053033079193321,0.38564273789649417,0.9639567566034908,1.0,5/27,11.59%,LCP1;HSPA8;STXBP5L;RHBDF2;SCFD1
prerank,positive regulation of protein catabolic process (GO:0045732),0.3053614599030807,1.0528692966918958,0.373546511627907,0.9633363082717363,1.0,17/84,13.86%,GSK3A;SH3D19;TNFAIP3;PLK2;NEDD4L;VPS11;APOE;RAB7A;TNFRSF1B;PTTG1IP;AXIN1;WNT5A;ATG7;EGLN2;NDUFA13;FAF1;APC
prerank,mitotic cytokinesis (GO:0000281),-0.2991431008144801,-1.0526418161674398,0.38605898123324395,0.7431004377454498,1.0,18/47,29.15%,ANK3;SON;ROCK2;CIT;ROCK1;KLHDC8B;RHOB;MITD1;TRIM36;STMN1;JTB;SNX18;RHOC;SPTBN1;CNTROB;RAB35;EFHC1;RTKN
prerank,negative chemotaxis (GO:0050919),0.35520584089918206,1.0515882422819045,0.401305057096248,0.9665136884149778,1.0,6/33,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,regulation of platelet aggregation (GO:0090330),0.41528576433708037,1.0514092213074457,0.400355871886121,0.965916301756341,1.0,4/17,9.31%,PRKG1;SYK;F11R;LYN
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.43609227269687634,-1.0512841481332915,0.4204322200392927,0.745925052979227,1.0,4/12,15.74%,BICD1;NINL;KIF3A;DCTN1
prerank,neuronal action potential (GO:0019228),-0.3636917211448435,-1.0511493791611384,0.3958333333333333,0.7454871428369724,1.0,6/22,13.06%,ANK3;SCN8A;SCN3A;SCN1A;KCNA1;CACNA1G
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3559068151628687,1.0509650673483741,0.3826955074875208,0.9661956751859525,1.0,5/33,4.06%,SEMA6A;JMJD8;KLF2;SMAD1;PPP1R16B
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.4592844029394072,1.050769341119123,0.3892988929889299,0.9656617155747044,1.0,3/11,11.50%,SIRT1;LYN;PIK3CD
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3463620762176955,1.0493816615836313,0.38552188552188554,0.9691917682210581,1.0,9/35,13.92%,PTPRC;OCIAD1;NOTCH1;IL10RB;NLK;CYP1B1;ADIPOR1;DOT1L;HES1
prerank,response to prostaglandin E (GO:0034695),0.4622661073540677,1.0493766710689387,0.40119760479041916,0.9680212136602951,1.0,2/10,6.32%,PTGER2;GNB1
prerank,telomere organization (GO:0032200),0.33936673213280805,1.0492605979580503,0.38057324840764334,0.9671970210312472,1.0,13/43,16.75%,CTC1;ERCC4;DCLRE1B;POLD3;ACD;TERT;HUS1;NBN;DOT1L;LTO1;TERF2IP;ATR;PRKDC
prerank,mismatch repair (GO:0006298),0.37250126543811557,1.0492122595409565,0.40293040293040294,0.9661955172405222,1.0,6/27,9.71%,TDG;PMS2;POLD3;MLH1;PMS1;MSH3
prerank,negative regulation of protein metabolic process (GO:0051248),-0.3001376037737738,-1.0491010689842313,0.39385474860335196,0.7503209142249164,1.0,18/48,19.07%,EGFR;FLNA;SIRT2;FLOT2;FMN2;ROCK1;IRAK3;LDLR;BANP;AZIN1;EIF2AK1;NFKB1;VBP1;PFDN2;CYP51A1;CRYAB;SNX3;MDM4
prerank,positive regulation of lymphocyte migration (GO:2000403),0.45151510894108815,1.048227135288177,0.42115027829313545,0.9683770891504793,1.0,4/12,17.42%,CXCL12;APP;DOCK8;JAM2
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.37718476426673675,-1.0480303476018715,0.3744493392070485,0.7524290013037844,1.0,2/17,1.05%,BMP6;SASH1
prerank,cellular response to organic substance (GO:0071310),-0.2550370012578995,-1.0476671988227049,0.33090909090909093,0.752601595972546,1.0,33/116,19.93%,ROBO2;NFAT5;PTPN13;AKAP6;SMAD3;DPYSL3;IGFBP5;PTPN14;TGFBR1;PID1;TGFBR2;CTNNB1;RHOA;GHR;CLEC3B;ACVR1;SOCS2;ACVR1B;RAMP1;IL1RAPL1;IL18;NCOA1;RACK1;TGFB1;BMPR1B;PTPN23;PTPN2;CDK9;TWF2;RPS6KB1;BMPR1A;CPNE3;BMPR2
prerank,sarcomere organization (GO:0045214),-0.3394419705096391,-1.0468088470309136,0.3883495145631068,0.7541950509669864,1.0,4/27,14.39%,TPM1;ACTN2;CSRP2;WDR1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.4456328511357507,1.0467805829298205,0.42418426103646834,0.9722555863820553,1.0,3/13,10.93%,TDG;UPP2;SMUG1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.2837124535654274,-1.046580808585371,0.3446327683615819,0.7540100398947092,1.0,13/57,13.37%,UACA;GRIN2B;CYFIP2;MALT1;FIS1;LGMN;GRAMD4;MAP3K5;CTSD;AIM2;USP50;PDCD5;TBC1D10A
prerank,mRNA splice site selection (GO:0006376),-0.3333693171099724,-1.0458682307806575,0.37343358395989973,0.7551392123418185,1.0,6/30,7.45%,CELF2;SRSF5;CELF4;PSIP1;SRSF6;SRSF1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.36870592336070107,1.0458395896317487,0.3903281519861831,0.9743711621646359,1.0,8/28,13.83%,MAP3K7;TNFAIP3;TAB2;TAB3;RELA;UBE2V1;NOD1;MAP2K6
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2737029652151972,-1.0458199424993004,0.35454545454545455,0.754436515882771,1.0,28/75,27.26%,ATP1A2;ATP1B1;SLC6A1;ATP1B3;SLC12A2;SLC39A14;ATP1A1;KCNJ2;ATP1B2;SLC24A2;KCNJ6;SLC9A2;ABCC9;SLC39A8;SLC12A6;KCNJ13;SLC12A4;ATP1A3;SLC12A9;KCNJ10;SLC39A6;CACNA2D1;SLC12A7;KCNK9;HCN2;TRPV2;SLC12A8;SLC12A5
prerank,cell part morphogenesis (GO:0032990),-0.4112679085009206,-1.045669803613714,0.4025157232704403,0.7539815706653137,1.0,3/13,7.71%,PID1;WASF1;FIS1
prerank,mitotic spindle organization (GO:0007052),0.27923121461317935,1.0454068337471036,0.35714285714285715,0.9746427006210668,1.0,36/153,17.79%,ABRAXAS1;DYNC1I1;EML1;KIF18A;NUDC;PLK2;CLASP2;NEK9;DCTN2;MAP4;CDCA8;CENPC;MZT1;KIF2A;DYNLL1;BCCIP;MIS12;TNKS;XPO1;KIF3B;CHEK2;NEK6;PTPA;EFHC2;ARHGEF10;RCC1;DYNC1I2;CLIP1;CENPP;CENPO;STAG2;KPNB1;NUP160;CLASP1;RANGAP1;PAFAH1B1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.39780462401873784,-1.0451871570820481,0.4161073825503356,0.7545074418498533,1.0,3/16,7.01%,NFAT5;RHOA;IRAK1
prerank,positive regulation of proteolysis (GO:0045862),-0.2920174332695857,-1.0451676169158015,0.36314363143631434,0.7537179164399502,1.0,23/55,30.30%,NRDC;OGT;CYFIP2;FBXW11;RHBDD1;BTRC;IST1;CCBE1;TBC1D10A;RCN3;TNIP1;GPLD1;TANK;ATP5IF1;STUB1;PINK1;NKD2;ADRA2A;PERP;ZC3H12A;CTSC;PACSIN3;FGFR4
prerank,T cell migration (GO:0072678),0.44826680846055067,1.044864509104849,0.4192377495462795,0.9753287307560441,1.0,2/13,11.50%,PIK3CG;PIK3CD
prerank,positive regulation of B cell activation (GO:0050871),0.33043728977801323,1.0445131447600202,0.3902439024390244,0.9753010027000047,1.0,8/50,12.21%,PTPRC;VAV3;TIRAP;SYK;IRS2;CD81;KMT5B;TNIP2
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.34729737589188403,-1.0444040032868382,0.37971698113207547,0.7550143700514552,1.0,10/24,20.89%,WASF2;AUTS2;OCLN;PLCE1;ACTR3;ACTR2;CDC42;TWF2;PIK3R1;ARPC2
prerank,cellular calcium ion homeostasis (GO:0006874),-0.2464966294921844,-1.0443709276288526,0.3563636363636364,0.7542790990471596,1.0,24/133,14.53%,ANK2;SLC24A3;HTR2C;STIM2;MCU;PDZD8;ATP1B1;PACS2;STIM1;ATP13A5;TRPC5;MICU2;PML;HERPUD1;TRPC1;PRKACA;SLC24A2;DMPK;CAMK2D;CCL14;TMCO1;AFG3L2;SLC35G1;CAV2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.4037204884687397,1.044128356597704,0.4028268551236749,0.9754389997400916,1.0,4/18,8.03%,GSK3A;HDAC3;BDNF;NOTCH1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.24246687013357526,1.0439559564964016,0.2864321608040201,0.974825488543529,1.0,268/1646,14.92%,TBX4;SOX30;LRRFIP1;DBX2;ATF3;IRX1;PRKAR1A;TOX4;MAZ;ZBTB42;CTCFL;MAP2K7;FOXQ1;CCDC85B;GCLC;DACH1;MECOM;SIM1;ELOC;SS18L1;ARID5A;ONECUT1;ILF3;KLF8;TRAPPC2;L3MBTL4;FOXN2;TRIB3;TFCP2;NR4A2;CDK17;MTERF3;TAL1;EZH2;ACTL6A;ATF6;TRIM28;ZFAT;HSPA8;LEF1;HES6;CIPC;EED;CTDSP1;RUVBL2;PPP3CB;BTAF1;GTF2IRD1;RPS6KA1;DMAP1;PHF14;RPS6KA4;KLF2;CCNC;HIPK2;ATXN1L;ELK3;ING4;PAX8;ZHX3;ZBTB24;ZBTB33;HDAC9;GABPA;BCL6B;BACH2;RPS6KA5;BCL11B;SMAD1;HDAC3;ZKSCAN1;PHF5A;PPP2CA;PRDM15;SBNO2;HNRNPAB;HEY1;NR5A1;RLF;ZBTB41;APOE;CCNH;IRF9;MYBL2;FLI1;BBX;SMARCA2;SOX2;MEIS1;HNRNPK;YY1;PHB2;GMEB2;TOX3;ZNF83;KDM3A;KDM2A;SPIN1;ZNF740;USF2;UBE2I;ZSCAN2;CDKN1A;NPAT;IRF2BPL;EP300;VEZF1;RFX3;TBX1;ZNF260;NFX1;MED23;CARF;RET;PCGF3;TGFBRAP1;SRSF10;CEBPG;CALCOCO1;CNOT2;FOXF2;ACTR8;MAMLD1;PPARD;MED12;CDK11B;CHMP1A;ZNF205;SFPQ;CDC45;FBXO5;UXT;SMAD7;SIRT1;ACTR5;DRAP1;CLOCK;RNF187;ZNF3;PFDN5;HEY2;AXIN1;SETD5;ZBTB14;NOTCH1;CAND2;RUVBL1;USP47;CNOT7;WNT5A;LCORL;ATXN7L3;ATAD2;GTF2H1;ZXDC;SOX13;ACVRL1;RSF1;RELA;SOD2;JUND;NAB2;POLA1;HOXA7;PCID2;BCLAF1;MDM2;RAI1;PLCB1;PIAS2;TFAP4;ERG;PKN1;RNF6;TRPS1;TSFM;ZKSCAN3;KLF6;UBE2V1;CIR1;TAF15;CITED2;YEATS4;RYBP;ING2;PBXIP1;CHD1;WBP2;CCAR2;MGA;HIC2;ESR1;SETD3;RBPJ;NLK;DACH2;RHOG;HP1BP3;CREBBP;USP22;CARM1;CTBP1;PIAS1;NFIC;MED4;PA2G4;POLR3F;JMJD1C;HDGF;PICALM;LANCL2;ILF2;E2F3;SP1;IKBKB;MZF1;SMARCD1;MDFIC;IRF2;CHD3;ERC1;NUP35;CHUK;PITHD1;ACTA2;ZBTB45;ZSCAN12;RRP8;YWHAH;NDUFA13;TRRAP;TGIF1;CTBP2;HDAC5;ING5;EPAS1;EDRF1;CHEK2;DDIT3;SP110;THRA;ZKSCAN5;BRD2;CREBRF;HES1;KDM5C;HCFC1;YBX1;GRHL1;SP8;RNF20;SIX5;PHF8;PURG;NCOA7;BAZ2A;NSD2;CAMKK2;AEBP2;E2F6;TMPRSS6;BRIP1;BACH1;MAP3K10;PHF10;FUS;TSHZ1;TFAM
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.3713400544930395,-1.0437621891979911,0.4232456140350877,0.7550773819548152,1.0,8/18,25.56%,FLNA;WDR43;SIRT7;ATF4;UTP15;EIF2AK3;ERBB2;POLR2K
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.38875777254800975,-1.0436817874071458,0.4107142857142857,0.754464683318899,1.0,12/16,36.55%,GPR137C;KLHL22;SEH1L;FLCN;TELO2;LAMTOR5;PIP4P1;GPR137B;PIH1D1;RRAGD;GPR137;RRAGA
prerank,presynaptic endocytosis (GO:0140238),-0.3523149622811068,-1.0436528288888172,0.36877828054298645,0.7537135913923412,1.0,10/24,23.09%,AMPH;NLGN2;STON2;NLGN1;STON1;VAMP2;STX1A;SYT2;PACSIN1;NLGN3
prerank,epithelial tube morphogenesis (GO:0060562),0.3590580454301553,1.0435012252997844,0.3963515754560531,0.9752920362487908,1.0,7/32,9.75%,PRKX;PRKD2;ACVRL1;RASIP1;CSF1R;PODXL;PAK1
prerank,amyloid fibril formation (GO:1990000),-0.29408532240895185,-1.0434126252115468,0.3746556473829201,0.7535074808424504,1.0,14/51,25.76%,GSN;SNCAIP;MAPT;SORL1;HSPG2;GGA2;BACE1;UBC;SIAH2;GGA3;TGFBI;TSPAN15;MFGE8;APH1B
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3989660128817126,1.0434025110472873,0.42334494773519166,0.974453511496899,1.0,11/20,20.82%,CNOT7;AGO4;HELZ;CNOT6;CNOT1;MOV10;WTIP;EIF6;AGO1;CNOT8;TNRC6A
prerank,protein deacylation (GO:0035601),0.38752469664438727,1.0433663077671924,0.42280701754385963,0.9734038002525736,1.0,5/23,7.29%,PPT1;HDAC7;HDAC3;SIRT3;SIRT1
prerank,negative regulation of protein depolymerization (GO:1901880),-0.3490073911142484,-1.0432910322850717,0.38461538461538464,0.7530267043566601,1.0,7/24,13.07%,NAV3;PLEKHH2;HDGFL3;LIMA1;STMN2;TTBK2;TAOK1
prerank,positive regulation of dendrite extension (GO:1903861),0.4141482111398047,1.043278911265053,0.40754039497307004,0.9724927412975016,1.0,2/17,4.22%,CPNE5;NEDD4L
prerank,negative regulation of response to external stimulus (GO:0032102),-0.2539694234972022,-1.043096351252743,0.33557046979865773,0.7527402452144693,1.0,23/105,17.92%,LRFN5;CTNNA2;GRID2;PTPRS;PPM1B;SIRT2;ILRUN;PRKCD;PPARA;PTGIS;IRAK3;TRAFD1;OTULIN;SIRPA;RORA;SELENOS;AJAP1;CCN3;PTPN2;ENPP3;CERS2;TNFAIP6;CD109
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.38357634730067,1.0429732386904724,0.40476190476190477,0.9722976312582671,1.0,6/24,11.70%,CTC1;SRC;ERCC4;HNRNPC;ACD;TNKS
prerank,receptor-mediated endocytosis (GO:0006898),-0.24358818706650856,-1.0429688414469966,0.3333333333333333,0.7522689041574088,1.0,31/132,14.60%,DNAJC6;LRP1;DAB2;CALCRL;AP2B1;SNAP91;AP2A2;PDLIM7;SORL1;LRP1B;HSPG2;CTTN;WASF1;GPR107;RAB31;AP2A1;SPARC;LDLR;GRK3;ACKR3;IGF2R;RAMP1;GRB2;HIP1R;DNM1;M6PR;DNAJC13;VLDLR;FCHSD2;CAV2;LMBR1L
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3138637632557319,1.0428982649626843,0.39285714285714285,0.9713988609250397,1.0,19/63,17.96%,PLK2;CNOT11;CDKN1A;EP300;CRADD;CNOT2;RGCC;CNOT7;MDM2;RFWD3;CARM1;CNOT6;CHEK2;CNOT1;CNOT6L;PRKDC;CNOT10;BAX;RPL26
prerank,positive regulation of RNA splicing (GO:0033120),0.3651441251636977,1.042853982174213,0.3967741935483871,0.970392878408098,1.0,4/29,6.86%,NCBP1;RBMXL1;RBM22;RBM20
prerank,ncRNA catabolic process (GO:0034661),-0.3367941163555258,-1.0427327987067116,0.40875912408759124,0.7520765726282593,1.0,15/28,35.07%,LIN28B;EXOSC10;SND1;DIS3L;MTREX;DIS3;TRIR;RBM7;ZCCHC8;EXOSC8;EXOSC2;DEDD2;EXOSC3;EXOSC5;TENT4B
prerank,regulation of epithelial cell differentiation (GO:0030856),0.4029057129146345,1.0426553259657372,0.39926062846580407,0.9698962054827186,1.0,1/17,0.25%,PRKX
prerank,methylguanosine-cap decapping (GO:0110156),0.4680114890038416,1.0426542056375818,0.40332640332640335,0.9687373199338397,1.0,5/10,19.40%,PATL2;PATL1;DCP1A;LSM1;DCP1B
prerank,negative regulation of interferon-beta production (GO:0032688),-0.443395940196326,-1.0426168050529512,0.4288659793814433,0.7515869950466137,1.0,5/10,13.01%,PTPRS;PPM1B;REL;SIRPA;RELB
prerank,regulation of rRNA processing (GO:2000232),-0.3901920925315186,-1.042222427900931,0.4036281179138322,0.7518555972807281,1.0,8/16,32.22%,RIOK1;RIOK2;WDR43;SIRT7;UTP15;BUD23;KAT2B;YTHDF2
prerank,DNA damage checkpoint signaling (GO:0000077),0.36278998360735437,1.0421811854344918,0.40033783783783783,0.969129845616954,1.0,10/28,16.92%,TIPRL;RAD1;CLOCK;HUS1;NBN;DOT1L;CHEK2;BRIP1;ATR;USP28
prerank,response to UV-B (GO:0010224),0.44417737540976665,1.0417645597152472,0.42830188679245285,0.9693908095159174,1.0,3/12,9.03%,MME;CDKN1A;RELA
prerank,positive regulation of inflammatory response (GO:0050729),-0.2626251207962005,-1.0415981094714488,0.3588235294117647,0.7528037459508062,1.0,26/86,29.10%,OSMR;SNX4;NUPR1;LBP;NAPEPLD;IL16;IL17RA;GPR4;IL18;IL33;IL6ST;TNIP1;GPRC5B;AGTR1;CX3CL1;SETD4;PLA2G7;VAMP8;TLR3;FEM1A;SERPINE1;PDE2A;CCN4;KARS1;MDK;SNCA
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.38567080607109455,1.0415419022202852,0.3993174061433447,0.969010781639031,1.0,9/24,18.60%,ABCB10;ABCG2;TSPO;COX15;COX10;SLC25A38;ALAS1;FECH;NFE2L1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3196150174108229,-1.0413399720487668,0.3795454545454545,0.7526877144440698,1.0,13/33,19.98%,DNAJC6;AMPH;SNAP91;NLGN2;STON2;NLGN1;STON1;DNM1;VAMP2;STX1A;ITSN2;SYT2;PACSIN1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.3029370167465123,1.0412530133154507,0.37445573294629897,0.9688336415342752,1.0,16/88,12.07%,PTPRM;PDCL3;PRKD2;NRAS;PPP1R16B;EGFL7;APOE;TEK;KRIT1;RGCC;SIRT1;WNT5A;ACVRL1;TIE1;PIK3CD;NF1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.347710540839068,1.04096639770996,0.3993453355155483,0.9686200472361978,1.0,11/36,16.92%,TIPRL;RAD1;CDC45;CLOCK;HUS1;NBN;DOT1L;CHEK2;BRIP1;ATR;USP28
prerank,membrane fusion (GO:0061025),-0.32210758586348714,-1.040960093444495,0.3865336658354115,0.7529728975173033,1.0,12/33,22.62%,RIMS1;UBXN2A;UBXN2B;HUWE1;MYOF;NSFL1C;DNM1;VAMP2;USO1;SNAP29;VPS33B;GCA
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.36759750499503185,-1.0402105022363028,0.4038876889848812,0.754318455137407,1.0,10/18,33.75%,SKI;CDC73;TP53;MED25;PEX2;EMD;SFRP1;B4GALT7;CD300A;TRIM32
prerank,positive regulation of JUN kinase activity (GO:0043507),0.38516775382739177,1.039928775061396,0.3890845070422535,0.9710036892082425,1.0,6/23,14.82%,MAP3K11;MAP3K7;MAP3K4;PAK1;RPS3;MAP3K10
prerank,gluconeogenesis (GO:0006094),0.3447206583325527,1.0397889605320167,0.4,0.9703032687961525,1.0,4/39,5.68%,PCK1;SLC25A1;GOT2;TPI1
prerank,signal peptide processing (GO:0006465),0.4554663281229729,1.0390329960426672,0.43453510436432635,0.971688195262122,1.0,4/11,13.55%,SEC11A;SPCS3;SPPL3;SPCS2
prerank,MAPK cascade (GO:0000165),0.2588461431192631,1.0389111892882157,0.37959667852906287,0.97095732114911,1.0,55/295,14.57%,GFRA3;PSMB10;PSMC4;MAP2K7;PSMB6;MAPK3;DUSP7;PSMD8;SPTB;PSMD5;PSMD12;MAP3K7;SHANK3;NRAS;ZFP36L1;PSMD11;TEK;PSMB4;FYN;SPRED1;PSMC1;RASGRP3;MAPK8;RET;FGF13;YWHAB;IRS2;MINK1;PSMC2;PAK1;PSMD2;ICMT;RASA2;NF1;TNIP2;MAP4K4;IKBKB;ARTN;MAPK12;PDE6D;CUL3;CHUK;ZDHHC9;NRG2;PSMD14;PPP5C;PSMC6;PSMD1;RGL2;PSMB1;PTPRA;MAP3K3;RGL3;GFRA1;CAMKK2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.42273162975164114,1.0388722323021866,0.41894353369763204,0.9699359933032073,1.0,4/15,13.10%,TTLL12;CNOT7;USP18;NLRC5
prerank,canonical Wnt signaling pathway (GO:0060070),-0.2770308193964796,-1.0384391705720102,0.3537234042553192,0.7584467021196707,1.0,20/68,17.78%,WNT5B;FZD6;RYK;CTNNB1;PLPP3;DIXDC1;CSNK1A1;WNT4;LRP5;CSNK1E;DVL3;FZD2;GSK3B;WNT9A;SCYL2;LRP6;TCF7L2;FZD4;DVL1;SFRP4
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.4379022508933379,1.038306661089244,0.4011627906976744,0.9706164433135244,1.0,5/12,17.13%,EZH2;KLF2;CTBP2;CNOT1;CALR
prerank,fatty acid transport (GO:0015908),0.41091141376101925,1.0378420821410486,0.40816326530612246,0.9709898034332297,1.0,3/17,6.77%,GOT2;APOE;PPARD
prerank,Notch signaling involved in heart development (GO:0061314),0.4524612298265796,1.0374562334174655,0.4245810055865922,0.9712408782124315,1.0,5/11,16.11%,HEY1;HEY2;NOTCH1;RBPJ;HEYL
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3799814004802572,1.0368143415584825,0.4295652173913043,0.9722382319445974,1.0,7/24,13.83%,MAP3K7;TNFAIP3;TAB2;TAB3;UBE2V1;NOD1;MAP2K6
prerank,action potential (GO:0001508),-0.30312602866226046,-1.0367435861716587,0.351010101010101,0.7622779563047981,1.0,10/44,13.06%,ANK3;AKAP6;KCND2;SCN8A;SCN3A;KCNJ2;SCN1A;KCNA1;SRI;CACNA1G
prerank,metal ion transport (GO:0030001),-0.2666921486774224,-1.0363408529150198,0.3772455089820359,0.7625513858466476,1.0,16/86,13.46%,CACNA1C;ITPR1;CALCRL;CACNA1D;RYR3;SLC41A1;TRPC5;NIPA2;MRS2;CACNA1B;TRPC1;NDFIP1;CACNG7;RAMP1;NIPAL2;SLC39A8
prerank,regulation of apoptotic process (GO:0042981),0.24510388788560436,1.0362164008107568,0.3680851063829787,0.9731110452357915,1.0,106/676,13.90%,LRP8;CIDEA;HIGD2A;ERCC3;GCLC;MAP3K11;CBL;ATF6;FRZB;LEF1;ACER2;TIAM1;SOD1;VAV3;PSEN2;PLK2;RPS6KA1;BCL2L2;GLS2;CHM;GREM1;DNAJA3;ARHGEF26;PPT1;SRC;MCF2L;ING4;PAX8;BIRC2;NME1;HDAC3;ITSN1;SIGMAR1;TNFRSF10B;TEK;CIAPIN1;HNRNPK;SLK;PHB2;TOX3;CASP6;WFS1;CFL1;CIB1;AKT1S1;MAPK8;BAG1;ARHGEF6;CRADD;ARHGEF7;PIM1;TRIO;ACTN4;SIRT1;OMA1;NAA35;ARHGEF18;USP47;WNT5A;ITGA6;TJP1;PHLPP1;FBXO11;LATS2;RELA;PCID2;BCLAF1;FZD9;TFAP4;PARK7;TARDBP;AIFM1;TMBIM4;CITED2;RYBP;PRKAA2;ING3;CCAR2;BAD;NAE1;DDX3X;CYP1B1;CREBBP;HIGD1A;ANKLE2;RPS3;PA2G4;ATG7;EGLN2;BMF;IP6K2;BNIP3L;NF1;PRKCI;MAP4K4;IKBKB;API5;ERC1;ING5;UTP11;DIABLO;AVEN;FAF1;PROC;APC;NFKBIA
prerank,regulation of endothelial cell migration (GO:0010594),-0.25673305000331514,-1.0361420070678296,0.33762057877813506,0.7622557899725477,1.0,18/85,12.11%,FOXP1;ANXA3;SASH1;NR2F2;BMPER;NRP1;FGF1;BMP4;ROCK2;ADAMTS9;GLUL;SPARC;SMOC2;THBS1;NRP2;RHOJ;FOXC2;RHOB
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.30361619879007584,-1.0360106859039793,0.36895674300254455,0.7618074460312473,1.0,16/41,22.88%,PRKAG2;OGT;PRKAG1;NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;LACC1;NUP85;AAAS;RAE1;NUP37;NUP214;PGAM1
prerank,negative regulation of DNA binding (GO:0043392),0.3646933113731817,1.0358553374558015,0.4186851211072664,0.9731392687310437,1.0,7/28,13.90%,LEF1;HEY1;HEY2;RSF1;TFAP4;TNKS;NFKBIA
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.30019963511864056,1.0356297424817273,0.3864306784660767,0.9727364961859628,1.0,17/83,14.75%,CDK17;PLK2;CCNH;CDKN1A;NPAT;POLE;CDC45;FBXO5;CDK4;LATS2;POLA1;USP37;E2F3;CUL3;PHF8;RCC1;BACH1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.31210821640165604,1.0348040245116545,0.4058192955589586,0.9744013426647212,1.0,13/59,13.90%,MAP3K7;TAB2;BIRC2;TAB3;NLRC3;RELA;RBCK1;NFKBIL1;IKBKB;ERC1;CHUK;FAIM;NFKBIA
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4249156314791572,1.0347095100568178,0.43833017077798864,0.9735499807261627,1.0,6/14,16.18%,SFSWAP;SRSF10;SRSF4;PTBP1;SRSF7;U2AF2
prerank,negative regulation of interleukin-2 production (GO:0032703),0.3974737034072121,1.0343568606658249,0.4098671726755218,0.9735242801157434,1.0,3/18,3.58%,PTPRC;TNFAIP3;HDAC7
prerank,regulation of lymphocyte migration (GO:2000401),-0.4352801291718954,-1.0337626705778327,0.41929133858267714,0.7672630167288876,1.0,3/10,24.53%,WASL;MSN;AKT1
prerank,regulation of centrosome duplication (GO:0010824),0.3647680849368004,1.0336397978755274,0.4010327022375215,0.9748002735149792,1.0,5/29,10.23%,ALMS1;PLK2;CHMP1A;SIRT1;CHMP2A
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.2407974792760315,1.0333353577079414,0.3602865916069601,0.9747115137309211,1.0,191/1082,14.95%,SOX30;ATF3;MAZ;CTCFL;MAP2K7;MAPK3;MECOM;CHCHD2;SS18L1;ONECUT1;EIF5A;ILF3;TFCP2;NR4A2;TAL1;ATF6;TRIM28;PIN1;LEF1;RUVBL2;PPP3CB;RPS6KA1;RPTOR;RPS6KA4;KLF2;MRTFA;CCNC;GREM1;PCBP1;HIPK2;ELK3;MAP2K5;PAX8;GABPA;PRKD2;RPS6KA5;BCL11B;MRTFB;SMAD1;HDAC3;PHF5A;PRDM15;SBNO2;HNRNPAB;HEY1;NR5A1;RLF;MMP12;APOE;CCDC62;PRDM4;MYBL2;FLI1;SMARCA2;SOX2;MEIS1;YY1;TOX3;KDM3A;SPIN1;USF2;IER2;NPAT;IRF2BPL;EP300;VEZF1;DCAF6;RFX3;TBX1;ICE1;ASXL3;RET;CEBPG;CALCOCO1;FOXF2;PPARD;MED12;RGCC;SFPQ;SMAD7;SIRT1;DRAP1;PAXBP1;CLOCK;TET3;RNF187;HEY2;LMO7;AXIN1;NOTCH1;CAND2;GLMP;WNT5A;ITGA6;ATXN7L3;ATAD2;GTF2H1;ZXDC;ACVRL1;RSF1;RELA;JUND;HOXA7;PCID2;BCLAF1;RAI1;ECD;PLCB1;TFAP4;ERG;PARK7;RNF6;KANSL3;AKAP8L;RHOQ;ZKSCAN3;PPP1R12A;KLF6;LMO2;UBE2V1;TAF15;CITED2;YEATS4;RYBP;ING2;WBP2;ESR1;ACVR2A;CD81;SETD3;THRB;DDX3X;RBPJ;RHOG;CREBBP;USP22;APP;NFIC;ZBED3;MED4;ATAD2B;ZBED4;TNKS;PPP3CA;PICALM;PPP3R1;AGRN;ILF2;TNIP2;E2F3;SP1;IKBKB;SS18;MZF1;SMARCD1;MDFIC;IRF2;DOT1L;CHUK;PITHD1;ACTA2;YWHAH;NLRC5;CTBP2;HDAC5;ING5;EPAS1;EDRF1;CHEK2;DDIT3;POGZ;THRA;SSBP4;CREBRF;NFKBIA;HES1;DR1;HCFC1;YBX1;GRHL1;RNF20;PHF8;NCOA7;HEATR1;CAMKK2;SCAF8;TMPRSS6;CRTC3;PHF10;TFAM;INO80
prerank,cellular response to estradiol stimulus (GO:0071392),0.4062175194207649,1.0333030089179727,0.40808823529411764,0.9736949401110638,1.0,3/18,10.46%,RUVBL2;CCDC62;ESR1
prerank,endothelial cell proliferation (GO:0001935),0.41750592641748635,1.0332874156331113,0.42077464788732394,0.9726192258206657,1.0,3/17,8.88%,PRKX;TEK;ACVRL1
prerank,ephrin receptor signaling pathway (GO:0048013),0.3003613324346295,1.0332032320513993,0.3914285714285714,0.9717621231781237,1.0,17/82,10.62%,ARPC3;TIAM1;VAV3;PSEN2;AP2S1;ACTB;SRC;ITSN1;ARPC4;FYN;ARHGEF7;PAK3;EPHA5;EFNA1;LYN;PAK1;YES1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.36860311825708897,-1.033102686653515,0.42953020134228187,0.7682445069723479,1.0,10/19,28.78%,TAPT1;PML;TOPORS;TAF8;PINK1;HK2;AKT1;SUPT7L;ARL2;BCL3
prerank,neural tube closure (GO:0001843),-0.3135756230406946,-1.0330489536849823,0.3842364532019704,0.7675543671720333,1.0,17/34,31.81%,LMO4;SKI;COBL;MTHFR;DVL3;MTHFD1;PLXNB2;LRP6;TGFB1;DVL1;TSC2;PAX2;BCL10;FUZ;KDM2B;SCRIB;VANGL2
prerank,negative regulation of heart contraction (GO:0045822),0.4433412713635555,1.0327179969517704,0.4157706093189964,0.9722338746177275,1.0,2/11,1.75%,PIK3CG;PDE4D
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.24275024234637593,1.0324956704179413,0.3643979057591623,0.9718452932224033,1.0,140/834,14.06%,SOX30;ATF3;CTCFL;MAPK3;CHCHD2;SS18L1;ONECUT1;EIF5A;TFCP2;NR4A2;TAL1;ATF6;PIN1;LEF1;RUVBL2;PPP3CB;RPS6KA1;RPS6KA4;KLF2;MRTFA;CCNC;GREM1;PCBP1;HIPK2;ELK3;MAP2K5;PAX8;GABPA;PRKD2;RPS6KA5;BCL11B;MRTFB;SMAD1;HDAC3;PRDM15;SBNO2;HEY1;NR5A1;RLF;MMP12;CCDC62;PRDM4;MYBL2;SMARCA2;SOX2;MEIS1;YY1;TOX3;USF2;IER2;NPAT;IRF2BPL;EP300;VEZF1;DCAF6;RFX3;TBX1;ASXL3;CEBPG;CALCOCO1;FOXF2;PPARD;MED12;RGCC;SFPQ;SMAD7;SIRT1;DRAP1;PAXBP1;CLOCK;TET3;HEY2;LMO7;NOTCH1;GLMP;WNT5A;ITGA6;ATAD2;ACVRL1;RSF1;RELA;JUND;HOXA7;BCLAF1;ECD;ERG;PARK7;KANSL3;AKAP8L;RHOQ;PPP1R12A;KLF6;LMO2;CITED2;YEATS4;WBP2;ESR1;ACVR2A;TERT;CD81;SETD3;THRB;DDX3X;RBPJ;CREBBP;APP;NFIC;ZBED3;MED4;ATAD2B;ZBED4;TNKS;PPP3CA;PPP3R1;AGRN;TNIP2;E2F3;SP1;IKBKB;SS18;MZF1;SMARCD1;IRF2;DOT1L;CHUK;NLRC5;CTBP2;HDAC5;EPAS1;DDIT3;POGZ;THRA;SSBP4;CREBRF;NFKBIA;HES1;DR1;HCFC1;YBX1;GRHL1
prerank,cellular protein catabolic process (GO:0044257),-0.28732556151299926,-1.0322585639492015,0.3893333333333333,0.7688930507142213,1.0,18/59,17.84%,ADAMTS12;AP2B1;CAPN2;AP2A2;AFG1L;MALT1;AP2A1;PSMA6;FAP;LGMN;CLPP;TCIRG1;CTSO;SIAH2;VLDLR;RNF123;CTSZ;MYLIP
prerank,regulation of intracellular transport (GO:0032386),-0.30985098194645655,-1.032178992343442,0.3877551020408163,0.7683082840509301,1.0,16/38,29.14%,MAP2;DYNC1H1;ATP9A;TTC21B;GAS1;RBM4;ATPSCKMT;RINT1;RNF139;CRYAB;AAAS;NUP214;DYNLT2B;CAPN10;INPP5F;NEFH
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.32316418395043534,-1.032069962164429,0.3763157894736842,0.7677678019196673,1.0,14/32,20.84%,ADGRB3;CUX1;SDC2;HECW1;GSK3B;CUX2;SEMA4D;IL1RAPL1;OBSL1;RAPGEF2;HECW2;KNDC1;NEDD4;NSMF
prerank,cellular response to catecholamine stimulus (GO:0071870),0.382726734062025,1.0320448385566672,0.3971119133574007,0.9721606727166373,1.0,3/23,6.32%,MAPK3;GABPA;GNB1
prerank,nuclear membrane organization (GO:0071763),-0.36813973121654375,-1.031955186196296,0.4059633027522936,0.7672837368066696,1.0,13/19,35.36%,UBXN2A;UBXN2B;TOR1AIP1;NSFL1C;TOR1B;DCTN1;NEMP1;VPS4A;EMD;TMEM43;TOR1A;GPER1;CHMP7
prerank,cellular iron ion homeostasis (GO:0006879),0.3249531020730578,1.0319465564687291,0.39938556067588327,0.9713365486092626,1.0,10/55,12.10%,CAND1;HMOX2;SOD1;ABCG2;FBXL5;ATP6V0D1;ISCU;GLRX3;ATP6AP1;ACO1
prerank,negative regulation of apoptotic process (GO:0043066),0.2502968363042828,1.0317304412057116,0.39226519337016574,0.9709292938618269,1.0,63/444,12.44%,CIDEA;HIGD2A;MAZ;FOXQ1;GCLC;MAPK3;CBL;NR4A2;LEF1;SOD1;PSEN2;PLK2;RPS6KA1;PRKCH;BCL2L2;GREM1;CRLF1;PPT1;SRC;MAP2K5;BIRC2;HDAC3;APOE;TEK;CIAPIN1;HNRNPK;PHB2;TOX3;WFS1;CFL1;CIB1;MAPK8;TBX1;CARD16;BAG1;SFPQ;PIM1;BDNF;SIRT1;NAA35;NOTCH1;USP47;WNT5A;TJP1;MERTK;RELA;SOD2;PCID2;FZD9;FZD3;PARK7;TMBIM4;CITED2;PRKAA2;DDX3X;HIGD1A;ANKLE2;PA2G4;BNIP3L;PRKCI;MAP4K4;IKBKB;API5
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.4495305177574801,-1.0316077133318649,0.4263565891472868,0.7674396373902468,1.0,3/10,15.42%,RYK;CTNNB1;LRP6
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.42948155642922353,1.0307626921582433,0.3988439306358382,0.9730403642497129,1.0,1/12,0.61%,IMPDH1
prerank,regulation of monocyte differentiation (GO:0045655),-0.39817519586902983,-1.0307499464339938,0.4452054794520548,0.7690933763084127,1.0,3/14,9.85%,FOXP1;IL34;CDK6
prerank,cAMP-mediated signaling (GO:0019933),-0.34428038656004945,-1.030746771077115,0.4098360655737705,0.7682692660675859,1.0,4/24,3.20%,KSR1;AKAP6;ADCY2;ADCY1
prerank,nitrogen compound transport (GO:0071705),0.27598319831499785,1.0306391222748852,0.40599455040871935,0.9723042438306181,1.0,14/141,7.90%,SLC18A1;SLC5A7;SLC7A8;ABCG2;PPT1;SLC3A2;SLC52A2;RAMP2;RAB7A;SLC52A3;SLC6A6;CHMP1A;TMEM30B;SLC44A1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.4387466743408923,1.0305722682685996,0.43548387096774194,0.9714081930515062,1.0,4/12,12.62%,CSGALNACT1;EXTL2;UGP2;SLC35A3
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2513701719304948,1.030479874833189,0.4,0.970592834602911,1.0,56/417,10.44%,CCDC85B;GCLC;DACH1;MECOM;ARID5A;ILF3;L3MBTL4;TRIB3;MTERF3;EZH2;TRIM28;HSPA8;LEF1;CIPC;EED;BTAF1;DMAP1;ELK3;ING4;ZHX3;ZBTB33;HDAC9;RPS6KA5;HDAC3;SBNO2;HEY1;SMARCA2;PHB2;UBE2I;RFX3;PPARD;CHMP1A;SFPQ;SIRT1;CLOCK;PFDN5;HEY2;ZBTB14;NOTCH1;USP47;CNOT7;WNT5A;SOX13;RSF1;RELA;HOXA7;BCLAF1;MDM2;PLCB1;TFAP4;ZKSCAN3;CIR1;CITED2;PBXIP1;CCAR2;HIC2
prerank,acidic amino acid transport (GO:0015800),-0.37736776453168286,-1.0304476505907887,0.4269911504424779,0.7682512452534429,1.0,6/17,10.60%,SLC1A3;SLC6A13;LRRC8D;SLC6A1;SLC25A13;GJA1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.39195434842928656,1.030388999778905,0.4423076923076923,0.9697510823562252,1.0,4/18,10.81%,STOX1;FBXO5;CDK4;RAD51B
prerank,regulation of cell growth (GO:0001558),0.2662855888719484,1.0302279597204511,0.39768339768339767,0.9691727485995582,1.0,29/204,12.39%,CISH;CCDC85B;NCBP1;PTPRJ;FRZB;ST7L;DERL2;RPS6KA1;RPTOR;RERG;PPT1;LTBP4;PPP2CA;SMARCA2;CIB1;CDKN1A;LAMTOR1;CDK11B;SIRT1;USP47;EXOSC9;ACVRL1;LGI1;EIF4G2;CCAR2;DDX3X;EGLN2;IP6K2;EI24
prerank,tRNA wobble base modification (GO:0002097),0.4210224859218958,1.0301999480482857,0.4280442804428044,0.9681590503031448,1.0,1/14,0.85%,MOCS3
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.45235910523128403,-1.029983234483771,0.44288577154308617,0.7686655101466432,1.0,7/10,31.20%,SIRT2;BAG3;JUN;IMPACT;VHL;HIF1AN;NCK1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.3130762687224829,-1.0296340690289194,0.43358395989974935,0.7688081042845595,1.0,12/34,20.89%,WASF2;AUTS2;OCLN;FER;PLCE1;ACTR3;ACTR2;CDC42;TWF2;CAPZB;PIK3R1;ARPC2
prerank,negative regulation of cell development (GO:0010721),-0.34214172865410497,-1.0296200481586837,0.3923766816143498,0.7680158728667374,1.0,5/25,10.56%,IGF1;FBN1;APPL2;SORL1;GSK3B
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4155308885258611,-1.029613472912958,0.4343220338983051,0.7672131741983019,1.0,1/12,5.54%,ZBTB1
prerank,negative regulation of calcium ion transport (GO:0051926),-0.3959296867398352,-1.029248612606361,0.41950113378684806,0.7673824004156354,1.0,1/15,0.15%,ATP1A2
prerank,regulation of lamellipodium organization (GO:1902743),-0.40040088230366366,-1.029199490366285,0.40877598152424943,0.7666731903889215,1.0,6/14,25.42%,PDPN;FER;CDC42;TWF2;CAPZB;DMTN
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.4333722988957709,-1.029156529207054,0.4194915254237288,0.7659909775031041,1.0,3/11,16.23%,IL34;HSF1;TGFB1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.43995057979094065,1.0291281022085608,0.3976143141153082,0.9705203464546776,1.0,3/12,7.51%,APOE;PFDN6;PFDN5
prerank,response to organophosphorus (GO:0046683),-0.38198967436667614,-1.0287065865830975,0.4104803493449782,0.7663488109041519,1.0,9/16,40.76%,P2RX4;ABCC9;STAT1;DGKQ;TRIM16;TRPC3;TYMS;RFC3;VGF
prerank,B cell activation (GO:0042113),0.30561793200340626,1.0285267410231123,0.4063926940639269,0.9714273930414922,1.0,9/68,13.21%,DCAF1;PTPRJ;PTPRC;HDAC9;PHB2;CEBPG;KLF6;PIK3CD;HDAC5
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.4395783267342929,-1.028299623246381,0.4414784394250513,0.766744617729903,1.0,8/10,49.66%,SORL1;SACS;DNAJB2;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,telomere capping (GO:0016233),0.40749583607909895,1.0281679178677108,0.424408014571949,0.9715171548989455,1.0,7/16,17.42%,CTC1;DCLRE1B;ACD;NBN;TERF2IP;PRKDC;DCLRE1C
prerank,morphogenesis of an epithelium (GO:0002009),0.37325768020598743,1.027930454715131,0.44,0.9711772156150477,1.0,5/25,10.61%,PRKX;ACTB;DAG1;LIN7C;TRAF3IP1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2478525098916595,1.0275894285905005,0.3923076923076923,0.9711507179119733,1.0,94/497,16.15%,CCDC85B;GCLC;DACH1;MECOM;GSK3A;ARID5A;ILF3;L3MBTL4;TRIB3;MTERF3;EZH2;TRIM28;HSPA8;LEF1;CIPC;PATL2;EED;BTAF1;DMAP1;ELK3;ING4;ZHX3;ZBTB33;HDAC9;RPS6KA5;HDAC3;SBNO2;HEY1;SMARCA2;PHB2;UBE2I;DBI;CDKN1A;RFX3;FXR1;PAIP2B;PPARD;CHMP1A;SFPQ;SIRT1;CLOCK;PFDN5;HEY2;ZBTB14;NOTCH1;USP47;CNOT7;WNT5A;TSC1;SOX13;ACVRL1;RSF1;RELA;HOXA7;BCLAF1;MDM2;PLCB1;TFAP4;ZKSCAN3;CIR1;CITED2;PBXIP1;CCAR2;HIC2;DDX3X;RBPJ;NANOS3;CTBP1;RPS3;PA2G4;LANCL2;MDFIC;NDUFA13;CTBP2;HDAC5;DDIT3;THRA;HES1;KDM5C;YBX1;CNOT1;CAPRIN1;TMPRSS6;MAP3K10;PHF10;GAS6;NKAP;BCL6;TRIM33;ATR;SMARCA4;ID2;HEYL;ZBTB18
prerank,regulation of protein acetylation (GO:1901983),0.43091245214130636,1.0272619692566503,0.4256120527306968,0.9711056045007326,1.0,5/12,15.22%,RAPGEF3;SIRT1;PARK7;DDX3X;TERF2IP
prerank,regulation of epithelial cell migration (GO:0010632),0.3227921289792981,1.0271989321266848,0.41166936790923825,0.9702159411172651,1.0,7/51,4.76%,PTPRR;PTPRG;SRC;CLASP2;EVL;INSL3;PFN1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4475553694841086,1.0271942967704797,0.4155597722960152,0.9691295452341702,1.0,4/11,16.57%,PCBP1;NOVA2;PCBP3;ZNF445
prerank,lamellipodium organization (GO:0097581),-0.32616210208097607,-1.0268036374641538,0.4155844155844156,0.7700926784324067,1.0,12/29,21.63%,SNX2;KIT;VCL;CTTN;WASF1;SPATA13;ABLIM2;ABLIM3;PTPRO;ARFIP2;ARHGEF4;P2RY12
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.387524199464352,-1.0264604192601687,0.4116279069767442,0.7702360038256536,1.0,4/16,6.19%,PDGFRB;NRP1;FER;PDGFRA
prerank,"base-excision repair, gap-filling (GO:0006287)",0.33614381553986294,1.026454310461071,0.4264705882352941,0.9703463285836459,1.0,7/35,13.19%,PNKP;XRCC1;TDG;POLE;POLD3;SMUG1;MPG
prerank,proteasome assembly (GO:0043248),0.4488900534765788,1.0264008279471837,0.4058252427184466,0.9694326739870277,1.0,3/11,7.66%,PSMD5;PSMD11;PSMG1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.44125661244779546,1.0263248474076558,0.4391634980988593,0.9685933110078063,1.0,3/12,10.77%,TRIB3;SIRT1;ERLIN2
prerank,lipoprotein catabolic process (GO:0042159),0.45570897385061937,1.0262060245213906,0.42638623326959846,0.9679093971389079,1.0,2/11,4.59%,PPT1;APOE
prerank,carnitine shuttle (GO:0006853),-0.427688775328675,-1.026171091227223,0.4444444444444444,0.7702511116140047,1.0,4/11,14.84%,PRKAG2;CPT1A;PRKAB2;CPT2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.4233642544236811,-1.0259354139197487,0.4335511982570806,0.770098632184387,1.0,3/11,15.12%,NRP1;SIRT2;STMN1
prerank,regulation of isotype switching (GO:0045191),-0.40003845756337564,-1.025906040830516,0.403470715835141,0.7693600563411818,1.0,5/14,20.12%,PAXIP1;SHLD1;PARP3;RIF1;SLC15A4
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.3687081213898035,-1.0258460264057703,0.41555555555555557,0.7687216855990575,1.0,7/18,35.43%,FBN1;TCTA;TLR3;GPR137B;TMEM178A;MAFB;GPR137
prerank,UV-damage excision repair (GO:0070914),0.43295479201206066,1.0258051698226622,0.4232902033271719,0.9680494762957738,1.0,5/12,14.95%,SIRT1;ACTR5;POLD3;POLA1;INO80
prerank,mesenchyme morphogenesis (GO:0072132),0.403163672533547,1.0252687695217453,0.42641509433962266,0.9687434260474724,1.0,5/17,16.11%,HEY1;NOTCH1;ACVRL1;NOS3;HEYL
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3525297737415456,1.024780125912482,0.40816326530612246,0.9693269439158304,1.0,6/33,8.88%,MAP2K5;APOE;MMRN2;RGCC;NOTCH1;ACVRL1
prerank,histone H4-K5 acetylation (GO:0043981),0.42349537961333833,1.0247059446849398,0.4543828264758497,0.9674077357557791,1.0,5/15,14.04%,JADE3;ING4;KANSL2;KANSL3;HCFC1
prerank,histone H4-K8 acetylation (GO:0043982),0.42349537961333833,1.0247059446849398,0.4543828264758497,0.9674077357557791,1.0,5/15,14.04%,JADE3;ING4;KANSL2;KANSL3;HCFC1
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.434488629786866,1.0240446388359692,0.43761996161228406,0.9684708294069064,1.0,6/13,20.77%,PRR5L;CNOT7;CNOT1;MOV10;RC3H1;CNOT8
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3692152672247155,1.0238048104601378,0.43478260869565216,0.968126761441633,1.0,4/27,7.75%,MAP3K7;TAB2;TIRAP;TAB3
prerank,COPII-coated vesicle budding (GO:0090114),0.3076995940711648,1.0235533501023477,0.39762611275964393,0.9678743575281318,1.0,13/68,12.84%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;GOSR2;F8;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3
prerank,cellular response to oxidative stress (GO:0034599),0.2825190819006438,1.0234510390063878,0.407557354925776,0.967098189035522,1.0,16/118,10.33%,MAPK3;ROMO1;CHCHD2;PRR5L;TXNRD2;SLC25A24;SOD1;EIF2S1;CYCS;ZFAND1;MAPK8;LONP1;GPX7;SOD2;PARK7;PRKAA2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4383819004320888,1.0231263608249548,0.4477317554240631,0.9670900156598301,1.0,3/12,10.59%,BCDIN3D;ESR1;TERT
prerank,cellular component assembly (GO:0022607),-0.22171014456852417,-1.023048383875637,0.3701923076923077,0.7756282709603206,1.0,61/253,20.02%,CALD1;ANK3;RIMS1;TEAD1;PAWR;GSN;PARVA;DPYSL3;GPM6B;LRRTM3;KMT2A;PCLO;LIMA1;WASL;DLG4;WIPF1;OCLN;RHOA;NLGN2;FLNA;NEDD9;PPARGC1A;TAPBP;TUBGCP4;PEX14;PML;WASF1;DARS1;YTHDF1;NLGN1;EZR;PPID;TLCD2;RHOJ;DCX;TP53;ILK;STK25;BAIAP2L1;RANBP9;IKBKG;AFG3L2;WDR19;BSN;VAMP2;MYO1B;QSOX1;TGFB1;TRAF2;DVL1;CDC42;CARD10;CLDN14;ADD2;ZFYVE27;MDM4;TEAD2;SHANK1;SPG7;TTLL3;ZW10
prerank,membrane organization (GO:0061024),-0.22485247500243852,-1.0228247048054973,0.37222222222222223,0.7754287249747118,1.0,81/227,26.09%,ANK2;ANK3;RIMS1;DNAJC6;DAB2;EGFR;AMPH;STX18;CHRM2;AP2B1;A4GALT;SH3GL2;TOR1AIP2;STAM2;WASL;AP2A2;STON2;UBXN2A;ARPC1A;CTTN;NUP155;SYT9;AP2A1;LDLR;ACTR3;PLEKHA8;UBXN2B;TOR1AIP1;BIN1;HUWE1;MYOF;TMEM33;DMPK;IGF2R;TLCD2;UBC;NUP93;NSFL1C;MITD1;GRB2;MYADM;HIP1R;EPN1;DNM1;M6PR;VAMP2;TOR1B;USO1;NEMP1;MTCH1;FZD4;ACTR2;SUN1;CHMP2B;SYT2;SNX3;CHMP5;SNAP29;GLTP;STAM;ARPC2;VPS4A;CNTN2;HGS;VPS33B;GCA;COX18;CTDNEP1;EMD;VAPB;CLN3;VAMP8;LEMD2;SERP1;TMEM170A;SPTBN1;SGCZ;PICK1;FNBP1;TMEM43;SYP
prerank,activation of phospholipase C activity (GO:0007202),-0.3307036159498909,-1.0220790891743337,0.41745283018867924,0.7766360841636449,1.0,5/29,6.20%,LPAR1;EGFR;NTRK2;ARHGAP6;EDNRA
prerank,activation of protein kinase B activity (GO:0032148),-0.3233258857257156,-1.0220026143018952,0.4215686274509804,0.7760094849171975,1.0,3/29,3.14%,NTRK3;IGF1;FGF1
prerank,response to interleukin-6 (GO:0070741),0.4697935780891261,1.0216437789939514,0.43859649122807015,0.9708813633923566,1.0,4/10,11.92%,SBNO2;PTPRT;RELA;ST3GAL6
prerank,regulation of cellular respiration (GO:0043457),0.3932701914565407,1.021062128409982,0.42190305206463197,0.9717077345484247,1.0,3/17,9.96%,IFNLR1;IL10RB;IFNAR1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.37575305642830237,1.0210323778358332,0.443859649122807,0.9707144417583741,1.0,3/22,4.99%,EIF5A;RPL23;SPRED1
prerank,transepithelial transport (GO:0070633),0.4123193219798854,1.02100426228425,0.4349442379182156,0.9697203229187925,1.0,3/15,8.22%,SLC1A1;ABCG2;SLC1A2
prerank,long-chain fatty acid transport (GO:0015909),-0.3226185348352872,-1.0209420294179476,0.4488778054862843,0.7780524327273819,1.0,7/30,14.84%,PRKAG2;ACSL1;CPT1A;PRKAB2;SLC27A1;ABCD2;CPT2
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3977828676487744,-1.020818579979571,0.4473684210526316,0.7776085342626599,1.0,10/14,39.85%,ADGRV1;ULK4;MYADM;GPD1L;ADRA1A;VEGFA;FLT4;WNT11;CD40;SPHK2
prerank,endothelial cell migration (GO:0043542),-0.3051726504777398,-1.0206256204948967,0.4045226130653266,0.7773303426317298,1.0,18/37,26.43%,FSTL1;ADGRA2;NRP1;RHOA;PXN;DPP4;STARD13;FAP;PLEKHG5;PLXND1;CCN3;SCG2;STAT1;TNFSF12;VEGFA;EMP2;NR4A1;RAB13
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.2369925497300349,1.02062106771428,0.3953722334004024,0.9699078739902001,1.0,294/1668,16.22%,TBX4;SOX30;LRRFIP1;DBX2;ATF3;IRX1;PRKAR1A;TOX4;MAZ;ZBTB42;CTCFL;DCAF1;FOXQ1;DACH1;MAPK3;MECOM;CHCHD2;AASS;SIM1;ELOC;SS18L1;ARID5A;ONECUT1;EIF5A;KLF8;TRIB3;TFCP2;NR4A2;TAL1;EZH2;ACTL6A;ATF6;TRIM28;PIN1;LEF1;HES6;RPL23;EED;CTDSP1;RUVBL2;JAZF1;PPP3CB;GTF2IRD1;RPS6KA1;DMAP1;PHF14;RPS6KA4;KLF2;MRTFA;CCNC;GREM1;DNAJA3;PCBP1;HIPK2;ELK3;MAP2K5;PAX8;ZHX3;ZBTB24;ZBTB33;HDAC9;GABPA;BCL6B;BACH2;PRKD2;RPS6KA5;BCL11B;MRTFB;SMAD1;HDAC3;ZKSCAN1;PRDM15;SBNO2;HEY1;NEDD4L;NR5A1;RLF;MMP12;ZBTB41;APOE;CCNH;IRF9;CCDC62;PRDM4;MYBL2;FLI1;BBX;SMARCA2;SOX2;MEIS1;HNRNPK;YY1;GMEB2;TOX3;ZNF83;WFS1;KDM3A;KDM2A;VPS72;ZNF740;USF2;IER2;UBE2I;ZSCAN2;CDKN1A;NPAT;IRF2BPL;BEND3;EP300;VEZF1;DCAF6;RFX3;RPS14;TBX1;ZNF260;NFX1;MED23;CARF;ASXL3;PCGF3;CEBPG;CALCOCO1;CNOT2;FOXF2;MAMLD1;PPARD;MED12;RGCC;ZNF205;SFPQ;UXT;SMAD7;SIRT1;BMI1;DRAP1;PAXBP1;CLOCK;TET3;ZNF3;HEY2;LMO7;ZBTB14;NOTCH1;MED15;SAP130;EDNRB;GLMP;RUVBL1;CDK4;WNT5A;ITGA6;LCORL;ATXN7L3;ATAD2;EFNA1;GTF2H1;ZXDC;SOX13;ACVRL1;RSF1;RELA;CSF1R;SOD2;JUND;HOXA7;BCLAF1;MDM2;RAI1;ECD;PIAS2;TFAP4;ERG;PKN1;PARK7;TRPS1;KANSL3;AKAP8L;BUD31;RHOQ;ZKSCAN3;PPP1R12A;KLF6;LMO2;CIR1;CITED2;YEATS4;CHD1;WBP2;MGA;HIC2;ESR1;ACVR2A;CD81;SETD3;THRB;DDX3X;RBPJ;DACH2;CREBBP;CTBP1;AGO4;APP;PIAS1;ORC2;NFIC;ZBED3;MED4;ATAD2B;ZBED4;TNKS;JMJD1C;HDGF;IFI27;PPP3CA;PPP3R1;AGRN;TNIP2;N4BP2L2;E2F3;SP1;IKBKB;SS18;MZF1;SMARCD1;IRF2;CHD3;DOT1L;CHUK;ZBTB45;ZSCAN12;NLRC5;TGIF1;CTBP2;HDAC5;EPAS1;DDIT3;SP110;POGZ;THRA;SSBP4;ZKSCAN5;BRD2;CREBRF;NFKBIA;HES1;DR1;HCFC1;YBX1;GRHL1;TRIM27;SP8;SIX5;PHF8;PURG;USP9X;NCOA7;CNOT1;AEBP2;E2F6;TMPRSS6;BRIP1;BACH1;CRTC3;PHF10;FUS;TSHZ1;INO80;EZH1;PRDM10;TCF20;ZFP62;MOV10;TFEB;TAF6L;NKAP;TCERG1;NAMPT;FOXJ3;TAF1;ELK4;BCL6;WIZ;TRIM33;AKIRIN1;SMARCA4;ID2;ZNF483;TCF7L1;TCF3;HEYL;TSHZ2;ZBTB18;PURB;TAF3
prerank,negative regulation of MAP kinase activity (GO:0043407),0.32912288436820647,1.0204271635101232,0.43485342019543977,0.9694452085164164,1.0,4/44,4.59%,RGS2;DUSP7;PTPRJ;APOE
prerank,sulfur amino acid metabolic process (GO:0000096),0.3740940074603508,1.0203453506935423,0.44028520499108736,0.9686509461394084,1.0,2/24,2.94%,GCLC;MTR
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.4063338282044938,-1.0201611527236738,0.42283298097251587,0.7777934224971501,1.0,2/12,2.73%,FOXP1;MBP
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.4522777827945483,1.0201394948503417,0.4817658349328215,0.9681836361080969,1.0,4/11,16.16%,CCT2;CCT5;TCP1;DKC1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3572913922844313,1.019995197709534,0.4186851211072664,0.9675872310754345,1.0,5/27,9.20%,CSGALNACT1;XYLT1;CHSY3;PXYLP1;B3GAT2
prerank,positive regulation of response to wounding (GO:1903036),-0.3363067270128798,-1.0199896110263056,0.4295774647887324,0.7774620055698512,1.0,12/24,33.70%,OCLN;VTN;ANXA1;PTK2;SCARF1;ADRA2A;DMTN;MDK;HBEGF;MYLK;CLDN1;PTN
prerank,negative regulation of viral release from host cell (GO:1902187),0.4283733640560952,1.0196043648330042,0.4274661508704062,0.9677277397090666,1.0,2/13,3.72%,TRIM28;TRIM8
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.40927242329125396,-1.0192885372698173,0.42505133470225875,0.7785619318010999,1.0,4/12,33.41%,IL18;IL17D;CD80;PAEP
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3734965244577907,1.0190482279547672,0.4395017793594306,0.9684426733967243,1.0,7/22,16.46%,TIPRL;BOD1;PPP1R11;MGAT5;IKBKB;PTPA;FKBP1A
prerank,cellular response to insulin stimulus (GO:0032869),0.2801924987558916,1.018866557879179,0.4323943661971831,0.96796056919037,1.0,33/124,18.42%,PCK1;GSK3A;TRIB3;INSIG1;BCAR3;HDAC9;ATP6V1D;ZFP36L1;ATP6V0D1;MYO5A;AP3S1;TBC1D4;IRS2;ATP6V0E1;RHOQ;ATP6AP1;PRKCI;GRB14;HDAC5;APC;ZDHHC7;DENND4C;PIK3C2A;ATP6V1B2;NAMPT;SHC1;PRKDC;BAIAP2;INSR;C2CD5;SYAP1;ATP6V1A;IRS1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.30699477543935055,-1.0188532176888316,0.4278481012658228,0.7789318968832715,1.0,7/39,7.69%,ANK2;FGF12;CACNA1D;FHL1;WWP2;CHRM3;PTPN3
prerank,embryonic axis specification (GO:0000578),-0.38345309555388624,-1.0179210437531498,0.43923240938166314,0.7807691119128102,1.0,3/15,11.62%,COBL;SMAD6;TBX3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.3544436539191871,1.0177618947213551,0.43031358885017423,0.9704302194944041,1.0,13/29,20.90%,HBS1L;CNOT7;EXOSC9;PATL1;NT5C3B;CNOT6;EXOSC1;DCP1A;LSM1;DCP1B;EXOSC7;CNOT8;DDX6
prerank,regulation of centriole replication (GO:0046599),0.4040356381953709,1.0176635463174681,0.44,0.9696771221694723,1.0,2/17,2.58%,ALMS1;PLK2
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3470550157755788,1.017331435452401,0.41367521367521365,0.9697103331909668,1.0,14/32,20.79%,EIF2A;GEMIN5;TMED10;TSC1;METAP1;NANOS3;APP;PICALM;RBM4B;CYFIP1;RPL10;EIF4E;MTPN;SAMD8
prerank,negative regulation of T cell proliferation (GO:0042130),0.3579978519531364,1.0170058177596766,0.43373493975903615,0.96970443203237,1.0,3/28,13.01%,PRKAR1A;PRNP;CD274
prerank,pore complex assembly (GO:0046931),-0.360235539736734,-1.0169598158894617,0.425,0.7827270555921978,1.0,10/19,31.36%,NUP205;AFDN;AHCTF1;NUP93;ANO6;GSDMD;PLEKHA7;TMEM170A;NUP153;PDZD11
prerank,ion transport (GO:0006811),-0.24766760828621412,-1.0166484916965894,0.4154929577464789,0.7827916323304279,1.0,23/111,14.68%,TRPM3;SLC24A3;GABRB1;SLC1A3;GLRB;WNK1;SLC26A7;PIEZO2;VDAC1;SLC12A2;SLC26A2;GLRA1;SLC24A2;WNK4;ANO1;LASP1;SLC20A1;SLC9A2;CTNS;ANO6;SLC26A11;SLC12A6;SLC4A2
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.4390900984862719,-1.0165502156245936,0.4577319587628866,0.781431287056607,1.0,3/10,12.99%,MBP;WNK1;MYADM
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.4390900984862719,-1.0165502156245936,0.4577319587628866,0.781431287056607,1.0,3/10,12.99%,MBP;WNK1;MYADM
prerank,positive regulation of protein import (GO:1904591),-0.31850496529717254,-1.0164509287245844,0.4188861985472155,0.7809346084265553,1.0,13/30,20.03%,ZIC1;SMAD3;FLNA;BAG3;PRKCD;UBR5;EFCAB7;CDH1;PDCD5;ARHGEF5;TGFB1;MAVS;PIK3R1
prerank,sulfur compound biosynthetic process (GO:0044272),-0.2514944246757944,-1.016442543641785,0.4014084507042254,0.7801427121833804,1.0,42/104,28.53%,UST;DSE;GLCE;B4GALT1;CHSY1;VCAN;OGN;SLC26A2;SLC35B3;CSGALNACT2;GGTA1;CHST15;GSTT1;B4GALT6;CHST11;GSTZ1;SLC35D2;UGDH;CSPG4;GGT5;ST3GAL4;PAPSS2;PRELP;DSEL;ESD;LUM;B4GALT4;GSTA4;GSTM1;CDO1;BGN;DCN;CHPF2;CHST2;OPLAH;CHAC2;HPGDS;CHST3;MGST1;CSPG5;OMD;CHST12
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.30078513052216127,-1.0160310151068241,0.4239401496259352,0.7804843663146646,1.0,21/40,40.90%,IGF1;FAM162A;BCL2L11;TP53;GHITM;PDCD5;PINK1;AKT1;BCL2L1;GPX1;BID;FXN;PRELID1;GPER1;PLSCR3;CLU;HGF;BBC3;PLAUR;OPA1;PPIF
prerank,anion transport (GO:0006820),-0.3190693723961015,-1.0158251348366694,0.416,0.780263481538573,1.0,9/33,15.92%,SLC13A3;LRRC8D;SLC26A7;LRRC8B;VDAC1;SLC13A4;SLC22A6;SLC4A2;SLC19A1
prerank,regulation of TOR signaling (GO:0032006),0.30827841518595805,1.0156614455327504,0.42170542635658914,0.9729332187679928,1.0,15/67,15.25%,GSK3A;RPTOR;RFFL;HDAC3;EPM2A;AKT1S1;LAMTOR1;SIRT1;GNA12;TSC1;PRKAA2;LARS1;RRAGC;TMEM127;GAS6
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.3618557640837874,1.0156314059274802,0.4339622641509434,0.9719529546486285,1.0,7/26,13.83%,MAP3K7;TNFAIP3;TAB2;TAB3;UBE2V1;NOD1;MAP2K6
prerank,protein maturation (GO:0051604),-0.25631681253622285,-1.0154149654275666,0.4013377926421405,0.7806101828895403,1.0,33/95,25.94%,AEBP1;OGT;PCSK2;PCSK5;MMP16;MMP14;F3;SORL1;ADAM19;CCS;BACE1;NAA40;ADAMTS3;CPM;NNAT;AFG3L2;PCSK6;NFU1;DDI2;MMS19;HSPD1;PITRM1;ISCA1;STUB1;CASP2;NAA60;CPXM2;CIAO1;CLN3;TSPAN15;PTCH1;APH1B;CPXM1
prerank,regulation of nervous system development (GO:0051960),0.3328964389094918,1.0153840106315342,0.4426751592356688,0.9716532815418926,1.0,9/37,16.11%,HES6;HEY1;TNFRSF1B;HEY2;PRUNE1;DOCK7;TENM4;HES1;HEYL
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4437855878819015,1.0153469398697046,0.4571984435797665,0.9706945095510643,1.0,3/11,11.25%,FYN;PARK7;UBQLN1
prerank,positive regulation of signaling (GO:0023056),-0.30620976240327263,-1.0152983368197055,0.4215686274509804,0.7801122341607918,1.0,19/37,35.12%,RIMS1;WLS;ANXA2;DLG4;CLSTN2;ILK;PTPN23;KCTD13;CLSTN3;RAB29;INPP5F;CD80;SNCA;SCRIB;CDKN2AIP;NMU;EDN1;SOX11;EDN3
prerank,eosinophil chemotaxis (GO:0048245),-0.39645447945686924,-1.0152942952455706,0.45806451612903226,0.7785083237340304,1.0,3/14,22.13%,SCG2;CX3CL1;CCL13
prerank,eosinophil migration (GO:0072677),-0.39645447945686924,-1.0152942952455706,0.45806451612903226,0.7785083237340304,1.0,3/14,22.13%,SCG2;CX3CL1;CCL13
prerank,protein localization to nucleus (GO:0034504),-0.25357396504987495,-1.0152521698225685,0.397212543554007,0.7778219319498784,1.0,49/102,32.77%,COL1A1;TOR1AIP2;BMP7;IPO9;BMP4;LMNA;TNPO3;APPL2;PML;NUP155;NUP188;BANP;TOR1AIP1;IPO11;NUP88;NUP93;TNPO2;TOPORS;TAF8;TOR1B;FAM53C;PAF1;NUTF2;DVL1;IPO13;TSC2;NUP85;SIX1;NUP214;APPL1;TBRG1;GBP2;CTDNEP1;PPP1R10;AKT1;NOP53;SEC13;SUPT7L;RPF2;ARL2;NUP153;ABCA7;BCL3;NXT2;RPAIN;RAN;TOR1A;EIF4ENIF1;HEATR3
prerank,response to UV-A (GO:0070141),0.42077147695674744,1.0151205994252304,0.45904761904761904,0.9703530684383749,1.0,2/14,4.44%,CERS1;MME
prerank,gland development (GO:0048732),-0.2739230715329369,-1.0151163339132439,0.4117647058823529,0.7773827706803056,1.0,12/59,11.85%,FGFR2;TGFBR3;GLI2;TGFBR1;ZBTB1;WNT4;DKK3;COBL;EZR;SALL1;TBX3;ANXA1
prerank,neutrophil activation involved in immune response (GO:0002283),0.24717264487010376,1.0149132601148882,0.4230769230769231,0.9699775694256401,1.0,72/428,14.82%,SURF4;IMPDH1;CAND1;ATP8A1;PSMD12;PTPRJ;HMOX2;EEF1A1;GLB1;HSPA8;PTPRC;GYG1;PRCP;PECAM1;PTGES2;SVIP;RAB5C;CCT2;PTPRB;PYGL;NRAS;TUBB;ATP6V1D;PSMD11;ATP11A;MME;RAB7A;TNFRSF1B;B2M;FUCA1;LAMTOR1;SYK;STOM;ATP6AP2;RAB6A;RAB14;CD47;NFASC;PSMC2;PSMD2;HRNR;MGAM;DYNLL1;PNP;VAT1;DDX3X;GPI;RHOG;PA2G4;ATG7;RAB5B;HGSNAT;ILF2;RAP2C;GM2A;GALNS;CD55;OSTF1;SCAMP1;NDUFC2;PSMD14;NPC2;ARPC5;PSMD1;ERP44;CD93;PSMB1;APAF1;CYBA;QPCT;CD44;NHLRC3
prerank,negative regulation of binding (GO:0051100),0.294193822555186,1.0147439518523227,0.4221556886227545,0.969474749955797,1.0,13/81,9.76%,RALB;PIN1;LEF1;BTAF1;ACTB;PSME3IP1;IFIT1;CDKN1A;MAPK8;CARD16;RSF1;TFAP4;PARK7
prerank,protein O-linked glycosylation (GO:0006493),-0.25377190652453896,-1.014533806091242,0.43508771929824563,0.7781430685304891,1.0,19/96,17.34%,GALNT13;GXYLT2;OGT;PLOD2;TMTC4;TET1;POFUT1;TRAK1;PLOD1;TMTC1;DPM1;RXYLT1;XXYLT1;LARGE1;FKTN;ST3GAL4;GALNT14;GALNTL6;POGLUT3
prerank,regulation of dopamine secretion (GO:0014059),-0.3426791056763717,-1.0143735349031084,0.4233409610983982,0.7777979312373953,1.0,11/25,30.46%,SYT9;SYT12;SYT11;SYT4;SYT7;SYT2;KCNA2;SYT10;SYT6;SNCA;DRD2
prerank,stem cell development (GO:0048864),0.4085598911084683,1.0143259012743644,0.45789473684210524,0.9697489743787978,1.0,2/16,4.12%,PTPRC;CDH2
prerank,focal adhesion assembly (GO:0048041),-0.35609447197982813,-1.0142677460001275,0.4507042253521127,0.7772854708407315,1.0,5/21,10.09%,SORBS1;BCR;PIP5K1A;CTTN;ACTN2
prerank,maintenance of blood-brain barrier (GO:0035633),0.35454092702887846,1.0142003462555589,0.4407079646017699,0.9690988244138475,1.0,10/30,13.39%,SLC1A1;PECAM1;ACTB;F11R;TJP1;ESAM;CLDN5;DMD;CDH5;LSR
prerank,tRNA wobble uridine modification (GO:0002098),0.4116560939572321,1.0141994124789213,0.448943661971831,0.9680461314961418,1.0,2/14,8.03%,MOCS3;ELP1
prerank,positive regulation of viral process (GO:0048524),0.30704093838194907,1.0141902028854581,0.4327666151468315,0.9670125428580248,1.0,12/60,12.67%,POLR2J;POLR2B;IFIT1;RAB7A;ADAR;CNOT7;RSF1;RAD23A;SRPK2;DDX3X;TMEM39A;MDFIC
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3432549492175464,1.0141440913182753,0.4057971014492754,0.9660997544543383,1.0,9/36,16.16%,EZH2;EED;UXT;BMI1;RYBP;MGA;APAF1;E2F6;RBBP4
prerank,regulation of gastrulation (GO:0010470),-0.3919817758656585,-1.0140124330494327,0.44349680170575695,0.7772158685744879,1.0,3/14,5.59%,PHLDB2;PHLDB1;OSR1
prerank,negative regulation of translation (GO:0017148),-0.25273536859478385,-1.0136663979413032,0.4448051948051948,0.7773373886347812,1.0,21/87,18.45%,SAMD4A;CPEB4;CPEB1;CPEB2;IGFBP5;PUM1;ROCK2;ROCK1;SYNCRIP;EIF4E2;YTHDF1;CNOT9;EIF2AK2;PUS7;RBM4;UNK;RACK1;TOB1;RNF139;PCIF1;DAPK1
prerank,regulation of interferon-gamma production (GO:0032649),0.29975866746540825,1.0136465088475044,0.43478260869565216,0.9666001744665822,1.0,11/71,15.25%,IL1R1;PDE4D;CYRIB;CEBPG;CD47;VSIR;PRNP;CD274;DDIT3;TRIM27;GAS6
prerank,negative regulation of DNA recombination (GO:0045910),0.32857235359049686,1.0134976678876,0.45190839694656487,0.9660200567180638,1.0,8/43,15.33%,POLR2J;ZRANB3;POLR2B;ACD;MSH3;HELB;TERF2IP;UBQLN4
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.38811670157755784,-1.013457770682975,0.45080091533180777,0.7770945428934465,1.0,9/14,30.05%,DDB1;PPARGC1A;AKT2;ARPP19;GPLD1;PTPN2;AKT1;NNMT;SLC45A3
prerank,mitochondrion distribution (GO:0048311),-0.40889913579570425,-1.0134409047669373,0.4312896405919662,0.7763397028307765,1.0,3/12,10.29%,MAPT;TRAK1;ARMC1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.24371596769562606,1.013428440545195,0.44359255202628695,0.9651822111902071,1.0,83/509,14.29%,RAC2;MAZ;PIK3CG;CBL;TRIB3;ZDHHC17;PIK3AP1;JMJD8;PTPRJ;PTPRC;MAP3K7;RPL23;TAB2;PLK2;RPTOR;EEF1D;TIRAP;SRC;BCAR3;TRIM8;PRKD2;BIRC2;HDAC3;IFI35;ZDHHC13;TNFRSF10B;TEK;SOX2;FYN;PHB2;TMED4;TRIM14;EDAR;GPR89A;EP300;TBX1;CARD16;RET;LAMTOR1;TRAF5;SELP;ACTN4;SIRT1;TXN;IRS2;VWF;TAB3;TRIM25;WNT5A;RELA;RBCK1;LYN;BCLAF1;LURAP1;PARK7;UBE2V1;RNF13;ESR1;BAD;MFHAS1;DDX3X;RHOG;FLT1;USP15;APP;NOD1;PIK3CD;RPS3;PIK3R5;BMF;TNIP2;IKBKB;LARS1;CHUK;RRAGC;NRG2;PPP5C;DDIT3;ANKRD17;NEK6;ATP2C1;TRIM27;MAP3K3
prerank,transcription by RNA polymerase II (GO:0006366),-0.21636009010235502,-1.0133729332639851,0.3974358974358974,0.7757361703130451,1.0,87/305,20.07%,DDX5;NOTCH2;TEAD1;GLIS3;PRRX1;PABPN1;RARB;MAF;TBL1XR1;CCN2;ELP4;SOX5;MED26;RPRD1B;MAML1;HDAC1;GTF2I;MED1;PPARGC1A;CBFB;RREB1;POU2F1;ZBTB1;RBMX;DEK;ERCC6;PPARA;ELL;PIR;NOTCH3;CSTF3;MED17;RNGTT;CDC73;PHAX;SNW1;SRRT;GTF2A1;ELP2;RXRA;SYMPK;NFKB1;NR2C2;ESRRA;TBL1X;RARA;CDK7;NELFB;NR3C2;CCNT1;CSTF2;NFYA;ELOA;POLR2A;SNAPC3;DDX21;TAF8;RORA;SETX;INTS10;INTS8;CCNK;PAF1;TEAD3;MLLT1;INTS11;TAF6;CTDP1;RPAP1;WWTR1;NR3C1;CDK9;GTF2E2;EAF1;MAML2;TAF5L;TAF12;KLF13;PARP1;COPS2;MED20;NR2F1;NELFA;CDK12;TEAD2;CPSF3;NABP2
prerank,negative regulation of catabolic process (GO:0009895),-0.2917367135044808,-1.0133565594753149,0.4415954415954416,0.7749784701579087,1.0,10/47,9.26%,EGFR;HDAC4;FLNA;SIRT2;NUPR1;FMN2;PPARA;IRAK3;BANP;AZIN1
prerank,cellular response to cytokine stimulus (GO:0071345),0.2469751739013462,1.0132668566421466,0.4514285714285714,0.9646884954268691,1.0,55/416,13.09%,LRP8;MT1X;PTPN18;GSK3A;CBL;PTPRJ;IL1R1;HSPA8;OXSR1;LEF1;SMPD4;CXCL12;IFNLR1;IFITM2;CRLF1;LRCH1;IFIT1;SBNO2;ZFP36L1;GBP3;MME;SOX2;PTPN12;FYN;TNFRSF1B;CIB1;CDKN1A;RIPOR2;MAPK8;GBP4;PTPRT;ICAM1;SYK;RO60;PIM1;SIRT1;CCL25;WNT5A;ERBIN;RELA;CD47;CSF1R;INPP5D;IL10RB;IFNAR1;NPNT;PIK3CD;RPS3;ST3GAL6;CRKL;TYK2;IKBKB;LDLRAP1;CHUK;NDUFA13
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.3860573142758328,-1.013099312296327,0.4335511982570806,0.7749834865722165,1.0,4/15,25.24%,GSTZ1;KYAT1;QDPR;FAH
prerank,regulation of macroautophagy (GO:0016241),0.28357973404255,1.0129391398464562,0.4297752808988764,0.9647087664187374,1.0,32/105,19.34%,MAP3K7;RPTOR;EXOC8;ATP6V1D;EPM2A;SMG1;VPS26A;ATP6V0D1;MAPK8;LAMTOR1;SIRT1;ATP6V0E1;TSC1;TBC1D25;PRKAA2;UBQLN1;BNIP3L;RRAGC;SCOC;ATP6V1B2;VPS35;ATG13;SESN3;BNIP3;UBQLN2;ATP6V1A;USP36;ULK1;SH3GLB1;LZTS1;SESN1;LARP1
prerank,calcium ion import (GO:0070509),-0.3252782815851187,-1.0127195541166472,0.42025316455696204,0.7751991327152196,1.0,8/28,15.66%,CACNA1C;MCU;CACNA1D;MICU2;CACNA1B;CACNA1G;AFG3L2;MCUR1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3483133556759843,1.012692999090457,0.44,0.9644737924950009,1.0,14/31,20.90%,HBS1L;CNOT7;EXOSC9;PATL1;NT5C3B;CNOT6;EXOSC1;DCP1A;LSM1;DIS3L2;DCP1B;EXOSC7;CNOT8;DDX6
prerank,chemokine-mediated signaling pathway (GO:0070098),0.32468750433651117,1.0123546400480277,0.4411764705882353,0.9645403341100133,1.0,4/42,8.51%,OXSR1;CXCL12;CIB1;CCL25
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.2882806804184131,-1.0119490109480327,0.43820224719101125,0.776540458003245,1.0,8/48,12.21%,ANK2;AKAP6;CEMIP;UBASH3B;TRPC1;PRKACA;CAMK2D;SRI
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.34537649410704596,1.011667726131303,0.455,0.9656429665353654,1.0,11/33,18.42%,PIK3CG;PIK3C2G;ZFP36L1;HTR2A;PIK3CD;PIK3R5;NF1;PIK3C2A;PLEKHA1;NYAP2;IRS1
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.33494191970480786,1.0116171557288205,0.4394184168012924,0.9647571276678064,1.0,7/35,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;PLXNA4;SEMA4C
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.4098813484838971,1.0115906739052103,0.4606741573033708,0.9638028267085219,1.0,14/14,59.05%,ATP6AP1;CSF1;POU4F2;IFNG;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;TRAF6;TYROBP
prerank,innate immune response in mucosa (GO:0002227),-0.44521267382902674,-1.0115552502950937,0.4707070707070707,0.7768210653406755,1.0,2/10,16.05%,RNASE3;DEFA6
prerank,Wnt signaling pathway (GO:0016055),-0.25147753284791996,-1.0115169570425064,0.41228070175438597,0.7761526578971031,1.0,26/92,18.67%,WLS;NXN;WNT5B;FZD6;RYK;CTNNB1;PLPP3;DIXDC1;CSNK1A1;BTRC;WNT4;LRP5;CSNK1E;DVL3;CSNK1G2;FZD2;GSK3B;UBC;WNT9A;USP34;LRP6;TCF7L2;FZD4;DVL1;SFRP4;SNX3
prerank,positive regulation of nervous system process (GO:0031646),-0.36908328672461566,-1.0114718139400871,0.45146726862302483,0.775508664737339,1.0,7/18,23.53%,RIMS1;NLGN2;UNC13B;DICER1;ATPSCKMT;TPPP;RNF10
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3897575560773264,-1.0111763508186482,0.4406779661016949,0.7755372921580941,1.0,6/15,33.92%,GNAL;ADCY3;SYT10;SLC24A4;DRD2;MKKS
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.40753257250517255,-1.011037887610715,0.4523809523809524,0.7751206931729435,1.0,7/13,20.94%,BMP7;RREB1;NAPEPLD;VSTM2A;SIX1;PTGS2;TFE3
prerank,anterograde synaptic vesicle transport (GO:0048490),0.40562844277763077,1.0110168112180762,0.4361904761904762,0.9635163143224921,1.0,6/15,16.45%,AP3S1;DTNBP1;AP3M2;AP3M1;SNAPIN;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.40562844277763077,1.0110168112180762,0.4361904761904762,0.9635163143224921,1.0,6/15,16.45%,AP3S1;DTNBP1;AP3M2;AP3M1;SNAPIN;BLOC1S5
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.38285713497278323,1.010728259421716,0.4185185185185185,0.9634256373165428,1.0,8/19,19.53%,GSK3A;PARK7;FBXO7;CSNK2A2;CAMKK2;DNM1L;USP36;FBXW7
prerank,cellular response to interleukin-6 (GO:0071354),-0.3319163941978604,-1.0104349502599543,0.4261501210653753,0.7759529035678768,1.0,8/26,10.66%,ST18;JAK1;PID1;SMAD4;FER;IL6R;PTGIS;NFKB1
prerank,nucleotide biosynthetic process (GO:0009165),0.39082771950952305,1.0103873922165538,0.44712430426716143,0.9634840442270515,1.0,9/18,20.59%,RRM2B;PRPS1L1;PRPS1;PNP;RRM1;NMNAT1;HPRT1;GART;PPAT
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.25766764356744015,1.0103104783462875,0.4392857142857143,0.9627034083764411,1.0,53/241,16.18%,POLR2J;SNRPD2;NCBP1;RBM22;HSPA8;POLR2B;PRPF31;PRPF3;SNRPD1;HNRNPH2;PCBP1;PHF5A;SF1;PRPF40A;HNRNPK;CPSF4;PPIL3;PLRG1;SRSF10;SNRNP27;PRCC;SFPQ;HNRNPC;GEMIN5;SMNDC1;YTHDC1;SF3B3;SRSF4;DNAJC8;SNU13;NOVA2;SF3A1;RSRC1;BUD31;SYF2;U2AF1;PAPOLA;EFTUD2;PTBP1;RBM10;YBX1;SRSF7;SNRPA;USP39;FUS;RBM4B;SF3B6;HNRNPL;TRA2B;GTF2F2;RBM41;UPF3B;U2AF2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.26123373059679933,1.0099831163275765,0.45807259073842305,0.962642051122533,1.0,40/208,14.29%,ZDHHC17;JMJD8;MAP3K7;TNFAIP3;TAB2;PLK2;EEF1D;TIRAP;TRIM8;BIRC2;ZDHHC13;TNFRSF10B;TMED4;TRIM14;EDAR;GPR89A;CARD16;TRAF5;SIRT1;TAB3;NLRC3;TRIM25;WNT5A;TRAF3;RELA;RBCK1;LURAP1;UBE2V1;ESR1;NOD1;TNIP2;IKBKB;MAPKBP1;CHUK;PPP5C;ANKRD17;NEK6;ATP2C1;TRIM27;MAP3K3
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.3825388292558604,-1.009934309751434,0.4380733944954128,0.7764803612480908,1.0,4/16,9.91%,FOXD1;FGF1;BMP4;SALL1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.31592794391339896,-1.0097789887845743,0.43276283618581907,0.7761374688137661,1.0,3/32,2.15%,MAGI2;PDGFRB;CAMTA1
prerank,mRNA processing (GO:0006397),0.25530829211397427,1.0097518864720914,0.45813953488372094,0.9623625703547596,1.0,46/287,11.00%,POLR2J;ERCC3;SNRPD2;NCBP1;RBM22;HSPA8;POLR2B;PRPF31;PRPF3;SNRPD1;HNRNPH2;PCBP1;PHF5A;SF1;CCNH;PRPF40A;HNRNPK;CPSF4;CHTOP;PPIL3;PLRG1;SRSF10;SNRNP27;PRCC;SFPQ;HNRNPC;GEMIN5;SMNDC1;YTHDC1;SF3B3;SRSF4;DNAJC8;SNU13;NOVA2;SARNP;GTF2H1;PRMT9;SF3A1;RSRC1;AKAP8L;BUD31;SYF2;U2AF1;CPSF6;PAPOLA;EFTUD2
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.31884466629421054,-1.0096169684357845,0.42676767676767674,0.7758090182741337,1.0,7/30,15.09%,ACSL1;HACD3;HACD1;HACD4;TECR;ABCD2;PEX2
prerank,protein targeting to peroxisome (GO:0006625),-0.3215095137126277,-1.0095920358147807,0.4532710280373832,0.7750989722884067,1.0,10/29,18.06%,ACBD5;RAB8B;PEX14;FIS1;ALDH3A2;PXMP4;ABCD2;PEX2;PEX5;PEX6
prerank,regulation of establishment of protein localization (GO:0070201),-0.3998229003123124,-1.0095451995077858,0.4461538461538462,0.7744452407676508,1.0,4/13,15.16%,SPIDR;CEP120;CTSD;CEP295
prerank,regulation of protein phosphorylation (GO:0001932),0.2563143086362159,1.0095286373492753,0.4441747572815534,0.9620371741777917,1.0,42/256,12.63%,ROPN1;ATF3;MAPK3;PRR5L;RALB;LIMCH1;RAP2A;PIN1;SOD1;PECAM1;SMG8;PDCL3;HDAC3;PPP2CA;TEK;FYN;NPTN;CIB1;TBX1;FXR1;CCDC88C;SIRT1;AXIN1;KDM4D;EFNA1;AKTIP;CDK2AP1;MOB1B;CSF1R;LYN;PAK1;PARK7;AKAP8L;TARDBP;ACVR2A;TRAF3IP1;APP;ZBED3;PRNP;CRKL;WDFY2;CDH5
prerank,determination of heart left/right asymmetry (GO:0061371),-0.2841707484591059,-1.0094337408309852,0.4177215189873418,0.7739573025345746,1.0,10/42,25.89%,AHI1;MICAL2;TGFBR2;SMO;TBX3;SETDB2;BBS5;CCDC39;NDRG4;TBX2
prerank,negative regulation of cell adhesion (GO:0007162),-0.2628588592651195,-1.0093963847735632,0.41260744985673353,0.7732809372636187,1.0,34/72,28.34%,PLXNA2;ADAM22;SPOCK1;FBLN1;DSCAM;RHOA;JAM3;CDH1;EPHB2;SEMA4D;SIPA1;PLXND1;NF2;PTK2;ARHGDIA;PLXNB2;PTPRO;PLXNC1;CBLL1;TGFB1;FZD4;SEMA5A;TGFBI;FZD7;CX3CL1;ARHGDIB;DUSP1;ITGB1BP1;PLXNB1;DMTN;SERPINE1;PLXNA1;MDK;LPXN
prerank,positive regulation of vascular permeability (GO:0043117),-0.4108962980836579,-1.0092784414768157,0.4411134903640257,0.7727974340568783,1.0,2/12,3.92%,BMP6;OCLN
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.37530835457920847,1.0092394200229335,0.45878136200716846,0.9619341324991911,1.0,5/21,11.16%,FCGR2B;PRKCH;LYN;CD81;SLC39A10
prerank,cellular response to ATP (GO:0071318),-0.384369604284152,-1.0089376088153426,0.44805194805194803,0.7728865476538643,1.0,4/14,21.63%,RYR3;P2RX4;SSH1;P2RY12
prerank,negative regulation of protein kinase activity (GO:0006469),0.2890112163999872,1.0086325583420828,0.4460431654676259,0.9628852573264298,1.0,11/88,7.80%,PTPRQ;TRIB3;PTPRC;GNAQ;PTPRB;SPRED1;CDKN1A;AKT1S1;DTNBP1;PTPRT;ADAR
prerank,positive regulation of glycolytic process (GO:0045821),-0.3524791396613648,-1.0085865913900591,0.44759825327510916,0.7723175927498261,1.0,2/20,0.57%,ZBTB20;IGF1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3524791396613648,-1.0085865913900591,0.44759825327510916,0.7723175927498261,1.0,2/20,0.57%,ZBTB20;IGF1
prerank,regulation of chromatin binding (GO:0035561),0.45397522449545685,1.008469280829919,0.46037735849056605,0.962433810637212,1.0,2/10,8.54%,BTAF1;KDM4D
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4134332286960014,1.0083670550134136,0.46771037181996084,0.960707771939826,1.0,4/15,14.50%,ZFP36L1;CNOT7;NANOS3;CNOT1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4134332286960014,1.0083670550134136,0.46771037181996084,0.960707771939826,1.0,4/15,14.50%,ZFP36L1;CNOT7;NANOS3;CNOT1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.4173996562941479,-1.0082850272450121,0.4681724845995893,0.772383078050035,1.0,3/11,7.88%,FGFR2;TGFBR2;LRP5
prerank,positive regulation of protein modification process (GO:0031401),0.2594463147588657,1.008142571537876,0.44095477386934673,0.9604170073861457,1.0,43/203,15.37%,MAPK3;RALB;LIMCH1;RAP2A;PIN1;PECAM1;SVIP;HDAC3;PPP1R16B;TEK;NPTN;CIB1;TBX1;FXR1;CNEP1R1;CALM3;RAPGEF3;SIRT1;SPPL3;TXN;AXIN1;EFNA1;AKTIP;CDK2AP1;CSF1R;LYN;PAK1;ACVR2A;DDX3X;ANKLE2;APP;PTBP1;ATG7;CRKL;WDFY2;CDH5;PTPA;CAMKK2;VEGFC;TERF2IP;GAS6;ATG14;RAB3GAP1
prerank,membrane lipid metabolic process (GO:0006643),0.3669253648279327,1.007788615693991,0.42010771992818674,0.9605664045083171,1.0,5/22,11.92%,SERINC1;CERKL;TEX2;CYP1B1;ST3GAL6
prerank,regulation of amyloid fibril formation (GO:1905906),0.4094142012165385,1.007727492971659,0.4477317554240631,0.9597114587795624,1.0,4/15,11.27%,APOE;PFDN6;PFDN5;APP
prerank,endothelial tube morphogenesis (GO:0061154),-0.4352273855575802,-1.007554118727149,0.453027139874739,0.7735417709642283,1.0,5/10,12.11%,CTNNB1;RHOA;BMP4;STARD13;RHOB
prerank,endosome organization (GO:0007032),0.32729852480787663,1.0075297991182544,0.44776119402985076,0.9593516439264889,1.0,14/41,19.20%,EXOC8;CLCN3;VPS11;TMEM9;LAMTOR1;AKTIP;RAB22A;LAPTM4B;HOOK3;VPS18;CORO1C;RAB27A;ALS2;PI4K2B
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.33353290811382874,1.0074823516420113,0.4634146341463415,0.9584969069805184,1.0,13/37,16.68%,RPL23;PDCL3;HIPK2;RPL5;PARK7;RYBP;CCAR2;TLK2;GIPC1;CSNK2A2;UCHL5;TAF1;N4BP1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.34561853589168584,-1.0068596078697012,0.4518348623853211,0.7731502957329818,1.0,14/20,49.42%,ZWINT;KLHL22;BUB3;ATM;ZW10;TEX14;MAD2L2;MAD2L1;BUB1B;TTK;IK;CENPF;KNTC1;TRIP13
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.34561853589168584,-1.0068596078697012,0.4518348623853211,0.7731502957329818,1.0,14/20,49.42%,ZWINT;KLHL22;BUB3;ATM;ZW10;TEX14;MAD2L2;MAD2L1;BUB1B;TTK;IK;CENPF;KNTC1;TRIP13
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.34561853589168584,-1.0068596078697012,0.4518348623853211,0.7731502957329818,1.0,14/20,49.42%,ZWINT;KLHL22;BUB3;ATM;ZW10;TEX14;MAD2L2;MAD2L1;BUB1B;TTK;IK;CENPF;KNTC1;TRIP13
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.40588620578350953,1.0062630886521706,0.44972577696526506,0.9612566198915127,1.0,2/15,3.56%,AMDHD2;EXTL2
prerank,positive regulation of programmed cell death (GO:0043068),0.2523394151201596,1.0060866428096076,0.44,0.9607480191881032,1.0,54/272,16.61%,ERCC3;MAP3K11;ATF6;FRZB;TIAM1;SOD1;VAV3;PSEN2;ARHGEF26;MCF2L;ING4;ITSN1;TNFRSF10B;MAPK8;ARHGEF6;CRADD;ARHGEF7;SYK;TRIO;SIRT1;OMA1;ARHGEF18;ITGA6;LATS2;BCLAF1;FZD9;TFAP4;AIFM1;RYBP;ING3;CCAR2;BAD;DDX3X;CYP1B1;ATG7;BMF;IP6K2;BNIP3L;NF1;ING5;UTP11;DIABLO;FAF1;APC;PTPA;APAF1;MAP3K10;GNA13;APH1A;BCL6;DNM1L;BNIP3;QRICH1;RASGRF2
prerank,lysine catabolic process (GO:0006554),0.4351073900858883,1.006063589960521,0.4608030592734226,0.958791698835257,1.0,3/12,15.27%,AASS;PHYKPL;SLC25A21
prerank,lysine metabolic process (GO:0006553),0.4351073900858883,1.006063589960521,0.4608030592734226,0.958791698835257,1.0,3/12,15.27%,AASS;PHYKPL;SLC25A21
prerank,protein K63-linked ubiquitination (GO:0070534),-0.30469296928142764,-1.0060479417455137,0.42355889724310775,0.7744719139951416,1.0,17/41,26.39%,RNF152;UBE2N;HECTD1;WWP2;RNF4;RNF135;RNF168;RNF8;TRAF3IP2;TRAF2;TRIM5;STUB1;NEDD4;ARIH2;UBE2B;UBE2E2;UBE2S
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.31860218278180225,1.0060072176641042,0.4435483870967742,0.9579677847260765,1.0,8/50,10.80%,RPS6KA1;SRC;MAP2K5;RFFL;CARD16;USP47;PARK7;DDX3X
prerank,regulation of synapse organization (GO:0050807),-0.3256105969041168,-1.0059241956251952,0.4439359267734554,0.7740439556363615,1.0,10/26,29.18%,CTNNA2;PDLIM5;ARHGAP22;IL1RAPL1;NEDD4;CAMK2B;CLN3;SLITRK4;MDGA1;ABHD17A
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2705740564578812,1.0055693016176595,0.42572944297082227,0.9583222249304004,1.0,39/132,18.85%,SLC4A4;GSK3A;PRR5L;ATF6;SH3D19;PLK2;SVIP;TRIM8;VPS11;APOE;TNFRSF1B;TRIM14;PTTG1IP;IRS2;CNOT7;DXO;PRKAA2;BAD;P2RX7;PFKFB3;APP;TMEM59;FAF1;TRIM27;CNOT1;PIK3C2A;VPS35;DAGLB;MOV10;TFEB;BNIP3;ADAM9;INSR;IRS1;RDX;RC3H1;ULK1;MID2;SH3GLB1
prerank,cellular response to chemokine (GO:1990869),0.3212741736407417,1.005195291060989,0.4634146341463415,0.958534114066918,1.0,5/46,8.51%,OXSR1;CXCL12;LRCH1;RIPOR2;CCL25
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.40431016420516797,-1.0049737428073786,0.4470842332613391,0.775815262285973,1.0,3/13,6.59%,NFIB;BMP4;PPARA
prerank,cytosolic calcium ion transport (GO:0060401),-0.32586190176607993,-1.0049559618829083,0.45977011494252873,0.7750996202633311,1.0,10/28,22.26%,CACNA1C;MCU;MICU2;AFG3L2;SLC35G1;MCUR1;ADRA1A;MCUB;CACNA2D1;ATP2B3
prerank,neuromuscular junction development (GO:0007528),-0.3419208883481798,-1.0049325234943753,0.45274725274725275,0.7743932770360964,1.0,4/24,2.47%,PDZRN3;ANK3;CACNB4;PPFIBP1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.28335326842132813,1.0048779860686063,0.44396551724137934,0.9584955149669302,1.0,16/100,11.82%,MAZ;MAPK3;PIK3CG;CBL;PIK3AP1;SRC;PPP1R16B;TEK;SELP;SIRT1;IRS2;NLRC3;LYN;FLT1;PIK3CD;PIK3R5
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.41487318007831053,1.0043362429982667,0.4489795918367347,0.9591759556253249,1.0,4/15,19.56%,APOE;SCARB1;PLTP;ABCG1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.4565155479418824,1.004182530051723,0.45271629778672035,0.9586538501079003,1.0,3/10,10.93%,ACER2;NEXMIF;CYP1B1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.35696608433531263,1.004122112132028,0.4683760683760684,0.9578342868065709,1.0,7/28,11.09%,FITM2;TNFRSF1B;ADIPOR2;SIRT1;CD47;PRKAA2;ADIPOR1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4011740606054714,1.0039601697540443,0.44871794871794873,0.9573175069202021,1.0,2/16,6.48%,TUBB;CEBPG
prerank,regulation of axon regeneration (GO:0048679),-0.4076427066778889,-1.0039230614449521,0.4656652360515021,0.7764276035464915,1.0,5/12,33.70%,PTPRS;CERS2;SCARF1;INPP5F;PTN
prerank,lipid catabolic process (GO:0016042),0.3887831150117217,1.0036584849811065,0.4518900343642612,0.9572463260211785,1.0,2/18,4.71%,PPT1;PLAAT3
prerank,long-term synaptic potentiation (GO:0060291),-0.3390203683301457,-1.0036046685590672,0.44930875576036866,0.7764995260062314,1.0,9/21,23.78%,GRIN2B;TSHZ3;PRKCZ;SLC24A2;VAMP2;SHANK2;NFATC4;GRIN2D;MPP2
prerank,cellular response to peptide (GO:1901653),0.3109884833248489,1.0035584151546357,0.4382716049382716,0.9565677793193542,1.0,11/56,11.93%,CACNA1A;RPL23;FCGR2B;SRC;ZFP36L1;FYN;ICAM1;MDM2;APP;NOD1;PRNP
prerank,negative regulation of RNA metabolic process (GO:0051253),0.3967180260476937,1.003189316129445,0.4542314335060449,0.9566815717088026,1.0,4/18,11.65%,RPS26;ESR1;TERT;PTBP1
prerank,double-strand break repair (GO:0006302),0.2677388482960929,1.0030165834885867,0.43523316062176165,0.9562133887622711,1.0,34/158,14.95%,ABRAXAS1;ZSWIM7;ERCC4;YY1;HPF1;XRCC1;KDM2A;CIB1;TENT4A;APLF;MAPK8;ACTR8;SFPQ;ACTR5;DCLRE1B;UBE2V2;EYA3;KDM4D;POLA1;SEM1;RFWD3;EXD2;RAD51B;APTX;HUS1;NBN;PSMD14;BRCC3;PPP5C;CHEK2;RMI1;NSD2;BRIP1;INO80
prerank,actin filament organization (GO:0007015),-0.231634165168299,-1.0023247785541487,0.4366812227074236,0.7792546619127915,1.0,32/151,15.85%,SVIL;MCU;PPP1R9A;GSN;DPYSL3;CGNL1;TMOD2;SPIRE1;WASL;SHROOM3;ABI1;TPM1;RHOA;FLNA;NEDD9;GAS2;ARHGAP12;COBL;RND3;RHOBTB2;BIN3;FHOD1;RHOB;BAIAP2L1;RHOBTB1;INPPL1;DLG1;HIP1R;TRIOBP;ERMN;MYO1B;TPM4
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.362500795047735,-1.0023071010659885,0.4421052631578947,0.7785447607945452,1.0,2/17,3.00%,NTRK3;NRP1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.3426723639516172,1.0022739752829135,0.4557823129251701,0.9574952366293461,1.0,4/33,3.01%,LRP8;CACNA1A;GRIK5;GRIK2
prerank,positive regulation by host of viral transcription (GO:0043923),0.40682672547367826,1.0021832161653481,0.42829827915869984,0.9568032466864168,1.0,6/15,15.98%,LEF1;EP300;TFAP4;CHD1;SP1;SMARCA4
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.25277938737211225,-1.002083133967467,0.44,0.7783557515420593,1.0,22/87,15.35%,NOTCH2;LRP1;GPM6B;IQGAP1;EFNA5;PDGFRB;RHOA;ROCK2;PRKCD;PDGFRA;ROCK1;EZR;RND3;RHOBTB2;EPHA3;RHOB;RHOBTB1;HIP1R;TAOK1;ARHGDIA;ARHGEF5;IQGAP2
prerank,establishment of vesicle localization (GO:0051650),-0.3621108847666038,-1.0020642385828804,0.4696261682242991,0.7776570894725602,1.0,7/18,16.97%,KIF5C;CCDC186;SYT11;RAB11A;IKBKG;KIF5A;LIMK2
prerank,peptidyl-lysine modification (GO:0018205),-0.24597160227607495,-1.0020296766725985,0.4483985765124555,0.7769720979170155,1.0,38/99,23.28%,EYA1;HDAC4;PLOD2;LOXL1;SIRT2;SENP3;ATP7A;NUP205;NUP155;NUP188;IFIH1;PLOD1;USPL1;BCL11A;NUP88;NUP93;LOXL3;P3H3;NNAT;SEH1L;TOPORS;PIAS3;SIRT7;ATPSCKMT;SENP7;EEF1AKMT1;STX1A;NUP85;AAAS;NSMCE2;RAE1;SIRT5;PIAS4;NUP37;LOX;VPS33B;NUP214;METTL21A
prerank,epiboly involved in wound healing (GO:0090505),-0.3788338453856568,-1.0020133218651348,0.46008403361344535,0.7762516204281579,1.0,5/16,6.18%,TMEFF2;PDPN;RHOA;FLNA;DDR1
prerank,cellular response to calcium ion (GO:0071277),-0.2682640657476403,-1.0019381344941056,0.4319526627218935,0.7756663833588588,1.0,17/67,15.88%,CPNE8;RYR3;IQGAP1;ADCY1;CLIC4;ADGRV1;SYT9;NLGN1;LGMN;CAMK2D;SYT12;SYT11;SYT4;RASGRP2;CPNE2;SYT7;GPLD1
prerank,striated muscle cell development (GO:0055002),0.4115485585978196,1.0017604838744458,0.4758364312267658,0.9571174690809201,1.0,2/14,4.82%,PGM5;FLII
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3133312755831017,-1.0015766544279616,0.42930591259640105,0.7757941925017096,1.0,10/29,23.83%,AMBRA1;PDGFRB;KIT;PDGFRA;PTK2;TGFB1;PRKD1;P2RY12;EPHA8;TNFAIP8L3
prerank,chemical homeostasis (GO:0048878),0.30234172602447534,1.0015445177276168,0.4657534246575342,0.956821660317571,1.0,10/61,11.53%,SLC4A4;SLC4A5;KLHL3;FITM2;NEDD4L;ACOX3;USF2;IRS2;DDX3X;PNPLA8
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4302675552408739,1.0014566049923943,0.4538152610441767,0.9560978023931836,1.0,1/11,0.14%,CIDEA
prerank,positive regulation of secretion (GO:0051047),-0.4204030223800225,-1.0012516441728951,0.47619047619047616,0.7759028296403065,1.0,2/11,16.75%,GPLD1;NPR1
prerank,sterol metabolic process (GO:0016125),0.30828015836774536,1.00105322898661,0.4492063492063492,0.9563780475357178,1.0,11/60,12.69%,EBP;INSIG1;HMGCR;APOE;SOAT1;PPARD;SC5D;OSBPL1A;NSDHL;CYP1B1;LDLRAP1
prerank,protein import into nucleus (GO:0006606),0.3002512832078366,1.0010050028686683,0.4559505409582689,0.9555391306483686,1.0,18/66,17.68%,RPL23;MMP12;PHB2;KPNA3;PTTG1IP;NUP54;SYK;NXT1;NUP50;RANBP17;KPNA1;E2F3;NUP35;IPO8;HIKESHI;KPNB1;POM121;STAT3
prerank,mitochondrial transport (GO:0006839),0.3090791206361669,1.0009571487420035,0.47368421052631576,0.9547122259307329,1.0,8/53,10.66%,TOMM20;ABCB10;SLC25A24;TIMM17B;TSPO;FBXO7;BAD;MAIP1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3407008404501299,1.0005595385478492,0.45691056910569106,0.954976216690199,1.0,9/33,18.65%,MAZ;NCBP1;CPSF4;PAPOLA;SCAF8;SLBP;WDR33;CLP1;SNRPD3
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.34974094687104157,1.000175700684145,0.44370860927152317,0.9551846082791667,1.0,9/32,14.60%,MAP2K5;HDAC7;HDAC9;CIB1;MMRN2;NOTCH1;HDAC5;MAP3K3;PIK3C2A
prerank,neutrophil degranulation (GO:0043312),0.24400032054418735,1.0000574204143502,0.4623287671232877,0.9545675630051841,1.0,71/425,14.82%,SURF4;IMPDH1;CAND1;ATP8A1;PSMD12;PTPRJ;HMOX2;EEF1A1;GLB1;HSPA8;PTPRC;GYG1;PRCP;PECAM1;PTGES2;SVIP;RAB5C;CCT2;PTPRB;PYGL;NRAS;TUBB;ATP6V1D;PSMD11;ATP11A;MME;RAB7A;TNFRSF1B;B2M;FUCA1;LAMTOR1;STOM;ATP6AP2;RAB6A;RAB14;CD47;NFASC;PSMC2;PSMD2;HRNR;MGAM;DYNLL1;PNP;VAT1;DDX3X;GPI;RHOG;PA2G4;ATG7;RAB5B;HGSNAT;ILF2;RAP2C;GM2A;GALNS;CD55;OSTF1;SCAMP1;NDUFC2;PSMD14;NPC2;ARPC5;PSMD1;ERP44;CD93;PSMB1;APAF1;CYBA;QPCT;CD44;NHLRC3
prerank,regulation of feeding behavior (GO:0060259),-0.4128152296029546,-0.9998914272039386,0.4766734279918864,0.7788465642561151,1.0,2/11,6.86%,LEPR;CFAP20
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.3927914993288246,-0.999859062378745,0.4485776805251641,0.7781744358800261,1.0,4/13,19.95%,DDX5;PLA2R1;ATM;SPRED3
prerank,detection of visible light (GO:0009584),0.3943125481199039,0.9996973402131193,0.4673721340388007,0.954742420945573,1.0,2/16,8.84%,GNAQ;GNA11
prerank,protein targeting (GO:0006605),0.27282891523602426,0.9994442589762607,0.4346590909090909,0.9545289834670059,1.0,21/118,14.50%,RTP3;TOMM20;CHM;CDC37;TIMM17B;TSPO;PEX1;SPCS3;ZDHHC14;PIKFYVE;AP4S1;ZDHHC15;FBXO7;ICMT;VPS37B;PRKCI;ZDHHC9;SPCS2;GIPC1;ZDHHC7;PARD3
prerank,peptide hormone secretion (GO:0030072),0.35799796353273056,0.9993735474114407,0.44839255499153974,0.9537853210742306,1.0,4/26,9.76%,LTBP4;RAB1A;CYB5R4;PARK7
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.42119451920797735,0.9991798038570243,0.4613899613899614,0.9533969002766599,1.0,4/13,13.32%,SOD1;APOE;ERLIN2;PLEK
prerank,monocyte differentiation (GO:0030224),0.4515062898238976,0.9985614584028643,0.4838095238095238,0.9543336819265921,1.0,1/10,0.08%,MT1G
prerank,blood vessel diameter maintenance (GO:0097746),0.3376318776722588,0.9979804172249667,0.4630225080385852,0.9551666373633068,1.0,6/34,11.15%,GCLC;KLF2;GCLM;EDNRB;KCNMB2;NOS3
prerank,kinetochore organization (GO:0051383),0.42279083751732627,0.9979403466229348,0.4867924528301887,0.954328170069386,1.0,3/13,13.56%,CENPC;MIS12;POGZ
prerank,apoptotic process (GO:0006915),0.2569465125497067,0.9979011904505731,0.4616368286445013,0.9534941825929096,1.0,36/203,14.82%,ERCC3;SEMA6A;BNIPL;AHCYL1;MAP3K7;FASTKD2;MAL;MAGI3;ING4;PPP2CA;TNFRSF10B;SCN2A;CASP6;CIB1;EP300;TBX1;FXR1;ARHGEF6;BCL2L13;PPARD;CDK11B;BCLAF1;MDM2;AIFM1;BAD;NAE1;CDIP1;APP;IFI27;BMF;RRAGC;DIABLO;NFKBIA;ELMO1;APAF1;MAP3K10
prerank,fatty acid beta-oxidation (GO:0006635),0.31430270359888557,0.9977761688849427,0.4610492845786963,0.9529168280059379,1.0,12/51,16.59%,CRAT;ACOX3;ACAT1;PPARD;ETFA;HSD17B4;ACOT8;BDH2;ECHDC1;ECHS1;ACAA2;ACADL
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.35050421778871615,0.9977203438445179,0.4674657534246575,0.9521201084859993,1.0,9/29,15.69%,COG5;COPG2;GOSR2;RAB6B;NAPA;RAB6A;COPG1;COG3;TRAPPC10
prerank,microtubule polymerization or depolymerization (GO:0031109),0.368522060029197,0.9971709068558537,0.47368421052631576,0.9527611913199459,1.0,5/24,9.66%,KIF18A;PIN1;FGF13;TRPV4;KIF2A
prerank,regulation of cellular protein localization (GO:1903827),-0.28562755117979954,-0.9970629986503217,0.44594594594594594,0.7851605999863134,1.0,11/45,9.77%,MAP2;GPC6;SPIDR;MAPT;CTNNB1;VCP;GPC3;CCDC66;CSNK1E;GPC5;DVL3
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.35777535067551114,-0.9969757792852488,0.42953020134228187,0.7846399194107133,1.0,7/18,20.71%,KMT2A;SETD7;EHMT2;KMT2B;SMYD2;KMT2D;SETD4
prerank,protein import (GO:0017038),-0.2532960823532677,-0.9965422977836583,0.46774193548387094,0.7850749527981905,1.0,41/84,32.77%,ACBD5;IPO9;TNPO3;RAB8B;APPL2;PEX14;HSPA4;NUP155;FIS1;NUP188;IPO11;NUP88;NUP93;ALDH3A2;TNPO2;PXMP4;ABCD2;FAM53C;PEX2;NUTF2;PEX5;IPO13;TSC2;NUP85;GDAP1;NUP214;APPL1;PPP1R10;AKT1;SEC13;SAMM50;ABCD3;HSP90AA1;NUP153;NXT2;PEX26;PEX19;RPAIN;RAN;EIF4ENIF1;HEATR3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.26742165063052153,0.9959737766150273,0.4699599465954606,0.9554895311549955,1.0,30/129,14.01%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PIN1;PRDM15;PSMD11;PSMB4;PSMC1;TMEM9;CSNK1G3;ATP6AP2;AXIN1;RUVBL1;USP47;PSMC2;FZD9;PSMD2;CCAR2;TRPM4;DDX3X;ZBED3;TNKS;PSMD14;RNF146;PSMC6;PSMD1;PSMB1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2639559676797087,0.9956150928894735,0.473474801061008,0.9555233399441352,1.0,25/170,9.91%,CAVIN4;PIN1;PTPRC;SORT1;PCBP1;STOX1;ZFP36L1;HNRNPAB;APOE;PRDM4;SOX2;HNRNPK;TRIM14;NPAT;LAMTOR1;RO60;BMI1;RNF187;KDM6A;CDK4;TOB2;NOVA2;ARF1;MARF1;TARDBP
prerank,cellular response to interleukin-4 (GO:0071353),0.44368752805355033,0.9954489144246214,0.4616858237547893,0.9550755150103991,1.0,1/10,2.03%,LEF1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.33090445127721435,0.9952545568761039,0.46166134185303515,0.954689188683721,1.0,7/38,12.24%,LRP8;PTPRC;EFNA1;CSF1R;APP;PRNP;RAP2C
prerank,negative regulation of wound healing (GO:0061045),-0.32102751142670505,-0.9952081314074004,0.45433255269320844,0.7879566079253298,1.0,7/28,17.92%,PHLDB2;TFPI;SLC12A2;VTN;CD34;AJAP1;CD109
prerank,peptidyl-threonine modification (GO:0018210),-0.26192640173165366,-0.9951410125059781,0.4457831325301205,0.7873860859510976,1.0,17/66,14.50%,GALNT13;TGFBR1;TGFBR2;WNK1;CDC42BPB;ROCK2;CIT;PRKCD;HIPK3;ROCK1;ACVR1;GSK3B;CAMK2D;HIPK1;ACVR1B;WNK3;MAP3K12
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3020171543996094,-0.9949504468850113,0.43099273607748184,0.7871612166873253,1.0,11/35,19.51%,SULF1;NR2F2;COL4A3;XDH;SPARC;THBS1;AIMP1;CAV2;ATP5IF1;SCG2;STAT1
prerank,phosphorylation (GO:0016310),0.2443338036055659,0.994799516737867,0.49321266968325794,0.955078644864327,1.0,81/384,16.75%,MAP3K11;MAPK3;SNRK;GSK3A;ILF3;PIK3CG;CDK17;DGKB;OXSR1;CDK19;PPP3CB;PLK2;NEK11;PNKP;PRKCH;RPS6KA4;HIPK2;MEX3B;PRKG1;PRKD2;RPS6KA5;PANK2;MAP3K9;PKN3;FYN;CERKL;MAPK8;RET;PAK3;SIK3;SYK;CDK11B;PIM1;PEAK1;MINK1;CDK4;MERTK;ACVRL1;LATS2;CDKL4;LYN;NRBP1;ERG;PKN1;PAK1;NIM1K;PRKAA2;ACVR2A;SRPK2;NLK;NEK7;CTBP1;APP;PI4KA;PIK3CD;STRADB;TYK2;PRKCI;MAP4K4;MAPK6;IKBKB;CHUK;CHEK2;TLK2;NEK6;BRD2;CAMKK2;COPS8;BMP2K;GAS6;DYRK2;CDKL5;TOP1;TAF1;CERK;BRAF;PTK2B;PIK3R4;CDK14;WNK2;PRKDC
prerank,regulation of protein catabolic process (GO:0042176),0.27984102260610394,0.9943777354493735,0.49445983379501385,0.9553949330046363,1.0,19/99,13.86%,GSK3A;EEF1A1;PIN1;TNFAIP3;PLK2;HMGCR;NEDD4L;RAB7A;TMEM9;AXIN1;SF3B3;WNT5A;MDM2;ATG7;EGLN2;NDUFA13;CHEK2;FAF1;APC
prerank,peptidyl-glutamic acid modification (GO:0018200),0.35789528075861177,0.9943673176402394,0.4791288566243194,0.9544657545338562,1.0,6/24,13.49%,TTLL1;CEP41;AGTPBP1;AGBL5;NAA80;TTLL7
prerank,primary alcohol metabolic process (GO:0034308),-0.3284339682989098,-0.9942259980055326,0.4779582366589327,0.7883301487729484,1.0,5/25,11.98%,IGF1;DHRS3;NAPEPLD;RBP4;ALDH3A2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4293439429562712,0.9941680026967012,0.4619771863117871,0.9540943978117352,1.0,3/10,15.25%,CXCL12;LYN;GAS6
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.42806921725543967,0.9937725700500333,0.45315487571701724,0.954349518618234,1.0,5/12,16.81%,ACTB;CELSR1;TRAF3IP1;ZDHHC7;LAMA5
prerank,regulation of DNA biosynthetic process (GO:2000278),0.3523771336491272,0.9935331462625967,0.467687074829932,0.9541104327750686,1.0,6/27,11.70%,DACH1;PRKD2;CDKN1A;RGCC;ACVRL1;TNKS
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.38117693840483885,0.9935104614909485,0.4710017574692443,0.953220001379801,1.0,3/20,11.01%,GSK3A;EP300;PGP
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.42301264400164346,0.9934613606067694,0.45792563600782776,0.9524051235553854,1.0,2/12,6.88%,PDE4D;CALM3
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.23439060206910337,0.9934238207078937,0.5267015706806283,0.9515536647421899,1.0,143/807,16.22%,SOX30;LRRFIP1;ATF3;IRX1;MAZ;DCAF1;CCDC85B;GCLC;DACH1;MECOM;AASS;ARID5A;ILF3;KLF8;L3MBTL4;TRIB3;NR4A2;MTERF3;EZH2;TRIM28;HSPA8;LEF1;CIPC;RPL23;EED;JAZF1;BTAF1;GTF2IRD1;DMAP1;KLF2;DNAJA3;ELK3;ING4;MAP2K5;ZHX3;ZBTB33;HDAC9;BCL6B;RPS6KA5;HDAC3;SBNO2;HEY1;NEDD4L;SMARCA2;SOX2;YY1;PHB2;WFS1;KDM2A;VPS72;UBE2I;IRF2BPL;BEND3;EP300;RFX3;RPS14;NFX1;CNOT2;PPARD;CHMP1A;ZNF205;SFPQ;UXT;SMAD7;SIRT1;BMI1;DRAP1;CLOCK;ZNF3;PFDN5;HEY2;ZBTB14;NOTCH1;SAP130;EDNRB;USP47;CNOT7;WNT5A;EFNA1;SOX13;RSF1;RELA;NAB2;HOXA7;BCLAF1;MDM2;PLCB1;TFAP4;TRPS1;ZKSCAN3;CIR1;CITED2;PBXIP1;CCAR2;HIC2;ESR1;THRB;RBPJ;CREBBP;CTBP1;ORC2;NFIC;PA2G4;HDGF;IFI27;LANCL2;N4BP2L2;MZF1;MDFIC;IRF2;CHD3;NDUFA13;TGIF1;CTBP2;HDAC5;DDIT3;THRA;HES1;KDM5C;DR1;HCFC1;TRIM27;USP9X;CNOT1;E2F6;TMPRSS6;BACH1;MAP3K10;PHF10;EZH1;GAS6;NKAP;TCERG1;TAF1;ELK4;BCL6;TRIM33;SMARCA4;ID2;TCF3;HEYL;ZBTB18;TAF3
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.30836463420668936,-0.9933920739171164,0.46798029556650245,0.7898891672715112,1.0,4/32,8.60%,AKAP6;CEMIP;P2RX4;TRPC1
prerank,establishment of mitotic spindle localization (GO:0040001),-0.3147731633556815,-0.9931986309299256,0.49507389162561577,0.7896614182663774,1.0,8/28,20.02%,FBXW11;HTT;UBXN2B;GJA1;NSFL1C;DCTN1;NDE1;ZW10
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.31419406833066355,0.9931662997677361,0.4481658692185008,0.9513601408943265,1.0,6/48,7.29%,AEN;BCL2L2;HIPK2;TNFRSF1B;EP300;SIRT1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3416477799437042,-0.9929897480148898,0.448512585812357,0.7894165119129056,1.0,5/22,15.64%,AHNAK;CACNB4;SRI;GNB5;PDE4B
prerank,cell cycle G1/S phase transition (GO:0044843),0.3003439096981668,0.9929331094076668,0.44769230769230767,0.9511433956905282,1.0,12/61,14.66%,MAP3K11;PLK2;CCNH;CDKN1A;POLE;CDK4;LATS2;USP37;E2F3;CUL3;PHF8;RCC1
prerank,regulation of cell junction assembly (GO:1901888),-0.3231593190243919,-0.9925726182825894,0.42857142857142855,0.789777592975102,1.0,6/27,9.54%,PDLIM5;OCLN;CBFB;ROCK2;ROCK1;PRKACA
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3686643097327803,-0.9922747183409185,0.4703389830508475,0.7898744855757339,1.0,3/16,17.75%,SOX5;FOXC1;SOX6
prerank,regulation of chemokine production (GO:0032642),-0.2948622526727662,-0.9921130520893001,0.4600484261501211,0.7895544052988112,1.0,5/36,13.42%,FOXP1;IL6R;EIF2AK2;IL18;IL33
prerank,"transcription, DNA-templated (GO:0006351)",0.25485820280476507,0.9921130246851595,0.47434292866082606,0.9525925085485308,1.0,41/207,16.22%,POLR2J;ERCC3;NCBP1;ELOC;NR4A2;POLR2B;POLR1C;GTF3C1;PAX8;CCNH;IRF9;GMEB2;NFX1;GTF3C5;PWP1;RO60;TRIP11;IVNS1ABP;DRAP1;GTF2H1;RSF1;TAF15;THRB;GTF2A2;NFIC;MED4;ELOB;TSC22D1;TAF4B;TBP;RRAGC;RNMT;PPP5C;THRA;BAZ2A;TFAM;NOCT;TAF1;GTF3C2;GTF2F2;TAF3
prerank,autophagosome assembly (GO:0000045),0.31099246701633954,0.9920300614752273,0.4763358778625954,0.951911903724494,1.0,19/52,18.80%,MAP1LC3B;ATP2A2;RAB7A;RAB43;TRAPPC8;VMP1;RAB1A;UBQLN1;ATG7;ATG16L1;ATG14;TMEM41B;GABARAPL1;ATG13;TP53INP2;UBQLN2;BECN1;GABARAP;ULK1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.43173853927026506,-0.9915952796728802,0.48088531187122735,0.7901860480356454,1.0,3/10,5.56%,BMP5;BMP7;ARHGAP12
prerank,regulation of fatty acid metabolic process (GO:0019217),0.39744596924541553,0.9915447925911047,0.46715328467153283,0.9524267289038364,1.0,5/17,11.09%,PANK2;PPARD;ADIPOR2;PRKAA2;ADIPOR1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.4140469950110295,-0.9913926646806632,0.48643006263048016,0.7899177355786965,1.0,7/11,45.25%,CAMK4;MAVS;TICAM1;TYROBP;ITGB2;SPI1;ITGAM
prerank,synaptic vesicle recycling (GO:0036465),-0.3142173829797766,-0.9913403092287557,0.46904761904761905,0.7892857648881609,1.0,10/31,19.98%,AMPH;NLGN2;STON2;NLGN1;STON1;VAMP2;SYT7;STX1A;SYT2;PACSIN1
prerank,import into nucleus (GO:0051170),0.295747853195396,0.9912377625534557,0.46597633136094674,0.952363530828269,1.0,11/73,8.71%,SNRPD2;SNRPD1;BACH2;MMP12;PHB2;PTTG1IP;SYK;NXT1;GEMIN5;NUP50;RANBP17
prerank,negative regulation of mRNA processing (GO:0050686),0.40636084798347827,0.9912003937790081,0.4847908745247148,0.9515261694129855,1.0,6/15,16.18%,SFSWAP;SRSF10;SRSF4;PTBP1;SRSF7;U2AF2
prerank,glucan catabolic process (GO:0009251),-0.3788455591441416,-0.9911308867726515,0.5057736720554272,0.7890406907708585,1.0,7/15,19.39%,PYGB;AGL;PHKA2;PYGM;PGM2;GAA;PHKG2
prerank,regulation of hydrolase activity (GO:0051336),0.29504061075364707,0.9909852226721093,0.49028400597907323,0.9512112658088271,1.0,12/71,8.96%,CFAP73;SOD1;VAV3;CHN2;PRKG1;TBC1D10B;TDG;EPHA5;FGD5;RAPGEF6;RASIP1;PLXNA4
prerank,sodium ion import across plasma membrane (GO:0098719),0.3882776864751495,0.9909214911060498,0.48300536672629696,0.950437122516186,1.0,3/17,10.54%,SLC9A7;SLC9A6;TRPM4
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.30183952353474097,0.9904751162399865,0.476038338658147,0.9507896146988634,1.0,16/53,17.81%,PSME3IP1;APOE;FOXF2;DESI1;GNA12;RAD23A;PSMC2;OPHN1;ECSCR;XPO1;PSMD14;PSMC6;UCHL5;UBQLN4;TMTC3;RAD23B
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.369406507961889,-0.9902741180611006,0.47357293868921774,0.7906189186155314,1.0,7/15,27.69%,NTRK3;F3;IL16;SCG2;VEGFA;VEGFB;PGF
prerank,Notch signaling pathway (GO:0007219),0.30026736895633094,0.9902280324787102,0.4595808383233533,0.9505933639565465,1.0,14/59,16.11%,SORBS2;JAG2;PSEN2;HEY1;EP300;HEY2;NOTCH1;RBPJ;CREBBP;DTX4;HES1;YBX1;APH1A;HEYL
prerank,neutrophil mediated immunity (GO:0002446),0.2410367290305064,0.9902144420978358,0.4813137032842582,0.9496764878546968,1.0,71/432,14.82%,SURF4;IMPDH1;CAND1;ATP8A1;PSMD12;PTPRJ;HMOX2;EEF1A1;GLB1;HSPA8;PTPRC;GYG1;PRCP;PECAM1;PTGES2;SVIP;RAB5C;CCT2;PTPRB;PYGL;NRAS;TUBB;ATP6V1D;PSMD11;ATP11A;MME;RAB7A;TNFRSF1B;B2M;FUCA1;LAMTOR1;STOM;ATP6AP2;RAB6A;RAB14;CD47;NFASC;PSMC2;PSMD2;HRNR;MGAM;DYNLL1;PNP;VAT1;DDX3X;GPI;RHOG;PA2G4;ATG7;RAB5B;HGSNAT;ILF2;RAP2C;GM2A;GALNS;CD55;OSTF1;SCAMP1;NDUFC2;PSMD14;NPC2;ARPC5;PSMD1;ERP44;CD93;PSMB1;APAF1;CYBA;QPCT;CD44;NHLRC3
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2572375947380232,-0.9899921356922669,0.45151515151515154,0.7905627729156421,1.0,17/76,25.10%,LPAR1;HTR2C;GRM5;CHRM2;PLCE1;ADRA1B;ACTN2;ANO1;GPR4;OPRM1;GNA14;AGTR1;ADRA1A;P2RY12;CMKLR1;LPAR6;ADRA2A
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.28464945359190236,0.9898418282924728,0.4848024316109423,0.9498795969560111,1.0,14/86,12.24%,LRP8;PTPRJ;PTPRC;PECAM1;PDCL3;SRC;FYN;SAMSN1;CNOT7;EFNA1;CD81;APP;PRNP;RAP2C
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.38526726771009034,0.9894444249313268,0.47602131438721135,0.9501415231875497,1.0,8/18,18.42%,VPS11;APOE;PTTG1IP;CD81;FAF1;VPS35;RNF128;RDX
prerank,positive regulation of cell motility (GO:2000147),0.25682713938474744,0.9893834229813346,0.48195876288659795,0.9493963209475355,1.0,31/205,12.63%,PHPT1;SPOCK2;MAZ;SEMA6A;SEMA6D;SEMA7A;LEF1;TIAM1;PECAM1;CXCL12;SEMA3C;CIB1;RET;SEMA6B;ACTN4;RUFY3;NOTCH1;ITGA6;TJP1;SEMA4C;CSF1R;SOD2;PODXL;PAK1;VSIR;FLT1;PIK3CD;PPP3CA;MAP4K4;MGAT5;CDH5
prerank,cardiac muscle cell development (GO:0055013),-0.35075082885393605,-0.9893195261307932,0.4782608695652174,0.7915830757960527,1.0,4/20,6.19%,PDLIM5;PDGFRB;CXADR;PDGFRA
prerank,dendrite self-avoidance (GO:0070593),-0.3702437140092607,-0.9888327842663672,0.46813186813186813,0.7921780422000099,1.0,4/16,6.72%,CNTN4;CNTN6;DSCAM;PALLD
prerank,regulation of protein polymerization (GO:0032271),-0.3013646509071978,-0.9887909093819308,0.471563981042654,0.7915127484533955,1.0,17/35,29.32%,MAP2;MAPT;ARHGAP28;PLEKHG2;CTTN;FCHSD2;DBNL;PFN2;TPPP;HSP90AA1;TPPP3;DBN1;TTBK1;ARL2;HAX1;COTL1;GBA2
prerank,protein-containing complex assembly (GO:0065003),0.24931895624758738,0.9886521440391773,0.4868255959849435,0.9505948756272814,1.0,57/259,16.83%,SH3BGR;CAND1;TRAPPC2;CAPZA2;LEF1;TIAM1;CNIH1;CXCL12;KIFAP3;SKAP2;NDUFAF1;ANKRD28;SEC23IP;EP300;KPNA3;GOSR2;F8;MAGI1;NAPA;GEMIN5;AXIN1;PDE4DIP;TMED10;CAND2;SLC2A1;RUVBL1;MDM2;RAB1A;TFAP4;BAD;TERT;P2RX7;DMD;CREBBP;TLE4;SCFD1;ELOB;TRAPPC6B;PICALM;MCFD2;HGSNAT;CUL3;TRRAP;APC;HES1;AP2M1;PARD3;PPP6R1;TRAPPC10;SMARCA4;TCF7L1;DNM1L;PTK2B;TUBGCP2;LIN7A;DNAJB14;CD2AP
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.3864054285958824,0.988311188840339,0.4824561403508772,0.9506567243210192,1.0,3/18,4.40%,MAPK3;SRC;VPS11
prerank,keratan sulfate metabolic process (GO:0042339),-0.30514209214939836,-0.9881772619313208,0.45363408521303256,0.7923879861121559,1.0,11/31,20.24%,B4GALT1;OGN;HEXA;HEXB;B4GALT6;SLC35D2;ST3GAL4;PRELP;GNS;LUM;B4GALT4
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.42634608386656536,0.9878481488495994,0.47884615384615387,0.9511384976653752,1.0,3/12,8.19%,PCGF3;YTHDC1;CDYL
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.3508042430029328,-0.9877058087638417,0.47608695652173916,0.7928827982853519,1.0,6/20,8.63%,CFLAR;OGT;CYLD;NUPR1;FLOT2;BIRC3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.409879270867203,0.9876548067230437,0.4699248120300752,0.9507943425791148,1.0,2/14,6.20%,RFFL;CARD16
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.2507267059506641,-0.9870351651113582,0.46229508196721314,0.7940098329878347,1.0,24/84,17.39%,CELF2;DDX5;TIA1;SON;DDX17;KHDRBS1;CELF4;KHDRBS2;RBM39;RBMX;SRSF6;RBM15;SNW1;RBFOX3;HNRNPA1;SMU1;RBM3;RBM4;DAZAP1;SRRM4;RBM7;NOVA1;SRPK1;RNPS1
prerank,serine family amino acid catabolic process (GO:0009071),-0.4256826243512156,-0.9869588267930801,0.47863247863247865,0.7934709792916609,1.0,8/10,51.25%,DLD;AMT;CBS;GCSH;THNSL2;SHMT2;GLDC;SHMT1
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.23069775071254858,-0.9867312673336435,0.48221343873517786,0.7932805173708036,1.0,48/150,22.41%,NTRK3;LDLRAD4;PRKAG2;PTPN13;DNAJC3;ERRFI1;SH3GL2;FBLN1;RASSF2;PID1;OCLN;PLPP3;SIRT2;PRKCZ;ENPP1;PRKCD;PPM1E;XDH;UBASH3B;SMAD6;NIBAN1;EPHB2;CAMK2N1;SNX25;SEMA4D;DEPTOR;SIRPA;MYADM;TAB1;RACK1;LRP6;TGFB1;WWTR1;RTRAF;DVL1;TSC2;GPD1L;PPP1R15B;SPRED3;PAQR3;CADM4;FKBP8;HSPB1;PPM1F;DBNDD2;DGKQ;IMPACT;EMILIN1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.4251738970249851,0.9864005609395807,0.49427480916030536,0.9526164665140908,1.0,4/11,16.16%,CCT2;CCT5;TCP1;DKC1
prerank,regulation of protein localization to Cajal body (GO:1904869),0.4251738970249851,0.9864005609395807,0.49427480916030536,0.9526164665140908,1.0,4/11,16.16%,CCT2;CCT5;TCP1;DKC1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3774072391935037,0.9863726872165401,0.5034965034965035,0.951755550876878,1.0,7/20,17.09%,RSC1A1;RHOQ;PICALM;TMEM59;AP2M1;LZTFL1;PPP2R5A
prerank,apical junction assembly (GO:0043297),0.30685335061854613,0.9863319409132432,0.4671875,0.9509452338768548,1.0,11/53,14.50%,PECAM1;MARVELD2;RAMP2;F11R;ESAM;CLDN5;PRKCI;CDH5;APC;PATJ;PARD3
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.3929656634284811,-0.9863224849035073,0.4663951120162933,0.7935801527674173,1.0,5/12,25.50%,RNF168;RNF8;NELFB;NELFA;LARP7
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.3851313169725801,-0.9861038951349537,0.4725050916496945,0.793411551306654,1.0,4/13,7.28%,HACD3;HACD1;HACD4;TECR
prerank,negative regulation of response to stimulus (GO:0048585),0.30235271460429647,0.9860271209696267,0.471841704718417,0.9508748227662926,1.0,13/60,14.29%,FCGR2B;MAP2K5;WFS1;LPCAT3;FBXO5;SIRT1;LYN;ZKSCAN3;TERT;MCTP1;HHIP;YBX1;MAP3K3
prerank,protein stabilization (GO:0050821),0.25834188847618333,0.9859489489337451,0.4879356568364611,0.9501867753271195,1.0,37/168,16.43%,ZSWIM7;CDC37L1;PIN1;RPL23;GNAQ;PDCL3;CCT2;CDC37;PPIB;CCNH;CCT5;PFN1;PHB2;WFS1;CDKN1A;EP300;RPL5;BAG1;SMAD7;GLMP;EFNA1;TSC1;PARK7;OTUD3;NLK;ZBED3;TNIP2;USP33;CHEK2;COG3;HCFC1;USP9X;TAF1;WIZ;TCP1;NAA15;SOX17
prerank,protein ubiquitination (GO:0016567),0.23666648784767788,0.9858407285865051,0.5202247191011236,0.9495532748285104,1.0,96/471,16.75%,PSMB10;PSMC4;PSMB6;RAD18;CAND1;ELOC;RNF7;CBL;PSMD8;PSMD5;PSMD12;ARIH1;KLHL3;RNF38;SPOP;UBA1;BIRC2;PSMD11;NEDD4L;VPS11;NHLRC1;RBBP6;PSMB4;FBXL5;UBE3A;TRIM14;PSMC1;FBXW2;NFX1;SIRT1;RNF187;LMO7;UBE2V2;KLHL2;FBXO32;CAND2;TRIM25;AKTIP;FBXO11;CRBN;ANAPC7;RBCK1;MDM2;PJA2;RFWD3;MYCBP2;PSMC2;KLHL24;UBE3D;PSMD2;RNF6;ZNRF1;FBXO7;EIPR1;UBE2V1;RNF13;RNF25;CHFR;USP22;ANAPC11;ELOB;TNKS;DTX4;RNF11;CUL3;PSMD14;UBE2R2;EPAS1;RNF146;PSMC6;TSPAN17;PSMD1;PSMB1;TRIM27;RNF20;FANCL;USP9X;TRIM3;UBA6;NHLRC3;UBE2G1;FBXO22;RMND5A;RNF114;TAF1;TRIM33;KLHL7;PELI1;KLHL42;RNF125;UBE2H;PSMA4;KLHL13;VPS18;FBXL20;PRKDC
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.29616542712188615,-0.9856344044858882,0.49033816425120774,0.7938712657149678,1.0,13/37,17.47%,IFT81;WDR35;DYNC2I1;TTC21B;IFT46;IFT57;IFT52;IFT172;IFT74;KIF3A;WDR19;DYNLL2;IFT20
prerank,negative regulation of neuron death (GO:1901215),0.2823622512301924,0.9855618956539146,0.48265895953757226,0.9494773392765774,1.0,13/93,9.90%,FOXQ1;SOD1;CRLF1;PPT1;APOE;TNFRSF1B;TOX3;WFS1;BDNF;SOD2;FZD9;PARK7;FBXO7
prerank,snRNA processing (GO:0016180),-0.3717651338961194,-0.9855331516028996,0.4636752136752137,0.7933846979834819,1.0,10/16,37.25%,INTS10;INTS8;INTS11;INTS7;TUT1;INTS12;INTS9;INTS3;INTS1;TOE1
prerank,negative regulation of B cell proliferation (GO:0030889),0.42677775148492614,0.985307160705352,0.48417132216014896,0.9492997750741776,1.0,2/11,9.31%,FCGR2B;LYN
prerank,atrial septum morphogenesis (GO:0060413),-0.42649548130231196,-0.9851702912578718,0.49798387096774194,0.7935850891594054,1.0,2/10,9.13%,NOTCH2;ACVR1
prerank,limb morphogenesis (GO:0035108),0.368725434957014,0.9849661527155882,0.48342059336823734,0.9494443877961141,1.0,1/20,0.04%,TBX4
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3585165013330971,0.9848082046477247,0.4903339191564148,0.9489969130319706,1.0,5/25,8.20%,PRPF3;SRSF10;SMNDC1;SF3B3;SRSF4
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3822977675902436,0.9842682304180823,0.4911660777385159,0.9496268785654904,1.0,4/19,8.57%,CTC1;SRC;HNRNPC;ACD
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.3948739853382706,-0.9841347906606811,0.47878787878787876,0.7955120009299979,1.0,4/13,7.04%,ASPA;DDO;GLUL;GLUD1
prerank,hexose biosynthetic process (GO:0019319),0.3218522452490336,0.9840104567795166,0.4881889763779528,0.9494322266273526,1.0,4/42,5.68%,PCK1;SLC25A1;GOT2;TPI1
prerank,glycerol metabolic process (GO:0006071),0.4429391235734888,0.9838615097678066,0.5049701789264414,0.9489631655845993,1.0,3/10,11.01%,TPI1;COQ2;PGP
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.3821138229736037,0.9837425216957425,0.48841354723707664,0.9483815090973209,1.0,3/19,9.17%,MAPK3;CAMK1D;CSF1R
prerank,positive regulation of DNA repair (GO:0045739),-0.28227147699681765,-0.9835825802650418,0.4714285714285714,0.7962313319930554,1.0,10/46,9.48%,EYA2;EYA1;EGFR;SPIRE1;SPIDR;UBE2N;FMN2;ERCC6;MGMT;RNF168
prerank,regulation of mitochondrial translation (GO:0070129),0.3623733170812106,0.9834638775654743,0.4900181488203267,0.9482809236329572,1.0,5/21,17.58%,FASTKD2;NGRN;TSFM;MTG2;RCC1L
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.422030143044389,-0.98324673133022,0.504149377593361,0.7964048259957996,1.0,2/10,7.08%,WNK1;DPP4
prerank,regulation of cholesterol transport (GO:0032374),-0.341888488094759,-0.983126216018393,0.4838709677419355,0.795983609178441,1.0,5/20,12.78%,LRP1;OSBPL6;ABCA5;NFKB1;TTC39B
prerank,response to hydrogen peroxide (GO:0042542),0.31920675927892345,0.9818835709557734,0.4771986970684039,0.9520488828921253,1.0,9/45,11.52%,SOD1;TNFAIP3;FYN;SIRT1;RELA;PARK7;CYP1B1;APTX;RPS3
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.28860897416496467,-0.9817293359630717,0.4580152671755725,0.7989406700075554,1.0,15/41,22.88%,PRKAG2;OGT;PRKAG1;NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;PGAM1
prerank,cardiac ventricle development (GO:0003231),0.3713220398114915,0.9817103837549173,0.49110320284697506,0.9516142001640818,1.0,7/20,16.11%,HEY1;HEY2;NOTCH1;MATR3;DAND5;HES1;HEYL
prerank,embryonic hemopoiesis (GO:0035162),-0.3976024038823823,-0.9816845822496806,0.47433264887063653,0.7983101039707483,1.0,3/12,4.76%,KMT2A;TGFBR2;KIT
prerank,regulation of dendrite development (GO:0050773),0.3231281332580639,0.9816636246044727,0.4887459807073955,0.9508481702671314,1.0,6/37,9.64%,LRP8;RAP2A;CAMK1D;NEDD4L;CAMSAP2;ZDHHC15
prerank,multivesicular body assembly (GO:0036258),-0.3067819058541963,-0.9815078410256213,0.4950980392156863,0.798004894277071,1.0,10/30,22.03%,STAM2;IST1;SNF8;RAB11A;TSG101;CHMP2B;CHMP5;STAM;VPS4A;HGS
prerank,cardiolipin metabolic process (GO:0032048),-0.39323364450952747,-0.9812929187608714,0.47058823529411764,0.7978253151674254,1.0,5/13,21.48%,PLA2G4A;SLC27A1;CRLS1;PGS1;PLA2G6
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.32104434874450155,0.9811145631777789,0.48513302034428796,0.9514539843993313,1.0,6/41,9.17%,LRP8;SRC;FYN;BDNF;EFNA1;CSF1R
prerank,vitamin D metabolic process (GO:0042359),-0.3968779303610742,-0.9808382791547002,0.5010438413361169,0.7982654167188915,1.0,4/13,33.90%,LGMN;PIAS4;CUBN;CYP2R1
prerank,rRNA methylation (GO:0031167),-0.3372834789180865,-0.9808276511609,0.5011185682326622,0.7975493179473195,1.0,17/22,44.85%,METTL15;NSUN4;NSUN3;METTL5;BUD23;MTERF4;FTSJ3;NOP2;NSUN5;ZCCHC4;FBL;MRM1;FDXACB1;MRM2;MRM3;TRMT112;METTL16
prerank,neuron projection organization (GO:0106027),-0.3717907391738072,-0.9804488180333534,0.4957805907172996,0.7977831473520133,1.0,9/15,26.56%,LGMN;GSK3B;ABCD2;MAP1A;DCTN1;ATP1A3;PLS1;PICK1;CHRNA7
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.43244289151594173,-0.9804320467084869,0.4979166666666667,0.7970720440354573,1.0,4/10,21.82%,SOX5;BMPR1B;SOX6;PKDCC
prerank,clathrin-dependent endocytosis (GO:0072583),-0.32082541632300954,-0.980040684607438,0.47333333333333333,0.7973782219883319,1.0,6/26,7.94%,DNAJC6;AP2B1;SNAP91;AP2A2;GPR107;AP2A1
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.2092580443253515,-0.9797944222881659,0.5178571428571429,0.7972810171433189,1.0,52/308,13.61%,LRP1;DAB2;LEPR;COL1A1;SMAD3;ACSL1;OGT;FOXD1;SMURF2;EBF2;TGFBR1;DYNC1H1;SOX5;TGFBR2;SNX4;CTNNB1;PDPN;SMAD4;TAPT1;MED1;BMP4;GHR;PPARGC1A;RREB1;SMO;APPL2;SORL1;PER2;ROCK1;LBP;ADRA1B;PLA2R1;STAT6;LPIN1;FOXC1;PAXIP1;NLGN1;SHLD1;NIBAN2;ACVR1;KSR2;EIF2AK2;GJA1;NR2C2;PRKAB2;HSF1;ABCA1;ACVR1B;SLC27A1;IL18;IL33;GRB10
prerank,sensory perception of taste (GO:0050909),0.43814724157409163,0.9791769292340423,0.49015748031496065,0.956319743114895,1.0,10/10,56.21%,ASIC2;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;CD36;ASIC1;PKD1L3;PKD2L1
prerank,regulation of immune response (GO:0050776),0.26663359731270164,0.9791717285115382,0.5041436464088398,0.9554159360116691,1.0,12/135,10.70%,LRP8;SH2D1A;FCGR2B;TIRAP;BIRC2;B2M;ICAM1;SYK;IFITM1;TRAF3;LYN;CD81
prerank,protein K48-linked deubiquitination (GO:0071108),0.36644333540693297,0.9791232879396367,0.48201438848920863,0.9546326084387597,1.0,9/23,17.18%,TNFAIP3;YOD1;OTUD3;USP37;OTUD5;USP33;MINDY2;OTUD4;ATXN3
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.2657817989163787,-0.9790689329831196,0.49719101123595505,0.7984762301486562,1.0,14/66,12.92%,EGFR;KANK2;PKD1;FHL1;RBL2;APPL2;MYO16;CDC73;ADAMTS1;BRD7;CCND3;CDK6;ANXA1;DLG1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.32500933731046217,-0.9789717890930025,0.4825174825174825,0.7979909772117536,1.0,10/26,26.95%,LGR4;FLOT2;APPL2;IRAK3;BIRC3;FLOT1;GPR108;APPL1;TLR3;LRRC14
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.27708949327564975,0.9789181743933446,0.4912536443148688,0.9543078555198732,1.0,16/101,11.82%,PIK3CG;RALB;EZH2;MTCP1;RPTOR;SRC;PPP2CA;CIB1;RGCC;CALM3;SIRT1;WNT5A;CSF1R;DDX3X;FLT1;PIK3R5
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.37774747896065586,0.9788252703524699,0.48381294964028776,0.9536534507565236,1.0,4/17,10.56%,VEZF1;RFX3;TMEM100;BAD
prerank,negative regulation of viral transcription (GO:0032897),0.41014835832037455,0.9785437189260995,0.49812734082397003,0.9535304963565895,1.0,6/13,18.83%,TRIM14;IFITM3;TRIM27;UBP1;HEXIM1;MID2
prerank,positive regulation of mitochondrial translation (GO:0070131),0.4014355860586448,0.9785005543425914,0.48859315589353614,0.9527441434937919,1.0,2/14,8.85%,FASTKD2;NGRN
prerank,mitochondrial fission (GO:0000266),0.3967782593639254,0.9781399528673381,0.4849056603773585,0.9528551687641785,1.0,2/16,3.84%,DNM3;MTFR1
prerank,regulation of cell division (GO:0051302),0.2901476283390694,0.9781166918408991,0.4779874213836478,0.9520119317035695,1.0,8/72,6.88%,TAL1;PIN1;PLK2;PRDM15;CSPP1;PRPF40A;CIB1;CALM3
prerank,regulation of platelet activation (GO:0010543),0.3728983359013921,0.9780558637853223,0.4940577249575552,0.951275244663165,1.0,6/21,13.32%,APOE;SELP;SYK;LYN;NOS3;PLEK
prerank,organelle assembly (GO:0070925),-0.20242507397245604,-0.9780543899586727,0.549618320610687,0.7997227417288382,1.0,89/384,17.47%,BICD1;AMBRA1;GSN;ULK2;PARVA;AHI1;PKD1;CC2D2A;EXOC3;TMOD2;PACS2;STAM2;DYNC1H1;MAPT;RILPL1;FLNA;PIBF1;IFT81;DZIP1;TTC8;WDR35;UBXN2A;WIPI1;PIK3C3;DYNC2I1;RAB8B;DCDC2;TUBGCP4;NUDCD3;CCDC66;CCDC57;CFAP20;IST1;OGFOD1;EXOC6;TTC39C;IFT46;IFT52;GOLGA2;ACTR3;YTHDF1;CEP89;UBXN2B;CEP126;IFT172;CEP20;IFT74;CFAP44;RP2;ARL13B;DISC1;CD34;NSFL1C;TTBK2;ABLIM3;LIMD1;KIF3A;STX12;DZIP1L;TUBGCP6;BBS9;G3BP1;CCDC61;SNF8;CDS2;RAB11A;WDR19;WDR11;ATXN2L;INTU;RAB23;DHX29;CDS1;BBS2;TSG101;CYS1;ARF4;EXOC7;EXOC1;PTPN23;HPS4;CEP250;EHD1;RAB8A;EHD3;DYNLL2;ACTR2;CHMP2B;IFT20
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3328872842307281,-0.9778655834303916,0.4590909090909091,0.7995029995894463,1.0,14/23,41.86%,DDB1;DDB2;UBC;PARP1;XPC;COPS2;COPS5;COPS7A;COPS6;RBX1;XPA;GPS1;UBA52;CETN2
prerank,positive regulation of chromosome organization (GO:2001252),-0.3757524099155813,-0.9778179660408574,0.47045454545454546,0.7988806269446833,1.0,7/15,26.93%,PML;RAD50;MRE11;GNL3;RTEL1;PPP1R10;RAD21
prerank,cellular response to dsRNA (GO:0071359),0.3963153868614041,0.9778148928082516,0.48867924528301887,0.9510607001153566,1.0,2/15,3.70%,RALB;IFIT1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3517505772854037,0.977806713216076,0.47435897435897434,0.9501800312113862,1.0,3/25,3.83%,EVI5L;TBC1D30;EVL
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3012971166753107,0.977794471232712,0.4889937106918239,0.9493122806235922,1.0,12/54,12.35%,XYLT1;SGSH;GLB1;EXT2;HS6ST1;PXYLP1;FUCA1;HS3ST2;B3GAT2;HGSNAT;AGRN;IDS
prerank,regulation of G0 to G1 transition (GO:0070316),0.3291897064688556,0.9777904259194623,0.4632952691680261,0.948421988266675,1.0,9/38,16.16%,EZH2;EED;UXT;BMI1;RYBP;MGA;APAF1;E2F6;RBBP4
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.34470676664674904,0.9776888984425032,0.4731369150779896,0.9478329037800521,1.0,3/25,10.81%,CBL;BCAR3;RBPJ
prerank,cation transport (GO:0006812),-0.22412852963974372,-0.9771666073230661,0.496,0.7998732467809333,1.0,43/166,23.76%,TRPM3;ATP1A2;KCNB2;KCNMA1;ATP1B1;SLC41A1;TRPM6;SLC47A1;SCN8A;SCN3A;PIEZO2;SLC12A2;SLC6A9;KCNK5;KCNJ2;SCN1A;KCNA1;SLC22A4;SGK1;ANO1;NDFIP1;KCNJ6;SLC9B2;ABCC9;ANO6;KCNJ13;NDUFA9;KCNS3;KCNQ4;SLC5A6;SLC38A7;SLC5A5;ANO10;KCNJ10;KCNA6;KCNA2;SLC11A2;GRIN1;TRPC6;MCOLN1;KCNC1;PANX1;CLN3
prerank,positive regulation of translational initiation (GO:0045948),-0.3539083350789928,-0.9770865791475701,0.48214285714285715,0.799334048337818,1.0,9/18,33.10%,KHDRBS1;YTHDF1;HABP4;RPS6KB1;EIF2B5;RPS6KB2;POLR2G;YTHDF2;MTOR
prerank,amino acid import across plasma membrane (GO:0089718),0.36086203670511297,0.9768181388396351,0.4785714285714286,0.9495361802620021,1.0,5/24,8.22%,SLC7A8;SLC1A1;SLC3A2;SLC6A6;SLC1A2
prerank,secondary palate development (GO:0062009),-0.38106327758871006,-0.9767570025881188,0.4893162393162393,0.7994425045628627,1.0,3/14,4.04%,TGFBR3;TGFBR2;SMAD4
prerank,acyl-CoA metabolic process (GO:0006637),0.33157576587329074,0.9766694874327136,0.4901639344262295,0.9490789697099175,1.0,6/35,11.78%,MLYCD;DBI;GPAT4;ACACB;HMGCS2;ACOT8
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.2676267272754759,-0.976072155270062,0.48909657320872274,0.8004370981103103,1.0,19/61,19.32%,EYA2;EYA1;EGFR;PDGFRB;UBE2N;TOX;ERCC6;PML;RAD50;SMOC2;RNF168;MRE11;RNF8;PARP3;USP7;NPAS2;BABAM1;GNL3;SMCHD1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.31281309658570267,0.9759867196261197,0.5040387722132472,0.9501624334020701,1.0,9/44,15.25%,RPS6KA1;SRC;MAP2K5;CARD16;USP47;PCID2;DDX3X;CD44;GAS6
prerank,sensory perception of light stimulus (GO:0050953),-0.25008474605343706,-0.9758721027677071,0.5033333333333333,0.800212653267199,1.0,9/87,6.49%,PCDH15;SLC4A10;COL1A1;EML2;COL11A1;ADGRV1;EFEMP1;DHRS3;DNAJC19
prerank,regulation of protein import into nucleus (GO:0042306),-0.2932825334870313,-0.9758198528421665,0.4963325183374083,0.7996099228079759,1.0,14/36,20.03%,ZIC1;SMAD3;FLNA;BMP4;BAG3;PRKCD;UBR5;EFCAB7;CDH1;RAB23;TGFB1;MAVS;APOD;PIK3R1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.36462538580957937,-0.9757278379686217,0.49414519906323184,0.7990818799088842,1.0,7/16,19.39%,PYGB;AGL;PHKA2;PYGM;PGM2;GAA;PHKG2
prerank,regulation of DNA binding (GO:0051101),0.3130581448775054,0.9756124584454641,0.48538961038961037,0.9503340784730219,1.0,11/44,13.92%,LEF1;NME1;MAPK8;CEBPG;TXN;HJURP;RSF1;TFAP4;DOT1L;NFKBIA;HES1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.23588509366628674,0.9753411487842093,0.5685393258426966,0.9502184657175515,1.0,84/476,14.24%,MAZ;CTCFL;MAP2K7;MECOM;SS18L1;ILF3;TAL1;TRIM28;LEF1;PPP3CB;RPS6KA1;KLF2;HIPK2;PAX8;PHF5A;HNRNPAB;HEY1;RLF;APOE;FLI1;SMARCA2;SOX2;KDM3A;SPIN1;NPAT;EP300;RFX3;TBX1;RET;CALCOCO1;FOXF2;PPARD;MED12;CLOCK;RNF187;HEY2;AXIN1;NOTCH1;CAND2;WNT5A;ATXN7L3;ATAD2;GTF2H1;ZXDC;ACVRL1;RSF1;RELA;PCID2;RAI1;PLCB1;TFAP4;RNF6;ZKSCAN3;KLF6;UBE2V1;TAF15;CITED2;YEATS4;RYBP;ING2;WBP2;ESR1;SETD3;RHOG;CREBBP;USP22;MED4;PICALM;ILF2;SP1;IKBKB;MDFIC;CHUK;PITHD1;ACTA2;YWHAH;ING5;EDRF1;CHEK2;DDIT3;HES1;HCFC1;RNF20;PHF8
prerank,DNA strand elongation (GO:0022616),0.3792936740491925,0.9752916686101366,0.49005424954792043,0.9494731006239935,1.0,5/18,12.55%,DCLRE1B;POLD3;POLA1;TERT;NBN
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.35805970535962445,0.9750810267797916,0.48653198653198654,0.9491964581212402,1.0,8/24,16.16%,EZH2;EED;BMI1;PPHLN1;TRIM27;TASOR;AEBP2;RBBP4
prerank,osteoclast differentiation (GO:0030316),-0.33562344483383383,-0.9749751697430388,0.45905707196029777,0.8003671176268674,1.0,3/22,3.50%,FOXP1;ANXA2;MAPK14
prerank,positive regulation of protein import into nucleus (GO:0042307),0.33931458634091494,0.9745734575415022,0.48353552859618715,0.9498386689279849,1.0,4/28,3.90%,RBM22;TRIM28;DMAP1;HDAC3
prerank,microtubule anchoring (GO:0034453),0.42528431256891036,0.9745114070285181,0.5276679841897233,0.9491120280872364,1.0,6/12,17.20%,CLASP2;DAG1;GCC2;BCCIP;BICD2;CLASP1
prerank,detection of calcium ion (GO:0005513),0.41263100881274073,0.9743507469627611,0.4942084942084942,0.9486578024156201,1.0,5/13,18.82%,CALM3;KCNMB2;KCNMB3;RYR2;CALM1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.38036713935266947,-0.9740024793329185,0.4829787234042553,0.8021598003973113,1.0,9/14,37.64%,ME1;NMNAT2;NMNAT3;AK5;AK3;AK4;CMPK2;AK1;NME2
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.3455057936583751,-0.9739751272415855,0.47334754797441364,0.8014935679368649,1.0,12/18,35.82%,CTNNA1;ILRUN;GSK3B;RAB23;APOD;FLCN;CABP1;OTUD7B;SUFU;CHP1;POLR1A;LATS1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.2774763524706596,-0.9737592686752234,0.47214854111405835,0.8013426876086247,1.0,16/48,22.88%,PRKAG2;OGT;PRKAG1;NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;PRDM16;NUP85;AAAS;RAE1;NUP37;NUP214;PGAM1
prerank,negative regulation of protein binding (GO:0032091),0.28939261731937616,0.9737571189790755,0.5015151515151515,0.9495695020065674,1.0,10/71,6.20%,RALB;PIN1;ACTB;PSME3IP1;IFIT1;ATP2A2;B2M;CDKN1A;MAPK8;CARD16
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.4126195030437855,0.9734117569922894,0.49544626593806923,0.9496653121567066,1.0,4/14,12.65%,RGCC;PLCG1;PRKCI;ECSCR
prerank,response to ionizing radiation (GO:0010212),0.2923488905934276,0.9732818185951053,0.5111111111111111,0.9491291401938823,1.0,11/70,9.53%,AEN;ABRAXAS1;EEF1D;RAD1;CDKN1A;COP1;SIRT1;CLOCK;EYA3;KDM4D;RFWD3
prerank,membrane depolarization (GO:0051899),-0.3051112533041955,-0.9732525477741469,0.5106382978723404,0.8019160004128842,1.0,10/32,17.73%,CACNB4;P2RX4;SCN8A;SCN3A;CACNA1B;SCN1A;CACNA1G;CACNG4;ATP5IF1;CACNG2
prerank,glycine metabolic process (GO:0006544),-0.39963976996548795,-0.9726670021105386,0.4945770065075922,0.8027223687173195,1.0,8/12,51.25%,DLD;RIDA;AMT;GCSH;SHMT2;GCAT;GLDC;SHMT1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.38970417390392154,0.9725600427439173,0.49822695035460995,0.9504032721894484,1.0,2/16,2.31%,RBM22;SFSWAP
prerank,lipoprotein transport (GO:0042953),0.4451412078537529,0.9714301411926772,0.5149812734082397,0.9528451955093029,1.0,5/10,21.08%,ZDHHC17;VMP1;UNC119B;MIA3;PPARG
prerank,positive regulation of cytokine production (GO:0001819),0.24159587039048858,0.971254048043639,0.5410225921521997,0.9524793024805374,1.0,33/292,11.58%,LRRFIP1;CADM1;PIK3CG;IL1R1;PDE4D;PTPRC;MAP3K7;SOD1;POLR1C;TIRAP;PRKD2;RAB7B;CYRIB;EP300;CEBPG;SYK;RGCC;TMED10;WNT5A;RELA;CSF1R;RAB1A;PLCB1;LURAP1;PARK7;PNP;CYP1B1;CREBBP;APP;NOD1;PIK3CD;RPS3;POLR3F
prerank,monoacylglycerol metabolic process (GO:0046462),-0.3806407610986846,-0.971206671886494,0.4936440677966102,0.8059508113153139,1.0,1/13,1.27%,PLA2G4A
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.24280626332467556,-0.9710228045011267,0.5047619047619047,0.8057066617033329,1.0,20/95,12.12%,LDLRAD4;TGFBR3;DAB2;SMAD3;SMURF2;TGFBR1;TGFBR2;ZEB2;SMAD4;PPARA;SKI;HTRA3;DKK3;SNW1;SMAD6;THBS1;SNX25;UBC;STK11;PPM1A
prerank,amino acid transport (GO:0006865),0.3053772034240137,0.9709970977436287,0.4968051118210863,0.952359583645109,1.0,5/49,5.53%,SLC7A8;SLC36A4;SLC25A44;SLC3A2;SLC6A6
prerank,aerobic respiration (GO:0009060),0.37410659717206995,0.9708487180803252,0.5025295109612141,0.951880258991434,1.0,3/20,4.37%,ME3;MTFR1;SIRT3
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.3282302083657831,-0.9707168416505522,0.484304932735426,0.8058131630100185,1.0,7/22,13.88%,IGF1;SMAD4;P2RX4;ROCK2;ROCK1;CAMK2D;IL6ST
prerank,protein palmitoylation (GO:0018345),0.33785472782778314,0.9707060655634256,0.4942528735632184,0.9514111550882198,1.0,7/30,14.05%,ZDHHC17;ZDHHC13;ZDHHC14;SELENOK;ZDHHC15;ZDHHC9;ZDHHC7
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3995832653609098,0.9703972286557814,0.47155963302752296,0.9513986504984251,1.0,1/15,0.77%,ZC3H12D
prerank,chromosome condensation (GO:0030261),0.31777291535354624,0.9703253693969027,0.48966613672496023,0.9506922165915425,1.0,7/36,14.34%,BANF1;TENT4A;CHMP1A;AKAP8L;AIFM1;PHF8;CSNK2A2
prerank,regulation of ossification (GO:0030278),-0.28486698634648067,-0.9696994843002945,0.48448687350835323,0.8076896900769975,1.0,14/36,28.26%,BMP4;CHSY1;ENPP1;ANKH;SMAD6;ACVR1;ECM1;LRP6;BMPR2;TXLNG;NOTUM;SFRP1;BMP2;MDK
prerank,regulation of angiogenesis (GO:0045765),-0.2172562185775775,-0.9696192381948218,0.5575221238938053,0.8071460350427433,1.0,33/192,12.39%,SULF1;ANXA3;SASH1;ADAM12;ITGB8;ADGRA2;BMPER;STIM1;FGF1;COL4A3;CTNNB1;GTF2I;ROCK2;F3;GLUL;CEMIP2;HSPG2;ROCK1;HOXA5;PML;PTGIS;SPARC;ADAMTS1;FOXC1;THBS2;NIBAN2;SMOC2;THBS1;HIPK1;RHOJ;CD34;RHOB;ECM1
prerank,histone lysine demethylation (GO:0070076),0.3461382024905356,0.9694566316115537,0.5095652173913043,0.9523274310755769,1.0,7/25,14.24%,KDM3A;KDM2A;KDM6A;KDM4D;JMJD1C;KDM5C;PHF8
prerank,vasculature development (GO:0001944),-0.36282293779689345,-0.9691856209534743,0.4933920704845815,0.8075762516915818,1.0,7/16,26.13%,PDGFRB;ERRFI1;PDGFRA;STK11;BMPR2;STRA6;NOTCH4
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.35883961593687863,0.9689726673727225,0.4858156028368794,0.9527981289914895,1.0,3/22,10.54%,TNFRSF1B;WNT5A;TRPM4
prerank,regulation of organelle organization (GO:0033043),0.28332299765247193,0.9686539105189582,0.5217391304347826,0.9528257354216292,1.0,13/80,11.03%,SURF4;MAPK3;STOX1;VPS11;MYO5A;EP300;USP6NL;F11R;CAMSAP2;PDE4DIP;TJP1;TBC1D25;RBSN
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.33013450230983765,-0.9683741886710538,0.46697038724373574,0.8089901209336394,1.0,7/24,15.93%,SORBS1;IGF1;ENPP1;AKT2;GSK3B;IGF2;SELENOS
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.39228731257786814,-0.9680356840939706,0.474468085106383,0.8091512239518842,1.0,3/12,3.66%,NBL1;WASL;BMP5
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3291848042289377,0.9678951766323697,0.48292682926829267,0.9541922024534667,1.0,9/35,11.77%,DDX54;SRC;UBE3A;KDM3A;CALCOCO1;PLPP1;WBP2;ESR1;EGLN2
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.24171691820374971,-0.9668790920731629,0.5092250922509225,0.8115623580838629,1.0,18/92,13.00%,FOXP1;ANXA3;SASH1;DOCK5;DOCK1;NRP1;FGF1;BMP4;RREB1;ROCK2;EPB41L4B;SPARC;SMOC2;THBS1;NRP2;FOXC2;RHOB;RAB11A
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.34048325137133095,-0.9664925169330517,0.48157248157248156,0.8119030768942047,1.0,4/20,9.33%,SULF1;SULF2;SMOC2;THBS1
prerank,sensory perception of smell (GO:0007608),-0.4125518383811003,-0.966350419005697,0.5166666666666667,0.8115365109321395,1.0,5/11,33.92%,ADCY3;SYT10;SLC24A4;DRD2;MKKS
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.32872435648447396,-0.9662125371145447,0.4975,0.8111819851878102,1.0,7/24,17.75%,ADAMTS12;TGFBR1;SOX5;EFEMP1;WNT9A;BMPR1B;SOX6
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.27881534902909405,-0.9661962239519233,0.5359116022099447,0.810484198635828,1.0,10/47,12.24%,PDGFRB;MAPK14;PID1;TGFBR2;MAPT;PRKCD;XDH;THBS1;TP53;GRB2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.26763437621082514,-0.9660190189966961,0.50997150997151,0.8102045373452077,1.0,16/53,19.95%,EYA2;DDX5;EYA1;EGFR;UBE2N;PRKCD;ERCC6;PLA2R1;RNF168;RNF8;ATM;NACC2;NPAS2;BABAM1;SMCHD1;SPRED3
prerank,B cell receptor signaling pathway (GO:0050853),0.3330669538208183,0.9657678353665622,0.4983388704318937,0.9594529034948032,1.0,4/32,11.50%,PTPRC;VAV3;SYK;PIK3CD
prerank,regulation of protein processing (GO:0070613),-0.33848192423644646,-0.9656015071169635,0.4967032967032967,0.8105789601138169,1.0,6/21,23.76%,RHBDD1;GAS1;CCBE1;RNF139;NKD2;CLN3
prerank,macroautophagy (GO:0016236),0.26571234294558715,0.965600745627294,0.5303030303030303,0.9590358071451468,1.0,34/118,18.89%,TOMM20;MTERF3;MAP1LC3B;KLHL3;MTMR14;SRC;YOD1;ATG4B;EPG5;TECPR1;CHMP2A;PRKAA2;DYNLL1;VPS37B;UBQLN1;NBR1;ATG7;PLAA;EI24;CSNK2A2;ATG16L1;ATG14;GABARAPL1;ATG13;PIK3R4;ZFYVE1;VPS37C;BECN1;PIP4K2A;VPS33A;GABARAP;VPS4B;ULK1;LAMP2
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.32389016801174353,-0.9651274255331531,0.4988558352402746,0.8110742340418036,1.0,8/25,21.12%,ERRFI1;PPARA;SLC6A9;EPHB2;ZGPAT;TSG101;SOCS5;SNX6
prerank,cellular response to hydrogen peroxide (GO:0070301),0.330426141716476,0.9650942134298746,0.5134680134680135,0.9595897697951611,1.0,7/33,11.52%,TNFAIP3;SIGMAR1;SIRT1;RELA;PARK7;CYP1B1;RPS3
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.3293632673885565,0.9646975770242628,0.49829351535836175,0.9598285385804379,1.0,4/34,10.85%,PTPRC;PHB2;WNT5A;GPI
prerank,regulation of viral transcription (GO:0046782),0.3201620911706071,0.9646410235695033,0.5140961857379768,0.95910928122442,1.0,11/39,18.83%,POLR2J;POLR2B;TRIM14;IFITM3;RSF1;MDFIC;TRIM27;GTF2F2;UBP1;HEXIM1;MID2
prerank,negative regulation of protein modification process (GO:0031400),0.28208718578880165,0.9645122411537571,0.5163690476190477,0.9585959392061558,1.0,27/79,17.28%,PRR5L;PNKP;PPP1R16B;XRCC1;CIB1;DBI;YWHAB;SIRT1;CDYL;LYN;PARK7;TARDBP;PRKAA2;MFHAS1;TRAF3IP1;DMD;ZBED3;PRNP;CRKL;PTPA;TERF2IP;ATG14;PPP1R8;DNAJC10;PRKDC;WARS1;CORO1C
prerank,limb development (GO:0060173),0.34436869366359657,0.9641526210775109,0.4990990990990991,0.9587830261368028,1.0,2/28,3.08%,TBX4;GREM1
prerank,maturation of SSU-rRNA (GO:0030490),-0.2930269186007281,-0.9641061210997891,0.5278514588859416,0.812969077202496,1.0,18/34,28.34%,RIOK1;BMS1;RIOK2;UTP6;NOL11;DDX52;RPS16;UTP4;NAT10;NOB1;RIOK3;NOP14;WDR3;LSM6;RRP36;TSR2;NOL10;UTP3
prerank,T-helper cell differentiation (GO:0042093),-0.37749588359929664,-0.9640873663244939,0.511340206185567,0.8122769486369877,1.0,2/14,5.67%,FOXP1;ATP7A
prerank,intracellular lipid transport (GO:0032365),-0.3354213149284048,-0.9639983014364815,0.5120192307692307,0.8117832857434667,1.0,6/21,14.84%,PRKAG2;CPT1A;PLEKHA8;PRKAB2;ABCD2;CPT2
prerank,regulation of protein kinase activity (GO:0045859),0.26489874053138246,0.9639863436690254,0.5428973277074542,0.9584232516268539,1.0,22/106,16.82%,TRIB3;PTPRC;SOD1;TAB2;GNAQ;SMG8;SPRED1;CDKN1A;AKT1S1;DTNBP1;SIRT1;LCP2;PARK7;MMD;NF1;RAP2C;TRIM27;CAMKK2;GAS6;PRKRIP1;PTK2B;WARS1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3256380347557437,-0.9639584275290034,0.5091324200913242,0.8111499283303375,1.0,2/23,0.57%,ZBTB20;IGF1
prerank,glucose import (GO:0046323),0.4033110761222115,0.9633748260885028,0.5035971223021583,0.959287444834333,1.0,3/13,14.05%,SORT1;SLC2A1;ZDHHC7
prerank,necroptotic process (GO:0070266),0.3863446892578648,0.963299017304072,0.5081967213114754,0.9586379863424139,1.0,4/16,16.21%,MLKL;TRPM7;ITPK1;DNM1L
prerank,acylglycerol metabolic process (GO:0006639),0.3213982788878958,0.9629381980567363,0.49331103678929766,0.9587976394146903,1.0,4/37,5.08%,DGKB;APOE;PLAAT3;LMF1
prerank,regulation of protein autophosphorylation (GO:0031952),-0.2961813190040007,-0.962915306003213,0.5220994475138122,0.8131895778501607,1.0,14/36,22.49%,ERRFI1;RASSF2;EPHA7;ENPP1;RAD50;TNKS1BP1;MRE11;PPP2R5E;TOM1L1;PDGFD;PDGFA;VEGFA;IMPACT;PPP2R5D
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.3921194986037979,-0.9628622988590465,0.5072765072765073,0.8126073113440455,1.0,3/12,8.48%,NOTCH2;DOCK10;DOCK11
prerank,response to peptide (GO:1901652),0.3289488716169973,0.9624857521499628,0.5103092783505154,0.9592063240293537,1.0,7/33,11.93%,CACNA1A;MMP12;FYN;EIF2B3;ERBIN;GNAI1;PRNP
prerank,nuclear membrane reassembly (GO:0031468),-0.2663719202896789,-0.9622466246661031,0.5233918128654971,0.8135254055054432,1.0,22/54,25.21%,SIRT2;PPP2R2A;UBXN2A;LMNA;NUP205;IST1;NUP155;NUP188;UBXN2B;AHCTF1;NUP93;NSFL1C;SEH1L;CHMP2B;NUP85;CC2D1B;NUP37;VPS4A;EMD;LEMD2;SEC13;LBR
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.3366852108428263,-0.9615950121416625,0.4964705882352941,0.8145982825051805,1.0,7/20,20.17%,GSN;PLA2R1;THBS1;ANO6;SFRP4;ITGA4;PIAS4
prerank,calcium import into the mitochondrion (GO:0036444),-0.41256959802136184,-0.9615506947228153,0.5258964143426295,0.8139877171527891,1.0,5/10,21.72%,MCU;MICU2;AFG3L2;MCUR1;MCUB
prerank,organophosphate ester transport (GO:0015748),0.35188195164689173,0.9611917015488673,0.5206896551724138,0.9619960833192198,1.0,7/24,13.80%,PRELID3B;EPG5;PRELID2;PITPNA;SCARB1;NPC2;OSBPL2
prerank,dendritic spine morphogenesis (GO:0060997),-0.36361277879965037,-0.9609616722656962,0.5,0.8147316345000061,1.0,6/15,10.62%,EPHB1;WASL;DLG4;CTNND2;DOCK10;EPHB2
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.31586006164619823,-0.9605340548529123,0.49774774774774777,0.8150795758442823,1.0,11/27,26.45%,RIMS1;SYT9;SYT12;SYT11;SYT4;VAMP2;SYT7;SYT2;ARHGAP17;SYT10;SYT6
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.25804100445841793,0.95991716246568,0.5765645805592543,0.9647540984740253,1.0,18/150,11.82%,RAC2;MAZ;PIK3CG;TRIB3;PIK3AP1;PTPRJ;SRC;TEK;FYN;RET;TXN;IRS2;PARK7;ESR1;MFHAS1;RHOG;PIK3CD;PIK3R5
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3105357169463053,-0.9597025057937344,0.5352112676056338,0.8165190577380235,1.0,9/26,21.66%,ADCY5;EFNA5;LRP5;CDK16;ANO1;STXBP4;GPLD1;PLA2G6;ADCY8
prerank,mitotic recombination (GO:0006312),-0.37260958746118655,-0.9594443013370693,0.5392781316348195,0.8164983232562661,1.0,8/15,33.43%,SMC6;RAD50;TPRKB;RAD51D;NSMCE2;DMC1;RAD54B;ERCC1
prerank,positive regulation of catabolic process (GO:0009896),0.2892695617639641,0.9591465938498882,0.5247376311844077,0.9660335206150944,1.0,12/65,13.86%,GSK3A;TNFAIP3;PLK2;NEDD4L;RAB7A;AXIN1;WNT5A;VSIR;ATG7;EGLN2;NDUFA13;APC
prerank,apoptotic cell clearance (GO:0043277),-0.30345129833284623,-0.9588129198766129,0.5119047619047619,0.8173990114196701,1.0,9/30,12.68%,XKR4;LRP1;TXNDC5;XKR6;THBS1;RHOBTB2;ANXA1;RARA;RHOBTB1
prerank,regulation of cellular component biogenesis (GO:0044087),0.3195509110899167,0.9586838246428472,0.5141430948419301,0.9664831147278266,1.0,7/39,9.82%,HSPA8;VPS11;APOE;HJURP;NOTCH1;TJP1;TIE1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.24293664419851765,0.9586727347638089,0.58274231678487,0.9656311937282335,1.0,56/264,16.18%,POLR2J;SNRPD2;NCBP1;RBM22;HSPA8;POLR2B;PRPF31;PRPF3;SNRPD1;HNRNPH2;PCBP1;PHF5A;SF1;PRPF40A;HNRNPK;CPSF4;PPIL3;PLRG1;SRSF10;SNRNP27;PRCC;SFPQ;HNRNPC;GEMIN5;SMNDC1;YTHDC1;SF3B3;SRSF4;DNAJC8;SNU13;NOVA2;COIL;SF3A1;RSRC1;BUD31;SYF2;U2AF1;PAPOLA;SRPK2;EFTUD2;PTBP1;RBM10;STRAP;YBX1;SRSF7;SNRPA;USP39;FUS;RBM4B;SF3B6;HNRNPL;TRA2B;GTF2F2;RBM41;UPF3B;U2AF2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.4097966796934222,-0.9586652515169565,0.53,0.8170737197015455,1.0,5/10,33.66%,LPGAT1;ABCD2;NR1H2;SLC45A3;MID1IP1
prerank,regulation of ion transport (GO:0043269),-0.25252658935992656,-0.9581125504433743,0.5436046511627907,0.8177225474900037,1.0,22/76,21.12%,ANK3;WNK1;P2RX4;WWP2;ATP1A1;SYT9;KCNJ2;SIK1;KCNJ6;PER1;SYT12;SYT11;SYT4;NKAIN4;VAMP2;SYT7;KCNJ13;SYT2;KCNJ10;KCNA2;NEDD4;SNX6
prerank,negative regulation of cell growth (GO:0030308),0.26450010874801555,0.9580489020872739,0.5344352617079889,0.966471762314537,1.0,20/121,13.09%,CCDC85B;GSK3A;PTPRJ;FRZB;ST7L;RERG;PPT1;PPP2CA;SMARCA2;CDKN1A;DIP2B;FGF13;SIRT1;ACVRL1;RNF6;CCAR2;DDX3X;IP6K2;EI24;NDUFA13
prerank,regulation of focal adhesion assembly (GO:0051893),-0.2662312122373953,-0.9580289096498946,0.5431034482758621,0.8172028132395917,1.0,11/54,6.65%,PHLDB2;GPM6B;EFNA5;NRP1;MACF1;RHOA;ROCK2;VCL;ARHGAP6;ROCK1;LDB1
prerank,blood circulation (GO:0008015),0.30582352743212243,0.9579303352119297,0.5267175572519084,0.9659321074402053,1.0,5/49,4.35%,GCLC;SOD1;CXCL12;TBC1D8;GCLM
prerank,lysosome organization (GO:0007040),0.3183775881285549,0.9579200996039472,0.5114235500878734,0.9650772214221359,1.0,15/36,21.13%,LAMTOR1;TMEM165;TPP1;AKTIP;ZKSCAN3;MBTPS1;CLVS1;SNAPIN;TFEB;HOOK3;VPS18;VPS33A;GRN;TPCN2;LRRK2
prerank,selective autophagy (GO:0061912),0.29426872261258635,0.9578698232093878,0.49612403100775193,0.9643396756984274,1.0,16/56,15.94%,DYNC1I1;MAP1LC3B;KLHL3;UFC1;RAB7A;PHB2;AUP1;PARK7;UBE2V1;DYNLL1;UBQLN1;NBR1;LGALS8;DYNC1I2;ATG14;ATG13
prerank,regulation of viral release from host cell (GO:1902186),0.3560984100157992,0.9576798693851752,0.5045372050816697,0.9639926491266885,1.0,5/21,10.51%,TRIM28;TRIM8;TRIM25;CHMP2A;VPS37B
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.255395810617271,0.9575165458656035,0.550531914893617,0.9635694786388584,1.0,10/152,4.57%,MTNR1A;HTR1F;PTGER2;ADGRE1;ADGRL4;GNAQ;ADGRL3;TSHR;INSL3;RAMP2
prerank,protein modification by small protein conjugation (GO:0032446),0.23436988693994326,0.957342583993144,0.5816917728852838,0.963156148746457,1.0,79/361,17.52%,RAD18;MOCS3;CAND1;ELOC;RNF7;CBL;TRIM28;ARIH1;KLHL3;SAE1;RNF38;UFC1;UBA1;DCUN1D4;NEDD4L;VPS11;FBXL5;TRIM14;UBE2I;NFX1;NUP54;SIRT1;RNF187;UBA2;NUP50;LMO7;UBE2V2;KLHL2;FBXO32;CAND2;FBXO11;CRBN;ANAPC7;MDM2;PJA2;RFWD3;MYCBP2;KLHL24;PIAS2;RNF6;FBXO7;EIPR1;UBE2M;RNF25;TRPM4;NAE1;CHFR;ANAPC11;PIAS1;ELOB;ATG7;DTX4;CUL3;NUP35;UBE2R2;EPAS1;UBE2F;TSPAN17;TRIM27;RNF20;USP9X;UBA6;UBE2G1;NDC1;TRIM33;KLHL7;UBE2H;KLHL13;VPS18;PRKDC;DCUN1D2;NUP160;DCUN1D1;UBR3;MSL2;UVSSA;POM121;PEX13;RANGAP1
prerank,cellular respiration (GO:0045333),0.31426896448153646,0.9566315531291473,0.5208012326656395,0.9643125275899836,1.0,9/41,14.41%,CYCS;ME3;MTFR1;SIRT3;ETFA;SDHA;COX15;UQCRB;COX10
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.2851491226980919,0.9564134266167377,0.5273264401772526,0.9640655773704143,1.0,13/72,7.51%,HSPA8;SHANK3;CLASP2;APOE;PFN1;CYRIB;CIB1;KANK3;PFDN6;FGF13;SSH2;CAMSAP2;PFDN5
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.28823019287169954,0.9562391898703707,0.5495495495495496,0.9636784194772878,1.0,7/63,13.01%,PTPRC;VAV3;TIRAP;IRS2;PNP;CD81;CD274
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3427750292707079,0.9559735160507657,0.5236427320490368,0.9627017592399776,1.0,9/23,20.97%,MAPK8;YWHAB;BAD;PPP3R1;YWHAH;YWHAQ;YWHAE;YWHAZ;TFDP2
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3427750292707079,0.9559735160507657,0.5236427320490368,0.9627017592399776,1.0,9/23,20.97%,MAPK8;YWHAB;BAD;PPP3R1;YWHAH;YWHAQ;YWHAE;YWHAZ;TFDP2
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.35805110084617225,-0.9549340269562866,0.5239179954441914,0.824619473791005,1.0,2/16,2.05%,DDX5;DDX17
prerank,platelet degranulation (GO:0002576),0.25827739956035267,0.9548216747824958,0.5185694635488308,0.9651937240355195,1.0,18/118,11.43%,ABCC4;CDC37L1;SOD1;PECAM1;MANF;NHLRC2;CYRIB;SELP;SELENOP;F8;ACTN4;VWF;LGALS3BP;LYN;GTPBP2;APP;A2M;OLA1
prerank,negative regulation by host of viral process (GO:0044793),-0.4109745760206121,-0.9548169718677147,0.532,0.824188656622102,1.0,3/10,27.69%,CCNK;PSMC3;ZC3H12A
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.38923285004052777,0.9546917505748582,0.5270758122743683,0.9646594218027245,1.0,4/15,15.57%,SYK;PNP;CD55;NKAP
prerank,regulation of interleukin-13 production (GO:0032656),-0.37851124139307746,-0.9546605699378499,0.5391120507399577,0.8238830274844625,1.0,4/13,13.39%,PRKCZ;RARA;TNFRSF21;IL18
prerank,keratinocyte differentiation (GO:0030216),-0.30337310369726334,-0.9539268366855336,0.5224215246636771,0.8251029780338944,1.0,5/29,11.85%,CLIC4;MED1;BCR;PIP5K1A;ANXA1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.37295565572484246,0.9535509405321044,0.527681660899654,0.9670100248685787,1.0,5/18,14.60%,HDAC7;HDAC9;CIB1;MAP3K3;PIK3C2A
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.3477753642345481,0.9535169337487178,0.5325131810193322,0.9662410731567376,1.0,6/24,16.78%,CXCL12;SIRT1;ING2;CCAR2;CD44;TMEM161A
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.35590266095957923,-0.9534372610734138,0.5344036697247706,0.8256513050394552,1.0,3/16,3.24%,OGT;AUTS2;RASGRF1
prerank,RNA 3'-end processing (GO:0031123),-0.2498851310934268,-0.9530615325160674,0.5487012987012987,0.8259212280196759,1.0,25/69,24.61%,SRSF5;SRSF11;PABPN1;CASC3;RPRD1B;SRSF2;SRSF6;LIN28B;SRSF1;POLDIP3;DDX39B;CSTF3;SYMPK;CSTF2;THOC5;SLU7;CDC40;RNPS1;CPSF3;SUPV3L1;EIF4A3;NCBP2;TUT1;THOC1;RBM8A
prerank,response to molecule of bacterial origin (GO:0002237),0.28553963270767213,0.9522284729408195,0.5300462249614792,0.9690502888643243,1.0,13/69,16.06%,TNFAIP3;TAB2;FCGR2B;TIRAP;CYRIB;SELP;ERBIN;IFNAR1;NOS3;OTUD5;GCH1;NOCT;PELI1
prerank,positive regulation of heart rate (GO:0010460),0.370351555132326,0.9521822134935554,0.5163043478260869,0.9683258004187555,1.0,3/17,10.54%,PDE4D;ATP2A2;TRPM4
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.3164605643126145,0.9519206544510801,0.5340136054421769,0.9681239705067329,1.0,6/33,12.91%,TAL1;ABCB10;RAB7B;MTURN;ACVR2A;PITHD1
prerank,regulation of fibroblast proliferation (GO:0048145),-0.2715756951255213,-0.9518127087252817,0.5447368421052632,0.8283708136281681,1.0,10/45,15.09%,IGF1;CTNNB1;PDGFRA;SKI;CDC73;CDK6;FN1;TP53;MED25;PEX2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.4140236455121962,0.9517724150198712,0.5412474849094567,0.9676861048551206,1.0,2/12,6.27%,SOAT1;LPCAT3
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.3447234509104291,-0.9516582053653695,0.5207877461706784,0.8280376475456147,1.0,8/17,27.58%,EMC7;CAMLG;SGTA;BAG6;EMC1;EMC8;EMC9;GET4
prerank,heterochromatin organization (GO:0070828),0.38711975677599936,0.951594801353149,0.5145631067961165,0.9673027765712712,1.0,4/14,15.04%,MECOM;SIRT1;HP1BP3;EZH1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.24562307464360314,0.9511936555676896,0.5798212005108557,0.9675556383633571,1.0,28/214,11.27%,MAP2K7;MAPK3;SEMA6A;PTPRR;ZDHHC17;SEMA7A;PIN1;PTPRC;TIRAP;PRKD2;APOE;TEK;PHB2;SPRED1;CIB1;ICAM1;SYK;HTR2A;CNKSR3;MTURN;NOTCH1;CCL25;CSF1R;LYN;MFHAS1;ATP6AP1;NPNT;APP
prerank,neuron remodeling (GO:0016322),-0.411384309250221,-0.9511426966815706,0.5108225108225108,0.8287001401442058,1.0,4/10,21.76%,ADGRB3;SCARF1;CX3CL1;EPHA8
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.25757839470765703,0.9511050558567323,0.5580774365821095,0.9669422269538487,1.0,24/140,12.28%,RAC2;TIAM1;VAV3;ARHGEF26;CHN2;SRC;MCF2L;ITSN1;ARAP2;CYRIB;ARHGAP25;ARHGEF6;ARHGEF7;TRIO;ARHGEF18;MYO9A;FAM13A;RHOQ;OPHN1;ARHGAP39;RHOG;A2M;ARHGAP23;MYO9B
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.2936106279263446,-0.9509916166305985,0.5347043701799485,0.8283421423484053,1.0,4/35,6.92%,MAGI2;PDGFRB;CRY2;HTT
prerank,regulation of neurogenesis (GO:0050767),0.2929715726375438,0.950963031524719,0.5297805642633229,0.9664566230266805,1.0,12/55,16.23%,HES6;HEY1;MME;B2M;HEY2;NOTCH1;PRUNE1;DOCK7;FAIM;HES1;HEYL;HOOK3
prerank,regulation of interleukin-12 production (GO:0032655),-0.27279683691640105,-0.9508465188712457,0.5319148936170213,0.8280058711790417,1.0,6/47,11.35%,FOXP1;MAPK14;PIBF1;IRAK3;THBS1;IL16
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3316565994963268,-0.9507449685690685,0.5233853006681515,0.8275407501569734,1.0,8/21,23.29%,MCU;PDZD8;MICU2;FIS1;AFG3L2;MCUR1;MCUB;ANXA6
prerank,regulation of cell development (GO:0060284),0.3149839298429345,0.9506246984714035,0.5460526315789473,0.9665927033206311,1.0,10/36,16.11%,HES6;HDAC9;HEY1;CLOCK;HEY2;PRUNE1;DOCK7;HES1;FBXO22;HEYL
prerank,epidermal cell differentiation (GO:0009913),-0.28161282901303514,-0.9505444194836714,0.5348258706467661,0.8273220825332628,1.0,6/41,6.02%,CLIC4;CTNNB1;HDAC1;MED1;BCR;PIP5K1A
prerank,regulation of regulated secretory pathway (GO:1903305),-0.28928032539785975,-0.9505129581920192,0.5484633569739953,0.8266690719705421,1.0,8/34,14.55%,RIMS1;SYT9;SYN1;GSK3B;SYT12;SYT11;SYT4;SYT7
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3365803959435882,-0.9502267695915483,0.5189309576837416,0.8266146915348992,1.0,13/18,43.67%,COX16;COX19;COX17;COX18;PET100;COX20;COX14;BCS1L;COA5;SCO1;COA3;SURF1;FASTKD3
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.38820457927985597,-0.9492884822273947,0.5182186234817814,0.8283692483159536,1.0,4/12,18.87%,SNAP25;STX3;STX1A;SNAP29
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.35543247473150774,0.9491751224550434,0.5341296928327645,0.969739047369473,1.0,3/23,10.72%,SAG;METAP2;METAP1
prerank,regulation of DNA replication (GO:0006275),0.3005168339425418,0.9490210293169441,0.5504885993485342,0.9692903228523516,1.0,11/49,13.81%,CTC1;BCAR3;ORC3;PPP2CA;RBBP6;FBXO5;ACVRL1;ESCO1;USP37;ANKRD17;FAF1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.4249965472925394,0.9488558960626067,0.5097276264591439,0.9689047180283208,1.0,3/10,10.09%,RAP2A;MYO9A;OPHN1
prerank,positive regulation of neuron differentiation (GO:0045666),-0.27732334036037853,-0.9483301299444331,0.5470297029702971,0.8300957321682103,1.0,9/40,16.72%,NRCAM;NBL1;BRINP1;RHOA;ZEB1;BRINP2;NGF;TCF4;GPRC5B
prerank,vasculogenesis (GO:0001570),0.3271788946276526,0.9480041792465816,0.5334507042253521,0.9704176717621351,1.0,6/32,8.94%,EGFL7;RAMP2;SPRED1;HEY2;NOTCH1;RASIP1
prerank,cognition (GO:0050890),-0.27801277257847135,-0.9477360293363909,0.5374331550802139,0.830916844678647,1.0,20/42,35.67%,GRM5;SOBP;TTC8;NIPBL;CUX2;CTNS;ST3GAL4;MAGT1;CHMP2B;DGCR2;LINS1;STRA6;FAM107A;CHRNA7;SLC1A4;MFSD2A;JAKMIP1;NSUN5;SLC8A2;METTL23
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.36894562039905693,0.9476613016829036,0.5308411214953271,0.9705221570832694,1.0,5/17,14.41%,CYCS;COX6B1;COX5A;COX15;COX10
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.2459098773226458,-0.9473257159344258,0.5709969788519638,0.8312159357500316,1.0,29/78,25.53%,SORBS1;LRP1;DAB2;EGFR;PID1;PPFIA1;MMP14;STX8;ZDHHC5;STX3;DPP10;EPHB2;EPHA3;CLIP3;DLG1;WNK3;TGFB1;TMBIM1;ZDHHC8;PIK3R1;VPS4A;APPL1;NKD2;CLN3;VAMP8;PLS1;AKT1;SPTBN1;BCL2L1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.42713315470175856,0.9472639996060697,0.5190839694656488,0.9707523802190373,1.0,4/10,18.79%,SSBP1;INO80;WIZ;ATRX
prerank,regulation of biomineral tissue development (GO:0070167),0.3451280775327322,0.9465492664494369,0.5517241379310345,0.9718854580535276,1.0,8/26,15.25%,HEY1;FBXO5;HEY2;NOTCH1;NOS3;NBR1;BMP2K;GAS6
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.24727186665694595,0.9461442125371666,0.5858064516129032,0.9721865836995419,1.0,36/190,13.40%,GSK3A;TRIB3;PTPRJ;PDE4D;TNFAIP3;BCL2L2;SRC;HDAC7;RFFL;IFI35;PRDM15;EPM2A;SPRED1;CYRIB;CIB1;AKT1S1;ARHGAP25;SIRT1;NLRC3;DAG1;PHLPP1;TSC1;RELA;LYN;MDM2;PRKAA2;ESR1;OTUD3;DDX3X;P2RX7;ADIPOR1;NF1;MAPKBP1;NDUFA13;PLEK;DDIT3
prerank,glycoprotein catabolic process (GO:0006516),-0.35096840175737726,-0.946081126539147,0.5221445221445221,0.8336985901246681,1.0,3/17,5.49%,ADAMTS12;NGLY1;ADAMTS9
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.39696183781867034,-0.9455034298082037,0.5273109243697479,0.8345193449459801,1.0,6/10,24.27%,DDX39B;CRY1;THOC5;WDR76;ETAA1;THOC1
prerank,regulation of endocytosis (GO:0030100),-0.2602072622485781,-0.945270017225071,0.5758513931888545,0.8343788294864573,1.0,22/61,21.58%,LRP1;DAB2;RUFY2;ARFGAP1;STON2;GPC3;ROCK1;ZFYVE16;STON1;EPHA3;RIT2;CLIP3;SYT11;HIP1R;SCAMP5;CBLL1;LRSAM1;ABL2;TSC2;PACSIN1;FLOT1;PRKD1
prerank,regulation of mitochondrial fission (GO:0090140),-0.31169221903806044,-0.9449924201031029,0.5296912114014252,0.8343637754012426,1.0,5/24,7.71%,MCU;SPIRE1;MAPT;STAT2;FIS1
prerank,cell-substrate junction assembly (GO:0007044),-0.2950810951000722,-0.9441679676618202,0.543859649122807,0.8357914245321157,1.0,7/33,11.11%,SORBS1;PLEC;BCR;PIP5K1A;CTTN;ACTN2;FN1
prerank,regulation of exit from mitosis (GO:0007096),0.31428263343204427,0.9441370274160907,0.5368248772504092,0.9769133758865007,1.0,7/38,12.43%,ANAPC2;PHB2;RGCC;ANAPC7;ANAPC11;ANAPC10;ANAPC4
prerank,response to interferon-gamma (GO:0034341),0.28262644332671244,0.9440805445408361,0.5552238805970149,0.976219371690589,1.0,8/67,9.09%,IFITM2;GBP3;GBP4;IFITM3;CCL25;WNT5A;IFITM1;CD47
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3029379305334699,0.9436568540157576,0.5544715447154471,0.9764788995570913,1.0,8/43,15.25%,CIDEA;TNFAIP3;NLRC3;VSIR;NFKBIL1;CD274;TRIM27;GAS6
prerank,myeloid leukocyte differentiation (GO:0002573),0.28473219709514025,0.9429952358568109,0.5204855842185129,0.9774212562294701,1.0,8/65,9.17%,MT1G;LEF1;SBNO2;CDKN1A;EP300;SIRT1;CDK4;CSF1R
prerank,regulation of T cell mediated immunity (GO:0002709),0.42949893551823454,0.9427836054909645,0.5339805825242718,0.9771634414619349,1.0,2/10,10.54%,TNFRSF1B;TRPM4
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3334640832021283,-0.9425748147928986,0.5202702702702703,0.8390458654165731,1.0,8/18,22.91%,ASPA;SLC25A13;MTHFR;MTHFD1;NAALAD2;SMS;GOT1;ASPG
prerank,cellular response to mechanical stimulus (GO:0071260),0.29826113283254624,0.9425720126985332,0.5287539936102237,0.9769004708469233,1.0,6/46,10.56%,MAPK3;TNFRSF10B;MAPK8;CRADD;F11R;BAD
prerank,aortic valve development (GO:0003176),-0.29149382011727704,-0.942536884830626,0.5470737913486005,0.8384092737292305,1.0,6/34,8.66%,ROBO2;ROBO1;BMP4;ROCK2;ROCK1;SMAD6
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.40848186215787746,-0.9423636936578345,0.5272373540856031,0.8381243583257496,1.0,5/10,31.61%,GFPT1;HK2;GFPT2;PFKM;PFKL
prerank,regulation of myoblast fusion (GO:1901739),-0.40273944653024596,-0.942181618991772,0.5498084291187739,0.8378943593237467,1.0,4/11,20.46%,CFLAR;MAPK14;EHD1;FLOT1
prerank,glycogen biosynthetic process (GO:0005978),0.41402391173874864,0.9420935049140673,0.5438931297709924,0.9765511394925779,1.0,4/12,15.56%,GYG1;NHLRC1;UGP2;PGM2L1
prerank,glucan biosynthetic process (GO:0009250),0.41402391173874864,0.9420935049140673,0.5438931297709924,0.9765511394925779,1.0,4/12,15.56%,GYG1;NHLRC1;UGP2;PGM2L1
prerank,positive regulation of DNA replication (GO:0045740),-0.3579961506050504,-0.9417597766456126,0.5773420479302832,0.8383221541128055,1.0,6/16,14.07%,EGFR;GLI2;KAT7;STN1;BRPF3;ATAD5
prerank,regulation of fibrinolysis (GO:0051917),-0.3732784133862492,-0.9413285164665651,0.5307855626326964,0.8387324114676422,1.0,2/13,9.67%,THBS1;FAP
prerank,regulation of autophagy (GO:0010506),0.24222620321384372,0.9404570150920722,0.5987179487179487,0.9802967531281969,1.0,57/216,18.94%,GSK3A;TRIB3;ATF6;EEF1A1;ACER2;TAB2;PLK2;RPTOR;EXOC8;SVIP;TRIM8;ATP6V1D;VPS29;VPS26A;ATP6V0D1;TRIM14;EP300;MAPK8;LAMTOR1;TAB3;DRAM2;ATP6V0E1;RASIP1;ZKSCAN3;PRKAA2;EIF4G2;BAD;CISD2;UBQLN1;BMF;TMEM59;TBC1D14;RRAGC;USP33;DDIT3;TLK2;TRIM27;CSNK2A2;PIK3C2A;ATP6V1B2;VPS35;TFEB;ATG13;DNM1L;BNIP3;UBQLN2;WDR41;DAPL1;PIP4K2A;STAT3;FOXK2;ATP6V1A;USP36;ULK1;MID2;SH3GLB1;EIF4G1
prerank,regulation of neuron differentiation (GO:0045664),-0.24471514342010636,-0.9404528757761795,0.5838150289017341,0.8402146439116625,1.0,12/76,9.11%,CNTN4;NRCAM;NBL1;BRINP1;BMP7;RHOA;MED1;ZEB1;ROCK1;BRINP2;NLGN1;BIN1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.3801770005540167,0.9404104303866906,0.5428571428571428,0.9795814926101225,1.0,1/16,1.01%,GSK3A
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3554021469760784,0.9403453278625513,0.5478723404255319,0.9788978115914888,1.0,2/21,4.13%,MAPK3;ZFP36L1
prerank,protein export from nucleus (GO:0006611),-0.3089328734994045,-0.9402199753280063,0.5775656324582339,0.8400664474880865,1.0,8/27,16.23%,RANBP3L;PKD1;XPO6;DUSP16;RANBP3;STRADA;NUTF2;TGFB1
prerank,Golgi to lysosome transport (GO:0090160),0.4163417073068063,0.9401189457090161,0.5363128491620112,0.9786602168803957,1.0,3/11,11.03%,SORT1;AP1G1;RBSN
prerank,tryptophan metabolic process (GO:0006568),-0.3963189365591394,-0.9400414105027167,0.5458333333333333,0.8398042353328615,1.0,2/11,17.82%,ATP7A;KYAT1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.38836116436348256,-0.9394780249301723,0.5571725571725572,0.8397974661770653,1.0,2/12,10.56%,FHL2;GSK3B
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.38836116436348256,-0.9394780249301723,0.5571725571725572,0.8397974661770653,1.0,2/12,10.56%,FHL2;GSK3B
prerank,entry into host (GO:0044409),0.3949276031640761,0.9394235634031848,0.5513833992094862,0.9797222761596677,1.0,2/13,3.25%,CBL;SRC
prerank,regulation of protein localization to membrane (GO:1905475),-0.30448782332234803,-0.9393418086114405,0.5558139534883721,0.8394418453074979,1.0,12/28,24.74%,GPC6;GSN;MMP14;GPC3;STX8;GPC5;VPS4A;GPC4;APPL1;CLN3;VAMP8;SPTBN1
prerank,multivesicular body organization (GO:0036257),-0.29189030378362124,-0.9391205089891181,0.5746268656716418,0.8392900532878846,1.0,10/31,22.03%,STAM2;IST1;SNF8;RAB11A;TSG101;CHMP2B;CHMP5;STAM;VPS4A;HGS
prerank,calcium ion transport into cytosol (GO:0060402),-0.3290518882429345,-0.9387284065674971,0.5509761388286334,0.839570098221401,1.0,2/21,1.54%,CACNA1C;GRIN2B
prerank,RNA metabolic process (GO:0016070),-0.22159583828320076,-0.9385645302768916,0.622568093385214,0.8392802779315263,1.0,30/127,15.32%,CELF2;RBMS1;BICD1;HNRNPH1;DDX17;PABPN1;ELAVL4;RBM39;RBMX;SYNCRIP;SNRNP40;DDX39B;RNGTT;DDX24;HNRNPA2B1;SIDT2;AGO3;HNRNPA1;RNASEH2B;RBM3;RBM4;ATXN1;TP53RK;SND1;POLR2A;DICER1;SETX;PABPC4;MTREX;RNASE3
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.3923973700033139,0.9382803473616241,0.5481481481481482,0.9820344135415074,1.0,3/14,8.56%,SEMA7A;SIRT1;WNT5A
prerank,regulation of protein secretion (GO:0050708),-0.22594082002636545,-0.9380498804485015,0.624561403508772,0.8398633841700438,1.0,34/119,26.16%,BMP6;IGF1;CACNA1C;ITPR1;SNAP25;CACNA1D;KCNC2;SERGEF;SLC12A2;PER2;DPP4;ENSA;EZR;STXBP5;PPID;UNC13B;SYT7;EXOC1;TGFB1;STX1A;KCNS3;CYP51A1;ITPR2;RHBDF1;P3H1;LLGL1;TGFB3;IER3IP1;UQCC2;ADRA2A;PICK1;APBB1;SYTL4;PPIA
prerank,anterior/posterior pattern specification (GO:0009952),-0.26289846927560384,-0.9379096828239398,0.5691489361702128,0.8395014166986007,1.0,9/53,8.39%,WLS;PCSK5;TGFBR1;HOXC6;HOXA3;HOXA5;SKI;LRP5;BHLHE40
prerank,DNA packaging (GO:0006323),0.37289698550811495,0.9378546579898487,0.5206766917293233,0.9822964667240589,1.0,4/16,18.84%,BANF1;AIFM1;RBBP4;HAT1
prerank,protein modification process (GO:0036211),0.27601505148989963,0.9376275896878793,0.5775075987841946,0.9820432254016068,1.0,22/76,18.51%,DUSP12;UBE2I;FBXW2;CSNK1G3;SLC35A1;PIGH;FBXO11;UBE2M;ICMT;YES1;PLAT;ST3GAL6;ADPRH;ST3GAL1;MSRA;QPCT;FBXO22;NTAQ1;PRKDC;LCMT1;SEPHS1;UBE2D3
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.33428574658783383,-0.9375334463408712,0.5292792792792793,0.8397079796054757,1.0,8/19,24.37%,ROBO1;XDH;CCBE1;SMOC2;ADAMTS3;JCAD;CADM4;DCN
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3462994751235497,0.9375264988407342,0.5357142857142857,0.981454646194688,1.0,6/22,13.92%,OCIAD1;NOTCH1;IL10RB;CYP1B1;MGAT5;HES1
prerank,positive regulation of mRNA processing (GO:0050685),0.35051341537456987,0.9374670740708967,0.5288135593220339,0.9807457477333661,1.0,2/21,0.93%,NCBP1;RBMXL1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.3548677667099794,-0.9373263845816804,0.5655172413793104,0.8395088894744555,1.0,5/15,10.64%,BMPER;FGF1;JAK1;ITGA5;PKM
prerank,mRNA export from nucleus (GO:0006406),-0.23315849449609216,-0.937009187477135,0.6289752650176679,0.8396272699229295,1.0,38/102,24.95%,SRSF5;SRSF11;PABPN1;CASC3;SRSF2;ALKBH5;SRSF6;NUP205;ENY2;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;NUP88;NUP93;DDX19B;SEH1L;THOC5;SLU7;DDX19A;CDC40;UPF1;RNPS1;NUP85;AAAS;RAE1;CPSF3;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.2988628003138883,-0.9369748361818653,0.5493975903614458,0.838984996433781,1.0,14/30,24.88%,OGT;WAC;FHIT;CAMLG;DDRGK1;TRIM39;MAP1A;USP7;SGTA;STYX;EIF3H;BAG6;UBXN1;NOP53
prerank,rRNA catabolic process (GO:0016075),-0.35012181901316664,-0.9367993749664735,0.5340425531914894,0.8387091147419306,1.0,9/16,34.82%,EXOSC10;DIS3L;DIS3;TRIR;EXOSC8;EXOSC2;DEDD2;EXOSC3;EXOSC5
prerank,GTP metabolic process (GO:0046039),0.38144506559278185,0.9365369316221234,0.5397412199630314,0.9824391256595925,1.0,3/15,12.36%,IMPDH1;RHOQ;EFL1
prerank,lipoprotein localization (GO:0044872),0.4157316690865569,0.936176811200112,0.5483271375464684,0.982658514880468,1.0,2/11,7.14%,ZDHHC17;VMP1
prerank,protein homotetramerization (GO:0051289),0.29615346431405287,0.9358839527594162,0.5721153846153846,0.9825729705852646,1.0,7/49,10.54%,THG1L;GLS;B2M;SSBP1;ACACB;SOD2;TRPM4
prerank,regulation of embryonic development (GO:0045995),0.3204161136929109,0.9356200389718389,0.5474209650582362,0.9824567512040704,1.0,12/34,19.65%,CLASP2;CFL1;TDG;DAG1;RAB14;PLCB1;ZBED3;SOX17;CLASP1;INSR;DHX36;POGLUT1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.354539228598801,-0.9350469857918867,0.5446985446985447,0.8424552149966162,1.0,3/15,8.46%,ATP1B1;ATP1A1;KCNJ2
prerank,regulation of mitochondrial depolarization (GO:0051900),0.41567163896881065,0.9346197532840671,0.5235294117647059,0.984448359481004,1.0,2/10,9.65%,SRC;FZD9
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2618955518651854,0.9343748668657577,0.5682451253481894,0.9842368249263029,1.0,16/91,11.90%,MAPK3;PTPRC;AP2S1;SRC;RAB5C;STXBP5L;RAB11B;RALA;SYK;SNX17;OPHN1;MBTPS1;SCFD1;RAB5B;SCARB1;PICALM
prerank,positive regulation of defense response (GO:0031349),-0.23282419286888884,-0.9343437470531942,0.6097560975609756,0.8435528048516273,1.0,28/89,29.26%,NAPEPLD;OPTN;PLSCR1;IL16;IL17RA;POLR3C;GPR4;IL18;IL33;TNIP1;NPAS2;LRSAM1;GPRC5B;GBP5;RIOK3;AGTR1;SLC15A4;CX3CL1;SETD4;PLA2G7;TLR3;FEM1A;SERPINE1;PDE2A;CCN4;MDK;SNCA;POLR3G
prerank,response to growth factor (GO:0070848),-0.2692320860127086,-0.9338913615232819,0.5815789473684211,0.8439810291397155,1.0,26/41,36.63%,TGFBR1;TGFBR2;CTNNB1;ACVR1;ACVR1B;RACK1;BMPR1B;TWF2;RPS6KB1;BMPR1A;CPNE3;BMPR2;EMD;AKT1;ERBB2;SFRP1;HDAC6;TBC1D7;NOS1;GATA6;SPHK1;PLK5;MAPK7;EPHA2;URI1;HTRA2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.2971179380556242,0.9337114503868297,0.5727411944869831,0.9852081056787199,1.0,9/48,12.95%,POLR1C;ACTB;EP300;POLR1G;ATAD2;WBP2;ATAD2B;SMARCD1;TBP
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3309264169106917,0.9336202365661029,0.5528169014084507,0.9845945953092116,1.0,6/29,13.10%,TTLL12;CDC37;CNOT7;WNT5A;USP18;NLRC5
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3804152105887333,-0.9335164602142193,0.5617977528089888,0.8442289291929488,1.0,3/13,6.03%,SLC4A10;SHISA9;SHISA6
prerank,regulation of gene expression (GO:0010468),0.2194187095620418,0.933354257116864,0.7239583333333334,0.9844464382957249,1.0,164/903,16.10%,TBX4;MAZ;CTCFL;MAPK3;GSK3A;ONECUT1;CAVIN4;TRAPPC2;FOXN2;EZH2;ZFAT;DIP2A;PIN1;LEF1;PTPRC;HES6;RPL23;GTF2IRD1;RPS6KA4;PDCL3;NWD1;HNRNPH2;SORT1;PCBP1;ATXN1L;STOX1;GABPA;BCL6B;RPS6KA5;SMAD1;PPP2CA;SBNO2;ZFP36L1;HNRNPAB;HEY1;NR5A1;RAMP2;APOE;PRDM4;MYBL2;SMARCA2;SOX2;HNRNPK;YY1;TRIM14;FAM50A;SPIN1;NPAT;CPSF4;EP300;RFX3;MAPK8;TDG;DTNBP1;NFX1;MED23;RPL5;TGFBRAP1;SRSF10;CALCOCO1;ACTR8;RO60;RGCC;CDK11B;RBM20;ZNF205;SFPQ;SIRT1;BMI1;ACTR5;DRAP1;CLOCK;RNF187;PFDN5;KDM6A;HEY2;YTHDC1;NOTCH1;CNOT7;CDK4;WNT5A;TOB2;NOVA2;SOX13;ACVRL1;TRAF3;RELA;NAB2;LYN;MARF1;PARK7;RNF6;CLDN5;TARDBP;VSIR;UBE2V1;CITED2;RYBP;PRKAA2;ING2;CCAR2;ESR1;TERT;SRPK2;DDX3X;RBPJ;NLK;P2RX7;HP1BP3;CREBBP;CARM1;NOS3;MATR3;AGO4;APP;PIK3CD;RPS3;PTBP1;JMJD1C;PICALM;PCBP3;CRKL;SP1;MZF1;CDH5;IRF2;CHD3;ERC1;NUP35;ACTA2;TRRAP;HDAC5;CHEK2;DDIT3;POGZ;ZKSCAN5;HCFC1;YBX1;TRIM27;RNF20;BAZ2A;NSD2;BACH1;FUS;VPS35;PRDM10;TERF2IP;GAS6;ATG14;MOV10;HNRNPL;NOCT;TFEB;TAF6L;NKAP;TRA2B;APBB2;TAF1;BCL6;BRAF;TDRD7;ID2;TCF7L1;TCF3
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.296420194475721,-0.9332708482649698,0.5483870967741935,0.8441408109047418,1.0,4/29,5.33%,NOTCH2;IGF1;RASGRF1;RELN
prerank,cellular response to retinoic acid (GO:0071300),-0.27224707473765614,-0.9327955512946651,0.5538461538461539,0.8446071646836673,1.0,12/42,17.63%,WNT5B;BRINP1;PTK7;BRINP2;SNW1;EPHA3;WNT9A;ATM;SETX;ABL2;FZD4;TWF2
prerank,positive regulation of cell migration (GO:0030335),0.2361218066820118,0.9323635955751461,0.6408977556109726,0.9863113456996744,1.0,39/253,12.63%,MAZ;SEMA6A;SEMA6D;SEMA7A;LEF1;PTPRC;TIAM1;PECAM1;CXCL12;SRC;CLASP2;INSL3;PFN1;SEMA3C;CIB1;RET;SEMA6B;ARHGEF7;FBXO5;ACTN4;RUFY3;NOTCH1;PLCG1;ITGA6;TJP1;SEMA4C;CSF1R;SOD2;PODXL;PAK1;VSIR;FLT1;PIK3CD;PPP3CA;CRKL;PLAA;MAP4K4;MGAT5;CDH5
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.38803149981190843,-0.9321533527743742,0.5717255717255717,0.8455103759128937,1.0,3/10,19.12%,ACTN2;WDR1;SEMA5A
prerank,maintenance of protein location in nucleus (GO:0051457),0.35012967434524683,0.9321367145084144,0.5240549828178694,0.986145463951457,1.0,10/20,21.81%,SYNE1;ARL2BP;PARK7;TAF3;RANGAP1;MORC3;SP100;BBS4;SKP1;SUN2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.36856809647372546,-0.9320852282016556,0.547085201793722,0.8449608885879434,1.0,4/14,18.55%,ERCC6;MMS19;ACTR2;PARP1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.29631528848333805,0.9314721378087142,0.5655608214849921,0.9871446531920484,1.0,12/52,13.86%,GSK3A;EXTL2;WFS1;ATP6V0D1;PDIA6;GOSR2;TPP1;HYOU1;HDGF;TATDN2;FKBP14;PDIA5
prerank,anion transmembrane transport (GO:0098656),0.27634197609607675,0.9313414215408105,0.5735735735735735,0.9866544566743555,1.0,17/67,17.21%,SLC7A8;SLC1A1;SLC36A4;SLC25A1;SLC3A2;LRRC8C;SLC1A2;SLC35A1;SLC35B1;SFXN1;SLC25A12;SLC35A3;SLC38A5;SLC25A21;SLC25A42;SLC25A38;SLC7A5
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.31893128946260174,0.9313105461044864,0.5581787521079258,0.9858994846045557,1.0,2/33,4.13%,LEF1;ZFP36L1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.38204179900901813,-0.9313063341170419,0.5534979423868313,0.8461831697144566,1.0,7/11,26.50%,OGFOD1;P4HB;P4HTM;EGLN3;P4HA2;CRTAP;EGLN1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.25012805423335543,0.9310934531234999,0.6108843537414966,0.9856358878673356,1.0,30/136,16.22%,HES6;TNFAIP3;NWD1;MAP2K5;PHB2;WFS1;CEBPG;PIM1;SMAD7;SIRT1;NLRC3;MTURN;ERBIN;TRAF3;RBCK1;NFKBIL1;ESR1;CYP1B1;PRNP;CHUK;NLRC5;DDIT3;NFKBIA;HES1;MAP3K10;GAS6;TAF1;ID2;HEYL;TAF3
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.3697167468616209,-0.9309450166774424,0.5577342047930284,0.8456648358921071,1.0,2/12,2.87%,EFNA5;FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.3697167468616209,-0.9309450166774424,0.5577342047930284,0.8456648358921071,1.0,2/12,2.87%,EFNA5;FBLN1
prerank,negative regulation of gene expression (GO:0010629),0.23182794852095137,0.9302499865138862,0.6289752650176679,0.9871139071850134,1.0,61/302,17.21%,CIDEA;ZC3H12D;ILF3;EZH2;DIP2A;PATL2;EED;FCGR2B;RPS6KA4;STOX1;HDAC9;RPS6KA5;NUDT12;APOE;YY1;NPTN;FXR1;PAIP2B;RGCC;RPS26;SIRT1;BMI1;HEY2;PPP1R11;NOTCH1;CNOT7;TSC1;ACVRL1;DXO;PARK7;CLDN5;TARDBP;CITED2;PRKAA2;ESR1;TERT;DDX3X;NANOS3;AGO4;APP;RPS3;PTBP1;PICALM;CRKL;PPHLN1;YBX1;TRIM27;CNOT1;TASOR;CAPRIN1;AEBP2;MOV10;NOCT;TAF1;ID2;RBBP4;N4BP1;CNOT10;TIPARP;CALR;SLC7A5
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.3850743547245942,0.9299738511430393,0.5695732838589982,0.9870599486237522,1.0,6/15,18.60%,GRM7;GRM3;HOMER1;DAGLB;GRM8;HOMER3
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.33139928139098984,-0.9298070058673693,0.5498938428874734,0.8478629604678414,1.0,8/19,22.30%,BMP6;ADAM19;AFDN;DENND6A;PTPRU;FLOT1;PPM1F;VEGFA
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.30778868345324145,0.9294866390461234,0.5634266886326195,0.9875597049699953,1.0,9/35,16.88%,SLC25A1;PPT1;ACAT1;FAR2;HMGCS2;PAM;BDH2;HPGD;ACACA
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.30404396577616644,-0.9287481647359684,0.5534441805225653,0.8498723861818306,1.0,2/26,0.72%,EYA2;EYA1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.33231575934883983,0.92858245909663,0.5578231292517006,0.9891461730330214,1.0,7/26,16.98%,FBXO5;ANAPC7;ANAPC11;ANAPC4;CUL3;NEK6;LCMT1
prerank,protein N-linked glycosylation (GO:0006487),0.27900719792945955,0.9279249773074467,0.5700934579439252,0.9900751314863349,1.0,10/66,13.43%,NUDT14;ALG6;ASGR1;ALG8;TMEM165;OST4;STT3B;MCFD2;MGAT5;ST3GAL1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.34269257292223376,0.9278145061341954,0.5486725663716814,0.9895343806607819,1.0,6/22,13.45%,PSMC4;MED12;PSMC2;ESR1;MED4;PSMC6
prerank,regulation of necroptotic process (GO:0060544),-0.3196954068332222,-0.9277519091554991,0.5525727069351231,0.8516021568610104,1.0,6/23,8.63%,CFLAR;OGT;CYLD;FLOT2;YBX3;BIRC3
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.3250666140274257,0.9271300295238518,0.5711864406779661,0.9905119974513661,1.0,8/29,14.34%,SHANK3;PFN1;CYRIB;KANK3;SSH2;TJP1;FKBP4;TWF1
prerank,regulation of phosphorylation (GO:0042325),-0.22356239977066789,-0.927115318828369,0.6551724137931034,0.8524644354651478,1.0,26/120,13.35%,PRKAG2;EGFR;GRM5;OGT;NRP1;BMP7;DSCAM;FER;PRKAG1;SIRT2;STAT2;BMP4;NUP205;ROCK1;LDB1;PML;NUP155;CDKN1B;NUP188;THBS1;FN1;ILK;NUP88;NUP93;FNIP1;SEH1L
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2718347716469368,0.9270756938517241,0.5948406676783005,0.9897883058161466,1.0,11/78,10.51%,ACTB;CDC37;CDK5RAP1;CCNH;CDKN1A;RGCC;GTF2H1;LATS2;CCNG2;TFAP4;BCCIP
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.40937088871378724,0.9267453243865459,0.5335968379446641,0.9898279362084389,1.0,2/10,8.36%,RUVBL2;RUVBL1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.29250126907275664,0.9265156728274175,0.5930599369085173,0.9896012686256012,1.0,10/47,12.48%,FRZB;CCDC71L;ZFP36L1;PPARD;PIM1;AAMDC;SOX13;TRPM4;CARM1;WDFY2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.39000219561743005,-0.926267390251113,0.5571725571725572,0.853922908984529,1.0,4/10,16.43%,PARP14;PIBF1;NF2;PTPN2
prerank,positive regulation of endocytosis (GO:0045807),0.2961890640888238,0.9261136457773902,0.590443686006826,0.9898806264498778,1.0,7/45,5.45%,CBL;PPT1;NEDD4L;SGIP1;APOE;HNRNPK;B2M
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.2756179687862196,-0.9260030607462153,0.5693430656934306,0.8538351457806238,1.0,15/39,28.14%,BMP6;MBP;WNK1;PPARA;CDH1;MYADM;NF2;PTK2;TGFB1;PPM1F;VEGFA;AKT1;NOTCH4;AKNA;BMP2
prerank,reticulophagy (GO:0061709),-0.3782532731818502,-0.9258642698888867,0.5506607929515418,0.8534616784668911,1.0,4/12,14.47%,ULK2;UFL1;DDRGK1;TEX264
prerank,regulation of actomyosin structure organization (GO:0110020),-0.36609343385399096,-0.925860926034773,0.5652173913043478,0.8527495609631062,1.0,5/13,17.35%,AKAP13;ROCK2;ROCK1;FHOD1;CDC42
prerank,positive regulation of apoptotic process (GO:0043065),0.23063338662903518,0.9258406761658754,0.6694214876033058,0.9897899006055374,1.0,58/293,16.61%,ERCC3;MAP3K11;ATF6;FRZB;TIAM1;SOD1;VAV3;PSEN2;ARHGEF26;MCF2L;ING4;ITSN1;TNFRSF10B;MAPK8;ARHGEF6;CRADD;ARHGEF7;TRIO;SIRT1;OMA1;ARHGEF18;ITGA6;LATS2;BCLAF1;FZD9;TFAP4;AIFM1;RYBP;ING3;CCAR2;BAD;SRPK2;DDX3X;CYP1B1;RPS3;ATG7;PRNP;BMF;IP6K2;BNIP3L;NF1;ING5;UTP11;DDIT3;DIABLO;FAF1;APC;PTPA;APAF1;MAP3K10;GNA13;TPD52L1;APH1A;BCL6;DNM1L;BNIP3;QRICH1;RASGRF2
prerank,cellular response to amino acid stimulus (GO:0071230),-0.2859596840054499,-0.9256286677317557,0.5544041450777202,0.8526017258470466,1.0,6/33,7.73%,CPEB4;CPEB1;CAPN2;KLHL22;CASTOR2;GLRA1
prerank,T cell homeostasis (GO:0043029),-0.3975908458847631,-0.9255338876363531,0.5483870967741935,0.8521096907796849,1.0,4/10,28.12%,PPP2R3C;AKT1;NCKAP1L;ZC3H8
prerank,regulation of MAP kinase activity (GO:0043405),0.2633289410119378,0.9255072510208547,0.6390870185449358,0.9898882336735494,1.0,6/92,1.51%,RGS2;PIK3CG;TRIB3;DUSP7;PTPRJ;EZH2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.30493616683544805,0.9253456988788386,0.5692307692307692,0.989492881305849,1.0,5/37,8.79%,ERCC3;ERCC4;POLK;POLD3;GTF2H1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.3748527947997573,0.9251997861064893,0.5499092558983666,0.9890193673923119,1.0,3/15,10.80%,ATF3;ZFAND1;DDX3X
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.2286364205662188,-0.924729782178957,0.6538461538461539,0.8534559133181546,1.0,18/98,13.20%,SORBS1;ANK3;LRP1;EGFR;CEMIP;AKT2;FIS1;ZDHHC5;STX3;EFCAB7;DPP10;EPHB2;EPHA3;TP53;CLIP3;DLG1;PDCD5;WNK3
prerank,regulation of actin filament bundle assembly (GO:0032231),0.33240497996264917,0.9247111371949494,0.5568760611205433,0.9895188891817241,1.0,4/26,8.86%,ALMS1;SHANK3;PFN1;TSC1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.368607023680411,0.9243530344686929,0.569811320754717,0.9896202046892649,1.0,5/17,13.20%,KLHDC10;SEMA4C;LYN;RNF13;MID1
prerank,regulation of inflammatory response (GO:0050727),0.23901899001044033,0.9238233490483412,0.6266149870801033,0.9901900645820566,1.0,26/190,13.90%,PIK3AP1;IL1R1;SEMA7A;TNFAIP3;BCL6B;BIRC2;IFI35;SBNO2;APOE;TEK;TNFRSF1B;SPATA2;LPCAT3;PPARD;NLRC3;WNT5A;RELA;CD47;PARK7;MFHAS1;NLRP6;APP;USP18;CDH5;PROC;NFKBIA
prerank,cell differentiation in spinal cord (GO:0021515),0.417756636254492,0.9236329211409867,0.5434343434343434,0.9898716172812687,1.0,2/10,10.16%,SOX13;ZC4H2
prerank,receptor metabolic process (GO:0043112),-0.25480812586081675,-0.9233927852389676,0.5902061855670103,0.8560540287092875,1.0,15/53,16.80%,LRP1;ARFGEF2;CALCRL;RAB31;GRK3;LGMN;ACKR3;UVRAG;SNX25;RAMP1;GRB2;DNM1;TGFB1;GRK4;EHD3
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.3752733963864908,0.9229870179806868,0.5745062836624776,0.9907989372079933,1.0,2/14,7.29%,PRKAR1A;SIRT1
prerank,angiogenesis involved in wound healing (GO:0060055),0.4048008600987216,0.9229243387934556,0.5508637236084453,0.9901321755265087,1.0,2/11,7.27%,PRCP;ADIPOR2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.25692164074190216,0.9226530167862833,0.6085753803596127,0.9900028202384208,1.0,31/119,17.22%,CISH;PIK3CG;PIK3C2G;MTMR14;EFR3B;SMG1;PIKFYVE;RAB14;PIGH;ARF1;INPP5D;PIGB;PI4KA;PIK3CD;PIK3R5;PGAP2;INPP4B;IP6K2;SYNJ2;RUFY1;PIK3C2A;IMPA1;PIGN;MTMR2;PIGU;MBOAT7;PLEKHA1;ITPKB;PIK3R4;PIP4K2A;PLEKHA3
prerank,glycolipid metabolic process (GO:0006664),0.2941393295215828,0.9226190013487121,0.6053459119496856,0.9892641619434331,1.0,11/47,16.11%,GLB1;SMPD4;ST6GALNAC3;ESYT2;FUCA1;UGCG;ST3GAL6;GM2A;ST8SIA6;CERK;GBGT1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.32601148809086217,0.9224576022770945,0.581981981981982,0.9888834106867488,1.0,4/24,8.15%,XRCC1;POLK;POLE;POLD3
prerank,icosanoid secretion (GO:0032309),0.3989409654508974,0.9222596381607644,0.564299424184261,0.9885891343640328,1.0,2/12,11.53%,ABCC4;PNPLA8
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3767902805790495,-0.9216591887648659,0.5618860510805501,0.8598054317780247,1.0,5/11,18.58%,DAB2;SORL1;EZR;PTPN23;MSN
prerank,positive regulation of superoxide anion generation (GO:0032930),0.3890225445784402,0.9215573828577873,0.5509803921568628,0.9895986078986178,1.0,2/13,6.70%,SOD1;SYK
prerank,regulation of autophagosome assembly (GO:2000785),0.3134617625684778,0.9214816281474543,0.5962837837837838,0.9889752428844042,1.0,15/33,21.39%,RALB;PIKFYVE;TBC1D12;SCFD1;ADPRH;FEZ2;TMEM39A;TBC1D14;RAB3GAP1;UBQLN2;PIP4K2A;SH3GLB1;RAB5A;LRRK2;PIP4K2C
prerank,membrane protein proteolysis (GO:0033619),0.3043754182700009,0.9212435584728694,0.580327868852459,0.9887290265560339,1.0,12/37,18.21%,PSEN2;RET;NAPSA;SPPL3;DAG1;RELA;MBTPS1;TMPRSS6;APH1A;MYH9;ADAM9;SPPL2A
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3299033170995815,0.9211353126920617,0.5797598627787307,0.9881792361004627,1.0,4/25,12.58%,MAP3K7;B2M;WNT5A;CD55
prerank,lipoprotein biosynthetic process (GO:0042158),0.40950612031042,0.9210841663592179,0.5561904761904762,0.9874785025373329,1.0,3/11,11.74%,APOE;UGCG;ATG7
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2920452742186604,0.9207027541725714,0.573268921095008,0.9877160661235918,1.0,9/48,16.27%,PTPRC;TTLL12;RFFL;CARD16;CNOT7;USP18;NLRC5;GAS6;OTUD4
prerank,regulation of macrophage differentiation (GO:0045649),0.37495305756827285,0.9205471882014682,0.5656192236598891,0.9873254521260133,1.0,1/15,0.75%,C1QC
prerank,positive regulation of metabolic process (GO:0009893),0.2577407805923125,0.9205086793934361,0.6144244105409153,0.9865990287508992,1.0,13/103,8.89%,ALMS1;UCP2;CAMK1D;HDAC3;TSHR;KDM3A;ELOVL6;BEND3;GATM;SYK;ADIPOR2;OMA1;ACACB
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.30820578762941103,0.9202679693029296,0.5494880546075085,0.9864267722692768,1.0,7/35,9.17%,PHPT1;TEK;RAPGEF3;F11R;TJP1;ESAM;CSF1R
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.3997129135140517,-0.9202176369030796,0.5670103092783505,0.8627313879946312,1.0,6/10,22.25%,OGT;SIRT7;SELENOS;USP7;ZNF692;DGKQ
prerank,mucosal immune response (GO:0002385),0.37178780564000863,0.9200937567329641,0.5881294964028777,0.9860549351330865,1.0,1/15,2.81%,IFNLR1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3210039474457423,-0.9200839311408545,0.5717592592592593,0.862351994414657,1.0,13/21,28.53%,CHSY1;VCAN;CSGALNACT2;CHST15;CHST11;UGDH;CSPG4;BGN;DCN;CHPF2;CHST3;CSPG5;CHST12
prerank,response to tumor necrosis factor (GO:0034612),0.26277832159542314,0.9199686821297907,0.5886524822695035,0.9855622277293435,1.0,13/91,12.87%,MAP2K7;SMPD4;ZFP36L1;GBP3;CIB1;SIRT1;CCL25;ERBIN;RELA;NPNT;RPS3;IKBKB;CHUK
prerank,"phagocytosis, engulfment (GO:0006911)",0.30689944421341003,0.9198015681931448,0.6061643835616438,0.9851886982594295,1.0,4/36,5.90%,RAC2;XKR8;FCGR2B;ARHGAP25
prerank,regulation of establishment of cell polarity (GO:2000114),0.3693310565029364,0.9197118781276293,0.5436720142602496,0.9846027782368497,1.0,7/16,18.22%,CYRIB;RIPOR2;KRIT1;RUFY3;CDH5;PTK2B;ARFGEF1
prerank,regulation of cell cycle (GO:0051726),0.23084505914804707,0.919447574448633,0.6694510739856802,0.9844927395190067,1.0,54/271,16.16%,DYNLT3;FBXL6;MECOM;CKS2;GAS2L1;PTPRC;RPL23;TTLL12;HIPK2;ING4;BIRC2;MYBL2;SOX2;CDKN1A;EP300;RGCC;CDK11B;CHMP1A;PRCC;FBXO5;SIRT1;NOTCH1;CDK4;TSC1;JUND;MDM2;RAD23A;FZD9;TFAP4;TARDBP;CITED2;EIF4G2;SRPK2;NEK7;NANOS3;CTBP1;WDR12;NBN;MAPK12;RRP8;ANKRD17;RPS15A;NEK6;MAP2K6;APC;HCFC1;RNF20;CSNK2A2;WHAMM;APBB2;ADARB1;HPGD;ID2;RBBP4
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.3656802615470774,-0.9194327381893593,0.5787234042553191,0.8633079106876752,1.0,3/14,6.97%,ZEB1;OSR1;XDH
prerank,microtubule nucleation (GO:0007020),-0.33069809600641303,-0.919259778185716,0.5801886792452831,0.8630228367908425,1.0,8/19,17.94%,TUBGCP4;CCDC57;GOLGA2;AKAP9;SLAIN2;TUBGCP6;RANBP9;NDE1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3379879864024222,-0.9192458094826806,0.593952483801296,0.862328628547441,1.0,6/17,24.21%,VIM;BMP4;WNT4;TGFB1;CREB3L1;TGFB3
prerank,snRNA transcription (GO:0009301),-0.242872692366111,-0.9190462248911251,0.6752136752136753,0.8620761906820046,1.0,41/70,33.07%,RPRD1B;POU2F1;ELL;PHAX;SRRT;USPL1;GTF2A1;CDK7;CCNT1;POLR2A;SNAPC3;TAF8;INTS10;INTS8;CCNK;INTS11;TAF6;CDK9;GTF2E2;NABP2;GTF2B;INTS7;SNAPC4;NCBP2;TAF13;POLR2K;INTS12;GTF2E1;INTS9;TAF11;POLR2H;INTS3;ZC3H8;NABP1;POLR2G;POLR2F;POU2F2;POLR2C;TAF5;GTF2F1;INTS1
prerank,regulation of vasculogenesis (GO:2001212),0.3781437356984041,0.9188432881391475,0.5746268656716418,0.9853508225705618,1.0,3/14,7.63%,HEY1;TMEM100;HEY2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2581934847996172,0.9185822116197013,0.6384839650145773,0.9852085857409567,1.0,25/94,18.70%,TRIB3;BCL2L2;HIPK2;TNFRSF10B;SCN2A;TNFRSF1B;CDKN1A;SELENOK;AIFM1;BAD;DDX3X;CYP1B1;CUL3;RRP8;CHEK2;DDIT3;DIABLO;APAF1;DNAJC10;BNIP3;QRICH1;PRKDC;BAX;GSKIP;HINT1
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.24753834661855104,-0.9185427844020333,0.6097560975609756,0.8626240018305016,1.0,11/62,9.85%,KMT2A;HDAC1;MEIS2;CBFB;HOXA5;CDC73;RBM15;THBS1;AGO3;RBBP5;CDK6
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.2974901571693855,0.9180511384927202,0.5908372827804107,0.9857662108287618,1.0,10/48,14.60%,HDAC7;HDAC9;PRKD2;CIB1;SIRT1;PLCG1;NOS3;SP1;MAP3K3;PIK3C2A
prerank,phosphatidylcholine metabolic process (GO:0046470),0.2719292835200536,0.9180482069816657,0.5847076461769115,0.9849542622964125,1.0,13/70,16.60%,LPCAT2;PLAAT3;DBI;LPCAT3;GPAT4;MBOAT1;SLC44A1;PNPLA8;CEPT1;ABHD4;CSNK2A2;MBOAT7;SLC44A2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.33665062873234086,0.9179903398437532,0.5974025974025974,0.9842854662320223,1.0,4/21,10.81%,STOX1;FBXO5;CDK4;RAD51B
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3355606370938162,0.9178297617722264,0.5580985915492958,0.9838695002524924,1.0,8/25,19.41%,SORT1;LEPROTL1;CHMP1A;CHMP2A;LAPTM4B;VPS4B;LEPROT;DENND10
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.27317018147147176,0.9177541484203067,0.6086286594761171,0.9832659657299851,1.0,21/69,19.58%,DERL2;YOD1;WFS1;FAM8A1;SGTB;TRIM25;AUP1;RHBDD2;ERLIN2;STT3B;UBQLN1;PSMC6;DNAJC10;UFD1;UBQLN2;DNAJB14;UBXN4;EDEM2;DNAJB9;DERL1;SEL1L
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.21585452552294018,-0.9174222134066544,0.6875,0.8647322356343191,1.0,16/142,10.71%,ATP1A2;LPAR1;CACNA1C;ADCY5;SMAD3;DLG4;TRPC5;PLCE1;PDGFRA;EDNRA;ADRA1B;FIS1;CCR9;TRPC1;PRKACA;ACKR3
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.37576560594928793,0.9173356452903644,0.556390977443609,0.9835279470284408,1.0,3/14,11.13%,UPP1;UPP2;ERH
prerank,microtubule polymerization (GO:0046785),-0.2969151668320342,-0.9171002921405437,0.5670886075949367,0.8647900479787763,1.0,10/28,13.34%,HDGFL3;MAPT;TUBGCP4;CCDC57;GOLGA2;AKAP9;SLAIN2;CKAP5;TUBGCP6;RANBP9
prerank,regulation of MAPK cascade (GO:0043408),0.24172881831929105,0.916867118438922,0.6507115135834411,0.9839736823860111,1.0,26/157,12.33%,MAPK3;ZDHHC17;PTPRJ;PTPRC;GREM1;BCAR3;PRDM15;TEK;SOX2;SPRED1;TBX1;RET;LAMTOR1;PAK3;SYK;ATP6AP2;DAG1;MINK1;PHLPP1;LYN;PAK1;P2RX7;FLT1;NBR1;NF1;MAP4K4
prerank,regulation of cilium movement (GO:0003352),-0.40040555719621,-0.9167434851492725,0.5411255411255411,0.8650001348804249,1.0,9/10,56.06%,CCDC39;DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,dendritic spine organization (GO:0097061),0.32629554738022065,0.91671526120007,0.5851979345955249,0.9835570956806996,1.0,7/26,12.26%,DIP2A;SHANK3;FYN;PAK3;ARF1;PRNP;ITGA3
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3064407482615179,-0.9163929732621697,0.5594405594405595,0.8651578619606136,1.0,4/22,10.56%,CNTN4;BMP7;MED1;GSK3B
prerank,intermediate filament organization (GO:0045109),-0.3322487131258215,-0.9161945779534827,0.5862068965517241,0.8649487335455431,1.0,10/17,44.05%,VIM;NEFL;GFAP;BFSP2;DES;PKP2;BFSP1;MTM1;DSP;TCHH
prerank,regulation of cell-matrix adhesion (GO:0001952),0.2772243142375677,0.9161494047524498,0.6023916292974589,0.9842805226080624,1.0,18/64,17.28%,LIMCH1;ACER2;SLK;CIB1;NEXMIF;PEAK1;MINK1;CCL25;TSC1;HOXA7;NF1;MAP4K4;PTPRA;SEMA3E;PTK2B;CDH13;CLASP1;CORO1C
prerank,regulation of cellular response to heat (GO:1900034),0.2652929576776292,0.9158553745637821,0.6093979441997063,0.9842393324867893,1.0,23/77,19.39%,MAPK3;HSPA8;RPTOR;AKT1S1;EP300;BAG1;NUP54;SIRT1;NUP50;CCAR2;CREBBP;FKBP4;NUP35;NDC1;CAMK2G;ATR;HIKESHI;NUP160;POM121;NUP42;YWHAE;NUP133;HSPB8
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.38598889403529857,-0.915759435048515,0.5723684210526315,0.865287495538637,1.0,4/11,13.86%,MPV17L;SLC30A10;PPARA;ABCD2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.3330288518626763,-0.9152990702008472,0.5625,0.8656577634451434,1.0,7/17,19.51%,PBX1;MAML1;NOTCH3;SNW1;PLXND1;MAML2;STAT1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.3628972542851259,-0.9151907323271363,0.5762004175365344,0.8652027577857843,1.0,4/13,13.42%,IGF1;GOLGA2;RAMP1;IL33
prerank,positive regulation of cell junction assembly (GO:1901890),-0.25732485421909457,-0.9151299052614228,0.6056338028169014,0.8646317407604365,1.0,12/56,12.29%,NRXN1;GRID2;EPHB1;NRP1;NLGN2;SYNDIG1;ROCK1;CLSTN2;NLGN1;EPHB2;CUX2;IL1RAPL1
prerank,UV protection (GO:0009650),-0.3964475822274046,-0.9150318849955286,0.6007984031936128,0.8641228314428534,1.0,3/10,8.37%,SCARA3;ERCC5;CAT
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.2470386579993862,0.9150078441383208,0.6524725274725275,0.9856271375692641,1.0,21/151,12.14%,MAP2K7;MAPK3;SEMA7A;PTPRC;TIRAP;PRKD2;APOE;TEK;PHB2;CIB1;ICAM1;HTR2A;MTURN;NOTCH1;CCL25;CSF1R;MFHAS1;ATP6AP1;NPNT;APP;CRKL
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.37381057545189955,-0.9149118796428891,0.5609243697478992,0.8636880965976155,1.0,8/12,32.79%,WAC;TP53;SDE2;FBXO31;CDK2;RPS27L;CCND1;PLK5
prerank,steroid catabolic process (GO:0006706),0.4103347394341275,0.9147560938952461,0.5441767068273092,0.985447895950233,1.0,2/10,13.07%,HSD17B11;YWHAH
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.21151436446402447,-0.9146215139931566,0.6973684210526315,0.8637068435402356,1.0,48/172,22.56%,PTPN13;PLD1;PLA2G4A;PLEKHA2;AGPAT4;ABHD5;PIK3C2B;MTMR7;PIK3C3;AGPAT5;PIP5K1A;DGKH;SACM1L;PIK3R3;VAC14;LPIN1;PLEKHA8;PLSCR1;PIP4K2B;MTMR12;HDHD5;PITPNM3;CHKA;AGK;PCYT1B;INPPL1;CDS2;SLC27A1;ETNK2;MTMR9;CDS1;PTDSS2;CRLS1;MTMR4;PCYT2;PGS1;ABHD3;INPP4A;GPD1L;LPCAT1;CPNE3;PIK3R1;SBF1;BMX;LPIN2;DGKQ;PIP5K1B;CHKB
prerank,receptor recycling (GO:0001881),-0.3857614370866597,-0.9144486152504673,0.5887265135699373,0.8634299137167442,1.0,8/10,37.77%,ARFGEF2;SORL1;EHD3;LMTK2;NSG1;PHETA1;PLEKHJ1;REP15
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.22263207596100248,-0.9143377069028719,0.6513409961685823,0.862986517906937,1.0,23/109,15.31%,PTPN13;PLA2G4A;PDGFRB;PLEKHA2;LPGAT1;PIK3C2B;MTMR7;PIK3C3;PIP4P2;PIP5K1A;SACM1L;PIK3R3;VAC14;PLEKHA8;PIP4K2B;MTMR12;PLCB3;PITPNM3;INPPL1;SLC27A1;MTMR9;CDS1;MTMR4
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.29099495934060726,0.9142212677512898,0.5583596214511041,0.986109783392587,1.0,19/45,20.75%,EIF2A;GEMIN5;YTHDC1;TSC1;METAP1;NANOS3;MATR3;APP;RBM4B;ATG14;TDRD7;LARP4;CYFIP1;RPL10;RC3H1;LARP1;EIF4E;MTPN;GCNT2
prerank,telomere maintenance via recombination (GO:0000722),-0.3884459251229788,-0.9140272381490684,0.6049382716049383,0.863035783191248,1.0,5/11,19.17%,SMC6;RAD50;TPRKB;RAD51D;NSMCE2
prerank,DNA duplex unwinding (GO:0032508),-0.25862961605301515,-0.9137942557053294,0.6441558441558441,0.8628855502486189,1.0,17/50,22.64%,DDB1;DDX1;DDB2;RAD50;MRE11;RPA1;UBC;ANXA1;PURA;MCM9;PARP1;XPC;BLM;SUPV3L1;RECQL;RTEL1;MCM6
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.34234750112629814,0.9134196439705247,0.576592082616179,0.9873423874014823,1.0,4/20,10.77%,TRIB3;PRMT3;ASXL3;ERLIN2
prerank,axoneme assembly (GO:0035082),-0.2870339240481412,-0.913205192800838,0.5886363636363636,0.8636438924624994,1.0,19/30,51.72%,DCX;SPAG1;TTLL3;CCDC39;CFAP74;RP1;TOGARAM1;SPAG16;GAS8;RSPH9;CFAP46;DNAAF3;LRGUK;DRC1;SPAG17;JHY;FOXJ1;CCDC65;DNAAF2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3182067026339353,0.9130073240242863,0.5704584040747029,0.9875393342335252,1.0,8/28,18.07%,SORT1;TNFRSF10B;CRADD;DDX3X;DIABLO;DELE1;BAX;GABARAP
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.33452709135953,0.9125478703215892,0.5864527629233511,0.9879038595165829,1.0,2/23,2.43%,SURF4;DERL2
prerank,cellular amino acid catabolic process (GO:0009063),0.26239658460539955,0.912460821457931,0.6097560975609756,0.9873402376172689,1.0,8/87,5.63%,AASS;BCKDHB;ALDH5A1;SLC25A44;GLS2;GLS;GOT2;ACAT1
prerank,lipid droplet formation (GO:0140042),0.4016671860974817,0.9124593013452422,0.5587121212121212,0.9865376474043694,1.0,4/10,20.57%,FITM2;AUP1;ZFYVE1;BSCL2
prerank,heart contraction (GO:0060047),-0.26780009843317854,-0.9115320567714824,0.6042780748663101,0.8671452102747528,1.0,3/41,4.07%,ATP1A2;ATP1B1;TPM1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.34806175796377625,0.9114024746023368,0.584070796460177,0.988411734407277,1.0,6/22,12.55%,RAP2A;GREM1;CALM3;DDX3X;RAP2C;NBN
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.3004221764516556,-0.9113339958239336,0.5910112359550562,0.8669284526057064,1.0,9/24,22.41%,ITGA5;NIBAN2;VTN;GRB10;TMEM204;NEDD4;CADM4;HGS;EMILIN1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.281871362496518,-0.9110896303370607,0.5824742268041238,0.8668445584149832,1.0,16/38,27.76%,OTUD7A;PPM1B;TLE1;PER1;PPM1A;TRIM39;RORA;TNIP1;USP10;TANK;RIOK3;STAT1;OTUD7B;TRIM59;ZC3H12A;RHOH
prerank,regulation of translation (GO:0006417),0.2379558334553964,0.910943823265508,0.6571798188874515,0.9887646833287966,1.0,56/173,21.43%,NCBP1;ILF3;PATL2;EIF2A;RPS6KA1;LARP4B;EIF3B;FXR1;RPL5;PAIP2B;GEMIN5;PYM1;CNOT7;EIF4H;TSC1;TSFM;EIF4G2;METAP1;DDX3X;NANOS3;APP;EIF4B;RPS3;YBX1;CNOT1;CAPRIN1;EIF5;RBM4B;UPF3B;LARP4;PRKDC;MTG2;CYFIP1;CNOT10;CALR;NPM1;EIF6;RPL26;RPL10;EIF4G1;MRPL13;DHX36;EIF3E;LARP1;MTIF2;METTL14;EIF4E;EIF1;MTPN;CNOT8;DDX6;TRAP1;EIF2AK4;GLE1;DHX9;GSPT1
prerank,regulation of protein localization (GO:0032880),-0.24368570061887482,-0.9105972706701588,0.6311475409836066,0.8673994778098908,1.0,17/58,21.09%,MAP2;UFL1;CSNK1E;DVL3;AFDN;RAB9A;DZIP1L;CTSD;DLG1;CAMK1;RACK1;KDM1A;DVL1;PARP1;TRIM5;PPM1F;VPS4A
prerank,regulated exocytosis (GO:0045055),0.23825703680631663,0.9105166357339923,0.6559139784946236,0.9890776665459258,1.0,25/173,11.43%,ABCC4;CDC37L1;SOD1;PECAM1;PPP3CB;MANF;SDF4;NHLRC2;RAB11B;SYNGR2;CYRIB;SELP;SELENOP;F8;ACTN4;VWF;RAB11FIP5;TMED10;LGALS3BP;RAB11FIP2;LYN;GTPBP2;APP;A2M;OLA1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.30825744733787896,0.9103999090253986,0.6026711185308848,0.988575536397745,1.0,2/33,3.56%,CBL;BCAR3
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.3435971363024122,-0.9096424268900473,0.5767543859649122,0.8690462569200298,1.0,3/15,6.18%,EGFR;TEC;DDR1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2426609663153746,-0.9093794299914532,0.632183908045977,0.8689747906792383,1.0,16/59,14.50%,TGFBR1;TGFBR2;WNK1;CDC42BPB;ROCK2;CIT;PRKCD;HIPK3;ROCK1;ACVR1;GSK3B;CAMK2D;HIPK1;ACVR1B;WNK3;MAP3K12
prerank,DNA metabolic process (GO:0006259),0.22999571259012921,0.9091554762222789,0.6930572472594397,0.9909085371197878,1.0,50/270,16.85%,ERCC3;ZRANB3;RAD18;TRIM28;CTC1;PNKP;ORC3;ERCC4;RAD1;XRCC1;POLK;TDG;POLE;CDC45;LONP1;DCLRE1B;ORC4;UBE2V2;POLD3;ACD;GTF2H1;POLA1;EXD2;MSH3;PARK7;TERT;SRPK2;RAD51B;SMUG1;HUS1;ORC2;TOP3A;KMT5B;PWWP3A;NBN;DOT1L;HELB;TRRAP;MPG;LTO1;FANCL;BACH1;INO80;TERF2IP;TOP1;ATR;ENDOV;ZNF445;PRKDC;SMARCAD1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.38684721486943574,-0.9088818368970021,0.6153846153846154,0.8694921790040537,1.0,3/10,18.74%,ACSL1;SLC27A1;RPS6KB1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.32528871758661554,0.908864988178552,0.5963455149501661,0.9908653765921522,1.0,6/23,11.09%,HDAC7;IFI35;NLRC3;RELA;DDX3X;ADIPOR1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.40647990560790337,0.9087514167787617,0.5780346820809249,0.990338572193636,1.0,2/10,5.71%,LRCH1;RIPOR2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.256546775352763,0.9087449333630586,0.6207906295754027,0.9895520917062144,1.0,14/95,13.01%,TNFAIP3;FCGR2B;TIRAP;SBNO2;TNFRSF1B;CYRIB;MAPK8;CARD16;WNT5A;RELA;NFKBIL1;PLAA;TNIP2;CD274
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.3494533063302142,-0.9080477199816596,0.577639751552795,0.8707661060847847,1.0,3/14,19.91%,OSMR;IL6ST;PTGS2
prerank,mRNA destabilization (GO:0061157),0.3011896836482943,0.9079321241098407,0.5786061588330632,0.9908960595295473,1.0,12/38,20.13%,ZC3H12D;ZFP36L1;TARDBP;TUT7;CNOT1;TUT4;MOV10;FTO;RC3H1;DIS3L2;DHX36;METTL14
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.3786331214084333,-0.9075389621172112,0.579064587973274,0.8712653907163305,1.0,3/12,10.62%,EPHB1;B4GALT6;EPHB2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.24647602732081758,0.9075165107730064,0.6413502109704642,0.9911818823112071,1.0,29/124,16.84%,ROPN1;FAM161B;PTPRM;KIFAP3;MANF;CFAP126;APOE;CNTNAP2;DTNBP1;TMEM108;TTC17;MAP4;ODF2;CSF1R;LGI1;LYN;OPHN1;DOCK7;FRY;APP;TBC1D24;PLEK;SNAPIN;TBC1D23;LRP12;PLEKHA1;BLOC1S5;FRYL;CYFIP1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.35998530424774317,0.9074967465160922,0.5850091407678245,0.9904357659911058,1.0,4/16,14.26%,APOE;TERT;SCARB1;GCH1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.35638373245978944,0.9074055493710433,0.581981981981982,0.9898605435207664,1.0,4/19,12.33%,PTPRJ;TEK;TSC1;MAP4K4
prerank,secondary alcohol metabolic process (GO:1902652),0.29886574505137103,0.907394703938864,0.6023890784982935,0.9890820629384784,1.0,7/42,12.69%,EBP;APOE;SOAT1;PPARD;OSBPL1A;NSDHL;LDLRAP1
prerank,primary neural tube formation (GO:0014020),-0.284225315258253,-0.9071486873014571,0.5517241379310345,0.8715254154945548,1.0,9/30,17.83%,LMO4;SKI;COBL;MTHFR;MTHFD1;PLXNB2;LRP6;TGFB1;TSC2
prerank,nuclear body organization (GO:0030575),-0.3731806977216988,-0.9069970339910415,0.5809128630705395,0.8711824464697826,1.0,5/12,17.04%,AFF2;PML;USPL1;USP50;HABP4
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.21688117040658936,0.906964424335223,0.7581344902386117,0.9893964183249123,1.0,99/572,16.22%,SOX30;LRRFIP1;ATF3;IRX1;MAZ;DCAF1;DACH1;AASS;ARID5A;KLF8;TRIB3;NR4A2;EZH2;RPL23;EED;JAZF1;GTF2IRD1;DMAP1;KLF2;DNAJA3;MAP2K5;HDAC9;BCL6B;HDAC3;HEY1;NEDD4L;SMARCA2;SOX2;YY1;WFS1;VPS72;UBE2I;IRF2BPL;BEND3;EP300;RPS14;NFX1;CNOT2;PPARD;ZNF205;SFPQ;UXT;SMAD7;SIRT1;BMI1;DRAP1;ZNF3;HEY2;NOTCH1;SAP130;EDNRB;EFNA1;SOX13;RELA;HOXA7;MDM2;TRPS1;ZKSCAN3;CIR1;CITED2;ESR1;THRB;RBPJ;CREBBP;CTBP1;ORC2;NFIC;HDGF;IFI27;N4BP2L2;MZF1;IRF2;CHD3;TGIF1;CTBP2;HDAC5;DDIT3;THRA;HES1;DR1;HCFC1;TRIM27;USP9X;CNOT1;E2F6;TMPRSS6;BACH1;EZH1;NKAP;TCERG1;TAF1;ELK4;BCL6;TRIM33;SMARCA4;ID2;TCF3;ZBTB18;TAF3
prerank,regulation of myoblast differentiation (GO:0045661),0.30689441371151166,0.9069595176308008,0.5935483870967742,0.9886033831644765,1.0,5/32,9.59%,XKR8;ZFP36L1;RIPOR2;NOTCH1;PLCB1
prerank,cellular response to starvation (GO:0009267),0.24432960041854832,0.906934350255017,0.6470588235294118,0.9878660480935774,1.0,38/147,19.06%,MAPK3;RALB;GAS2L1;MAP1LC3B;HSPA8;EIF2S1;RPTOR;ATP6V1D;ATP6V0D1;XPR1;CDKN1A;MAPK8;LAMTOR1;SIRT1;ATP6V0E1;NIM1K;PRKAA2;ATG7;LARS1;RRAGC;RRP8;USP33;ATP6V1B2;ATG14;TFEB;GABARAPL1;KPTN;SESN3;PIK3R4;ZFYVE1;DAPL1;BECN1;ATP6V1A;GABARAP;SH3GLB1;LAMP2;NUAK1;SESN1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.2505345335215144,0.9067129658170789,0.636896046852123,0.9876552646453736,1.0,9/110,6.34%,PTGER2;ADGRE1;ADGRL4;GNAQ;ADGRL3;TSHR;RAMP2;GNB1;RXFP1
prerank,polarized epithelial cell differentiation (GO:0030859),0.3839083962137404,0.9064852205914418,0.5623800383877159,0.9874249989946305,1.0,4/13,14.05%,RAP2A;MYO9A;OPHN1;ZDHHC7
prerank,regulation of exosomal secretion (GO:1903541),-0.3243356767007346,-0.9062050883392655,0.5809312638580931,0.8724239585808599,1.0,7/19,22.03%,ATP9A;SMPD3;SNF8;TSG101;STAM;VPS4A;HGS
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.2804897005392609,-0.9055529825792861,0.6247030878859857,0.8733330328055324,1.0,6/31,12.78%,PACRG;BAG3;RHBDD1;OPTN;HSF1;TM7SF3
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.2718728503165764,-0.9054957886262656,0.6253369272237197,0.8727508406903872,1.0,12/36,22.53%,CYLD;TAOK3;EZR;PER1;SIRPA;DLG1;FKTN;DACT1;PTPN22;PINK1;SH3RF2;DUSP1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.3987652215383345,0.9054171395702435,0.5923694779116466,0.9894090568685501,1.0,2/10,4.90%,PTPRJ;PTPN12
prerank,gliogenesis (GO:0042063),-0.3430992169246027,-0.9054146463523511,0.6203090507726269,0.87224259513107,1.0,4/15,11.85%,NFIB;RELN;CDK6;ANXA1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.35625864201238294,0.9053388990542572,0.5798165137614679,0.9888119858315697,1.0,5/17,15.22%,TDG;ACD;SMUG1;MPG;TERF2IP
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.29249841430135637,0.9050674910428925,0.6262295081967213,0.988754923586633,1.0,5/41,10.28%,CIDEA;TNFAIP3;NLRC3;VSIR;NFKBIL1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.24934757725320136,-0.9042646342580846,0.6540697674418605,0.8743488904063053,1.0,16/55,19.93%,PDGFRB;MAPK14;PID1;TGFBR2;SIRT2;AATF;XDH;THBS1;TP53;GRB2;MPV17;ARF4;SIRT5;AGTR1;SLC25A33;PINK1
prerank,negative regulation of type I interferon production (GO:0032480),-0.27028444079275127,-0.9040471571079401,0.6151832460732984,0.8741796488068498,1.0,12/40,13.01%,CYLD;PTPRS;PPM1B;ILRUN;TAX1BP1;IFIH1;RNF135;REL;IKBKE;NPLOC4;SIRPA;RELB
prerank,regulation of RNA metabolic process (GO:0051252),-0.24815721616390193,-0.9037884374701278,0.6486486486486487,0.8740724396363608,1.0,7/59,4.72%,HNRNPH1;SNRNP70;AHNAK;SON;AFF2;CLK4;MED1
prerank,autophagosome organization (GO:1905037),0.28825444898358565,0.903624208945182,0.6159874608150471,0.9916727629522306,1.0,18/50,18.80%,MAP1LC3B;ATP2A2;RAB7A;RAB43;VMP1;RAB1A;UBQLN1;ATG7;ATG16L1;ATG14;TMEM41B;GABARAPL1;ATG13;TP53INP2;UBQLN2;BECN1;GABARAP;ULK1
prerank,negative regulation of defense response (GO:0031348),-0.2321496618098225,-0.902949502436891,0.6586102719033232,0.8754666237783616,1.0,17/77,17.42%,LRFN5;PPM1B;SIRT2;ILRUN;PRKCD;PPARA;PTGIS;IRAK3;TRAFD1;OTULIN;SIRPA;RORA;SELENOS;CCN3;PTPN2;ENPP3;TNFAIP6
prerank,lipid modification (GO:0030258),0.3011249536641466,0.902812382560123,0.5943238731218697,0.992995500145883,1.0,6/37,8.19%,DGKB;PLPP6;LPCAT3;PLPP1;MBOAT1;SGPP2
prerank,response to progesterone (GO:0032570),0.3573315959762847,0.9027728087611049,0.5948905109489051,0.9922915240334506,1.0,3/18,10.40%,SRC;UBE3A;WBP2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3468791821699936,0.902637675574433,0.6070175438596491,0.9918420051538942,1.0,5/21,16.34%,MAPK3;CSF1R;MTUS1;AKIRIN1;PTK2B
prerank,regulation of tumor necrosis factor production (GO:0032680),0.25012026131512555,0.9025339377370958,0.6522988505747126,0.9912925421680774,1.0,12/112,11.27%,CIDEA;PTPRJ;PTPRC;TNFAIP3;TIRAP;SYK;NLRC3;WNT5A;CD47;VSIR;NFKBIL1;APP
prerank,negative regulation of myotube differentiation (GO:0010832),0.38095790809983743,0.902509322675069,0.592391304347826,0.990563928010327,1.0,4/12,13.21%,HDAC3;BDNF;NOTCH1;HDAC5
prerank,regulation of cellular component organization (GO:0051128),0.24468477189455587,0.9023472805078511,0.6720430107526881,0.9902071822282666,1.0,20/135,11.90%,CISH;HSPA8;AP2S1;RPTOR;RAB5C;LTBP4;APOE;LAMTOR1;CDK11B;CAMSAP2;HJURP;SNX17;SETD5;WNT5A;TJP1;PARK7;OPHN1;EGLN2;RAB5B;PICALM
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.2645021479851035,-0.9022883719147079,0.6273458445040214,0.8764241856056822,1.0,15/40,26.65%,PID1;MAPT;VCP;AKT2;SPART;SLC25A36;ATP5IF1;SLC25A33;PINK1;BCL2;STOML2;AKT1;BCL2L1;PRDX3;RNF122
prerank,protein lipidation (GO:0006497),0.2792088975852016,0.9022648977710449,0.6273006134969326,0.9896079528604189,1.0,14/59,16.30%,ZDHHC17;ZDHHC13;UGCG;ZDHHC14;SELENOK;PIGH;ZDHHC15;PIGB;ATG7;PGAP2;ZDHHC9;ZDHHC7;PIGN;PIGU
prerank,positive regulation of viral transcription (GO:0050434),0.32978032697727844,0.9021979797237245,0.6031746031746031,0.9889631461365089,1.0,2/25,2.00%,POLR2J;POLR2B
prerank,tube closure (GO:0060606),-0.2816811601882269,-0.9020488828537042,0.5703517587939698,0.8762547275738867,1.0,9/31,17.83%,LMO4;SKI;COBL;MTHFR;MTHFD1;PLXNB2;LRP6;TGFB1;TSC2
prerank,positive regulation of DNA recombination (GO:0045911),-0.2920184961650921,-0.901615340546878,0.601965601965602,0.8765348136207246,1.0,7/27,19.21%,ERCC6;PAXIP1;SHLD1;MMS19;ACTR2;PARP1;RIF1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.332393550361042,0.901604005244159,0.5926573426573427,0.9897048929020886,1.0,3/22,6.91%,DUSP7;PPP2CA;PPP2CB
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.3567585528946886,-0.9014993321095474,0.5778251599147122,0.8761213513155663,1.0,3/13,13.39%,AXL;ZBTB1;IL18
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.38991618253139726,0.9012062047979452,0.5992141453831041,0.9899372790040394,1.0,3/11,15.25%,CXCL12;MERTK;GAS6
prerank,mononuclear cell differentiation (GO:1903131),0.325741664705152,0.9011250558411849,0.6089965397923875,0.9893575872486222,1.0,3/24,9.31%,MT1G;CSF1R;LYN
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.22867923157766168,-0.9007665143493923,0.691131498470948,0.8771394869406965,1.0,34/85,26.76%,DAB2;HECTD1;RNF14;SIRT2;RCHY1;NUPR1;USP13;VCP;CSNK1A1;CSNK1E;GSK3B;TMEM259;DDRGK1;RACK1;RNFT1;RNF19B;KEAP1;DVL1;SOCS5;USP5;STUB1;OSBPL7;PSMC5;DNAJB2;PSMC3;ARIH2;SH3RF2;BAG6;NKD2;NOP53;RNF185;RNF144A;HSPBP1;DDA1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.3823983986885403,-0.9007240492225713,0.5826446280991735,0.8765557321184818,1.0,4/10,11.95%,RARB;SNW1;RXRA;RARA
prerank,regulation of protein ubiquitination (GO:0031396),0.24831794166794172,0.9005193495496717,0.6474719101123596,0.9901284116782246,1.0,18/108,11.52%,GSK3A;TNFAIP3;PRMT3;BIRC2;HDAC3;UBE3A;WFS1;PTTG1IP;FOXF2;SMAD7;IVNS1ABP;AXIN1;SPRTN;MYCBP2;PARK7;SPOPL;UBQLN1;RPS3
prerank,positive regulation of cell population proliferation (GO:0008284),0.2170711317976134,0.9002756959357077,0.7437070938215103,0.9899318848788201,1.0,60/423,13.08%,MAZ;ROMO1;EZH2;LEF1;PTPRC;ACER2;TIAM1;RPL23;DERL2;PRKCH;GREM1;CRLF1;STOX1;MCTS1;TBC1D8;NME1;TSHR;SLC35F6;MEIS1;SINHCAF;CIB1;CDKN1A;TBX1;CHTOP;FBXO5;PIM1;SIRT1;BMI1;RNF187;IRS2;NOTCH1;CNOT7;CDK4;WNT5A;TJP1;RELA;CD47;CSF1R;LYN;MDM2;FZD9;PAK1;CLDN5;ESM1;TRPM4;BAD;TERT;SRPK2;RPS9;CD81;RBPJ;RHOG;FLT1;ACER3;CRKL;PRKCI;DHPS;DOT1L;CUL3;CNOT6
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.3861376264061933,0.9002403059938611,0.6003717472118959,0.9892349028767826,1.0,3/12,10.75%,GAS2L1;LMO2;THRB
prerank,regulation of water loss via skin (GO:0033561),0.36799322754414415,0.900187515083213,0.6179159049360147,0.9878052479543711,1.0,3/15,13.39%,UGCG;HRNR;LSR
prerank,establishment of skin barrier (GO:0061436),0.36799322754414415,0.900187515083213,0.6179159049360147,0.9878052479543711,1.0,3/15,13.39%,UGCG;HRNR;LSR
prerank,negative regulation of defense response to virus (GO:0050687),-0.38734790687264425,-0.8996807034971088,0.6142241379310345,0.8782706068201405,1.0,2/10,5.90%,PPM1B;ILRUN
prerank,synaptonemal complex organization (GO:0070193),-0.3364151730614473,-0.8996229519124171,0.5689655172413793,0.8769870689152709,1.0,12/15,64.38%,BAG6;RAD21;P3H4;TEX11;REC8;TRIP13;SYCE2;TEX12;STAG3;SYCP2;RAD21L1;HORMAD1
prerank,synaptonemal complex assembly (GO:0007130),-0.3364151730614473,-0.8996229519124171,0.5689655172413793,0.8769870689152709,1.0,12/15,64.38%,BAG6;RAD21;P3H4;TEX11;REC8;TRIP13;SYCE2;TEX12;STAG3;SYCP2;RAD21L1;HORMAD1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.35657920977803137,-0.8995374373267782,0.5680345572354212,0.8764975912496071,1.0,9/13,45.22%,SERTAD2;ARID1B;PADI2;SERTAD1;ZMIZ2;ELOF1;SPI1;CDCA4;CHEK1
prerank,response to gamma radiation (GO:0010332),-0.30451619769107063,-0.8994257502848059,0.6377171215880894,0.8760609339782954,1.0,15/24,40.93%,MAP3K20;TP53;HSF1;ATM;KDM1A;CRYAB;TMEM109;YAP1;PRKAA1;MEN1;DCUN1D3;TRIM13;HRAS;TSPYL5;FANCD2
prerank,response to thyroid hormone (GO:0097066),0.3769215917237455,0.898823829704813,0.6081330868761553,0.9904808586989818,1.0,3/13,10.75%,GAS2L1;LMO2;THRB
prerank,regulation of membrane repolarization (GO:0060306),-0.3597161830843679,-0.8987829601310412,0.5852631578947368,0.8769320018164923,1.0,3/13,8.46%,AKAP6;AKAP9;KCNJ2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.33885324567415676,0.8987688100997686,0.6021314387211367,0.9890497457420812,1.0,3/21,8.79%,ERCC3;ERCC4;GTF2H1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.33885324567415676,0.8987688100997686,0.6021314387211367,0.9890497457420812,1.0,3/21,8.79%,ERCC3;ERCC4;GTF2H1
prerank,regulation of JUN kinase activity (GO:0043506),0.30853152115264126,0.8984915971017354,0.615,0.9889725584545824,1.0,7/33,14.82%,MAP3K11;MAP3K7;MAP3K4;PAK1;RPS3;AIDA;MAP3K10
prerank,regulation of histone modification (GO:0031056),0.3766471078918432,0.8983849620803942,0.5714285714285714,0.9884802595927387,1.0,4/13,9.85%,HPF1;SETD5;PARK7;AKAP8L
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3112932356996448,0.8983095419498344,0.6234676007005254,0.9879074844016998,1.0,8/28,17.79%,TRIB3;TNFRSF10B;SELENOK;AIFM1;DDIT3;DNAJC10;QRICH1;BAX
prerank,positive regulation of cellular component organization (GO:0051130),0.2499681758457147,0.8980352525846973,0.6623931623931624,0.9878292276258555,1.0,26/107,17.79%,SURF4;TAL1;SLF1;ANAPC2;SHANK3;TIRAP;NEDD4L;APOE;ICE1;SYK;RAPGEF3;PARK7;RPS3;BMF;CDH5;FAF1;ATP10A;ASAP1;ADGRL1;LRP4;BNIP3;SLF2;WARS1;INSR;TMEM30A;BAX
prerank,negative regulation of developmental process (GO:0051093),-0.23441297011177972,-0.8979738446542104,0.6711409395973155,0.8781361335686027,1.0,12/69,9.85%,DCC;NFIB;PTPRS;MAPT;BMP4;ROCK2;ROCK1;FOXC1;ANP32B;BCL11A;HUWE1;CDK6
prerank,calcium ion homeostasis (GO:0055074),-0.22089562963155732,-0.897595143262695,0.729483282674772,0.8783503052206922,1.0,7/95,3.53%,ANK2;SLC24A3;HTR2C;STIM2;ATP1B1;STIM1;ATP13A5
prerank,response to purine-containing compound (GO:0014074),-0.3254465805098834,-0.8974302534945884,0.613882863340564,0.878018199784618,1.0,9/17,40.76%,P2RX4;ABCC9;STAT1;DGKQ;TRPC3;P2RY1;TRPM2;P2RY6;VGF
prerank,actin filament network formation (GO:0051639),0.4013392374978419,0.897389590127683,0.5873320537428023,0.9886700542542892,1.0,1/11,0.56%,LCP1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.26212676544829583,0.8973020373323795,0.6255639097744361,0.9881271803079582,1.0,11/70,11.88%,GSK3A;BCL2L2;SORT1;TNFRSF10B;TNFRSF1B;CIB1;CRADD;BAD;DDX3X;P2RX7;IFI27
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.35690740595040593,0.8971944765210974,0.6057866184448463,0.9876181356565373,1.0,5/16,18.52%,CXCL12;CCAR2;RPS3;TMEM161A;FBH1
prerank,cellular response to purine-containing compound (GO:0071415),-0.3838925820218726,-0.8969073054209578,0.5995717344753747,0.8784312275168886,1.0,6/10,41.44%,RYR3;P2RY1;GSTM2;TRPM2;P2RY6;CASQ2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.281176274121976,-0.8968113575468298,0.6375321336760925,0.8779233552862687,1.0,14/30,27.39%,PARP14;PIBF1;PRKCZ;PRKCD;SRCIN1;SEMA4D;NF2;PTPN2;CADM4;SH3BP5;SH3BP5L;DMTN;SFRP1;INPP5F
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3100968689711702,-0.8964050948308554,0.625,0.8781814878209678,1.0,6/22,16.60%,TAFA1;TOX;APPL2;KDM1A;SLC16A2;NES
prerank,response to interferon-beta (GO:0035456),0.32566123873255126,0.8961774065400967,0.6228070175438597,0.9894527145625246,1.0,5/22,13.09%,IFITM2;XAF1;IFITM3;IFITM1;NDUFA13
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.33954684309571914,0.8955850944628174,0.6059479553903345,0.9901386069237905,1.0,4/19,11.58%,RPTOR;ICE1;NAB2;POLR3F
prerank,positive regulation of angiogenesis (GO:0045766),0.25186041303355144,0.8954434343362543,0.6605890603085554,0.9897142796894307,1.0,19/108,12.63%,JMJD8;PDCL3;HIPK2;PRKD2;SMAD1;RAMP2;TEK;RAPGEF3;SIRT1;PLCG1;WNT5A;TJP1;TIE1;CYP1B1;FLT1;NOS3;PIK3CD;SP1;CDH5
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.26075626949473074,-0.8952036388960487,0.6464646464646465,0.8802812660563706,1.0,6/46,6.34%,PLD1;PLA2G4A;AGPAT4;ABHD5;AGPAT5;DGKH
prerank,lytic vacuole organization (GO:0080171),0.3025101661875234,0.8946979560001366,0.6120996441281139,0.9908769224746192,1.0,10/32,16.65%,LAMTOR1;TPP1;AKTIP;ZKSCAN3;MBTPS1;CLVS1;SNAPIN;TFEB;HOOK3;VPS18
prerank,regulation of wound healing (GO:0061041),-0.25879527368479854,-0.8942613520676028,0.640506329113924,0.8818973718582274,1.0,16/42,31.78%,OCLN;SRSF6;VTN;EPHB2;ANXA1;PTK2;AJAP1;CD109;CADM4;ADRA2A;DMTN;SERPINE1;HBEGF;MYLK;CLDN1;CAV1
prerank,positive regulation of peptidase activity (GO:0010952),-0.31269495722679563,-0.8940600010899838,0.6160919540229886,0.881638275553681,1.0,11/20,34.71%,VCP;DDRGK1;RCN3;TANK;PINK1;APH1B;PSME2;PSME3;PSME1;PRELID1;PSENEN
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.3886698218112508,0.893544197790745,0.5597609561752988,0.993030898057305,1.0,3/11,19.80%,SIRT1;HDAC2;XBP1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3289317721886359,0.8933910300033965,0.6129597197898424,0.9926431115209016,1.0,4/24,9.76%,TXNDC12;WFS1;LPCAT3;PARK7
prerank,zinc ion transport (GO:0006829),-0.3083574107978435,-0.8933879022396948,0.6197183098591549,0.8824961125196646,1.0,8/21,25.23%,SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC39A8;SLC39A7;SLC39A6;SLC30A5
prerank,regulation of protein kinase A signaling (GO:0010738),-0.3137766611968118,-0.8929773808934709,0.6043956043956044,0.8827323844064975,1.0,3/20,4.28%,AKAP6;AKAP12;ADGRV1
prerank,negative regulation of platelet activation (GO:0010544),0.3533547103448614,0.892861301529627,0.6194690265486725,0.9931741092343522,1.0,6/16,20.78%,PRKG1;APOE;NOS3;CD9;THBD;PDGFB
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.33789210969137307,0.8927042818128245,0.5989110707803993,0.9927960783205106,1.0,5/21,15.56%,TALDO1;RPIA;GPI;PGLS;PGM2L1
prerank,RNA processing (GO:0006396),0.23758047089594553,0.8915760145006876,0.69375,0.994909063412805,1.0,50/176,17.93%,SNRPD2;NCBP1;FASTKD2;PRPF3;SNRPD1;DDX54;PPP2CA;HNRNPK;PPIG;TENT4A;USB1;SFPQ;HNRNPC;IVNS1ABP;ADAR;SF3B3;SRSF4;YJU2;PRMT9;SF3A1;XRN2;RSRC1;AKAP8L;TARDBP;U2AF1;CPSF6;DUSP11;CCAR2;SRPK2;ADARB2;PTBP1;TUT7;RRAGC;SRSF7;USP39;FUS;TUT4;HNRNPL;TCERG1;ADARB1;TSEN2;DKC1;U2AF2;LSM1;NONO;SNRPA1;HNRNPF;DHX8;DDX23;PRPF18
prerank,substrate-dependent cell migration (GO:0006929),0.36565499308357874,0.891563356456373,0.6070763500931099,0.9941696901049182,1.0,5/14,16.83%,PTPRC;ITGA2;OPHN1;VEGFC;CD2AP
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.3197507560155727,-0.8914694109557108,0.6152125279642058,0.8855048927775161,1.0,6/19,24.34%,ENPP1;SLC26A2;SLC35B3;PAPSS2;BPNT1;ABHD14B
prerank,mitotic nuclear division (GO:0140014),0.2663395869742925,0.8914187587679446,0.6338880484114977,0.9937974526086666,1.0,17/71,17.20%,ABRAXAS1;KIF18A;PPP2R2D;CLASP2;CDCA8;MZT1;KIF2A;CHMP2A;BCCIP;MIS12;KIF3B;CHEK2;ARHGEF10;INO80;STAG2;KPNB1;CLASP1
prerank,alcohol catabolic process (GO:0046164),0.4114792011928201,0.8914081113502047,0.6019047619047619,0.9930494517442325,1.0,2/10,7.61%,APOE;SNX17
prerank,mitotic cell cycle phase transition (GO:0044772),0.2292354871650701,0.8912166930002287,0.7144638403990025,0.9927077606711971,1.0,32/203,14.76%,FBXL6;ALMS1;PLK2;PPP2R2D;HAUS4;HAUS5;CEP41;CLASP2;TUBB;CCNH;DCTN2;CDKN1A;POLE;ODF2;CDK4;WEE1;LATS2;CCNG2;CEP164;ANAPC7;DCTN3;PLCB1;PPP1R12A;CHMP2A;DYNLL1;USP37;E2F3;CUL3;CHEK2;PHF8;RCC1;DYNC1I2
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.26421111884558673,-0.8909911286129084,0.6449086161879896,0.8859207201629724,1.0,17/39,23.24%,RIOK1;RIOK2;NOL11;DDX52;RPS7;RPS16;RPS6;NOM1;UTP4;RPS17;NOB1;RIOK3;NOP14;WDR3;LSM6;METTL17;RRP36
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.34708288649830776,0.8903384873637692,0.6032315978456014,0.994190091781091,1.0,5/18,12.84%,RIPOR2;SCAI;RASIP1;ITGA3;CUL3
prerank,cellular response to hexose stimulus (GO:0071331),0.3273936169502155,0.8901070678018217,0.6086956521739131,0.9939932713363036,1.0,1/23,0.01%,PCK1
prerank,response to lipid (GO:0033993),0.2523514294175605,0.8901031045109526,0.6666666666666666,0.9932290434934765,1.0,12/105,12.24%,PCK1;ACER2;TAB2;TIRAP;PAQR8;SELP;PPARD;ERBIN;IFNAR1;ESR1;NOS3;OTUD5
prerank,mesenchymal to epithelial transition (GO:0060231),-0.37731217740056855,-0.8900143639532493,0.6038135593220338,0.8875363308403353,1.0,5/10,24.84%,BMP4;SALL1;FZD7;BASP1;PAX2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.34016412045725497,0.8900022485841912,0.6179577464788732,0.9927248849290972,1.0,5/19,12.43%,PRKCH;F11R;TJP1;CLDN5;IKBKB
prerank,fat cell differentiation (GO:0045444),-0.24417530659396894,-0.8898374423921097,0.6842105263157895,0.8872586623294232,1.0,18/57,23.90%,WNT5B;OSBPL11;PID1;MED1;PPARGC1A;PER2;AKT2;SMAD6;CLIP3;BBS9;BBS2;TMEM120B;TCF7L2;PRDM16;ATF5;OSBPL8;TMEM120A;C1QTNF3
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.2921506781604738,-0.8897916167808158,0.6451612903225806,0.8866788750743374,1.0,11/26,36.76%,SMAD3;P2RX4;DDAH1;PTGS2;AKT1;HSP90AA1;DDAH2;ASS1;EDN1;TMEM106A;CLU
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.32069909808505215,0.8895003470340804,0.6067226890756302,0.9931989759640077,1.0,8/27,15.69%,GSK3A;FCGR2B;MBOAT1;FBXO7;EFHC2;HOMER1;VPS35;CAMK2G
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.367438027585538,-0.8894882065549942,0.6012396694214877,0.8867082486887022,1.0,3/11,10.09%,CAB39;BIN1;ACTN2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.30702148353690706,0.8894243224006297,0.6128472222222222,0.9926341828478168,1.0,5/29,11.09%,PPP2CA;SPRED1;SMAD7;EFNA1;ADIPOR1
prerank,histone H3 deacetylation (GO:0070932),0.36463406375886503,0.8891756896280085,0.6241007194244604,0.9924908486940622,1.0,4/15,7.29%,HDAC9;HDAC3;SFPQ;SIRT1
prerank,axonemal dynein complex assembly (GO:0070286),0.3142195365237733,0.8888299069519259,0.6234676007005254,0.9926424800060953,1.0,2/27,6.62%,CFAP73;DNAL1
prerank,positive regulation of double-strand break repair (GO:2000781),-0.25859110292122645,-0.8887623061867921,0.6685236768802229,0.8877067486648291,1.0,13/39,21.13%,SPIRE1;SPIDR;FMN2;ERCC6;SHLD1;MGMT;PARP3;MMS19;ACTR2;PARP1;RIF1;SMCHD1;DTX3L
prerank,water-soluble vitamin metabolic process (GO:0006767),0.26992367249928895,0.8886885189237586,0.6510948905109489,0.9922450081370667,1.0,8/68,8.35%,ALDH1L1;MTR;FLAD1;PANK2;SLC52A2;SLC52A3;MTHFS;SLC2A1
prerank,cellular response to ionizing radiation (GO:0071479),-0.2520219336311832,-0.8886482641703725,0.6853932584269663,0.8872878896482832,1.0,19/47,23.20%,SPIDR;MAPK14;MAP3K20;NIPBL;TNKS1BP1;TP53;HSF1;NUCKS1;RHOB;GRB2;ATM;KDM1A;TANK;CRYAB;BLM;TMEM109;INTS7;YAP1;RAD9B
prerank,amino acid import (GO:0043090),-0.31448178700327106,-0.8885317716072316,0.6160520607375272,0.886830199618292,1.0,6/21,9.28%,SLC1A3;SLC6A13;SLC47A1;SLC6A1;SFXN2;SLC22A4
prerank,regulation of mast cell degranulation (GO:0043304),0.36470534817510114,0.8885104107944152,0.6225045372050817,0.9919248917962731,1.0,3/14,9.52%,SYK;LYN;CD84
prerank,transition metal ion homeostasis (GO:0055076),0.317397949687101,0.8883480453507556,0.6308724832214765,0.9915511022870388,1.0,7/28,15.46%,HMOX2;FBXL5;B2M;PICALM;CUTC;TMPRSS6;BDH2
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.3733922922851888,-0.8883312982236158,0.6103092783505155,0.8866539678013945,1.0,4/10,31.60%,PLA2G4A;PLA2G6;PLA2G7;PLA2G15
prerank,aorta morphogenesis (GO:0035909),0.3478042853422646,0.8878757450713367,0.6146953405017921,0.9919286368464644,1.0,5/17,10.81%,HEY1;TBX1;HEY2;ACVRL1;RBPJ
prerank,protein localization to phagophore assembly site (GO:0034497),-0.372559117067323,-0.8877538104422459,0.6059322033898306,0.8872191724469479,1.0,2/11,5.34%,PACS2;WIPI1
prerank,regulation of response to oxidative stress (GO:1902882),0.3889100858489952,0.8877268093483693,0.5963488843813387,0.9915132780287049,1.0,2/11,10.97%,STOX1;MCTP1
prerank,cellular biogenic amine catabolic process (GO:0042402),0.38852379589098635,0.8876648852869904,0.5939849624060151,0.9909055492016555,1.0,2/10,7.90%,SMOX;SLC44A1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3954221548689091,0.8875991821785839,0.594541910331384,0.9903092780038145,1.0,3/11,12.04%,CYCS;UQCC3;UQCRB
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.26083175603052744,-0.887556007641907,0.6883116883116883,0.8869712724683062,1.0,9/39,16.41%,MCU;NLGN2;GLUD1;RBP4;AIMP1;TM7SF3;NNAT;PSMD9;TCF7L2
prerank,L-glutamate transmembrane transport (GO:0015813),0.3960927492333566,0.887313397080927,0.6203522504892368,0.9902486196393488,1.0,3/10,12.49%,SLC1A1;SLC1A2;SLC25A12
prerank,negative regulation of stem cell differentiation (GO:2000737),0.37557686855055245,0.8871061857730396,0.6095617529880478,0.9899905876820397,1.0,3/12,13.92%,NOTCH1;N4BP2L2;HES1
prerank,autophagy of mitochondrion (GO:0000422),0.29158459023171623,0.8870855616325678,0.6225165562913907,0.9892823470189333,1.0,19/38,22.30%,MAP1LC3B;PHB2;FBXO7;CISD2;ATG7;ATG14;GABARAPL1;ATG13;BNIP3;BECN1;GABARAP;ULK1;WDR45B;ATG2B;FUNDC1;USP30;ATG12;SQSTM1;GABARAPL2
prerank,regulation of ERBB signaling pathway (GO:1901184),0.36360911711632943,0.8870584852765343,0.6074074074074074,0.9885926749694108,1.0,4/15,10.81%,PTPN18;PTPN12;RHBDF2;RBPJ
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.2848254695135692,0.8868265755862583,0.6447166921898928,0.9884210442323901,1.0,9/47,13.20%,MAPK3;RAP2A;GREM1;KLHDC10;PHLPP1;SEMA4C;NBR1;MAP4K4;MID1
prerank,epithelial cell development (GO:0002064),-0.3167786813104681,-0.8865363475409046,0.6284403669724771,0.8886717071819452,1.0,2/20,4.42%,WNT5B;RILPL1
prerank,chromatin assembly or disassembly (GO:0006333),-0.37272555651224604,-0.8865139109941417,0.6175869120654397,0.8880171408502872,1.0,7/11,43.71%,TP53;MTA2;NOC2L;CDAN1;HIRIP3;SUV39H2;CHAF1A
prerank,long-term memory (GO:0007616),-0.3186214637538465,-0.8858224043761002,0.6150537634408603,0.8889377268259172,1.0,6/19,19.80%,RASGRF1;CAMK4;LDLR;SGK1;NFATC4;SHANK1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3702498125124067,0.8857124053803521,0.6095238095238096,0.990413745359273,1.0,4/13,16.56%,PIK3AP1;EPG5;TNIP2;PIK3R4
prerank,positive regulation of transmembrane transport (GO:0034764),0.3723147314339263,0.8854976075216161,0.6182495344506518,0.9901775033433812,1.0,5/13,17.59%,ACSL5;CA2;P2RX7;BRAF;C2CD5
prerank,regulation of small molecule metabolic process (GO:0062012),0.3149943668367803,0.8854606828011509,0.6481802426343154,0.9895094738420338,1.0,5/28,11.09%,MLYCD;PANK2;APOE;SIRT1;ADIPOR1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.3264317080493424,0.8854059371404536,0.6298157453936348,0.9888926148250102,1.0,4/22,6.40%,PFN1;CYRIB;KANK3;SSH2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3309863722232059,0.8853511587981434,0.656140350877193,0.9882704369260221,1.0,3/20,15.93%,TSPO;STARD3NL;STARD3
prerank,tRNA 5'-leader removal (GO:0001682),0.36973123393750823,0.8853244587150719,0.6092592592592593,0.9875866236613094,1.0,3/13,14.97%,RPP25L;POP5;SSB
prerank,cilium movement (GO:0003341),0.27762875499638034,0.8850828113228205,0.627831715210356,0.987426408969865,1.0,2/47,2.17%,CFAP73;CABYR
prerank,cellular response to oxygen-containing compound (GO:1901701),0.22035842724129895,0.8845278292818008,0.7572590011614402,0.9880468923347444,1.0,39/291,13.09%,CERS1;MAPK3;ROMO1;BRINP3;INSIG1;TNFAIP3;RUVBL2;ACTB;RPTOR;TIRAP;MTR;SBNO2;ZFP36L1;TSHR;CCDC62;TNFRSF1B;ZFAND1;MAPK8;TBX1;CARD16;RET;GNB1;LAMTOR1;RAPGEF3;WNT5A;RELA;LYN;NFKBIL1;ESR1;P2RX7;RPS3;IP6K2;PLAA;TNIP2;LARS1;CHUK;RRAGC;CD274;NDUFA13
prerank,positive regulation of developmental process (GO:0051094),0.2348888385917174,0.8844388896279605,0.7125984251968503,0.9875174568472214,1.0,23/164,12.16%,LRP8;ANAPC2;RPS6KA1;SHANK3;SRC;CLASP2;APOE;CFL1;SLC6A6;RALA;ARHGEF7;RAPGEF3;FBXO5;SIRT1;DAG1;DDHD1;WNT5A;PLCB1;ZDHHC15;TRPM4;ZBED3;PA2G4;KMT5B
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.25954797101157445,0.8843451957427295,0.660458452722063,0.9869735765699208,1.0,13/75,14.05%,RGS2;SAG;RGS5;GNG7;METAP2;YWHAB;RGS3;PLCB1;METAP1;USP33;PLEK;RPGRIP1L;ZDHHC7
prerank,skeletal muscle contraction (GO:0003009),0.34404080181804086,0.884253285678692,0.6394316163410302,0.9864367602700856,1.0,1/19,3.35%,STAC
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3411464357016457,0.8841809916807472,0.623400365630713,0.9851283219091567,1.0,3/20,5.63%,BCKDHB;SLC25A44;ACAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3411464357016457,0.8841809916807472,0.623400365630713,0.9851283219091567,1.0,3/20,5.63%,BCKDHB;SLC25A44;ACAT1
prerank,positive regulation of cytokinesis (GO:0032467),-0.27592009378823645,-0.8840885102411931,0.6776649746192893,0.8922625958613007,1.0,3/32,6.06%,SVIL;RHOA;CIT
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.3725713957063369,-0.8838928993667259,0.6428571428571429,0.8919858313904218,1.0,4/10,19.28%,JARID2;KDM1A;RIF1;DNMT1
prerank,actin filament capping (GO:0051693),-0.32745309485702934,-0.8836266282900944,0.6473118279569893,0.8912029541668817,1.0,8/18,20.98%,SVIL;GSN;TRIOBP;ADD3;TWF2;ADD2;CAPZB;VILL
prerank,barbed-end actin filament capping (GO:0051016),-0.32745309485702934,-0.8836266282900944,0.6473118279569893,0.8912029541668817,1.0,8/18,20.98%,SVIL;GSN;TRIOBP;ADD3;TWF2;ADD2;CAPZB;VILL
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.23427116108861482,-0.8834233501168616,0.7478753541076487,0.8909748380186521,1.0,40/69,33.07%,RPRD1B;POU2F1;ELL;PHAX;SRRT;GTF2A1;CDK7;CCNT1;POLR2A;SNAPC3;TAF8;INTS10;INTS8;CCNK;INTS11;TAF6;CDK9;GTF2E2;NABP2;GTF2B;INTS7;SNAPC4;NCBP2;TAF13;POLR2K;INTS12;GTF2E1;INTS9;TAF11;POLR2H;INTS3;ZC3H8;NABP1;POLR2G;POLR2F;POU2F2;POLR2C;TAF5;GTF2F1;INTS1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3065858981665377,0.8829141834820019,0.6009852216748769,0.9874597877235983,1.0,8/29,18.10%,UTP20;RPS21;RPS14;NGDN;HELB;HEATR1;DCAF13;RPS8
prerank,neuron differentiation (GO:0030182),0.2323962143367952,0.8828649659091244,0.7251612903225807,0.9868303038532408,1.0,17/165,10.10%,IRX1;ERCC3;NR4A2;PIN1;MANF;PPT1;HS6ST1;IER2;MYEF2;UGCG;EPHA5;WNT5A;ITM2C;NGRN;FZD3;OPHN1;ACSL4
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.2864715209351544,0.8824893870464248,0.6174496644295302,0.9870209669375115,1.0,5/39,8.79%,ERCC3;ERCC4;POLK;POLD3;GTF2H1
prerank,response to nutrient levels (GO:0031667),0.34190821880952593,0.8818712770106424,0.6126629422718808,0.9878044070443142,1.0,4/17,18.94%,RPTOR;PRKAA2;ULK1;EIF4G1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.28256614671754177,-0.8817612773212667,0.6650943396226415,0.8940343045222805,1.0,7/27,17.83%,FGF12;SNTA1;PTPN3;CAMK2D;DLG1;COMMD1;GPD1L
prerank,DNA geometric change (GO:0032392),-0.2909968081664304,-0.881735790911238,0.6674816625916871,0.8933965200152179,1.0,10/24,21.24%,DDX1;RAD50;HNRNPA2B1;MRE11;ANXA1;MCM9;BLM;SUPV3L1;RECQL;RTEL1
prerank,regulation of lymphocyte activation (GO:0051249),0.3729207206076206,0.8813145471308288,0.6259259259259259,0.9883950924234141,1.0,12/12,62.74%,PAG1;SIT1;CD4;CD19;LCK;CRTAM;CCL5;THEMIS2;IKZF3;LAT;DCAF15;KAT2A
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.27890637621351555,-0.880829252753909,0.6299019607843137,0.8948184633816139,1.0,4/32,8.60%,AKAP6;CEMIP;HTT;TRPC1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3597777075274269,0.8807781345322112,0.5944954128440367,0.9889084518697275,1.0,4/14,14.27%,RAP2A;MYO9A;OPHN1;PATJ
prerank,cell cycle G2/M phase transition (GO:0044839),0.23722122082251038,0.8805682489595165,0.7238605898123325,0.9886738162241326,1.0,17/129,10.49%,FBXL6;ALMS1;HAUS4;HAUS5;CEP41;TUBB;CCNH;DCTN2;CDKN1A;ODF2;WEE1;CEP164;DCTN3;PLCB1;AKAP8L;PPP1R12A;DYNLL1
prerank,sulfur compound transport (GO:0072348),-0.2851831367620649,-0.8805150064406897,0.6741854636591479,0.8948357212303755,1.0,14/27,32.14%,SLC6A13;LRRC8D;SLC26A7;SLC13A4;SLC35F3;SLC27A1;SLC26A11;SLC5A6;SLC25A30;SLC19A2;SLC25A11;MGST1;SLC36A1;SLC25A19
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.35817968060749095,-0.880250422341397,0.6166328600405679,0.8947492462014552,1.0,5/12,28.89%,PPARA;ABCA5;ABCA1;NR1H2;ITGB3
prerank,generation of neurons (GO:0048699),0.23007186922616987,0.8802225548150805,0.7271557271557272,0.9887441093264328,1.0,23/190,10.55%,IRX1;EML1;NR4A2;PIN1;HES6;ASTN2;ADGRL3;HEY1;POMGNT2;IER2;MYEF2;FGF13;HEY2;WNT5A;ITM2C;NGRN;PRUNE1;FZD3;CELSR1;OPHN1;ACSL4;DOCK7;NAV1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3205215361427589,0.8800394724537939,0.6416382252559727,0.9884288859202492,1.0,6/26,12.77%,TNFAIP3;CARD16;NLRC3;NFKBIL1;TRAF3IP1;MAPKBP1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3618506194441081,0.8797440736050391,0.6026615969581749,0.9883736307299055,1.0,1/14,0.61%,IMPDH1
prerank,sensory organ development (GO:0007423),0.27612958356532075,0.8796828931774866,0.6598101265822784,0.9877731137516235,1.0,5/51,4.88%,ATF6;HIPK2;PAX8;SOX2;MEIS1
prerank,negative regulation of blood pressure (GO:0045776),0.36925646890075764,0.8793917218581424,0.634862385321101,0.9877444836075664,1.0,2/13,11.15%,PRCP;NOS3
prerank,gene silencing by miRNA (GO:0035195),-0.27441665386817954,-0.8793862893096503,0.6550868486352357,0.8960534260061261,1.0,8/32,14.25%,ZC3H7A;PUM1;ZC3H7B;PUM2;AGO3;RBM4;LIMD1;DICER1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.31206178127782414,-0.8793368661530692,0.6538461538461539,0.8954731953996509,1.0,6/21,16.63%,MED13;MED1;MED17;PAXIP1;SETX;JUN
prerank,receptor internalization (GO:0031623),0.27878035480865765,0.8787118449060936,0.6537162162162162,0.9886843946060104,1.0,9/44,14.38%,SAG;DNM3;RAMP2;SYK;SNX1;CD81;PICALM;LDLRAP1;AP2M1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.26454547932922634,0.8786843051293612,0.7005730659025788,0.9880076608425118,1.0,14/75,16.35%,PDCL3;PRKD2;NRAS;PPP1R16B;EGFL7;TEK;SIRT1;PLCG1;WNT5A;PIK3CD;SP1;VEGFC;ANG;CDH13
prerank,positive regulation of immunoglobulin production (GO:0002639),0.30121025044719685,0.8784835392716597,0.6411960132890365,0.9877566499843903,1.0,9/31,21.31%,PTPRC;PHB2;GPI;KMT5B;DNAJB9;TFRC;XBP1;KMT5C;STX4
prerank,cytoplasmic microtubule organization (GO:0031122),0.2747985397328437,0.8782281148422336,0.6914556962025317,0.9876433779691528,1.0,9/54,7.89%,TUBGCP5;SLK;CIB1;DST;CRIPT;CCDC88C;CLIP2;CAMSAP2;TRPV4
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.3633991795113416,-0.8778618782615408,0.6206140350877193,0.8981100608160619,1.0,1/11,4.75%,P2RX4
prerank,cranial nerve development (GO:0021545),-0.36256352520336377,-0.8778073758345138,0.621505376344086,0.8975264797994628,1.0,9/11,59.65%,SALL1;PAX2;TMEM126A;ERBB3;CHRNB2;TFAP2A;POU4F1;TIFAB;ISL1
prerank,erythrocyte development (GO:0048821),0.3892321872436053,0.8776280325044761,0.5992578849721707,0.9883333389519234,1.0,1/10,1.61%,ABCB10
prerank,purine-containing compound salvage (GO:0043101),-0.34849030092795485,-0.8773416056307624,0.6063829787234043,0.8979653450741109,1.0,3/12,9.95%,AMPD3;DGUOK;ADK
prerank,phagosome acidification (GO:0090383),0.30960855932843356,0.8773128761809428,0.6452173913043479,0.9883494531973437,1.0,4/26,8.45%,ATP6V1D;RAB7A;ATP6V0D1;ATP6V0E1
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.28709242107867516,-0.8769474247227474,0.6592920353982301,0.898208553481202,1.0,5/25,11.33%,EGFR;NRP1;DSCAM;THBS1;ILK
prerank,protein glycosylation (GO:0006486),-0.21084905020162642,-0.8768128590569513,0.8100358422939068,0.8978175539899523,1.0,37/125,26.26%,MGAT4C;MAN1C1;OGT;PLOD2;B4GALT1;TET1;FUT8;POFUT1;TRAK1;PMM2;ALG9;GOLGA2;PLOD1;FUT10;DPM1;LARGE1;FKTN;B3GALT5;SLC39A8;ST3GAL4;B3GALNT1;MAGT1;ENTPD5;B3GALT1;ST8SIA2;ALG5;ALG10B;C1GALT1C1;ALG11;GFPT1;STT3A;GAL3ST1;SERP1;AQP11;GFPT2;ALG12;KRTCAP2
prerank,global genome nucleotide-excision repair (GO:0070911),0.3135849319330724,0.8764269683479532,0.6397849462365591,0.9897647034728808,1.0,3/26,8.79%,ERCC3;ERCC4;GTF2H1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4008708624451998,0.876230571543857,0.6200378071833649,0.9895071842442796,1.0,4/10,17.42%,DCLRE1B;ACD;TERF2IP;DCLRE1C
prerank,positive regulation of macroautophagy (GO:0016239),0.28161771613995834,0.8761803897233597,0.6902086677367576,0.9888721899114524,1.0,16/48,19.39%,RALB;MAP3K7;EPM2A;SIRT1;FYCO1;PRKAA2;BNIP3L;SCOC;RAB3GAP1;SESN3;BNIP3;PIP4K2A;SH3GLB1;SESN1;LARP1;HSPB8
prerank,prostaglandin metabolic process (GO:0006693),-0.281947001820071,-0.8759821148056532,0.6477541371158393,0.8990426538622651,1.0,8/26,27.59%,PLA2G4A;PTGDS;PTGIS;PTGES;PTGS2;GSTM1;TBXAS1;HPGDS
prerank,positive regulation of calcium ion import (GO:0090280),0.376574834827408,0.8751535960905065,0.6418439716312057,0.9906233510630914,1.0,1/12,2.58%,CXCL12
prerank,positive regulation of myoblast differentiation (GO:0045663),0.34772979089066997,0.8745922517356288,0.6341911764705882,0.9911727042964202,1.0,3/16,9.59%,XKR8;RIPOR2;PLCB1
prerank,acylglycerol homeostasis (GO:0055090),0.33608933527896123,0.8745699156930974,0.6313868613138686,0.9904889790517143,1.0,3/20,11.85%,APOE;PNPLA8;SCARB1
prerank,hepaticobiliary system development (GO:0061008),-0.3065158042022792,-0.8743300516335567,0.6466512702078522,0.9020552371723574,1.0,4/20,7.76%,TGFBR3;WNT4;COBL;NIPBL
prerank,amino acid transmembrane transport (GO:0003333),-0.25644751354897266,-0.8742162906416451,0.7066326530612245,0.9016234627695268,1.0,8/45,11.38%,SLC7A11;SLC6A13;SLC47A1;LRRC8D;SLC25A13;SFXN2;SLC22A4;SLC38A11
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.37811879446761054,0.8740270379644989,0.6335403726708074,0.9910722307218351,1.0,2/11,8.56%,NR4A2;WNT5A
prerank,phosphatidic acid metabolic process (GO:0046473),-0.25241102172604457,-0.8737899078206323,0.6556122448979592,0.9018866146208847,1.0,6/48,6.34%,PLD1;PLA2G4A;AGPAT4;ABHD5;AGPAT5;DGKH
prerank,lipid phosphorylation (GO:0046834),-0.3726966729323713,-0.8734218914957884,0.6471816283924844,0.9019948085144057,1.0,2/10,6.34%,DGKI;DGKH
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.3320807227119588,0.8733794157587195,0.6280373831775701,0.9919055791818014,1.0,3/18,9.29%,POLE;POLD3;POLA1
prerank,erythrocyte differentiation (GO:0030218),0.2871271282829909,0.8728482319702523,0.671451355661882,0.9924143816875846,1.0,7/44,10.58%,TAL1;ABCB10;HIPK2;RPS14;CEBPG;LYN;MFHAS1
prerank,negative regulation of signal transduction (GO:0009968),0.22352607826445922,0.8727624070489501,0.7726723095525998,0.991899057084429,1.0,21/249,7.11%,SOX30;RGS2;MAZ;SEMA6A;PTPN18;GSK3A;NR4A2;PTPRJ;EZH2;FRZB;PTPRC;TNFAIP3;PTPRE;HEY1;EGFL7;PTPN12;MMRN2;CARD16;YWHAB;PTPRT;BDNF
prerank,macrophage differentiation (GO:0030225),-0.3468072942111328,-0.8727321298297599,0.6396761133603239,0.9028679643670221,1.0,5/13,22.30%,BMP4;IL31RA;CDC42;PARP1;VEGFA
prerank,tRNA transport (GO:0051031),0.29366561432336385,0.8725510361096573,0.6416666666666667,0.9916721292250356,1.0,11/35,19.26%,TOMM20;NUP54;NUP50;NUP35;YBX1;SSB;NDC1;NUP160;POM121;NUP42;NUP133
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.36309932865594335,0.8724021800692182,0.625,0.9912744424120898,1.0,5/13,17.79%,BAD;BMF;BNIP3L;BNIP3;BAX
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.2920045574762726,0.8719918099275156,0.6739864864864865,0.9915118935910433,1.0,8/33,11.13%,GPAM;EP300;AXIN1;PKN1;PARK7;RNF6;ESR1;CARM1
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.33589108613415114,-0.8719595910997868,0.6568848758465011,0.9039379158987821,1.0,5/16,17.61%,LRP1;HDAC1;ROCK1;IFNGR1;CYP51A1
prerank,positive chemotaxis (GO:0050918),-0.326816356446192,-0.8716686712810727,0.6427015250544662,0.9039128582663347,1.0,10/17,32.41%,NRP1;SCG2;TSC2;SEMA5A;MET;CX3CL1;VEGFA;SCRIB;FGF10;FGF7
prerank,protein mannosylation (GO:0035268),0.3239751508191331,0.8716147530168651,0.6306620209059234,0.9916767384339903,1.0,5/22,12.46%,TMTC2;POMGNT2;DPY19L4;DPY19L1;CRPPA
prerank,interstrand cross-link repair (GO:0036297),-0.2411288331171592,-0.8713363113000556,0.7094017094017094,0.9039683767898052,1.0,34/53,45.06%,VCP;RNF168;RPA1;UBC;RNF8;NUCKS1;MCM9;FANCE;FAN1;USP1;ATRIP;SLX4;POLN;DCLRE1A;FAAP100;MSH6;FANCC;ERCC1;MUS81;FANCI;FAAP20;RPA3;XPA;FANCB;UBA52;FANCD2;FANCG;NEIL3;MCM8;RPA2;EXO5;RAD51;RAD51AP2;CENPX
prerank,carbohydrate derivative transport (GO:1901264),0.33240443696956323,0.8705600801710541,0.6223908918406073,0.9934594253415284,1.0,7/18,20.16%,SLC10A7;SLC29A1;SCARB1;NPC2;PLTP;ABCG1;SLC15A2
prerank,placenta development (GO:0001890),0.36848807072372164,0.8702477635697097,0.6164122137404581,0.993459408822797,1.0,1/12,2.23%,SOD1
prerank,regulation of intracellular signal transduction (GO:1902531),0.21210155295293323,0.8700458188560272,0.8197474167623421,0.9931777586613264,1.0,75/420,14.48%,RAC2;PRKAR1A;MAPK3;PIN1;TIAM1;VAV3;ARHGEF26;CHN2;HIPK2;MCF2L;RFFL;PRKD2;BIRC2;PPP1R16B;ITSN1;TEK;RAD1;SPRED1;SGMS1;ARAP2;EP300;ARHGAP25;RPL5;ARHGEF6;TRAF5;ARHGEF7;PAK3;TRIO;ATP6AP2;VWF;ARHGEF18;MINK1;GNA12;WNT5A;MYO9A;PHLPP1;TRAF3;RELA;LYN;MDM2;FAM13A;PJA2;TTC5;PAK1;RHOQ;OPHN1;TAF15;TMBIM4;PRKAA2;ING2;ARHGAP39;RHOG;HUS1;A2M;GNAI1;TOP3A;ARHGAP23;MYO9B;MAP4K4;PAK1IP1;TAF4B;NBN;CHD3;TBP;PTPMT1;RRAGC;ING5;DEPDC1B;CHEK2;MAP2K6;NFKBIA;ARHGAP15;CSNK2A2;RMI1;SYDE1
prerank,positive regulation of protein processing (GO:0010954),-0.31485504612344495,-0.8699559316040011,0.6390134529147982,0.9063584638135194,1.0,4/19,8.97%,GSN;RHBDD1;CLEC3B;CCBE1
prerank,glycosphingolipid metabolic process (GO:0006687),0.2816054911629283,0.8699300109580055,0.6605351170568562,0.9927403281241152,1.0,6/42,6.57%,GLB1;SMPD4;ST6GALNAC3;ESYT2;UGCG;ST8SIA1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.28577278753045576,0.869857080532566,0.6594090202177294,0.9921851381036232,1.0,8/39,13.12%,DYNC1I1;MYO5A;ACTN4;TANC2;RAB1A;MYO1D;PPFIA2;MYO1E
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.34145441264167575,0.8692504113854714,0.6396917148362236,0.9928966532416111,1.0,5/16,18.69%,MLYCD;SIRT1;ADIPOR1;FOXK2;PDK3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3665229671871729,0.8692223035053565,0.6199261992619927,0.992225279887227,1.0,4/12,17.96%,SIRT1;ING2;CD44;RPL26
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.2944986748631753,-0.869198748976749,0.6555819477434679,0.9067222434927187,1.0,6/23,11.55%,DAB2;ZEB2;SMAD4;SNW1;THBS1;STK11
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.2944986748631753,-0.869198748976749,0.6555819477434679,0.9067222434927187,1.0,6/23,11.55%,DAB2;ZEB2;SMAD4;SNW1;THBS1;STK11
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.27712534254672827,0.868809806540852,0.6629746835443038,0.9924409834671906,1.0,9/44,13.80%,EBP;INSIG1;HMGCR;SC5D;OSBPL1A;PARK7;HSD17B4;ACOT8;OSBPL2
prerank,protein localization to condensed chromosome (GO:1903083),0.37372895852552784,0.8684923576997292,0.6051587301587301,0.9924672083405863,1.0,3/12,14.60%,CHAMP1;MIS12;MTBP
prerank,peptide catabolic process (GO:0043171),0.3206148048010993,0.8683457331999112,0.6362007168458781,0.9920952442834319,1.0,1/23,0.22%,LVRN
prerank,mitochondrion localization (GO:0051646),-0.30860389948533173,-0.8682645927291373,0.6604651162790698,0.908096702675308,1.0,13/19,48.70%,TRAK1;NECTIN2;MFN1;ATCAY;MARK2;MSTO1;BRAT1;MUL1;TRAK2;MEF2A;MTM1;TLE6;HAP1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.30949510987959294,-0.8679334402351639,0.6393805309734514,0.9081915137195133,1.0,4/18,10.56%,RIMS1;NLGN1;SYN1;GSK3B
prerank,positive regulation of neuron death (GO:1901216),-0.2487027058140422,-0.8679002206086744,0.6941489361702128,0.9075542338336124,1.0,9/46,10.96%,GRIN2B;EFNB2;MAPT;CTNNB1;EPHA7;NUPR1;BACE1;GSK3B;MAP3K5
prerank,histone H3-K9 demethylation (GO:0033169),0.3780842215098186,0.8677371506649922,0.632183908045977,0.9927841102383176,1.0,6/11,19.49%,KDM3A;KDM4D;JMJD1C;PHF8;KDM4C;KDM3B
prerank,negative regulation of JNK cascade (GO:0046329),-0.26743483249618044,-0.867472579533474,0.6921052631578948,0.9078426100915644,1.0,8/31,14.82%,CYLD;TAOK3;HIPK3;PER1;SIRPA;FKTN;DACT1;PTPN22
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.31834011415780483,0.867355620507014,0.644808743169399,0.9929579396853472,1.0,6/22,12.41%,GSK3A;EFNA1;RELA;LYN;PICALM;SP1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2137108269402219,0.8672697078015614,0.8155452436194895,0.9924386293062212,1.0,60/336,15.85%,ERCC3;ZRANB3;RAD18;MAPK3;TRIM28;SLF1;ACER2;VAV3;PNKP;BCL2L2;UBA1;ERCC4;RAD1;RBBP6;YY1;TNFRSF1B;HPF1;CIB1;POLK;CDKN1A;APLF;SIRT1;USP47;AKTIP;GTF2H1;SPRTN;POLA1;LYN;RFWD3;MSH3;PAK1;PARK7;ALKBH7;SUSD6;CHCHD6;RAD51B;APTX;HUS1;RPS3;KMT5B;PWWP3A;NBN;MAPK12;DOT1L;HELB;TRRAP;CHEK2;DDIT3;TLK2;MAP2K6;APC;FANCL;UBA6;BACH1;INO80;UBQLN4;DYRK2;TAF1;BCL6;ATR
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.24907383342195166,0.867059140255931,0.7110157367668097,0.9922148096159755,1.0,18/87,14.50%,CBL;MAP3K7;LRRC32;SRC;SMAD1;TGFBRAP1;F11R;SMAD7;SIRT1;ARHGEF18;ACVRL1;CLDN5;NLK;USP15;ZFYVE9;CDH5;USP9X;PARD3
prerank,positive regulation of type 2 immune response (GO:0002830),-0.33688488926336324,-0.8670331196842848,0.6503067484662577,0.9081444634109571,1.0,3/14,13.39%,PRKCZ;RARA;IL18
prerank,vesicle transport along microtubule (GO:0047496),0.31698320521603374,0.8670191373015985,0.6232876712328768,0.9915839461056328,1.0,6/23,13.20%,DYNC1I1;KIFAP3;FYCO1;RAB1A;KIF13A;KIF3B
prerank,cellular amide metabolic process (GO:0043603),0.24255880604207053,0.8670096294609946,0.7276536312849162,0.9908806022539937,1.0,10/102,6.76%,ALDH1L1;MLYCD;PPP2CA;PANK2;MME;PLAAT3;DBI;MTHFS;GPAT4;PLPP1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.25843177010944285,-0.8669375450640363,0.7128712871287128,0.9076460461850283,1.0,10/39,13.72%,MEGF11;TLN1;FLNA;PLPP3;VCL;PDGFRA;UBASH3B;FN1;ILK;STXBP1
prerank,regulation of dendritic spine development (GO:0060998),0.3311318199559631,0.8668524528013214,0.6722846441947565,0.9905217152212609,1.0,5/19,15.57%,SHANK3;APOE;TANC2;PPFIA2;ARF6
prerank,regulation of response to stress (GO:0080134),0.38179446022434826,0.8666728187839287,0.619140625,0.9902166628412643,1.0,3/10,18.94%,STOX1;CORO2B;EIF4G1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.338865936535519,0.866639675701686,0.655417406749556,0.9895558185017271,1.0,3/19,9.70%,AASS;GOT2;PHYKPL
prerank,response to glucose (GO:0009749),0.275021800994388,0.8665392355737017,0.6987577639751553,0.989066944303175,1.0,6/46,11.51%,PCK1;SELENOT;IRS2;EIF2B3;PRKAA2;ZBED3
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.2901978597552817,0.8663094388950258,0.6655844155844156,0.9888899552532375,1.0,7/38,13.62%,TNFAIP3;RFFL;TNFRSF10B;ICAM1;DDX3X;NOS3;FAIM
prerank,chromatin disassembly (GO:0031498),-0.33058327598109627,-0.866213837048462,0.6229508196721312,0.9077799335668829,1.0,4/14,22.05%,SET;SMARCD3;SMARCD2;SMARCC1
prerank,nucleosome disassembly (GO:0006337),-0.33058327598109627,-0.866213837048462,0.6229508196721312,0.9077799335668829,1.0,4/14,22.05%,SET;SMARCD3;SMARCD2;SMARCC1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3154856746160577,0.865994784929596,0.6572847682119205,0.9888726826177003,1.0,6/22,17.31%,UTP20;RPS21;EXOSC9;WDR12;ERI2;URB1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.3438111457621723,-0.8659764064316845,0.6754966887417219,0.9075804448345206,1.0,4/13,10.62%,ADCY1;RELN;LGMN;EPHB2
prerank,regulation of RNA splicing (GO:0043484),0.25987033694682615,0.8659560868147513,0.6945668135095447,0.9882280293158905,1.0,11/69,7.96%,KHDRBS3;RBM22;HNRNPH2;SF1;QKI;HNRNPK;FAM50A;SRSF10;RBM20;RPS26;YTHDC1
prerank,autophagy of nucleus (GO:0044804),-0.3316944401773876,-0.8659315343136508,0.6674057649667405,0.9069912499089624,1.0,2/16,5.34%,ULK2;WIPI1
prerank,serine family amino acid metabolic process (GO:0009069),0.34713552750762056,0.8658954981500114,0.6420664206642066,0.987649333937168,1.0,1/16,0.78%,GCLC
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.2017315578822267,-0.8652216920437136,0.844106463878327,0.9079011876625336,1.0,12/140,8.11%,LPAR1;HTR2C;CACNA1C;ADCY5;DLG4;PLCE1;P2RX4;PDGFRA;EDNRA;ADRA1B;FIS1;CCR9
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.28013899772622197,0.8651930238121887,0.6672131147540984,0.9885571605736712,1.0,8/40,10.36%,SMG1;FXR1;FBXO5;UBE2V2;BCLAF1;RFWD3;UBE2V1;ING2
prerank,regulation of interleukin-4 production (GO:0032673),0.32696121134853,0.8650106014092054,0.6510416666666666,0.9882626059843992,1.0,4/21,17.21%,LEF1;SYK;DDIT3;SLC7A5
prerank,vascular process in circulatory system (GO:0003018),0.366188811424378,0.8649646779546877,0.6457564575645757,0.986921328226081,1.0,3/13,11.15%,GCLC;GCLM;NOS3
prerank,regulation of tube diameter (GO:0035296),0.366188811424378,0.8649646779546877,0.6457564575645757,0.986921328226081,1.0,3/13,11.15%,GCLC;GCLM;NOS3
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.36775918532345636,0.8648470558512728,0.6348314606741573,0.9864897908578386,1.0,3/12,15.93%,TSPO;STARD3NL;STARD3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.25468632807956715,0.8647129965727038,0.7276720351390923,0.986109742618261,1.0,17/80,17.10%,CYCS;RPS6KA1;SRC;MAP2K5;SOX2;CARD16;SYK;SIRT1;USP47;BAD;DDX3X;NOD1;NDUFA13;CD44;GAS6;DELE1;BCAP31
prerank,response to endoplasmic reticulum stress (GO:0034976),0.24179725129118268,0.8645707601408417,0.7456896551724138,0.9857196853431178,1.0,25/107,18.48%,ATF3;TRIB3;ATF6;EIF2S1;GORASP2;UFC1;ATP2A2;TNFRSF10B;WFS1;SELENOK;MBTPS1;AIFM1;HYOU1;UBQLN1;DDIT3;ERP44;DNAJC10;QRICH1;RASGRF2;TMTC3;BCAP31;BAX;DNAJB9;CCDC47;PDIA4
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.27557819636844394,0.8644430700713815,0.6881028938906752,0.9853249175058,1.0,7/42,9.29%,POLK;POLE;SIRT1;POLD3;TRIM25;SPRTN;POLA1
prerank,regulation of neuron death (GO:1901214),0.24803823529428176,0.8644395122280758,0.7204783258594918,0.984616987244036,1.0,14/82,11.93%,SNCG;EIF2S1;FCGR2B;SIGMAR1;FYN;TNFRSF1B;AKT1S1;WNT5A;TSC1;PARK7;NAE1;EGLN2;PICALM;PRNP
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.2887650169594357,0.8642939066678718,0.6785079928952042,0.9842222733316944,1.0,7/33,13.50%,EZH2;RPTOR;PHB2;RGCC;PLCB1;DDX3X;ANKRD17
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3558122541236822,-0.8642831543527183,0.6470588235294118,0.9092839554223373,1.0,8/11,45.22%,SERTAD2;ARID1B;PADI2;SERTAD1;ZMIZ2;ELOF1;CDCA4;CHEK1
prerank,positive regulation of transport (GO:0051050),0.24794759514466214,0.8641863930841875,0.7198795180722891,0.983762973953129,1.0,10/85,9.09%,GSK3A;FCGR2B;ACTB;CAMK1D;NEDD4L;LMAN2;APOE;ZNF205;MERTK;CD47
prerank,endocrine system development (GO:0035270),-0.29569777012539467,-0.8637609744559374,0.6658767772511849,0.9097514805853394,1.0,5/21,9.91%,GLI2;TGFBR1;WNT4;DKK3;SALL1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.3712544430341361,0.8633819451501551,0.6342857142857142,0.9849235383251134,1.0,4/12,16.16%,CCT2;CCT5;TCP1;DKC1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3702133326453064,0.8633347234292231,0.6368932038834951,0.9843119255164617,1.0,2/12,9.31%,PTPRC;LYN
prerank,neuron projection regeneration (GO:0031102),0.38299221889691665,0.8632310405925819,0.6427221172022685,0.9838423926110497,1.0,1/10,2.94%,MTR
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.34317646922668443,-0.8631344542464973,0.6449579831932774,0.9104334394863095,1.0,3/13,13.37%,CYFIP2;LGMN;TBC1D10A
prerank,pinocytosis (GO:0006907),0.39026459731079355,0.8630727367449839,0.6377952755905512,0.9834896942886343,1.0,1/10,3.22%,PPT1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.2982248571637861,0.863072089136029,0.6510851419031719,0.9827814173211148,1.0,9/29,16.09%,LEF1;EP300;RUVBL1;TERT;CREBBP;TLE4;TRRAP;SMARCA4;TCF7L1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.2738236671385143,-0.8630428190493903,0.7156398104265402,0.9099556924296803,1.0,10/29,25.95%,DDO;GSTZ1;ALDH4A1;ACADSB;PRODH;KYAT1;FAH;SARDH;HOGA1;MTRR
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.3215754575656426,-0.8630261506615585,0.642706131078224,0.9092975005331755,1.0,3/16,20.39%,CLDN11;CLDN14;CLDN12
prerank,response to sterol (GO:0036314),-0.36186080511125035,-0.8630141173075903,0.6536885245901639,0.908636000853609,1.0,4/11,16.23%,TGFBR1;TGFBR2;RORA;TGFB1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.25140539961137476,0.8628036320179099,0.7095808383233533,0.9826586941190655,1.0,11/77,10.80%,MAZ;NR4A2;BCL2L2;SRC;SLC35F6;BDNF;ITGA6;RELA;FZD9;PARK7;DDX3X
prerank,pentose-phosphate shunt (GO:0006098),0.38029889306123177,0.8627395472135728,0.651394422310757,0.9820882417581726,1.0,3/11,11.57%,TALDO1;RPIA;PGLS
prerank,establishment of epithelial cell polarity (GO:0090162),0.3298237900600053,0.8620898313814758,0.6787003610108303,0.982862015725582,1.0,7/19,18.47%,RAP2A;MYO9A;OPHN1;PARD3;CLASP1;MYO18A;CYTH1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.3318182297273932,0.8618707339859281,0.6453382084095064,0.9826767258620087,1.0,5/18,16.16%,CCT2;CCT5;CORO2B;TCP1;DKC1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.30006343102166394,-0.8618599801763014,0.6607929515418502,0.9104658616054266,1.0,4/21,10.62%,CGNL1;ARHGAP12;LZTR1;EPHB2
prerank,sodium-independent organic anion transport (GO:0043252),-0.37219629027514356,-0.8616291154048935,0.6247464503042597,0.9102512144314252,1.0,1/10,0.94%,SLCO3A1
prerank,mRNA 3'-end processing (GO:0031124),-0.22076760936780637,-0.8615975169251766,0.7531645569620253,0.9096352235784945,1.0,27/78,24.61%,SRSF5;SRSF11;PABPN1;CASC3;RPRD1B;SRSF2;SRSF6;SRSF1;POLDIP3;DDX39B;CSTF3;CDC73;SYMPK;CSTF2;THOC5;SLU7;PAF1;CDC40;RNPS1;GRSF1;CPSF3;PABPC1;EIF4A3;NCBP2;TUT1;THOC1;RBM8A
prerank,response to muramyl dipeptide (GO:0032495),-0.35393216770255775,-0.8614406909243246,0.6652542372881356,0.9093106635390301,1.0,4/12,18.87%,VIM;TRIM41;PTPN22;CHMP5
prerank,Golgi inheritance (GO:0048313),-0.36086970418718434,-0.8613425923895992,0.6412371134020619,0.9088234236876241,1.0,2/11,11.61%,GOLGA2;STK25
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.2356997168431751,-0.8612882220820268,0.7602179836512262,0.9082571146358961,1.0,15/55,21.96%,TGFBR1;CYLD;NUPR1;PML;GSDME;FIS1;BCL2L11;TP53;TRIM39;RACK1;TRAF2;TRAF7;BCL2;LTBR;TNFSF12
prerank,amyloid-beta metabolic process (GO:0050435),0.34767102746438583,0.861203654684429,0.6514598540145985,0.9834737942196324,1.0,2/16,4.44%,PSEN2;MME
prerank,ether lipid metabolic process (GO:0046485),0.3608520382956499,0.8611252417757123,0.6621880998080614,0.9829429196747521,1.0,5/14,14.30%,PLAAT3;PEDS1;PEX7;AGPS;GNPAT
prerank,cellular response to decreased oxygen levels (GO:0036294),0.25838887263494553,0.8610857934944732,0.6964285714285714,0.9823436441477014,1.0,16/65,13.26%,HIPK2;ZFP36L1;SCN2A;CARD16;RGCC;SIRT1;TSC1;MDM2;BAD;TERT;HYOU1;HP1BP3;UBQLN1;EGLN2;BNIP3L;EPAS1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.36652409481895837,0.8610604738960715,0.6285178236397748,0.9816995873762611,1.0,3/11,14.70%,SIRT1;ING2;CD44
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.2680264226807632,-0.8610392199827694,0.7036082474226805,0.9080809688313232,1.0,15/36,24.93%,OGT;WAC;FHIT;CAMLG;PSMF1;DDRGK1;TRIM39;MAP1A;USP7;EIF3H;BAG6;UBXN1;PRKCG;NOP53;AQP11
prerank,histone H4-K16 acetylation (GO:0043984),0.3359543299418175,0.8609165611936801,0.6552315608919382,0.9813242399740408,1.0,7/19,18.81%,JADE3;ING4;KANSL2;KANSL3;HCFC1;MSL2;MSL3
prerank,divalent inorganic cation homeostasis (GO:0072507),0.3105166560943645,0.8608680719800671,0.6457960644007156,0.9807365269308216,1.0,3/25,5.56%,TMTC2;WFS1;TRPM7
prerank,regulation of chromosome segregation (GO:0051983),0.3481344960211706,0.8607596760576756,0.6580882352941176,0.9802713202184965,1.0,1/16,0.79%,RAD18
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.29228708139326925,-0.8601837383522555,0.6601731601731602,0.9092374935112482,1.0,8/23,16.23%,PRKAG2;BMP7;CEMIP;CAB39;TNKS1BP1;WNK3;UBE2K;TGFB1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3368951280670562,-0.8600930048673321,0.65625,0.9087500708521664,1.0,5/14,28.75%,PAXIP1;SHLD1;RIF1;NECTIN2;SHLD2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.21739101308402578,-0.8600108604291142,0.8194444444444444,0.9082591072576083,1.0,35/96,24.95%,SRSF5;SRSF11;CASC3;SRSF2;ALKBH5;SRSF6;NUP205;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;NUP88;NUP93;DDX19B;SEH1L;THOC5;SLU7;CDC40;UPF1;RNPS1;NUP85;AAAS;RAE1;CPSF3;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13
prerank,N-glycan processing (GO:0006491),-0.31520117502383593,-0.8599675268635812,0.6815144766146993,0.9076620215734441,1.0,4/18,10.81%,MAN1C1;FUT8;GANC;MAN2A2
prerank,renal absorption (GO:0070293),-0.3736616203218126,-0.8597263870396903,0.679920477137177,0.9075168888577444,1.0,3/10,10.22%,GSN;WNK4;SGK1
prerank,positive regulation of reproductive process (GO:2000243),-0.271255800592266,-0.8596662061399877,0.6944444444444444,0.9069716270986292,1.0,5/31,12.18%,SMURF2;SIRT2;LHFPL2;GLRA1;ACVR1B
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.22245338472789583,-0.859618497696361,0.7784256559766763,0.9063981859148245,1.0,18/76,21.71%,NTRK3;NRP1;DYNC1H1;FER;CTTN;BIN1;SYNPO2;BAIAP2L1;PFDN2;FCHSD2;WDR1;CDC42EP5;NES;CDC42EP1;CDC42;SEMA5A;CX3CL1;PFN2
prerank,tRNA export from nucleus (GO:0006409),-0.26468139979227956,-0.859421429444529,0.7194244604316546,0.9054915149180846,1.0,16/32,33.24%,NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;SEC13;NUP153;RAN;NUP43;NUP210
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.26468139979227956,-0.859421429444529,0.7194244604316546,0.9054915149180846,1.0,16/32,33.24%,NUP205;NUP155;NUP188;NUP88;NUP93;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;SEC13;NUP153;RAN;NUP43;NUP210
prerank,prostaglandin biosynthetic process (GO:0001516),-0.30991556291878963,-0.8594026597050748,0.648960739030023,0.9048464384593539,1.0,3/18,7.23%,PLA2G4A;PTGDS;PTGIS
prerank,regulation of myotube differentiation (GO:0010830),0.3124200232493998,0.8590841169072411,0.6608996539792388,0.983381299621653,1.0,5/24,8.03%,HDAC9;HDAC3;ATP11A;BDNF;NOTCH1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.27119633000112847,-0.8586649720133033,0.687192118226601,0.9057288238436572,1.0,16/29,34.30%,RFC1;RAD50;TNKS1BP1;MRE11;RPA1;PPP6C;PPP6R3;RTEL1;TELO2;PPIA;HSP90AA1;CDK2;TERF1;TERF2;GAR1;TINF2
prerank,nucleotide catabolic process (GO:0009166),-0.32465667338008497,-0.8582001712710848,0.6558891454965358,0.9060243891996536,1.0,9/16,38.20%,VCP;XDH;DERA;NUDT3;ITPA;GPX1;GDA;NT5C;NT5C1A
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.30000424799613135,-0.8579886369442745,0.6703786191536748,0.9057684207116709,1.0,7/20,20.31%,OSR1;HECW1;CAB39;ACTN2;CAMK2D;HECW2;NEDD4
prerank,cholesterol homeostasis (GO:0042632),0.26011796481976274,0.8578780325335141,0.7208588957055214,0.985440191248309,1.0,10/64,13.55%,INSIG1;HDAC9;APOE;SOAT1;LAMTOR1;SIRT1;SCARB1;LDLRAP1;NPC2;NPC1
prerank,regulation of developmental growth (GO:0048638),-0.27388779175140887,-0.857515707513373,0.7002341920374707,0.9060923622989273,1.0,6/29,10.56%,IGF1;NRCAM;GHR;CTTN;NIPBL;GSK3B
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.383896992375263,0.8574426172125551,0.6429872495446266,0.9857257173886157,1.0,5/11,20.30%,SRC;ARHGEF7;CD44;CORO1C;ENPP2
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.2707785178282102,-0.8573258650955065,0.6894736842105263,0.9057875501627207,1.0,6/28,10.62%,ADCY1;RELN;YTHDF1;LGMN;GSK3B;EPHB2
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.38454731149299276,0.856710714878288,0.6274509803921569,0.986677758192266,1.0,2/10,9.50%,UPP1;UPP2
prerank,negative regulation of lipid storage (GO:0010888),-0.30637329753146275,-0.8566470922990924,0.6516129032258065,0.9065651082948472,1.0,8/19,28.89%,ABHD5;PPARA;ABCA1;TTC39B;PTPN2;OSBPL8;NR1H2;ITGB3
prerank,regulation of viral life cycle (GO:1903900),-0.2997869276083077,-0.8565793799076531,0.6695652173913044,0.9060428230296108,1.0,8/21,26.16%,HS3ST5;AXL;TSG101;TRIM5;VPS4A;NECTIN2;TRIM62;PPIA
prerank,response to steroid hormone (GO:0048545),0.29775887686327585,0.8564833907388417,0.6753246753246753,0.9865042985062696,1.0,3/31,5.00%,SOX30;PAQR8;UBE3A
prerank,response to iron ion (GO:0010039),-0.35067961834527284,-0.8564008976685743,0.6444444444444445,0.9057548046803245,1.0,1/12,0.22%,BMP6
prerank,glycolytic process (GO:0006096),0.3088130478678144,0.8561738855816109,0.6960950764006791,0.9865591230436126,1.0,3/28,10.85%,ENO4;TPI1;GPI
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.30298983865973506,-0.8560043267042516,0.6790697674418604,0.9058670589345199,1.0,3/18,14.82%,WNK1;PPARA;PTPN22
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.33475687165906615,-0.8557977594682276,0.6611570247933884,0.9056573142084656,1.0,5/13,16.96%,BMP7;MED1;BMP4;NR3C2;NR3C1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.33203036395103114,-0.8557541654176655,0.6468085106382979,0.9050663617437775,1.0,8/15,45.89%,IL17RA;GBP5;APPL1;IL17D;TICAM1;NOD2;MYD88;TLR4
prerank,cortical cytoskeleton organization (GO:0030865),-0.25269879219835184,-0.8556813411738057,0.7291666666666666,0.9045344875545606,1.0,12/41,12.92%,EPB41L3;RHOA;ROCK2;ROCK1;NLGN1;EZR;RND3;RHOBTB2;FHOD1;RHOB;RHOBTB1;DLG1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.32046917669671793,-0.8556074408307202,0.6753246753246753,0.9039983485439249,1.0,7/16,29.45%,OGFOD1;IRAK3;UPF1;CLN3;SHFL;HDAC6;MTRF1
prerank,sterol homeostasis (GO:0055092),0.2587935004809467,0.8555950230509303,0.7288135593220338,0.987122702960189,1.0,10/65,13.55%,INSIG1;HDAC9;APOE;SOAT1;LAMTOR1;SIRT1;SCARB1;LDLRAP1;NPC2;NPC1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3167791269546568,0.8552613560266134,0.658493870402802,0.9871666587487903,1.0,2/23,2.03%,CBL;PTPRC
prerank,regulation of leukocyte activation (GO:0002694),0.35730319120607945,0.855254596827956,0.6467289719626168,0.9864755383991158,1.0,3/14,10.58%,LYN;PJA2;MFHAS1
prerank,lipid homeostasis (GO:0055088),0.2619476795820599,0.8550799248149384,0.7158730158730159,0.9861645968839867,1.0,9/57,11.53%,FITM2;APOE;ACOX3;USF2;SIRT1;IRS2;PRKAA2;DDX3X;PNPLA8
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.24684121346905347,-0.8550101304211181,0.7412790697674418,0.904530901666419,1.0,10/42,21.24%,SPIDR;ERCC6;SHLD1;MMS19;KDM1A;ACTR2;PARP1;RIF1;SMCHD1;RTEL1
prerank,protein depolymerization (GO:0051261),-0.2737402937919589,-0.8547879847128533,0.7057416267942583,0.9043212469624592,1.0,8/27,17.63%,GSN;MICAL2;MICAL3;STMN2;CKAP5;WDR1;STMN1;TWF2
prerank,protein-containing complex subunit organization (GO:0043933),0.23919942463495822,0.8546563699943182,0.7584187408491947,0.9864337845263307,1.0,27/109,17.74%,SH3BGR;CAPZA2;KIFAP3;SKAP2;NDUFAF1;KPNA3;NUP54;MAGI1;GEMIN5;SLC2A1;MDM2;TFAP4;CREBBP;ELOB;PICALM;NUP35;APC;HES1;PARD3;NDC1;DNM1L;PTK2B;TUBGCP2;LIN7A;CD2AP;CAPZA1;ST13
prerank,regulation of microtubule depolymerization (GO:0031114),0.3119807558685355,0.8545769789501791,0.6888888888888889,0.9859104397332055,1.0,6/25,7.89%,CLASP2;MAP1S;CIB1;FGF13;CAMSAP2;TRPV4
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3591908047267149,0.8541988323916285,0.6388888888888888,0.9860421225803059,1.0,2/13,5.79%,ALG6;ALG8
prerank,keratan sulfate catabolic process (GO:0042340),-0.3498106265203371,-0.8541151795847582,0.6583333333333333,0.9051100954609309,1.0,6/11,20.05%,OGN;HEXA;HEXB;PRELP;GNS;LUM
prerank,cardiac atrium morphogenesis (GO:0003209),-0.32009265332240755,-0.8538639419437417,0.6728395061728395,0.9049759501621448,1.0,1/16,0.30%,NOTCH2
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.355877912636908,-0.853659762035673,0.6773504273504274,0.9047378824726772,1.0,6/12,21.51%,PARP6;PARP3;PARP12;PARP1;PARP16;PARP2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.31887663245674963,0.8536288636928357,0.6563573883161512,0.9866348367740337,1.0,4/21,10.98%,PDE4D;CNKSR3;SMAD7;DMD
prerank,negative regulation of macrophage activation (GO:0043031),0.3416712085273552,0.8531754561345574,0.6536203522504892,0.9869402635887814,1.0,2/16,2.51%,PTPRC;FCGR2B
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.33162571786541095,0.8531604982443001,0.6501901140684411,0.9862810301593862,1.0,2/15,4.96%,EZH2;PHB2
prerank,regulation of multicellular organism growth (GO:0040014),0.34284566967822705,0.8529227779009342,0.6804308797127468,0.9861138226691735,1.0,3/15,11.27%,SOD1;PPIB;APP
prerank,mRNA catabolic process (GO:0006402),0.2725144232601609,0.8528614461134598,0.7138211382113822,0.9855665872582597,1.0,14/44,20.65%,ZC3H12D;NUDT12;EXOSC9;XRN2;DXO;AGO4;TUT7;TUT4;NBDY;CNOT10;RC3H1;DIS3L2;AGO1;ERN1
prerank,O-glycan processing (GO:0016266),-0.23125716173554123,-0.8526474769231113,0.7653631284916201,0.9061556457696216,1.0,9/54,22.24%,GALNT13;GXYLT2;POFUT1;XXYLT1;ST3GAL4;GALNT14;ST6GAL1;GALNT12;C1GALT1C1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.31796478749631346,-0.8526285045662436,0.6431623931623932,0.9055171187157436,1.0,7/16,24.49%,ABHD5;LDLR;SLC27A1;GPLD1;SREBF1;CTDNEP1;NR1H2
prerank,nucleus organization (GO:0006997),0.2706483372517819,0.8526148088760517,0.7142857142857143,0.9854219445647243,1.0,12/47,19.26%,SYNE1;LEMD3;NUP54;CHMP1A;REEP3;CHMP2A;NUP35;NDC1;VPS4B;USP36;PITPNB;NUP133
prerank,spliceosomal complex assembly (GO:0000245),0.2760351339480356,0.8522800294939189,0.6749226006191951,0.985476349837258,1.0,8/46,10.59%,SNRPD2;NCBP1;SNRPD1;SF1;SRSF10;YTHDC1;SF3A1;SRPK2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.2358589543807525,0.8522056027721956,0.7310344827586207,0.9849602067938463,1.0,19/112,12.63%,CBL;MAP3K7;LRRC32;SRC;SMAD1;ZFP36L1;TGFBRAP1;F11R;SMAD7;SIRT1;ARHGEF18;WNT5A;ACVRL1;CLDN5;NLK;USP15;ZFYVE9;CRKL;CDH5
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.26263258576463905,0.8521585334558238,0.7151607963246555,0.984378816882777,1.0,9/54,12.87%,TNFAIP3;RFFL;BIRC2;SPATA2;CARD16;SYK;RBCK1;IKBKB;CHUK
prerank,carboxylic acid metabolic process (GO:0019752),-0.2654309731539916,-0.8518009859531968,0.6963855421686747,0.90659707668398,1.0,5/33,7.23%,PLA2G4A;DDO;GLUD1;CYB5A;PTGIS
prerank,cellular response to alkaloid (GO:0071312),-0.3114416169660217,-0.8517032946528607,0.6751152073732719,0.9061533991568896,1.0,5/17,22.88%,RYR3;SPIDR;CASP7;BLM;CASP3
prerank,carboxylic acid transport (GO:0046942),0.2650519311109759,0.8516653078270833,0.7198067632850241,0.9847961251198529,1.0,5/55,5.53%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC6A6
prerank,megakaryocyte differentiation (GO:0030219),0.37881234058237906,0.850734328047504,0.6146435452793835,0.9861204754136521,1.0,1/11,1.49%,TAL1
prerank,protein-containing complex disassembly (GO:0032984),0.26096123002020577,0.8504783941787993,0.7057877813504824,0.985976692689638,1.0,8/54,11.25%,MAP1LC3B;HSPA8;RPL23;AXIN1;PYM1;EPG5;TECPR1;UBQLN1
prerank,protein sumoylation (GO:0016925),0.270367509519374,0.8504559071925788,0.7221374045801526,0.9853253240106336,1.0,16/49,19.26%,TRIM28;SAE1;UBE2I;NUP54;UBA2;NUP50;PIAS2;TRPM4;PIAS1;NUP35;NDC1;NUP160;POM121;RANGAP1;NUP42;NUP133
prerank,response to muscle stretch (GO:0035994),-0.3262678877048275,-0.8504522391975131,0.6514161220043573,0.908061183577097,1.0,2/15,3.91%,GSN;CTNNB1
prerank,response to nitric oxide (GO:0071731),0.3517012307162059,0.8495874351997426,0.6697761194029851,0.9865692809077858,1.0,2/13,7.36%,MTR;TXN
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.3226767337542736,-0.8493447060835619,0.6674259681093394,0.9096886086435925,1.0,8/16,21.78%,BMP7;RREB1;NAPEPLD;VSTM2A;SIX1;PTGS2;TFE3;FLCN
prerank,cyclooxygenase pathway (GO:0019371),-0.36542611165508376,-0.8489855955660905,0.6941431670281996,0.9097573727134409,1.0,6/10,27.59%,PTGDS;PTGIS;PTGES;PTGS2;TBXAS1;HPGDS
prerank,negative regulation of ossification (GO:0030279),0.31213406281849576,0.8489309882576375,0.6554934823091247,0.9873139840060656,1.0,6/23,16.36%,GREM1;NOTCH1;TRPM4;RBPJ;PTK2B;LRP4
prerank,positive regulation of protein sumoylation (GO:0033235),0.3864019063934252,0.8488891791824975,0.6451612903225806,0.9867197749938686,1.0,3/10,11.40%,SAE1;UBA2;PIAS1
prerank,adherens junction organization (GO:0034332),0.2686254354604274,0.8486604275177302,0.7151799687010955,0.986523847283496,1.0,7/48,8.66%,CADM1;ACTB;CDH2;RAMP2;CDH12;SMAD7;TJP1
prerank,histone H4 deacetylation (GO:0070933),-0.37102370968403614,-0.8485271894851982,0.6918367346938775,0.9100355538335151,1.0,3/10,4.58%,HDAC4;HDAC1;SIRT2
prerank,cellular glucan metabolic process (GO:0006073),-0.34376188798957213,-0.8483610159015733,0.6778242677824268,0.9097127586916247,1.0,4/11,19.39%,PRKAG2;GSK3B;PYGM;PHKG2
prerank,positive regulation of exocytosis (GO:0045921),0.28036030642645643,0.8483446502848122,0.6773648648648649,0.9865452372945568,1.0,6/35,10.69%,CLASP2;RAB7A;CADPS;RAB2B;CHMP2A;ATP6AP1
prerank,nuclear transport (GO:0051169),0.33878429684130096,0.8482799241373695,0.6579406631762653,0.9860030612826127,1.0,4/16,12.90%,BANF1;NXT1;RSRC1;XPO1
prerank,regulation of monooxygenase activity (GO:0032768),-0.28935248443731754,-0.8481783450728239,0.6929824561403509,0.9093971069923031,1.0,12/23,31.78%,EGFR;WASL;ZDHHC21;DDAH1;NOSIP;AKT1;HSP90AA1;DDAH2;CYGB;SNCA;POR;CAV1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3042387491486681,0.8478378146893953,0.6883561643835616,0.9862802969472525,1.0,9/26,17.58%,BEND3;TET3;SETD5;SETD3;SETD1B;KMT5B;ETFBKMT;SETD2;TET2
prerank,positive regulation of DNA binding (GO:0043388),-0.26495763374027237,-0.8476431264660677,0.7360774818401937,0.9098223610534373,1.0,7/31,16.23%,IGF1;SIRT2;SKI;FOXC1;NIBAN2;NGF;TGFB1
prerank,RNA export from nucleus (GO:0006405),-0.2126130454442414,-0.847381811912579,0.8571428571428571,0.909708504680562,1.0,36/100,24.95%,SRSF5;SRSF11;CASC3;SRSF2;ALKBH5;SRSF6;NUP205;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;HNRNPA1;NUP88;NUP93;DDX19B;SEH1L;THOC5;SLU7;CDC40;UPF1;RNPS1;NUP85;AAAS;RAE1;CPSF3;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13
prerank,response to retinoic acid (GO:0032526),-0.23257596527856583,-0.8472472169599212,0.7890173410404624,0.9092937516867765,1.0,15/59,17.63%,WNT5B;BRINP1;PTK7;RBP4;BRINP2;SNW1;RXRA;EPHA3;RARA;WNT9A;ATM;SETX;ABL2;FZD4;TWF2
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.3638783861849144,-0.8466912639746214,0.6605691056910569,0.90908973789401,1.0,4/10,49.08%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.3638783861849144,-0.8466912639746214,0.6605691056910569,0.90908973789401,1.0,4/10,49.08%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,positive regulation of ATPase activity (GO:0032781),-0.25573683554595206,-0.8466847229211335,0.7435897435897436,0.9084398465992287,1.0,8/41,9.90%,TOR1AIP2;ATP1B1;TPM1;DNAJC24;ATP1B3;TOR1AIP1;ATP1B2;PLSCR1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3220714233972175,-0.8465262652682264,0.6939655172413793,0.9081126492324693,1.0,3/15,8.19%,MED1;BMP4;FOXC1
prerank,positive regulation of insulin secretion (GO:0032024),-0.25403653537508636,-0.8447679919259319,0.726790450928382,0.9110705970604006,1.0,15/36,27.17%,MCU;NLGN2;GLUD1;RBP4;ANO1;TM7SF3;NNAT;PSMD9;GPLD1;TCF7L2;PLA2G6;ADCY8;CAPN10;AACS;LRRC8A
prerank,cortical actin cytoskeleton organization (GO:0030866),0.3251771079242169,0.8446939941971124,0.6780575539568345,0.9924615580277159,1.0,6/20,17.02%,LCP1;RHOQ;IKBKB;PLEK;ARF6;STRIP1
prerank,cellular response to inorganic substance (GO:0071241),-0.2991233441057266,-0.8446232299124545,0.7167919799498746,0.9107212534826001,1.0,11/21,38.98%,KCNC2;SPIDR;DDI2;RTF2;BLM;GUCY1B1;CDK2;DDX11;NSMCE3;TIMELESS;MT3
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.3015496603105393,-0.8444449066687381,0.671264367816092,0.910392278546123,1.0,10/20,24.31%,BICD1;MGRN1;GRK3;RNF157;GPRASP1;CRY1;STMN1;MET;GRK2;APLP1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.2826168307578456,-0.844314552535317,0.7253521126760564,0.9099984663585239,1.0,9/25,33.26%,SMAD3;P2RX4;DDAH1;PTGS2;AKT1;HSP90AA1;DDAH2;ASS1;EDN1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3104991873928323,0.8442868989237559,0.6890034364261168,0.9926431324454976,1.0,7/24,17.09%,RSC1A1;RHOQ;PICALM;TMEM59;AP2M1;LZTFL1;PPP2R5A
prerank,ceramide catabolic process (GO:0046514),0.34858498024210083,0.8439186043147252,0.6685082872928176,0.9927527809549319,1.0,3/14,12.30%,ACER2;ACER3;GM2A
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3181579452468186,0.8438391942223684,0.6709796672828097,0.9922404917475339,1.0,2/20,2.89%,GSK3A;BCL2L2
prerank,regulation of translational initiation (GO:0006446),0.25666733579440476,0.8438319301494078,0.7142857142857143,0.991569303305136,1.0,8/63,11.42%,ATF3;NCBP1;EIF3B;PAIP2B;EIF4H;EIF4G2;DDX3X;EIF4B
prerank,regulation of cell size (GO:0008361),0.30692702432103747,0.8437437615767767,0.6754385964912281,0.991093996646938,1.0,5/23,13.32%,VAV3;RPTOR;AKT1S1;LARS1;PLEK
prerank,mRNA transport (GO:0051028),-0.21094082444576628,-0.8434757513635973,0.8415492957746479,0.9110155606910433,1.0,36/101,24.95%,SRSF5;SRSF11;CASC3;SRSF2;KIF5C;ALKBH5;SRSF6;NUP205;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;NUP88;NUP93;DDX19B;SEH1L;THOC5;SLU7;CDC40;UPF1;RNPS1;NUP85;AAAS;RAE1;CPSF3;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.317773547613122,0.8434177399540524,0.6649572649572649,0.9911259874449928,1.0,7/21,18.21%,PSEN2;SPPL3;DAG1;APH1A;MYH9;ADAM9;SPPL2A
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.32420113484640867,-0.8433656949253955,0.6630669546436285,0.910551692188366,1.0,6/14,30.88%,NRP1;FOXC1;VEGFA;VEGFB;PGF;FLT4
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.20703438261677534,-0.8432324968923076,0.8053691275167785,0.9101561499141406,1.0,22/101,19.59%,PABPN1;MAPK14;AXL;VIM;RHOA;LBP;IRAK1;CDC73;TRIM41;NFKB1;SIRPA;IL18;PTPN22;PAF1;PDE4B;SELENOS;UPF1;DEFA6;TGFB1;MTDH;CHMP5;IRGM
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.28681019946835484,0.8432162541207125,0.6802030456852792,0.9908798253994716,1.0,8/32,16.92%,AEN;HIPK2;EP300;SIRT1;CDIP1;RRP8;DYRK2;USP28
prerank,inositol phosphate metabolic process (GO:0043647),0.2719115623322858,0.8428548853770832,0.7003154574132492,0.9909896104671657,1.0,12/46,18.82%,PPIP5K2;NUDT11;PLCG1;INPP5D;PLCB1;INPP4B;IP6K2;ITPK1;IMPA1;ITPKB;MINPP1;CALM1
prerank,fatty acid catabolic process (GO:0009062),-0.22509200222727938,-0.8427763964672095,0.7957317073170732,0.9104347182495905,1.0,25/67,31.60%,ACBD5;ECI2;PCCB;LPIN1;ALDH3A2;ABCD2;ACAD11;PCCA;CPT2;PEX2;PHYH;ABHD3;EHHADH;ACAD10;LPIN2;ECHDC2;NUDT7;ACAT2;ABCD3;ECI1;LPIN3;SLC27A4;PECR;MCEE;PLA2G15
prerank,positive regulation of stem cell proliferation (GO:2000648),0.3285455407890266,0.8425535149758387,0.678373382624769,0.990971112182942,1.0,3/17,12.29%,PTPRC;TERT;N4BP2L2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.22667223854585886,0.8423411379541601,0.7994652406417112,0.9907508000385534,1.0,16/128,10.49%,FBXL6;ALMS1;HAUS4;HAUS5;CEP41;TUBB;CCNH;DCTN2;CDKN1A;ODF2;WEE1;CEP164;DCTN3;PLCB1;PPP1R12A;DYNLL1
prerank,arachidonic acid metabolic process (GO:0019369),-0.25554634397822384,-0.842307909691003,0.7581047381546134,0.9106939337100367,1.0,4/35,7.23%,PLA2G4A;PTGDS;EPHX1;PTGIS
prerank,regulation of cell population proliferation (GO:0042127),0.1991162578697828,0.8418420665296393,0.9163987138263665,0.991146607435492,1.0,79/691,11.40%,MAZ;ROMO1;JAG2;BNIPL;UTP20;PTPRJ;EZH2;FRZB;LEF1;ACER2;TIAM1;SHCBP1;RPL23;DERL2;IFNLR1;GREM1;DNAJA3;CRLF1;RERG;FABP7;ING4;STOX1;GNRH1;MCTS1;TBC1D8;BCL6B;BIRC2;NME1;CD164;IFI35;ZFP36L1;TSHR;SMARCA2;SLC35F6;MEIS1;SINHCAF;CIB1;TSPO;CDKN1A;P3H2;TBX1;CHTOP;TMEM115;PLPP1;RGCC;FBXO5;SIRT1;RNF187;IRS2;NOTCH1;CNOT7;CDK4;TJP1;IFITM1;TSC1;ACVRL1;RELA;CD47;CSF1R;SOD2;JUND;LYN;MDM2;TFAP4;PAK1;CLDN5;ESM1;TRPM4;SRPK2;RPS9;CD81;CYP1B1;RHOG;HP1BP3;FLT1;NOS3;CTBP1;APP;PIAS1
prerank,muscle tissue morphogenesis (GO:0060415),-0.3143179962789745,-0.8417501085757328,0.7119047619047619,0.9111585722371986,1.0,2/16,4.74%,TGFBR3;BMP4
prerank,extracellular transport (GO:0006858),0.3530428407872343,0.8412329475022134,0.6564885496183206,0.9918353876790409,1.0,1/12,2.17%,CABYR
prerank,positive regulation of lipid transport (GO:0032370),0.37413795279580997,0.8408069639329779,0.6586270871985158,0.9921027492654481,1.0,2/12,5.62%,APOE;DBI
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.2686620517138256,-0.8405626940861003,0.7180722891566265,0.9129748933907583,1.0,5/27,14.92%,NFAT5;RHOA;IRAK1;SIRPA;HSPD1
prerank,mitotic spindle assembly (GO:0090307),0.27494760876121344,0.8404926493091562,0.7160883280757098,0.9921288328328941,1.0,11/42,17.20%,ABRAXAS1;CLASP2;MZT1;KIF2A;BCCIP;KIF3B;CHEK2;ARHGEF10;STAG2;KPNB1;CLASP1
prerank,cellular response to reactive oxygen species (GO:0034614),0.25587972969787554,0.8402597135659952,0.7481259370314842,0.9919656814959226,1.0,10/59,12.87%,MAPK3;ROMO1;TNFAIP3;MAPK8;SIRT1;RELA;PARK7;CYP1B1;RPS3;CHUK
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.2522644009241914,-0.8400898202531991,0.6952141057934509,0.9132991037872309,1.0,14/37,33.36%,DLG4;SIRT2;AATF;OPTN;NFKB1;RIN3;SIRT5;PINK1;PAX2;ITGB3;ANKRD13D;ABCA2;EDN1;ANKRD13B
prerank,positive regulation of chemokine production (GO:0032722),0.26294761600992694,0.8400637846272618,0.6810897435897436,0.9917091638240011,1.0,6/44,11.27%,TIRAP;SYK;WNT5A;CSF1R;DDX3X;APP
prerank,striated muscle contraction (GO:0006941),-0.23249059281028378,-0.839949064401875,0.7727272727272727,0.9129476460369097,1.0,3/53,4.07%,ATP1A2;ATP1B1;TPM1
prerank,postreplication repair (GO:0006301),0.26619157993646825,0.8396473481368786,0.7068145800316957,0.9919664585234674,1.0,7/45,10.17%,RAD18;POLK;UBE2V2;POLD3;TRIM25;SPRTN;UBE2V1
prerank,protein autophosphorylation (GO:0046777),0.2247567530483904,0.8396000745103931,0.8116883116883117,0.9913778433167292,1.0,18/157,9.75%,PRKX;MAP3K11;MAPK3;OXSR1;SRC;MEX3B;PRKD2;MAP3K9;TEK;SMG1;SLK;PIM1;PIKFYVE;PEAK1;MINK1;CSF1R;LYN;PAK1
prerank,tRNA 5'-end processing (GO:0099116),0.3355922232136044,0.838941673053434,0.670863309352518,0.9921189271275612,1.0,3/15,14.97%,RPP25L;POP5;SSB
prerank,thymus development (GO:0048538),0.34969735685960357,0.8383151703608278,0.6731448763250883,0.9928326805930716,1.0,2/13,5.97%,SOD1;TBX1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3022460799195074,0.8383018137193221,0.6894736842105263,0.992177080185914,1.0,4/23,10.99%,PLK2;PRCC;WEE1;CHFR
prerank,regulation of cellular catabolic process (GO:0031329),-0.22664878878807876,-0.8382836942813179,0.7710526315789473,0.9156616123046251,1.0,20/62,21.21%,ITPR1;PSAP;DEPDC5;MAPT;NUPR1;USP13;ROCK1;PIP4K2B;ATM;MTMR4;KEAP1;USP10;DAPK2;RAB8A;ABL2;FBXL2;DAPK1;OSBPL7;HSPB1;KAT8
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.25951512199222515,0.8381258323521664,0.7201907790143084,0.9918601734288686,1.0,15/49,17.79%,BCL2L2;SRC;SGMS1;BCLAF1;BAD;DDX3X;UBQLN1;BMF;PTPMT1;NDUFA13;DDIT3;DNM1L;BECN1;BCAP31;BAX
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.33044872549900023,0.8379675673436627,0.663003663003663,0.9915280748542035,1.0,6/17,13.85%,F11R;CLDN5;PPP1R12A;IKBKB;CDH5;PROC
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.3017864882113692,0.8375740972509291,0.688663282571912,0.9916899295670172,1.0,4/26,8.30%,EEF1A1;ZFP36L1;PTPN12;PLCG1
prerank,positive regulation of viral genome replication (GO:0045070),0.2935284510420861,0.8374539133355616,0.6897163120567376,0.9912622695283397,1.0,7/29,12.53%,IFIT1;ADAR;CNOT7;RAD23A;SRPK2;DDX3X;TMEM39A
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.28258373676269116,-0.8372448757559788,0.7517401392111369,0.9170740606977789,1.0,7/23,19.59%,JAK1;PARP14;IFNGR1;PTPN2;IFNGR2;STAT1;IRGM
prerank,iron ion transport (GO:0006826),-0.2440542280097895,-0.8371666673132588,0.760752688172043,0.9165558885358908,1.0,9/47,12.83%,CP;ATP6V1E1;ATP6V0B;SLC39A14;SCARA5;TCIRG1;ATP6V0A4;STEAP3;ATP6V0C
prerank,regulation of cell morphogenesis (GO:0022604),0.29545062267863265,0.8371387461789821,0.6991735537190082,0.9912456714072805,1.0,10/30,17.02%,SH3D19;FITM2;ZMYM4;CFL1;MYO9A;CD44;MOV10;LARP4;WTIP;STRIP1
prerank,error-prone translesion synthesis (GO:0042276),-0.2897093903902928,-0.8371273063535353,0.7213483146067415,0.9159631154260914,1.0,14/21,42.56%,RFC1;RPA1;UBC;PRIMPOL;RFC2;PCNA;POLE2;POLI;REV3L;RPA3;RFC3;MAD2L2;UBA52;RPA2
prerank,positive regulation of protein depolymerization (GO:1901881),-0.3391623088652339,-0.8369454664505088,0.6900212314225053,0.9156846615299049,1.0,4/11,19.12%,STMN2;WDR1;NES;SEMA5A
prerank,apoptotic nuclear changes (GO:0030262),-0.2784156738319391,-0.8368820330791488,0.7155555555555555,0.9151440810572763,1.0,17/24,46.62%,DICER1;DFFA;CASP3;ACIN1;EXOG;H1-0;CDK5RAP3;DNASE2;DEDD2;HMGB1;GPER1;HMGB2;ACVR1C;DFFB;TOP2A;FOXL2;BLCAP
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.23750912115972897,0.836652828869445,0.7629733520336606,0.9916037559315536,1.0,10/90,7.51%,ALMS1;UCP2;HDAC3;TSHR;KDM3A;ELOVL6;GATM;SYK;ADIPOR2;OMA1
prerank,heart morphogenesis (GO:0003007),-0.23086838063274734,-0.8364561379894203,0.7664835164835165,0.9153684162620294,1.0,11/50,19.72%,TGFBR3;FLRT2;TGFBR1;NIPBL;EPHB4;ACVR1;TBX3;PTK2;MDM4;BMPR1A;OLFM1
prerank,cell differentiation in hindbrain (GO:0021533),-0.3546416921728005,-0.8363095355782462,0.7134020618556701,0.9149848274337162,1.0,2/11,5.67%,GRID2;ATP7A
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.3658272319756937,0.8362609503230323,0.6952191235059761,0.990423637546331,1.0,4/11,16.92%,PANK2;ACAT1;PANK1;PANK4
prerank,coenzyme A biosynthetic process (GO:0015937),0.3658272319756937,0.8362609503230323,0.6952191235059761,0.990423637546331,1.0,4/11,16.92%,PANK2;ACAT1;PANK1;PANK4
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.3658272319756937,0.8362609503230323,0.6952191235059761,0.990423637546331,1.0,4/11,16.92%,PANK2;ACAT1;PANK1;PANK4
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.29841551060362514,0.8362520037180804,0.7111913357400722,0.9897642221656199,1.0,2/25,1.61%,TAL1;ABCB10
prerank,organelle disassembly (GO:1903008),-0.26034866901872555,-0.8356757690812883,0.7312661498708011,0.9155680284229585,1.0,8/33,14.48%,ULK2;UFL1;VCP;GOLGA2;DDRGK1;MRRF;TEX264;EIF2D
prerank,ncRNA export from nucleus (GO:0097064),-0.25016321767019173,-0.8353672790886104,0.7206982543640897,0.9155200150328585,1.0,14/36,24.95%,NUP205;NUP155;NUP188;PHAX;NUP88;NUP93;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;NCBP2;SEC13
prerank,primary miRNA processing (GO:0031053),-0.3629766166208059,-0.8352851664298824,0.678714859437751,0.9150238739983668,1.0,3/10,9.20%,SMAD3;SRRT;HNRNPA2B1
prerank,cilium-dependent cell motility (GO:0060285),0.30739825963165274,0.8348422089227916,0.6887298747763864,0.9921579763300766,1.0,2/22,5.93%,DNAH3;RFX3
prerank,response to amino acid starvation (GO:1990928),0.24719225088171157,0.8347019631111389,0.7406855439642325,0.9917857257024191,1.0,20/72,19.34%,MAPK3;EIF2S1;RPTOR;ATP6V1D;ATP6V0D1;CDKN1A;MAPK8;LAMTOR1;ATP6V0E1;LARS1;RRAGC;ATP6V1B2;TFEB;KPTN;SESN3;DAPL1;ATP6V1A;SH3GLB1;SESN1;LARP1
prerank,mRNA metabolic process (GO:0016071),0.23925144086854172,0.8344992195401554,0.7790368271954674,0.9915659850551857,1.0,24/90,17.29%,ZC3H12D;NCBP1;PRPF3;NUDT12;SFPQ;SRSF4;PRMT9;SF3A1;DXO;AKAP8L;U2AF1;CPSF6;AGO4;PTBP1;PCBP3;SRSF7;USP39;SSB;TCERG1;RNASE4;SLBP;U2AF2;CNOT10;NONO
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.3761101633026402,0.8342219050593325,0.6653306613226453,0.9914494629057337,1.0,3/10,8.03%,NEXMIF;RGCC;NOTCH1
prerank,DNA replication checkpoint signaling (GO:0000076),0.330426612211238,0.8339232424096107,0.6902654867256637,0.9913956761470694,1.0,3/16,11.28%,CDC45;NAE1;HUS1
prerank,protein localization to microtubule organizing center (GO:1905508),0.3359043535224858,0.8335557916900111,0.6685393258426966,0.991490558087531,1.0,6/15,21.09%,DCTN2;CEP83;HOOK3;CCDC14;CEP192;BBS4
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2805199192666733,0.8333450891586341,0.7,0.9912747103425921,1.0,8/32,17.23%,PNKD;PREPL;DTNBP1;MCTP2;MCTP1;SNAPIN;VPS18;SLC30A1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.3220599782295873,0.8330832217364522,0.7086206896551724,0.9911253149251336,1.0,4/18,7.16%,GRIK5;GRIK2;SLC17A6;NAPA
prerank,positive regulation of myelination (GO:0031643),0.3678756053212403,0.8330583001789355,0.6761133603238867,0.9904984976190344,1.0,3/11,14.50%,TNFRSF1B;TENM4;PARD3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.24765039693118715,0.8326242190531405,0.75,0.9907153718526159,1.0,11/68,13.54%,MLYCD;DBI;ACAT1;GPAT4;SULT1A1;RHOQ;BAD;ACOT8;NT5C2;EFL1;GMPR2
prerank,positive regulation of translation (GO:0045727),0.2351257192988063,0.8324374598625627,0.7842565597667639,0.9904228887287869,1.0,11/94,10.80%,JMJD4;EIF5AL1;EIF5A;FASTKD2;LARP4B;FXR1;RPL5;PYM1;NGRN;RPS9;DDX3X
prerank,peptidyl-amino acid modification (GO:0018193),0.3709008966089473,0.8323125222797697,0.6851485148514852,0.9900117933906801,1.0,2/10,10.72%,METAP2;METAP1
prerank,regulation of p38MAPK cascade (GO:1900744),-0.2528402870112444,-0.832277447499509,0.7481840193704601,0.9202457662939512,1.0,8/35,14.82%,SASH1;CYLD;XDH;EZR;ULK4;PER1;DLG1;PTPN22
prerank,genitalia development (GO:0048806),-0.3390016086773935,-0.8322475639024215,0.6900212314225053,0.9196525483811675,1.0,3/12,11.62%,PKD1;DNAJC19;TBX3
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.33118141902608283,0.8321105499557866,0.6943942133815552,0.9897614698766699,1.0,5/17,20.23%,BACH2;CD55;STAT3;CD46;BTN3A3
prerank,response to axon injury (GO:0048678),0.3233468686932621,0.8318952272223764,0.6894639556377079,0.9895453541017933,1.0,2/18,2.94%,SOD1;MTR
prerank,negative regulation of complement activation (GO:0045916),0.36567840043464245,0.8318082728814407,0.6750483558994197,0.9890667659075377,1.0,3/10,18.17%,A2M;CD55;CD46
prerank,negative regulation of chemokine production (GO:0032682),0.34166761167090837,0.831725727158169,0.6876190476190476,0.988572836408412,1.0,1/14,3.42%,MAP2K5
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3133158426435624,0.831524336023957,0.6873857404021938,0.9883266209982905,1.0,5/18,12.41%,GSK3A;EFNA1;RELA;PICALM;SP1
prerank,regulation of actin nucleation (GO:0051125),-0.3322812765458665,-0.8314212682467665,0.7120879120879121,0.9206385010734249,1.0,5/12,28.76%,GSN;WASHC5;ARFIP2;PICK1;ARPIN
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.2712590814480562,0.8313320908973578,0.7392739273927392,0.9880549449580207,1.0,5/43,6.54%,CBL;PTPRJ;RAB7A;EPS15L1;ARHGEF7
prerank,cellular glucose homeostasis (GO:0001678),-0.24238184666640666,-0.8311848345246724,0.7552631578947369,0.9204261325342639,1.0,13/41,22.39%,ZBTB20;LRRC8D;PPARGC1A;SLC39A14;PRKACA;NUCKS1;UNC13B;RACK1;FOXK1;PIK3R1;PCK2;ADCY8;HK2
prerank,polyol metabolic process (GO:0019751),0.2658115774832437,0.831056046496882,0.7162576687116564,0.9879677496389395,1.0,12/46,18.82%,PPIP5K2;NUDT11;PLCG1;INPP5D;PLCB1;INPP4B;IP6K2;ITPK1;IMPA1;ITPKB;MINPP1;CALM1
prerank,mesenchymal cell development (GO:0014031),0.3205159956637195,0.8309020213166124,0.7013651877133106,0.9876365791151429,1.0,3/18,8.03%,CDH2;HEY2;NOTCH1
prerank,regulation of microglial cell activation (GO:1903978),0.3306534323619439,0.8308523777974844,0.696969696969697,0.9870772490588816,1.0,1/15,2.03%,PTPRC
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.22235555115995204,-0.8307526292626746,0.8202247191011236,0.9205737759741001,1.0,16/66,27.69%,FOXP1;IGF1;MALT1;AIM2;SIRPA;USP50;GBP5;GSDMD;CX3CL1;HSPB1;PANX1;GIT1;TRIM16;CX3CR1;EGR1;ZC3H12A
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.3572097732604974,-0.8305244709079759,0.7174887892376681,0.9203698722866117,1.0,3/10,13.63%,KMT2A;SMAD4;CAMK1
prerank,folic acid metabolic process (GO:0046655),0.32967535600144265,0.8304682741153915,0.6853526220614828,0.9872444523006735,1.0,2/18,6.17%,ALDH1L1;MTHFS
prerank,regulation of chromatin organization (GO:1902275),0.3501136128831391,0.8304043336930144,0.6925925925925925,0.9867014411018267,1.0,3/14,13.47%,HPF1;SETD5;TLK2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3292045345852814,0.8303275407081389,0.6890130353817505,0.9862148206902279,1.0,2/19,6.20%,TNFAIP3;CARD16
prerank,glutamine family amino acid catabolic process (GO:0009065),0.35062812137964094,0.8300610999524144,0.6791044776119403,0.9861139337637822,1.0,3/13,11.15%,GLS2;GLS;NOS3
prerank,positive regulation of vasculature development (GO:1904018),0.23755478455983214,0.8298768720344387,0.7585714285714286,0.985843372891252,1.0,16/94,12.63%,PDCL3;HIPK2;PRKD2;RAMP2;TEK;RAPGEF3;SIRT1;PLCG1;WNT5A;TIE1;CYP1B1;FLT1;NOS3;PIK3CD;SP1;CDH5
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.3361518564598267,0.8297694550669117,0.6852207293666027,0.9853973757726411,1.0,4/13,16.35%,SYK;CD81;CD9;CDH13
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2971183586224281,0.8295882580893973,0.7205882352941176,0.9850959386784753,1.0,5/26,14.26%,APOE;PARK7;TERT;SCARB1;GCH1
prerank,positive regulation of macrophage activation (GO:0043032),-0.30568478453606884,-0.8295382256679279,0.6858407079646017,0.9216638398013071,1.0,6/17,27.50%,LBP;THBS1;IL33;HSPD1;TTBK1;KARS1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.3449580120685496,0.8293675399792279,0.692,0.9848589135781314,1.0,2/14,5.04%,PTPRC;TNFRSF1B
prerank,substantia nigra development (GO:0021762),-0.25379810240924355,-0.8290846183710607,0.745679012345679,0.9218572739331041,1.0,8/37,10.05%,PLP1;MBP;RHOA;SIRT2;GLUD1;NDRG2;NDUFS3;CKB
prerank,protein localization to cilium (GO:0061512),0.2876060791381239,0.8289878997607537,0.7246621621621622,0.984983454752336,1.0,4/32,11.47%,ROPN1;ATP6V1D;RABEP1;IFT140
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.27194594088995755,0.8288574881231573,0.7554438860971524,0.9845982801695499,1.0,5/40,9.71%,ZRANB3;POLE;RFWD3;EXD2;MSH3
prerank,cellular response to amino acid starvation (GO:0034198),0.2464699432162138,0.8288200476970599,0.7488789237668162,0.9840122498872407,1.0,19/71,19.06%,MAPK3;EIF2S1;RPTOR;ATP6V1D;ATP6V0D1;CDKN1A;MAPK8;LAMTOR1;ATP6V0E1;LARS1;RRAGC;ATP6V1B2;TFEB;KPTN;SESN3;DAPL1;ATP6V1A;SH3GLB1;SESN1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3176751433437327,0.8286252636936235,0.7140287769784173,0.9837546970796543,1.0,6/20,17.09%,RSC1A1;RHOQ;PICALM;TMEM59;AP2M1;PPP2R5A
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.3190654272254234,-0.8285866467208685,0.707983193277311,0.9221200618435349,1.0,9/15,35.09%,NLGN2;NLGN1;STXBP1;ADRA1A;USP46;CLN3;DRD2;ZDHHC3;BAIAP3
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.23330780555301747,-0.8285392151425847,0.7841530054644809,0.9215466961543013,1.0,14/49,19.25%,LDLRAD4;PRKCZ;JAM3;SORL1;SMAD6;GSK3B;HSF1;PPM1A;DACT1;RAF1;PEX5;CDC42;CRYAB;RIOK3
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.299085811713655,-0.8282009559212798,0.6910755148741419,0.921501291833969,1.0,3/19,5.54%,AXL;MMP14;ZBTB1
prerank,response to hexose (GO:0009746),0.2999634540679701,0.8280371129840635,0.6981132075471698,0.9842721266508203,1.0,4/25,11.51%,SELENOT;IRS2;EIF2B3;ZBED3
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.3541981880589801,0.827927691024697,0.6809701492537313,0.9838064907174883,1.0,3/12,17.51%,ZNF205;CYBA;RAB27A
prerank,toll-like receptor signaling pathway (GO:0002224),0.23780621644385075,0.8273011445930006,0.7692307692307693,0.9844469714986005,1.0,11/84,12.87%,PIK3AP1;MAP3K7;TAB2;TIRAP;BIRC2;TAB3;EPG5;TRAF3;TNIP2;IKBKB;CHUK
prerank,Golgi localization (GO:0051645),-0.3474837297837302,-0.8272557869513782,0.7211740041928721,0.9227340870446862,1.0,5/11,24.83%,UVRAG;STK25;TBCCD1;CDC42;RIPOR1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.24445349026395694,0.827089513897072,0.7696879643387816,0.9842092189355274,1.0,13/74,11.15%,TNFAIP3;SRC;MAP2K5;RFFL;TNFRSF10B;ICAM1;EYA3;ITGA6;RELA;PARK7;TERT;DDX3X;NOS3
prerank,regulation of protein export from nucleus (GO:0046825),-0.2774023780110837,-0.8270741839223495,0.6893424036281179,0.9224352009361134,1.0,8/23,16.41%,PTPN14;BAG3;ANP32B;GSK3B;TP53;CAMK1;SIRT7;TCF7L2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.35457298740152143,0.8267641263434474,0.6780952380952381,0.9842377906417471,1.0,1/12,1.58%,ATF6
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2943747200312221,0.8264782893257179,0.7172774869109948,0.9841458227307611,1.0,2/27,4.64%,ZC3H12D;RNASE6
prerank,DNA replication initiation (GO:0006270),0.2751675169971304,0.8264602306994959,0.732463295269168,0.9835166198341982,1.0,6/37,11.47%,ORC3;POLE;CDC45;ORC4;POLA1;ORC2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.35251549669257815,-0.8262554346129716,0.6919831223628692,0.9233670676236283,1.0,3/11,8.63%,NUPR1;YBX3;BIRC3
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.346921639094817,0.8261123426654122,0.663003663003663,0.9835982068011114,1.0,2/14,9.17%,MAPK3;CSF1R
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3179126531298462,0.8258108863228613,0.6968576709796673,0.9835539851418101,1.0,5/18,13.92%,TNFRSF1B;NOTCH1;NF1;TENM4;HES1
prerank,positive regulation of isotype switching (GO:0045830),-0.31779793349121305,-0.8257566313055569,0.7216035634743875,0.9236260447631656,1.0,9/15,42.22%,PAXIP1;SHLD1;TGFB1;RIF1;SHLD2;CD40;MAD2L2;CLCF1;TNFSF13
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.33861979258244684,-0.8256639632531273,0.7223382045929019,0.9231434799114938,1.0,3/12,7.34%,DSCAM;NKD1;SDK2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.32919290827630715,0.8256321811836644,0.7041420118343196,0.9832640243605237,1.0,3/17,9.19%,PRKG1;CDKN1A;SOD2
prerank,C4-dicarboxylate transport (GO:0015740),0.3399965345822821,0.8254232012751649,0.6804511278195489,0.9829991931784067,1.0,3/14,12.49%,SLC1A1;SLC1A2;SLC25A12
prerank,positive regulation of cell death (GO:0010942),0.2517778595353849,0.8251097484701381,0.775112443778111,0.9829970726310366,1.0,10/59,13.86%,ACER2;EIF2S1;FCGR2B;FYN;SLC6A6;WNT5A;PICALM;PRNP;FAF1;APC
prerank,myelination in peripheral nervous system (GO:0022011),0.34992835203460604,0.8250618186014611,0.6958250497017893,0.982435023769442,1.0,5/13,14.63%,SOD1;NF1;ADGRG6;PARD3;ARHGEF10
prerank,translesion synthesis (GO:0019985),-0.23878389972409006,-0.824223194135343,0.7820823244552058,0.9251910692457598,1.0,30/42,46.52%,RFC1;RCHY1;ZBTB1;VCP;RPA1;UBC;NPLOC4;POLDIP2;USP10;PRIMPOL;RFC2;POLN;PCNA;POLE2;POLI;UBE2L6;ISG15;REV3L;FAAP20;RPA3;RFC3;MAD2L2;UBA52;USP43;POLD2;RPA2;PCLAF;RFC4;POLD4;POLD1
prerank,monocyte chemotaxis (GO:0002548),-0.25857391983923594,-0.8240788036951785,0.7702020202020202,0.9248174870419523,1.0,6/32,22.13%,IL6R;ANXA1;CCL14;PTPRO;CX3CL1;CCL13
prerank,lipid oxidation (GO:0034440),0.35204728258928425,0.8239409788037401,0.6757281553398058,0.9840463066575433,1.0,2/12,11.09%,ADIPOR2;ADIPOR1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.23004190740608832,0.8238596755956221,0.8013986013986014,0.9835619558621584,1.0,12/98,9.96%,ROMO1;CHCHD2;IFNLR1;GREM1;PAX8;APOE;CDKN1A;PPARD;ACACB;RAB1A;IL10RB;IFNAR1
prerank,B cell proliferation (GO:0042100),0.32372551642752867,0.8234846626954452,0.6955684007707129,0.9836749618408939,1.0,1/17,2.03%,PTPRC
prerank,histone mRNA catabolic process (GO:0071044),-0.3146546901795899,-0.823360955881312,0.7120535714285714,0.9255570423252358,1.0,6/15,23.79%,EXOSC10;DCP2;ATM;UPF1;ERI1;TUT1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.35339215634749643,-0.8223851910295261,0.687374749498998,0.9267438094034087,1.0,4/10,25.87%,GHR;STAT6;PRLR;STAT5A
prerank,regulation of proteolysis (GO:0030162),-0.2352399330917256,-0.8221220451601046,0.8045685279187818,0.9265866677428075,1.0,20/48,31.78%,OGT;CYFIP2;FBXW11;BTRC;IST1;CAMK2N1;NEDD8;GSAP;TBC1D10A;RNF139;STUB1;BAG6;CLN3;AKT1;PERP;HDAC6;DNAJC1;CDK5;FGFR4;CAV1
prerank,purine-containing compound catabolic process (GO:0072523),-0.3281740161686477,-0.8221206301563783,0.6901098901098901,0.9259331886036295,1.0,2/13,6.97%,DPYD;XDH
prerank,organelle transport along microtubule (GO:0072384),0.28679670648685696,0.8220496438454081,0.7400662251655629,0.9859639091642746,1.0,8/31,14.53%,DYNC1I1;MAP1S;COPG2;UXT;RAB6A;RAB1A;COPG1;BICD2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2791031540092739,0.8219493509044938,0.7508361204013378,0.9855243062861925,1.0,5/34,10.58%,TNFAIP3;RAB7B;LYN;NFKBIL1;MFHAS1
prerank,telomere maintenance (GO:0000723),0.2577597453181377,0.8218410251120004,0.7565084226646248,0.9850978911805518,1.0,12/50,16.75%,CTC1;ERCC4;DCLRE1B;POLD3;ACD;TERT;HUS1;NBN;LTO1;TERF2IP;ATR;PRKDC
prerank,negative regulation of synaptic transmission (GO:0050805),0.30477744429362014,0.8216305495184725,0.7106690777576854,0.9848598201268609,1.0,3/23,9.28%,PLK2;PNKD;ARF1
prerank,gonad development (GO:0008406),-0.23906993745116242,-0.8214152542380939,0.8015665796344648,0.9266297772068665,1.0,6/41,12.96%,NR2F2;KIT;WNT4;SALL1;NCOA4;MSH2
prerank,lipid translocation (GO:0034204),0.3098110312797483,0.8213016539103452,0.7182608695652174,0.9848774688808394,1.0,7/21,18.56%,ATP8A1;ATP11A;TMEM30B;ATP11C;ATP10A;TMEM30A;ATP9B
prerank,phospholipid biosynthetic process (GO:0008654),0.27743924386651164,0.8204891400965633,0.747008547008547,0.985811192805178,1.0,6/36,11.32%,GPAM;FITM2;SGMS1;MBOAT1;IDI1;AGPAT3
prerank,visual system development (GO:0150063),0.27208874408289707,0.8204604199091236,0.7364975450081833,0.9852228512306291,1.0,4/37,4.88%,ATF6;HIPK2;SOX2;MEIS1
prerank,cellular response to oxygen levels (GO:0071453),0.3657438760935152,0.8204462905489817,0.6666666666666666,0.9846035712258777,1.0,3/10,10.69%,ATP6V0D1;NDUFS2;ATP6AP1
prerank,positive regulation of embryonic development (GO:0040019),-0.29485383802131315,-0.8204141676840176,0.7282850779510023,0.9278212372102357,1.0,5/19,14.16%,OSR1;WNT4;NIBAN2;NR2C2;RACK1
prerank,protein destabilization (GO:0031648),0.28187714798286967,0.819930783182922,0.717206132879046,0.9849603889669116,1.0,8/32,12.84%,EP300;CCDC88C;SIRT1;MDM2;RAD23A;CREBBP;PRNP;CUL3
prerank,homocysteine metabolic process (GO:0050667),-0.3463578520855386,-0.8196559478930672,0.6946902654867256,0.9285491260956461,1.0,2/11,11.53%,MTHFR;NOX4
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.3626523716043098,-0.8192388873935535,0.7051792828685259,0.9280241910172407,1.0,5/10,17.84%,AP2B1;AP2A2;AP2A1;VLDLR;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.3626523716043098,-0.8192388873935535,0.7051792828685259,0.9280241910172407,1.0,5/10,17.84%,AP2B1;AP2A2;AP2A1;VLDLR;MYLIP
prerank,mitotic cytokinetic process (GO:1902410),-0.29096376428387105,-0.8191806018162536,0.7511520737327189,0.9274603324966432,1.0,7/20,25.32%,RHOA;KLHDC8B;MITD1;CHMP2B;CHMP5;VPS4A;CNTROB
prerank,RNA biosynthetic process (GO:0032774),-0.2568998838249962,-0.8191686313299692,0.7548543689320388,0.9268230331876913,1.0,14/31,32.64%,NCOA6;POLR2A;SETX;TAF6;TAF12;PRIM2;GTF2B;TAF13;SMN1;PRMT5;POLA2;PRIM1;TAF7;TAF5
prerank,cellular response to unfolded protein (GO:0034620),0.2907402115853074,0.8191543108901751,0.7305699481865285,0.9858431994022935,1.0,2/26,1.88%,ABCB10;HSPA8
prerank,PERK-mediated unfolded protein response (GO:0036499),0.3668681202055588,0.8190531861931598,0.6957364341085271,0.9853895542728129,1.0,3/10,16.60%,EIF2S1;DDIT3;QRICH1
prerank,autophagy of peroxisome (GO:0030242),0.3510699159284083,0.8188837443171518,0.6990825688073394,0.9850809276491533,1.0,3/12,11.65%,MAP1LC3B;TRAPPC8;NBR1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.326518253210418,0.8187118845869701,0.7055555555555556,0.9847667420797679,1.0,3/16,16.59%,TRIB3;ERLIN2;ACADL
prerank,organonitrogen compound catabolic process (GO:1901565),0.2492683875832131,0.8185479242344342,0.7623604465709729,0.9844577366024253,1.0,3/57,3.22%,LVRN;AMDHD2;PPT1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.3031083872863493,0.8184830737687042,0.7274368231046932,0.9839388839798199,1.0,5/22,11.77%,MAP3K4;MINK1;PJA2;MFHAS1;RELL1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.34787584322318177,0.8179409418305841,0.7027027027027027,0.9843843802864803,1.0,2/12,6.35%,PRPS1L1;PRPS1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.32350939486118035,0.8179385891575701,0.7050092764378478,0.9837455031906647,1.0,1/16,0.61%,IMPDH1
prerank,peptidyl-arginine modification (GO:0018195),0.33042350472978876,0.8179087179863428,0.7054409005628518,0.9831645286356673,1.0,2/15,9.76%,NDUFAF5;PARK7
prerank,regulation of B cell apoptotic process (GO:0002902),-0.3325926334312964,-0.8175932545801211,0.7316561844863732,0.9291420173789944,1.0,1/12,0.28%,FOXP1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.3402656286546838,-0.8174558124006152,0.7068273092369478,0.9287292172815146,1.0,4/11,19.91%,THBS1;CD34;BMPR1A;PTGS2
prerank,autonomic nervous system development (GO:0048483),-0.29670202142030655,-0.8169934463197608,0.7454954954954955,0.9289470709260295,1.0,3/17,11.11%,NRP1;SEMA3A;FN1
prerank,microglial cell activation (GO:0001774),-0.2881014045293178,-0.8169661562737259,0.7210401891252955,0.9283320105585355,1.0,13/21,50.17%,MAPT;IFNGR1;CX3CL1;CX3CR1;SNCA;C1QA;CLU;TYROBP;ITGB2;ITGAM;AGER;AIF1;TREM2
prerank,regulation of protein kinase B signaling (GO:0051896),0.2123502041872742,0.8166266577397561,0.8721518987341772,0.9851019310884676,1.0,23/193,11.82%,RAC2;MAZ;PIK3CG;TRIB3;PIK3AP1;PTPRJ;SRC;TEK;FYN;CIB1;RET;SIRT1;TXN;IRS2;DAG1;PHLPP1;PARK7;ESR1;MFHAS1;OTUD3;RHOG;PIK3CD;PIK3R5
prerank,atrioventricular valve development (GO:0003171),-0.32531113619798113,-0.8164877719852067,0.7052401746724891,0.9285943813727685,1.0,5/14,19.93%,TGFBR2;ACVR1;MDM4;BMPR1A;BMPR2
prerank,platelet aggregation (GO:0070527),0.2804944873103935,0.8164415763307415,0.7345132743362832,0.9848277568567786,1.0,8/33,15.74%,PIK3CG;ACTB;MYL9;METAP1;PLEK;CSRP1;FIBP;MYH9
prerank,amide transport (GO:0042886),-0.26439900239670605,-0.8164264786177519,0.785,0.9280511763162671,1.0,9/26,24.93%,PDPN;PLEKHA8;SLC25A32;SLC27A1;SLC19A1;SLC5A6;GLTP;ABCB9;AQP11
prerank,cellular response to superoxide (GO:0071451),0.3597118138045108,0.8161620400492101,0.6988416988416989,0.9847331118429546,1.0,3/10,11.15%,SOD1;SOD2;NOS3
prerank,protein targeting to membrane (GO:0006612),0.23571205641890133,0.8161403595762481,0.7933042212518195,0.9841281073637093,1.0,14/83,14.50%,RTP3;CHM;SGTB;ZDHHC14;PIKFYVE;PXMP2;ZDHHC15;ICMT;VPS37B;SEC62;PRKCI;ZDHHC9;ZDHHC7;PARD3
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.35407180585367876,0.81613727891196,0.6706349206349206,0.9834913036882614,1.0,1/12,0.88%,SEMA6A
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.35782280490418034,0.8159309242275028,0.7123287671232876,0.98325086782244,1.0,2/11,6.27%,ATL1;LPCAT3
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2995863449503906,0.8156264198556615,0.7160493827160493,0.9832196283279452,1.0,5/22,13.86%,CDK5RAP1;CDKN1A;LATS2;TFAP4;APC
prerank,organic substance transport (GO:0071702),-0.1970348507364982,-0.8147995356087058,0.9285714285714286,0.9303190243823786,1.0,24/120,15.92%,CALCRL;ABCA9;SLC47A1;SNX4;ARRDC3;LRP1B;ABCA4;ABCA5;TCN2;SLC35F3;PLEKHA8;SLC22A4;SCAMP2;FLVCR1;KIF3A;ABCA1;CHKA;RAMP1;ABCD2;VAMP2;SLC22A6;RCN3;SCAMP5;SLC19A1
prerank,mitochondrion transport along microtubule (GO:0047497),0.3373086848602743,0.8147098153051331,0.6987060998151571,0.9844089808565251,1.0,2/13,7.04%,MAP1S;UXT
prerank,second-messenger-mediated signaling (GO:0019932),-0.2085799235668009,-0.8146543035006089,0.878125,0.9299166608912584,1.0,10/82,10.84%,MCU;PPP1R9A;NUDT4;PLCE1;P2RX4;CHRM3;CCR9;KSR2;ACKR3;DDAH1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.3332676335177782,0.8146501968188411,0.6906077348066298,0.9838806159375545,1.0,3/14,12.58%,SYK;CD81;CD55
prerank,heterochromatin assembly (GO:0031507),-0.2795185759546571,-0.8143905732089809,0.7668161434977578,0.9297512358044737,1.0,10/20,29.77%,HDAC1;SIRT2;ZNFX1;CENPV;HELLS;SMCHD1;NRDE2;BAHD1;HMGA2;SUV39H1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3375902710877434,0.8140750019432914,0.7044609665427509,0.984347480974431,1.0,4/14,13.21%,MAP2K5;MMRN2;NOTCH1;HDAC5
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2606026263404583,0.813947728505391,0.749185667752443,0.9839756550906549,1.0,10/44,17.44%,VASP;EVL;ARPC4;PFN1;CDC42EP3;LMOD1;WHAMM;ARF6;PTK2B;BAIAP2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.2525042212575828,0.8139249919131057,0.7824074074074074,0.9833831302495578,1.0,20/57,21.16%,RPL35A;RPL5;EMG1;RPS28;RPS24;LTV1;RBIS;WDR12;PAK1IP1;XPO1;LTO1;NPM1;RPL38;RPL26;NVL;RPL7;RPL14;TGS1;GTF3A;SDAD1
prerank,recombinational repair (GO:0000725),0.24048388949551938,0.8137687737520926,0.7965116279069767,0.9830678189026855,1.0,15/77,14.95%,ZSWIM7;ERCC4;YY1;XRCC1;SFPQ;KDM4D;SEM1;RFWD3;EXD2;RAD51B;HUS1;NBN;PSMD14;RMI1;INO80
prerank,xenobiotic transport (GO:0042908),-0.30585555957923194,-0.8137232712216524,0.7130434782608696,0.9303517398638457,1.0,3/16,10.60%,SLC47A1;SLC22A4;GJA1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.22590947355285296,-0.8136496980629324,0.8123249299719888,0.929820294971837,1.0,20/56,30.99%,SFTPA2;SFTPA1;LBP;IRAK1;LGMN;UBC;TAB1;LACC1;IRAK4;IRAK2;CNPY3;CTSK;TLR3;BCL10;MAPKAPK2;CTSB;TIFA;CTSS;S100A1;TLR7
prerank,modulation by host of symbiont process (GO:0051851),0.2789257137551566,0.8135485237414644,0.727580372250423,0.9828495209335449,1.0,6/31,12.41%,LEF1;EP300;TFAP4;TARDBP;CHD1;SP1
prerank,positive regulation of protein deacetylation (GO:0090312),0.33667943856933547,0.8134096371634892,0.7026022304832714,0.9824660890682594,1.0,3/14,11.22%,AKAP8L;ING2;CTBP1
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.2736642395212976,-0.8130573683806847,0.7168949771689498,0.9302212346147534,1.0,4/24,9.32%,CTNNB1;EPHA7;NUPR1;BACE1
prerank,icosanoid metabolic process (GO:0006690),-0.23822389933628552,-0.8129113330763106,0.7925,0.9298353740715332,1.0,20/40,46.43%,PLA2G4A;EPHX1;PTGIS;GGT5;PTGS2;GPX1;TBXAS1;MAPKAPK2;ABCC10;FADS1;ALOX12;PTGS1;PLA2G4C;DAGLA;FAAH;CYP2S1;LTA4H;PTGR1;MGLL;GGT1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.24188626208922176,0.8128176142918001,0.7873303167420814,0.9829814729812059,1.0,6/66,4.67%,RBM22;TRIM28;DMAP1;CCT2;HDAC3;CCT5
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3413447371425464,0.812805566934926,0.7303370786516854,0.9823679911285832,1.0,1/13,5.41%,CYRIB
prerank,steroid biosynthetic process (GO:0006694),0.24697816988604832,0.8127414357595303,0.7757296466973886,0.9818569450618246,1.0,9/56,13.80%,EBP;INSIG1;HMGCR;SC5D;OSBPL1A;HSD17B4;ACOT8;LSS;OSBPL2
prerank,negative regulation of programmed cell death (GO:0043069),0.19907145419306832,0.8126089944912734,0.929384965831435,0.9814727965742648,1.0,46/355,12.73%,HIGD2A;GCLC;MECOM;CBL;LEF1;PSEN2;PLK2;RPS6KA1;BCL2L2;GREM1;PPT1;SRC;BIRC2;HDAC3;TEK;RAB7A;CIAPIN1;HNRNPK;PHB2;WFS1;CFL1;CIB1;MAPK8;BAG1;PIM1;SIRT1;NAA35;USP47;WNT5A;TJP1;RELA;PCID2;PARK7;TMBIM4;CITED2;PRKAA2;DDX3X;HIGD1A;ANKLE2;PA2G4;BNIP3L;PRKCI;MAP4K4;IKBKB;API5;ERC1
prerank,hippo signaling (GO:0035329),0.2850910994806778,0.8125957968128678,0.7229965156794426,0.9808614768404057,1.0,5/26,9.10%,AMOTL1;YWHAB;TJP1;LATS2;MOB1B
prerank,protein autoprocessing (GO:0016540),0.31426955026475756,0.8123645795794909,0.701688555347092,0.9806690438867359,1.0,2/17,9.11%,OMA1;SPRTN
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.22997605815877137,0.8121899280720423,0.8114874815905744,0.9803760645613926,1.0,27/100,18.07%,GSK3A;TRIB3;ARIH1;COP1;FOXF2;SMAD7;DESI1;GNA12;MDM2;RAD23A;PARK7;RYBP;CCAR2;PIAS1;ELOB;XPO1;TLK2;GIPC1;RNF180;UCHL5;FBXO22;UBQLN4;TAF1;N4BP1;RAD23B;BBS7;GABARAP
prerank,telomere maintenance via telomerase (GO:0007004),-0.25947702671977546,-0.8121362696334224,0.7413793103448276,0.9305700965297052,1.0,15/28,34.30%,RFC1;RAD50;TNKS1BP1;MRE11;RPA1;PPP6C;PPP6R3;RTEL1;TELO2;HSP90AA1;CDK2;TERF1;TERF2;GAR1;TINF2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.36384189863349187,0.8119110588271788,0.7198364008179959,0.9803030766688134,1.0,3/10,14.72%,ATP5MG;ATP5MC2;ATP5F1C
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2701949278739887,-0.8118606076566943,0.766743648960739,0.9304499313511884,1.0,4/24,7.71%,ANK3;CEMIP;AKT2;FIS1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.23664414292036334,0.8115830013897694,0.7994186046511628,0.980289879283913,1.0,10/82,10.49%,ALMS1;HAUS4;HAUS5;CEP41;TUBB;DCTN2;ODF2;CEP164;DCTN3;DYNLL1
prerank,positive regulation of chromatin organization (GO:1905269),0.34407235324230795,0.8114763126233019,0.7056530214424951,0.9798368666399804,1.0,5/12,18.79%,TAL1;ACD;TERF2IP;SIN3A;ATRX
prerank,integrated stress response signaling (GO:0140467),0.3349549337248608,0.8113147875309189,0.6925925925925925,0.9795293944277612,1.0,4/14,16.60%,EIF2S1;OMA1;DDIT3;QRICH1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.2796157327416819,0.8109437866461908,0.7583187390542907,0.9795739646022582,1.0,3/31,9.59%,TIRAP;SYK;PLCB1
prerank,protein processing (GO:0016485),0.22626697331864937,0.8105234974341549,0.8502139800285307,0.9797562440264901,1.0,10/102,10.03%,PCSK1;PSEN2;MME;SEC11A;METAP2;SPCS3;SPPL3;OMA1;SPRTN;VSIR
prerank,vitamin transport (GO:0051180),0.286543056859973,0.8104593871688724,0.7406143344709898,0.9792633168584539,1.0,3/29,5.01%,ABCG2;SLC52A2;SLC52A3
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3113961010985846,0.8100638480267618,0.7198581560283688,0.9793843459172563,1.0,4/20,7.83%,ATP2A2;WFS1;RAP1GDS1;SELENOK
prerank,negative regulation of leukocyte activation (GO:0002695),-0.30103918204501845,-0.8096730115712587,0.7330508474576272,0.9337414221580358,1.0,2/15,7.05%,LRFN5;IL31RA
prerank,glial cell development (GO:0021782),-0.2697483009737743,-0.809290372302451,0.7687224669603524,0.9337493633225019,1.0,17/25,41.94%,CDK6;MXRA8;TPPP;NRROS;PICK1;EIF2B5;CSPG5;MDK;EIF2B2;EIF2B4;MYRF;NSUN5;SOX11;SOX10;MT3;SOX4;EIF2B1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.33766997527265574,-0.8092672085757951,0.7349137931034483,0.933134590455688,1.0,2/11,2.13%,OGT;KMT2A
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.20291275697896133,-0.8092204809571736,0.9082278481012658,0.9325624204260603,1.0,21/86,21.71%,NAV3;MAPT;OCLN;FER;CTTN;STMN2;AKAP9;SLAIN2;BIN1;SYNPO2;BAIAP2L1;FCHSD2;WDR1;CDC42EP5;DCTN1;CDC42EP1;SEMA5A;MET;CX3CL1;EFEMP2;PFN2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.3162992134409408,0.8091764267294689,0.7300177619893428,0.9804356859127595,1.0,2/19,6.17%,ALDH1L1;MTHFS
prerank,polyamine metabolic process (GO:0006595),0.3324507169753752,0.8090752719338137,0.712430426716141,0.9800049904275364,1.0,4/13,15.27%,SMOX;DHPS;AMD1;ODC1
prerank,polyol biosynthetic process (GO:0046173),0.3303147135901572,0.8088175819070765,0.7254901960784313,0.9798785918104372,1.0,4/16,16.52%,PPIP5K2;ACER3;IP6K2;ITPKB
prerank,protein monoubiquitination (GO:0006513),0.26561398631510164,0.8087799546617922,0.7714776632302406,0.9793231965273596,1.0,8/36,14.31%,RAD18;TRIM25;ATXN7L3;UBE3D;CUL3;UBE2R2;RNF20;FANCL
prerank,positive regulation of intracellular transport (GO:0032388),0.2651393797499128,0.8086599220050102,0.7639344262295082,0.9789167030966895,1.0,5/38,9.94%,PRR5L;ZFAND1;ICE1;RUFY3;EIPR1
prerank,regulation of histone deacetylation (GO:0031063),0.3351041407506534,0.8084756808645993,0.7054409005628518,0.9786193335669999,1.0,3/13,11.22%,AKAP8L;ING2;CTBP1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.29984594554522465,-0.8082203659275962,0.75,0.9336707929558488,1.0,9/16,31.78%,PARP14;PIBF1;NF2;PTPN2;HGS;VHL;INPP5F;BCL3;CAV1
prerank,regulation of superoxide anion generation (GO:0032928),0.3322949925359904,0.8078783743727995,0.7377690802348337,0.9791459334614081,1.0,2/14,6.70%,SOD1;SYK
prerank,insulin receptor signaling pathway (GO:0008286),0.24317565713667652,0.807685544741973,0.7920489296636085,0.9789044801661886,1.0,21/69,18.86%,GSK3A;BCAR3;ATP6V1D;ATP6V0D1;AP3S1;IRS2;ATP6V0E1;RHOQ;ATP6AP1;GRB14;APC;PIK3C2A;ATP6V1B2;NAMPT;SHC1;BAIAP2;INSR;C2CD5;ATP6V1A;IRS1;ZNF106
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.23857154845400358,0.8075802114371436,0.8348348348348348,0.9784784229463374,1.0,9/72,9.68%,ERCC3;RNASE6;ERCC4;POLK;POLD3;GTF2H1;XRN2;DXO;EXD2
prerank,macrophage chemotaxis (GO:0048246),0.3670053220613378,0.8071913859859793,0.7189292543021033,0.9785690577115456,1.0,1/10,8.25%,EDNRB
prerank,regulation of plasminogen activation (GO:0010755),0.3391516607841469,0.8070726624288557,0.7053231939163498,0.978176755479041,1.0,1/12,1.93%,PLGRKT
prerank,vasoconstriction (GO:0042310),0.35330378618655756,0.8069136772572425,0.6853932584269663,0.9778555362892937,1.0,3/11,14.60%,EDNRB;ACTA2;PIK3C2A
prerank,regulation of mast cell activation (GO:0033003),0.3592229700308832,0.80664556981437,0.705078125,0.9777284181410512,1.0,2/10,9.52%,LYN;CD84
prerank,regulation of mononuclear cell migration (GO:0071675),0.2987864030420443,0.8064821643232508,0.7363013698630136,0.9774032698390919,1.0,3/23,9.31%,MAPK3;CSF1R;LYN
prerank,endoplasmic reticulum organization (GO:0007029),0.23501519568073725,0.8061794054062943,0.8124054462934948,0.9773597535643096,1.0,10/72,11.93%,REEP1;SMPD4;LMAN2;ATL1;LPCAT3;REEP3;DOP1B;APP;ZBED3;PRNP
prerank,cellular component disassembly (GO:0022411),0.2462302637679666,0.8061509389115554,0.7954911433172303,0.9767928765809417,1.0,4/53,4.43%,LCP1;BSG;EXOC8;MMP12
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.30122521855923073,-0.8061215884580205,0.7340909090909091,0.9367338701581946,1.0,6/17,16.42%,VCP;RHBDD1;HERPUD1;NPLOC4;SELENOS;HM13
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.313431409893179,0.8060769967970968,0.7228260869565217,0.9763086130383987,1.0,6/17,18.94%,SPRED1;CALM3;SMAD7;PARD3;CALM1;EIF4G1
prerank,regulation of organelle assembly (GO:1902115),0.24078771665852952,0.8058196138558521,0.8046153846153846,0.9761742335611721,1.0,13/72,13.25%,ALMS1;PLK2;TBC1D8;VPS11;TBC1D10B;USP6NL;PIKFYVE;TBC1D12;IFT140;ADPRH;TBC1D24;TBC1D14;RABGAP1
prerank,histone deubiquitination (GO:0016578),0.31497199092045225,0.8058104593625103,0.7247191011235955,0.9755740503186787,1.0,7/18,19.51%,ATXN7L3;USP22;USP15;TRRAP;BRCC3;USP36;UIMC1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.28396241206228007,-0.8056810226853323,0.7488888888888889,0.9368363888357327,1.0,7/20,26.71%,EGFR;PKD1;CCND3;CCNYL1;AKT1;SPDYA;TTBK1
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.28466649623867235,-0.805064157839138,0.7629310344827587,0.937260033331597,1.0,4/19,9.34%,CBFB;IRAK1;IFIH1;ELF1
prerank,nucleosome organization (GO:0034728),0.25386789905114227,0.8050537759645044,0.7828282828282829,0.9764044747147927,1.0,14/55,19.09%,DMAP1;NAP1L4;VPS72;RSF1;SMARCD1;ZNHIT1;BRD2;INO80;SMARCA4;SETD2;NPM1;ACTR6;ATRX;SMARCB1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.2864159088865594,0.8048579551052626,0.7277486910994765,0.9761690441956478,1.0,9/26,19.36%,TRIB3;ADIPOR2;PRKAA2;ERLIN2;ADIPOR1;ACADL;EIF6;ELOVL5;NR1H3
prerank,extracellular matrix disassembly (GO:0022617),0.24603595552984753,0.804514409687292,0.7967741935483871,0.9761500719400645,1.0,4/53,4.43%,LCP1;BSG;EXOC8;MMP12
prerank,regulation of autophagosome maturation (GO:1901096),0.3389999478217864,0.8040348206907689,0.7287822878228782,0.9764609046854442,1.0,4/13,15.33%,FYCO1;TBC1D25;TMEM39A;UBQLN4
prerank,carbohydrate derivative catabolic process (GO:1901136),0.3142076743137614,0.8028266385552512,0.7362637362637363,0.9781206405703307,1.0,3/18,10.87%,BPGM;FUCA1;STT3B
prerank,ruffle organization (GO:0031529),-0.29685039649875183,-0.8027815833008382,0.7537473233404711,0.9405968315746088,1.0,3/16,6.02%,LIMA1;TPM1;PIP5K1A
prerank,base-excision repair (GO:0006284),0.2519093188769663,0.8027406106361739,0.782258064516129,0.9776534773295494,1.0,8/48,13.19%,PNKP;XRCC1;TDG;POLE;POLD3;USP47;SMUG1;MPG
prerank,positive regulation of interferon-beta production (GO:0032728),-0.24775925002860394,-0.8025878992599562,0.8259860788863109,0.9402838615285748,1.0,15/33,37.14%,IFIH1;RNF135;POLR3C;MAVS;RIOK3;FLOT1;TLR3;OAS2;HSP90AA1;POLR3G;TOMM70;TLR7;POLR3D;ISG15;DHX58
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.36287667801509266,0.8024659957779904,0.7193308550185874,0.9775292496045541,1.0,4/10,21.13%,TXN;PARK7;PDE8A;LRRK2
prerank,regulation of lipase activity (GO:0060191),-0.32357792596381474,-0.8019391090581215,0.746606334841629,0.9407355930171291,1.0,3/13,13.47%,PCSK5;RHOA;PCSK6
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.2643917968675847,0.8009026214675491,0.766612641815235,0.9798006628797965,1.0,7/38,10.76%,TRIB3;PTPRJ;CIB1;SIRT1;DAG1;PHLPP1;OTUD3
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.3317047217393769,-0.8006763046972538,0.7456896551724138,0.9422332177417317,1.0,1/12,3.91%,CTNNB1
prerank,response to ketone (GO:1901654),-0.26677624094739893,-0.800263122420842,0.7801418439716312,0.9422978483244944,1.0,9/24,33.81%,TGFBR3;THBS1;TGFB1;CATSPER2;YAP1;TGFB3;CAV1;ABCB4;CATSPER3
prerank,glycerolipid metabolic process (GO:0046486),0.34932988983136626,0.7994727719753152,0.686046511627907,0.9817656713580533,1.0,2/11,11.01%,DGKB;PGP
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.269680404480718,-0.799334043066908,0.7785234899328859,0.9432072082622696,1.0,4/21,13.65%,ZWINT;KLHL22;BUB3;ATM
prerank,cell junction maintenance (GO:0034331),-0.31133206081076825,-0.7991940360969422,0.7453798767967146,0.9427965854540156,1.0,3/14,15.74%,NLGN2;MYADM;DCTN1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.2690178560194108,0.799069566259846,0.7748776508972267,0.9819332821324025,1.0,4/37,9.23%,NCBP1;NUDT5;RNASE6;XRN2
prerank,regulation of cholesterol metabolic process (GO:0090181),0.30561645762651957,0.7990180786396105,0.7604355716878403,0.9814159974507498,1.0,6/20,16.80%,APOE;LPCAT3;MBTPS1;LDLRAP1;ACADL;KPNB1
prerank,sister chromatid segregation (GO:0000819),0.2718520193997579,0.7988969238064758,0.7677304964539007,0.9810268393093842,1.0,4/31,10.52%,KIF18A;CHAMP1;CDCA8;MIS12
prerank,regulation of interleukin-10 production (GO:0032653),0.25241357965954203,0.7985715578716822,0.7844408427876823,0.9810066468485225,1.0,5/44,13.01%,FCGR2B;SYK;CD47;VSIR;CD274
prerank,positive regulation of leukocyte activation (GO:0002696),-0.2873447035085608,-0.7980080150048071,0.7315436241610739,0.9441496071444807,1.0,6/18,27.50%,LBP;THBS1;IL33;HSPD1;NECTIN2;KARS1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3522123821802542,0.7978900904417572,0.7345309381237525,0.9816247711334817,1.0,1/10,0.91%,NCBP1
prerank,protein hydroxylation (GO:0018126),0.3265106188465409,0.7978745770404203,0.7290448343079922,0.9810348056764319,1.0,3/15,10.90%,JMJD4;P3H2;PLOD3
prerank,maturation of 5.8S rRNA (GO:0000460),-0.29329592538897864,-0.7978724226436045,0.764172335600907,0.9437443651299294,1.0,8/17,23.72%,NSA2;EXOSC10;LAS1L;MTREX;C1D;RPF1;NOL9;MAK16
prerank,regulation of erythrocyte differentiation (GO:0045646),0.2657635068881872,0.7978195189600449,0.7717206132879046,0.9805214178742172,1.0,5/35,10.56%,TAL1;ABCB10;ZFP36L1;LYN;ACVR2A
prerank,sulfur compound catabolic process (GO:0044273),0.25754499984613577,0.7976453938192326,0.7872,0.9802337640492255,1.0,7/38,14.21%,GLB1;MLYCD;FITM2;ACAT1;IDS;GALNS;TXN2
prerank,protein O-linked mannosylation (GO:0035269),-0.2879554837307649,-0.7974978749359491,0.7553648068669528,0.9437999307187512,1.0,6/18,13.05%,TMTC4;TMTC1;DPM1;RXYLT1;LARGE1;FKTN
prerank,melanosome organization (GO:0032438),0.2863728637457391,0.7974929558057792,0.7618243243243243,0.9799202740773646,1.0,6/26,16.45%,DTNBP1;AP1G1;PIKFYVE;KIF13A;SNAPIN;BLOC1S5
prerank,regulation of astrocyte differentiation (GO:0048710),0.3388864001399955,0.7973550146424161,0.7628083491461101,0.9795440027150365,1.0,3/12,16.05%,NOTCH1;HES1;ID2
prerank,lamellipodium assembly (GO:0030032),-0.25854478393507835,-0.7972702457043683,0.7531486146095718,0.9435412627888421,1.0,9/26,21.63%,KIT;VCL;SPATA13;ABLIM2;ABLIM3;PTPRO;ARFIP2;ARHGEF4;P2RY12
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3068713653487217,0.7971055743812226,0.7246376811594203,0.9793849070345881,1.0,4/21,9.35%,BIRC2;SOX2;FYN;PCID2
prerank,mitotic nuclear membrane organization (GO:0101024),-0.22279089671078597,-0.7968954120361985,0.8184438040345822,0.9428825336687049,1.0,19/51,25.21%,SIRT2;PPP2R2A;LMNA;NUP205;IST1;NUP155;NUP188;AHCTF1;NUP93;SEH1L;CHMP2B;NUP85;CC2D1B;NUP37;VPS4A;EMD;LEMD2;SEC13;LBR
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.22279089671078597,-0.7968954120361985,0.8184438040345822,0.9428825336687049,1.0,19/51,25.21%,SIRT2;PPP2R2A;LMNA;NUP205;IST1;NUP155;NUP188;AHCTF1;NUP93;SEH1L;CHMP2B;NUP85;CC2D1B;NUP37;VPS4A;EMD;LEMD2;SEC13;LBR
prerank,regulation of macrophage activation (GO:0043030),-0.2494712310529377,-0.7968809772089388,0.803921568627451,0.9422547308382495,1.0,6/30,14.92%,LRFN5;LBP;IL31RA;THBS1;IL33;HSPD1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.315078436526282,0.7962689489749458,0.7366482504604052,0.9802900985276222,1.0,1/16,0.39%,BCAP29
prerank,positive regulation of organelle assembly (GO:1902117),0.2531222629422983,0.7959104525772914,0.8073836276083467,0.9803113810017414,1.0,9/44,15.37%,LCP1;RALB;CNOT2;G3BP2;CNOT6;CNOT1;ASAP1;CNOT6L;RAB3GAP1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.31387571954395177,0.7957659144379012,0.7576301615798923,0.979949430555219,1.0,2/17,5.79%,ALG6;ALG8
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.27492358316016857,0.7955582857267074,0.7681660899653979,0.9797167224090706,1.0,5/28,12.78%,CXCL12;PFN1;PAK3;ESAM;NAA80
prerank,mitotic DNA replication (GO:1902969),0.3608688519598704,0.7947646405387372,0.726530612244898,0.9805094492357959,1.0,2/10,9.29%,CDC45;POLA1
prerank,negative regulation of phagocytosis (GO:0050765),-0.2950809306554111,-0.7946763371594697,0.7262443438914027,0.945416858697587,1.0,7/17,22.56%,PIP4P2;PLSCR1;SYT11;SIRPA;RACK1;SNX3;APPL1
prerank,synaptic vesicle membrane organization (GO:0048499),-0.29116123516856607,-0.7946067361431213,0.7586912065439673,0.9448891714178609,1.0,9/17,31.84%,SNAP25;STX3;STX1A;SNAP29;SYP;STX1B;AP3D1;SYNGR1;TOR1A
prerank,regulation of nuclear division (GO:0051783),0.2922076507290062,0.794506721142621,0.7632508833922261,0.98035148007958,1.0,2/20,7.00%,PIN1;FBXO5
prerank,protein localization to lysosome (GO:0061462),-0.25857876925396583,-0.7942593225493983,0.8239277652370203,0.9448474191475286,1.0,14/28,27.39%,SORL1;ZFYVE16;NCOA4;M6PR;AP4M1;GGA3;SZT2;NEDD4;MFSD1;VPS4A;HGS;LAMTOR5;LMBRD1;SH3BP4
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3149044313057945,0.7942430081100426,0.7281021897810219,0.9802174922951723,1.0,5/17,15.82%,NCBP1;CPSF6;ZC3H14;RNF20;ZC3H3
prerank,protein tetramerization (GO:0051262),0.23848976321427384,0.7939809810112971,0.8195956454121306,0.980066127055793,1.0,11/67,14.95%,THG1L;GLS;B2M;SSBP1;ACACB;SOD2;CPSF6;TRPM4;CUTC;OSBPL2;HOMER1
prerank,regulation of cell death (GO:0010941),0.22448174410636296,0.793973424097872,0.8556998556998557,0.9794737873178948,1.0,18/94,17.17%,RAD18;SNCG;SLC25A24;TXNDC12;ACER2;TNFRSF1B;TSC1;PARK7;CHMP2A;ACER3;BNIP3L;FAF1;APC;SPEF1;VPS35;BNIP3;BECN1;PDE8A
prerank,negative regulation of kinase activity (GO:0033673),0.2381115056694031,0.793498777787331,0.8214826021180031,0.9797012195440225,1.0,8/62,9.76%,TRIB3;PTPRC;GNAQ;SPRED1;AKT1S1;DTNBP1;IRS2;PARK7
prerank,brain morphogenesis (GO:0048854),-0.3187927243270046,-0.7932207320285546,0.7538126361655774,0.9459903794929716,1.0,2/12,5.15%,CTNNA2;FBXW11
prerank,aminoglycan catabolic process (GO:0006026),0.2766042720878986,0.7931996346484869,0.7678571428571429,0.9796261527061445,1.0,6/28,12.35%,SGSH;GLB1;FUCA1;HGSNAT;AGRN;IDS
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.225910864265672,0.7931936370617061,0.8525547445255475,0.9790284155084471,1.0,15/88,14.54%,ILF3;PATL2;APOE;FXR1;PAIP2B;EDNRB;CNOT7;TSC1;DDX3X;NANOS3;RPS3;PLAT;YBX1;CNOT1;CAPRIN1
prerank,negative regulation of autophagy (GO:0010507),-0.22394885462979847,-0.7931524413930524,0.8498659517426274,0.945453305112811,1.0,16/54,20.77%,SNRNP70;LEPR;SIRT2;NUPR1;KDM4A;KLHL22;GOLGA2;NRBP2;CTSA;MTMR9;PTPN22;QSOX1;FOXK1;MET;PINK1;BCL2
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.33370537868354877,-0.7929418221860937,0.7326530612244898,0.945159460735131,1.0,3/10,20.69%,ATP7A;KYAT1;QDPR
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.269286555798079,0.7927441024158678,0.7632933104631218,0.9792145148627175,1.0,4/33,9.19%,TNFAIP3;PRKG1;CDKN1A;SOD2
prerank,DNA methylation or demethylation (GO:0044728),0.2980038566629565,0.7925698654370695,0.774822695035461,0.9783052095631062,1.0,2/19,5.83%,DMAP1;BEND3
prerank,DNA alkylation (GO:0006305),0.2980038566629565,0.7925698654370695,0.774822695035461,0.9783052095631062,1.0,2/19,5.83%,DMAP1;BEND3
prerank,mitotic sister chromatid segregation (GO:0000070),0.22261425310549685,0.7921953899690273,0.8538681948424068,0.9783906089538921,1.0,15/98,14.95%,KIF18A;NUDC;BOD1;DCTN2;TENT4A;CHMP1A;CDCA8;AKAP8L;CHMP2A;MIS12;CUL3;POGZ;PHF8;CSNK2A2;INO80
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.2993252910212928,0.7920971485042966,0.7590579710144928,0.9779677016494827,1.0,6/20,18.21%,PSEN2;RELA;MBTPS1;APH1A;ADAM9;SPPL2A
prerank,visual perception (GO:0007601),0.23073865243882652,0.792094040695006,0.8200290275761973,0.9773692729379669,1.0,8/84,10.37%,RS1;ATF6;WFS1;DRAM2;EYA3;MYO9A;PITPNA;ABLIM1
prerank,response to interleukin-1 (GO:0070555),-0.20500869204671782,-0.7919022571970021,0.8938053097345132,0.9462247635703729,1.0,13/73,16.28%,ADAMTS12;HDAC4;RBMX;IRAK1;PTGIS;IRAK3;NFKB1;ANXA1;SIRPA;CCL14;UPF1;USP10;TANK
prerank,acylglycerol catabolic process (GO:0046464),0.2742689581152777,0.7918261697096518,0.7838283828382838,0.9772353133027788,1.0,29/30,65.44%,FABP7;ABHD12;ABHD16A;FABP2;PNLIPRP2;PNPLA1;PNPLA5;LIPI;ABHD12B;APOC3;FABP6;CPS1;APOA2;LIPG;ABHD6;FABP12;FABP4;ABHD2;LIPC;LIPH;FABP3;MGLL;FAAH;DAGLA;PNPLA3;FABP5;LPL;PNPLA2;LYPLA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.34786212670744976,-0.7918119747962095,0.7554671968190855,0.9444323560757144,1.0,6/10,36.61%,SMARCAL1;BLM;SLX4;TERF1;ERCC1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.34786212670744976,-0.7918119747962095,0.7554671968190855,0.9444323560757144,1.0,6/10,36.61%,SMARCAL1;BLM;SLX4;TERF1;ERCC1;DNA2
prerank,t-circle formation (GO:0090656),-0.34786212670744976,-0.7918119747962095,0.7554671968190855,0.9444323560757144,1.0,6/10,36.61%,SMARCAL1;BLM;SLX4;TERF1;ERCC1;DNA2
prerank,negative regulation of cholesterol transport (GO:0032375),-0.3398826310067574,-0.7917567309816685,0.7479166666666667,0.9438838726631367,1.0,2/10,31.27%,NFKB1;ABCA2
prerank,carbohydrate transport (GO:0008643),-0.3336425904632063,-0.7915614662022376,0.7597402597402597,0.9435753252764056,1.0,9/11,61.61%,AQP11;SLC50A1;SLC26A6;SLC2A2;SLC23A1;SLC23A2;AQP1;SLC2A5;AQP9
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.23495973966551872,0.7906843617265519,0.8250377073906485,0.9786755378245166,1.0,6/65,6.54%,CBL;PTPRJ;BCAR3;PTPN12;EPS15L1;ARHGEF7
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3357978273387081,-0.7904798459451421,0.7504990019960079,0.944800044557879,1.0,9/10,51.67%,NAF1;RPUSD4;GAR1;NOP10;TSR3;RPUSD1;NHP2;RPUSD2;RPUSD3
prerank,phospholipid translocation (GO:0045332),0.2789522373460116,0.7901937791167424,0.7847457627118644,0.978955812376602,1.0,6/28,13.91%,ATP8A1;ATP11A;TMEM30B;P2RX7;ATP11C;ATP10A
prerank,negative regulation of endocytosis (GO:0045806),-0.2593964447049986,-0.7898732909977745,0.7885985748218527,0.9451839951655968,1.0,10/24,32.28%,EPHA3;SYT11;SCAMP5;LRSAM1;PRKD1;NR1H2;ABCA7;PACSIN3;CAV1;CD300A
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.32249727922023846,0.7895583382759781,0.7371225577264654,0.979461284909882,1.0,3/15,13.35%,NEK11;HUS1;CHEK2
prerank,histone H3-K4 methylation (GO:0051568),-0.26006016542337385,-0.7893598093333553,0.8028846153846154,0.9453433532746169,1.0,8/26,20.71%,OGT;KMT2A;PAXIP1;RBBP5;KMT2B;KMT2D;DPY30;SETD4
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.32681698768161715,-0.7890777950288909,0.7473903966597077,0.9451531521828489,1.0,7/11,38.37%,EXOSC10;LARP7;EXOSC2;EXOSC3;EXOSC5;TENT4B;FBL
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3065925108420555,0.7890676077721327,0.7513611615245009,0.9797480181395147,1.0,1/18,4.13%,ZFP36L1
prerank,linoleic acid metabolic process (GO:0043651),-0.2887556206065845,-0.7887572403018976,0.7629310344827587,0.9450354912118023,1.0,6/17,37.60%,ACSL1;FADS2;ELOVL1;FADS1;GSTM2;ALOX12
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.24406435242172936,0.7876124419397128,0.8138041733547352,0.9817306163674062,1.0,9/50,11.52%,IFI35;PHB2;EP300;ACTN4;RELA;DDX3X;APP;NOD1;RPS3
prerank,embryonic heart tube development (GO:0035050),0.3226224224047573,0.787438222123741,0.7339622641509433,0.9814118989955548,1.0,5/14,19.22%,CITED2;HES1;SOX17;RYR2;IFT122
prerank,protein secretion (GO:0009306),-0.21874675141510622,-0.7871224435605818,0.8670076726342711,0.9471157060120473,1.0,14/56,18.72%,WLS;TANGO2;PCSK5;RAB3C;RAB8B;MON1A;ANXA1;ABCA1;STEAP3;RCN3;OLFM2;RAB8A;SCG2;MTTP
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3259135471331784,-0.7869107873469203,0.7363083164300203,0.9468248612118382,1.0,6/11,24.49%,LDLR;SLC27A1;GPLD1;SREBF1;CTDNEP1;NR1H2
prerank,carboxylic acid catabolic process (GO:0046395),0.33718167122770415,0.7867344075526744,0.7480769230769231,0.9820438985745046,1.0,2/12,11.78%,AMDHD2;ACOT8
prerank,synaptic vesicle localization (GO:0097479),-0.30665409798171545,-0.7866688690523127,0.7882599580712788,0.9465344107774597,1.0,4/13,15.75%,KIF5C;SYNDIG1;NLGN1;KIF5A
prerank,response to amyloid-beta (GO:1904645),0.2509327160110863,0.7860913711272876,0.7961476725521669,0.9825610173138004,1.0,7/44,11.93%,CACNA1A;FCGR2B;MMP12;FYN;ICAM1;APP;PRNP
prerank,arachidonate transport (GO:1903963),-0.3392802570794584,-0.7856938377384379,0.7720739219712526,0.9468168348017647,1.0,4/10,30.46%,ANXA1;ACE;BDKRB2;DRD2
prerank,arachidonic acid secretion (GO:0050482),-0.3392802570794584,-0.7856938377384379,0.7720739219712526,0.9468168348017647,1.0,4/10,30.46%,ANXA1;ACE;BDKRB2;DRD2
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.25308976886868767,-0.7848180642753938,0.7829268292682927,0.9475960816625266,1.0,5/28,9.05%,EGFR;MMP14;WWP2;NOTCH3;NIBAN2
prerank,B cell homeostasis (GO:0001782),0.34323602561370276,0.7846432936053723,0.724950884086444,0.9845593676659524,1.0,2/10,9.31%,TNFAIP3;LYN
prerank,positive regulation of mitochondrion organization (GO:0010822),0.23764085386377698,0.7846395473783082,0.8208722741433022,0.9839609334533981,1.0,13/57,16.50%,GSK3A;RALA;ZNF205;DDHD1;PARK7;FBXO7;BAD;BMF;MIEF1;CAMKK2;VPS35;DNM1L;BNIP3
prerank,positive regulation of behavior (GO:0048520),-0.3370634330756832,-0.7835830927314916,0.790650406504065,0.9489888225601686,1.0,4/10,23.36%,CFAP20;NLGN1;NPAS2;STRA6
prerank,proton transmembrane transport (GO:1902600),0.2629624055895343,0.7835231448002256,0.7964458804523424,0.9852670295702579,1.0,5/36,11.55%,UCP2;SLC25A27;ATP6V0D1;ATP6V0E1;COX15
prerank,regulation of actin filament polymerization (GO:0030833),0.23364609711051584,0.7834275537383634,0.8623298033282905,0.9848195435117371,1.0,16/69,18.87%,VASP;EVL;PFN1;CYRIB;KANK3;SSH2;PAK3;ESAM;CDC42EP3;TWF1;LMOD1;ARF6;PTK2B;BAIAP2;ARFGEF1;PRKCE
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.22635105983655637,0.7833450615901212,0.8624813153961136,0.984364799938474,1.0,15/88,13.81%,TAL1;SLF1;TIRAP;PFN1;RAB7A;ICE1;SYK;RGCC;PARK7;CHMP2A;RPS3;BMF;CDH5;PLEK;FAF1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.27776710093566026,0.7829303141449119,0.760539629005059,0.9844478230291952,1.0,7/27,15.85%,SPRED1;PTTG1IP;SIRT1;YJU2;MDM2;CD44;ATR
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.25901032374314603,-0.7826678912062606,0.8009259259259259,0.949812201484814,1.0,11/27,27.57%,NAPEPLD;LPIN1;CHKA;SLC27A1;ETNK2;PCYT2;PLA2G6;LPIN2;CHKB;NAAA;LPIN3
prerank,vesicle transport along actin filament (GO:0030050),0.30306081764926596,0.7816806885070504,0.7455197132616488,0.9860099486548844,1.0,4/19,13.12%,MYO5A;ACTN4;MYO1D;MYO1E
prerank,catecholamine biosynthetic process (GO:0042423),-0.32630579226211454,-0.7816505193308282,0.7814569536423841,0.9507514035239197,1.0,1/11,2.84%,MOXD1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.2347352811404356,0.7813402795809042,0.8133333333333334,0.9859610643797571,1.0,9/66,11.82%,MAP3K11;PIK3CG;EZH2;MAP3K7;MAP3K4;PAK1;FLT1;RPS3;PIK3R5
prerank,glycoprotein biosynthetic process (GO:0009101),-0.20264948154880386,-0.7813303438274818,0.9131736526946108,0.9505795866951119,1.0,34/79,35.62%,IGF1;ATP7A;CSGALNACT2;PMM2;GOLGA2;FUT10;CHST11;LARGE1;B3GALT5;ST3GAL4;TNIP1;B3GALNT1;BMPR1B;B3GALT1;ST8SIA2;CHST8;BMPR2;ALG5;ALG10B;CANT1;SERP1;FOXL1;CHST12;B4GALT7;ALG1;B3GALT2;DDOST;CHST10;B4GALT5;GCNT1;TMEM106A;ST8SIA3;ST8SIA5;ST3GAL5
prerank,protein localization to Golgi apparatus (GO:0034067),0.27931413696560464,0.7809154788172689,0.7706896551724138,0.9860774454893235,1.0,6/27,10.13%,ARL5C;RAB6A;TMED10;ARL5B;ZDHHC15;GCC2
prerank,C-terminal protein amino acid modification (GO:0018410),0.3336603744143772,0.780620015568363,0.7408829174664108,0.9859685417262181,1.0,5/11,19.25%,AGTPBP1;ICMT;ATG7;LCMT1;FOLH1
prerank,regulation of mitotic spindle organization (GO:0060236),-0.2379043451806532,-0.7805505838160969,0.855072463768116,0.9512193369340625,1.0,8/35,20.58%,DYNC1H1;PARP3;EML3;DCTN1;CHMP2B;CHMP5;RAE1;MAP9
prerank,regulation of centrosome cycle (GO:0046605),0.2938810786137044,0.7801828497660297,0.7371225577264654,0.986115887777729,1.0,5/21,18.10%,CHMP1A;SIRT1;CHMP2A;NPM1;VPS4B
prerank,regulation of defense response to virus by host (GO:0050691),0.26861202203850876,0.7801669250409439,0.7857142857142857,0.9855412570782108,1.0,2/30,2.81%,TNFAIP3;IFNLR1
prerank,transferrin transport (GO:0033572),0.2611679698811596,0.780119369563576,0.8089700996677741,0.9850267011572676,1.0,5/33,10.69%,ATP6V1D;RAB11B;ATP6V0D1;ATP6V0E1;ATP6AP1
prerank,response to lipopolysaccharide (GO:0032496),0.21054515979500837,0.7800216947402974,0.8913043478260869,0.9845743282578994,1.0,19/138,13.01%,TNFAIP3;TAB2;TIRAP;SBNO2;TNFRSF1B;MAPK8;CARD16;SELP;WNT5A;ERBIN;RELA;IFNAR1;NFKBIL1;NOS3;SCARB1;PLAA;TNIP2;OTUD5;CD274
prerank,regulation of synapse maturation (GO:0090128),-0.3364434450375908,-0.7799590052580985,0.758095238095238,0.9514745686436604,1.0,2/10,5.33%,NRXN1;RELN
prerank,regulation of monocyte chemotaxis (GO:0090025),0.2860419232279212,0.7797011193849116,0.7810344827586206,0.9845121184860259,1.0,3/24,9.31%,CXCL12;GREM1;LYN
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.3051948635700289,-0.7795152433877806,0.7614107883817427,0.9515023142661043,1.0,5/13,22.41%,NIBAN2;NEDD4;CADM4;HGS;EMILIN1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.34571141556928664,0.7794292240912315,0.7295719844357976,0.9843541641818654,1.0,1/10,2.23%,SOD1
prerank,cellular defense response (GO:0006968),-0.2316973657805766,-0.7793090781088479,0.8534031413612565,0.9511605933490495,1.0,6/40,14.57%,DCDC2;LBP;CCR9;LSP1;TCIRG1;RAB23
prerank,endocardial cushion development (GO:0003197),0.2893276903072129,0.7791408672462513,0.7720848056537103,0.9842085800963296,1.0,4/21,11.15%,HEY1;NOTCH1;ACVRL1;NOS3
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.3156611544155734,0.779106874846431,0.7481343283582089,0.9836648687665894,1.0,2/15,8.11%,SMAD7;CUEDC2
prerank,glycolipid biosynthetic process (GO:0009247),-0.23219524180895712,-0.7787614247433202,0.8535353535353535,0.9513552150396815,1.0,19/38,35.62%,A4GALT;B4GALT6;DPM1;ST6GALNAC5;LARGE1;ST3GAL4;PIGV;PIGG;PIGA;PIGM;PGAP4;PIGF;MPPE1;DPM2;PIGC;DPM3;ST8SIA3;ST8SIA5;ST3GAL5
prerank,negative regulation of potassium ion transport (GO:0043267),-0.29944168662509274,-0.7786281061854642,0.7605042016806722,0.9509227699762464,1.0,3/13,10.09%,CAB39;BIN1;ACTN2
prerank,negative regulation of insulin secretion (GO:0046676),-0.28536664025583813,-0.7785577517987883,0.8067415730337079,0.9503898024894228,1.0,8/17,40.79%,PSMD9;CCN3;ADRA2A;SFRP1;SIRT4;PIM3;CHGA;INHBB
prerank,P-body assembly (GO:0033962),0.333316204054538,0.7784488160283831,0.7587476979742173,0.9841689435755779,1.0,2/12,9.63%,PATL2;PATL1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.322211409485127,0.7783978500179717,0.7351351351351352,0.983645808398239,1.0,3/14,9.91%,TIRAP;HNRNPC;TARDBP
prerank,protein localization to kinetochore (GO:0034501),0.3211267948428277,0.7783166910834433,0.7355212355212355,0.9831857066037564,1.0,3/14,14.60%,CHAMP1;MIS12;MTBP
prerank,nucleoside catabolic process (GO:0009164),0.34085369548311345,0.777814829841643,0.7529411764705882,0.9834347480481728,1.0,2/11,9.50%,UPP1;UPP2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.2898512993601486,0.7777759232306846,0.7701543739279588,0.9828959134975366,1.0,5/24,15.57%,PTPRJ;TEK;TSC1;MAP4K4;ARF6
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.296310878972314,-0.777674919657056,0.7930283224400871,0.9511375856268723,1.0,9/15,32.89%,RAB3GAP2;SEC61A1;EDEM1;SRPRB;SRP14;ZFAND2A;SEC61G;SRPRA;SPCS1
prerank,cellular response to estrogen stimulus (GO:0071391),0.3219758460793597,0.7773870339010593,0.7495429616087751,0.982928211830648,1.0,2/14,10.40%,ARID5A;WBP2
prerank,cellular response to hormone stimulus (GO:0032870),0.23299106171064465,0.7767086736496212,0.8444767441860465,0.9834898414481145,1.0,9/69,10.75%,ARID5A;GAS2L1;SRC;PAX8;ZFP36L1;RAMP2;LMO2;WBP2;THRB
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.24714277873203577,-0.7766713526470889,0.8192771084337349,0.9520119037964809,1.0,4/30,14.92%,PIBF1;PRKCZ;CD34;HSPD1
prerank,negative regulation of hemostasis (GO:1900047),-0.32151438591680737,-0.7765882878388191,0.7603305785123967,0.9515096238379852,1.0,3/12,11.71%,TFPI;VTN;CD34
prerank,protein complex oligomerization (GO:0051259),0.22401438521554368,0.7763264995965912,0.8547904191616766,0.9835211903970525,1.0,13/85,12.34%,RS1;EHD4;ATL1;BEND3;LRRC8C;TRMT61B;CPSF6;CHMP2A;MAT2A;HGSNAT;G3BP2;LETM1;CUTC
prerank,regulation of DNA metabolic process (GO:0051052),0.24922476675527175,0.7755105384470592,0.7911908646003263,0.9842413353121369,1.0,13/44,18.25%,STOX1;SMG1;UBE2V2;UBE2V1;KPNA1;NBN;HELB;TERF2IP;WDR70;SMARCAD1;SMG6;POLH;SMG5
prerank,regulation of receptor recycling (GO:0001919),-0.291651192017403,-0.7754110516916032,0.7593360995850622,0.952682744391609,1.0,7/16,30.12%,ANXA2;OPTN;TBC1D16;RAB29;INPP5F;SNCA;SCRIB
prerank,cell-cell junction maintenance (GO:0045217),0.33659808257270707,0.775250452573266,0.7420634920634921,0.984067096167031,1.0,2/11,9.17%,TJP1;CSF1R
prerank,nucleotide metabolic process (GO:0009117),0.28003608890522685,0.7749237674758008,0.7878787878787878,0.9840117643661874,1.0,4/23,10.61%,REXO2;NUDT5;PARK7;PNP
prerank,positive regulation of leukocyte migration (GO:0002687),-0.25144645222805934,-0.7746377882478488,0.8199052132701422,0.953136818023932,1.0,8/27,35.12%,IL6R;JAM3;VEGFA;NCKAP1L;MDK;PTN;THY1;EDN3
prerank,membrane raft organization (GO:0031579),-0.29677519529592433,-0.7746124150346246,0.7806451612903226,0.9525530241268818,1.0,7/15,28.73%,ANXA2;FLOT2;MYADM;FLOT1;CLN3;EMP2;ABCA7
prerank,negative regulation of interleukin-1 production (GO:0032692),0.284744470513863,0.7743163039863505,0.7696335078534031,0.984369489949578,1.0,2/23,6.20%,TNFAIP3;CARD16
prerank,negative regulation of histone modification (GO:0031057),0.3169964476712729,0.7741778642242221,0.7666666666666667,0.9839962536557031,1.0,1/14,0.92%,AASS
prerank,negative regulation of T cell activation (GO:0050868),0.2602217321447729,0.7737878070111867,0.7783417935702199,0.9840282805234133,1.0,4/35,14.51%,FCGR2B;RIPOR2;CD274;PAG1
prerank,regulation of endocytic recycling (GO:2001135),-0.3260354067868928,-0.773766780403522,0.7842741935483871,0.9532184304720213,1.0,4/11,16.53%,ATP9A;SORL1;ACTN2;EHD1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.2989133570184589,-0.7737663935211841,0.7687366167023555,0.9525831902386941,1.0,6/15,16.41%,BAG3;ANP32B;GSK3B;TP53;CAMK1;TCF7L2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.27632048650238716,0.7736637158296187,0.7945205479452054,0.9836567966416737,1.0,2/27,3.86%,RRM2B;NME1
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.3068853746106679,-0.7735181402376982,0.7708779443254818,0.9523364249609438,1.0,3/13,16.23%,BMP4;TBX3;TGFB1
prerank,lymphocyte chemotaxis (GO:0048247),0.25947466621638515,0.7727006367640504,0.8073701842546064,0.9846044725527813,1.0,4/34,15.25%,PIK3CG;CCL25;PIK3CD;GAS6
prerank,histone lysine methylation (GO:0034968),-0.24289941492652994,-0.7726034341156535,0.85,0.9530436850177549,1.0,11/33,19.78%,PRDM5;KMT2A;PAXIP1;RBBP5;EHMT2;SETDB2;KMT2B;SMYD2;KMT2D;DPY30;N6AMT1
prerank,response to acidic pH (GO:0010447),0.31904861253615713,0.7720335200283949,0.7565543071161048,0.9851239291256834,1.0,2/13,8.00%,RAB11B;RAB11FIP5
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.29293474736954334,0.7720195946059318,0.7810344827586206,0.9845488960470766,1.0,5/20,10.81%,HEY1;HEY2;NOTCH1;ACVRL1;RBPJ
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.2651284507209177,-0.7719599930830755,0.8144578313253013,0.953369683462709,1.0,8/23,28.26%,WNT5B;BMP4;SMO;GJA1;SIX1;VEGFA;PAX2;MDK
prerank,excitatory postsynaptic potential (GO:0060079),-0.2758222698598892,-0.7718504367628316,0.8056768558951966,0.9529177728431605,1.0,7/19,24.53%,GRID2;GRIN2B;GSK3B;GRIN2D;GRIN1;MPP2;AKT1
prerank,reverse cholesterol transport (GO:0043691),0.3255664193107495,0.7718066212459607,0.7433460076045627,0.984321821488941,1.0,2/13,11.85%,APOE;SCARB1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.32344784965297824,0.7715601278701486,0.741635687732342,0.9841338249004403,1.0,2/12,10.54%,PPP3CB;TRPM4
prerank,nuclear pore organization (GO:0006999),-0.301737023109167,-0.7711883385892435,0.7931034482758621,0.9531982052960022,1.0,4/14,13.35%,NUP205;AHCTF1;NUP93;SEH1L
prerank,positive regulation of bone resorption (GO:0045780),0.3422227447927706,0.7710466278952998,0.7641509433962265,0.9844021472534715,1.0,2/11,10.69%,SYK;ATP6AP1
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2573090128111075,0.7710132639681042,0.8327702702702703,0.983854586019245,1.0,4/36,9.86%,SHANK3;GREM1;PARK7;BUD31
prerank,male gonad development (GO:0008584),0.2571943553578958,0.7701161309541257,0.7893890675241158,0.9847321482041771,1.0,4/34,10.36%,NR5A1;MAMLD1;WNT5A;ING2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.28510734495373014,0.7697125633305004,0.8043087971274686,0.9847897128356152,1.0,3/20,5.51%,ZFP36L1;MEIS1;CIB1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.2570978077424542,0.7695123273156393,0.8208469055374593,0.984510999428463,1.0,12/39,18.37%,ACER2;NEXMIF;ACTN4;NOTCH1;HOXA7;MAP4K4;AP1AR;CORO2B;SEMA3E;MELTF;CORO1C;CASK
prerank,regulation of protein sumoylation (GO:0033233),0.3095185705410609,0.7692355731562828,0.7803571428571429,0.9843665873727391,1.0,4/17,11.40%,SAE1;UBA2;PARK7;PIAS1
prerank,cellular response to interferon-gamma (GO:0071346),0.22177487261360793,0.7691807455863318,0.8817518248175182,0.9838538864941446,1.0,15/88,15.69%,TRIM8;GBP3;IRF9;B2M;GBP4;ICAM1;TRIM25;CCL25;WNT5A;CD47;IRF2;MID1;MT2A;CD44;CAMK2G
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.25634177005270764,-0.7689326768471103,0.8205128205128205,0.9559062403032355,1.0,8/24,17.68%,SEC31A;SEC24D;PDIA3;TAPBP;SEC23A;SEC24C;SEC24A;ACE
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.25268801775263133,-0.7688318401599316,0.8333333333333334,0.9554354823172263,1.0,1/26,0.15%,ATP1A2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.2376979374470749,-0.7684328732458285,0.8298368298368298,0.9553474133783977,1.0,9/33,15.47%,PKD1;APPL2;CDKN1B;CDC73;DDRGK1;STXBP4;TRIM39;PAF1;MN1
prerank,negative regulation of hormone secretion (GO:0046888),0.339981611797208,0.7681129322245913,0.7434343434343434,0.9849284459049134,1.0,2/10,17.43%,RAB11FIP5;RAB11FIP1
prerank,cellular senescence (GO:0090398),-0.2522039645062614,-0.7672909404445426,0.847255369928401,0.956403387491893,1.0,5/27,11.62%,MAPK14;PRKCD;PML;SMC6;TBX3
prerank,regulation of cell cycle process (GO:0010564),-0.18934614158354757,-0.767173263308175,0.9611307420494699,0.9559542674244683,1.0,28/104,25.77%,DYNC1H1;CTNNB1;RPRD1B;CUL9;PIK3C3;AHCTF1;UVRAG;E4F1;OBSL1;SND1;RAB11A;USP19;ENTR1;CAV2;CCP110;TTL;CEP250;CDC42;ATF5;TXLNG;MAP9;MYO19;FLCN;RAB11FIP4;PRMT5;BCL2L1;GIT1;SFRP1
prerank,negative regulation of telomere maintenance (GO:0032205),0.3103346729852158,0.7670689502022487,0.7560521415270018,0.9859843245766102,1.0,6/15,18.15%,ERCC4;TNKS;NBN;TERF2IP;SMG6;TNKS2
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.27667166036563257,-0.7663247806820812,0.8260869565217391,0.9565460707381663,1.0,5/19,18.38%,NFAT5;PLCE1;NFATC2;PPP3CC;NFATC4
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.25109420819485834,0.7660270377114472,0.8139130434782609,0.9870378544290301,1.0,6/37,7.73%,RPTOR;STOX1;SPRED1;CALM3;SMAD7;AXIN1
prerank,mitochondrion disassembly (GO:0061726),-0.2336224111943133,-0.765761358442156,0.8527918781725888,0.9567567890909158,1.0,4/34,7.71%,AMBRA1;ULK2;WIPI1;FIS1
prerank,protein targeting to lysosome (GO:0006622),-0.26880958382405823,-0.7654006588553282,0.8008849557522124,0.9566284077723637,1.0,10/20,22.03%,SORL1;ZFYVE16;NCOA4;M6PR;AP4M1;GGA3;NEDD4;VPS4A;GNPTAB;HGS
prerank,regulation of activated T cell proliferation (GO:0046006),0.26697998422637614,0.7651544519656956,0.8258706467661692,0.987771953259612,1.0,4/30,13.01%,PRKAR1A;RPS3;PRNP;CD274
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.32899251638289095,0.7650334846552677,0.7495107632093934,0.9873819272483682,1.0,3/12,13.35%,NAE1;HUS1;CHEK2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.22580655608373226,0.7647502438011567,0.8669724770642202,0.9872288130658087,1.0,6/69,11.27%,PTPRJ;PTPRC;TIRAP;SYK;WNT5A;APP
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.3163390337092014,0.7645558068712823,0.753199268738574,0.9869447211457768,1.0,2/13,6.88%,PDE4D;CALM3
prerank,regulation of mitochondrion organization (GO:0010821),0.24181311161489039,0.7644007198278729,0.8459016393442623,0.9866019266873821,1.0,5/47,7.51%,GSK3A;STOX1;CYRIB;EP300;OMA1
prerank,positive regulation of T cell activation (GO:0050870),0.22966315911289167,0.7635318164325038,0.8820895522388059,0.9873839022479789,1.0,14/62,21.75%,PTPRC;CYRIB;CD47;PNP;CD81;CD274;DOCK8;IL7;CD46;TFRC;XBP1;SLC7A1;VCAM1;IL15
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.307635069272119,0.7631280386219126,0.7695035460992907,0.9874232125021238,1.0,2/15,11.11%,STOX2;USP22
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.27983623924279755,0.7630116964363624,0.7982758620689655,0.9870212686922433,1.0,4/23,13.32%,GSK3A;EP300;PGP;PLEK
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.22438966472384367,-0.7627392712514586,0.8807785888077859,0.9599738052766692,1.0,3/41,4.84%,PLA2G4A;ACSL1;EPHX1
prerank,copper ion homeostasis (GO:0055070),-0.2823574041521465,-0.7626280735854336,0.7936507936507936,0.9595028478851803,1.0,6/17,18.71%,ATP7A;XIAP;SLC31A1;COMMD1;SLC31A2;COX19
prerank,establishment of protein localization to organelle (GO:0072594),0.2241752615334433,0.7624744151313665,0.863905325443787,0.9872882451509662,1.0,19/72,19.26%,MMP12;PHB2;RALA;PTTG1IP;SYK;NXT1;NUP50;RANBP17;ZDHHC15;E2F3;TSPAN17;IPO8;HIKESHI;KPNB1;POM121;STAT3;RYR2;LAMP2;NUP133
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.2896821997528356,-0.7624229837484289,0.7707006369426752,0.9591567004162465,1.0,2/16,1.62%,DPYD;DPYSL3
prerank,mRNA modification (GO:0016556),-0.26437169182678655,-0.7621991515132631,0.8398058252427184,0.9588439056031418,1.0,7/22,24.04%,PUS7;VIRMA;CBLL1;TRUB1;PCIF1;TRMT6;CMTR1
prerank,negative regulation of transport (GO:0051051),0.23860388678593664,0.761866776420697,0.8483920367534457,0.9876261913003145,1.0,3/51,4.78%,RSC1A1;FCGR2B;RAB7A
prerank,myelin assembly (GO:0032288),-0.3228357906222931,-0.7611571221210002,0.790224032586558,0.9596649185693078,1.0,6/10,32.26%,EPB41L3;DICER1;TPPP;CNTNAP1;ABCA2;GPC1
prerank,microtubule anchoring at centrosome (GO:0034454),-0.32995804132691275,-0.7611504272562014,0.7816764132553606,0.959040107215698,1.0,3/10,15.74%,NINL;KIF3A;DCTN1
prerank,urogenital system development (GO:0001655),-0.32161898140212114,-0.7611454051982499,0.7650862068965517,0.9584176118962927,1.0,3/11,11.85%,OSR1;EPHB2;ANXA1
prerank,cellular response to leucine (GO:0071233),0.34320223172964,0.7600774784687091,0.7718253968253969,0.9892308259381493,1.0,4/10,19.06%,RPTOR;LARS1;SESN3;SESN1
prerank,response to leucine (GO:0043201),0.34320223172964,0.7600774784687091,0.7718253968253969,0.9892308259381493,1.0,4/10,19.06%,RPTOR;LARS1;SESN3;SESN1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.2695172727081038,0.7599203539388925,0.7942664418212478,0.9888915366415545,1.0,6/28,12.15%,GAS2L1;CLASP2;MAP1S;CAMSAP2;PRUNE1;FKBP4
prerank,phospholipid metabolic process (GO:0006644),-0.19987308974967535,-0.7595708510100402,0.9279538904899135,0.959970259602503,1.0,13/71,16.54%,PLA2G4A;PLPPR1;AGPAT4;PLPP3;AGPAT5;PIP5K1A;PLPPR5;PIP4K2B;SMPD3;PLPPR4;PCYT2;FDFT1;PLCD1
prerank,covalent chromatin modification (GO:0016569),0.31354066638996386,0.7590484700125549,0.8077601410934744,0.9896657528911224,1.0,4/14,10.39%,SIRT1;SETD5;PARK7;CHD1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.24058270997213277,0.7589739234670281,0.8500797448165869,0.989205994467332,1.0,10/45,15.69%,TRIM8;IRF9;B2M;ICAM1;TRIM25;IRF2;MID1;MT2A;CD44;CAMK2G
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.30283149511176255,-0.7585442894337747,0.8054187192118226,0.9608390400698528,1.0,5/14,17.76%,DDX1;CSTF2;RTCB;RTRAF;ZBTB8OS
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.326048263654804,-0.7579474728214809,0.7620041753653445,0.9610260477077549,1.0,3/10,13.61%,ITGA5;VTN;GRB10
prerank,negative regulation of histone methylation (GO:0031061),0.33898129341911476,0.7577018193134974,0.7581573896353166,0.9905931188774251,1.0,1/10,0.92%,AASS
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.33398209722804156,0.7573846507628152,0.7775700934579439,0.9904743310081161,1.0,3/11,14.51%,TRIM28;PPHLN1;TASOR
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.2633116334039311,0.7573823670970482,0.8122866894197952,0.9898912855984524,1.0,3/29,8.79%,ERCC3;CCNH;GTF2H1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.29069471543159653,0.7573788924836921,0.7971274685816876,0.9893100037278701,1.0,3/18,9.76%,SIRT1;SOD2;PARK7
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.26260322274263415,-0.7569307158896007,0.8411214953271028,0.9617850852857688,1.0,5/22,16.35%,MAN1C1;UGGT2;UBC;EDEM1;RNF139
prerank,negative regulation of hydrolase activity (GO:0051346),-0.21267662440725665,-0.7568696699353836,0.8863049095607235,0.9612461250285688,1.0,20/49,33.51%,MAP2;CPEB2;WNK1;SLC39A14;GPSM1;GMIP;ECM1;ATP5IF1;SH3RF2;RRP1B;ZCCHC9;CAMK2A;EGLN1;SH3BP4;ARL2;NOS1;TERF2;CHP1;RASA4;MAPK7
prerank,zinc ion transmembrane transport (GO:0071577),-0.253128363961095,-0.7564584418922703,0.8461538461538461,0.9611627137418044,1.0,8/22,25.23%,SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC39A8;SLC39A7;SLC39A6;SLC30A5
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.24583129553930247,0.7563202427716281,0.8439024390243902,0.9903083219241456,1.0,5/42,8.86%,PTPRJ;TEK;CIB1;CCL25;TSC1
prerank,positive regulation of neuron migration (GO:2001224),0.33463936416561124,0.7561077843458559,0.7655310621242485,0.9900547731149257,1.0,1/11,0.88%,SEMA6A
prerank,modulation by host of viral genome replication (GO:0044827),0.32617144592479463,0.7559201982609773,0.7938342967244701,0.989753262841882,1.0,7/13,23.69%,PPIB;IFI27;YTHDC2;EIF2AK4;TBC1D20;VAPA;FMR1
prerank,ERAD pathway (GO:0036503),0.21936139961830187,0.7557126835856895,0.8724035608308606,0.9895014121305439,1.0,24/83,19.58%,DERL2;YOD1;WFS1;FAM8A1;SGTB;TRIM25;AUP1;RHBDD2;ERLIN2;STT3B;UBQLN1;PSMC6;DNAJC10;UFD1;UBQLN2;DNAJB14;ATXN3;UBXN4;UGGT1;DNAJB9;POMT2;CCDC47;DERL1;SEL1L
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.28577969590805885,-0.75546022708244,0.8400900900900901,0.961898628684716,1.0,7/16,30.08%,KCNC2;DDAH1;GUCY1A1;GUCY1B1;DDAH2;NDNF;NOS1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.27331309893867367,0.7553295893468401,0.8024691358024691,0.9895208704822632,1.0,10/25,19.28%,LONP1;OMA1;AUP1;CUL3;UFD1;YME1L1;ATXN3;UGGT1;POMT2;DERL1
prerank,protein autoubiquitination (GO:0051865),0.22872302755575358,0.7551815753892652,0.8798151001540832,0.9891463384420182,1.0,11/61,13.34%,RAD18;UBE3A;NFX1;RNF187;MDM2;KLHL24;UBE3D;RNF13;RNF11;CUL3;RNF146
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.33417894991574515,-0.7547695833115652,0.7861771058315334,0.9622201564414895,1.0,3/10,12.56%,MTHFD2L;MTHFR;MTHFD1
prerank,endocardial cushion morphogenesis (GO:0003203),0.29504640208214106,0.7547644109021434,0.8051001821493625,0.9891970109543488,1.0,4/18,11.15%,HEY1;NOTCH1;ACVRL1;NOS3
prerank,regulation of cellular metabolic process (GO:0031323),0.24129959987802738,0.7546218707408989,0.8519108280254777,0.9888236446977869,1.0,15/45,21.30%,PANK2;LAMTOR1;ACACB;ARF1;CYP1B1;NPC2;VPS35;MBOAT7;ACACA;EIF6;KIF16B;PDK3;ABCG1;FASN;RNF41
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3234706287104327,0.7546165960534892,0.7650273224043715,0.9882487377366713,1.0,2/12,8.02%,INSIG1;KDELR2
prerank,response to estradiol (GO:0032355),-0.24007447392790685,-0.7536350252800331,0.8592233009708737,0.96318212918829,1.0,6/31,16.23%,EGFR;CTNNB1;SOCS2;ANXA1;GGT5;TGFB1
prerank,hemidesmosome assembly (GO:0031581),0.33063408087567786,0.7533955736815706,0.7762376237623763,0.9895136846039909,1.0,2/11,8.58%,DST;ITGA6
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.28758419622368725,-0.7533194973190835,0.8387096774193549,0.9629946337226726,1.0,3/15,6.59%,LPGAT1;PPARGC1A;PPARA
prerank,cellular response to fatty acid (GO:0071398),-0.29695428101409466,-0.7529120069504025,0.8141025641025641,0.9629081287487142,1.0,6/12,43.17%,PID1;ZC3H12A;LPL;NR1H4;DGAT2;PDK4
prerank,miRNA metabolic process (GO:0010586),0.2821332238167853,0.7527240281036979,0.8028169014084507,0.9899691085148343,1.0,6/20,19.12%,BCDIN3D;XPO5;TUT7;TUT4;PARN;DIS3L2
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.337414382611133,0.7522944524895689,0.7842741935483871,0.990025016861996,1.0,2/10,8.03%,TNFRSF1B;NOTCH1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.21494431142065254,0.7519649266494632,0.9130434782608695,0.9899097395819353,1.0,16/95,14.95%,ZSWIM7;ERCC4;YY1;XRCC1;SFPQ;CDC45;KDM4D;SEM1;RFWD3;EXD2;RAD51B;HUS1;NBN;PSMD14;RMI1;INO80
prerank,regulation of response to interferon-gamma (GO:0060330),-0.29514715907824707,-0.7518787997495088,0.8239277652370203,0.9636486387974306,1.0,5/14,19.51%,JAK1;IFNGR1;PTPN2;IFNGR2;STAT1
prerank,female gonad development (GO:0008585),0.2873474763373312,0.7508708453729616,0.8036697247706422,0.9909634987262418,1.0,2/19,4.24%,SOD1;NR5A1
prerank,myelination (GO:0042552),0.23863486211052862,0.7504196434516599,0.8646496815286624,0.9910528036982189,1.0,12/46,14.63%,MAL;MPZ;SCN2A;NFASC;PMP22;MARVELD1;ACER3;SBF2;NF1;ADGRG6;PARD3;ARHGEF10
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.33105818391784236,0.7503402075140262,0.76953125,0.9905773951507999,1.0,3/10,18.42%,PRKG1;CD9;RDX
prerank,mitotic chromosome condensation (GO:0007076),0.26374932809535573,0.7503202687957322,0.8271812080536913,0.9900211719709262,1.0,5/26,14.34%,TENT4A;CHMP1A;AKAP8L;PHF8;CSNK2A2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3300081274595122,0.7500646991179633,0.7897838899803536,0.9897978027996444,1.0,4/11,20.30%,PARK7;FBXO7;NONO;REST
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.23394942875083,-0.7499341650622613,0.8660287081339713,0.965673220941446,1.0,20/33,40.90%,IGF1;MAPT;MPV17L;HUWE1;GHITM;PINK1;FLCN;AKT1;BCL2L1;GPX1;TMEM14A;FXN;SLC25A5;ADCK1;PRELID1;CLU;HGF;MUL1;OPA1;PPIF
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.3294864680215746,0.7493033808820452,0.7707129094412332,0.9902716486438586,1.0,2/12,10.59%,ESR1;TERT
prerank,negative regulation of cell cycle process (GO:0010948),0.23142823816077832,0.7491603487161687,0.8968253968253969,0.9899156679645958,1.0,8/61,10.42%,EZH2;EED;FBXO5;UXT;BMI1;CHMP2A;RYBP;MGA
prerank,synaptic vesicle transport (GO:0048489),0.3256043007668578,0.7489262879973836,0.7938342967244701,0.9896906291943105,1.0,5/11,19.66%,TMEM230;SPG11;SNAPIN;RAB27A;KIF5B
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.31591796710863224,-0.7487133759961746,0.8013392857142857,0.9665869159857713,1.0,2/11,5.46%,NECAB1;BACE2
prerank,regulation of stem cell proliferation (GO:0072091),0.297041483745499,0.748656422553861,0.8188539741219963,0.9894971398336441,1.0,3/17,10.59%,PTPRC;ZFP36L1;TERT
prerank,regulation of glucose metabolic process (GO:0010906),0.25000162435023443,0.7484740056929312,0.8217317487266553,0.9891867514446018,1.0,5/34,11.09%,SDHAF3;MLYCD;SIRT1;IRS2;ADIPOR1
prerank,endothelial cell differentiation (GO:0045446),-0.31016480613655234,-0.7477049914415493,0.8200836820083682,0.9673147085903161,1.0,4/12,22.00%,FSTL1;SCUBE1;BMPR2;KDM6B
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.26074541846281807,-0.7475986429272948,0.8352668213457076,0.9668365538047115,1.0,2/20,3.31%,TGFBR1;DCUN1D5
prerank,positive regulation of lymphocyte activation (GO:0051251),0.26455333641559536,0.7469615201017794,0.8338983050847457,0.9907930601910678,1.0,5/28,17.85%,CYRIB;CD47;TNIP2;PRKDC;SH3KBP1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.27125166413293095,-0.7467281623599934,0.8341121495327103,0.9673566297284208,1.0,3/18,7.71%,MCU;SPIRE1;FIS1
prerank,cellular response to amyloid-beta (GO:1904646),0.2504241443451578,0.7466141924342975,0.8564273789649416,0.9907252541714489,1.0,7/35,14.38%,CACNA1A;FCGR2B;FYN;ICAM1;APP;PRNP;GRIN2A
prerank,protein localization to vacuole (GO:0072665),0.3179010115121374,0.7456922104774059,0.7810077519379846,0.9915061239911682,1.0,5/13,18.85%,GLMP;CD81;KPTN;RNF128;SH3GLB1
prerank,lipid transport (GO:0006869),0.2102069818431331,0.745644703800389,0.9166666666666666,0.990993309461245,1.0,16/97,15.56%,ATP8A1;ABCC4;GOT2;APOE;PRELID3B;UGCG;PPARD;PRELID2;PITPNA;SCARB1;GM2A;NPC2;OSBPL2;SPNS2;SLCO1C1;CERT1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.22712802231639148,0.7455379074441871,0.869894099848714,0.9905651124341937,1.0,19/62,21.38%,POLR2J;POLR2B;FXR1;NUP54;NUP50;NUP35;IPO8;NDC1;WTIP;NUP160;POM121;STAT3;NUP42;EIF4G1;NUP133;AGO1;TNRC6A;PPARG;DHX9
prerank,cochlea morphogenesis (GO:0090103),0.33690254591931185,0.7455242494594159,0.7644710578842315,0.990005909096494,1.0,1/10,5.97%,TBX1
prerank,signal transduction in response to DNA damage (GO:0042770),0.2352617266903434,0.7454059206140963,0.8681672025723473,0.9895972565510255,1.0,11/49,16.92%,TIPRL;ACER2;RAD1;CLOCK;HUS1;NBN;DOT1L;CHEK2;BRIP1;ATR;USP28
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.28623673538692596,0.7452839261786076,0.8294849023090586,0.989205431326128,1.0,6/21,14.13%,CLASP2;CIB1;FGF13;CAMSAP2;APC;SPEF1
prerank,negative regulation of GTPase activity (GO:0034260),-0.25757339703804427,-0.7452616840016135,0.8399122807017544,0.9686289078353061,1.0,4/22,11.60%,CPEB2;WNK1;GPSM1;GMIP
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.22968098918378782,-0.7449988183328092,0.8617511520737328,0.9683313753868195,1.0,17/32,32.20%,TAOK3;MRE11;BRSK1;TAOK1;ATM;TRIM39;RINT1;FOXN3;BABAM1;BLM;NOP53;CDC14B;TOPBP1;TAOK2;HMGA2;CDK5RAP3;CLSPN
prerank,regulation of B cell differentiation (GO:0045577),0.28933395540394125,0.7447521105528436,0.7902350813743219,0.9893929363516994,1.0,2/17,6.70%,ZFP36L1;SYK
prerank,pre-miRNA processing (GO:0031054),0.30651106324943056,0.7441281427710706,0.8144144144144144,0.9897145843897627,1.0,4/14,15.07%,ADAR;AGO4;TUT7;TUT4
prerank,regulation of spindle assembly (GO:0090169),-0.24375964500585232,-0.7436580582954082,0.8758314855875832,0.9693642317031702,1.0,5/25,18.87%,DYNC1H1;RNF4;EML3;CHMP2B;CHMP5
prerank,macrophage activation (GO:0042116),0.24937596608482454,0.7433821747734793,0.8406040268456376,0.9901822540440194,1.0,6/34,14.77%,IFI35;SBNO2;SYK;APP;CD93;CRTC3
prerank,positive regulation of lamellipodium organization (GO:1902745),0.2562750941394042,0.7429375503538749,0.8578274760383386,0.9902620301787854,1.0,3/32,6.54%,RAC2;SRC;ARHGEF7
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.26807949126291164,-0.7427797778875194,0.8410138248847926,0.9699033902251407,1.0,7/18,40.79%,PSMD9;CCN3;ADRA2A;SFRP1;SIRT4;CHGA;INHBB
prerank,signal transduction by p53 class mediator (GO:0072331),-0.2378651764806718,-0.7422865132960184,0.8702290076335878,0.9699064201265687,1.0,5/30,11.55%,DDX5;FHIT;PAXIP1;TP53;STK11
prerank,dorsal/ventral pattern formation (GO:0009953),-0.25585293365965456,-0.7421742043075259,0.8561797752808988,0.9694280208418552,1.0,8/20,28.65%,GLI2;NBL1;ACVR1;BMPR1B;BMPR1A;PTCH1;SFRP1;MDFI
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2142184613834807,0.7420402769612234,0.9235294117647059,0.9910002519626843,1.0,15/84,14.54%,ILF3;PIN1;PATL2;APOE;FXR1;PAIP2B;CNOT7;TSC1;DDX3X;NANOS3;RPS3;PRNP;YBX1;CNOT1;CAPRIN1
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.2526447929548511,-0.741673129125599,0.8466819221967964,0.9694151957767596,1.0,5/22,11.30%,BMP7;BMP4;ROCK1;CDKN1B;TP53
prerank,DNA modification (GO:0006304),0.27688558792655105,0.7414756737128219,0.8236331569664903,0.9912008958526449,1.0,5/22,15.22%,TDG;ACD;SMUG1;MPG;TERF2IP
prerank,establishment of melanosome localization (GO:0032401),0.2845532037410846,0.741103648580706,0.7878228782287823,0.9911706656463092,1.0,5/19,17.83%,RAB11B;MYO5A;BLOC1S5;RAB27A;BBS7
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.31938960727475946,0.7407769467165173,0.7922330097087379,0.9910638090951011,1.0,1/11,1.77%,AMDHD2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.24495182444437702,-0.7407654930793806,0.8545454545454545,0.9699800823945091,1.0,8/27,24.49%,PPARA;ABCA5;NFKB1;ABCA1;IL18;AGTR1;MAPK9;NR1H2
prerank,diacylglycerol metabolic process (GO:0046339),0.2748080615337878,0.7403728344424445,0.8150087260034904,0.9910583573263386,1.0,2/23,2.68%,DGKB;GPAM
prerank,microtubule bundle formation (GO:0001578),0.24137187840090724,0.7403601845751429,0.8658940397350994,0.9905001191657271,1.0,7/42,17.27%,GAS2L1;MAP1S;NAV1;SPEF1;CLIP1;CLASP1;NCKAP5
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.31399507095562196,-0.7403318841738469,0.8285714285714286,0.9698810883206481,1.0,5/10,39.33%,HIPK3;PTPN22;DNAJA1;MAPK8IP1;DUSP19
prerank,atrioventricular valve morphogenesis (GO:0003181),0.28247019947776064,0.7398422299572623,0.8078291814946619,0.9906323309844155,1.0,4/19,8.67%,HEY1;HEY2;NOTCH1;EFNA1
prerank,organic hydroxy compound transport (GO:0015850),-0.22555820926219594,-0.7395759765339398,0.8698979591836735,0.9701619663284505,1.0,7/36,15.66%,RBP4;OSBP;RXRA;RALBP1;NCOA1;STARD5;ATP8B1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.31297611412982157,0.739479449854942,0.8040665434380776,0.9905386038675283,1.0,2/12,7.54%,MLYCD;IRS2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.32827441519777584,0.7394439718640955,0.8254901960784313,0.9900188029087181,1.0,1/10,2.74%,PRKCH
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.3155987892537324,-0.7393577096483488,0.8031189083820662,0.9698256132337826,1.0,2/10,7.24%,DGKH;GAP43
prerank,negative regulation of bone mineralization (GO:0030502),0.3074249782343261,0.7393432496796531,0.7709923664122137,0.9896000670410752,1.0,3/13,16.34%,GREM1;TRPM4;PTK2B
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.26359146522874677,0.7386234078291171,0.8342151675485009,0.9900075706644255,1.0,4/27,8.56%,CDKN1A;BMI1;CDK4;WNT5A
prerank,mitochondrial protein processing (GO:0034982),0.3261288431297437,0.7386182303335215,0.784,0.9894466362008193,1.0,4/11,17.39%,IMMP2L;OMA1;YME1L1;MIPEP
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.288789874885103,-0.7385498337743692,0.8258706467661692,0.9702079323160788,1.0,5/15,17.76%,DDX1;CSTF2;RTCB;RTRAF;ZBTB8OS
prerank,negative regulation of macroautophagy (GO:0016242),0.26282027976833583,0.7377588080013369,0.8202995008319468,0.9900903892744873,1.0,11/26,21.34%,SMG1;TSC1;SCFD1;FEZ2;TMEM39A;UBQLN4;USP36;LZTS1;RUBCN;LRRK2;PIK3CA
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.27658255411006016,0.737667479160502,0.8388278388278388,0.9896501257129969,1.0,2/22,8.79%,ERCC3;GTF2H1
prerank,cellular response to pH (GO:0071467),0.29134735322662686,0.7376159567229069,0.8288973384030418,0.9891519303248416,1.0,2/17,8.00%,RAB11B;RAB11FIP5
prerank,melanosome localization (GO:0032400),0.278135750884372,0.7372767827771767,0.8037037037037037,0.9890407100961213,1.0,6/21,18.03%,RAB11B;MYO5A;BLOC1S5;RAB27A;BBS7;VPS33A
prerank,melanosome transport (GO:0032402),0.28525284761293385,0.736515719869568,0.8047882136279927,0.988968140185889,1.0,5/18,17.83%,RAB11B;MYO5A;BLOC1S5;RAB27A;BBS7
prerank,pigment granule transport (GO:0051904),0.28525284761293385,0.736515719869568,0.8047882136279927,0.988968140185889,1.0,5/18,17.83%,RAB11B;MYO5A;BLOC1S5;RAB27A;BBS7
prerank,carboxylic acid transmembrane transport (GO:1905039),0.24244037839746882,0.7364919209410582,0.8615136876006442,0.9884298314385201,1.0,2/40,1.30%,SLC7A8;SLC36A4
prerank,positive regulation of protein transport (GO:0051222),-0.19628873277767606,-0.7353508320621798,0.9571428571428572,0.9735266989307476,1.0,21/67,26.16%,BMP6;IGF1;EZR;PPID;UNC13B;VAMP2;RACK1;ARHGEF5;OAZ1;EXOC1;TGFB1;CNST;OAZ2;RAB29;CLN3;TGFB3;IER3IP1;RIPOR1;APBB1;SYTL4;PPIA
prerank,positive regulation of glial cell differentiation (GO:0045687),0.28649011526551915,0.7348549689043021,0.8091743119266055,0.9900855899492748,1.0,5/17,16.05%,TNFRSF1B;NOTCH1;TENM4;HES1;ID2
prerank,cellular macromolecule catabolic process (GO:0044265),0.23101835878022,0.7343148818318427,0.8771384136858476,0.990217499978723,1.0,8/49,15.44%,NCBP1;RNASE6;MAGEC2;XRN2;STT3B;CHEK2;UBE2G1;PPP1R8
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.23553770129547663,0.7341967771037077,0.8824451410658307,0.9898160743315688,1.0,7/47,13.32%,TRIB3;PRMT3;FYN;EP300;ERLIN2;PGP;PLEK
prerank,protein-DNA complex disassembly (GO:0032986),0.29357115443836757,0.7328771615103165,0.8323809523809523,0.9909233764447403,1.0,4/16,19.09%,RPL23;SMARCD1;SMARCA4;SMARCB1
prerank,amino sugar biosynthetic process (GO:0046349),0.3106067996836968,0.7325959396265088,0.798828125,0.990743653236079,1.0,1/12,1.77%,AMDHD2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.20937016784301432,0.7325610301295961,0.9382022471910112,0.9902253695798102,1.0,11/94,10.49%,ALMS1;HAUS4;HAUS5;CEP41;TUBB;DCTN2;SCLT1;ODF2;CEP164;DCTN3;DYNLL1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.3095825379016621,0.7320101143056934,0.8054474708171206,0.9903552681684497,1.0,1/13,1.17%,CBL
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.2314349866022538,-0.7316407898781196,0.8816425120772947,0.9774831730294824,1.0,7/30,17.68%,UFL1;BMP4;KIT;TP53;LMBR1L;TGFB1;ACE
prerank,positive regulation of vacuole organization (GO:0044090),-0.3228073373615025,-0.7314187589197005,0.8423236514522822,0.9771210401981837,1.0,4/10,16.48%,ANXA2;RAB3GAP2;PIP4K2B;LRSAM1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.30313780890053077,0.7310207348387123,0.7889908256880734,0.9911109944971389,1.0,5/13,18.23%,TMEM30B;CD81;BCAP31;TMEM30A;EDEM2
prerank,regulation of T cell activation (GO:0050863),0.24098363839925796,0.7309060255659668,0.8975155279503105,0.9907078426483311,1.0,3/42,9.09%,TNFRSF1B;CYRIB;CD47
prerank,fatty acid metabolic process (GO:0006631),0.2021424516130706,0.7308404017032213,0.9481582537517054,0.9902259569041577,1.0,12/115,11.78%,CRAT;ACSL5;MLYCD;GPAM;PPARD;ADIPOR2;NUDT19;ALKBH7;ACSL4;ADIPOR1;PNPLA8;ACOT8
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.30278161254273556,0.7308387470632399,0.8210922787193974,0.9896644370849824,1.0,2/14,9.76%,TXNDC12;PARK7
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.30698648794328137,0.7307529954428471,0.8097014925373134,0.9892012715178653,1.0,5/14,13.32%,PPP2R2D;PPP2CA;PPP2CB;PPP3CA;PPP5C
prerank,regulation of protein targeting to membrane (GO:0090313),-0.23602058967774592,-0.7303829907127991,0.888095238095238,0.977702868546719,1.0,4/28,7.71%,ANK3;CEMIP;AKT2;FIS1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.2935209829445675,-0.7302350725482284,0.8210735586481114,0.9772710014236381,1.0,6/12,24.36%,TET1;MPHOSPH8;SETDB2;RESF1;DNMT1;ATF7IP
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.32549553184795604,0.7301871600526917,0.8109756097560976,0.9893354429750418,1.0,1/10,1.77%,AMDHD2
prerank,negative regulation of protein processing (GO:0010955),-0.29424721022693506,-0.7299748383559159,0.8373626373626374,0.9769505470737663,1.0,4/12,25.87%,GAS1;THBS1;CTSZ;SERPINE1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.31639804466801186,0.7295429493548239,0.811787072243346,0.9895970190313425,1.0,5/12,16.46%,APOE;TMED10;PICALM;PRNP;FKBP1A
prerank,pancreas development (GO:0031016),0.3098589983545333,0.7294598203192336,0.8105065666041276,0.989151713146403,1.0,1/12,4.00%,SELENOT
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.21276615579088898,0.7290591708078078,0.9308270676691729,0.9891355750836478,1.0,6/73,11.27%,PTPRJ;PTPRC;TIRAP;SYK;WNT5A;APP
prerank,negative regulation of cell death (GO:0060548),0.20722578051887905,0.7289421807551945,0.9513590844062947,0.988717844528085,1.0,6/88,5.19%,RAD18;MECOM;TXNDC12;FYN;TNFRSF1B;WFS1
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2926147035370571,0.7288780080173362,0.826007326007326,0.9882372113062812,1.0,2/16,14.45%,ERCC4;RMI1
prerank,cellular response to virus (GO:0098586),0.2522767383251411,0.7288643481538514,0.8273504273504273,0.9876958421845893,1.0,5/30,14.23%,EIF5A;ARF1;DDX3X;CHUK;LGALS8
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.31504207590124406,-0.72884192129691,0.808300395256917,0.9777266924643907,1.0,7/10,46.57%,SIRT2;CDC42;RCC2;RACGAP1;ECT2;KNSTRN;SPAG5
prerank,regulation of hemopoiesis (GO:1903706),-0.3104149262737991,-0.7286645460737505,0.8336842105263158,0.9773007423822275,1.0,5/10,33.70%,CBFB;MYSM1;IL17D;MAFB;PTN
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.26043160112010644,0.7286327610178178,0.8515901060070671,0.9874258030118757,1.0,2/25,3.34%,GSK3A;INSYN2A
prerank,positive regulation of sodium ion transport (GO:0010765),0.3082819974394143,0.728558866088913,0.8175046554934823,0.9869631771574112,1.0,2/12,6.92%,AHCYL1;CNKSR3
prerank,regulation of lipid storage (GO:0010883),0.2685788193651941,0.7285188542616234,0.8286713286713286,0.9864640602558138,1.0,5/22,15.62%,SIRT1;ALKBH7;MEST;NFKBIA;FTO
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.27061914537407633,-0.7282612689028478,0.8318385650224215,0.9771999881608877,1.0,6/16,27.48%,THBS1;JCAD;AGTR1;VEGFA;GATA2;FGFBP1
prerank,tryptophan catabolic process (GO:0006569),-0.3079337183027868,-0.7281880666050505,0.836864406779661,0.9766672625755473,1.0,11/11,69.23%,KYAT1;AFMID;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3232170876070926,0.7277215162869416,0.7976190476190477,0.9868970234120421,1.0,1/10,1.75%,PDE4D
prerank,negative regulation of TOR signaling (GO:0032007),0.24462702685949436,0.7276329718076845,0.875,0.9864524261692856,1.0,9/36,16.19%,GSK3A;EPM2A;AKT1S1;SIRT1;TSC1;PRKAA2;TMEM127;KPTN;SESN3
prerank,phosphate ion homeostasis (GO:0055062),0.3225500407659032,0.7272560357335762,0.7951127819548872,0.9863747684934204,1.0,1/10,5.33%,XPR1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.25642885657857917,0.7262537076417535,0.8542713567839196,0.98708043972782,1.0,8/27,18.81%,RUVBL2;EP300;RUVBL1;CREBBP;TRRAP;TAF6L;NAA50;MSL3
prerank,positive regulation of exosomal secretion (GO:1903543),-0.2775341581711597,-0.7253363017127837,0.851380042462845,0.9794066102779115,1.0,6/15,22.03%,SMPD3;SNF8;TSG101;STAM;VPS4A;HGS
prerank,protein import into peroxisome matrix (GO:0016558),0.30688514252099985,0.7252241810855476,0.8143939393939394,0.9878565717407557,1.0,2/12,6.57%,PEX1;PEX7
prerank,ceramide transport (GO:0035627),-0.2928193367687606,-0.7250122103570824,0.7991360691144709,0.9791797389148401,1.0,2/12,8.49%,PSAP;PLEKHA8
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.2904712203815799,-0.7246880208669064,0.8172690763052208,0.9789415419156404,1.0,4/12,35.41%,BMP7;FLOT1;THY1;SKAP1
prerank,cellular response to acid chemical (GO:0071229),-0.2382971358742898,-0.7233683785681838,0.8695652173913043,0.9798442578154481,1.0,3/27,2.38%,CPEB4;CPEB1;CAPN2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.2766651444083375,-0.7233011184025294,0.8432671081677704,0.9792905163692133,1.0,2/15,9.88%,MOXD1;SAT1
prerank,filopodium assembly (GO:0046847),0.2852453636066231,0.722940355646167,0.8186619718309859,0.9901647795297583,1.0,3/16,14.13%,DNM3;FGD5;SPEF1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.2754859345836026,-0.7224699934691937,0.8480492813141683,0.9796324245467348,1.0,6/16,18.89%,A4GALT;B4GALT6;ST6GALNAC5;LARGE1;ST6GALNAC6;ST8SIA2
prerank,negative regulation of cyclase activity (GO:0031280),-0.278813135384955,-0.722355550139781,0.8104575163398693,0.9791483247334305,1.0,2/14,7.83%,ADGRV1;GABBR2
prerank,superoxide metabolic process (GO:0006801),-0.2313659212160026,-0.7217493144142385,0.8978102189781022,0.9792003979614846,1.0,10/29,23.37%,ATP7A;SH3PXD2A;CCS;NOX4;PREX1;SOD3;PRDX1;PRDX2;SH3PXD2B;NRROS
prerank,response to unfolded protein (GO:0006986),0.22910616956013932,0.7210752229491784,0.9083601286173634,0.9919373307983687,1.0,15/48,20.74%,HSPA8;HSPA4L;DNAJB5;STT3B;HSPE1;DDIT3;ERP44;HSPA13;HSPA14;SERPINH1;BAX;DERL1;HSPB8;ERN1;HSP90AB1
prerank,early endosome to late endosome transport (GO:0045022),-0.2563538223139994,-0.7207563059976713,0.8623853211009175,0.9797008253235501,1.0,8/20,23.94%,PIK3C3;EEA1;STX8;SNF8;PTPN23;HOOK2;LMTK2;EMP2
prerank,cell proliferation in forebrain (GO:0021846),-0.30884031508943777,-0.7207317353339839,0.8269230769230769,0.9791091896290645,1.0,2/10,10.88%,CEP120;NUMBL
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.26654217787296286,-0.720574338596284,0.8803611738148984,0.9786577199112083,1.0,6/18,27.00%,ROCK1;SLC39A8;ITGA4;ADD2;PODXL2;CX3CR1
prerank,cholesterol transport (GO:0030301),0.22907154873395746,0.7203206384346814,0.9028006589785832,0.9923455465164684,1.0,9/45,15.93%,APOE;SOAT1;SCARB1;LDLRAP1;NPC2;NPC1;OSBPL2;SERAC1;STARD3
prerank,negative regulation of blood coagulation (GO:0030195),0.2413869068283863,0.7197225065959763,0.9033333333333333,0.9924760779793393,1.0,6/38,13.85%,APOE;F8;NOS3;A2M;PLAT;PROC
prerank,regulation of cytokinesis (GO:0032465),0.20832706037003693,0.7193855314781818,0.9287833827893175,0.9923237705511988,1.0,20/78,20.22%,PIN1;PLK2;CSPP1;PRPF40A;CALM3;KIF13A;CUL3;GIPC1;PIK3R4;KLHL13;SETD2;BECN1;KLHL9;ZFYVE19;CALM1;SH3GLB1;PRKCE;PKN2;CDC14A;ZFYVE26
prerank,glycerophospholipid metabolic process (GO:0006650),0.21407279300652787,0.7193668569534389,0.927007299270073,0.9917889628608383,1.0,12/75,14.23%,SERINC1;SMPD4;PLCG1;PIGH;CSF1R;PLCB1;SERINC5;PGP;PIGB;ABHD12;PLEK;PNPLA6
prerank,microtubule depolymerization (GO:0007019),0.2799505718018679,0.7185316157054873,0.8342440801457195,0.9922366837972968,1.0,4/17,18.21%,KIF18A;KIF2A;NCKAP5;KIF24
prerank,negative regulation of protein secretion (GO:0050709),0.23769133058973188,0.7184371841963423,0.8836065573770492,0.9917943860787132,1.0,4/38,10.01%,HMGCR;APOE;RAB11FIP5;RHBDF2
prerank,carbohydrate catabolic process (GO:0016052),0.2408787805235842,0.7183922671103324,0.8933333333333333,0.9912847481494358,1.0,2/38,5.68%,ENO4;TPI1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.311407833208852,-0.7178985386207373,0.8378378378378378,0.9811390838276192,1.0,8/10,52.68%,AKT1;TICAM1;MYD88;TLR4;CD68;TREM2;CD36;TLR6
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.2561449753908013,0.7177093229629042,0.8573943661971831,0.991526563794032,1.0,6/26,13.92%,TAL1;MDM2;USP22;APP;CUL3;HES1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.29028989601960337,0.7172988655566652,0.8451492537313433,0.9914843291296622,1.0,1/15,2.74%,PRKCH
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.25961011153223973,-0.7171555301904537,0.8459770114942529,0.9813679118808156,1.0,9/18,30.97%,NELL1;VGLL4;EZR;DACT1;MSN;AMER1;HSP90AA1;RGP1;CDK5RAP3
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.2298284482686328,-0.7169513517188487,0.8953229398663697,0.9809829150558446,1.0,9/27,27.69%,IRAK3;SYT11;SIRPA;PTPN22;SELENOS;CX3CL1;C1QTNF3;NCKAP1L;ZC3H12A
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.27161781583805844,-0.7165092868594404,0.8470066518847007,0.9807799735730033,1.0,10/15,39.85%,PRKCD;SMPD3;RACK1;PLA2G6;ORMDL3;SMPD2;SPHK1;ORMDL1;ORMDL2;SPHK2
prerank,DNA double-strand break processing (GO:0000729),-0.2587148420674933,-0.7165082182640264,0.864367816091954,0.9801589478915717,1.0,10/18,36.61%,UBE2N;RAD50;MRE11;ATM;BLM;SLX4;KAT5;BARD1;SETMAR;DNA2
prerank,cellular response to misfolded protein (GO:0071218),0.27178948930406027,0.7163374229769218,0.8378870673952641,0.992094926601371,1.0,9/20,20.99%,AUP1;CUL3;UFD1;DNAJB14;ATXN3;UGGT1;POMT2;DERL1;KLHL15
prerank,negative regulation of protein ubiquitination (GO:0031397),0.22640509933142997,0.7162724440299266,0.9154471544715447,0.9916147606182196,1.0,8/50,11.52%,TNFAIP3;PRMT3;FBXO5;SMAD7;IVNS1ABP;PARK7;SPOPL;RPS3
prerank,negative regulation of cell division (GO:0051782),-0.30213866672166767,-0.7161137262133042,0.8197064989517819,0.9799582274203712,1.0,3/11,21.09%,ORC6;BLM;VPS4A
prerank,cellular copper ion homeostasis (GO:0006878),0.2897613175938039,0.7156157389020588,0.8181818181818182,0.9918110915193684,1.0,4/14,14.68%,ARF1;APP;PRNP;MT2A
prerank,calcineurin-mediated signaling (GO:0097720),-0.310249077661928,-0.7146592372308325,0.8619329388560157,0.9802740621679225,1.0,4/10,18.38%,NFAT5;NFATC2;PPP3CC;NFATC4
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.310249077661928,-0.7146592372308325,0.8619329388560157,0.9802740621679225,1.0,4/10,18.38%,NFAT5;NFATC2;PPP3CC;NFATC4
prerank,regulation of exocytosis (GO:0017157),0.22159189152204262,0.7141383978504704,0.9066022544283414,0.993028962538747,1.0,6/46,10.69%,CLASP2;STXBP5L;RALA;CADPS;RAB2B;ATP6AP1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.2822551183270372,-0.7140053387067118,0.8376068376068376,0.9802955779464929,1.0,2/13,7.83%,ADGRV1;GABBR2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.31537265953655247,0.7130555379607618,0.8442622950819673,0.9937470710478084,1.0,1/11,3.08%,GREM1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.3040615719342849,-0.7130416848776865,0.8266384778012685,0.9806601536177447,1.0,6/10,33.10%,EPB41L4B;IQSEC1;MAPRE2;FGF10;FGF7;MTOR
prerank,carnitine metabolic process (GO:0009437),0.3109356419889278,0.7127519794786307,0.8252788104089219,0.993531095578187,1.0,1/12,1.43%,CRAT
prerank,regulation of transposition (GO:0010528),-0.2840037689858945,-0.712064082250914,0.8504273504273504,0.9810873896822995,1.0,9/13,58.60%,SIRT7;UBR2;TEX15;SMYD5;PIWIL2;TDRD9;DDX4;PIWIL4;SPOCD1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.3151631851254068,0.7118510607069469,0.793036750483559,0.9940329474601851,1.0,4/10,19.12%,CHFR;TUT7;TUT4;DIS3L2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.23694780331101675,0.7118291482988662,0.9123102866779089,0.9935086737837006,1.0,7/36,14.26%,SPR;APOE;TERT;NOSTRIN;NOS3;SCARB1;GCH1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.21685901851028722,0.7110942459364926,0.9206106870229007,0.9938680406099807,1.0,13/58,17.42%,ABRAXAS1;ERCC4;KDM2A;DCLRE1B;UBE2V2;POLA1;NBN;PSMD14;BRCC3;NSD2;XRCC4;PRKDC;DCLRE1C
prerank,positive regulation of secretion by cell (GO:1903532),-0.18704121718869812,-0.7109649424123055,0.9779005524861878,0.9816603212809626,1.0,13/70,16.64%,BMP6;IGF1;P2RX4;SLC12A2;RAB27B;EZR;STXBP5;PPID;RAB9A;UNC13B;EXOC1;TGFB1;STX1A
prerank,indolalkylamine catabolic process (GO:0046218),-0.3079143915144668,-0.710811685118695,0.8308977035490606,0.9812288613665532,1.0,10/10,69.23%,KYAT1;KMO;KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,negative regulation of gluconeogenesis (GO:0045721),0.30866471038028015,0.7098497049782514,0.828996282527881,0.994773162617219,1.0,2/11,11.01%,EP300;PGP
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.2509348187180508,0.7092341519901236,0.8819320214669052,0.9949055898992807,1.0,6/26,14.60%,RPTOR;RGCC;PLCB1;DDX3X;ANKRD17;MTBP
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.20840603229385118,0.7090256044779751,0.9455081001472754,0.9945859457548449,1.0,10/76,11.60%,GSK3A;TRIB3;ARIH1;COP1;SMAD7;AXIN1;MDM2;RAD23A;PIAS1;ELOB
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.2793137282402145,0.7086415701387029,0.8387681159420289,0.9944613873754741,1.0,4/17,10.81%,HEY1;HEY2;NOTCH1;RBPJ
prerank,Golgi ribbon formation (GO:0090161),0.2946827534728499,0.7085682974829933,0.8214285714285714,0.993991198071676,1.0,3/13,10.13%,TRIP11;TMED5;GCC2
prerank,response to organic cyclic compound (GO:0014070),-0.1981852045581207,-0.7084125651851678,0.9587912087912088,0.9831848900599571,1.0,10/52,17.44%,IGFBP5;CTNNB1;HLCS;SOCS2;ANXA1;IL18;GGT5;SPP1;TGFB1;ALPL
prerank,cell projection assembly (GO:0030031),0.26321980507763043,0.7081187704586005,0.8561643835616438,0.9939191474498009,1.0,3/22,11.05%,RAC2;RHOQ;RHOG
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.19046746178410334,0.7080739828461269,0.9814814814814815,0.9934124155783287,1.0,30/148,16.22%,PIN1;RPL23;HIPK2;RFFL;RAD1;EP300;RPL5;MDM2;TTC5;TAF15;PRKAA2;ING2;HUS1;TOP3A;PAK1IP1;TAF4B;NBN;CHD3;TBP;ING5;CHEK2;MAP2K6;CSNK2A2;RMI1;BRIP1;DYRK2;TAF1;ATR;RBBP4;TAF3
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.27571552773162367,-0.7080041813853285,0.8406113537117904,0.9829905536266699,1.0,7/13,34.23%,RAB23;ENTPD7;AK3;GTPBP1;MFN1;RAN;AK4
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.26977513221888777,-0.707926639306281,0.8688172043010752,0.9824525308312719,1.0,5/16,22.64%,RPA1;PURA;BLM;RECQL;MCM6
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.269162753620666,0.7077976588598595,0.8540145985401459,0.9931474781544054,1.0,7/20,20.59%,IMPDH1;NT5C2;GMPR2;HPRT1;GART;ATIC;PPAT
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.27080715292831825,-0.7072878172572044,0.8565121412803532,0.9824618438928275,1.0,5/15,24.84%,BMP4;SMO;SIX1;VEGFA;PAX2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2356421948083168,-0.7072064805908244,0.8738738738738738,0.981927690092816,1.0,11/23,36.14%,DICER1;DNASE1L1;DFFA;CASP3;EXOG;H1-0;DNASE2;HMGB1;HMGB2;SETMAR;MUS81
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.23945174621084417,-0.7068603234354135,0.8830275229357798,0.9810454160625339,1.0,11/24,31.61%,PKM;FOXK1;ALDOA;ENO2;PGK1;HK2;PGAM1;PFKM;GAPDH;ALDOC;PFKL
prerank,canonical glycolysis (GO:0061621),-0.23945174621084417,-0.7068603234354135,0.8830275229357798,0.9810454160625339,1.0,11/24,31.61%,PKM;FOXK1;ALDOA;ENO2;PGK1;HK2;PGAM1;PFKM;GAPDH;ALDOC;PFKL
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.2291166852695036,-0.7061085906925177,0.9200968523002422,0.981209553047324,1.0,13/26,35.43%,FBN1;CDK6;RARA;PTPN2;TCTA;TLR3;INHBA;GPR137B;CEACAM1;TMEM178A;MAFB;ZFPM1;GPR137
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.24120087638606186,0.7059721491514025,0.8594771241830066,0.9946431517598805,1.0,5/33,10.59%,CTC1;ANKRD28;DCLRE1B;ACD;TERT
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.2738161865990377,0.7052080212505605,0.8761061946902655,0.9949152058851075,1.0,3/18,9.18%,CLASP2;RGCC;COLGALT1
prerank,mitochondrial membrane organization (GO:0007006),0.24388063507570795,0.7051514120935718,0.8924914675767918,0.9944236565080906,1.0,9/32,17.58%,IMMT;BAD;MAIP1;CHCHD6;CHCHD3;DNAJC11;MICOS10;BNIP3;RCC1L
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.22219605635433767,-0.704160478069237,0.9384236453201971,0.9825908642519998,1.0,2/34,1.84%,IGF1;PDGFRB
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.2574195598675578,0.7040822324604035,0.8797127468581688,0.9950681581626621,1.0,6/24,16.34%,APOE;UBE3A;EFNA1;PSMD14;UCHL5;PTK2B
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.28495157816731387,0.7039463748664417,0.8689138576779026,0.9946656442615381,1.0,2/15,7.11%,SORT1;BDNF
prerank,lysosome localization (GO:0032418),0.22988362286030284,0.7034499477666158,0.8919803600654664,0.9946564135292325,1.0,10/37,19.66%,PIK3CG;LAMTOR1;PIK3CD;SNAPIN;S100A13;TFEB;MYH9;VPS33A;PLEKHM2;KIF5B
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.25742451980250025,-0.7032545313747276,0.8761261261261262,0.9829154211813884,1.0,4/18,11.77%,PUM1;PUM2;BIRC3;NPLOC4
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.22497865180734625,-0.7028364856571434,0.9067357512953368,0.9826825128208249,1.0,9/28,21.13%,ERCC6;SHLD1;HSF1;PARP3;SIRT7;ACTR2;RIF1;SMCHD1;DTX3L
prerank,steroid metabolic process (GO:0008202),-0.1828121937698094,-0.7026400383628523,0.990990990990991,0.982280680764378,1.0,18/72,30.38%,CYP27A1;CYP7B1;LGMN;MSMO1;CYP26B1;FDX1;FDFT1;CYP51A1;PIAS4;ARV1;PRLR;DHRS4;LIPA;CUBN;GBA2;AMACR;DHCR24;DHRS11
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.29415190104115885,-0.7024163413920818,0.8693069306930693,0.9818772215656469,1.0,3/11,11.96%,PUM1;PUM2;LIMD1
prerank,negative regulation of anoikis (GO:2000811),0.292016371957763,0.7021060100120582,0.8415300546448088,0.9955867672739962,1.0,2/14,8.03%,SRC;NOTCH1
prerank,histone H2A monoubiquitination (GO:0035518),-0.25844992113949505,-0.7017926264603415,0.8716814159292036,0.9818435209776558,1.0,6/17,19.07%,DDB1;DDB2;RNF168;PCGF2;BCOR;PCGF6
prerank,mRNA methylation (GO:0080009),-0.2662065611458302,-0.7016987276225362,0.8622222222222222,0.9813223292896148,1.0,5/15,24.04%,VIRMA;CBLL1;PCIF1;TRMT6;CMTR1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2791840901223405,-0.7010032387106281,0.8671023965141612,0.9813939818224655,1.0,7/13,35.78%,UFL1;DDRGK1;RACK1;PPP1R15B;ABCA7;NCK1;ATF6B
prerank,coenzyme A metabolic process (GO:0015936),0.29010818709960695,0.7009820760370342,0.861003861003861,0.9962342252409775,1.0,2/14,5.63%,PANK2;ACAT1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2246467025190112,-0.7005085754511382,0.930715935334873,0.9812649636150463,1.0,8/28,20.64%,NUPR1;DDRGK1;PTK2;RNF139;ATP5IF1;OSBPL7;PSMC5;PSMC3
prerank,positive regulation of type I interferon production (GO:0032481),0.20476147487886817,0.7000201137098961,0.9560117302052786,0.9967232897090194,1.0,16/73,19.12%,LRRFIP1;POLR1C;EP300;RELA;DDX3X;CREBBP;POLR3F;CHUK;POLR3B;SETD2;PRKDC;PTPN11;POLR3K;POLR3GL;TRIM56;DHX36
prerank,neuron apoptotic process (GO:0051402),-0.24610135733117872,-0.6999406045470922,0.9148418491484185,0.9811842728648092,1.0,9/19,29.69%,TRPC5;CIT;FAM162A;TNFRSF21;ATN1;BCL2;GAPDH;BID;CDK5
prerank,glycoprotein metabolic process (GO:0009100),-0.19637855385903938,-0.6999220895133282,0.9575070821529745,0.9805855146656461,1.0,12/53,18.89%,MAN1C1;NGLY1;FUT8;ADAMTS9;GANC;MAN2A2;LARGE1;PCSK6;ST3GAL4;TNIP1;ST6GALNAC6;ST8SIA2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.28593606338670785,0.6998691032474318,0.8671454219030521,0.9963430559949225,1.0,1/16,5.04%,TNFRSF1B
prerank,regulation of glycogen metabolic process (GO:0070873),-0.28471437021140833,-0.6995937494959263,0.8574338085539714,0.9802987775766523,1.0,9/12,56.66%,PPP1R3B;AKT1;INPP5K;PPP1R3C;RUBCNL;KHK;PPP1R3E;PPP1R3D;GCGR
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.2775145484285403,0.6986834180915551,0.8434442270058709,0.9971058986493234,1.0,6/15,21.08%,PPARD;IRS2;LDLRAP1;IRS1;PRKCE;PPARG
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.2797989435404775,-0.6985530672498508,0.8690228690228691,0.9806621280060573,1.0,8/13,36.62%,TOB1;PABPC1;BTG2;POLR2G;TNRC6C;TNRC6B;EIF4ENIF1;ZFP36
prerank,release of cytochrome c from mitochondria (GO:0001836),0.27279323662177596,0.6984407167513182,0.8574144486692015,0.9967980646619599,1.0,5/17,17.79%,SOD2;FZD9;BAD;DNM1L;BAX
prerank,bile acid and bile salt transport (GO:0015721),0.2536237296475646,0.6983143950342229,0.8859649122807017,0.996391862793267,1.0,1/24,1.40%,ABCC4
prerank,regulation of gene silencing by RNA (GO:0060966),0.21993800281126913,0.6977419779727292,0.9144634525660964,0.9958846048509165,1.0,13/50,20.08%,POLR2J;POLR2B;NUP54;NUP50;NUP35;IPO8;NDC1;NUP160;POM121;NUP42;EIF4G1;NUP133;AGO1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.21993800281126913,0.6977419779727292,0.9144634525660964,0.9958846048509165,1.0,13/50,20.08%,POLR2J;POLR2B;NUP54;NUP50;NUP35;IPO8;NDC1;NUP160;POM121;NUP42;EIF4G1;NUP133;AGO1
prerank,RNA methylation (GO:0001510),0.2118179864890256,0.6966374006877654,0.9326186830015314,0.9964600171957333,1.0,15/60,20.60%,TRMO;BCDIN3D;THUMPD2;TRMT61B;METTL2B;METTL2A;NSUN6;ZC3H13;NSUN2;TFB1M;FTSJ1;TFB2M;METTL14;TGS1;ALKBH8
prerank,phosphate ion transport (GO:0006817),0.27945007143839473,0.6963503770112033,0.86996336996337,0.9962323771680051,1.0,2/16,9.67%,XPR1;SLC37A3
prerank,vesicle organization (GO:0016050),0.2209176431508123,0.6961265872223246,0.9151712887438825,0.9959315352205492,1.0,12/46,19.20%,SORT1;EXOC8;VPS11;LAMTOR1;AKTIP;RAB22A;LAPTM4B;HOOK3;VPS18;FNBP1L;ALS2;PI4K2B
prerank,inhibitory synapse assembly (GO:1904862),-0.28275319808382815,-0.6954536075435436,0.8703703703703703,0.9830436515231903,1.0,5/11,24.47%,GABRA2;GABRG2;LGI2;GABRA1;PLXNB1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.23168795222950742,0.6947838522033222,0.8990536277602523,0.9967421896673563,1.0,10/42,17.73%,RAC2;NOTCH1;MINK1;TSC1;NPNT;NF1;CORO2B;ATXN3;CORO1C;FBLN2
prerank,regulation of steroid biosynthetic process (GO:0050810),0.30230493841883155,0.6937114556453746,0.8589981447124304,0.9973343347886573,1.0,2/11,7.29%,NR5A1;SIRT1
prerank,quinone biosynthetic process (GO:1901663),0.2838818227602215,0.6922823941377849,0.8548094373865699,0.9982276354780281,1.0,6/14,19.46%,COQ2;PDSS2;COQ5;PDSS1;COQ3;COQ10A
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.22391840218501385,0.6920001989334842,0.9089430894308943,0.9979802056227498,1.0,7/43,13.29%,ABRAXAS1;CDKN1A;NAE1;CHFR;HUS1;NBN;BRCC3
prerank,rRNA 3'-end processing (GO:0031125),0.30600771309514607,0.6918728586490801,0.8539741219963032,0.9975750843292065,1.0,2/10,8.81%,RPS21;EXOSC9
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.27901711787210126,0.6916638871742741,0.8605504587155963,0.9972406295357764,1.0,3/15,14.50%,TENT4A;CNOT7;CNOT1
prerank,sterol transport (GO:0015918),0.2636728030768646,0.691568467388069,0.8636363636363636,0.9967925541662094,1.0,5/19,15.93%,LDLRAP1;NPC2;NPC1;OSBPL2;STARD3
prerank,mesoderm development (GO:0007498),0.26435181522848866,0.691125363621383,0.8803571428571428,0.9967016674420599,1.0,3/18,10.46%,TBX1;TIE1;MEST
prerank,histone mRNA metabolic process (GO:0008334),0.24477140914440207,0.6904062149480692,0.8972125435540069,0.996875895644428,1.0,7/27,18.65%,NCBP1;TUT7;SSB;TUT4;SLBP;LSM1;SNRPD3
prerank,hydrogen peroxide metabolic process (GO:0042743),0.2664684838931994,0.6899305462808274,0.881508078994614,0.9967895352241879,1.0,3/19,14.46%,SOD1;PARK7;CYBA
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2037027850952019,0.6898457943686097,0.967016491754123,0.9963362290258211,1.0,17/78,18.07%,GSK3A;TRIB3;ARIH1;COP1;SMAD7;MDM2;RAD23A;UBQLN1;PIAS1;ELOB;RNF180;FBXO22;TAF1;UBQLN2;BCAP31;BBS7;GABARAP
prerank,development of primary male sexual characteristics (GO:0046546),-0.20748870204681336,-0.6895104333501824,0.9357326478149101,0.9880913142702086,1.0,5/34,12.96%,KIT;LHFPL2;WNT4;NCOA4;MSH2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.25003223472699876,-0.6887875103807474,0.9100877192982456,0.9881224000104377,1.0,9/18,31.24%,USP13;BCL2L11;TMEM259;RNFT1;PIK3R1;BAG6;RNF185;NCK1;BOK
prerank,regulation of macrophage migration (GO:1905521),0.31068035203748856,0.688640292590373,0.8757281553398059,0.9969918794824444,1.0,3/10,16.34%,CD81;MTUS1;PTK2B
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.27535974233428684,-0.6885407212758803,0.8747300215982722,0.9877331275428852,1.0,6/14,36.48%,ACE;ENPEP;AGTR1;EDN1;EDN3;ACE2
prerank,phosphate ion transmembrane transport (GO:0035435),0.2932568601040948,0.6872733680418694,0.8533333333333334,0.9978274051841002,1.0,2/12,9.67%,XPR1;SLC37A3
prerank,positive regulation of vasculogenesis (GO:2001214),-0.29492941654931126,-0.6866945363304734,0.8517786561264822,0.9888518961141056,1.0,6/10,35.71%,CD34;RAPGEF2;HIF1AN;CEACAM1;RRAS;RIN2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.27451900100344795,0.6861549783148484,0.8566493955094991,0.998431445029126,1.0,4/16,16.75%,PNKP;KDM4D;KMT5B;PRKDC
prerank,adipose tissue development (GO:0060612),-0.28811630568375,-0.6850394053909034,0.8900634249471459,0.9896889385047356,1.0,6/11,41.47%,LRP5;PGRMC2;SH3PXD2B;DYRK1B;DGAT2;SOX8
prerank,regulation of microtubule nucleation (GO:0010968),-0.30094997070580115,-0.6848053975093416,0.8807692307692307,0.9892818201193616,1.0,3/10,15.74%,EML2;CKAP5;DCTN1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.2913871920073884,-0.6845957817133108,0.8539094650205762,0.9888463650730523,1.0,3/10,15.31%,DNAJC19;MTMR9;MTMR4
prerank,DNA replication (GO:0006260),0.1917129803979527,0.6844785135287628,0.9790794979079498,0.9995393348901832,1.0,19/105,15.85%,PNKP;ING4;ORC3;RAD1;POLE;CDC45;ORC4;CDK2AP1;POLA1;HUS1;ORC2;TOP3A;NBN;HELB;ING5;RMI1;BRIP1;TOP1;ATR
prerank,cobalamin metabolic process (GO:0009235),0.26775792754707756,0.683400656994723,0.8820422535211268,1.0,1.0,1/17,2.94%,MTR
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.25613277295462955,0.6824790637376204,0.8822495606326889,1.0,1.0,4/20,13.86%,CDK5RAP1;LATS2;TFAP4;APC
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.24689532040664708,-0.6821754826448525,0.890625,0.9903701311171516,1.0,10/18,33.32%,MMP14;STX8;VPS4A;APPL1;CLN3;VAMP8;SPTBN1;CDK5;ABCA2;VTI1B
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.2767642758141629,0.6813941175420899,0.8704379562043796,1.0,1.0,3/16,8.88%,SRC;CLASP2;ACVRL1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.2767642758141629,0.6813941175420899,0.8704379562043796,1.0,1.0,3/16,8.88%,SRC;CLASP2;ACVRL1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.23490128227716106,0.6811994165310338,0.9112227805695142,0.9999472966352728,1.0,3/31,13.01%,FCGR2B;LYN;CD274
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.2834197724657422,0.6797161297648524,0.867704280155642,1.0,1.0,1/13,1.77%,AMDHD2
prerank,intracellular cholesterol transport (GO:0032367),0.26890579666970227,0.67964968460997,0.8893280632411067,1.0,1.0,5/15,13.98%,LDLRAP1;NPC2;NPC1;OSBPL2;SERAC1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.2696803620284307,-0.6796490783097284,0.8833693304535637,0.9919756157448605,1.0,7/13,28.65%,PKD1;FLNA;KEAP1;SUFU;DBN1;GET4;MDFI
prerank,regulation of interferon-beta production (GO:0032648),0.2162097657781284,0.678885272742035,0.9368770764119602,1.0,1.0,8/46,13.48%,TIRAP;YY1;NLRC3;TRAF3;DDX3X;POLR3F;RNF216;POLR3B
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.2772133422496728,-0.6783946368477479,0.8633540372670807,0.9923748841925651,1.0,4/12,26.39%,BTRC;GOLGA2;CDC14B;UBE2S
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.20007741972763682,0.6782484825175361,0.9704049844236761,1.0,1.0,13/67,15.63%,TBC1D8;PPP1R16B;TBC1D10B;FXR1;USP6NL;PODXL;IFT140;TBC1D24;TBC1D14;RABGAP1;TWF1;ARF6;CDKL5
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.2865191592076317,-0.6778171575571327,0.8763796909492274,0.9916192553393267,1.0,4/10,21.48%,PRKCD;SMPD3;RACK1;PLA2G6
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.2865191592076317,-0.6778171575571327,0.8763796909492274,0.9916192553393267,1.0,4/10,21.48%,PRKCD;SMPD3;RACK1;PLA2G6
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.21049742507248093,0.6772786013152277,0.9509493670886076,1.0,1.0,10/49,18.08%,RAB7B;MYL9;CIB1;EP300;MTURN;AGO4;PITHD1;MOV10;EIF6;SIN3A
prerank,Golgi to endosome transport (GO:0006895),0.2716673877195739,0.6771818815444212,0.8709677419354839,1.0,1.0,6/16,17.75%,SORT1;RAB14;DOP1B;AP1AR;CORO7;KIF16B
prerank,positive regulation of vasoconstriction (GO:0045907),-0.26958697106760127,-0.6768113364793421,0.8907922912205567,0.9918645128432027,1.0,4/13,32.25%,ADRA1B;ADRA1A;CAV1;TBXA2R
prerank,NAD biosynthetic process (GO:0009435),0.2524053724210832,0.6766354188428322,0.8865248226950354,1.0,1.0,5/20,16.87%,NUDT12;NADSYN1;NAMPT;NAXD;NMNAT1
prerank,mRNA polyadenylation (GO:0006378),0.23665652985869606,0.6766156843017911,0.8974358974358975,0.9994065435491847,1.0,9/26,21.53%,AHCYL1;PAPOLA;APP;SCAF8;WDR33;CLP1;PAPOLG;TENT2;MTPAP
prerank,RNA polyadenylation (GO:0043631),0.23665652985869606,0.6766156843017911,0.8974358974358975,0.9994065435491847,1.0,9/26,21.53%,AHCYL1;PAPOLA;APP;SCAF8;WDR33;CLP1;PAPOLG;TENT2;MTPAP
prerank,mitochondrial transcription (GO:0006390),-0.2862345351386475,-0.6762943328264149,0.8713692946058091,0.9916730967190072,1.0,7/10,41.27%,SLC25A33;FOXO3;MTERF2;MRPL12;TEFM;POLRMT;TWNK
prerank,endodermal cell fate commitment (GO:0001711),0.3062415644444406,0.6759896974715462,0.8663967611336032,0.9994470646333864,1.0,1/10,4.86%,SOX2
prerank,cellular lipid catabolic process (GO:0044242),0.24102673113708797,0.6758921919622874,0.9133448873483535,0.9989952573322871,1.0,5/27,12.53%,PPARD;NUDT19;CYP1B1;ACOT8;ABHD12
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.22525826716358016,-0.6756965895745187,0.9327146171693735,0.991575017398028,1.0,6/25,15.84%,AMPD3;DGUOK;ADK;GMPS;MTHFD1;PRPSAP2
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.2533149010284021,-0.6755429512136848,0.8831460674157303,0.9910943957628173,1.0,6/17,28.78%,ANXA4;ANXA1;PTPN22;SSC5D;OTUD7B;BCL3
prerank,phasic smooth muscle contraction (GO:0014821),0.3046507249105629,0.6753837022261908,0.85546875,0.9989141797660417,1.0,10/10,69.55%,EDNRB;EDN2;HTR1D;TIFAB;GDNF;HTR2B;EDN3;PTGER3;EDN1;DRD2
prerank,B cell activation involved in immune response (GO:0002312),0.28613390425891916,0.6753687692208955,0.869811320754717,0.9983880600867079,1.0,1/13,2.51%,FCGR2B
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.21900496995580326,-0.6751102190099845,0.9247572815533981,0.9908422860706654,1.0,5/26,12.91%,GRIN2B;MBP;ROCK2;AIM2;USP50
prerank,negative regulation of neurogenesis (GO:0050768),0.22481453246166452,0.6746546160921608,0.9254237288135593,0.9985016383105852,1.0,8/34,17.53%,B2M;RUFY3;NOTCH1;NF1;YWHAH;HOOK3;LRP4;LINGO1
prerank,regulation of T cell proliferation (GO:0042129),0.2020428238342596,0.6740595111497871,0.9553158705701078,0.9984856701261953,1.0,4/61,13.01%,PTPRC;TNFRSF1B;PNP;CD274
prerank,establishment of protein localization to extracellular region (GO:0035592),0.21748589517676684,0.673695001064142,0.9428571428571428,0.9982658884305292,1.0,10/39,19.58%,MIA2;ARL4D;COPG2;PPY;COPG1;TANGO6;TVP23B;MIA3;PDIA4;SEL1L
prerank,piRNA metabolic process (GO:0034587),0.25741019844260243,0.6724650852409496,0.9020979020979021,0.9988235192328313,1.0,19/19,74.29%,MYBL1;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MAEL;FKBP6;PIWIL4;TDRD12;DDX4;TDRD9;PIWIL2;EXD1;TEX15;TDRKH
prerank,positive regulation of TOR signaling (GO:0032008),0.22178122285032187,0.6722813575889273,0.927536231884058,0.9984442316100239,1.0,7/40,15.25%,RPTOR;HDAC3;LAMTOR1;SIK3;LARS1;RRAGC;GAS6
prerank,protein localization to chromatin (GO:0071168),0.26251283563040845,0.6720052498048451,0.8865248226950354,0.9981675922562111,1.0,4/18,14.51%,RUVBL2;ESR1;PPHLN1;TASOR
prerank,regulation of cholesterol storage (GO:0010885),-0.2576112441526688,-0.6717447803669957,0.9085239085239085,0.9929779594263711,1.0,4/15,16.53%,PPARA;ABCA1;TTC39B;EHD1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.25766482613014197,-0.6703976687922258,0.9235807860262009,0.9934693578682852,1.0,8/14,40.71%,PPARA;AKT2;ABCD2;AKT1;MFSD2A;TWIST1;TYSND1;MTLN
prerank,protein localization to centrosome (GO:0071539),-0.24972960928093027,-0.6703398504638679,0.8879120879120879,0.9928987318988455,1.0,3/17,10.50%,PIBF1;NUDCD3;GOLGB1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.2821375184025178,-0.6700636002790211,0.8951781970649895,0.9925052544823112,1.0,5/11,28.51%,NBL1;RIN3;CCN3;DUSP1;PADI2
prerank,rRNA modification (GO:0000154),0.24992045733268423,0.6698709432082769,0.9027522935779817,0.9994577611885644,1.0,1/21,1.09%,THUMPD1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.2726937273704226,0.6697836071652937,0.875717017208413,0.9990059339053088,1.0,3/15,11.85%,FITM2;CNEP1R1;SCARB1
prerank,regulation of cell aging (GO:0090342),0.29248392870766543,0.6690167661576267,0.8838475499092558,0.999151414536582,1.0,4/11,18.90%,ING2;NEK6;RSL1D1;NUAK1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.29531247820227363,0.668696172875551,0.8633776091081594,0.9983529732236991,1.0,3/11,18.82%,CALM3;FKBP1A;CALM1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.29531247820227363,0.668696172875551,0.8633776091081594,0.9983529732236991,1.0,3/11,18.82%,CALM3;FKBP1A;CALM1
prerank,protein catabolic process (GO:0030163),0.2038851989994636,0.6684904527222578,0.9529042386185244,0.9979909659851597,1.0,8/59,15.10%,HSPA8;PPT1;APOE;MAGEC2;TPP1;STT3B;CHEK2;UBE2G1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.2548418275220353,-0.6683826996465074,0.908695652173913,0.9932532230150851,1.0,8/16,31.79%,PIGV;PIGG;PIGX;PIGA;PIGM;PIGF;DPM2;PIGC
prerank,GPI anchor metabolic process (GO:0006505),-0.21767291655035634,-0.6670643050807917,0.9325301204819277,0.9936610490711225,1.0,12/26,33.86%,DPM1;GPLD1;PIGV;PIGG;PIGA;PIGM;PGAP4;PIGF;MPPE1;DPM2;PIGC;DPM3
prerank,glial cell differentiation (GO:0010001),-0.21519767833107353,-0.6669982112512377,0.9227053140096618,0.9931049353550019,1.0,18/28,41.74%,NFIB;RELN;TPPP;PAX2;PICK1;EIF2B5;CDK5;MYRF;FGF10;GPC1;SOX11;ERBB3;GPR157;SOX10;METRN;SOX4;SOX8;PTPRZ1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.20291969066840143,0.6668523200183658,0.9699248120300752,0.9988696539408328,1.0,12/64,18.12%,ACSL5;ELOVL6;ACSL4;CYP1B1;PNPLA8;HSD17B4;ACOT8;DAGLB;HPGD;ACADL;AIG1;ELOVL5
prerank,tetrapyrrole metabolic process (GO:0033013),0.25976319875969905,0.666848513259554,0.9035087719298246,0.9983367894656591,1.0,1/18,2.94%,MTR
prerank,regulation of myelination (GO:0031641),-0.22277568493851121,-0.6667047202656408,0.9146067415730337,0.9927074286834435,1.0,12/25,35.79%,SIRT2;TNFRSF21;DICER1;TPPP;RNF10;EIF2AK3;LGI4;MYRF;PTN;NSUN5;ZPR1;TMEM98
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.23166246092789294,-0.6661922967968188,0.9251700680272109,0.9925009145027773,1.0,7/21,27.57%,ACBD5;LPIN1;CYP26B1;LPIN2;FAH;HOGA1;LPIN3
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.26940103195861553,0.6660770404817054,0.8882466281310212,0.9984437015254478,1.0,2/15,6.97%,RIPOR2;RAPGEF3
prerank,negative regulation of organelle assembly (GO:1902116),-0.1955954508226367,-0.6657911367846706,0.9741602067183462,0.9922133571417913,1.0,17/35,32.80%,SMAD4;NUPR1;FEZ1;CCP110;LIMK2;PINK1;PHF23;RBM14;YAP1;MDM1;CDK10;TBC1D7;CEP97;KAT2B;TCHP;TRIM37;SMCR8
prerank,negative regulation of interferon-gamma production (GO:0032689),0.2410694530237848,0.6653114952185869,0.9138840070298769,0.9986132663647658,1.0,5/23,15.25%,VSIR;PRNP;CD274;DDIT3;GAS6
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.2711276677569023,-0.6652679547446204,0.8835758835758836,0.9920046217939723,1.0,1/12,1.66%,ACSL1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.22994822775655,-0.6647620604475097,0.9158878504672897,0.991764218784306,1.0,14/21,43.67%,COX16;COX19;COX17;COX18;PET100;COX20;COX14;BCS1L;COA5;SCO1;COA3;SURF1;COA6;FASTKD3
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.28519971063874994,0.6647470046769535,0.8823529411764706,0.9985535989379529,1.0,3/12,13.63%,SGTB;SEC62;SEC61A2
prerank,mesoderm formation (GO:0001707),0.25938431676520124,0.664145317176006,0.8954372623574145,0.9985153814125308,1.0,2/17,12.26%,ITGA2;ITGA3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.20776745421330697,0.6636400888583096,0.9677938808373591,0.9984087086839718,1.0,8/54,11.52%,TNFAIP3;PRMT3;RPL5;SMAD7;IVNS1ABP;PARK7;SPOPL;RPS3
prerank,steroid hormone biosynthetic process (GO:0120178),0.22993324282439057,0.6627551074295919,0.9098639455782312,0.998633280104467,1.0,4/29,15.93%,TSPO;HSD17B11;STARD3NL;STARD3
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.23380191310131723,0.6627264008724925,0.9289340101522843,0.998120973533185,1.0,5/29,11.27%,GRIK2;NETO1;APOE;MCTP1;APP
prerank,positive regulation of cell development (GO:0010720),0.23122643283426367,0.6623605632530437,0.9300341296928327,0.9978876094273006,1.0,5/31,13.62%,MME;RFX3;BAD;ATP6AP1;FAIM
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.23863756116057094,-0.6622784025427054,0.940552016985138,0.993046488937892,1.0,7/20,23.61%,MCU;MICU2;AFG3L2;MCUR1;SPG7;MCUB;STOML2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.30101297694630746,0.6621120067023045,0.8654205607476636,0.9975764492867629,1.0,1/10,4.59%,APOE
prerank,potassium ion export across plasma membrane (GO:0097623),-0.2621099345327303,-0.6618691918499531,0.908183632734531,0.9927433595875764,1.0,5/13,45.89%,KCNK5;KCNQ1;KCNIP2;KCNE4;KCNH2
prerank,positive regulation of T cell proliferation (GO:0042102),-0.1789548589241409,-0.6599873462202921,0.9803921568627451,0.9934921466113492,1.0,6/55,14.13%,IGF1;IGFBP2;ANXA1;IL18;IL6ST;IGF2
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.25321858287295085,-0.6593666447493884,0.9084967320261438,0.9933338049212577,1.0,4/13,22.02%,NUPR1;FEZ1;PINK1;PHF23
prerank,regulation of T cell differentiation (GO:0045580),-0.20614964893989995,-0.6577450794639037,0.9314720812182741,0.9938647600964698,1.0,3/33,6.99%,CBFB;ZBTB1;CAMK4
prerank,positive regulation of macrophage migration (GO:1905523),0.2530241602371033,0.6573248054004845,0.9113475177304965,1.0,1.0,2/19,9.17%,MAPK3;CSF1R
prerank,macrophage migration (GO:1905517),-0.2557251301689758,-0.6564126686269073,0.9002267573696145,0.9942208216496988,1.0,3/13,24.20%,P2RX4;P2RY12;CKLF
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.22027552298094394,-0.6562876451496504,0.930715935334873,0.9937154300533443,1.0,11/25,31.61%,PKM;FOXK1;ALDOA;ENO2;PGK1;HK2;PGAM1;PFKM;GAPDH;ALDOC;PFKL
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.23361600135663788,-0.6560701134319776,0.9316037735849056,0.9932424229660571,1.0,12/19,37.45%,PMM2;RENBP;UGDH;NAGK;GFPT1;GNPDA2;GFPT2;GNPDA1;GNPNAT1;PMM1;UAP1;NANS
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.2620258352787103,-0.6559679574915529,0.9173387096774194,0.9927064958542806,1.0,2/13,15.93%,IL33;SELENOS
prerank,regulation of keratinocyte migration (GO:0051547),-0.26262782930267015,-0.6558189210867994,0.8884120171673819,0.9921919147948758,1.0,6/12,33.10%,EPB41L4B;IQSEC1;MAPRE2;FGF10;FGF7;MTOR
prerank,regulation of membrane depolarization (GO:0003254),0.2526468702201505,0.6556264422947253,0.9097605893186004,1.0,1.0,2/18,7.28%,NEDD4L;SMAD7
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.2716846268665746,0.6538077777778851,0.8994708994708994,1.0,1.0,2/13,8.20%,RIC3;TMEM35A
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.2477785856998414,-0.6532554916479897,0.9064587973273942,0.993342033606283,1.0,9/14,38.47%,ZNHIT6;NOL9;RPF2;FTSJ3;BOP1;NIFK;RPL7L1;PES1;DDX18
prerank,lymphocyte migration (GO:0072676),0.22166297456791345,0.652125520134277,0.9276315789473685,1.0,1.0,2/32,8.51%,RET;CCL25
prerank,ncRNA 3'-end processing (GO:0043628),0.2686915840670171,0.6508284331149573,0.8932806324110671,1.0,1.0,6/14,20.28%,PTCD1;INTS14;SSB;INTS6;TRNT1;INTS2
prerank,cellular response to interleukin-15 (GO:0071350),-0.26368502804949756,-0.6507726169366946,0.9028697571743929,0.9938293736838271,1.0,2/13,12.24%,JAK1;GRB2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.26368502804949756,-0.6507726169366946,0.9028697571743929,0.9938293736838271,1.0,2/13,12.24%,JAK1;GRB2
prerank,DNA methylation (GO:0006306),0.23250020071495672,0.650570760867286,0.935374149659864,1.0,1.0,2/23,5.83%,DMAP1;BEND3
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.26972618221221867,-0.6504080618465982,0.913135593220339,0.9934667400872454,1.0,4/12,22.92%,ATP7A;HNMT;SMS;OAZ2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.20305910827032803,0.6501834259273543,0.9703588143525741,1.0,1.0,2/51,2.58%,MAPK3;CXCL12
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.2582743464953944,0.6492384478075849,0.893048128342246,1.0,1.0,1/17,2.58%,CXCL12
prerank,regulation of stem cell population maintenance (GO:2000036),0.2518163057878029,0.6491217671676767,0.911275415896488,1.0,1.0,5/18,20.30%,CNOT2;CNOT1;TAF6L;ZC3H13;REST
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.27051818212029216,0.649087615814003,0.9029304029304029,1.0,1.0,3/13,15.95%,NUDT12;NAMPT;NAXD
prerank,intracellular sterol transport (GO:0032366),0.26543614134775906,0.6489519263776649,0.9021113243761996,1.0,1.0,4/13,13.98%,NPC2;NPC1;OSBPL2;SERAC1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.23584054868540696,0.6470338126477122,0.9367088607594937,1.0,1.0,4/25,12.74%,HEY1;HEY2;PARK7;DOT1L
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.19995728013838346,-0.6469672805107024,0.9689922480620154,0.9951661740713865,1.0,4/35,8.39%,CDH10;CDH11;CDH7;NLGN1
prerank,positive regulation of cholesterol transport (GO:0032376),0.2321313163485434,0.6457612561695153,0.9335604770017035,1.0,1.0,3/27,7.29%,APOE;LPCAT3;SIRT1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.2819299978270506,-0.645580769933236,0.8930131004366813,0.9948904803537454,1.0,5/10,33.57%,CDC42EP5;CDC42EP1;CDC42;CDC42EP2;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.2819299978270506,-0.645580769933236,0.8930131004366813,0.9948904803537454,1.0,5/10,33.57%,CDC42EP5;CDC42EP1;CDC42;CDC42EP2;WASHC1
prerank,protein alkylation (GO:0008213),-0.2199331685155704,-0.6448996400928391,0.9353348729792148,0.9947443040729682,1.0,8/22,28.29%,CAMKMT;FAM98A;EEF1AKMT1;PRMT2;METTL21A;PRMT8;PRMT1;EEF2KMT
prerank,regulation of cilium assembly (GO:1902017),0.19486463489819172,0.6441685487025676,0.9688473520249221,1.0,1.0,9/62,13.25%,EVI5L;TBC1D30;TBC1D8;TBC1D10B;USP6NL;IFT140;TBC1D24;TBC1D14;RABGAP1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.26632975614456555,-0.6407954981518295,0.9161554192229039,0.9967880181181413,1.0,1/11,3.95%,SCARA3
prerank,glycerophospholipid catabolic process (GO:0046475),0.2315169884666518,0.6400038341206206,0.9301948051948052,1.0,1.0,4/27,14.23%,SMPD4;PNPLA8;ABHD12;PNPLA6
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.21878072207114185,0.6391370693286313,0.9432989690721649,1.0,1.0,6/32,16.60%,LPCAT3;GPAT4;SLC44A1;CEPT1;CSNK2A2;SLC44A2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.2790191486033008,0.6389613867500176,0.8822429906542056,1.0,1.0,3/11,16.71%,SYK;PTK2B;SHC1
prerank,cellular response to interleukin-2 (GO:0071352),0.2790191486033008,0.6389613867500176,0.8822429906542056,1.0,1.0,3/11,16.71%,SYK;PTK2B;SHC1
prerank,ubiquinone metabolic process (GO:0006743),0.2560333608774627,0.6389294772279367,0.908273381294964,1.0,1.0,6/15,19.46%,COQ2;PDSS2;COQ5;PDSS1;COQ3;COQ10A
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.27060978778637973,-0.638138403506089,0.9260042283298098,0.9978810925843218,1.0,4/11,20.49%,EFNB2;TGFB1;SOX6;FZD7
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.28646010651954007,0.6377474109885748,0.9137931034482759,1.0,1.0,1/10,6.88%,CALM3
prerank,regulation of DNA recombination (GO:0000018),0.2177904210463195,0.6368061175498042,0.9522240527182867,1.0,1.0,6/32,16.85%,ZRANB3;MSH3;KPNA1;TERF2IP;SETD2;SMARCAD1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.25977325623817055,-0.6364144398176567,0.9256900212314225,0.9983801717963753,1.0,3/13,17.65%,AXL;IFIH1;MAVS
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.2566584616531727,0.6361002439683822,0.9219600725952813,1.0,1.0,5/15,19.58%,DERL2;AUP1;UFD1;DERL1;SEL1L
prerank,glycerolipid catabolic process (GO:0046503),0.24687658013386826,0.6357885065773632,0.9275862068965517,1.0,1.0,3/19,14.23%,SMPD4;ABHD12;PNPLA6
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.27736867749054783,0.6355539631488963,0.890625,1.0,1.0,2/11,13.01%,VSIR;CD274
prerank,cell projection organization (GO:0030030),0.22118581471904314,0.6350287868834946,0.9603960396039604,1.0,1.0,6/30,16.84%,RAC2;RHOQ;RHOG;PLEK;PACSIN2;CYFIP1
prerank,regulation of telomere maintenance (GO:0032204),0.22727223643950678,0.6350080067661535,0.9431616341030196,1.0,1.0,8/26,19.12%,ERCC4;SMG1;NBN;TERF2IP;SMG6;SMG5;ATRX;DHX36
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.2724153487663129,-0.6347474621316995,0.9090909090909091,0.9988334533088493,1.0,4/10,23.59%,EMC7;EMC1;EMC8;EMC9
prerank,ganglioside biosynthetic process (GO:0001574),0.2603010907254268,0.6346537557336904,0.8980392156862745,1.0,1.0,3/15,14.61%,ST6GALNAC3;ST3GAL1;ST8SIA6
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.1949672287702262,0.6338069777153873,0.9703588143525741,1.0,1.0,8/57,13.35%,ABRAXAS1;NEK11;CDKN1A;RFWD3;HUS1;NBN;BRCC3;CHEK2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.24045745293093593,-0.6333625896129292,0.9420935412026726,0.9990801999719875,1.0,6/15,26.99%,ALDH4A1;GGT5;PRODH;SARDH;HOGA1;CHAC2
prerank,histone H3-K36 demethylation (GO:0070544),-0.276166566010041,-0.633158489446543,0.917004048582996,0.9985852706631879,1.0,2/10,5.28%,KDM4A;KDM7A
prerank,neuromuscular process (GO:0050905),0.2548219480119765,0.6328645288219567,0.9045871559633027,1.0,1.0,5/16,17.79%,AGTPBP1;TPP1;MYCBP2;GCH1;PAFAH1B1
prerank,myelin maintenance (GO:0043217),0.2840130601119206,0.6327158873419142,0.9176954732510288,1.0,1.0,1/10,2.23%,SOD1
prerank,chromosome organization (GO:0051276),0.17665830321655157,0.6318724054625329,0.9957264957264957,1.0,1.0,16/99,16.09%,EZH2;HDAC3;SOX2;FAM50A;SIRT1;CDCA8;RFWD3;MSH3;COPS7B;PWWP3A;DOT1L;HDAC5;COPS8;EZH1;SMARCA4;TCF7L1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.2631417001375826,0.6315464811014084,0.8959537572254336,1.0,1.0,3/13,17.68%,CRLF1;TYK2;STAT3
prerank,RNA interference (GO:0016246),-0.23043605602014627,-0.6305967610586664,0.9585365853658536,0.9995119664670177,1.0,6/17,28.60%,TSN;AGO3;DICER1;NRDE2;CELF1;DROSHA
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.2448226439355385,0.6302790419787487,0.9410714285714286,1.0,1.0,1/18,2.43%,DERL2
prerank,negative regulation by host of viral transcription (GO:0043922),-0.25707796953835416,-0.6302331104649566,0.9106029106029107,0.9991225717285729,1.0,5/12,29.17%,HDAC1;JUN;PSMC3;INPP5K;HMGA2
prerank,purine nucleotide metabolic process (GO:0006163),0.22830624862310178,0.630081915055249,0.9351535836177475,1.0,1.0,4/24,12.02%,PRPS1L1;PRPS1;PNP;NT5C2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.2833113663465762,0.6297099326747965,0.8927875243664717,1.0,1.0,10/10,71.69%,ETFBKMT;OXA1L;GZMA;DRD5;PRKN;HP;AOC3;MT3;SNCA;HDAC6
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.26472771786888727,0.6286805428123167,0.9166666666666666,1.0,1.0,1/13,3.56%,EXTL2
prerank,cellular response to interferon-beta (GO:0035458),0.2600043744135542,0.6286313322837885,0.9181286549707602,1.0,1.0,2/14,13.09%,IFITM2;NDUFA13
prerank,GPI anchor biosynthetic process (GO:0006506),-0.1991756300513753,-0.6272990593101432,0.9702233250620348,1.0,1.0,14/30,33.86%,DPM1;PIGV;PIGG;PIGX;PIGA;PIGM;PGAP4;PIGS;PIGF;GPAA1;MPPE1;DPM2;PIGC;DPM3
prerank,hexose transmembrane transport (GO:0008645),0.23942076806246432,0.626869828963569,0.9530685920577617,1.0,1.0,2/21,8.35%,PPARD;SLC2A1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.23859370497314888,0.6264714066243747,0.9412811387900356,1.0,1.0,6/19,18.52%,POLD3;TERT;PNP;GMPR2;GMPR;HPRT1
prerank,cardiac cell development (GO:0055006),-0.26235815795168,-0.6263696149485996,0.9322381930184805,1.0,1.0,3/11,24.78%,CXADR;VEGFA;MYH11
prerank,neural crest cell differentiation (GO:0014033),-0.22511117848478884,-0.625282956391535,0.948905109489051,1.0,1.0,13/18,50.32%,TAPT1;LRP6;PEF1;TCOF1;NOLC1;FBXL17;SOX11;SOX8;KBTBD8;HTR2B;SNAI2;NRG1;MEF2C
prerank,regulation of store-operated calcium entry (GO:2001256),-0.2700422169649149,-0.6247635610422402,0.9240246406570842,0.9997251309222327,1.0,1/10,3.09%,STIM1
prerank,cellular response to leucine starvation (GO:1990253),-0.2655314184159011,-0.6232363969158594,0.9279661016949152,0.9999721965088687,1.0,5/10,33.65%,GCN1;IMPACT;SESN2;MTOR;RRAGD
prerank,actin filament-based transport (GO:0099515),0.23489767830495428,0.6230820504706567,0.9358752166377816,1.0,1.0,4/21,13.12%,MYO5A;ACTN4;MYO1D;MYO1E
prerank,striated muscle cell differentiation (GO:0051146),0.2525830114699925,0.6223863265685963,0.9128856624319419,1.0,1.0,2/16,5.81%,SORT1;MYEF2
prerank,macromolecule catabolic process (GO:0009057),-0.20533472762944704,-0.6217845593315149,0.9655913978494624,1.0,1.0,12/26,33.10%,LGMN;UVRAG;SNX25;UCHL3;TGFB1;LRSAM1;NEDD4;CLPX;CLN5;SMURF1;MVB12A;MTOR
prerank,apoptotic mitochondrial changes (GO:0008637),-0.19312871411823576,-0.6216950987691555,0.9669811320754716,0.9995695755959839,1.0,9/32,25.53%,ERBB4;FIS1;HSPD1;THEM4;BCL2;HK2;CAMK2A;AIFM2;BCL2L1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.2536484293488877,-0.6216690847910299,0.9355509355509356,0.998979430811157,1.0,1/12,7.87%,RBP4
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.26447606756521524,0.6215018374696303,0.9027027027027027,1.0,1.0,2/13,12.41%,PLCG1;SP1
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.21967319608197666,-0.6211706092506626,0.9513742071881607,0.9986454534402813,1.0,13/18,45.30%,ATP7A;ABL2;AGTR1;RFK;PDP1;POR;FXN;EDN1;EDN3;AGT;NOD2;GDNF;PDP2
prerank,regulation of ruffle assembly (GO:1900027),0.22710955001056052,0.6205489755724496,0.9529837251356239,1.0,1.0,2/23,4.76%,EVL;PFN1
prerank,defense response to fungus (GO:0050832),0.24340399993376027,0.6205306521639834,0.937381404174573,1.0,1.0,1/17,6.03%,FAM3A
prerank,negative regulation of secretion (GO:0051048),-0.27003864514066983,-0.6201682352809165,0.909853249475891,0.9985766885379618,1.0,6/10,50.19%,VAMP8;PTGER3;EGF;ERBB3;SPX;NRG1
prerank,fibrinolysis (GO:0042730),0.2587570621468927,0.6193870541233141,0.9148148148148149,1.0,1.0,13/13,74.15%,PLAT;FGG;SERPINF2;KRT1;F2;GP1BA;CPB2;SERPINB2;PLG;HRG;PLAU;PLAUR;SERPINE1
prerank,organophosphate catabolic process (GO:0046434),0.2685789605824755,0.619078015148091,0.926829268292683,1.0,1.0,11/11,73.16%,ABHD12;ENPP2;PNLIPRP2;APOA2;LIPG;PON1;PDXP;NUDT15;PLBD1;ANGPTL3;PLBD2
prerank,positive regulation of innate immune response (GO:0045089),0.21268624585026585,0.6179402563285292,0.956953642384106,1.0,1.0,5/30,13.48%,IFI35;WNT5A;POLR3F;NLRC5;POLR3B
prerank,negative regulation of translational initiation (GO:0045947),0.2560393049478461,0.6178379705516576,0.9312839059674503,1.0,1.0,7/13,23.69%,PAIP2B;EIF3E;LARP1;EIF2AK4;PAIP2;AGO2;FMR1
prerank,regulation of mitochondrial fusion (GO:0010635),0.2775286316867312,0.6166149372783883,0.9174664107485605,1.0,1.0,4/11,19.06%,OMA1;VAT1;BNIP3;TFRC
prerank,amyloid precursor protein catabolic process (GO:0042987),0.2587179268443279,0.6158351454830322,0.9152542372881356,1.0,1.0,1/14,2.47%,PSEN2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.26286467885613957,0.6157350628394115,0.9272388059701493,1.0,1.0,1/12,3.46%,PAX8
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.22628364072704144,0.615537534780171,0.9398998330550918,1.0,1.0,3/24,10.98%,PDE4D;CALM3;DMD
prerank,muscle tissue development (GO:0060537),0.2553264879573506,0.6153363280770832,0.9226415094339623,1.0,1.0,3/13,13.39%,PGM5;NF1;CSRP1
prerank,regulation of interleukin-6 production (GO:0032675),0.17261583697286098,0.6146338324287062,0.9956584659913169,1.0,1.0,7/96,9.09%,TNFAIP3;TIRAP;RAB7B;SYK;NLRC3;WNT5A;CD47
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.26753691313111927,0.6145220671375984,0.923828125,1.0,1.0,2/11,11.09%,PTPRT;ADIPOR1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.20217790706814923,-0.6144389871757152,0.9651162790697675,1.0,1.0,4/25,13.07%,FAM162A;BCL2L11;TP53;PDCD5
prerank,regulation of acrosome reaction (GO:0060046),-0.26561565219781386,-0.6142390758620171,0.9372294372294372,1.0,1.0,1/10,7.73%,GLRA1
prerank,regulation of RNA export from nucleus (GO:0046831),0.2692228773660793,0.613091535041911,0.9057692307692308,1.0,1.0,5/11,21.38%,AKAP8L;CPSF6;SETD2;NSUN2;DHX9
prerank,ureteric bud morphogenesis (GO:0060675),0.2426343281218163,0.6126209166122513,0.9356521739130435,1.0,1.0,2/16,11.08%,PAX8;NPNT
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.21690153084472916,-0.6110991177007552,0.9527027027027027,1.0,1.0,8/18,43.79%,GPLD1;SPG21;BAG6;CMKLR1;SH2B2;FCER1G;BCAR1;C3AR1
prerank,ubiquinone biosynthetic process (GO:0006744),0.24725475091150703,0.6109509863524107,0.9384057971014492,1.0,1.0,6/15,19.46%,COQ2;PDSS2;COQ5;PDSS1;COQ3;COQ10A
prerank,peptidyl-lysine methylation (GO:0018022),-0.19889693417302226,-0.6099284861930123,0.969047619047619,1.0,1.0,17/26,43.88%,SETD7;EHMT2;ATPSCKMT;EEF1AKMT1;SMYD2;N6AMT1;SETD4;METTL21A;EEF2KMT;SUV39H1;EEF1AKMT2;SMYD1;ANTKMT;SUV39H2;VCPKMT;SETD6;TRMT112
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.21175426528423708,-0.609733330311488,0.9630484988452656,1.0,1.0,12/22,34.59%,LMAN1;GDI1;RAB23;APOD;CABP1;ITGB1BP1;DMTN;SUFU;INPP5K;CHP1;SIAH3;BARD1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.22698051039916506,-0.6093812475512568,0.9515011547344111,1.0,1.0,6/17,36.25%,PRKCZ;RARA;CEBPB;CD86;HAVCR2;FCER1G
prerank,mitochondrial genome maintenance (GO:0000002),-0.2540455681066406,-0.609310854283666,0.9494736842105264,0.9997393637728315,1.0,4/11,19.83%,SLC25A36;MPV17;PARP1;SLC25A33
prerank,ovarian follicle development (GO:0001541),0.25610458234287226,0.6092012865208382,0.913894324853229,1.0,1.0,1/13,2.23%,SOD1
prerank,snRNA 3'-end processing (GO:0034472),0.23244642504721222,0.6089123168687006,0.9406307977736549,1.0,1.0,6/19,20.28%,USB1;EXOSC9;INTS14;INTS6;EXOSC7;INTS2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.22398613884717297,-0.6085171479848764,0.9427917620137299,0.9995182278711069,1.0,10/16,44.30%,SHLD1;RIF1;SMCHD1;SHLD2;POLQ;FANCB;CGAS;MAD2L2;RMI2;PARPBP
prerank,modulation by symbiont of host process (GO:0044003),0.2694007573642034,0.6080856093424436,0.9009708737864077,1.0,1.0,1/10,5.45%,B2M
prerank,positive regulation of ruffle assembly (GO:1900029),-0.2441161437526117,-0.6073583599264054,0.9175946547884187,0.9994709229500462,1.0,5/13,24.17%,NLGN1;FAM98A;PLEKHM1;P2RY12;EPS8L2
prerank,modulation by symbiont of entry into host (GO:0052372),-0.2266290759830164,-0.6056530652651377,0.9553752535496958,0.9996592339597953,1.0,9/16,35.44%,HS3ST5;EXOC7;TRIM5;NECTIN2;TRIM62;FUCA2;CAV1;TRIM21;TRIM68
prerank,negative regulation of receptor internalization (GO:0002091),-0.25007382241627973,-0.605375341900721,0.9417040358744395,0.9992091930143924,1.0,2/12,15.61%,DLG4;RIN3
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.21284577071056957,0.6041776834455539,0.9556313993174061,1.0,1.0,4/29,12.87%,BIRC2;TRAF3;IKBKB;CHUK
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.26395944039694486,-0.6040254299285552,0.9522776572668112,0.9991985608637387,1.0,1/10,3.61%,TGFBR2
prerank,iron-sulfur cluster assembly (GO:0016226),0.21793692615840152,0.603839110658964,0.9590017825311943,1.0,1.0,4/24,13.46%,CIAPIN1;ISCU;GLRX3;HSCB
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.20383784648828135,0.6037933549894224,0.9716666666666667,1.0,1.0,5/35,12.84%,RIPOR2;SCAI;RASIP1;ITGA3;CUL3
prerank,fatty acid biosynthetic process (GO:0006633),-0.16023552528639368,-0.6035093208061927,0.9969879518072289,0.9988268111819716,1.0,24/63,39.25%,HACD3;HACD1;HACD4;TECR;ACLY;ABHD3;ACOT7;PTGS2;DEGS1;EPHX2;ABCD3;ELOVL4;FADS3;DECR2;CBR4;SCD;ELOVL1;LIAS;FADS1;ACSBG1;LPL;ALOX12;HSD17B8;OXSM
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.23757055070061478,0.603262002331616,0.9299145299145299,1.0,1.0,3/18,12.41%,PLCG1;FLT1;SP1
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.22619120171627416,0.6021117849765186,0.9602076124567474,1.0,1.0,4/22,14.05%,ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.22619120171627416,0.6021117849765186,0.9602076124567474,1.0,1.0,4/22,14.05%,ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2099464789033985,0.6016914293205029,0.9663299663299664,1.0,1.0,4/30,12.87%,BIRC2;TRAF3;IKBKB;CHUK
prerank,negative regulation of leukocyte migration (GO:0002686),-0.25512225717139225,-0.6005213033665893,0.9356846473029046,0.9995665305507011,1.0,1/10,3.66%,BMP5
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.20649251288325227,-0.6004932838051076,0.9814385150812065,0.9989870628232592,1.0,18/22,66.02%,IL18;TGFB1;SPHK1;ZBTB7B;NR1H4;NOD2;MYD88;LY9;SLAMF6;PRKCQ;CARD9;IL23A;IL6;IL23R;CCL1;IL12B;IL2;OSM
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.19407889884143345,0.6003762036704129,0.9823434991974318,1.0,1.0,12/44,20.82%,PRR5L;ZFP36L1;CNOT7;NANOS3;CNOT1;MOV10;FTO;RC3H1;DHX36;METTL14;CNOT8;TNRC6A
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.2666034239018834,0.5996973717532875,0.9184060721062619,1.0,1.0,2/10,11.22%,SIRT1;CTBP1
prerank,ESCRT III complex disassembly (GO:1904903),0.26875092380827337,0.598970678904147,0.9371428571428572,0.9997999854901864,1.0,2/10,10.23%,CHMP1A;CHMP2A
prerank,ESCRT complex disassembly (GO:1904896),0.26875092380827337,0.598970678904147,0.9371428571428572,0.9997999854901864,1.0,2/10,10.23%,CHMP1A;CHMP2A
prerank,negative regulation of centrosome duplication (GO:0010826),-0.25188592439296187,-0.5985250306730284,0.9380165289256198,0.9992099625583682,1.0,7/11,43.95%,RBM14;MDM1;KAT2B;TRIM37;KAT2A;CCNF;BRCA1
prerank,fatty acid oxidation (GO:0019395),0.18255830428370842,0.598451190068831,0.992526158445441,0.9995391639275387,1.0,11/57,17.51%,ACAT1;PPARD;ADIPOR2;ADIPOR1;HSD17B4;BDH2;ECHDC1;ECHS1;ACAA2;ACADL;PEX13
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.257968009621551,-0.5983873789271423,0.9384920634920635,0.9986818060231734,1.0,3/10,20.71%,SETD7;SMYD2;SETD4
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.22142040615948044,-0.5959710584304316,0.9419642857142857,0.9990631556079653,1.0,4/16,20.40%,TMEM50A;SNF8;CHMP5;STAM
prerank,protein localization to mitochondrion (GO:0070585),0.2615497296468704,0.5953759747065633,0.9309021113243762,1.0,1.0,2/11,10.66%,RALA;MAIP1
prerank,sulfur amino acid catabolic process (GO:0000098),0.25952425782966193,0.5942264620819497,0.9282868525896414,1.0,1.0,10/10,74.06%,TXN2;BLMH;MAT1A;GADL1;TST;MPST;ADO;CTH;CBS;MTRR
prerank,ncRNA metabolic process (GO:0034660),0.19766408698381127,0.5939670637126482,0.9838709677419355,0.9999900587158443,1.0,6/37,16.46%,BCDIN3D;XPO5;TUT7;TUT4;DTD1;PARN
prerank,negative regulation of histone acetylation (GO:0035067),0.2585840006273287,0.5933694826447579,0.9384615384615385,0.9997422462447259,1.0,2/11,11.22%,SIRT1;CTBP1
prerank,plasma membrane tubulation (GO:0097320),-0.2339652471796647,-0.59267497797802,0.9530612244897959,0.9998508925348365,1.0,5/13,32.60%,BIN3;PACSIN1;PACSIN3;CAVIN2;MICALL1
prerank,electron transport chain (GO:0022900),0.2427909089131626,0.5923416637714691,0.9385474860335196,0.9996994595966531,1.0,3/15,13.86%,ETFA;SDHA;PDIA5
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.2588446023051416,-0.5906020859827984,0.9276315789473685,1.0,1.0,2/10,14.25%,TSN;DICER1
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.24673054592319824,-0.5901851585507425,0.9336016096579477,0.9996566480960182,1.0,5/11,52.62%,AGTR1;PLA2G7;AGT;LIPC;PLA2G5
prerank,apoptotic DNA fragmentation (GO:0006309),-0.22027311850562145,-0.5900772478787586,0.9481641468682506,0.9990962826014433,1.0,8/16,35.83%,DICER1;DFFA;CASP3;EXOG;H1-0;DNASE2;HMGB1;HMGB2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.24235893416223903,-0.5897274999875102,0.9458874458874459,0.9986377145744263,1.0,5/11,32.14%,ENPP3;NT5C3A;SLC19A2;DCK;SLC25A19
prerank,oligodendrocyte differentiation (GO:0048709),-0.2093998050637803,-0.5890729326827095,0.9686800894854586,0.998299505708719,1.0,12/19,41.94%,SOX6;TPPP;EIF2B5;EIF2B2;CDK5;EIF2B4;MYRF;NSUN5;SOX10;SOX8;PTPRZ1;EIF2B1
prerank,negative regulation of DNA replication (GO:0008156),-0.23435558140124782,-0.5889311881829181,0.9622641509433962,0.9977610050230031,1.0,9/13,54.19%,S100A11;TSPYL2;CDAN1;TERF1;PDS5A;GMNC;RAD17;GMNN;CDC6
prerank,cGMP biosynthetic process (GO:0006182),0.2656968227352332,0.5873630439920005,0.9383429672447013,1.0,1.0,2/10,14.19%,NPPC;NPR2
prerank,homologous chromosome segregation (GO:0045143),-0.20886305860140678,-0.5871659625393857,0.9653579676674365,0.9978716600220318,1.0,11/20,53.28%,FMN2;SIRT7;PTTG1;PRDM9;TERB1;MEI4;FANCD2;ZCWPW1;SGO1;MAJIN;MEIOB
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.1753649482424061,-0.5867957017870068,0.9929742388758782,0.99742558863264,1.0,18/36,49.18%,AXL;PARP14;UBE2K;MAVS;IRGM;AGPAT1;PARP9;EDN1;LAPTM5;AGPAT2;TRIM6;HSPA1A;ZBP1;TXK;CASP1;HSPA1B;CXCR4;CD300LF
prerank,eye photoreceptor cell development (GO:0042462),-0.2246147097138,-0.5849526671104273,0.9546485260770975,0.9974795489745532,1.0,8/15,49.39%,TOPORS;VEGFA;RP1;THY1;RPGRIP1;TULP1;MYO7A;RORB
prerank,chromatin assembly (GO:0031497),0.1966108062883169,0.5840063295489174,0.9826388888888888,1.0,1.0,8/38,18.79%,NAP1L4;SIRT1;RSF1;BRD2;EZH1;RBBP4;NPM1;ATRX
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.2108411760225593,0.583877895833018,0.9739583333333334,1.0,1.0,1/26,1.17%,CBL
prerank,negative regulation of transposition (GO:0010529),0.23184556277635865,0.5829714831518373,0.9625668449197861,1.0,1.0,4/16,19.15%,TUT7;TUT4;MOV10;MYBL1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.21843674615489106,0.5819271311825303,0.963963963963964,1.0,1.0,3/21,13.40%,TXNDC12;PARK7;DDIT3
prerank,respiratory electron transport chain (GO:0022904),0.23999625411717096,0.5807967695678856,0.96,1.0,1.0,3/14,12.49%,ETFA;SDHA;SLC25A12
prerank,leukocyte tethering or rolling (GO:0050901),-0.21614268209301604,-0.580694764406524,0.973741794310722,0.9984457735774879,1.0,5/17,27.00%,ROCK1;ITGA4;ADD2;PODXL2;CX3CR1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.24783677025656897,-0.5798704141615526,0.9519832985386222,0.9981642346842101,1.0,5/10,30.05%,AKT2;GPLD1;AKT1;SNCA;SLC45A3
prerank,RNA stabilization (GO:0043489),0.20158143437870674,0.5794083117380989,0.975736568457539,1.0,1.0,10/33,19.34%,TAF15;YBX1;FUS;NOCT;DKC1;ZCCHC17;PARN;NSUN2;DHX36;LARP1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.2430680394538551,-0.5792203637474639,0.9513184584178499,0.9977983681718378,1.0,7/12,31.28%,CLCN2;MBTPS2;SREBF1;DGKQ;H6PD;ABCA2;RAN
prerank,regulation of cholesterol efflux (GO:0010874),0.20427232826786795,0.5788200692987252,0.9770723104056437,1.0,1.0,3/30,7.29%,APOE;LAMTOR1;SIRT1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2331600331968514,0.5780003539877351,0.9522058823529411,1.0,1.0,6/16,19.12%,ERCC4;TNKS;SMG6;TNKS2;SMG5;DHX36
prerank,regulation of transferase activity (GO:0051338),0.22512946941238027,0.5776279492844578,0.9677996422182469,1.0,1.0,1/17,1.41%,JMJD8
prerank,regulation of interferon-alpha production (GO:0032647),-0.19844633450667903,-0.5760941927085875,0.9840909090909091,0.9982770277226434,1.0,5/23,19.51%,PTPRS;IFIH1;HSPD1;MAVS;STAT1
prerank,muscle filament sliding (GO:0030049),-0.17398421838533515,-0.5757520818108586,0.994475138121547,0.9972110746598774,1.0,3/38,10.09%,TPM1;VIM;ACTN2
prerank,actin-myosin filament sliding (GO:0033275),-0.17398421838533515,-0.5757520818108586,0.994475138121547,0.9972110746598774,1.0,3/38,10.09%,TPM1;VIM;ACTN2
prerank,regulation of mitotic spindle assembly (GO:1901673),0.22243060156647634,0.5746501647036093,0.9487666034155597,1.0,1.0,2/19,10.23%,CHMP1A;CHMP2A
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.2535364995587316,0.5744070345473824,0.9416342412451362,1.0,1.0,1/10,7.28%,SMAD7
prerank,negative regulation of cell activation (GO:0050866),0.2375320364321058,0.5732655482285695,0.9741219963031423,1.0,1.0,2/14,11.15%,APOE;NOS3
prerank,secretory granule organization (GO:0033363),0.2591028136496463,0.5731473178945589,0.9476987447698745,1.0,1.0,1/10,6.05%,DTNBP1
prerank,negative regulation of biosynthetic process (GO:0009890),-0.21471813853852575,-0.5725848375206793,0.9586956521739131,0.9977065266491175,1.0,3/16,13.86%,SLC30A10;PPARA;ABCD2
prerank,maturation of LSU-rRNA (GO:0000470),0.20581705729247382,0.5724875619514479,0.9750830564784053,0.9999103611836911,1.0,7/26,17.54%,RRP15;SNU13;WDR12;RPL35;RSL1D1;URB1;EIF6
prerank,regulation of anoikis (GO:2000209),0.2225702193143545,0.5722830254559461,0.9647266313932981,0.9994708528644984,1.0,2/19,8.03%,SRC;NOTCH1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.2411674415076951,-0.5720432910736525,0.9694501018329938,0.9972894956587288,1.0,6/11,33.10%,NOL11;SIRT7;NOP53;PIH1D1;DDX11;MTOR
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.24959457785487832,-0.5716487524797369,0.9611451942740287,0.9968211417903545,1.0,7/10,46.96%,NPLOC4;RIOK3;GPATCH3;DHX58;C1QBP;TKFC;TSPAN6
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.20687631499273731,0.5701108680244384,0.9621993127147767,0.9997252372978924,1.0,9/25,22.03%,APP;PICALM;ARF6;MTMR2;UBQLN2;RAC1;ANKRD13A;PSEN1;ATXN2
prerank,positive regulation of cholesterol efflux (GO:0010875),0.21880138750323513,0.5696403749042226,0.9664179104477612,0.9993637405435317,1.0,7/21,21.08%,APOE;SIRT1;NFKBIA;PLTP;EEPD1;NR1H3;PPARG
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.24618869431723522,-0.568051996027812,0.9466403162055336,0.9974288088395988,1.0,3/10,27.41%,SORL1;HSP90AA1;EGR1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.23959169217238926,0.5672928984605566,0.9521178637200737,0.999653872045087,1.0,2/13,9.76%,TXN;PARK7
prerank,response to fatty acid (GO:0070542),-0.20134151298304354,-0.5671601011657752,0.9775784753363229,0.9971248024744127,1.0,1/17,3.56%,PID1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.2314326421118332,0.5668313062608367,0.9638336347197106,0.9992973846395833,1.0,1/14,3.76%,NUDT5
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.24811699723826275,0.5666790102794804,0.9640831758034026,0.9983360606813997,1.0,11/11,75.21%,SYNJ2;IMPA1;INPP5B;SYNJ1;INPP5J;PTEN;IMPA2;INPP1;INPP5K;OCRL;INPP5A
prerank,inositol phosphate dephosphorylation (GO:0046855),0.24811699723826275,0.5666790102794804,0.9640831758034026,0.9983360606813997,1.0,11/11,75.21%,SYNJ2;IMPA1;INPP5B;SYNJ1;INPP5J;PTEN;IMPA2;INPP1;INPP5K;OCRL;INPP5A
prerank,tyrosine metabolic process (GO:0006570),0.24861471873710494,0.5664965442047735,0.9412878787878788,0.9978851068152113,1.0,1/11,9.16%,THAP4
prerank,ribosomal subunit export from nucleus (GO:0000054),0.23593880316793325,0.563682386557875,0.941972920696325,0.9983048995289366,1.0,6/13,21.77%,LTV1;XPO1;NPM1;EIF6;SDAD1;NMD3
prerank,ganglioside metabolic process (GO:0001573),-0.19795664323103018,-0.5636455150481006,0.9698275862068966,0.9976201799548189,1.0,10/20,35.62%,HEXA;HEXB;ST6GALNAC5;ST6GALNAC6;ST8SIA2;ST6GALNAC4;ABCA2;NEU1;ST8SIA3;ST3GAL5
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.22389593134930186,-0.5635020013741314,0.962800875273523,0.9970910977353028,1.0,7/13,34.59%,RAB23;APOD;CABP1;SUFU;NUP153;CHP1;BARD1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.22264291677441275,-0.5628157683289262,0.9661016949152542,0.996714967710217,1.0,1/14,1.93%,PKD1
prerank,regulation of chromosome organization (GO:0033044),-0.19213583847867965,-0.5613278384164276,0.9886363636363636,0.9965537429783541,1.0,4/22,17.70%,MAPT;CENPV;UPF1;YLPM1
prerank,mRNA stabilization (GO:0048255),0.1874272501731789,0.5610095860226939,0.9722675367047309,0.998685669031182,1.0,7/40,15.51%,TIRAP;HNRNPC;TARDBP;TAF15;YBX1;FUS;NOCT
prerank,replication fork processing (GO:0031297),0.1867369080213684,0.5605937197324419,0.9951219512195122,0.9983119213288922,1.0,3/38,9.68%,ZRANB3;RFWD3;EXD2
prerank,calcium ion import across plasma membrane (GO:0098703),-0.22092630672030933,-0.5581542446822967,0.9725158562367865,0.9968716640542479,1.0,6/14,37.04%,SLC24A2;CACNA2D1;TRPV2;SLC8A2;TRPM2;ATP2B4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.23088301157148525,-0.5573914093313053,0.9675324675324676,0.9959172385779592,1.0,5/11,36.62%,AGO3;RBM4;NOTCH4;TNRC6C;ZFP36
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.23088301157148525,-0.5573914093313053,0.9675324675324676,0.9959172385779592,1.0,5/11,36.62%,AGO3;RBM4;NOTCH4;TNRC6C;ZFP36
prerank,cGMP metabolic process (GO:0046068),-0.22319456744725014,-0.5571374598044626,0.9748427672955975,0.9954009077840867,1.0,4/12,26.26%,GUCY1A1;NPR1;GUCY1B1;PDE2A
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.2510512772233729,0.5564981470361554,0.9576923076923077,0.9990797364587173,1.0,10/10,74.91%,FBXW7;ADAM17;AREG;EPGN;TGFA;NCF1;BTC;EGF;HBEGF;ADRA2A
prerank,midbody abscission (GO:0061952),0.21827616676502304,0.5544826038724732,0.9617486338797814,0.9991934266250874,1.0,2/17,10.23%,CHMP1A;CHMP2A
prerank,positive regulation of immune system process (GO:0002684),-0.20390915401778673,-0.5532871341127544,0.9823008849557522,0.9958487796280521,1.0,6/16,41.21%,ANXA1;VEGFA;NCKAP1L;RSAD2;PIK3CB;TGFB2
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.2218679184609384,0.5529998643384972,0.9710144927536232,0.999120817955138,1.0,1/15,4.13%,ZFP36L1
prerank,prostanoid metabolic process (GO:0006692),0.2300088329012155,0.5513866907896445,0.9619047619047619,0.9991115348583098,1.0,3/13,15.80%,PLAA;PTGR2;HPGD
prerank,regulation of sensory perception of pain (GO:0051930),0.24010098109935102,0.5493637477408813,0.9576427255985267,0.9991805995164782,1.0,1/11,7.31%,TMEM100
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.22536095417451352,0.549134511175527,0.9568480300187617,0.9987454593602214,1.0,13/13,77.48%,PCID2;LCMT1;CDK5RAP2;USP44;TPR;CCNB1;XRCC3;NDC80;GEN1;MAD2L1;DYNC1LI1;ANAPC15;DUSP1
prerank,female gamete generation (GO:0007292),-0.17390021993305854,-0.54758450836402,0.9880382775119617,0.9968152470554261,1.0,2/29,5.66%,DIAPH2;FMN2
prerank,phospholipid catabolic process (GO:0009395),0.2037034533921966,0.5457207157142201,0.9833055091819699,0.9991542209806024,1.0,3/24,14.23%,SMPD4;ABHD12;PNPLA6
prerank,protein deneddylation (GO:0000338),-0.23364344332620096,-0.5433270522212338,0.9528487229862476,0.9972868242805702,1.0,6/10,38.79%,COPS2;COPS5;COPS7A;TOR1A;COPS6;GPS1
prerank,negative regulation of cation channel activity (GO:2001258),0.1971138456287204,0.5426949341346247,0.9847457627118644,0.999482978761567,1.0,5/26,18.82%,CALM3;KCNAB1;UBQLN1;FKBP1A;CALM1
prerank,endoderm development (GO:0007492),0.22536095417451363,0.5423575776142826,0.965183752417795,0.9990611446835378,1.0,13/13,77.48%,SOX17;KIF16B;APELA;EOMES;GATA4;DUSP2;DUSP5;TBX20;DUSP4;LHX1;LAMC1;SOX7;DUSP1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.20396957854320275,0.5390059329827541,0.9769911504424779,0.999412924034163,1.0,3/20,11.27%,TXN;P2RX7;APP
prerank,oxoacid metabolic process (GO:0043436),-0.17593708428535604,-0.5384292283043108,0.9976359338061466,0.9978316434799283,1.0,2/27,5.42%,DDO;ENPP1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.23291343784845525,-0.5380553866092701,0.9793388429752066,0.9973440148236149,1.0,6/10,43.18%,FN1;GATA6;CD24;TSKU;TYROBP;CDH3
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.2321088648618908,-0.5359148325902499,0.9706457925636007,0.9972221885423632,1.0,5/10,37.76%,SRI;PDE4B;CACNA2D1;NIPSNAP2;CACNB3
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.2057780511088918,-0.5356434030486706,0.9828693790149893,0.9967071996227457,1.0,4/14,33.41%,IL18;IL17D;CD80;PAEP
prerank,lymphocyte mediated immunity (GO:0002449),0.22879118983940672,0.5352551530596797,0.9602272727272727,0.9998045427831763,1.0,3/12,20.23%,CD55;CD46;BTN3A3
prerank,inositol phosphate catabolic process (GO:0071545),-0.21233143112636121,-0.5342677615935281,0.9810126582278481,0.9964143248011991,1.0,6/12,36.35%,NUDT3;INPP5A;OCRL;INPP5K;INPP1;IMPA2
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.2318449292677311,0.534184561500352,0.9698681732580038,0.9995735469003516,1.0,1/11,7.28%,SMAD7
prerank,double-strand break repair via break-induced replication (GO:0000727),0.22641390998681837,0.5340085858112871,0.9662921348314607,0.9991087115861044,1.0,12/12,77.38%,CDC45;MCM2;GINS2;MCM5;MCM7;MCM3;GINS4;MCMDC2;MUS81;MCM4;CDC7;MCM6
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.2139705649954356,0.5339833745259125,0.967032967032967,0.9986146994570864,1.0,2/15,10.80%,NLRC3;DDX3X
prerank,regulation of interleukin-17 production (GO:0032660),0.18172949919535625,0.5305632558283455,0.9947552447552448,0.9988887867244921,1.0,4/31,17.21%,VSIR;PRNP;DDIT3;SLC7A5
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.1896342610012156,-0.5301299597172844,0.9912472647702407,0.9967196016262607,1.0,5/19,25.13%,IFIH1;HSPD1;MAVS;STAT1;TLR3
prerank,L-serine metabolic process (GO:0006563),0.23988766961680028,0.5296766890975779,0.9671179883945842,0.9985707835080818,1.0,2/10,11.35%,SERINC5;SERINC3
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.1833831505299647,0.528390140669167,0.9881756756756757,0.9983614758156826,1.0,1/29,2.58%,CXCL12
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.22080179955279652,-0.5283316812284926,0.979296066252588,0.9964946845242463,1.0,5/11,31.84%,VCP;UGGT2;BAG6;RNF185;TOR1A
prerank,androgen metabolic process (GO:0008209),0.20772143582899408,0.5279273313424562,0.9852941176470589,0.997968047247362,1.0,2/18,11.74%,HSD17B11;HSD17B4
prerank,neutrophil activation (GO:0042119),0.2296745275850927,0.5275709712125781,0.9596330275229358,0.997543623764155,1.0,1/12,6.70%,SYK
prerank,regulation of multicellular organismal development (GO:2000026),0.188625354913832,0.5233001518228905,0.9841549295774648,0.9979698796349735,1.0,5/25,19.12%,TDG;RAB14;SOX17;INSR;DHX36
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.22665433481189726,-0.5223699525196981,0.9832635983263598,0.9970436576428369,1.0,1/10,4.76%,KIT
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.15055130807969416,-0.5200161885516636,1.0,0.9968955413214073,1.0,21/45,47.58%,MALT1;AIM2;USP50;GBP5;GSDMD;HSPB1;PANX1;TRIM16;EGR1;TMEM106A;LPL;TYROBP;CASP8;CCL19;NOD2;PYCARD;MYD88;TLR4;CASP1;FZD5;AGER
prerank,oogenesis (GO:0048477),0.2066367559068401,0.5186495903669022,0.9764065335753176,0.9983879835263678,1.0,2/15,11.16%,MARF1;NANOS3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.18960326152389337,0.5185504963398725,0.9965095986038395,0.9979085707770259,1.0,5/22,18.10%,UBAP1;VPS37B;PLAA;VPS37C;VPS4B
prerank,calcium ion import into cytosol (GO:1902656),-0.20398503556507586,-0.5147204401731317,0.9827213822894169,0.9971906566339681,1.0,6/15,37.04%,SLC24A2;CACNA2D1;TRPV2;SLC8A2;TRPM2;ATP2B4
prerank,mitotic sister chromatid cohesion (GO:0007064),0.20786203048628554,0.513844347837163,0.9838420107719928,0.9983176615998197,1.0,1/16,3.93%,BOD1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.20701594137333906,-0.5137318328816483,0.9874476987447699,0.9967720971931672,1.0,3/13,24.34%,ENPP1;BPNT1;ABHD14B
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.19849293563579284,0.5101428612946097,0.9932088285229203,0.9985053561690848,1.0,18/18,80.17%,ALKBH7;BAD;BNIP3;SLC25A4;TMEM102;SLC25A31;HEBP2;NAIF1;PMAIP1;PPIF;BAK1;MUL1;SLC25A5;BCL2L1;CAMK2A;BCL2;THEM4;SPG7
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.1654648373769917,-0.5034389535430153,0.9975609756097561,0.997737310492019,1.0,7/26,29.10%,SLC30A10;PPARA;ABCD2;SLC25A33;GRIN1;SLC5A3;SNCA
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.16794606013368765,-0.5012655605620199,0.9955257270693513,0.9974726742326162,1.0,9/22,33.10%,NOL11;WDR43;ATF4;UTP15;EIF2AK3;ERBB2;PIH1D1;DDX11;MTOR
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.20721891109737364,-0.49995326993006206,0.9812889812889813,0.9970926034659802,1.0,3/11,27.27%,BMP4;BMPR1A;ZFPM2
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.2141772435859992,-0.4987691368183034,0.9880715705765407,0.9966633038867843,1.0,7/10,41.69%,ACAD11;ETFB;ACADS;ACADVL;IVD;ACADM;GCDH
prerank,outer dynein arm assembly (GO:0036158),0.20609111731757895,0.49711127786599457,0.988929889298893,1.0,1.0,1/14,6.62%,DNAL1
prerank,zymogen activation (GO:0031638),0.16420106390975203,0.4967126537193166,0.9933665008291874,0.9997283472642075,1.0,5/39,14.38%,OMA1;VSIR;BAD;PLAT;GRIN2A
prerank,positive regulation of interleukin-6 production (GO:0032755),0.14678938887775803,0.4947471531552259,0.9984639016897081,0.9995158811689873,1.0,5/68,11.27%,TIRAP;RAB7B;SYK;WNT5A;APP
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.20037487969131773,-0.49467656733703363,0.9875259875259875,0.9966322651609326,1.0,9/12,46.43%,SRR;MTHFD1;PSPH;PSAT1;CBS;PHGDH;SEPHS2;CTH;GGT1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.19111840777894393,-0.484774654273626,0.9956427015250545,0.9972370587607525,1.0,4/13,22.98%,NFU1;MMS19;ISCA1;CIAO1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.17846193560325457,0.4837667052245928,0.9927667269439421,1.0,1.0,2/22,7.13%,CIAPIN1;ISCU
prerank,lipoxygenase pathway (GO:0019372),0.19913365559671037,0.48272761834589145,0.9905838041431262,1.0,1.0,14/14,80.10%,HPGD;ALOX12B;ALOX15;GPX4;PON3;PON1;LTC4S;PON2;ALOX5;ALOXE3;ALOX5AP;ALOX12;GPX1;PTGS2
prerank,meiosis I (GO:0007127),0.17589052299160512,0.48131036190745696,0.9928825622775801,0.9998510943675704,1.0,21/23,57.77%,ING2;FOXJ3;ZSCAN21;MYBL1;BRDT;BTBD18;MEIOC;DNMT3L;MEI1;CCNA1;MEIKIN;MOV10L1;FOXJ2;SLC25A31;MEIOB;DDX4;TDRD9;SGO1;SYCP3;ZCWPW1;HSF2BP
prerank,defense response to protozoan (GO:0042832),0.208088187578099,0.4777559930662249,0.9903100775193798,0.9997737436434797,1.0,1/12,6.26%,GBP4
prerank,mitochondrial RNA metabolic process (GO:0000959),0.19618306233913,0.4715287720478141,0.9833024118738405,0.9999540918919635,1.0,14/14,80.40%,EARS2;TFAM;TFB1M;TFB2M;PNPT1;FASTKD5;TWNK;POLRMT;TEFM;MRPL12;MTERF2;FOXO3;SLC25A33;FASTKD1
prerank,response to glucocorticoid (GO:0051384),0.1726803873690953,0.4707653308204198,0.9945750452079566,0.9995384107118978,1.0,1/26,4.13%,ZFP36L1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.20278222548043406,-0.46540950676953885,0.9938271604938271,0.9985313862151404,1.0,1/10,13.42%,IL33
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.17731826950578664,-0.46506228238442665,0.9928400954653938,0.997978363884418,1.0,4/15,25.09%,RIOK2;PTTG1;HECW2;CDC27
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.1713567839195979,0.4607384304298618,0.9982363315696648,1.0,1.0,23/23,82.89%,ELOVL6;HPGD;ALOX12B;ALOX15;GPX4;ACSBG2;GSTP1;LTC4S;CYP1A1;GSTM4;CYP2E1;ALOX5;ALOXE3;ASAH2;LTA4H;ALOX12;ACSBG1;GSTM2;FADS1;EPHX2;GSTM1;PTGS2;ACOT7
prerank,sensory perception of pain (GO:0019233),0.17363354972889314,0.45405221329994216,0.9982638888888888,1.0,1.0,2/21,10.95%,MME;P2RX7
prerank,negative regulation of immune effector process (GO:0002698),0.1874424318529031,0.44778437004240945,0.9890310786106032,1.0,1.0,4/13,20.45%,CD47;CD55;RC3H1;GRN
prerank,DNA catabolic process (GO:0006308),0.19487900215793508,0.44450775614198423,0.9908925318761385,0.9998062813781865,1.0,2/11,18.52%,XRN2;FBH1
prerank,superoxide anion generation (GO:0042554),-0.17577691335733658,-0.4402187690996696,0.9977876106194691,0.9989566832531923,1.0,9/13,60.93%,NOX4;NCF2;ALOX12;CYBB;TAFA4;NCF1;NOX3;NCF4;DUOX1
prerank,regulation of phosphate metabolic process (GO:0019220),0.1686599487452874,0.42656066860659836,0.994661921708185,1.0,1.0,6/16,21.48%,IKBKB;SMG6;SMG5;IGBP1;SMG7;PSEN1
prerank,pseudouridine synthesis (GO:0001522),-0.16719602870005548,-0.42214944950783534,1.0,0.9992207403748632,1.0,10/13,50.82%,PUS7;TRUB1;PUS3;GAR1;NOP10;PUS1;PUS7L;NHP2;PUSL1;RPUSD2
prerank,purine nucleotide catabolic process (GO:0006195),0.17781642410404788,0.418018016351131,0.9927404718693285,1.0,1.0,2/13,12.02%,PNP;NT5C2
prerank,toxin transport (GO:1901998),0.18478061159191542,0.4084728479635762,1.0,1.0,1.0,2/10,15.84%,RAB40B;ANTXR1
prerank,inorganic ion transmembrane transport (GO:0098660),0.1699241688285244,0.4016431170007352,1.0,0.9999597025662723,1.0,1/12,10.54%,TRPM4
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.12925695909907656,0.3658946412138015,0.99822695035461,1.0,1.0,4/29,15.51%,TAF15;YBX1;FUS;NOCT
prerank,positive regulation of interleukin-1 production (GO:0032732),0.11386359319832487,0.3645404355889467,1.0,0.9997343397556285,1.0,4/51,11.27%,TMED10;WNT5A;P2RX7;APP
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.11602150076932682,-0.34232495383810496,1.0,0.9999407688592603,1.0,1/22,5.12%,CBFB
